data_2l0d_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2l0d _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.417 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 16.6 tt . . . . . 0 N--CA 1.451 -0.382 0 N-CA-C 110.301 -0.259 . . . . 0.0 110.301 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.493 ' HB3' ' HB2' ' A' ' 35' ' ' SER . 12.4 Cg_exo -69.84 116.99 4.82 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.17 1.913 . . . . 0.0 111.24 175.344 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -103.16 79.94 1.79 Allowed 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 178.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.496 ' O ' ' HA ' ' A' ' 98' ' ' ASN . 61.9 mt -73.27 103.42 3.96 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.775 -173.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.534 HG21 ' HB3' ' A' ' 97' ' ' ASN . 47.1 t -114.27 111.4 47.21 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.511 -176.5 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.574 ' HD2' ' O ' ' A' ' 97' ' ' ASN . 18.2 Cg_endo -64.03 107.44 0.78 Allowed 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 122.057 1.838 . . . . 0.0 110.046 167.37 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.0 t -82.51 -55.74 7.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.126 -170.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 58.6 p -141.44 158.3 44.04 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.182 -177.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.473 HD22 HD22 ' A' ' 80' ' ' LEU . 54.0 tp -130.24 104.42 7.28 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.021 177.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 22.0 p -115.02 146.18 35.64 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.216 -175.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -78.99 152.64 89.12 Favored 'Cis proline' 0 C--N 1.341 0.183 0 C-N-CA 123.186 -1.589 . . . . 0.0 112.562 -0.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.2 m -73.57 -19.77 18.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.045 0.45 . . . . 0.0 111.206 -178.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.449 ' HB ' HD11 ' A' ' 107' ' ' LEU . 0.2 OUTLIER -126.37 128.35 46.91 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 177.178 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.46 ' HB ' ' ND2' ' A' ' 21' ' ' ASN . 18.7 m -114.13 140.14 36.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -167.447 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.429 ' HA ' ' HD3' ' A' ' 17' ' ' PRO . 5.8 m -84.17 121.4 75.49 Favored Pre-proline 0 N--CA 1.449 -0.512 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.098 176.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.438 ' HA ' ' CB ' ' A' ' 71' ' ' LEU . 4.6 Cg_exo -77.97 55.75 5.42 Favored 'Trans proline' 0 N--CA 1.463 -0.269 0 C-N-CA 123.006 2.471 . . . . 0.0 111.667 176.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -122.97 -18.26 6.48 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.161 -0.472 . . . . 0.0 112.042 -176.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 14.7 t -157.25 -173.96 4.67 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.736 -0.386 . . . . 0.0 110.938 -171.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 46.7 t -82.32 110.11 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 169.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.46 ' ND2' ' HB ' ' A' ' 15' ' ' VAL . 5.1 m-20 -84.38 108.23 17.09 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.309 0.576 . . . . 0.0 110.702 -169.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.618 ' HA ' ' O ' ' A' ' 67' ' ' PHE . 11.3 m -79.41 83.44 5.43 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.256 -0.883 . . . . 0.0 109.355 176.341 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.513 ' HE3' HG11 ' A' ' 104' ' ' VAL . 82.8 mtp -79.5 152.21 30.34 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.41 -0.813 . . . . 0.0 110.403 -176.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 30.8 m -114.11 109.58 18.65 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.065 -175.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.419 ' HB3' ' HB ' ' A' ' 65' ' ' VAL . . . -92.14 120.09 32.41 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.548 173.585 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 61.2 m -92.76 101.29 13.68 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-O 121.12 0.486 . . . . 0.0 109.769 -179.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 15.3 mm -95.17 118.98 42.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.246 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -113.74 125.15 53.79 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.481 ' HB2' ' HG ' ' A' ' 57' ' ' LEU . 29.6 t30 -81.78 90.03 6.35 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.607 178.604 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -87.11 43.99 1.14 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.559 0.695 . . . . 0.0 110.788 -173.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -143.98 145.07 14.37 Favored Glycine 0 N--CA 1.442 -0.956 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 176.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -81.17 63.65 5.6 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.526 0.679 . . . . 0.0 111.039 -173.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 50.6 tptt -161.5 121.31 2.57 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.056 171.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -69.06 124.09 22.83 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.985 0.421 . . . . 0.0 110.567 -175.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.493 ' HB2' ' HB3' ' A' ' 3' ' ' PRO . 46.4 t -87.7 147.01 25.42 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.19 -174.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 21.7 p -86.54 -163.0 0.83 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.444 178.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.448 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 15.0 m -61.68 134.09 56.37 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 120.929 0.395 . . . . 0.0 111.338 -179.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.514 ' CE1' ' HB ' ' A' ' 54' ' ' VAL . 31.1 p90 -144.9 144.35 31.05 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.294 -177.339 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.486 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 25.7 m-80 -92.62 108.67 20.16 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.219 -174.272 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.428 HG21 ' HA ' ' A' ' 84' ' ' VAL . 2.1 t -98.29 116.75 41.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 121.392 0.615 . . . . 0.0 110.289 178.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 46.3 m -109.95 144.14 38.9 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.689 -177.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 46.9 tp -98.68 108.66 21.41 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.697 175.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.476 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 5.2 mp -98.93 108.45 21.13 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.427 -179.047 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 82.4 t -88.96 101.48 12.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 60.06 18.43 7.67 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.422 -179.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 124.49 -36.04 3.02 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.785 178.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.468 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 9.8 mm -79.81 145.55 9.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.905 0.383 . . . . 0.0 110.096 -176.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.405 HG23 ' HG ' ' A' ' 43' ' ' LEU . 40.8 t -96.96 101.75 12.65 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.824 -178.036 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 28.4 m -83.59 -30.78 8.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.615 -175.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 33.7 t0 -159.56 141.37 13.19 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.915 -0.314 . . . . 0.0 111.002 -177.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 88.6 m -129.07 123.36 32.05 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.308 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -127.3 105.69 8.71 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 -178.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.486 ' HA ' ' HA ' ' A' ' 39' ' ' ASN . 7.1 t -74.52 131.02 40.64 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.068 0.461 . . . . 0.0 110.38 178.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.514 ' HB ' ' CE1' ' A' ' 38' ' ' PHE . 39.1 t -95.28 138.57 20.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.774 -179.288 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.0 m -55.07 -43.28 73.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.246 -0.434 . . . . 0.0 112.039 -177.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 47.7 t -174.76 153.51 1.77 Allowed 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 -175.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.481 ' HG ' ' HB2' ' A' ' 29' ' ' ASN . 27.6 tp -134.15 109.5 8.95 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.16 0.505 . . . . 0.0 110.066 177.092 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.448 ' HB2' ' HB3' ' A' ' 61' ' ' ASN . 35.9 mt-10 -70.98 158.78 35.92 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.542 -0.754 . . . . 0.0 112.154 -174.278 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 12.3 p -64.12 122.98 17.88 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.095 179.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 65.09 20.2 11.98 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.453 179.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.448 ' HB3' ' HB2' ' A' ' 58' ' ' GLU . 61.1 t30 -116.62 155.2 29.17 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 176.036 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 2.4 m -115.28 145.66 42.25 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.657 0.265 . . . . 0.0 110.752 -175.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 13.3 t -119.2 143.85 47.04 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 175.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -96.05 112.03 23.88 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.873 0.368 . . . . 0.0 110.261 178.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.419 ' HB ' ' HB3' ' A' ' 25' ' ' ALA . 13.2 t -96.86 118.13 42.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.911 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.444 ' HA ' ' O ' ' A' ' 23' ' ' MET . 5.3 p-10 -95.13 119.67 34.04 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.512 0.672 . . . . 0.0 110.559 -179.227 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.618 ' O ' ' HA ' ' A' ' 22' ' ' THR . 33.2 m-85 -95.67 146.8 24.22 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.726 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 15.2 m80 -110.73 90.27 3.28 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.663 -0.698 . . . . 0.0 109.485 -178.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 12.5 t90 -123.62 113.67 18.99 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.389 0.614 . . . . 0.0 111.416 -172.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 49.7 m -78.22 114.67 17.33 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.351 -0.841 . . . . 0.0 110.282 174.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.438 ' CB ' ' HA ' ' A' ' 17' ' ' PRO . 1.0 OUTLIER -63.54 118.78 8.66 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.326 0.584 . . . . 0.0 111.145 178.358 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -83.56 -36.74 23.75 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.03 -178.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 83.19 17.91 65.92 Favored Glycine 0 N--CA 1.449 -0.475 0 N-CA-C 110.99 -0.844 . . . . 0.0 110.99 -174.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 3.9 p -68.99 -29.75 68.02 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.23 -0.485 . . . . 0.0 111.332 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -145.44 168.86 19.54 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.075 -179.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 49.5 m-80 -96.98 -15.09 21.26 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.397 0.618 . . . . 0.0 109.649 178.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 20.4 m -131.97 126.6 34.4 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.781 177.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -115.12 132.88 56.46 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 177.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.454 ' HA ' HD21 ' A' ' 103' ' ' LEU . 4.3 m -90.49 83.66 5.89 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.124 0.488 . . . . 0.0 109.773 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.473 HD22 HD22 ' A' ' 10' ' ' LEU . 7.7 mp -81.41 117.2 21.66 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.515 0.674 . . . . 0.0 110.762 -176.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.551 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 32.7 m -113.85 110.61 20.39 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.545 -177.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 60.9 t -85.55 99.69 7.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 176.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -95.64 109.38 21.64 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 178.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.462 HG11 ' CD2' ' A' ' 38' ' ' PHE . 83.3 t -75.42 102.96 2.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.445 -179.595 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.0 t70 51.76 82.61 0.24 Allowed Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 114.431 -1.258 . . . . 0.0 111.427 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -64.41 -11.34 27.85 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.871 2.38 . . . . 0.0 111.923 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -87.64 -14.86 38.87 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.081 178.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 24.0 m120 56.12 43.47 26.83 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.886 -178.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.05 -34.57 77.87 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.384 0.611 . . . . 0.0 110.09 177.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 39.5 t -111.42 98.75 7.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 172.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -59.06 112.29 1.63 Allowed 'General case' 0 C--O 1.235 0.311 0 O-C-N 123.35 0.406 . . . . 0.0 110.619 -173.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.446 ' HA ' ' O ' ' A' ' 3' ' ' PRO . 3.8 mp0 -82.41 166.93 18.98 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.705 -174.007 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -58.05 -100.83 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.395 0 CA-C-N 114.919 -1.037 . . . . 0.0 113.33 176.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.408 ' HB3' ' CG ' ' A' ' 97' ' ' ASN . 53.0 t30 -76.21 141.77 41.69 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 122.626 -0.338 . . . . 0.0 110.836 -177.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -59.87 -43.1 94.9 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.979 -173.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 20.1 m -89.78 3.22 53.52 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.827 -174.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.574 ' O ' ' HD2' ' A' ' 7' ' ' PRO . 5.9 m-20 -85.97 -24.4 26.52 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 -175.286 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.496 ' HA ' ' O ' ' A' ' 5' ' ' LEU . 13.8 p-10 -82.04 -5.34 58.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.007 0.432 . . . . 0.0 111.341 -174.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 4.9 m -116.17 152.27 34.04 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.066 0.46 . . . . 0.0 110.727 -178.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.551 ' O ' ' HA ' ' A' ' 81' ' ' THR . 56.0 tp -140.66 103.63 4.56 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.84 179.18 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 15.7 m -98.83 104.5 16.54 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.123 177.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -132.48 135.72 46.21 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.895 0.378 . . . . 0.0 111.035 -178.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.454 HD21 ' HA ' ' A' ' 79' ' ' THR . 82.4 mt -80.21 127.09 31.94 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.752 177.204 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.513 HG11 ' HE3' ' A' ' 23' ' ' MET . 32.7 m -109.13 134.72 50.23 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 172.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -105.16 170.92 18.23 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.04 -1.076 . . . . 0.0 111.038 -177.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 25.0 p -85.54 125.74 33.32 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 117.485 0.642 . . . . 0.0 109.821 175.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.449 HD11 ' HB ' ' A' ' 14' ' ' THR . 30.2 tp . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.608 -174.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.449 -0.494 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.4 ' HD2' ' O ' ' A' ' 91' ' ' ASN . 72.4 Cg_endo -83.79 156.84 13.75 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 122.023 1.815 . . . . 0.0 111.175 172.242 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -139.3 113.72 9.01 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 -178.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.512 HD22 HD21 ' A' ' 57' ' ' LEU . 31.5 mt -99.83 126.88 46.0 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -173.079 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.542 ' O ' ' HA ' ' A' ' 27' ' ' ILE . 8.4 t -124.91 140.22 35.3 Favored Pre-proline 0 C--N 1.318 -0.787 0 C-N-CA 120.341 -0.544 . . . . 0.0 110.263 -176.061 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.445 ' HB2' ' HB2' ' A' ' 100' ' ' LEU . 12.2 Cg_endo -96.52 98.18 0.09 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.57 0 C-N-CA 123.548 2.832 . . . . 0.0 109.733 167.05 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 26.2 m -80.37 -28.26 11.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.53 -167.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.3 t -165.71 158.9 15.76 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-O 120.816 0.341 . . . . 0.0 111.166 -177.083 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.48 HD11 ' HE3' ' A' ' 23' ' ' MET . 29.9 tp -127.6 126.58 42.34 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.298 175.285 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 62.5 p -122.21 131.53 24.39 Favored Pre-proline 0 C--N 1.319 -0.718 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.587 179.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.652 ' HD2' ' SD ' ' A' ' 23' ' ' MET . 95.8 Cg_endo -92.02 175.01 17.81 Favored 'Cis proline' 0 N--CA 1.455 -0.753 0 C-N-CA 123.742 -1.357 . . . . 0.0 112.947 1.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 17.6 m -91.13 -10.42 9.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-O 121.347 0.594 . . . . 0.0 110.599 178.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.531 ' HA ' ' O ' ' A' ' 105' ' ' GLY . 0.8 OUTLIER -120.05 151.14 39.45 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.155 174.574 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 17.1 m -143.06 157.25 17.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.217 0.532 . . . . 0.0 111.788 -176.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.681 HG12 ' H ' ' A' ' 18' ' ' ASN . 21.8 t -99.27 132.05 24.05 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.454 -0.793 . . . . 0.0 110.287 179.092 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.507 ' HA ' ' HG ' ' A' ' 71' ' ' LEU . 95.9 Cg_endo -92.62 11.3 2.2 Favored 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 122.834 2.356 . . . . 0.0 112.65 177.085 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.681 ' H ' HG12 ' A' ' 16' ' ' VAL . 66.6 m-20 -100.6 -14.26 18.25 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.141 -175.15 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 9.1 t -158.75 173.7 16.15 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 -175.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 54.9 t -69.54 133.1 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 CA-C-O 121.64 0.733 . . . . 0.0 109.752 176.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -114.22 133.47 55.6 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 114.638 -1.165 . . . . 0.0 108.927 -176.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 18.1 m -107.8 118.76 37.57 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-O 122.444 1.116 . . . . 0.0 108.693 -170.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.652 ' SD ' ' HD2' ' A' ' 12' ' ' PRO . 97.3 mmm -109.04 123.49 49.23 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 112.868 -1.969 . . . . 0.0 110.794 -162.712 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 23.2 m -111.91 124.57 52.67 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 121.865 0.841 . . . . 0.0 109.793 -176.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -119.39 132.52 55.85 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.075 -1.42 . . . . 0.0 108.445 -175.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 45.4 m -112.31 121.01 43.68 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 121.93 0.871 . . . . 0.0 110.064 -168.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.542 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 9.4 mm -116.53 120.02 63.7 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 CA-C-N 114.001 -1.454 . . . . 0.0 109.123 -172.151 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -118.79 128.69 54.71 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 -177.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 31.2 t30 -83.82 95.04 8.33 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 177.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -95.51 57.15 1.89 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.183 -174.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -144.1 168.07 26.66 Favored Glycine 0 N--CA 1.442 -0.928 0 CA-C-N 114.879 -1.055 . . . . 0.0 110.669 178.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 44.8 m-80 -75.71 -21.34 57.64 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 111.77 0.285 . . . . 0.0 111.77 -174.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 61.7 tttp -101.32 138.55 38.19 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.944 0.402 . . . . 0.0 111.029 -177.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.403 ' HA ' ' HB3' ' A' ' 59' ' ' SER . 2.4 t70 -76.99 140.05 40.28 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.745 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 13.9 p -105.74 155.76 18.96 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.03 0.443 . . . . 0.0 111.65 -175.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 12.6 p -99.1 -161.56 0.88 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.258 -177.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 9.8 m -53.76 136.3 40.07 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 122.656 0.383 . . . . 0.0 111.638 178.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.492 ' CE1' ' HB2' ' A' ' 57' ' ' LEU . 18.2 p90 -149.44 147.04 27.77 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 177.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.563 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 42.4 t-20 -101.2 125.46 47.82 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.439 0.162 . . . . 0.0 110.673 -176.137 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.513 HG23 ' HA ' ' A' ' 84' ' ' VAL . 2.7 t -111.28 127.02 68.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 121.185 0.517 . . . . 0.0 110.013 -179.198 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 19.5 m -119.88 144.08 47.59 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.662 -177.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 58.3 tp -100.11 112.7 25.0 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.874 178.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.414 ' HG ' HG23 ' A' ' 48' ' ' VAL . 5.0 mp -101.57 121.74 42.54 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.834 -178.592 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 89.1 t -97.27 115.33 36.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 172.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 25.5 t70 67.98 -75.02 0.07 Allowed 'General case' 0 N--CA 1.469 0.509 0 O-C-N 123.736 0.648 . . . . 0.0 110.739 -174.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -158.89 17.22 0.26 Allowed Glycine 0 N--CA 1.448 -0.554 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.8 178.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 9.9 mt -123.64 149.83 27.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.414 HG23 ' HG ' ' A' ' 43' ' ' LEU . 40.0 t -93.33 122.43 44.82 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 -177.614 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 26.5 m -96.95 -28.99 3.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.351 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 37.2 t0 -149.53 151.21 33.51 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 120.768 0.318 . . . . 0.0 110.441 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 21.9 m -144.13 121.84 11.88 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.954 -174.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -135.45 125.11 25.27 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.779 0.323 . . . . 0.0 110.555 -179.229 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.563 ' HA ' ' HA ' ' A' ' 39' ' ' ASN . 23.8 m -85.5 122.78 30.12 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.252 177.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 20.1 t -86.59 136.38 23.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 -179.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 14.6 m -55.28 -51.81 65.47 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 123.494 0.496 . . . . 0.0 111.844 -176.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 8.4 t -176.87 130.86 0.18 Allowed 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.512 HD21 HD22 ' A' ' 5' ' ' LEU . 21.1 tp -96.1 112.64 24.31 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.322 0.582 . . . . 0.0 110.088 177.442 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -71.82 144.62 49.06 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.542 -0.753 . . . . 0.0 110.577 -178.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.403 ' HB3' ' HA ' ' A' ' 34' ' ' ASP . 8.5 p -61.52 132.77 54.47 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.883 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 72.66 1.13 3.88 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.223 177.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -108.17 149.6 28.32 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 2.6 p -111.44 123.19 49.71 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.063 0.458 . . . . 0.0 110.789 -178.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 27.9 m -104.05 135.86 44.76 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.725 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -94.77 128.48 41.51 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.562 179.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 40.2 t -96.16 115.79 36.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.418 -179.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -84.07 101.11 11.54 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.594 179.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.462 ' CZ ' HG12 ' A' ' 40' ' ' VAL . 8.0 m-85 -100.47 148.62 24.56 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.015 0.436 . . . . 0.0 111.143 178.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 33.1 m-70 -120.05 107.87 13.6 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 178.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 14.4 t90 -115.97 118.73 33.73 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.342 0.591 . . . . 0.0 111.205 -172.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 4.6 m -88.7 113.48 24.31 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 168.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.507 ' HG ' ' HA ' ' A' ' 17' ' ' PRO . 0.1 OUTLIER -44.64 -40.54 5.93 Favored 'General case' 0 N--CA 1.469 0.516 0 O-C-N 123.898 0.748 . . . . 0.0 112.167 -169.669 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 15.9 t70 77.52 -53.9 0.53 Allowed 'General case' 0 N--CA 1.468 0.45 0 O-C-N 123.792 0.682 . . . . 0.0 111.035 175.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -117.21 -155.92 10.34 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 121.017 -0.611 . . . . 0.0 111.61 176.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 33.0 m -153.26 91.88 1.55 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.158 0.504 . . . . 0.0 110.47 177.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.453 ' H ' ' HE2' ' A' ' 78' ' ' TYR . . . -126.25 147.6 49.65 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.354 177.263 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -63.94 -27.14 68.94 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.227 0.454 . . . . 0.0 112.227 -173.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 38.4 m -145.67 119.26 9.12 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.058 0.456 . . . . 0.0 111.185 -179.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.453 ' HE2' ' H ' ' A' ' 75' ' ' ALA . 26.5 m-85 -105.74 141.67 36.77 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.177 177.309 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 21.9 m -93.43 100.02 12.4 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.056 178.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.411 HD12 HG23 ' A' ' 104' ' ' VAL . 8.6 mp -100.43 125.07 46.67 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.274 0.559 . . . . 0.0 110.519 -178.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.516 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 32.4 m -121.24 115.69 23.48 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.938 -176.494 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 92.9 t -86.94 108.6 18.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.685 175.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -101.8 121.19 41.62 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 176.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.513 ' HA ' HG23 ' A' ' 40' ' ' VAL . 77.8 t -87.58 108.8 18.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.187 -176.605 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 46.2 t0 61.61 85.25 0.18 Allowed Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 114.555 -1.202 . . . . 0.0 111.701 178.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -72.45 -4.36 15.12 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.732 2.288 . . . . 0.0 112.088 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -99.52 -15.87 18.51 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 177.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 48.04 71.89 0.31 Allowed 'General case' 0 C--O 1.233 0.201 0 CA-C-N 114.647 -1.16 . . . . 0.0 110.911 -177.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.06 -32.12 16.85 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.251 177.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 22.0 t -89.28 134.02 29.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.658 176.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.4 ' O ' ' HD2' ' A' ' 3' ' ' PRO . 58.1 t30 -78.04 99.19 6.01 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 177.577 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -89.95 156.1 18.66 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.899 -171.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -57.47 -100.88 0.01 OUTLIER Glycine 0 CA--C 1.518 0.231 0 CA-C-N 115.088 -0.96 . . . . 0.0 112.78 171.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.607 ' HB2' ' HB3' ' A' ' 97' ' ' ASN . 78.9 m-20 -83.76 123.41 29.84 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 120.847 -0.341 . . . . 0.0 110.733 -178.088 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -72.67 -15.92 61.7 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.651 0.739 . . . . 0.0 109.724 176.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -89.03 7.18 36.19 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.826 176.141 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.607 ' HB3' ' HB2' ' A' ' 94' ' ' ASN . 1.7 t30 -116.98 -28.86 6.15 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -173.291 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 20.2 p-10 -75.69 10.99 1.47 Allowed 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.065 0.46 . . . . 0.0 111.86 -173.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -126.38 143.64 51.1 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.799 0.333 . . . . 0.0 110.399 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.516 ' O ' ' HA ' ' A' ' 81' ' ' THR . 44.1 tp -128.73 104.65 7.76 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.472 179.552 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 53.0 m -92.05 106.39 18.42 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 174.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -121.72 153.54 38.09 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.537 -177.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 88.7 mt -104.38 124.02 48.47 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.001 0.429 . . . . 0.0 110.481 179.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.411 HG23 HD12 ' A' ' 80' ' ' LEU . 22.4 m -116.17 132.42 65.77 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.618 178.534 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.531 ' O ' ' HA ' ' A' ' 14' ' ' THR . . . -110.96 166.27 12.27 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.423 -0.894 . . . . 0.0 112.01 -175.575 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 18.4 p -68.22 135.49 52.09 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.745 0.273 . . . . 0.0 110.275 177.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 61.9 tp . . . . . 0 C--N 1.327 -0.388 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.589 -176.827 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.406 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 7.5 tp . . . . . 0 CA--C 1.537 0.458 0 CA-C-O 120.488 0.185 . . . . 0.0 110.845 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.53 ' HG3' ' HD3' ' A' ' 33' ' ' LYS . 6.5 Cg_endo -88.58 174.03 4.26 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 123.146 2.564 . . . . 0.0 112.128 173.092 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -151.42 105.91 3.23 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 179.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.528 ' O ' ' HA ' ' A' ' 98' ' ' ASN . 96.9 mt -99.57 103.3 15.01 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.192 0.52 . . . . 0.0 111.473 -168.611 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.517 HG21 ' HB3' ' A' ' 97' ' ' ASN . 11.5 t -114.57 116.58 43.5 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.653 -173.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.455 ' HB2' ' HB2' ' A' ' 100' ' ' LEU . 3.8 Cg_exo -79.33 104.07 1.7 Allowed 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 122.544 2.163 . . . . 0.0 109.76 169.006 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 31.8 m -92.14 -15.06 8.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -169.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 27.8 t -159.36 156.83 29.23 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.516 -0.474 . . . . 0.0 111.507 -177.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 60.1 tp -142.48 114.12 7.96 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.07 178.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 8.8 p -126.96 145.8 55.2 Favored Pre-proline 0 C--N 1.32 -0.708 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.99 -176.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.48 ' O ' ' HE1' ' A' ' 23' ' ' MET . 71.9 Cg_endo -77.77 155.88 95.21 Favored 'Cis proline' 0 C--N 1.341 0.18 0 C-N-CA 123.265 -1.556 . . . . 0.0 112.497 -0.68 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 30.2 m -80.16 -21.44 11.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.195 0.522 . . . . 0.0 110.282 177.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.613 ' HA ' ' O ' ' A' ' 105' ' ' GLY . 3.2 p -117.88 126.99 53.41 Favored 'General case' 0 N--CA 1.438 -1.067 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.355 176.236 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.491 ' HB ' ' ND2' ' A' ' 21' ' ' ASN . 29.2 m -113.57 140.36 34.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.134 0.492 . . . . 0.0 111.678 -173.032 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.408 ' HA ' ' HD3' ' A' ' 17' ' ' PRO . 8.1 m -90.67 124.67 61.76 Favored Pre-proline 0 N--CA 1.445 -0.698 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.425 174.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.503 ' HA ' ' HB3' ' A' ' 71' ' ' LEU . 3.0 Cg_exo -80.3 49.56 3.25 Favored 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 122.803 2.335 . . . . 0.0 111.723 178.408 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -116.71 -13.24 10.8 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.468 -175.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 15.2 t -167.98 -167.9 0.9 Allowed 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.928 -0.309 . . . . 0.0 110.799 -171.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.462 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 53.6 t -86.76 113.61 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 174.146 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.491 ' ND2' ' HB ' ' A' ' 15' ' ' VAL . 4.4 m-20 -88.08 137.07 32.65 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.237 -172.146 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 33.4 m -88.85 105.57 17.83 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.219 178.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.505 ' HB2' ' HB2' ' A' ' 67' ' ' PHE . 92.6 mmm -92.9 119.79 32.57 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.002 -178.32 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.516 ' HA ' ' O ' ' A' ' 65' ' ' VAL . 11.5 m -108.68 114.55 28.44 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.635 -176.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -105.71 133.03 51.1 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.387 -179.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 25.4 m -94.08 110.2 21.92 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.924 0.392 . . . . 0.0 110.827 -178.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 27.4 mm -102.64 116.32 46.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.789 -179.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -115.52 129.07 56.41 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.902 0.382 . . . . 0.0 110.177 178.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 24.6 t30 -92.76 98.87 11.67 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.114 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -96.22 53.85 1.38 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.707 -174.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -144.02 161.5 27.84 Favored Glycine 0 N--CA 1.448 -0.558 0 N-CA-C 111.441 -0.663 . . . . 0.0 111.441 179.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -86.93 46.73 1.4 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.473 0.654 . . . . 0.0 110.793 -174.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.53 ' HD3' ' HG3' ' A' ' 3' ' ' PRO . 31.5 tttm -161.51 146.21 13.3 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 174.203 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -76.55 149.27 36.67 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.023 0.44 . . . . 0.0 110.189 176.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.431 ' HG ' ' HB3' ' A' ' 57' ' ' LEU . 13.5 p -104.72 129.3 52.96 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 172.331 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -84.3 -148.57 0.1 Allowed 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 -176.458 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.511 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 56.4 m -65.18 108.36 1.85 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.005 0.431 . . . . 0.0 111.398 -175.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.512 ' HB2' ' HB2' ' A' ' 85' ' ' ASP . 54.0 p90 -123.09 154.9 37.96 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.032 177.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.477 ' O ' ' HA ' ' A' ' 85' ' ' ASP . 32.8 m-80 -105.27 110.92 23.47 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.107 -175.573 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.507 HG22 ' HA ' ' A' ' 84' ' ' VAL . 1.3 t -98.18 121.28 48.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 121.351 0.596 . . . . 0.0 109.716 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.561 ' HG ' HG21 ' A' ' 51' ' ' THR . 11.8 m -114.37 137.56 51.66 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.436 -175.258 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 55.0 tp -96.65 111.77 23.78 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.972 175.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.532 ' HG ' HG21 ' A' ' 48' ' ' VAL . 5.1 mp -94.46 132.29 39.26 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.336 178.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 85.5 t -105.96 97.42 5.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 173.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 70.81 -62.89 0.43 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.133 -0.94 . . . . 0.0 111.921 -179.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -147.34 -6.78 0.28 Allowed Glycine 0 CA--C 1.521 0.443 0 C-N-CA 120.886 -0.674 . . . . 0.0 113.496 179.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 6.5 mt -116.0 151.25 17.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 117.477 0.639 . . . . 0.0 110.45 -177.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.532 HG21 ' HG ' ' A' ' 43' ' ' LEU . 48.0 t -95.0 118.61 41.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 177.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 17.8 m -93.31 -33.08 5.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -176.299 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -152.98 143.07 22.33 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 110.278 -0.268 . . . . 0.0 110.278 -177.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.561 HG21 ' HG ' ' A' ' 41' ' ' SER . 39.2 m -132.86 132.55 42.24 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.318 -179.594 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -123.57 125.86 45.62 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 178.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 15.0 m -87.31 110.3 20.13 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 177.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.511 ' O ' ' HA ' ' A' ' 37' ' ' SER . 43.7 t -81.6 124.13 38.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.329 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 10.3 m -52.76 -44.18 66.3 Favored 'General case' 0 C--N 1.329 -0.287 0 O-C-N 123.543 0.527 . . . . 0.0 111.464 -177.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 34.1 t -179.95 157.76 0.72 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.598 -179.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.431 ' HB3' ' HG ' ' A' ' 35' ' ' SER . 47.9 tp -136.02 123.94 22.72 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.012 -179.458 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 44.4 mm-40 -71.98 161.12 31.39 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.817 -177.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 15.5 m -70.14 128.82 37.61 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.278 178.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 68.3 20.09 8.81 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.984 178.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -112.9 147.02 37.92 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.625 177.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 11.2 p -114.67 125.91 54.28 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.123 0.487 . . . . 0.0 110.576 179.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 50.9 m -118.21 138.7 52.14 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.208 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -94.28 133.69 37.55 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.101 0.477 . . . . 0.0 111.363 -177.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.516 ' O ' ' HA ' ' A' ' 24' ' ' THR . 21.5 t -96.77 135.36 31.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.961 179.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -104.05 97.31 7.31 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.926 -174.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.505 ' HB2' ' HB2' ' A' ' 23' ' ' MET . 57.0 m-85 -97.13 153.34 18.03 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.406 177.322 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 68.8 m-70 -128.67 116.05 18.97 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 171.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 3.5 t90 -129.69 124.23 33.08 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.657 -173.007 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.462 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 4.3 m -80.09 113.87 18.58 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.056 -178.617 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.503 ' HB3' ' HA ' ' A' ' 17' ' ' PRO . 0.8 OUTLIER -69.68 120.23 15.13 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.964 0.412 . . . . 0.0 110.973 177.409 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -87.73 -36.21 17.48 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.589 178.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 92.9 16.04 49.75 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.641 -0.79 . . . . 0.0 111.735 -178.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.5 -38.62 87.99 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.265 0.555 . . . . 0.0 110.621 -179.178 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -138.02 158.17 44.88 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.874 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.471 ' N ' HD21 ' A' ' 76' ' ' ASN . 1.0 OUTLIER -83.09 -12.3 57.21 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.027 0.441 . . . . 0.0 110.544 179.019 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 10.7 p -143.3 121.56 12.26 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.452 178.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 53.0 m-85 -105.73 149.97 25.92 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.314 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.497 ' HA ' HD21 ' A' ' 103' ' ' LEU . 8.9 m -96.46 88.27 4.66 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.906 0.384 . . . . 0.0 110.38 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 7.4 mp -88.13 120.2 29.25 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.555 0.693 . . . . 0.0 111.118 -177.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.422 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 34.5 m -118.28 117.66 29.72 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.34 -178.318 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 47.9 t -90.75 103.79 14.74 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 176.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -101.52 112.61 25.21 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 178.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.567 ' HB ' ' HB2' ' A' ' 98' ' ' ASN . 75.6 t -78.64 103.81 5.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.838 -176.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.512 ' HB2' ' HB2' ' A' ' 38' ' ' PHE . 7.9 t70 58.94 88.3 0.13 Allowed Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 114.091 -1.413 . . . . 0.0 112.019 179.58 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -72.63 -4.46 15.37 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 123.171 2.581 . . . . 0.0 111.561 176.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -83.77 -21.95 32.03 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.173 -179.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 64.09 35.3 10.53 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.581 -178.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -75.93 -34.27 59.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.56 177.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 95.2 t -99.98 112.11 31.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.173 172.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 61.8 t30 -82.74 126.0 31.9 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.509 -177.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -84.05 165.83 18.22 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.239 0.542 . . . . 0.0 111.281 178.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -57.58 -100.69 0.01 OUTLIER Glycine 0 N--CA 1.444 -0.813 0 N-CA-C 110.268 -1.133 . . . . 0.0 110.268 159.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 15.4 m-20 -72.8 88.44 1.32 Allowed 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 172.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -58.4 96.23 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.409 0 O-C-N 123.325 0.391 . . . . 0.0 110.913 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 7.8 m 173.35 -26.36 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.417 0 O-C-N 124.238 0.961 . . . . 0.0 110.072 -172.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.517 ' HB3' HG21 ' A' ' 6' ' ' VAL . 83.7 m-20 -74.68 -19.85 60.1 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.488 -177.603 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.567 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 24.9 p-10 -72.29 19.31 0.08 Allowed 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.624 0.602 . . . . 0.0 112.624 -175.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.414 ' H ' ' C ' ' A' ' 97' ' ' ASN . 1.4 m -130.36 149.03 52.23 Favored 'General case' 0 C--N 1.322 -0.625 0 O-C-N 121.881 -0.512 . . . . 0.0 111.235 -178.495 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.455 ' HB2' ' HB2' ' A' ' 7' ' ' PRO . 30.0 tp -145.45 103.46 3.82 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.686 178.114 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 15.4 m -92.37 98.26 11.37 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 177.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -116.59 127.71 54.74 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.117 0.484 . . . . 0.0 110.695 -177.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.497 HD21 ' HA ' ' A' ' 79' ' ' THR . 65.1 mt -85.77 120.12 26.84 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.649 178.555 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 26.8 m -106.46 132.92 52.44 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.409 178.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.613 ' O ' ' HA ' ' A' ' 14' ' ' THR . . . -117.32 155.6 16.07 Favored Glycine 0 N--CA 1.44 -1.097 0 C-N-CA 120.205 -0.998 . . . . 0.0 111.244 -176.325 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.464 ' HA ' ' O ' ' A' ' 15' ' ' VAL . 35.2 p -61.75 145.82 51.26 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 176.226 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.419 ' HA ' ' HB ' ' A' ' 14' ' ' THR . 49.3 tp . . . . . 0 C--N 1.327 -0.401 0 CA-C-O 120.816 0.341 . . . . 0.0 111.199 -176.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.428 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 1.1 tt . . . . . 0 N--CA 1.448 -0.553 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.506 ' HD2' ' O ' ' A' ' 91' ' ' ASN . 12.6 Cg_exo -70.72 157.04 59.63 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.44 2.093 . . . . 0.0 111.012 174.362 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . 0.601 ' HA ' ' OE1' ' A' ' 92' ' ' GLU . 13.7 t70 -132.73 91.78 2.96 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 175.566 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.515 ' O ' ' HB3' ' A' ' 97' ' ' ASN . 70.2 mt -99.76 126.45 45.84 Favored 'General case' 0 CA--C 1.499 -0.993 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 -173.105 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.0 t -125.4 140.57 36.6 Favored Pre-proline 0 C--N 1.311 -1.069 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.58 -173.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.536 ' HB2' ' HB2' ' A' ' 100' ' ' LEU . 17.2 Cg_endo -91.25 103.8 0.25 Allowed 'Trans proline' 0 N--CA 1.439 -1.688 0 C-N-CA 122.757 2.305 . . . . 0.0 109.495 168.045 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.8 t -80.02 -49.75 18.66 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 CA-C-N 114.765 -1.107 . . . . 0.0 111.306 -165.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 10.5 p -158.15 164.03 36.99 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.67 -178.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.499 HD13 ' HB3' ' A' ' 23' ' ' MET . 36.5 tp -127.73 126.51 41.97 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 176.486 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 37.0 p -122.3 131.71 24.36 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.502 176.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.529 ' HD2' ' SD ' ' A' ' 23' ' ' MET . 97.5 Cg_endo -90.83 176.4 18.03 Favored 'Cis proline' 0 N--CA 1.457 -0.619 0 C-N-CA 123.808 -1.33 . . . . 0.0 112.884 2.536 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.0 m -98.29 -12.05 8.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 121.431 0.634 . . . . 0.0 110.21 176.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.552 ' HA ' ' O ' ' A' ' 105' ' ' GLY . 0.8 OUTLIER -120.03 150.98 39.68 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.579 172.574 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.43 HG11 ' CZ3' ' A' ' 69' ' ' TRP . 7.5 m -143.14 155.15 17.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.056 0.455 . . . . 0.0 111.59 -173.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.9 m -104.33 130.26 23.63 Favored Pre-proline 0 N--CA 1.444 -0.764 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.15 -179.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.401 ' O ' ' HB2' ' A' ' 18' ' ' ASN . 4.3 Cg_exo -77.19 171.9 17.0 Favored 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 122.594 2.196 . . . . 0.0 111.648 175.164 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.401 ' HB2' ' O ' ' A' ' 17' ' ' PRO . 38.2 m-80 73.9 21.39 2.67 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.32 0.648 . . . . 0.0 111.391 178.443 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 15.1 t -167.07 -176.79 3.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.661 0.267 . . . . 0.0 110.706 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 57.8 t -102.33 132.91 47.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 178.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 32.4 m-80 -106.03 134.84 48.51 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.934 0.397 . . . . 0.0 110.362 -176.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 15.0 m -95.34 97.22 9.68 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.567 178.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.529 ' SD ' ' HD2' ' A' ' 12' ' ' PRO . 91.5 mmm -89.53 115.59 27.05 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.533 -175.087 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 25.2 m -93.44 111.28 22.91 Favored 'General case' 0 C--N 1.323 -0.576 0 O-C-N 123.563 0.54 . . . . 0.0 111.002 -178.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.514 ' HB1' ' HB ' ' A' ' 65' ' ' VAL . . . -99.01 119.53 37.95 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.09 175.236 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 5.7 m -83.5 108.81 16.88 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.082 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 28.5 mm -108.29 119.33 57.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 -179.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -117.67 133.11 56.29 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.608 0.242 . . . . 0.0 110.639 -177.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.596 ' ND2' ' HA ' ' A' ' 59' ' ' SER . 36.2 t30 -95.33 100.3 12.1 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.995 0.426 . . . . 0.0 109.889 177.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 67.5 mt-30 -104.89 52.36 0.74 Allowed 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.487 -173.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -143.99 178.19 22.18 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.11 -1.043 . . . . 0.0 113.183 -175.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -90.36 28.84 1.36 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.108 0.48 . . . . 0.0 111.711 -172.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.441 ' HD3' ' HD3' ' A' ' 3' ' ' PRO . 88.5 tttt -154.16 143.58 21.46 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 121.876 -0.515 . . . . 0.0 111.058 178.229 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -79.75 143.25 34.66 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 175.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.431 ' OG ' ' HB3' ' A' ' 57' ' ' LEU . 33.7 p -104.69 140.95 37.31 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.005 0.431 . . . . 0.0 111.429 -177.286 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 7.3 p -85.08 -165.49 1.22 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.052 -179.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 13.4 m -60.34 119.41 7.9 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.935 0.398 . . . . 0.0 111.547 179.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.44 ' CE2' HG23 ' A' ' 40' ' ' VAL . 26.4 p90 -137.26 153.19 50.39 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 177.574 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.584 ' O ' ' HD3' ' A' ' 86' ' ' PRO . 65.1 m-80 -94.98 138.56 32.55 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.094 0.473 . . . . 0.0 110.744 178.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.44 HG23 ' CE2' ' A' ' 38' ' ' PHE . 2.4 t -119.57 112.97 39.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 173.314 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.501 ' HB3' HG22 ' A' ' 51' ' ' THR . 33.4 p -108.79 139.28 43.84 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.24 -173.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 54.9 tp -96.46 115.85 28.1 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.403 177.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.521 ' HG ' HG21 ' A' ' 48' ' ' VAL . 5.5 mp -96.96 129.21 44.45 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.196 177.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.423 ' CG1' ' HD2' ' A' ' 78' ' ' TYR . 84.1 t -106.37 96.89 4.99 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.69 176.512 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.462 ' HA ' ' HB ' ' A' ' 79' ' ' THR . 2.9 m-20 70.9 -51.06 0.68 Allowed 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 115.156 -0.929 . . . . 0.0 112.452 178.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -166.29 14.73 0.08 OUTLIER Glycine 0 C--N 1.319 -0.391 0 C-N-CA 120.768 -0.73 . . . . 0.0 113.15 178.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 9.3 mt -136.18 152.14 29.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 -179.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.521 HG21 ' HG ' ' A' ' 43' ' ' LEU . 50.7 t -97.91 108.73 22.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 177.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 17.0 m -77.67 -37.83 24.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.592 -177.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -159.37 140.04 12.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.828 0.346 . . . . 0.0 110.175 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.501 HG22 ' HB3' ' A' ' 41' ' ' SER . 27.6 m -116.48 122.19 44.02 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.949 178.461 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 43.9 tt0 -105.13 122.7 46.44 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.014 0.435 . . . . 0.0 110.281 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 6.0 m -79.82 129.51 34.55 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.232 177.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 53.7 t -98.75 120.0 47.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 172.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.7 m -61.41 -38.01 85.54 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.629 -174.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 23.0 t -178.1 136.87 0.17 Allowed 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 178.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.458 HD22 HD22 ' A' ' 5' ' ' LEU . 39.7 tp -119.79 113.06 20.04 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.223 0.535 . . . . 0.0 109.731 176.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -67.84 156.9 36.07 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.888 -177.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.596 ' HA ' ' ND2' ' A' ' 29' ' ' ASN . 11.6 p -65.51 130.34 42.95 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.56 178.471 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 68.81 23.52 6.88 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.507 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -117.93 153.74 33.08 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.393 -0.821 . . . . 0.0 108.83 175.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 23.3 t -128.52 142.63 51.01 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 177.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 15.0 t -125.41 149.17 48.42 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.892 179.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -97.78 120.18 37.7 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.213 -178.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.514 ' HB ' ' HB1' ' A' ' 25' ' ' ALA . 21.4 t -98.7 107.02 19.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.546 -176.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -98.84 111.47 23.85 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.925 0.393 . . . . 0.0 110.666 -178.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -91.28 163.03 14.37 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.235 0.541 . . . . 0.0 111.194 -176.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 57.4 m80 -105.3 93.88 4.92 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.549 -0.751 . . . . 0.0 109.723 177.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . 0.43 ' CZ3' HG11 ' A' ' 15' ' ' VAL . 12.5 t90 -107.12 100.01 9.52 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.798 -177.201 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 12.3 t -73.82 121.96 21.71 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 172.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 15.9 tp -121.94 96.11 4.93 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.468 0.651 . . . . 0.0 111.671 -173.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -63.49 -60.71 3.0 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.876 -1.056 . . . . 0.0 109.916 172.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 128.38 67.33 0.13 Allowed Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.721 178.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 30.9 m -75.46 -69.48 0.48 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.884 0.374 . . . . 0.0 110.575 178.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -108.47 -173.19 2.21 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.456 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 -96.49 -18.21 20.0 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.866 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 20.6 m -133.7 133.93 42.44 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.995 0.426 . . . . 0.0 110.81 -179.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.423 ' HD2' ' CG1' ' A' ' 44' ' ' VAL . 49.3 m-85 -119.12 145.2 46.16 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.805 179.198 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.465 ' HA ' HD22 ' A' ' 103' ' ' LEU . 6.6 m -97.11 91.65 5.66 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.323 -179.235 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 7.9 mp -91.1 113.16 25.35 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.452 0.644 . . . . 0.0 111.265 -176.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.552 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 11.2 m -116.12 120.71 39.91 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.489 -178.05 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 85.8 t -86.96 109.63 19.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.399 178.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.547 ' HA ' ' O ' ' A' ' 98' ' ' ASN . 6.1 t30 -92.5 111.57 23.2 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.817 0.342 . . . . 0.0 110.204 176.02 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 94.0 t -92.02 124.77 44.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.338 179.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.751 ' OD2' ' HA ' ' A' ' 88' ' ' ASN . 31.2 t70 64.91 85.87 0.15 Allowed Pre-proline 0 N--CA 1.464 0.249 0 O-C-N 123.922 0.764 . . . . 0.0 111.461 176.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.584 ' HD3' ' O ' ' A' ' 39' ' ' ASN . 1.6 Cg_endo -85.15 -40.9 0.08 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 123.364 2.709 . . . . 0.0 112.754 178.69 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.486 ' OE1' ' HD2' ' A' ' 86' ' ' PRO . 27.1 mp0 -80.33 -10.28 59.75 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.174 -176.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . 0.751 ' HA ' ' OD2' ' A' ' 85' ' ' ASP . 12.9 m120 63.02 64.77 0.84 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.73 0.776 . . . . 0.0 110.273 -174.307 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -100.45 -28.58 12.85 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.641 -1.163 . . . . 0.0 109.172 178.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 54.7 t -115.81 107.67 23.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.421 175.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.506 ' O ' ' HD2' ' A' ' 3' ' ' PRO . 16.6 t-20 -66.13 106.19 1.57 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.29 -177.487 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.601 ' OE1' ' HA ' ' A' ' 4' ' ' ASP . 0.3 OUTLIER -79.95 151.48 30.05 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.439 -174.718 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -57.93 -101.11 0.01 OUTLIER Glycine 0 CA--C 1.522 0.515 0 CA-C-N 115.018 -0.992 . . . . 0.0 113.436 171.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -78.44 132.18 37.2 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.03 -0.585 . . . . 0.0 111.136 -173.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -73.78 76.77 1.58 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.172 0.511 . . . . 0.0 110.961 177.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 17.9 m -160.47 -40.27 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.564 -0.743 . . . . 0.0 109.885 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.515 ' HB3' ' O ' ' A' ' 5' ' ' LEU . 86.5 m-20 -67.47 -13.19 61.81 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.292 -0.867 . . . . 0.0 112.439 -173.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.547 ' O ' ' HA ' ' A' ' 83' ' ' ASN . 19.0 m120 -71.68 -5.01 30.67 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 111.675 0.25 . . . . 0.0 111.675 -175.616 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 2.5 p -142.41 122.54 13.77 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.552 ' O ' ' HA ' ' A' ' 81' ' ' THR . 42.2 tp -111.25 104.87 13.4 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 169.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.5 m -89.75 100.16 13.02 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.444 -178.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -120.57 128.05 52.7 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.081 0.467 . . . . 0.0 111.196 -177.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.465 HD22 ' HA ' ' A' ' 79' ' ' THR . 62.6 mt -85.51 125.82 33.36 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.57 177.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 33.3 m -116.82 142.85 28.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 177.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.552 ' O ' ' HA ' ' A' ' 14' ' ' THR . . . -122.65 155.91 17.11 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.235 -0.983 . . . . 0.0 112.291 -175.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 38.1 p -63.86 139.65 58.79 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 177.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 35.4 tp . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.044 -179.563 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 13.7 tt . . . . . 0 N--CA 1.451 -0.375 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -80.63 156.81 21.55 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 122.314 2.01 . . . . 0.0 111.297 174.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . 0.427 ' HB3' ' O ' ' A' ' 30' ' ' GLN . 13.5 t70 -146.65 104.63 3.76 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 176.234 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.532 HD22 HD22 ' A' ' 57' ' ' LEU . 14.6 mt -99.68 126.6 45.73 Favored 'General case' 0 CA--C 1.51 -0.573 0 C-N-CA 119.484 -0.886 . . . . 0.0 108.945 -172.272 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.3 t -125.55 140.69 37.04 Favored Pre-proline 0 C--N 1.318 -0.785 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.501 -176.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.65 ' HD3' ' O ' ' A' ' 97' ' ' ASN . 3.2 Cg_exo -81.89 109.39 1.96 Allowed 'Trans proline' 0 N--CA 1.446 -1.299 0 C-N-CA 122.598 2.199 . . . . 0.0 109.572 169.422 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 11.6 t -73.93 -53.59 17.19 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.037 -170.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 26.8 t -155.09 163.66 39.95 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.079 -179.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.419 HD11 ' HE1' ' A' ' 23' ' ' MET . 19.9 tp -127.64 126.56 42.21 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.156 0.503 . . . . 0.0 110.025 179.294 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.47 ' HG1' ' HB ' ' A' ' 24' ' ' THR . 41.4 p -122.17 131.47 24.4 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.558 177.299 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.494 ' HD2' ' SD ' ' A' ' 23' ' ' MET . 66.5 Cg_endo -90.68 177.19 17.19 Favored 'Cis proline' 0 N--CA 1.456 -0.72 0 C-N-CA 123.772 -1.345 . . . . 0.0 112.982 3.126 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.3 m -98.91 -13.36 8.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.376 177.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.405 ' HA ' ' O ' ' A' ' 105' ' ' GLY . 0.0 OUTLIER -120.24 151.1 39.64 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.892 173.586 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 17.0 m -143.16 157.36 17.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.574 0.226 . . . . 0.0 110.683 -177.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.491 ' HA ' ' HD3' ' A' ' 17' ' ' PRO . 2.2 t -99.25 131.84 24.44 Favored Pre-proline 0 C--N 1.325 -0.485 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 -178.173 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.539 ' HA ' ' HG ' ' A' ' 71' ' ' LEU . 3.2 Cg_exo -80.45 15.28 1.79 Allowed 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 123.3 2.667 . . . . 0.0 115.07 -171.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 29.4 p-10 -127.26 -2.47 6.31 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 -172.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 13.5 t -143.14 176.56 9.02 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.418 -172.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 62.0 t -81.01 134.46 27.13 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 CA-C-O 121.591 0.71 . . . . 0.0 109.405 174.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.546 ' ND2' HD23 ' A' ' 71' ' ' LEU . 32.7 m-80 -114.42 132.98 56.05 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 114.558 -1.201 . . . . 0.0 108.847 -173.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 23.7 m -108.2 118.88 37.93 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 108.166 -1.049 . . . . 0.0 108.166 -174.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.494 ' SD ' ' HD2' ' A' ' 12' ' ' PRO . 86.1 mmm -109.09 122.92 48.3 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 113.533 -1.667 . . . . 0.0 109.23 -166.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.524 ' HA ' ' O ' ' A' ' 65' ' ' VAL . 25.0 m -111.93 124.8 53.16 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-O 121.732 0.777 . . . . 0.0 109.531 -174.328 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -119.26 132.01 55.86 Favored 'General case' 0 N--CA 1.434 -1.248 0 CA-C-N 114.353 -1.294 . . . . 0.0 108.15 -176.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 93.6 m -112.36 121.45 44.89 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 -173.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.4 HD11 ' HA ' ' A' ' 7' ' ' PRO . 11.9 mm -116.14 131.86 67.39 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 -171.596 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -125.32 148.56 48.67 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.257 -177.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 37.6 t30 -101.15 95.99 6.92 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.442 -175.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.427 ' O ' ' HB3' ' A' ' 4' ' ' ASP . 92.8 mt-30 -88.08 62.2 6.68 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 122.048 0.927 . . . . 0.0 109.826 -179.564 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -173.5 147.14 9.31 Favored Glycine 0 N--CA 1.443 -0.841 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 178.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 32.5 p-10 -85.39 8.29 19.42 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 113.661 0.986 . . . . 0.0 113.661 -162.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -109.19 141.17 41.82 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 120.376 -0.529 . . . . 0.0 110.648 174.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -75.24 135.56 40.99 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.864 174.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 65.5 p -93.1 -161.75 0.87 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.909 -173.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 7.0 p -131.31 -167.97 1.94 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.436 178.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 13.4 m -59.38 124.27 19.49 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.876 178.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.502 ' HB2' ' HB2' ' A' ' 85' ' ' ASP . 23.9 p90 -136.53 150.73 48.79 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.95 -179.05 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.425 ' O ' ' HA ' ' A' ' 85' ' ' ASP . 22.1 m-80 -99.44 109.84 22.38 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.364 -173.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.453 HG21 ' CE2' ' A' ' 38' ' ' PHE . 2.4 t -98.3 114.2 35.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-O 121.337 0.589 . . . . 0.0 109.797 177.509 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.435 ' HA ' ' HA ' ' A' ' 51' ' ' THR . 25.2 p -112.65 141.91 45.88 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.745 -175.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 55.9 tp -96.47 114.45 26.12 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.982 177.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.509 ' HG ' HG22 ' A' ' 48' ' ' VAL . 5.1 mp -98.26 132.57 43.64 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.225 179.196 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 98.7 t -113.78 101.72 12.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.868 177.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 58.82 19.01 6.54 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.822 179.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 128.55 -38.71 2.01 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.892 177.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 5.6 mt -87.48 150.23 3.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 -177.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.509 HG22 ' HG ' ' A' ' 43' ' ' LEU . 44.8 t -96.77 121.11 46.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 19.9 m -94.73 -33.32 4.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -177.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 34.1 t0 -156.1 138.35 14.73 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.576 0.227 . . . . 0.0 110.518 -178.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.435 ' HA ' ' HA ' ' A' ' 41' ' ' SER . 30.6 m -126.83 123.29 36.98 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.262 -179.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -114.7 112.65 23.18 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.802 0.334 . . . . 0.0 110.377 -179.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 23.7 m -77.12 113.07 14.46 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.972 0.415 . . . . 0.0 110.607 177.149 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 27.5 t -83.36 144.15 10.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.881 -179.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.3 m -62.67 -49.06 76.61 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.585 -0.279 . . . . 0.0 111.231 -178.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 22.6 t -177.75 164.45 1.97 Allowed 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -178.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.532 HD22 HD22 ' A' ' 5' ' ' LEU . 18.1 tp -139.85 110.03 6.53 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.247 0.546 . . . . 0.0 110.79 175.645 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 29.3 mp0 -74.75 174.2 9.47 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.973 -178.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 34.6 p -74.89 128.94 36.77 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.699 0.285 . . . . 0.0 110.901 -177.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 66.95 18.34 10.59 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.026 178.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.46 ' O ' HD13 ' A' ' 57' ' ' LEU . 58.5 t30 -110.64 148.65 31.79 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 175.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -117.62 153.9 32.5 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 120.964 0.411 . . . . 0.0 111.015 -175.511 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.464 ' OG1' HD11 ' A' ' 57' ' ' LEU . 92.6 m -130.07 135.24 48.02 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.715 177.254 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -96.34 123.04 39.85 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.41 176.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.524 ' O ' ' HA ' ' A' ' 24' ' ' THR . 17.6 t -105.15 120.68 56.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.732 178.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -109.42 111.27 22.72 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.114 0.483 . . . . 0.0 110.321 -179.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -91.6 157.72 16.83 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.391 -177.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 65.1 m-70 -108.94 100.03 9.29 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.327 175.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 13.5 t90 -116.67 108.23 15.66 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.077 0.465 . . . . 0.0 110.925 -175.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 10.1 m -81.78 114.03 20.14 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.636 174.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.546 HD23 ' ND2' ' A' ' 21' ' ' ASN . 0.1 OUTLIER -72.64 124.73 25.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.701 0.286 . . . . 0.0 110.46 -177.462 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -84.3 -36.62 22.48 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.765 177.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 85.8 58.58 2.0 Allowed Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 121.104 -0.569 . . . . 0.0 112.917 174.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.4 p -112.09 -32.14 6.66 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.734 0.302 . . . . 0.0 111.636 178.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -124.1 166.3 16.02 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.785 0.326 . . . . 0.0 111.083 -177.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.46 ' HA ' HG23 ' A' ' 106' ' ' THR . 51.8 m-80 -101.65 -5.09 25.47 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.046 0.45 . . . . 0.0 110.321 177.267 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 20.5 m -145.18 114.21 6.95 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.841 178.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -105.91 138.79 41.5 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.15 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.443 ' HA ' HD22 ' A' ' 103' ' ' LEU . 9.5 m -90.59 88.23 7.05 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.529 -178.005 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.415 HD12 HG23 ' A' ' 104' ' ' VAL . 8.3 mp -89.02 124.82 34.64 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.35 0.595 . . . . 0.0 111.148 -177.295 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.47 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 76.2 m -123.53 124.4 42.76 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.67 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 61.7 t -90.28 99.03 8.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 174.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.541 ' HA ' ' O ' ' A' ' 98' ' ' ASN . 4.6 t30 -93.5 114.76 27.22 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 178.583 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.418 HG12 ' HB2' ' A' ' 5' ' ' LEU . 60.8 t -80.11 108.6 13.73 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.648 -178.62 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.502 ' HB2' ' HB2' ' A' ' 38' ' ' PHE . 8.1 t70 48.57 92.09 0.06 OUTLIER Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 114.056 -1.429 . . . . 0.0 112.511 -179.242 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -64.73 -8.19 16.92 Favored 'Trans proline' 0 C--O 1.234 0.313 0 C-N-CA 123.313 2.675 . . . . 0.0 112.452 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -94.26 -24.95 17.25 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.372 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 18.9 m120 58.57 48.18 12.24 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.686 -173.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -64.21 -25.66 68.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.012 176.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 20.4 t -101.66 125.74 55.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.564 175.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -74.83 116.53 15.65 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.435 -0.579 . . . . 0.0 109.435 176.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -118.41 168.38 10.7 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -171.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -57.97 -100.96 0.01 OUTLIER Glycine 0 CA--C 1.522 0.52 0 CA-C-N 113.985 -1.461 . . . . 0.0 114.756 179.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -85.54 -163.9 0.93 Allowed 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -166.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 49.0 mm-40 -100.45 -37.84 8.66 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.282 -173.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 15.3 m -84.98 -4.4 59.13 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.824 0.345 . . . . 0.0 111.749 -171.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.65 ' O ' ' HD3' ' A' ' 7' ' ' PRO . 23.6 p-10 -70.44 -34.07 72.03 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.562 -176.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.541 ' O ' ' HA ' ' A' ' 83' ' ' ASN . 9.2 m120 -77.56 -1.46 30.77 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -175.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 1.1 p -135.83 130.94 34.72 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -177.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.47 ' O ' ' HA ' ' A' ' 81' ' ' THR . 28.3 tp -128.35 98.52 5.09 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.234 168.152 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 98.5 m -95.72 107.0 19.18 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.121 0.486 . . . . 0.0 110.501 179.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -121.57 134.83 55.03 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.948 -179.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.443 HD22 ' HA ' ' A' ' 79' ' ' THR . 78.9 mt -84.96 120.03 26.05 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.349 0.595 . . . . 0.0 110.629 179.42 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.415 HG23 HD12 ' A' ' 80' ' ' LEU . 33.2 m -106.22 132.35 53.59 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.491 177.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.405 ' O ' ' HA ' ' A' ' 14' ' ' THR . . . -108.76 173.57 17.7 Favored Glycine 0 N--CA 1.443 -0.876 0 C-N-CA 120.399 -0.905 . . . . 0.0 111.855 -175.285 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.46 HG23 ' HA ' ' A' ' 76' ' ' ASN . 22.0 p -76.43 132.54 39.72 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 120.881 0.372 . . . . 0.0 110.084 176.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 37.2 tp . . . . . 0 C--N 1.322 -0.598 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.938 -175.718 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 16.1 tt . . . . . 0 CA--C 1.538 0.518 0 N-CA-C 110.301 -0.259 . . . . 0.0 110.301 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -71.68 165.08 33.62 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.647 2.231 . . . . 0.0 112.501 175.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -149.85 91.21 1.77 Allowed 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 177.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.451 HD22 HD23 ' A' ' 57' ' ' LEU . 66.3 mt -84.76 117.68 23.98 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.178 -168.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.502 HG23 ' HB3' ' A' ' 97' ' ' ASN . 21.7 t -120.52 110.41 35.63 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.118 -176.248 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.553 ' HD2' ' O ' ' A' ' 97' ' ' ASN . 20.3 Cg_endo -63.74 111.68 1.59 Allowed 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 122.388 2.059 . . . . 0.0 110.55 169.361 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.3 t -85.93 -48.78 15.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.454 -169.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 18.2 t -149.32 157.66 43.52 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.924 0.392 . . . . 0.0 111.097 -174.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 53.7 tp -135.51 111.95 9.88 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.213 178.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.566 ' OG1' ' HA ' ' A' ' 12' ' ' PRO . 13.6 t -131.0 148.13 69.05 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.656 -176.555 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.566 ' HA ' ' OG1' ' A' ' 11' ' ' THR . 5.8 Cg_exo -78.77 148.76 83.79 Favored 'Cis proline' 0 N--CA 1.46 -0.446 0 C-N-CA 123.366 -1.514 . . . . 0.0 112.44 1.21 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.5 m -72.13 -5.91 6.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.271 0.557 . . . . 0.0 110.957 177.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.547 ' HB ' ' HA ' ' A' ' 107' ' ' LEU . 0.9 OUTLIER -128.27 133.01 48.7 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.834 175.43 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.48 ' O ' ' HA ' ' A' ' 106' ' ' THR . 15.3 m -124.2 156.18 31.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 120.761 0.315 . . . . 0.0 111.232 -174.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.0 m -101.83 134.0 20.41 Favored Pre-proline 0 N--CA 1.445 -0.703 0 CA-C-O 121.038 0.446 . . . . 0.0 110.823 177.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.402 ' CB ' ' HA3' ' A' ' 73' ' ' GLY . 98.6 Cg_endo -79.63 174.04 12.26 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 122.42 2.08 . . . . 0.0 112.166 178.767 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 25.1 m-80 63.14 28.77 16.09 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.32 177.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 15.2 t -169.42 170.52 8.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.761 0.315 . . . . 0.0 110.602 -177.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.443 ' HA ' ' O ' ' A' ' 69' ' ' TRP . 58.4 t -91.4 129.88 41.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.853 0.359 . . . . 0.0 110.387 178.371 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 40.4 m-80 -106.9 116.15 31.43 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.608 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.575 ' HA ' ' O ' ' A' ' 67' ' ' PHE . 10.3 m -85.36 93.39 8.71 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 175.025 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.579 ' O ' ' HA ' ' A' ' 66' ' ' ASP . 83.0 mtp -94.73 148.34 22.39 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.132 -174.197 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.449 HG22 ' HB3' ' A' ' 64' ' ' ASN . 20.9 m -109.67 114.07 27.36 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.146 -175.537 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -104.23 112.29 25.25 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 172.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 38.8 m -83.38 104.78 13.8 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 120.923 0.392 . . . . 0.0 110.044 -177.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 31.9 mm -97.05 116.62 39.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.893 -179.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -113.2 122.43 47.46 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.006 0.431 . . . . 0.0 110.135 -178.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 31.0 t30 -79.05 98.44 6.49 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.513 177.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -101.02 56.62 0.86 Allowed 'General case' 0 C--N 1.319 -0.761 0 CA-C-O 121.601 0.715 . . . . 0.0 109.976 -174.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -144.08 177.78 22.53 Favored Glycine 0 N--CA 1.444 -0.775 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.886 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.422 ' N ' HD21 ' A' ' 32' ' ' ASN . 0.9 OUTLIER -73.14 -39.17 65.91 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 -173.758 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 55.7 tttp -101.21 147.58 26.1 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.424 0.631 . . . . 0.0 112.476 -170.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -65.81 138.82 58.17 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 114.523 -1.217 . . . . 0.0 110.809 173.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.414 ' OG ' HD23 ' A' ' 5' ' ' LEU . 13.8 p -105.62 137.43 43.47 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.288 176.585 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.1 m -90.14 -133.2 0.11 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.248 -179.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.491 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 26.8 m -75.62 109.47 9.22 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.085 0.469 . . . . 0.0 111.568 -175.347 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.538 ' CE2' HG21 ' A' ' 40' ' ' VAL . 19.9 p90 -122.6 148.81 44.79 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.13 178.103 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.523 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 4.2 t-20 -99.83 115.19 29.02 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 120.913 -0.315 . . . . 0.0 110.963 -173.591 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.538 HG21 ' CE2' ' A' ' 38' ' ' PHE . 2.7 t -98.48 111.96 29.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.597 0.713 . . . . 0.0 110.161 -178.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.532 ' HB3' HG22 ' A' ' 51' ' ' THR . 16.2 p -104.1 131.69 51.11 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.919 -176.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 62.9 tp -98.17 109.77 22.47 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 174.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 5.1 mp -97.78 142.05 30.03 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.669 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 81.7 t -108.56 99.23 8.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 172.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 37.3 t70 67.06 -73.95 0.07 Allowed 'General case' 0 C--N 1.329 -0.298 0 O-C-N 124.123 0.89 . . . . 0.0 111.139 -176.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -143.64 4.96 1.75 Allowed Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 121.278 -0.486 . . . . 0.0 112.314 179.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 8.4 mt -112.62 153.72 14.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -179.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 54.7 t -106.51 124.9 62.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 17.5 m -94.56 -33.05 4.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 C-N-CA 120.961 -0.295 . . . . 0.0 111.191 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -159.68 142.18 13.64 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.923 0.392 . . . . 0.0 110.673 178.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.532 HG22 ' HB3' ' A' ' 41' ' ' SER . 7.1 m -124.06 109.34 13.38 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.294 178.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 47.0 tt0 -109.08 113.01 25.5 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.104 0.478 . . . . 0.0 111.183 -172.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.523 ' HA ' ' HA ' ' A' ' 39' ' ' ASN . 10.4 m -76.32 120.0 20.97 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.358 177.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.491 ' O ' ' HA ' ' A' ' 37' ' ' SER . 25.0 t -92.58 127.18 44.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 177.091 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 27.0 m -58.05 -38.72 76.8 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.075 -0.511 . . . . 0.0 112.337 -173.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 11.2 p -169.97 163.55 9.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.671 0.272 . . . . 0.0 111.422 -177.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.481 HD13 ' O ' ' A' ' 61' ' ' ASN . 38.4 tp -156.52 114.24 3.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.869 176.195 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -77.32 169.41 18.38 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.605 -175.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 16.6 m -63.44 125.96 25.93 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.745 -0.662 . . . . 0.0 111.114 -179.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 66.27 15.8 10.21 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.96 176.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.481 ' O ' HD13 ' A' ' 57' ' ' LEU . 41.5 t-20 -97.63 143.51 28.23 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 175.277 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -114.44 115.76 27.8 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.351 -178.43 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.4 ' OG1' HD11 ' A' ' 57' ' ' LEU . 50.0 m -104.33 124.43 49.17 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.093 0.473 . . . . 0.0 110.738 -179.296 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.449 ' HB3' HG22 ' A' ' 24' ' ' THR . 94.8 m-20 -80.14 115.76 19.88 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.683 178.627 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 18.2 t -96.77 107.56 20.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.322 -178.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.579 ' HA ' ' O ' ' A' ' 23' ' ' MET . 28.5 m-20 -93.75 111.74 23.49 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.785 179.362 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.575 ' O ' ' HA ' ' A' ' 22' ' ' THR . 80.7 m-85 -91.38 167.46 12.26 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.978 179.576 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 2.5 p-80 -117.58 95.31 4.89 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.502 174.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . 0.622 ' CZ2' HD13 ' A' ' 71' ' ' LEU . 9.7 t90 -94.38 100.52 12.53 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.552 -176.324 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.436 ' HA ' HG21 ' A' ' 20' ' ' VAL . 17.8 m -73.74 91.52 1.92 Allowed 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 173.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.622 HD13 ' CZ2' ' A' ' 69' ' ' TRP . 22.2 tp -95.84 117.8 31.26 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.445 0.64 . . . . 0.0 112.102 -169.298 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -65.13 -56.86 10.51 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.807 -1.088 . . . . 0.0 109.666 171.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.402 ' HA3' ' CB ' ' A' ' 17' ' ' PRO . . . 101.22 50.31 1.24 Allowed Glycine 0 N--CA 1.446 -0.64 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.656 -179.434 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.9 m -81.65 -29.42 33.16 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.146 0.498 . . . . 0.0 110.553 -177.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -123.45 162.01 23.69 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.543 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 69.8 m-20 -97.47 -2.5 41.89 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.052 0.453 . . . . 0.0 110.668 179.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 53.6 m -149.3 112.49 4.93 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.479 176.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -105.79 149.36 26.55 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.289 178.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 89.8 m -98.7 98.06 9.24 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.876 175.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.426 HD13 ' CG2' ' A' ' 104' ' ' VAL . 6.6 mp -94.19 132.25 38.92 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.381 0.61 . . . . 0.0 110.419 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.438 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 17.3 m -129.69 113.97 15.42 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.283 -176.179 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 69.0 t -86.21 109.29 18.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 177.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -104.68 115.09 29.72 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 176.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.554 ' HB ' ' HB2' ' A' ' 98' ' ' ASN . 74.9 t -82.66 114.02 22.85 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-O 121.404 0.621 . . . . 0.0 111.304 -177.281 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 45.2 t0 63.27 90.37 0.09 OUTLIER Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 114.211 -1.359 . . . . 0.0 112.35 176.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.503 ' HD3' ' O ' ' A' ' 39' ' ' ASN . 1.9 Cg_endo -84.7 -6.93 9.7 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 123.195 2.597 . . . . 0.0 111.563 174.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -92.84 -16.67 25.02 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.738 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 57.51 54.96 6.02 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.464 -179.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -93.45 -30.17 15.19 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.008 -0.996 . . . . 0.0 109.703 179.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 47.9 t -110.03 101.51 12.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.486 173.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -64.78 129.69 40.7 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.098 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.407 ' OE1' ' HB2' ' A' ' 5' ' ' LEU . 36.0 mt-10 -108.62 164.14 12.62 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.626 -173.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -58.42 -101.06 0.01 OUTLIER Glycine 0 CA--C 1.519 0.309 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.516 168.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.427 ' C ' ' H ' ' A' ' 96' ' ' SER . 46.1 t30 -84.29 101.66 12.09 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 176.524 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -74.35 22.96 0.09 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.158 -174.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.427 ' H ' ' C ' ' A' ' 94' ' ' ASN . 16.2 m -111.82 -5.14 14.43 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.201 0.524 . . . . 0.0 109.839 174.261 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.553 ' O ' ' HD2' ' A' ' 7' ' ' PRO . 81.3 m-20 -87.52 -15.31 37.89 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.191 178.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.554 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 27.8 p-10 -77.04 1.64 17.37 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.685 -173.52 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 1.2 m -114.24 147.01 39.65 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.083 0.468 . . . . 0.0 110.984 -177.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.438 ' O ' ' HA ' ' A' ' 81' ' ' THR . 40.2 tp -143.57 102.19 3.9 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.904 179.584 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 8.5 m -95.96 110.64 22.82 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.969 178.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -128.5 138.8 52.45 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.902 -178.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 64.5 mt -87.67 121.46 30.12 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.449 177.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.509 HG13 ' HE3' ' A' ' 23' ' ' MET . 27.3 m -113.29 121.41 65.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.842 179.192 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.524 ' O ' ' HA ' ' A' ' 14' ' ' THR . . . -103.66 174.05 22.37 Favored Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 120.397 -0.906 . . . . 0.0 111.054 -177.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.48 ' HA ' ' O ' ' A' ' 15' ' ' VAL . 20.7 p -73.29 154.59 40.09 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 117.286 0.543 . . . . 0.0 109.808 175.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.547 ' HA ' ' HB ' ' A' ' 14' ' ' THR . 49.7 tp . . . . . 0 C--N 1.327 -0.403 0 CA-C-O 121.184 0.516 . . . . 0.0 112.153 -172.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 12.6 tt . . . . . 0 N--CA 1.451 -0.395 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.601 ' HD2' ' O ' ' A' ' 91' ' ' ASN . 16.9 Cg_exo -68.04 151.51 77.47 Favored 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 122.4 2.067 . . . . 0.0 111.697 175.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -141.46 90.41 2.29 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 179.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.501 HD22 HD21 ' A' ' 57' ' ' LEU . 58.4 mt -85.05 109.05 17.94 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.073 -171.401 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.521 HG21 ' HB3' ' A' ' 97' ' ' ASN . 17.7 t -117.46 123.1 30.19 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.207 -176.248 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.456 ' HG3' HG22 ' A' ' 84' ' ' VAL . 3.3 Cg_exo -79.32 101.59 1.43 Allowed 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 122.599 2.199 . . . . 0.0 110.014 170.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 29.3 m -83.66 -27.9 7.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -171.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 43.6 t -175.2 166.01 3.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.667 0.27 . . . . 0.0 110.573 -176.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.444 ' C ' HD12 ' A' ' 10' ' ' LEU . 3.2 pp -146.27 152.25 38.86 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 172.383 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 22.9 p -129.72 144.73 54.13 Favored Pre-proline 0 C--N 1.322 -0.588 0 CA-C-N 116.693 -0.231 . . . . 0.0 110.506 177.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -90.53 162.68 32.36 Favored 'Cis proline' 0 N--CA 1.457 -0.622 0 C-N-CA 123.283 -1.549 . . . . 0.0 112.365 -2.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 30.7 m -91.74 9.72 3.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.63 0.728 . . . . 0.0 110.398 177.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.522 ' HA ' ' O ' ' A' ' 105' ' ' GLY . 0.2 OUTLIER -142.29 122.22 13.61 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.223 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.419 HG23 ' CZ3' ' A' ' 69' ' ' TRP . 21.1 m -121.19 160.32 22.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -168.084 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.45 ' HA ' ' HD3' ' A' ' 17' ' ' PRO . 45.4 t -91.99 118.85 68.42 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.057 178.499 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.55 ' HA ' ' CB ' ' A' ' 71' ' ' LEU . 5.7 Cg_exo -77.79 16.14 1.17 Allowed 'Trans proline' 0 CA--C 1.53 0.318 0 C-N-CA 122.931 2.421 . . . . 0.0 113.455 -176.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 51.3 m-80 -122.61 16.16 10.33 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 121.009 -0.276 . . . . 0.0 111.628 -175.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 14.3 t -169.68 178.77 3.98 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 110.408 -0.219 . . . . 0.0 110.408 -179.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 45.2 t -85.07 125.3 40.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 176.013 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.48 ' ND2' HD23 ' A' ' 71' ' ' LEU . 28.0 m-80 -97.5 124.22 41.65 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.673 -175.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 23.8 m -80.95 105.43 12.17 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.564 -0.743 . . . . 0.0 109.52 175.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.438 ' HE2' HD11 ' A' ' 10' ' ' LEU . 42.0 mtp -102.69 136.53 42.34 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.36 -176.475 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.432 ' HA ' ' O ' ' A' ' 65' ' ' VAL . 22.0 m -115.33 103.74 11.1 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.863 -177.807 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -89.36 141.09 28.85 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.411 177.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 19.2 m -104.39 109.13 20.86 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.079 0.466 . . . . 0.0 110.376 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 14.3 mm -101.9 118.32 48.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.284 179.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -110.35 131.43 55.06 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 120.754 0.311 . . . . 0.0 110.698 -177.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 35.9 t30 -89.32 98.83 11.99 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.211 -0.449 . . . . 0.0 109.871 177.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -94.14 40.37 1.08 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.982 -174.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -143.96 147.36 18.62 Favored Glycine 0 N--CA 1.444 -0.831 0 N-CA-C 110.631 -0.987 . . . . 0.0 110.631 179.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -84.34 60.5 6.02 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.349 0.595 . . . . 0.0 111.157 -172.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.546 ' HD3' ' HD3' ' A' ' 3' ' ' PRO . 64.4 tttp -161.45 137.51 8.05 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.027 170.373 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -76.44 132.9 39.91 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.242 -176.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 58.7 p -95.69 145.1 25.54 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.144 0.497 . . . . 0.0 111.032 -176.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 24.1 p -86.47 -162.22 0.74 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.729 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.433 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 32.6 t -56.96 125.53 23.03 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 120.901 0.382 . . . . 0.0 111.085 178.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.548 ' HB2' ' HB2' ' A' ' 85' ' ' ASP . 42.6 p90 -138.32 143.66 40.04 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 177.354 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.555 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 65.2 t30 -102.55 115.56 30.83 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 121.048 -0.261 . . . . 0.0 111.422 -172.318 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.498 HG23 ' HA ' ' A' ' 84' ' ' VAL . 2.0 t -102.49 125.9 56.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.098 0.475 . . . . 0.0 110.566 -176.385 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.499 ' HB3' HG21 ' A' ' 51' ' ' THR . 52.5 p -117.66 138.27 52.09 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.914 -177.255 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 59.5 tp -96.46 107.8 20.26 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 176.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.441 ' HG ' HG21 ' A' ' 48' ' ' VAL . 4.6 mp -96.94 118.64 33.79 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.264 -179.099 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.503 HG22 ' HG ' ' A' ' 80' ' ' LEU . 95.8 t -100.87 102.08 12.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.083 178.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 59.29 22.45 10.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.374 -0.83 . . . . 0.0 112.399 176.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 121.81 -26.75 6.42 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.464 -0.874 . . . . 0.0 113.002 176.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 11.9 mm -97.85 148.6 5.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 -178.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.441 HG21 ' HG ' ' A' ' 43' ' ' LEU . 39.5 t -98.4 110.7 26.44 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 -179.383 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 28.7 m -91.53 -31.52 4.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.766 -175.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -148.95 139.82 22.85 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.676 0.274 . . . . 0.0 110.298 -177.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.499 HG21 ' HB3' ' A' ' 41' ' ' SER . 2.1 m -133.87 121.6 21.98 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.112 -0.495 . . . . 0.0 109.682 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -128.28 114.96 17.58 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.085 0.469 . . . . 0.0 110.297 -178.108 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.555 ' HA ' ' HA ' ' A' ' 39' ' ' ASN . 21.8 m -76.97 131.4 38.47 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.365 178.537 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.433 ' O ' ' HA ' ' A' ' 37' ' ' SER . 38.6 t -101.95 121.41 52.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 177.017 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.6 m -59.7 -36.16 75.96 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -174.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 21.2 t -172.53 152.46 2.63 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.959 0.409 . . . . 0.0 111.262 179.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.623 HD12 ' OG1' ' A' ' 63' ' ' THR . 23.3 tp -140.07 114.34 9.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.82 175.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -70.27 173.06 7.18 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.468 0.652 . . . . 0.0 112.035 -175.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 10.0 m -63.89 129.66 40.97 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.686 178.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 61.99 19.42 10.75 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.903 -0.59 . . . . 0.0 112.229 176.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -101.24 158.54 15.96 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 178.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 7.1 m -121.52 125.38 46.67 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.136 179.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.623 ' OG1' HD12 ' A' ' 57' ' ' LEU . 86.1 m -103.96 135.94 44.53 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.892 0.377 . . . . 0.0 110.973 -179.646 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -92.85 119.8 32.55 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.762 174.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.432 ' O ' ' HA ' ' A' ' 24' ' ' THR . 40.7 t -96.24 135.06 31.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.441 -177.34 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -96.39 112.13 23.98 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.579 -176.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.429 ' HB2' ' HB2' ' A' ' 23' ' ' MET . 36.1 m-85 -112.37 140.01 47.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.785 0.326 . . . . 0.0 111.016 177.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 22.0 m170 -115.86 97.46 6.12 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 176.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . 0.419 ' CZ3' HG23 ' A' ' 15' ' ' VAL . 18.6 t90 -108.65 114.38 28.14 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.17 0.509 . . . . 0.0 111.622 -173.511 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 9.7 m -82.88 123.9 29.83 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.05 176.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.55 ' CB ' ' HA ' ' A' ' 17' ' ' PRO . 1.0 OUTLIER -83.89 123.17 29.66 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.163 0.506 . . . . 0.0 111.756 -178.573 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 19.3 p-10 -79.19 -43.42 23.92 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.755 175.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 89.39 40.0 6.18 Favored Glycine 0 N--CA 1.45 -0.37 0 CA-C-N 115.772 -0.649 . . . . 0.0 113.152 176.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 18.2 m -99.39 -13.95 19.36 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.207 0.527 . . . . 0.0 110.524 178.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -145.04 152.5 40.22 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.567 178.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -90.09 -10.11 45.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.158 0.504 . . . . 0.0 110.645 179.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 24.7 m -140.53 121.52 14.61 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.316 179.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -116.32 153.31 32.21 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.252 179.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.405 ' HA ' HD21 ' A' ' 103' ' ' LEU . 4.4 m -96.54 89.59 5.06 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.881 179.125 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.503 ' HG ' HG22 ' A' ' 44' ' ' VAL . 10.7 mp -87.55 113.02 22.86 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.477 0.656 . . . . 0.0 110.256 -178.684 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.482 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 5.4 m -115.97 113.51 23.36 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.6 -173.209 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 59.9 t -87.55 109.16 19.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 116.311 -0.404 . . . . 0.0 109.94 177.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -105.83 120.78 42.61 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.135 0.493 . . . . 0.0 109.849 176.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.498 ' HA ' HG23 ' A' ' 40' ' ' VAL . 83.5 t -85.37 111.95 21.52 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.621 -175.601 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.548 ' HB2' ' HB2' ' A' ' 38' ' ' PHE . 20.6 t70 57.8 86.85 0.15 Allowed Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 114.294 -1.321 . . . . 0.0 112.92 173.493 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_exo -72.92 -9.0 23.18 Favored 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 122.797 2.331 . . . . 0.0 111.26 174.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -82.52 -27.12 31.9 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.27 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 10.2 m120 56.99 52.57 9.05 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.505 -177.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -83.98 -25.64 29.86 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.981 -1.009 . . . . 0.0 109.936 179.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 40.3 t -100.4 136.9 29.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.802 177.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.601 ' O ' ' HD2' ' A' ' 3' ' ' PRO . 43.8 m-80 -75.05 112.04 10.88 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 173.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.427 ' CD ' HD22 ' A' ' 98' ' ' ASN . 33.9 mt-10 -114.6 152.64 31.5 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 120.896 0.379 . . . . 0.0 111.752 -173.382 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -57.7 -101.09 0.01 OUTLIER Glycine 0 CA--C 1.519 0.326 0 CA-C-N 115.071 -0.968 . . . . 0.0 113.956 179.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -88.83 124.29 34.04 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.543 0.211 . . . . 0.0 111.015 -173.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -61.11 -33.76 73.88 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -174.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 10.9 p -75.05 -1.94 25.14 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.934 0.397 . . . . 0.0 111.398 -177.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.521 ' HB3' HG21 ' A' ' 6' ' ' VAL . 7.6 m-20 -91.7 -13.55 31.52 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.52 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.427 HD22 ' CD ' ' A' ' 92' ' ' GLU . 10.8 m120 -69.8 -18.02 63.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.903 -0.589 . . . . 0.0 112.257 -177.464 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 1.2 m -123.04 147.91 46.16 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.326 0.584 . . . . 0.0 112.102 -170.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.482 ' O ' ' HA ' ' A' ' 81' ' ' THR . 29.4 tp -131.89 104.61 6.96 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.096 -0.957 . . . . 0.0 109.694 178.52 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 7.0 m -87.98 99.47 12.18 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.277 178.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -113.62 148.85 35.49 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.91 0.386 . . . . 0.0 111.11 -178.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.405 HD21 ' HA ' ' A' ' 79' ' ' THR . 51.8 mt -112.83 120.46 41.53 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.384 178.535 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 27.8 m -110.19 156.78 11.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.371 -178.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.522 ' O ' ' HA ' ' A' ' 14' ' ' THR . . . -122.89 169.98 15.32 Favored Glycine 0 N--CA 1.442 -0.955 0 C-N-CA 120.292 -0.956 . . . . 0.0 111.468 179.153 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 27.3 p -81.47 139.28 35.29 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 174.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.483 ' HA ' HG21 ' A' ' 14' ' ' THR . 32.9 tp . . . . . 0 C--N 1.327 -0.381 0 CA-C-O 121.033 0.444 . . . . 0.0 111.907 -172.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 10.7 tt . . . . . 0 N--CA 1.452 -0.356 0 CA-C-O 120.78 0.324 . . . . 0.0 110.479 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -95.75 169.93 1.27 Allowed 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 123.09 2.527 . . . . 0.0 113.196 175.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -136.42 104.33 5.56 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.089 171.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.442 HD23 HD23 ' A' ' 57' ' ' LEU . 85.4 mt -89.69 90.79 8.38 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.34 0.59 . . . . 0.0 109.949 -176.731 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.475 ' HA ' ' HD2' ' A' ' 7' ' ' PRO . 25.0 t -104.24 111.73 65.25 Favored Pre-proline 0 C--N 1.319 -0.756 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.116 -174.155 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.495 ' HB2' HD22 ' A' ' 100' ' ' LEU . 18.5 Cg_endo -62.18 119.01 5.91 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 122.244 1.963 . . . . 0.0 109.956 169.099 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.5 t -91.0 -47.67 14.31 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.848 -168.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.9 t -160.67 173.68 15.1 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.489 -178.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 55.7 tp -136.46 127.74 28.22 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.83 -178.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.542 ' OG1' ' HA ' ' A' ' 12' ' ' PRO . 14.0 t -140.48 149.2 56.54 Favored Pre-proline 0 C--N 1.322 -0.589 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.542 ' HA ' ' OG1' ' A' ' 11' ' ' THR . 72.3 Cg_endo -76.56 148.12 88.33 Favored 'Cis proline' 0 N--CA 1.464 -0.251 0 C-N-CA 123.393 -1.503 . . . . 0.0 112.745 0.612 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 34.7 m -72.9 -22.35 19.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.724 177.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.616 ' HA ' ' O ' ' A' ' 105' ' ' GLY . 17.0 p -114.24 129.33 56.63 Favored 'General case' 0 N--CA 1.439 -1.016 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.164 174.17 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.489 HG12 ' CZ3' ' A' ' 69' ' ' TRP . 18.0 m -113.52 149.41 15.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.165 0.507 . . . . 0.0 111.923 -173.254 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 27.2 t -90.2 113.35 57.01 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.034 -179.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -83.27 42.09 1.2 Allowed 'Trans proline' 0 CA--C 1.53 0.289 0 C-N-CA 122.974 2.449 . . . . 0.0 113.384 -175.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -156.72 27.92 0.33 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.999 0.428 . . . . 0.0 110.984 177.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 11.2 t -170.99 -177.06 2.12 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.001 179.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 59.0 t -90.02 118.86 36.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.035 0.445 . . . . 0.0 109.91 177.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 44.8 m-80 -89.8 126.57 35.73 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.482 -178.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 17.8 m -80.04 89.0 5.35 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.527 175.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.521 ' HB2' ' HB2' ' A' ' 67' ' ' PHE . 91.3 mmm -79.38 113.21 17.34 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.925 -0.579 . . . . 0.0 109.607 -176.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.496 ' CG2' ' HB3' ' A' ' 64' ' ' ASN . 26.4 m -102.11 112.8 25.6 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.431 -175.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -101.21 124.05 46.3 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.38 179.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 25.0 m -86.12 110.6 19.66 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.285 179.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 19.8 mm -107.64 120.79 59.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 178.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -115.41 127.59 55.47 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.878 0.37 . . . . 0.0 110.889 -179.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 25.2 t30 -89.86 103.8 16.42 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.844 177.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 -99.51 56.73 1.01 Allowed 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.621 -175.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -144.05 170.73 25.81 Favored Glycine 0 N--CA 1.448 -0.527 0 N-CA-C 111.521 -0.632 . . . . 0.0 111.521 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 7.6 p-10 -86.84 0.97 53.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.04 0.448 . . . . 0.0 110.92 -174.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -120.91 132.33 54.9 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.51 -179.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -66.76 139.93 57.83 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.619 173.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.435 ' OG ' HD21 ' A' ' 5' ' ' LEU . 15.7 p -100.87 136.22 41.07 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.622 177.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.596 ' O ' ' HA ' ' A' ' 56' ' ' SER . 2.0 m -82.41 -128.02 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 120.91 -0.316 . . . . 0.0 110.246 -179.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 9.7 t -90.71 121.43 32.6 Favored 'General case' 0 C--N 1.323 -0.554 0 O-C-N 121.786 -0.571 . . . . 0.0 111.399 -172.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -128.92 142.04 51.08 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.624 -0.717 . . . . 0.0 109.361 176.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.654 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 64.1 t30 -90.31 120.13 31.19 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 120.832 0.349 . . . . 0.0 110.234 -176.486 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.445 HG11 HG12 ' A' ' 65' ' ' VAL . 0.3 OUTLIER -106.46 147.29 12.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -176.259 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 9.9 p -137.8 139.43 40.0 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 120.756 -0.378 . . . . 0.0 111.479 -175.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 62.2 tp -105.47 111.31 23.98 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.705 175.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.402 ' HG ' HG21 ' A' ' 48' ' ' VAL . 4.2 mp -98.55 141.49 31.33 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.936 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 87.4 t -123.83 106.09 16.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 176.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 57.53 23.49 9.25 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 115.791 -0.641 . . . . 0.0 112.083 178.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 120.99 -33.09 4.52 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.907 176.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 11.2 mm -90.89 149.25 4.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 -177.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.402 HG21 ' HG ' ' A' ' 43' ' ' LEU . 39.0 t -96.66 110.39 24.72 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 179.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 26.7 m -90.98 -25.69 5.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.686 -175.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -147.34 145.15 29.22 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 -178.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 22.1 m -141.74 113.52 7.86 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.076 0.465 . . . . 0.0 109.961 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.403 ' O ' HG13 ' A' ' 40' ' ' VAL . 0.1 OUTLIER -122.99 116.36 23.42 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.794 -174.922 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.654 ' HA ' ' HA ' ' A' ' 39' ' ' ASN . 8.6 m -80.69 112.64 18.25 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 176.499 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 49.2 t -77.6 133.27 30.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 -178.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 26.3 m -63.74 -43.74 95.59 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.614 -175.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.596 ' HA ' ' O ' ' A' ' 36' ' ' THR . 38.7 t -177.36 151.11 0.75 Allowed 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 -178.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.442 HD23 HD23 ' A' ' 5' ' ' LEU . 26.5 tp -131.04 121.76 25.58 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.836 177.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -71.16 163.07 28.34 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.52 -0.764 . . . . 0.0 112.124 -174.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 4.9 m -67.16 124.09 22.12 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.814 178.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 63.46 20.56 12.32 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.956 176.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 56.1 t30 -113.26 153.0 29.12 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 177.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.3 m -109.0 133.33 53.12 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.872 0.367 . . . . 0.0 110.286 -179.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.435 ' HB ' HD13 ' A' ' 57' ' ' LEU . 20.5 m -123.62 127.32 48.09 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.115 177.35 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.496 ' HB3' ' CG2' ' A' ' 24' ' ' THR . 56.7 m-80 -90.22 135.14 33.85 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.409 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.445 HG12 HG11 ' A' ' 40' ' ' VAL . 13.7 t -96.4 138.57 21.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.862 -176.628 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -94.55 97.2 9.97 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.921 -179.079 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.521 ' HB2' ' HB2' ' A' ' 23' ' ' MET . 67.5 m-85 -98.69 145.78 26.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.364 176.692 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 35.6 m-70 -114.99 100.95 8.57 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.221 0.534 . . . . 0.0 110.827 179.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . 0.489 ' CZ3' HG12 ' A' ' 15' ' ' VAL . 10.2 t90 -103.22 98.01 8.01 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.483 -177.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 18.8 m -74.03 100.33 3.55 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 175.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 28.5 tp -107.7 106.6 17.0 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.211 0.529 . . . . 0.0 111.391 -172.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -78.2 -19.85 53.02 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.172 175.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 89.8 87.27 1.3 Allowed Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.519 177.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 11.6 m -106.64 -33.74 7.55 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.024 0.44 . . . . 0.0 110.329 178.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -134.47 175.69 9.3 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.055 -0.521 . . . . 0.0 109.93 178.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.41 ' HA ' HG23 ' A' ' 106' ' ' THR . 31.7 p-10 -107.84 -8.88 15.87 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.03 0.443 . . . . 0.0 110.935 -179.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 3.2 p -137.2 116.81 12.94 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.345 -179.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -118.01 142.83 46.95 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.967 -178.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 25.5 m -99.21 94.32 6.42 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.051 179.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.422 HD11 HG22 ' A' ' 104' ' ' VAL . 10.2 mp -91.96 136.88 32.82 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.325 0.583 . . . . 0.0 110.777 -177.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.47 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 23.6 m -131.86 123.59 27.82 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.155 -178.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 46.8 t -95.4 108.84 21.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 177.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -100.06 119.51 38.4 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.475 HG22 ' HD3' ' A' ' 7' ' ' PRO . 88.6 t -92.52 106.36 17.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.735 -176.393 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 45.5 t0 62.38 92.67 0.06 OUTLIER Pre-proline 0 C--N 1.33 -0.272 0 O-C-N 124.276 0.985 . . . . 0.0 112.084 177.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -94.05 15.82 1.22 Allowed 'Trans proline' 0 N--CA 1.451 -0.996 0 C-N-CA 123.101 2.534 . . . . 0.0 111.839 174.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -125.5 -1.97 7.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.731 -174.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 65.5 t30 61.21 51.46 4.34 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.453 0.644 . . . . 0.0 110.714 177.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -89.33 -34.7 16.46 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.841 177.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 63.9 t -119.09 115.33 47.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.186 177.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 59.1 t30 -79.77 133.29 36.31 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 177.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -122.06 172.81 7.97 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.153 0.501 . . . . 0.0 112.27 -174.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -57.72 -100.82 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.526 0 CA-C-N 114.55 -1.205 . . . . 0.0 112.023 169.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -63.54 153.24 36.28 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.918 0.389 . . . . 0.0 110.684 178.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -98.62 -3.53 35.95 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.648 0.737 . . . . 0.0 109.817 176.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 8.3 p -87.3 -4.39 59.06 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.62 178.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.401 ' O ' ' HD2' ' A' ' 7' ' ' PRO . 55.3 m-20 -70.62 -35.54 73.01 Favored 'General case' 0 C--O 1.223 -0.303 0 CA-C-O 121.062 0.458 . . . . 0.0 110.244 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.453 ' HA ' ' HB ' ' A' ' 84' ' ' VAL . 13.1 m120 -72.34 18.87 0.08 Allowed 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 -165.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 1.8 m -150.38 149.81 30.56 Favored 'General case' 0 C--N 1.323 -0.552 0 O-C-N 121.883 -0.511 . . . . 0.0 111.345 -179.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.495 HD22 ' HB2' ' A' ' 7' ' ' PRO . 41.9 tp -152.46 100.95 2.62 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.61 176.016 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 61.8 m -92.94 113.38 25.64 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.365 178.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -130.14 134.13 47.11 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.777 -179.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 76.3 mt -85.6 126.17 33.69 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.638 178.321 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.422 HG22 HD11 ' A' ' 80' ' ' LEU . 19.1 m -116.86 147.05 20.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.581 177.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.616 ' O ' ' HA ' ' A' ' 14' ' ' THR . . . -123.72 164.08 17.05 Favored Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 120.495 -0.859 . . . . 0.0 111.389 -177.494 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.41 HG23 ' HA ' ' A' ' 76' ' ' ASN . 35.3 p -70.59 150.19 46.31 Favored 'General case' 0 C--N 1.317 -0.807 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.739 178.203 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.498 ' HA ' ' HB ' ' A' ' 14' ' ' THR . 39.1 tp . . . . . 0 C--N 1.326 -0.442 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.644 -177.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 15.9 tt . . . . . 0 N--CA 1.45 -0.439 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.568 ' HD2' ' O ' ' A' ' 91' ' ' ASN . 8.0 Cg_exo -73.22 161.69 42.38 Favored 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 122.553 2.169 . . . . 0.0 112.309 177.004 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -145.45 92.83 2.28 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 175.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.527 HD21 HD22 ' A' ' 57' ' ' LEU . 60.8 mt -90.72 101.24 13.99 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.47 0.652 . . . . 0.0 110.801 -169.142 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 22.5 t -104.49 112.18 65.33 Favored Pre-proline 0 C--N 1.318 -0.798 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.471 -174.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.493 ' HB2' ' HB2' ' A' ' 100' ' ' LEU . 33.1 Cg_endo -67.65 103.11 0.79 Allowed 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 121.941 1.76 . . . . 0.0 109.776 166.694 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 6.6 t -80.77 -49.18 18.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.315 -167.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 55.6 m -148.64 165.96 29.74 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.877 0.37 . . . . 0.0 111.312 -177.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.548 HD12 ' HE2' ' A' ' 23' ' ' MET . 31.0 tp -139.8 104.33 4.86 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.654 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 21.5 p -123.71 145.26 46.87 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.28 -175.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.475 ' O ' ' HE1' ' A' ' 23' ' ' MET . 4.8 Cg_exo -81.89 155.96 79.79 Favored 'Cis proline' 0 C--N 1.342 0.19 0 C-N-CA 123.723 -1.366 . . . . 0.0 112.015 -2.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 33.9 m -83.62 -11.47 11.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.892 0.377 . . . . 0.0 111.52 -177.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -116.72 126.88 53.8 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.82 0.343 . . . . 0.0 110.077 173.46 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.402 HG11 ' CZ3' ' A' ' 69' ' ' TRP . 34.7 m -113.52 165.39 8.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 120.896 0.379 . . . . 0.0 111.16 -176.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.425 ' HA ' ' HD3' ' A' ' 17' ' ' PRO . 4.9 t -110.15 117.61 51.27 Favored Pre-proline 0 C--N 1.324 -0.531 0 N-CA-C 109.524 -0.546 . . . . 0.0 109.524 177.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.517 ' HA ' ' HG ' ' A' ' 71' ' ' LEU . 7.1 Cg_exo -73.59 31.27 0.32 Allowed 'Trans proline' 0 CA--C 1.533 0.465 0 C-N-CA 123.295 2.664 . . . . 0.0 112.716 -178.505 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.424 ' H ' ' C ' ' A' ' 16' ' ' VAL . 6.3 m-20 -105.82 -29.34 10.09 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.124 -176.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 8.9 t -151.21 178.62 9.05 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.159 -170.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 92.5 t -73.44 120.76 22.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 176.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 36.8 m-80 -92.49 123.91 36.14 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.345 -176.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.43 ' HA ' ' O ' ' A' ' 67' ' ' PHE . 24.9 m -89.88 96.29 10.62 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 177.567 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.548 ' HE2' HD12 ' A' ' 10' ' ' LEU . 86.5 mtp -97.23 135.87 38.55 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.459 -176.245 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.571 ' HA ' ' O ' ' A' ' 65' ' ' VAL . 31.3 m -108.46 115.78 30.74 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.873 -176.429 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -105.53 120.45 41.65 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.017 176.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 28.4 m -83.53 112.92 20.42 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 120.55 0.214 . . . . 0.0 110.458 -179.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.445 HD12 ' HA ' ' A' ' 7' ' ' PRO . 21.5 mm -103.3 120.01 52.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 177.249 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -116.22 126.47 53.67 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.772 0.32 . . . . 0.0 110.632 -177.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.417 ' HB2' ' HG ' ' A' ' 57' ' ' LEU . 33.1 t30 -90.03 101.77 14.48 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.134 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -103.39 54.3 0.75 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.515 -175.164 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -144.02 169.19 26.29 Favored Glycine 0 N--CA 1.447 -0.589 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.375 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -91.09 45.41 1.25 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.257 0.551 . . . . 0.0 110.885 -173.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 46.1 tptt -161.51 135.18 6.59 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.038 176.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -83.85 124.9 31.43 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 178.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 9.5 p -86.2 143.83 27.77 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.9 0.381 . . . . 0.0 111.402 -175.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 12.6 p -81.74 -164.13 0.75 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.967 -179.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.487 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 17.5 m -61.32 114.85 3.41 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 121.08 0.467 . . . . 0.0 111.562 -177.441 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.462 ' CE2' HG22 ' A' ' 40' ' ' VAL . 22.2 p90 -127.64 154.12 45.63 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.249 178.419 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.457 ' O ' ' HD3' ' A' ' 86' ' ' PRO . 55.1 m-80 -100.46 125.93 46.81 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.881 0.372 . . . . 0.0 110.984 -178.252 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.462 HG22 ' CE2' ' A' ' 38' ' ' PHE . 2.3 t -108.21 111.31 35.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-O 121.333 0.587 . . . . 0.0 109.453 177.399 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.492 ' HB3' HG22 ' A' ' 51' ' ' THR . 24.0 p -109.76 140.91 43.11 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.367 -174.11 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.4 HD13 ' HB3' ' A' ' 80' ' ' LEU . 52.7 tp -101.49 114.73 29.01 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.103 177.169 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.7 mp -101.18 126.45 47.9 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.243 179.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 86.2 t -104.87 104.07 16.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 116.148 -0.478 . . . . 0.0 109.873 178.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 57.18 28.89 15.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.411 178.039 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 107.46 -18.5 35.38 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.854 -0.688 . . . . 0.0 112.822 177.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 6.3 mm -95.44 148.16 5.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 -178.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 96.7 t -97.99 113.52 32.81 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-O 121.076 0.465 . . . . 0.0 110.126 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 27.9 m -96.77 -38.86 8.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.445 -177.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -153.16 143.2 22.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.855 0.359 . . . . 0.0 110.941 -175.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.492 HG22 ' HB3' ' A' ' 41' ' ' SER . 41.3 m -136.38 120.5 17.75 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.992 -179.281 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 45.8 tt0 -106.5 137.22 44.89 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.766 0.317 . . . . 0.0 110.377 -178.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 18.0 m -97.56 114.88 26.87 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.195 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.487 ' O ' ' HA ' ' A' ' 37' ' ' SER . 23.5 t -91.03 120.7 40.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.7 m -56.11 -43.15 77.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.58 -177.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 44.0 t -172.88 150.5 2.07 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.997 -0.372 . . . . 0.0 109.997 -179.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.527 HD22 HD21 ' A' ' 5' ' ' LEU . 28.3 tp -133.63 112.54 11.53 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 176.127 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -83.23 162.08 21.32 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.377 -174.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 5.8 p -65.5 138.36 58.03 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.073 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 68.66 5.72 5.06 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 123.183 0.593 . . . . 0.0 111.218 -179.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -103.48 147.56 27.0 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.874 0.369 . . . . 0.0 110.419 179.081 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 2.9 p -121.57 122.69 40.23 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.26 177.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 33.5 m -104.1 126.01 50.88 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.502 -179.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.437 ' HB3' ' CG2' ' A' ' 24' ' ' THR . 90.8 m-20 -83.15 117.87 23.2 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.894 177.353 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.571 ' O ' ' HA ' ' A' ' 24' ' ' THR . 44.8 t -96.02 115.8 36.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.964 -176.148 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 40.4 m-20 -96.67 108.21 20.79 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.748 0.309 . . . . 0.0 110.351 -179.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.43 ' O ' ' HA ' ' A' ' 22' ' ' THR . 65.3 m-85 -91.34 154.97 18.85 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 120.932 0.396 . . . . 0.0 110.097 179.463 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 50.7 m-70 -114.74 88.28 2.83 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 176.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . 0.402 ' CZ3' HG11 ' A' ' 15' ' ' VAL . 15.1 t90 -98.28 111.18 23.61 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.449 -172.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 7.3 m -86.06 118.65 25.66 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 170.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.548 HD13 ' CZ ' ' A' ' 78' ' ' TYR . 0.1 OUTLIER -55.2 -43.82 74.77 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.454 0.539 . . . . 0.0 112.454 -167.947 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.414 ' HB3' ' O ' ' A' ' 71' ' ' LEU . 31.5 t70 71.46 4.21 4.97 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.534 0.683 . . . . 0.0 110.997 176.002 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 179.18 -158.78 23.1 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 121.084 -0.579 . . . . 0.0 111.996 179.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 85.2 m -155.16 94.93 1.67 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.139 0.495 . . . . 0.0 110.344 177.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.401 ' HB2' ' CE1' ' A' ' 78' ' ' TYR . . . -112.51 172.31 7.0 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.111 175.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -79.15 -30.17 43.44 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.451 -0.5 . . . . 0.0 110.534 -178.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.464 ' HB2' HD23 ' A' ' 103' ' ' LEU . 70.7 p -150.91 157.94 43.53 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.283 -178.604 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.548 ' CZ ' HD13 ' A' ' 71' ' ' LEU . 27.9 m-85 -136.64 152.4 50.38 Favored 'General case' 0 C--N 1.328 -0.331 0 O-C-N 123.152 0.282 . . . . 0.0 110.487 -179.397 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 4.4 m -103.22 89.36 3.38 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.92 0.391 . . . . 0.0 110.219 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.449 HD13 HG23 ' A' ' 104' ' ' VAL . 9.4 mp -92.47 122.36 34.83 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.246 0.546 . . . . 0.0 111.189 -175.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.512 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 73.2 m -120.43 119.76 33.97 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.647 -179.628 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 98.9 t -85.63 107.85 16.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 174.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -95.31 113.9 25.62 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.172 177.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.534 ' HB ' ' HB2' ' A' ' 98' ' ' ASN . 96.2 t -85.48 111.25 20.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.614 179.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 56.5 t0 62.89 95.49 0.05 OUTLIER Pre-proline 0 N--CA 1.467 0.424 0 CA-C-N 114.825 -1.08 . . . . 0.0 112.236 178.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.457 ' HD3' ' O ' ' A' ' 39' ' ' ASN . 2.2 Cg_endo -85.41 1.55 8.21 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 123.167 2.578 . . . . 0.0 111.832 175.59 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -98.97 -20.29 16.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.095 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 15.3 m120 64.8 33.64 10.05 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.218 -178.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -73.23 -37.09 66.52 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.402 177.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 43.7 t -96.65 118.0 42.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.192 178.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.568 ' O ' ' HD2' ' A' ' 3' ' ' PRO . 53.6 t30 -85.7 135.7 33.65 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 175.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -115.71 159.4 21.44 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.246 0.546 . . . . 0.0 112.383 -171.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -57.96 -100.59 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 114.613 -1.176 . . . . 0.0 112.501 172.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 39.7 t30 -68.4 96.52 0.68 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.68 0.276 . . . . 0.0 110.325 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -73.97 78.76 1.67 Allowed 'General case' 0 C--O 1.233 0.226 0 CA-C-O 121.475 0.655 . . . . 0.0 110.39 -176.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 20.9 t -179.29 25.46 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.61 -1.177 . . . . 0.0 108.814 176.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 24.1 p-10 -118.68 -28.11 5.71 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.596 -170.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.534 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 22.4 p-10 -68.88 0.34 4.54 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -169.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -119.92 118.38 30.58 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.157 0.503 . . . . 0.0 111.521 178.613 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.512 ' O ' ' HA ' ' A' ' 81' ' ' THR . 26.3 tp -111.34 99.94 8.65 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.759 176.518 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 96.2 m -93.74 97.36 10.39 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.502 0.668 . . . . 0.0 110.104 178.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.484 ' HB2' HD21 ' A' ' 10' ' ' LEU . . . -107.99 115.73 30.67 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.166 -0.925 . . . . 0.0 109.589 178.628 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.464 HD23 ' HB2' ' A' ' 77' ' ' SER . 5.0 tt -78.65 101.39 7.46 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.496 HG11 ' HE3' ' A' ' 23' ' ' MET . 29.9 m -90.57 158.78 2.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.219 -176.361 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -123.58 -170.88 13.47 Favored Glycine 0 N--CA 1.436 -1.317 0 C-N-CA 120.435 -0.888 . . . . 0.0 111.519 -178.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 18.6 p -107.95 140.05 41.67 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 177.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 47.6 tp . . . . . 0 C--N 1.33 -0.247 0 O-C-N 123.576 0.547 . . . . 0.0 110.653 -177.25 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.415 HG13 ' HD2' ' A' ' 3' ' ' PRO . 19.2 tt . . . . . 0 CA--C 1.534 0.346 0 N-CA-C 110.241 -0.281 . . . . 0.0 110.241 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.524 ' HD3' ' HD3' ' A' ' 33' ' ' LYS . 36.0 Cg_exo -60.9 136.53 66.5 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.411 2.074 . . . . 0.0 112.389 174.456 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -117.09 86.86 2.59 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 177.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.408 HD21 HD21 ' A' ' 57' ' ' LEU . 82.5 mt -82.1 107.96 15.2 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.332 -170.687 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 18.6 t -123.32 106.33 33.15 Favored Pre-proline 0 C--N 1.32 -0.702 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.984 -177.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.556 ' HD2' ' O ' ' A' ' 97' ' ' ASN . 11.2 Cg_endo -57.75 119.44 6.7 Favored 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 122.361 2.041 . . . . 0.0 110.465 167.596 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.9 t -93.16 -54.27 7.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.099 -169.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.8 p -150.79 154.36 37.17 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.051 0.453 . . . . 0.0 111.688 -177.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 49.8 tp -121.98 110.25 15.6 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.675 177.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 16.1 p -118.2 143.94 33.94 Favored Pre-proline 0 C--N 1.32 -0.71 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.949 -178.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.411 ' O ' ' HE2' ' A' ' 23' ' ' MET . 87.1 Cg_endo -88.97 160.62 39.53 Favored 'Cis proline' 0 N--CA 1.458 -0.599 0 C-N-CA 123.372 -1.512 . . . . 0.0 112.414 -2.359 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 31.7 m -81.52 6.05 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.045 0.45 . . . . 0.0 111.343 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.4 ' HA ' ' O ' ' A' ' 105' ' ' GLY . 0.1 OUTLIER -141.96 129.77 21.71 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 176.776 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.458 HG22 HD23 ' A' ' 71' ' ' LEU . 17.3 m -121.9 153.1 25.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 -171.725 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.427 ' HA ' ' HD3' ' A' ' 17' ' ' PRO . 2.5 t -83.83 110.98 29.04 Favored Pre-proline 0 CA--C 1.533 0.296 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 -179.482 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 16' ' ' VAL . 6.3 Cg_exo -79.75 58.3 6.9 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 123.288 2.659 . . . . 0.0 113.803 -172.574 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.408 ' OD1' HG13 ' A' ' 16' ' ' VAL . 33.2 p-10 -163.0 13.43 0.07 Allowed 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 176.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 15.3 t -162.34 179.23 8.0 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.711 0.291 . . . . 0.0 110.371 -177.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.515 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 41.1 t -84.05 119.91 34.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 176.404 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 24.4 m-80 -100.33 114.29 27.68 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.27 -177.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.508 ' HA ' ' O ' ' A' ' 67' ' ' PHE . 33.5 m -79.52 90.15 5.09 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 176.636 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.62 ' O ' ' HA ' ' A' ' 66' ' ' ASP . 82.1 mtp -87.32 153.43 21.47 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.901 -176.02 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.479 ' CG2' ' HB3' ' A' ' 64' ' ' ASN . 10.9 m -115.72 112.99 22.87 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.313 -174.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -101.7 116.03 31.84 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 173.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 28.7 m -83.85 109.08 17.27 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.167 -178.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 27.7 mm -103.22 117.96 49.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.533 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 31.0 tt0 -111.09 135.5 51.52 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.147 0.498 . . . . 0.0 111.301 -177.268 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 25.5 t30 -97.17 95.07 7.5 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.536 -0.757 . . . . 0.0 109.354 176.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 64.6 mt-30 -87.96 51.06 2.11 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.362 0.601 . . . . 0.0 110.555 -175.104 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -144.39 168.17 26.77 Favored Glycine 0 N--CA 1.445 -0.755 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.196 -178.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 31.4 p-10 -88.17 -1.98 58.33 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.806 0.336 . . . . 0.0 111.604 -173.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.524 ' HD3' ' HD3' ' A' ' 3' ' ' PRO . 85.1 tttt -111.27 128.74 56.03 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.773 0.32 . . . . 0.0 110.412 179.49 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -67.84 135.18 52.15 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.841 179.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.537 ' HB3' ' HB3' ' A' ' 57' ' ' LEU . 29.5 t -89.64 139.55 30.44 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.108 -178.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -88.22 -165.7 1.39 Allowed 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.717 179.636 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.413 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 31.9 m -61.01 119.38 8.18 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.961 0.41 . . . . 0.0 111.746 -177.479 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.45 ' CE2' HG21 ' A' ' 40' ' ' VAL . 24.4 p90 -135.06 155.72 50.26 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.887 179.523 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.459 ' HB2' ' HD2' ' A' ' 86' ' ' PRO . 15.1 m120 -99.21 117.31 33.4 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.747 -0.206 . . . . 0.0 110.855 -176.449 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.45 HG21 ' CE2' ' A' ' 38' ' ' PHE . 2.3 t -104.08 114.3 43.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 121.285 0.564 . . . . 0.0 109.779 175.627 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 19.4 p -110.57 138.32 47.12 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.573 -0.739 . . . . 0.0 111.135 -175.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 51.3 tp -98.06 117.92 33.5 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.015 177.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.9 mp -104.71 127.66 52.56 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.432 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 97.9 t -99.55 103.54 14.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.822 177.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 59.93 17.88 7.0 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.565 179.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 123.55 -26.91 5.88 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.744 -0.741 . . . . 0.0 113.036 177.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 6.2 mt -91.79 147.17 5.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.995 0.397 . . . . 0.0 110.173 -178.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 61.4 t -91.18 121.26 41.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-O 120.799 0.333 . . . . 0.0 110.437 -177.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 30.9 m -104.74 -28.01 3.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.541 -0.299 . . . . 0.0 111.639 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -151.15 138.84 19.72 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 121.127 -0.229 . . . . 0.0 110.537 -177.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 28.5 m -127.49 110.82 13.14 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 175.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.19 121.4 44.79 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.14 0.495 . . . . 0.0 110.304 -175.502 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 59.1 m -82.11 110.87 17.72 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.685 178.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.413 ' O ' ' HA ' ' A' ' 37' ' ' SER . 40.9 t -85.2 121.36 36.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 177.264 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -59.37 -39.87 84.68 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.863 -173.398 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 42.7 t -175.45 155.01 1.75 Allowed 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.537 ' HB3' ' HB3' ' A' ' 35' ' ' SER . 18.7 tp -130.74 110.74 11.57 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.185 0.517 . . . . 0.0 109.946 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.51 ' HB3' ' HB2' ' A' ' 61' ' ' ASN . 26.3 tt0 -61.65 149.61 38.91 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.55 -174.592 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.3 p -60.73 128.93 38.97 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.669 -179.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 60.98 25.41 15.44 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.012 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.51 ' HB2' ' HB3' ' A' ' 58' ' ' GLU . 17.9 m-80 -121.4 160.25 24.47 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.607 178.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.533 ' HA ' ' HA ' ' A' ' 28' ' ' GLU . 0.0 OUTLIER -116.07 144.13 44.54 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.399 178.58 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 19.6 m -121.52 134.05 55.04 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.385 177.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.479 ' HB3' ' CG2' ' A' ' 24' ' ' THR . 88.7 m-20 -88.86 115.62 26.54 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.494 -179.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 6.4 t -97.66 112.58 30.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.492 -178.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.62 ' HA ' ' O ' ' A' ' 23' ' ' MET . 16.7 m-20 -97.31 115.17 27.18 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.977 0.418 . . . . 0.0 110.772 -178.553 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.508 ' O ' ' HA ' ' A' ' 22' ' ' THR . 84.4 m-85 -91.97 165.19 13.34 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.246 -177.039 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 38.5 m-70 -114.78 87.73 2.71 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 175.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 16.4 t90 -110.33 113.01 25.33 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.284 0.564 . . . . 0.0 111.224 -176.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.515 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 5.7 m -81.69 114.05 20.1 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.015 176.572 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.458 HD23 HG22 ' A' ' 15' ' ' VAL . 0.5 OUTLIER -69.09 118.23 11.74 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.058 0.456 . . . . 0.0 111.329 -178.211 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -77.53 -34.76 53.82 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.845 177.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 83.47 15.63 70.8 Favored Glycine 0 C--N 1.329 0.194 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.661 176.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 22.9 m -75.81 -27.73 58.05 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.909 0.385 . . . . 0.0 111.013 -179.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -130.92 160.93 33.06 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.526 -178.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.43 ' HA ' HG22 ' A' ' 106' ' ' THR . 36.8 m-80 -101.9 -4.0 26.94 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.235 0.541 . . . . 0.0 110.452 177.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 37.3 m -144.71 118.38 9.2 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.022 177.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 81.1 m-85 -112.41 139.46 47.96 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.903 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.3 m -92.1 85.77 5.59 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.068 0.461 . . . . 0.0 109.949 179.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 7.6 mp -81.96 117.14 21.95 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.559 0.695 . . . . 0.0 110.979 -176.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.496 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 12.9 m -115.96 118.07 31.9 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.172 -177.514 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 66.5 t -87.81 110.25 20.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 177.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -98.91 112.65 24.69 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.885 0.374 . . . . 0.0 110.257 175.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.532 ' HB ' ' HB2' ' A' ' 98' ' ' ASN . 86.6 t -84.58 111.91 20.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.826 179.591 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 18.6 t0 65.38 96.04 0.05 OUTLIER Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 114.924 -1.034 . . . . 0.0 112.779 176.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.459 ' HD2' ' HB2' ' A' ' 39' ' ' ASN . 98.4 Cg_endo -95.16 6.05 2.21 Favored 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 123.186 2.59 . . . . 0.0 111.923 173.194 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -103.05 -11.39 18.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.615 -176.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 68.22 32.64 4.68 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.708 0.766 . . . . 0.0 109.555 -176.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -73.76 -38.57 64.67 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.987 177.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 65.7 t -128.92 115.06 35.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.17 -179.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -89.1 145.32 25.53 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 175.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -80.24 162.09 24.82 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.167 0.508 . . . . 0.0 111.962 -174.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -57.49 -100.56 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.558 0 N-CA-C 109.811 -1.315 . . . . 0.0 109.811 158.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -65.6 105.49 1.23 Allowed 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 170.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -77.81 68.75 3.93 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -169.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 48.3 m -165.91 18.64 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 111.821 0.304 . . . . 0.0 111.821 179.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.556 ' O ' ' HD2' ' A' ' 7' ' ' PRO . 44.9 m-80 -115.37 -18.83 10.93 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.484 -0.487 . . . . 0.0 111.965 -173.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.532 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 18.6 p-10 -61.16 -9.54 4.94 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 -172.465 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 1.4 m -114.26 145.26 41.98 Favored 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 120.222 -0.591 . . . . 0.0 111.129 179.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.496 ' O ' ' HA ' ' A' ' 81' ' ' THR . 40.8 tp -138.81 101.64 4.36 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.674 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 26.2 m -94.28 102.48 14.48 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.801 0.334 . . . . 0.0 110.348 -179.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -119.05 163.14 17.42 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.955 -178.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 96.2 mt -112.12 129.64 56.16 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.458 178.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.522 HG13 ' HE1' ' A' ' 23' ' ' MET . 34.2 m -119.35 141.76 37.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.788 177.17 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.4 ' O ' ' HA ' ' A' ' 14' ' ' THR . . . -111.57 177.47 18.93 Favored Glycine 0 N--CA 1.443 -0.837 0 C-N-CA 120.373 -0.918 . . . . 0.0 111.685 -177.327 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.43 HG22 ' HA ' ' A' ' 76' ' ' ASN . 40.2 p -87.59 131.98 34.22 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 120.866 0.365 . . . . 0.0 110.044 176.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 33.1 tp . . . . . 0 C--N 1.325 -0.481 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.663 -176.125 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.422 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 7.7 tt . . . . . 0 C--O 1.236 0.38 0 N-CA-C 110.257 -0.275 . . . . 0.0 110.257 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.49 ' HD3' ' HD3' ' A' ' 33' ' ' LYS . 3.6 Cg_exo -82.11 122.69 3.82 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 122.919 2.413 . . . . 0.0 111.068 172.63 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -111.57 95.01 5.25 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 -179.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.443 HD22 HD21 ' A' ' 57' ' ' LEU . 87.5 mt -79.83 108.73 13.62 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.56 -175.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.404 ' HA ' ' HD2' ' A' ' 7' ' ' PRO . 60.3 t -116.15 109.41 44.62 Favored Pre-proline 0 C--N 1.321 -0.647 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.097 -177.311 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.492 ' HD2' ' O ' ' A' ' 97' ' ' ASN . 28.4 Cg_endo -66.21 102.47 0.57 Allowed 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 122.219 1.946 . . . . 0.0 109.929 167.3 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 15.1 t -78.64 -55.78 9.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.674 -169.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 50.7 m -150.28 155.84 40.44 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.982 0.42 . . . . 0.0 111.172 -177.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 55.2 tp -119.27 107.35 13.3 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.21 177.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.7 p -117.76 146.17 38.22 Favored Pre-proline 0 C--N 1.32 -0.68 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.524 -175.297 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -79.55 164.16 82.64 Favored 'Cis proline' 0 CA--C 1.53 0.289 0 C-N-CA 123.153 -1.603 . . . . 0.0 112.639 -0.009 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 34.8 m -80.16 -22.03 11.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.043 0.449 . . . . 0.0 110.887 -179.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.549 ' HB ' ' HA ' ' A' ' 107' ' ' LEU . 23.2 p -114.5 130.43 56.74 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.741 174.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.9 m -113.48 157.48 14.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.257 0.551 . . . . 0.0 112.153 -171.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.694 HG23 HD22 ' A' ' 107' ' ' LEU . 21.3 t -92.64 107.22 22.51 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.148 -177.714 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.51 ' HA ' ' HB3' ' A' ' 71' ' ' LEU . 7.1 Cg_exo -74.21 9.9 1.63 Allowed 'Trans proline' 0 CA--C 1.531 0.373 0 C-N-CA 123.492 2.795 . . . . 0.0 114.497 -171.391 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -127.51 27.88 5.75 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.711 0.291 . . . . 0.0 111.574 -177.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 15.0 t -167.94 167.77 12.56 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.244 179.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.521 HG21 ' HB ' ' A' ' 70' ' ' THR . 58.2 t -79.94 124.46 38.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 174.684 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.462 ' N ' HD21 ' A' ' 21' ' ' ASN . 0.9 OUTLIER -100.14 117.79 35.12 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.908 0.385 . . . . 0.0 110.244 -175.249 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.479 HG21 ' HB3' ' A' ' 66' ' ' ASP . 6.9 m -83.21 83.85 7.71 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 173.566 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.521 ' HE3' HG13 ' A' ' 104' ' ' VAL . 71.8 mtp -82.31 142.36 32.12 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.899 -174.024 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.455 HG22 ' HB2' ' A' ' 64' ' ' ASN . 26.5 m -106.93 110.52 22.7 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.094 -175.695 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.586 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . . . -91.76 122.21 34.1 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 172.389 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 24.4 m -91.24 104.67 17.19 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.236 -177.233 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 15.5 mm -102.04 117.1 46.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 179.444 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.526 ' HG2' ' HB3' ' A' ' 62' ' ' SER . 53.0 mt-10 -109.6 139.7 44.3 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.945 0.403 . . . . 0.0 110.862 179.652 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.508 ' HB2' ' HG ' ' A' ' 57' ' ' LEU . 32.5 t30 -92.31 93.88 8.87 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.766 175.264 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 83.0 mm-40 -90.06 52.1 2.2 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.683 0.754 . . . . 0.0 110.236 -178.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -144.07 157.48 27.13 Favored Glycine 0 N--CA 1.441 -0.977 0 N-CA-C 110.353 -1.099 . . . . 0.0 110.353 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 33.8 p-10 -85.63 5.18 32.97 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.896 0.379 . . . . 0.0 111.76 -173.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.49 ' HD3' ' HD3' ' A' ' 3' ' ' PRO . 63.6 tttp -116.43 135.07 54.16 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 173.645 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -71.53 139.89 49.69 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.833 0.349 . . . . 0.0 110.161 -179.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.422 ' CB ' HD23 ' A' ' 5' ' ' LEU . 35.7 t -94.94 139.38 31.41 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.722 -177.026 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 24.3 p -83.45 -165.27 1.06 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.472 177.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 26.1 t -57.29 131.6 50.51 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.923 0.392 . . . . 0.0 110.943 178.08 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 31.3 p90 -142.46 148.62 38.03 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.395 177.211 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.458 ' O ' ' HA ' ' A' ' 85' ' ' ASP . 65.8 t30 -104.34 112.9 26.12 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.307 -172.013 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.526 HG22 ' HA ' ' A' ' 84' ' ' VAL . 2.2 t -102.77 123.47 56.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.035 0.445 . . . . 0.0 110.503 -175.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 11.2 t -114.17 144.32 43.38 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.553 -175.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.412 HD11 ' HB3' ' A' ' 80' ' ' LEU . 51.2 tp -105.9 112.58 25.69 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.232 178.414 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.8 mp -101.21 127.25 47.88 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.635 179.11 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.525 HG23 ' HG ' ' A' ' 80' ' ' LEU . 92.3 t -110.7 104.2 16.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 -177.773 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 64.49 19.2 11.72 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.049 0.452 . . . . 0.0 110.555 -176.15 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 117.74 -27.08 7.7 Favored Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.995 178.074 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.516 HG23 ' O ' ' A' ' 44' ' ' VAL . 0.1 OUTLIER -91.94 136.58 24.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.425 0.631 . . . . 0.0 112.385 -174.832 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 88.8 t -78.59 105.84 8.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.325 179.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 22.8 m -86.81 -40.64 14.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.588 179.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -155.29 154.95 32.89 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.714 0.292 . . . . 0.0 110.47 -178.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 13.6 m -143.4 130.29 20.5 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.028 -174.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -119.87 124.56 46.35 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.239 -179.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.405 ' HA ' ' HA ' ' A' ' 39' ' ' ASN . 15.5 m -90.92 116.02 28.41 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.912 0.387 . . . . 0.0 110.181 177.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.418 HG13 HG23 ' A' ' 63' ' ' THR . 43.0 t -82.34 140.32 16.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.987 -178.854 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 28.6 m -71.59 -43.35 66.42 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.82 0.343 . . . . 0.0 111.194 -177.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 32.6 t -173.14 146.94 1.52 Allowed 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 -177.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.508 ' HG ' ' HB2' ' A' ' 29' ' ' ASN . 31.5 tp -128.51 107.13 9.47 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.314 0.578 . . . . 0.0 109.963 178.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -75.34 163.04 27.87 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.986 -173.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 13.4 m -64.71 132.12 48.75 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.439 178.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 42.7 mm-40 67.12 9.41 6.91 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.522 -179.557 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -101.14 148.52 24.99 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.449 -0.342 . . . . 0.0 110.188 179.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.526 ' HB3' ' HG2' ' A' ' 28' ' ' GLU . 33.5 p -113.9 131.01 56.44 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.9 176.203 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.418 HG23 HG13 ' A' ' 54' ' ' VAL . 54.0 m -107.51 125.66 51.55 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 120.955 0.407 . . . . 0.0 110.084 175.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.455 ' HB2' HG22 ' A' ' 24' ' ' THR . 5.0 p-10 -80.34 114.76 19.47 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.093 177.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.586 ' HB ' ' HB2' ' A' ' 25' ' ' ALA . 21.9 t -96.7 105.89 17.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.773 178.227 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.513 ' HA ' ' O ' ' A' ' 23' ' ' MET . 41.8 m-20 -99.81 111.34 23.66 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.468 -175.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.466 ' O ' ' HA ' ' A' ' 22' ' ' THR . 72.1 m-85 -91.79 158.57 16.27 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.914 -176.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 30.8 m-70 -110.13 88.22 2.7 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.428 178.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 13.2 t90 -117.33 113.8 22.66 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.102 -175.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.521 ' HB ' HG21 ' A' ' 20' ' ' VAL . 5.7 t -80.12 120.49 24.33 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 171.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.51 ' HB3' ' HA ' ' A' ' 17' ' ' PRO . 0.2 OUTLIER -65.9 -45.03 83.48 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.598 -170.047 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.429 ' HB3' ' O ' ' A' ' 71' ' ' LEU . 20.9 t70 73.0 -54.27 0.7 Allowed 'General case' 0 N--CA 1.469 0.498 0 O-C-N 123.968 0.792 . . . . 0.0 110.503 -174.268 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 90.93 51.98 2.51 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 121.059 -0.591 . . . . 0.0 111.997 179.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -84.75 -38.67 19.37 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.139 0.495 . . . . 0.0 110.509 -179.23 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -134.93 171.13 14.84 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.919 -177.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 28.2 p-10 -79.15 -15.17 58.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.379 -178.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.468 ' HB3' ' CD2' ' A' ' 103' ' ' LEU . 44.2 m -154.87 147.74 24.51 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.717 0.294 . . . . 0.0 110.765 -177.733 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -126.99 142.66 51.49 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.215 178.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 5.7 m -90.58 90.95 8.21 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.769 0.319 . . . . 0.0 110.428 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.525 ' HG ' HG23 ' A' ' 44' ' ' VAL . 10.9 mp -91.64 116.22 28.7 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.354 0.597 . . . . 0.0 111.172 -176.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.456 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 52.9 m -113.75 118.86 35.48 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.473 -179.5 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.463 ' HB ' ' HB3' ' A' ' 100' ' ' LEU . 60.3 t -88.1 106.91 16.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.617 176.359 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -100.29 110.92 23.17 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 177.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.526 ' HA ' HG22 ' A' ' 40' ' ' VAL . 69.7 t -76.04 110.38 11.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.902 -179.102 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.458 ' HA ' ' O ' ' A' ' 39' ' ' ASN . 1.8 t70 56.52 94.97 0.05 OUTLIER Pre-proline 0 N--CA 1.465 0.29 0 CA-C-N 114.32 -1.309 . . . . 0.0 112.035 178.622 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -60.15 -24.74 77.94 Favored 'Trans proline' 0 N--CA 1.473 0.289 0 C-N-CA 123.369 2.713 . . . . 0.0 112.806 -178.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -92.12 -18.0 24.16 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.207 -179.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 25.6 m120 53.08 54.97 9.54 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.818 -171.034 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.85 -40.07 94.05 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.999 -178.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 41.0 t -83.71 139.36 17.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.79 178.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 60.9 t30 -75.09 95.04 2.99 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 175.234 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -93.88 177.18 6.08 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.28 -173.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -58.14 -100.78 0.01 OUTLIER Glycine 0 CA--C 1.521 0.432 0 CA-C-N 115.341 -0.845 . . . . 0.0 113.063 175.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 55.6 t30 -117.32 145.12 44.22 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.746 0.308 . . . . 0.0 110.242 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.624 ' HA ' ' OD1' ' A' ' 98' ' ' ASN . 42.3 mt-10 -75.43 -12.91 60.34 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.013 0.435 . . . . 0.0 111.567 -174.352 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 16.4 m -69.62 -9.57 54.67 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.793 -178.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.492 ' O ' ' HD2' ' A' ' 7' ' ' PRO . 2.6 p-10 -117.78 10.64 13.34 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.906 -0.318 . . . . 0.0 111.458 177.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.624 ' OD1' ' HA ' ' A' ' 95' ' ' GLU . 7.5 m120 -76.42 -27.69 56.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.859 0.361 . . . . 0.0 110.764 177.361 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -103.75 122.66 45.55 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.718 -179.484 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.463 ' HB3' ' HB ' ' A' ' 82' ' ' VAL . 38.5 tp -109.32 100.17 9.33 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.89 173.353 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 41.5 m -87.58 97.39 10.83 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.218 0.533 . . . . 0.0 110.371 179.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -113.28 107.39 15.82 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.964 179.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.468 ' CD2' ' HB3' ' A' ' 77' ' ' SER . 5.0 tt -83.81 105.67 14.89 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 108.806 -0.812 . . . . 0.0 108.806 -178.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.521 HG13 ' HE3' ' A' ' 23' ' ' MET . 21.2 m -89.64 144.13 9.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.614 -174.562 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -107.38 -179.03 22.47 Favored Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 120.793 -0.718 . . . . 0.0 111.31 -179.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.401 HG23 ' HG3' ' A' ' 17' ' ' PRO . 23.0 p -83.43 153.36 24.53 Favored 'General case' 0 C--N 1.315 -0.904 0 C-N-CA 120.904 -0.318 . . . . 0.0 110.481 178.738 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.694 HD22 HG23 ' A' ' 16' ' ' VAL . 19.2 tp . . . . . 0 C--N 1.331 -0.211 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.954 -178.235 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 6.6 tt . . . . . 0 N--CA 1.452 -0.334 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.447 ' HD2' ' O ' ' A' ' 91' ' ' ASN . 3.3 Cg_exo -84.26 156.94 12.86 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.804 2.336 . . . . 0.0 111.34 171.447 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -138.75 108.67 6.32 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 174.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.496 HD22 HD23 ' A' ' 57' ' ' LEU . 69.4 mt -99.81 126.96 45.98 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -173.422 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.428 HG21 ' ND2' ' A' ' 97' ' ' ASN . 2.4 t -125.36 140.39 36.12 Favored Pre-proline 0 C--N 1.317 -0.844 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.332 -176.234 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.426 ' HB2' ' HB2' ' A' ' 100' ' ' LEU . 9.3 Cg_endo -92.8 93.31 0.16 Allowed 'Trans proline' 0 N--CA 1.445 -1.367 0 C-N-CA 122.952 2.435 . . . . 0.0 109.758 166.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 28.3 m -83.84 -12.88 11.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-N 115.869 -0.605 . . . . 0.0 112.313 -169.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 31.4 t -163.43 143.42 8.71 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.124 0.487 . . . . 0.0 111.723 -176.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 62.7 tp -127.8 126.93 42.63 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.065 175.09 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.0 p -137.7 145.28 48.04 Favored Pre-proline 0 C--N 1.32 -0.709 0 CA-C-N 116.572 -0.286 . . . . 0.0 110.813 -177.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.485 ' HD2' ' SD ' ' A' ' 23' ' ' MET . 98.3 Cg_endo -80.23 163.02 82.89 Favored 'Cis proline' 0 N--CA 1.465 -0.199 0 C-N-CA 123.369 -1.513 . . . . 0.0 112.719 -1.555 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 24.5 m -85.51 -15.26 10.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.152 0.501 . . . . 0.0 110.565 177.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.563 ' HA ' ' O ' ' A' ' 105' ' ' GLY . 0.1 OUTLIER -131.61 124.94 30.98 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.647 174.718 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 20.5 m -114.57 150.47 16.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.625 -0.261 . . . . 0.0 111.141 -174.064 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 6.2 m -88.53 121.55 70.05 Favored Pre-proline 0 N--CA 1.445 -0.685 0 CA-C-O 120.957 0.408 . . . . 0.0 110.194 176.289 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.462 ' HA ' ' CB ' ' A' ' 71' ' ' LEU . 17.6 Cg_exo -68.04 172.51 10.77 Favored 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 122.497 2.132 . . . . 0.0 112.59 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 43.8 m-80 71.93 25.06 3.16 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.274 175.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 12.9 t -175.69 175.62 2.03 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.654 -0.248 . . . . 0.0 110.386 177.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.793 HG21 ' HB ' ' A' ' 70' ' ' THR . 44.4 t -91.24 135.37 27.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.343 178.51 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 21.7 m-80 -108.71 149.88 28.37 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.467 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.9 m -83.05 91.02 7.11 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.258 179.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.491 ' HB2' ' HB2' ' A' ' 67' ' ' PHE . 89.8 mmm -81.6 109.75 16.33 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.372 0.606 . . . . 0.0 110.246 -178.727 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 25.5 m -103.26 110.15 22.02 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.474 -177.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -101.33 120.13 39.79 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.072 178.062 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 28.5 m -85.88 104.43 15.53 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.62 -178.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.419 HG12 HG22 ' A' ' 65' ' ' VAL . 23.3 mm -98.5 119.35 46.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 178.691 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -120.55 139.18 53.31 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.425 -175.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.476 ' O ' ' HA ' ' A' ' 60' ' ' GLU . 54.8 t-20 -91.87 99.72 12.53 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 178.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -102.14 52.25 0.81 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.651 0.738 . . . . 0.0 110.418 -176.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -143.94 175.81 23.61 Favored Glycine 0 N--CA 1.446 -0.634 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.093 179.042 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -99.8 45.49 0.99 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.287 0.565 . . . . 0.0 111.402 -173.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.478 ' HG2' ' N ' ' A' ' 34' ' ' ASP . 50.3 tttm -161.49 157.06 24.38 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.254 169.167 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.478 ' N ' ' HG2' ' A' ' 33' ' ' LYS . 8.7 p-10 -68.42 165.13 19.48 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.06 173.553 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.468 ' OG ' ' HB3' ' A' ' 57' ' ' LEU . 10.0 p -129.99 134.4 47.41 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.925 0.393 . . . . 0.0 110.703 178.164 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 11.3 p -80.66 -167.59 1.43 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.322 -177.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 18.8 t -62.61 120.78 11.82 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.058 0.456 . . . . 0.0 111.109 -177.06 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -131.46 160.19 35.87 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.685 178.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -106.08 125.63 51.23 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 121.277 -0.169 . . . . 0.0 110.617 -176.219 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.503 HG13 HG21 ' A' ' 65' ' ' VAL . 1.4 t -111.49 123.85 67.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.156 0.503 . . . . 0.0 110.546 178.216 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 18.2 m -117.83 145.5 44.51 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.912 -176.184 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 49.7 tp -104.04 108.87 20.42 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.853 176.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.7 mp -98.45 112.73 24.66 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.201 -179.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 87.8 t -97.12 107.08 19.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.113 179.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 59.08 22.21 10.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.656 178.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 116.36 -25.19 9.37 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.598 -0.81 . . . . 0.0 112.953 176.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 8.8 mt -96.39 151.31 4.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 -178.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 47.5 t -97.2 109.69 23.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 110.094 -0.335 . . . . 0.0 110.094 -178.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 28.1 m -87.18 -29.72 5.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 C-N-CA 120.904 -0.318 . . . . 0.0 111.502 -177.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -158.0 159.56 36.55 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.836 0.35 . . . . 0.0 110.537 -179.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 95.9 m -149.81 126.87 11.23 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.986 -178.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -125.04 122.85 38.42 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.93 0.395 . . . . 0.0 109.988 179.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 19.5 m -80.09 130.88 35.58 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.056 177.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 42.6 t -98.16 131.72 44.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.2 m -61.55 -47.0 87.55 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.717 -177.093 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 29.8 t -179.98 152.8 0.48 Allowed 'General case' 0 C--O 1.235 0.293 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 -178.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.496 HD23 HD22 ' A' ' 5' ' ' LEU . 40.3 tp -129.75 125.68 36.4 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.057 0.456 . . . . 0.0 110.323 178.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -76.56 160.2 29.65 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.042 -176.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 10.5 m -60.31 120.18 9.35 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.259 -177.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.476 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 44.2 mt-10 60.81 25.53 15.41 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.325 177.585 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -101.24 160.96 13.96 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 171.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -122.31 119.03 29.91 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 -176.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 54.1 m -111.5 127.17 55.62 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.072 0.463 . . . . 0.0 110.719 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -86.76 134.89 33.54 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.54 179.5 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.503 HG21 HG13 ' A' ' 40' ' ' VAL . 28.2 t -96.16 133.55 36.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.154 179.544 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -97.75 97.0 8.63 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.297 -177.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.491 ' HB2' ' HB2' ' A' ' 23' ' ' MET . 21.3 m-85 -97.66 152.38 19.15 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.669 178.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 17.1 m80 -120.77 93.7 4.12 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 178.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 24.0 t90 -114.83 118.58 33.95 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.319 -174.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.793 ' HB ' HG21 ' A' ' 20' ' ' VAL . 15.1 t -89.73 144.85 25.64 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.433 179.46 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.462 ' CB ' ' HA ' ' A' ' 17' ' ' PRO . 3.1 mm? -110.47 127.46 55.15 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.94 0.4 . . . . 0.0 111.763 179.554 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 -90.39 -28.3 18.76 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.682 172.133 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 87.44 33.91 11.07 Favored Glycine 0 N--CA 1.448 -0.517 0 N-CA-C 111.226 -0.75 . . . . 0.0 111.226 -175.268 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.63 -33.03 74.15 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.229 0.538 . . . . 0.0 110.711 -178.607 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -141.27 155.54 45.98 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.237 -178.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -67.89 -30.97 70.45 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.426 178.003 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 19.5 m -136.85 135.96 38.35 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.073 0.464 . . . . 0.0 110.898 -179.025 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -112.48 146.46 38.42 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.12 178.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.47 ' HA ' HD23 ' A' ' 103' ' ' LEU . 6.6 m -95.43 87.61 4.83 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.885 0.374 . . . . 0.0 110.499 -178.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.437 HD13 HG23 ' A' ' 104' ' ' VAL . 9.4 mp -87.7 120.16 28.74 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.184 0.516 . . . . 0.0 111.272 -176.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.575 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 73.5 m -119.64 115.7 24.49 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.606 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 46.5 t -88.16 107.8 17.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.648 175.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -97.97 117.15 31.68 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.847 0.356 . . . . 0.0 110.075 176.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.526 ' HB ' ' HB2' ' A' ' 98' ' ' ASN . 94.7 t -85.71 109.01 17.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.957 -179.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 39.2 t0 65.68 91.91 0.07 OUTLIER Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 114.583 -1.189 . . . . 0.0 112.002 178.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -89.52 6.23 4.47 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 123.021 2.481 . . . . 0.0 111.714 174.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -110.76 -8.98 14.51 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.38 -178.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 5.3 m120 56.64 53.9 7.93 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.266 178.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -88.91 -35.3 16.58 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.55 176.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 61.6 t -108.76 119.73 58.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.439 -0.801 . . . . 0.0 109.882 176.016 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.447 ' O ' ' HD2' ' A' ' 3' ' ' PRO . 53.4 m-80 -74.12 124.19 25.85 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.443 179.212 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.485 ' HB2' ' HA ' ' A' ' 95' ' ' GLU . 0.4 OUTLIER -95.93 150.51 20.36 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.587 -175.543 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -57.78 -100.87 0.01 OUTLIER Glycine 0 CA--C 1.52 0.359 0 CA-C-N 115.068 -0.969 . . . . 0.0 112.734 172.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.471 ' HB3' ' OD1' ' A' ' 97' ' ' ASN . 11.1 t30 -65.33 -24.15 67.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.644 0.259 . . . . 0.0 110.491 -177.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.485 ' HA ' ' HB2' ' A' ' 92' ' ' GLU . 29.5 tt0 76.02 -63.0 0.41 Allowed 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 168.329 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 37.0 m -64.83 -4.93 4.92 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -171.034 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.471 ' OD1' ' HB3' ' A' ' 94' ' ' ASN . 4.0 p-10 -96.01 11.06 35.4 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.808 178.4 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.526 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 24.4 p-10 -85.0 3.02 40.51 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.92 0.39 . . . . 0.0 110.487 179.031 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -119.31 118.32 30.92 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 121.215 0.531 . . . . 0.0 111.575 -178.594 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.575 ' O ' ' HA ' ' A' ' 81' ' ' THR . 25.2 tp -108.46 99.39 8.78 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.241 178.568 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 93.1 m -92.15 97.75 11.11 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 121.155 0.503 . . . . 0.0 109.717 175.304 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -114.88 126.37 54.72 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.344 -177.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.47 HD23 ' HA ' ' A' ' 79' ' ' THR . 51.2 mt -78.93 115.88 18.9 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.214 0.531 . . . . 0.0 110.573 177.641 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.437 HG23 HD13 ' A' ' 80' ' ' LEU . 23.0 m -106.36 144.56 15.39 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.01 178.279 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.563 ' O ' ' HA ' ' A' ' 14' ' ' THR . . . -118.96 169.9 13.69 Favored Glycine 0 N--CA 1.437 -1.255 0 C-N-CA 120.004 -1.094 . . . . 0.0 111.271 -177.366 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 41.6 p -77.06 129.88 36.66 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 173.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 42.7 tp . . . . . 0 C--N 1.324 -0.505 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.19 -176.927 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.423 ' CG1' ' HD2' ' A' ' 3' ' ' PRO . 18.3 tt . . . . . 0 N--CA 1.451 -0.392 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.502 ' HD3' ' HD3' ' A' ' 33' ' ' LYS . 58.2 Cg_endo -76.0 157.1 38.68 Favored 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 122.453 2.102 . . . . 0.0 112.325 176.2 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -146.05 100.12 3.35 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 179.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.509 HD23 HD21 ' A' ' 57' ' ' LEU . 41.0 mt -99.88 126.76 46.06 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-O 121.545 0.688 . . . . 0.0 109.265 -170.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 6.0 t -125.46 140.37 36.17 Favored Pre-proline 0 N--CA 1.441 -0.92 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.638 -175.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.439 ' HB2' ' HB2' ' A' ' 100' ' ' LEU . 1.1 Cg_endo -87.34 107.09 0.65 Allowed 'Trans proline' 0 N--CA 1.446 -1.29 0 C-N-CA 122.815 2.343 . . . . 0.0 109.63 166.489 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.9 t -76.91 -60.23 2.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.566 -170.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 9.5 t -154.65 154.97 33.82 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 177.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.8 pp -127.95 127.49 43.38 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.399 0.618 . . . . 0.0 110.117 177.064 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.6 p -121.63 131.66 24.39 Favored Pre-proline 0 C--N 1.311 -1.075 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.792 -175.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.401 ' HD2' ' SD ' ' A' ' 23' ' ' MET . 84.4 Cg_endo -90.55 175.1 20.41 Favored 'Cis proline' 0 N--CA 1.461 -0.392 0 C-N-CA 123.539 -1.442 . . . . 0.0 113.5 8.723 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.5 m -99.25 -11.98 8.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.087 0.47 . . . . 0.0 111.274 178.2 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -120.09 151.0 39.69 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 174.26 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 20.9 m -143.29 157.36 17.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.029 0.442 . . . . 0.0 111.475 -177.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.8 m -99.11 144.13 27.66 Favored Pre-proline 0 N--CA 1.448 -0.564 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.114 178.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.516 ' HA ' ' CB ' ' A' ' 71' ' ' LEU . 2.9 Cg_endo -82.64 165.5 15.87 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.868 2.378 . . . . 0.0 112.589 178.79 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 34.9 m-80 71.87 24.2 3.4 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.639 175.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.5 t -163.52 162.91 24.79 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.983 -0.287 . . . . 0.0 110.592 -178.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.989 HG22 ' HB ' ' A' ' 70' ' ' THR . 21.2 t -94.56 130.81 42.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 175.464 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -119.65 152.63 36.79 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.273 179.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 90.9 m -96.83 109.22 21.96 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.332 -178.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.528 ' HB2' ' HB2' ' A' ' 67' ' ' PHE . 83.4 mmm -92.42 123.74 35.95 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.669 178.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.474 ' HA ' ' O ' ' A' ' 65' ' ' VAL . 19.3 m -106.87 103.06 12.4 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.637 0.256 . . . . 0.0 111.259 -177.577 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -97.75 123.12 41.55 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.494 176.28 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 18.8 m -87.81 121.29 30.05 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 120.813 0.34 . . . . 0.0 110.589 178.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 24.6 mm -106.88 116.37 50.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 179.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -110.27 128.91 55.77 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.918 0.389 . . . . 0.0 110.659 -178.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.431 ' ND2' ' HA ' ' A' ' 59' ' ' SER . 26.1 t30 -88.62 96.08 10.5 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.467 177.437 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 -92.74 43.98 1.14 Allowed 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.634 -174.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -144.08 150.13 22.17 Favored Glycine 0 N--CA 1.447 -0.582 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 179.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 16.1 t30 -84.47 62.77 7.46 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.497 0.665 . . . . 0.0 111.567 -172.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.502 ' HD3' ' HD3' ' A' ' 3' ' ' PRO . 62.3 tttp -161.46 136.84 7.63 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.321 166.833 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -72.16 114.39 10.23 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 177.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 16.1 p -83.56 144.77 29.26 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.054 0.454 . . . . 0.0 110.856 -178.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 3.1 p -83.4 -169.63 2.64 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.557 -178.154 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 33.0 t -54.76 132.63 46.37 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.577 -178.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 55.1 p90 -143.98 159.22 42.97 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.947 178.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 21.0 m-80 -109.04 110.5 21.79 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.483 0.182 . . . . 0.0 111.273 -175.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.445 HG13 HG22 ' A' ' 65' ' ' VAL . 1.5 t -98.43 124.85 51.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.271 0.558 . . . . 0.0 109.926 -179.594 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 18.7 m -120.56 148.18 44.2 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.047 -174.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 50.4 tp -102.21 117.36 34.59 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.787 177.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.519 ' HG ' HG21 ' A' ' 48' ' ' VAL . 5.0 mp -100.34 126.69 46.72 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.81 179.486 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 99.5 t -106.08 103.12 14.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 120.815 0.34 . . . . 0.0 110.201 179.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.48 ' HA ' ' HB ' ' A' ' 79' ' ' THR . 8.7 m-20 62.62 13.09 6.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.352 -0.84 . . . . 0.0 112.095 176.665 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 138.38 -38.63 1.67 Allowed Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.604 -0.808 . . . . 0.0 113.306 176.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 8.3 mt -98.19 150.8 4.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 120.77 0.319 . . . . 0.0 110.537 -174.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.519 HG21 ' HG ' ' A' ' 43' ' ' LEU . 55.9 t -87.43 127.17 40.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 -179.724 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 18.4 m -99.84 -39.34 7.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 111.852 0.316 . . . . 0.0 111.852 179.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -149.44 149.49 30.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.736 0.303 . . . . 0.0 110.936 -176.117 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 95.9 m -133.96 128.27 34.11 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.52 -178.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -118.97 119.28 33.85 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 177.637 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 25.6 m -80.9 126.42 31.34 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.362 178.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 47.7 t -96.6 128.92 47.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 178.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.8 p -56.4 -43.6 79.47 Favored 'General case' 0 C--N 1.329 -0.324 0 O-C-N 123.355 0.409 . . . . 0.0 111.957 -177.069 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 17.2 p -178.08 155.22 0.93 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.393 179.149 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.67 HD12 HG23 ' A' ' 63' ' ' THR . 17.4 tp -130.42 109.26 10.59 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.07 0.462 . . . . 0.0 109.783 177.44 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -63.98 160.86 16.92 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.41 -176.241 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.431 ' HA ' ' ND2' ' A' ' 29' ' ' ASN . 4.4 p -61.9 125.73 24.88 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.122 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 61.23 35.93 18.11 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.436 -179.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 13.5 m-80 -121.32 162.09 20.9 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.04 176.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 3.5 p -132.55 127.82 35.92 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.025 0.44 . . . . 0.0 111.54 -178.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.67 HG23 HD12 ' A' ' 57' ' ' LEU . 17.6 p -104.22 153.29 21.15 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.455 177.628 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -104.29 125.12 50.28 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 176.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.474 ' O ' ' HA ' ' A' ' 24' ' ' THR . 59.3 t -96.14 128.66 47.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-O 121.169 0.509 . . . . 0.0 110.963 -175.071 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -95.61 97.21 9.57 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.368 -177.097 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.528 ' HB2' ' HB2' ' A' ' 23' ' ' MET . 26.3 m-85 -92.26 147.18 23.13 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.212 0.529 . . . . 0.0 111.443 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 7.2 m80 -114.93 98.25 6.71 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.041 179.189 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 20.4 t90 -122.78 122.21 38.16 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.064 0.459 . . . . 0.0 111.444 -174.163 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.989 ' HB ' HG22 ' A' ' 20' ' ' VAL . 8.4 t -105.61 141.29 37.32 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.261 177.657 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.516 ' CB ' ' HA ' ' A' ' 17' ' ' PRO . 1.7 mm? -100.89 119.23 38.39 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.112 0.482 . . . . 0.0 111.038 176.348 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -84.37 -25.14 29.34 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.054 176.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -153.19 -155.21 7.04 Favored Glycine 0 N--CA 1.445 -0.731 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.856 -177.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 2.8 t -145.74 90.91 2.04 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-O 121.934 0.874 . . . . 0.0 111.267 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -80.87 2.45 26.47 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.882 172.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.475 ' O ' ' HA2' ' A' ' 105' ' ' GLY . 95.5 m-20 70.83 -59.11 0.55 Allowed 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.803 179.447 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 41.0 t -104.3 114.21 28.29 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 120.888 0.375 . . . . 0.0 110.415 -178.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.4 ' HB2' HG21 ' A' ' 104' ' ' VAL . 65.1 m-85 -116.92 134.0 55.31 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.323 179.105 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.48 ' HB ' ' HA ' ' A' ' 45' ' ' ASP . 7.3 m -96.69 88.05 4.52 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.911 0.386 . . . . 0.0 110.478 -177.014 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.405 HD21 HG13 ' A' ' 104' ' ' VAL . 8.1 mp -87.58 113.59 23.41 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.611 0.719 . . . . 0.0 110.56 -178.169 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.523 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 25.8 m -115.33 123.28 48.32 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.418 -177.785 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 49.5 t -90.17 112.03 24.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 176.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -108.19 117.76 34.98 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 175.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.583 ' HB ' ' HB2' ' A' ' 98' ' ' ASN . 84.8 t -83.57 103.37 10.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.995 -177.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.9 t70 59.81 89.54 0.1 Allowed Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 114.266 -1.334 . . . . 0.0 112.347 177.103 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -70.78 -12.46 30.99 Favored 'Trans proline' 0 C--O 1.232 0.215 0 C-N-CA 123.33 2.687 . . . . 0.0 112.217 179.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -89.73 -6.5 55.99 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.464 -178.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 58.41 42.1 21.82 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.61 177.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -69.26 -26.79 64.94 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.334 178.05 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 61.4 t -110.6 122.63 65.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.681 176.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 54.0 t30 -80.86 130.4 35.03 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 176.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -125.65 159.92 30.99 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.948 0.404 . . . . 0.0 112.008 -173.076 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -58.3 -100.81 0.01 OUTLIER Glycine 0 CA--C 1.522 0.489 0 CA-C-N 114.948 -1.024 . . . . 0.0 113.818 174.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -58.24 160.51 5.02 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 122.972 0.509 . . . . 0.0 111.452 -177.117 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.2 2.68 24.91 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 121.144 0.497 . . . . 0.0 111.413 -175.722 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 18.3 m -125.8 24.33 7.11 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.0 0.428 . . . . 0.0 110.465 -179.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 26.4 p-10 -98.09 -39.94 8.66 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.705 -174.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.583 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 23.9 p-10 -83.77 10.68 8.9 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.316 0.488 . . . . 0.0 112.316 -168.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 2.6 m -119.32 150.12 40.67 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.981 0.419 . . . . 0.0 110.643 -179.237 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.523 ' O ' ' HA ' ' A' ' 81' ' ' THR . 54.2 tp -148.52 106.59 3.72 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.649 178.565 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 31.0 m -93.51 98.65 11.32 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 120.9 0.381 . . . . 0.0 110.222 177.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -109.46 118.98 38.06 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.374 -179.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -81.47 111.24 17.63 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.161 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.405 HG13 HD21 ' A' ' 80' ' ' LEU . 21.5 m -103.38 162.85 3.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -179.302 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.475 ' HA2' ' O ' ' A' ' 76' ' ' ASN . . . -131.87 167.08 22.91 Favored Glycine 0 N--CA 1.439 -1.102 0 C-N-CA 119.858 -1.163 . . . . 0.0 111.955 -178.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 22.4 p -84.26 131.52 34.73 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 173.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 36.5 tp . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.634 -174.366 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 13.3 tt . . . . . 0 N--CA 1.454 -0.227 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -68.69 155.95 67.1 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 121.947 1.764 . . . . 0.0 111.484 176.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -147.51 76.78 1.41 Allowed 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 176.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.725 ' HG ' ' OE1' ' A' ' 92' ' ' GLU . 27.1 mt -72.8 103.66 3.74 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 114.948 -1.024 . . . . 0.0 110.856 -176.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.553 HG21 ' HB3' ' A' ' 97' ' ' ASN . 25.7 t -114.68 121.0 36.53 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.923 -177.228 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.49 ' HB2' ' HB2' ' A' ' 100' ' ' LEU . 1.9 Cg_endo -79.03 108.01 2.32 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 122.333 2.022 . . . . 0.0 109.919 171.185 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 27.3 m -93.95 -27.27 4.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 -171.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 60.7 m -146.49 145.04 30.05 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.983 0.421 . . . . 0.0 111.872 -175.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.454 HD21 ' HB1' ' A' ' 102' ' ' ALA . 50.1 tp -130.54 110.53 11.49 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.407 174.046 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.56 ' OG1' ' HA ' ' A' ' 12' ' ' PRO . 5.6 t -128.69 149.56 72.36 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.017 -177.143 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.56 ' HA ' ' OG1' ' A' ' 11' ' ' THR . 82.8 Cg_endo -77.76 154.2 94.41 Favored 'Cis proline' 0 N--CA 1.463 -0.296 0 C-N-CA 123.42 -1.492 . . . . 0.0 112.675 1.722 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.5 m -79.62 -6.64 9.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.13 178.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.411 ' HA ' ' O ' ' A' ' 105' ' ' GLY . 1.5 p -130.35 125.51 34.81 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.319 178.323 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.4 m -121.1 158.02 24.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.125 0.488 . . . . 0.0 112.115 -172.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.476 HG21 HD23 ' A' ' 107' ' ' LEU . 41.8 t -80.22 120.56 79.96 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.732 177.748 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.568 ' HA ' ' HG ' ' A' ' 71' ' ' LEU . 2.8 Cg_exo -75.5 59.28 5.47 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 123.193 2.596 . . . . 0.0 113.946 -173.286 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -176.98 -56.88 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.718 0.294 . . . . 0.0 111.506 174.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 14.6 t -80.4 178.29 8.4 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.293 -172.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.549 HG21 ' HG1' ' A' ' 70' ' ' THR . 45.2 t -80.74 124.29 38.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.106 178.42 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.561 ' ND2' HD23 ' A' ' 71' ' ' LEU . 38.7 m-80 -102.44 135.03 44.8 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.169 -179.308 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 21.2 m -82.9 97.68 8.8 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.033 -0.53 . . . . 0.0 109.95 177.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.527 ' HB2' ' HB2' ' A' ' 67' ' ' PHE . 91.5 mmm -91.56 132.26 36.42 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.269 -176.366 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.497 ' HA ' ' O ' ' A' ' 65' ' ' VAL . 10.4 m -116.27 117.07 29.0 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.638 -178.088 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -105.58 119.48 39.22 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.265 178.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 17.6 m -85.9 110.28 19.31 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.51 -178.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 24.4 mm -102.13 115.67 44.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.21 -179.065 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -103.15 132.74 49.18 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.091 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.442 ' HB2' ' HG ' ' A' ' 57' ' ' LEU . 51.9 t-20 -90.49 101.53 14.27 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 173.304 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 79.2 mm-40 -93.31 33.23 1.24 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.179 -176.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -144.09 166.87 27.0 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.024 -178.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -97.5 54.22 1.18 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.448 0.642 . . . . 0.0 111.063 -173.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 73.8 tttt -161.47 144.72 12.51 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.121 172.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.495 ' HB3' ' HA ' ' A' ' 58' ' ' GLU . 1.2 m-20 -89.19 129.71 35.73 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 -177.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 36.9 p -85.07 153.92 22.41 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 110.311 -0.255 . . . . 0.0 110.311 -179.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.409 HG22 ' H ' ' A' ' 37' ' ' SER . 0.2 OUTLIER -85.19 -167.82 1.98 Allowed 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 177.382 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.492 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 39.9 m -60.42 113.47 2.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.955 0.407 . . . . 0.0 110.701 178.692 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -124.25 154.21 40.52 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.313 -178.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -100.52 111.37 23.62 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.424 -176.072 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.468 HG11 HG23 ' A' ' 65' ' ' VAL . 1.4 t -98.34 119.11 45.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 176.356 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.42 ' HB3' HG11 ' A' ' 48' ' ' VAL . 41.2 m -113.49 138.15 50.53 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.327 -174.117 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 62.5 tp -97.89 111.82 23.97 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.58 174.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.426 ' HA ' ' O ' ' A' ' 47' ' ' ILE . 5.2 mp -96.9 140.8 30.91 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.024 -179.721 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 91.0 t -122.57 111.56 30.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 173.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 20.0 t70 67.71 -72.78 0.09 Allowed 'General case' 0 N--CA 1.47 0.542 0 O-C-N 124.036 0.835 . . . . 0.0 110.761 -176.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -153.08 9.15 0.52 Allowed Glycine 0 N--CA 1.448 -0.564 0 CA-C-N 115.969 -0.559 . . . . 0.0 112.14 177.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.426 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 3.4 mt -110.89 151.2 13.1 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.315 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 -178.603 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.42 HG11 ' HB3' ' A' ' 41' ' ' SER . 45.4 t -99.21 107.19 20.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 173.792 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 29.8 m -77.8 -33.51 18.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.304 -175.258 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -160.01 135.49 8.25 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.273 -179.101 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 95.4 m -120.88 126.41 49.97 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.832 177.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -109.83 123.27 49.27 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.068 178.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 30.3 m -81.25 104.18 11.54 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.249 -0.432 . . . . 0.0 109.905 176.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.492 ' O ' ' HA ' ' A' ' 37' ' ' SER . 21.9 t -81.4 123.26 37.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 178.632 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 20.9 m -56.14 -42.85 77.58 Favored 'General case' 0 C--N 1.329 -0.3 0 O-C-N 123.458 0.474 . . . . 0.0 111.594 -173.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 50.7 p 179.2 136.89 0.1 Allowed 'General case' 0 C--N 1.33 -0.261 0 O-C-N 123.246 0.341 . . . . 0.0 110.526 174.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.455 HD21 HD22 ' A' ' 5' ' ' LEU . 26.7 tp -105.94 110.23 22.43 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.123 0.487 . . . . 0.0 109.762 175.469 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.495 ' HA ' ' HB3' ' A' ' 34' ' ' ASP . 42.7 mt-10 -66.95 160.49 26.24 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.201 -177.044 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 2.7 p -60.73 124.87 21.68 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.372 -178.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 65.03 16.97 10.87 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.527 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -96.17 148.45 22.7 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 178.203 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 17.9 m -111.48 134.52 53.0 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.002 179.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 91.7 m -139.88 129.63 24.55 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.131 0.491 . . . . 0.0 111.123 -179.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -90.31 132.57 35.48 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.627 -179.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.497 ' O ' ' HA ' ' A' ' 24' ' ' THR . 40.2 t -96.53 133.07 39.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.448 -179.129 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -102.56 105.31 15.8 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.468 -177.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.527 ' HB2' ' HB2' ' A' ' 23' ' ' MET . 49.9 m-85 -102.03 147.83 26.1 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.912 179.046 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 35.5 m-70 -115.13 92.41 3.92 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 175.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 14.7 t90 -100.22 105.44 17.01 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.238 -173.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.549 ' HG1' HG21 ' A' ' 20' ' ' VAL . 6.8 m -73.96 108.7 6.94 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.014 171.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.568 ' HG ' ' HA ' ' A' ' 17' ' ' PRO . 0.1 OUTLIER -59.42 -69.13 0.22 Allowed 'General case' 0 C--O 1.234 0.284 0 O-C-N 123.131 0.27 . . . . 0.0 111.517 -172.645 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.436 ' HB3' ' O ' ' A' ' 71' ' ' LEU . 20.0 t70 72.87 -47.37 0.67 Allowed 'General case' 0 N--CA 1.47 0.57 0 O-C-N 123.918 0.761 . . . . 0.0 111.981 -178.126 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.556 ' HA3' ' OH ' ' A' ' 78' ' ' TYR . . . -74.34 -174.52 31.83 Favored Glycine 0 CA--C 1.518 0.244 0 C-N-CA 121.249 -0.501 . . . . 0.0 113.478 -177.511 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 9.5 t -142.43 12.82 1.95 Allowed 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.087 0.47 . . . . 0.0 111.347 -175.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.436 ' HB2' ' CE1' ' A' ' 78' ' ' TYR . . . -71.81 141.49 49.66 Favored 'General case' 0 C--N 1.33 -0.272 0 O-C-N 122.081 -0.387 . . . . 0.0 110.286 -179.446 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.462 ' HA ' HG21 ' A' ' 106' ' ' THR . 25.0 p-10 -77.73 -5.66 51.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.78 0.324 . . . . 0.0 111.514 -175.311 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 43.7 m -150.83 116.01 5.34 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.862 0.363 . . . . 0.0 110.722 -178.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.556 ' OH ' ' HA3' ' A' ' 73' ' ' GLY . 43.0 m-85 -111.47 138.26 48.21 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.89 176.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 37.2 m -92.65 97.97 11.14 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.88 179.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.429 HD11 HG22 ' A' ' 104' ' ' VAL . 10.2 mp -97.31 135.79 38.72 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.453 -179.479 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.483 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 27.4 m -130.36 116.96 19.04 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.64 -176.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.401 ' HB ' ' HB3' ' A' ' 100' ' ' LEU . 59.5 t -89.11 104.17 14.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 175.684 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -99.26 117.6 34.08 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 178.2 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.45 HG23 ' HG3' ' A' ' 7' ' ' PRO . 84.5 t -85.1 106.4 14.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.355 -176.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 51.3 t0 61.6 85.77 0.17 Allowed Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 114.563 -1.199 . . . . 0.0 111.487 178.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -74.91 -7.14 18.96 Favored 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 123.023 2.482 . . . . 0.0 111.715 178.174 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -94.57 -22.62 18.08 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 178.224 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 59.99 69.15 0.72 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.182 -179.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -93.05 -28.76 16.17 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.793 178.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.7 t -106.33 135.15 45.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.31 176.211 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -82.48 112.0 19.01 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.873 0.368 . . . . 0.0 110.008 178.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.725 ' OE1' ' HG ' ' A' ' 5' ' ' LEU . 66.6 mm-40 -100.43 173.63 6.49 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.478 -176.349 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -57.77 -101.11 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.387 0 CA-C-N 115.255 -0.884 . . . . 0.0 112.485 174.015 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.457 ' O ' ' HB2' ' A' ' 97' ' ' ASN . 60.5 m-20 -96.77 135.31 38.9 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -60.86 -29.24 69.41 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.138 0.494 . . . . 0.0 110.656 177.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 5.3 m -65.85 -19.72 65.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.252 0.548 . . . . 0.0 110.539 178.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.553 ' HB3' HG21 ' A' ' 6' ' ' VAL . 7.2 m-20 -81.24 -21.78 39.23 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.788 -178.296 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.718 HD22 ' HG3' ' A' ' 92' ' ' GLU . 16.7 m120 -78.11 -4.74 48.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.403 -177.617 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 3.2 m -110.32 154.74 23.06 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.079 0.466 . . . . 0.0 111.33 -175.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.49 ' HB2' ' HB2' ' A' ' 7' ' ' PRO . 48.8 tp -146.96 103.42 3.61 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.478 175.095 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 7.7 m -90.26 96.2 10.55 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 178.229 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.454 ' HB1' HD21 ' A' ' 10' ' ' LEU . . . -114.95 121.08 42.07 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.162 0.506 . . . . 0.0 110.82 -176.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 87.1 mt -86.26 121.21 28.52 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.215 177.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.429 HG22 HD11 ' A' ' 80' ' ' LEU . 18.5 m -111.48 137.26 44.79 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.72 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.411 ' O ' ' HA ' ' A' ' 14' ' ' THR . . . -107.61 -177.78 22.42 Favored Glycine 0 N--CA 1.439 -1.128 0 C-N-CA 120.532 -0.842 . . . . 0.0 111.22 -177.204 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.482 HG22 ' HG3' ' A' ' 17' ' ' PRO . 24.7 p -82.54 153.95 25.28 Favored 'General case' 0 C--N 1.312 -1.056 0 C-N-CA 120.856 -0.338 . . . . 0.0 110.338 178.112 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.476 HD23 HG21 ' A' ' 16' ' ' VAL . 27.1 tp . . . . . 0 C--N 1.326 -0.448 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.395 179.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 13.4 tt . . . . . 0 C--O 1.237 0.396 0 N-CA-C 110.424 -0.213 . . . . 0.0 110.424 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.626 ' O ' ' HA ' ' A' ' 92' ' ' GLU . 18.4 Cg_exo -68.54 148.7 73.24 Favored 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.64 2.226 . . . . 0.0 111.203 170.094 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -130.0 93.09 3.42 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 175.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.507 ' HB3' HG12 ' A' ' 84' ' ' VAL . 70.5 mt -76.08 102.18 5.6 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.108 -173.483 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 60.9 t -107.68 110.41 62.64 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.124 -179.197 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.525 ' HB2' ' HB2' ' A' ' 100' ' ' LEU . 56.8 Cg_endo -73.12 103.51 1.62 Allowed 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 121.898 1.732 . . . . 0.0 109.825 168.688 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.2 t -79.31 -51.25 16.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.573 -168.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 21.6 t -157.25 176.36 12.82 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.019 0.437 . . . . 0.0 111.028 -178.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 35.6 tp -145.44 104.32 3.9 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.071 -178.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.3 p -112.98 145.52 33.25 Favored Pre-proline 0 C--N 1.321 -0.659 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.431 -175.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.424 ' O ' ' HE3' ' A' ' 23' ' ' MET . 84.1 Cg_endo -86.0 157.22 56.85 Favored 'Cis proline' 0 N--CA 1.46 -0.474 0 C-N-CA 123.132 -1.612 . . . . 0.0 112.319 -2.691 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.467 ' HA ' HG12 ' A' ' 104' ' ' VAL . 35.9 m -83.94 13.0 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.25 0.547 . . . . 0.0 110.952 -179.756 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.52 HG23 ' HA ' ' A' ' 107' ' ' LEU . 0.3 OUTLIER -148.54 119.56 7.68 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 178.311 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.529 HG22 ' CZ3' ' A' ' 69' ' ' TRP . 24.9 m -128.41 153.53 37.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -167.21 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.451 HG23 HD21 ' A' ' 107' ' ' LEU . 7.4 t -76.01 129.77 79.97 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.052 179.086 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.553 ' HA ' ' CB ' ' A' ' 71' ' ' LEU . 6.1 Cg_exo -74.1 -173.88 1.57 Allowed 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 122.643 2.229 . . . . 0.0 111.577 174.75 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 8.1 p30 51.36 17.26 0.5 Allowed 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.349 1.059 . . . . 0.0 113.844 175.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 15.0 t -150.82 168.7 23.65 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 121.721 -0.612 . . . . 0.0 110.93 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.69 HG23 ' HG1' ' A' ' 70' ' ' THR . 25.9 t -99.0 112.39 30.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 175.144 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.445 ' ND2' ' HB ' ' A' ' 15' ' ' VAL . 26.5 p30 -101.62 162.84 12.61 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.049 -175.348 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.456 ' HA ' ' O ' ' A' ' 67' ' ' PHE . 7.9 m -113.48 95.77 5.53 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.006 -179.534 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.523 ' HE2' HG13 ' A' ' 104' ' ' VAL . 80.0 mtp -92.74 150.56 20.58 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.755 -176.814 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 3.1 m -118.02 115.91 25.82 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.424 -175.07 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -96.97 134.08 40.8 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.022 0.439 . . . . 0.0 110.457 176.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 4.1 m -91.33 100.2 13.04 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.087 179.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 21.9 mm -98.3 111.51 28.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 176.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.526 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 27.7 tt0 -119.19 132.27 55.94 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.149 0.5 . . . . 0.0 111.1 -176.557 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.54 ' HB2' ' HG ' ' A' ' 57' ' ' LEU . 54.2 t-20 -86.81 113.8 22.93 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.858 -179.471 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 83.0 mm-40 -101.13 54.92 0.84 Allowed 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.193 0.521 . . . . 0.0 110.745 179.077 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -143.99 -172.57 14.81 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.777 -0.725 . . . . 0.0 111.755 -177.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 29.9 p-10 -113.4 6.85 17.4 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.846 0.355 . . . . 0.0 111.729 -174.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -122.33 133.11 54.67 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 171.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -73.87 132.28 42.36 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.504 -179.179 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.526 ' HG ' ' HB3' ' A' ' 57' ' ' LEU . 4.5 p -93.11 138.81 31.21 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.084 0.469 . . . . 0.0 111.151 -178.199 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.0 p -83.1 -165.47 1.09 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.238 -179.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.572 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 22.4 m -56.91 121.5 10.04 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.99 0.424 . . . . 0.0 111.624 -179.073 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.415 ' CE2' HG23 ' A' ' 40' ' ' VAL . 31.3 p90 -133.87 153.73 51.54 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.295 -179.688 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.404 ' O ' ' HD3' ' A' ' 86' ' ' PRO . 89.3 m-20 -94.26 113.84 25.82 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.818 0.342 . . . . 0.0 111.245 -176.115 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.415 HG23 ' CE2' ' A' ' 38' ' ' PHE . 1.5 t -103.56 125.51 58.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.138 0.494 . . . . 0.0 109.815 176.453 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 9.7 m -113.3 139.39 48.88 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.676 -177.046 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 61.1 tp -103.01 116.97 33.55 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 174.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.484 ' HG ' HG22 ' A' ' 48' ' ' VAL . 5.1 mp -105.72 137.89 42.83 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.554 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 78.9 t -100.94 100.29 10.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 171.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 8.7 t70 69.2 -76.12 0.06 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.38 -176.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -136.95 -7.68 1.52 Allowed Glycine 0 CA--C 1.519 0.34 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.885 178.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 6.9 mt -100.03 148.75 6.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 110.029 -0.359 . . . . 0.0 110.029 -178.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.484 HG22 ' HG ' ' A' ' 43' ' ' LEU . 48.5 t -97.84 121.08 47.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.413 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 28.3 m -104.05 -28.51 2.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 C-N-CA 120.831 -0.347 . . . . 0.0 111.688 -177.213 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -144.27 150.07 37.3 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 -177.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 24.2 m -149.43 110.55 4.38 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 177.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -114.85 138.15 51.12 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.896 0.379 . . . . 0.0 110.546 -177.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 28.9 m -87.18 107.32 18.42 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 173.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.572 ' O ' ' HA ' ' A' ' 37' ' ' SER . 39.0 t -77.64 127.16 38.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 9.6 m -63.07 -39.39 94.56 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.896 -170.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 79.5 p -170.99 161.79 7.02 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.713 0.292 . . . . 0.0 110.52 178.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.54 ' HG ' ' HB2' ' A' ' 29' ' ' ASN . 37.9 tp -142.87 114.09 7.79 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.066 -0.515 . . . . 0.0 109.705 175.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -79.54 157.26 27.44 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.57 -0.741 . . . . 0.0 112.132 -172.126 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 16.5 m -59.63 119.9 8.45 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.362 -179.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.422 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 45.2 mt-10 60.5 28.65 18.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.66 179.072 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -124.9 159.64 30.68 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 172.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.526 ' HA ' ' HA ' ' A' ' 28' ' ' GLU . 33.2 p -112.76 163.86 14.07 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.059 0.457 . . . . 0.0 111.241 -176.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 79.9 m -133.97 124.46 26.36 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.918 173.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 31.4 m-80 -80.5 106.08 12.24 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.416 177.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.8 t -96.57 115.6 36.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.769 -175.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.48 ' HA ' ' O ' ' A' ' 23' ' ' MET . 19.2 m-20 -96.25 118.85 33.64 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.82 0.343 . . . . 0.0 111.223 -179.344 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.456 ' O ' ' HA ' ' A' ' 22' ' ' THR . 84.7 m-85 -102.1 174.27 6.01 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.952 178.401 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 86.3 m-70 -128.45 109.64 11.59 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 176.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . 0.529 ' CZ3' HG22 ' A' ' 15' ' ' VAL . 15.2 t90 -120.05 122.04 40.22 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.251 0.548 . . . . 0.0 111.281 -172.574 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.69 ' HG1' HG23 ' A' ' 20' ' ' VAL . 10.3 m -86.49 113.94 22.83 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.648 178.222 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.553 ' CB ' ' HA ' ' A' ' 17' ' ' PRO . 1.1 mm? -77.7 122.81 25.85 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.115 0.483 . . . . 0.0 111.678 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 16.4 p-10 -87.35 -33.72 19.07 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.154 173.063 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 82.64 19.55 63.55 Favored Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 115.589 -0.732 . . . . 0.0 113.55 172.054 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 30.0 m -70.45 -41.2 73.15 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.095 0.474 . . . . 0.0 110.401 179.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -110.25 157.24 19.67 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.041 176.382 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -97.05 -9.01 28.94 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.195 0.521 . . . . 0.0 109.734 178.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 71.9 p -137.62 110.1 7.47 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.935 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 46.5 m-85 -106.23 138.59 42.14 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.316 0.579 . . . . 0.0 111.095 -179.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.42 ' HA ' HD21 ' A' ' 103' ' ' LEU . 7.7 m -91.31 83.85 5.54 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.208 -0.906 . . . . 0.0 109.6 -179.59 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 7.9 mp -80.53 120.36 24.4 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.656 0.741 . . . . 0.0 110.267 -178.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.572 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 17.1 m -117.99 116.38 26.79 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.24 -173.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.414 ' HB ' ' HB3' ' A' ' 100' ' ' LEU . 92.8 t -87.43 110.98 21.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 177.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -96.57 117.14 30.33 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 175.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.507 HG12 ' HB3' ' A' ' 5' ' ' LEU . 47.5 t -93.47 108.14 20.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.975 -178.828 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 56.8 t0 66.38 95.91 0.05 OUTLIER Pre-proline 0 N--CA 1.466 0.374 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.447 178.005 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.404 ' HD3' ' O ' ' A' ' 39' ' ' ASN . 3.7 Cg_endo -85.1 0.56 8.81 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 123.319 2.679 . . . . 0.0 111.822 178.662 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -109.3 -14.82 14.39 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.043 -179.038 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 57.85 42.7 22.82 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.703 -178.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -80.58 -29.68 36.95 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.911 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 60.5 t -100.22 129.29 51.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.771 -0.649 . . . . 0.0 109.553 175.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -73.28 133.13 43.82 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.324 179.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.626 ' HA ' ' O ' ' A' ' 3' ' ' PRO . 0.0 OUTLIER -128.6 164.45 22.83 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.847 -179.544 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -57.72 -101.14 0.01 OUTLIER Glycine 0 CA--C 1.517 0.184 0 CA-C-N 115.251 -0.886 . . . . 0.0 112.999 173.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.487 ' O ' ' HB3' ' A' ' 97' ' ' ASN . 27.8 t-20 -89.38 126.11 35.41 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.868 0.366 . . . . 0.0 110.42 -179.446 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -76.32 -12.58 60.09 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.934 -173.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 22.3 m -92.31 -6.06 51.05 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.563 0.697 . . . . 0.0 109.774 174.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.487 ' HB3' ' O ' ' A' ' 94' ' ' ASN . 1.9 t30 -86.81 -21.66 26.32 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.082 -178.589 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.426 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 16.9 p-10 -74.24 -3.75 31.9 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.976 0.417 . . . . 0.0 111.189 -176.573 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 1.3 m -101.66 149.05 24.53 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.215 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.572 ' O ' ' HA ' ' A' ' 81' ' ' THR . 48.9 tp -136.48 111.6 9.0 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.394 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 6.2 m -90.43 89.86 7.77 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.941 178.07 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -102.69 112.02 24.6 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.04 0.448 . . . . 0.0 110.794 -177.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.42 HD21 ' HA ' ' A' ' 79' ' ' THR . 61.7 mt -83.79 116.24 22.62 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.44 178.606 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.523 HG13 ' HE2' ' A' ' 23' ' ' MET . 17.9 m -118.25 136.26 56.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.176 -177.31 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.501 ' O ' ' HA ' ' A' ' 14' ' ' THR . . . -111.6 173.74 15.99 Favored Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 120.378 -0.915 . . . . 0.0 111.858 -177.515 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 21.0 p -77.97 138.12 38.67 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.329 176.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.52 ' HA ' HG23 ' A' ' 14' ' ' THR . 32.3 tp . . . . . 0 C--N 1.326 -0.419 0 CA-C-N 115.677 -0.692 . . . . 0.0 112.098 -172.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.452 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 17.5 tt . . . . . 0 N--CA 1.452 -0.329 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.518 ' HD3' ' HD3' ' A' ' 33' ' ' LYS . 15.9 Cg_exo -70.25 159.76 51.93 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 122.611 2.207 . . . . 0.0 112.178 176.245 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -143.62 90.36 2.15 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 176.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.472 HD21 HD21 ' A' ' 57' ' ' LEU . 78.3 mt -85.59 109.82 18.82 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.417 0.627 . . . . 0.0 110.753 -170.013 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 45.9 t -114.79 111.29 45.81 Favored Pre-proline 0 C--N 1.32 -0.68 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.602 -175.055 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.491 ' HD2' ' O ' ' A' ' 97' ' ' ASN . 34.2 Cg_endo -68.08 101.66 0.72 Allowed 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 122.2 1.933 . . . . 0.0 109.81 167.113 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.7 t -79.34 -55.37 9.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.441 -169.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.3 t -146.21 163.42 35.48 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.54 -174.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 58.8 tp -134.59 104.61 6.14 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.712 -178.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 15.6 p -107.45 143.03 26.38 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.45 -177.153 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -86.25 157.73 55.23 Favored 'Cis proline' 0 N--CA 1.457 -0.624 0 C-N-CA 122.964 -1.682 . . . . 0.0 112.021 -3.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 34.9 m -82.69 5.84 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.355 0.597 . . . . 0.0 110.257 178.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.522 ' HA ' ' O ' ' A' ' 105' ' ' GLY . 2.6 m -147.35 116.94 7.06 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 176.065 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.426 HG23 HD23 ' A' ' 71' ' ' LEU . 22.0 m -113.47 152.2 15.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.139 0.495 . . . . 0.0 111.77 -170.61 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.583 HG22 HD21 ' A' ' 107' ' ' LEU . 1.8 t -97.77 115.59 65.75 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.65 178.71 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.538 ' HA ' ' CB ' ' A' ' 71' ' ' LEU . 23.9 Cg_exo -64.93 -175.3 0.36 Allowed 'Trans proline' 0 C--O 1.234 0.277 0 C-N-CA 122.495 2.13 . . . . 0.0 112.564 179.754 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 19.5 m-80 74.25 17.77 3.19 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.474 176.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 12.1 t -164.28 166.58 20.8 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 110.532 -0.173 . . . . 0.0 110.532 -177.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.47 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 52.6 t -85.84 109.7 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 172.365 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.657 ' OD1' HD21 ' A' ' 71' ' ' LEU . 9.8 m120 -85.52 125.64 33.22 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.068 -174.054 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 53.3 m -79.19 106.09 10.98 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.572 172.311 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.496 ' HE1' HG12 ' A' ' 104' ' ' VAL . 62.1 mtp -104.88 144.13 32.2 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.956 0.407 . . . . 0.0 110.339 -179.844 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.485 HG21 ' HB3' ' A' ' 64' ' ' ASN . 31.2 m -115.02 111.4 21.05 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.055 -174.666 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -97.92 118.37 34.33 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 173.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 38.7 m -87.59 107.81 18.77 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 120.878 0.37 . . . . 0.0 110.174 -179.257 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 20.2 mm -103.11 115.13 44.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.863 -179.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.518 ' HG2' ' HB3' ' A' ' 62' ' ' SER . 46.2 mt-10 -104.14 134.07 48.0 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.751 0.31 . . . . 0.0 110.836 177.527 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.48 ' HB2' ' HG ' ' A' ' 57' ' ' LEU . 29.9 t30 -90.44 92.06 8.72 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 173.496 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 80.4 mt-30 -87.86 53.18 2.68 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.615 0.721 . . . . 0.0 110.168 -176.087 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -143.89 160.5 27.76 Favored Glycine 0 N--CA 1.444 -0.829 0 CA-C-N 114.953 -1.022 . . . . 0.0 110.638 179.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 26.6 p-10 -84.9 -0.88 55.66 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 117.011 0.405 . . . . 0.0 111.91 -171.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.518 ' HD3' ' HD3' ' A' ' 3' ' ' PRO . 48.2 tttm -112.59 144.8 41.46 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 176.346 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 -75.15 148.77 39.34 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 176.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 35.7 p -109.12 141.99 40.52 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.95 0.405 . . . . 0.0 110.763 -178.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.9 p -76.61 -164.81 0.45 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.382 -179.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.43 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 16.8 m -65.13 129.66 40.51 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.736 0.303 . . . . 0.0 110.965 -179.16 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.55 ' HB2' ' HB2' ' A' ' 85' ' ' ASP . 49.4 p90 -141.12 152.54 44.82 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.216 179.707 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.448 ' O ' ' HA ' ' A' ' 85' ' ' ASP . 30.1 m-80 -103.35 113.32 26.72 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.561 -175.065 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.49 HG13 HG23 ' A' ' 65' ' ' VAL . 1.4 t -98.36 122.39 49.97 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-O 121.269 0.557 . . . . 0.0 109.659 178.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 10.4 m -115.35 142.79 46.22 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.057 -174.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.488 HD13 ' HB3' ' A' ' 80' ' ' LEU . 45.0 tp -102.49 110.92 23.01 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.816 176.401 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.444 ' HG ' HG23 ' A' ' 48' ' ' VAL . 4.7 mp -98.9 114.58 27.26 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.24 -179.812 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.433 HG23 ' HG ' ' A' ' 80' ' ' LEU . 96.5 t -97.51 105.53 17.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.085 178.65 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 58.74 21.49 8.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.708 177.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 122.42 -33.66 4.08 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.908 176.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 8.5 mt -91.62 150.56 3.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 O-C-N 122.737 -0.272 . . . . 0.0 110.348 -176.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.444 HG23 ' HG ' ' A' ' 43' ' ' LEU . 44.5 t -96.74 118.15 42.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -179.251 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 27.2 m -97.11 -23.23 4.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.608 -177.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -153.36 142.34 21.24 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.254 -179.028 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.2 m -133.46 108.26 8.55 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.759 178.121 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -109.19 138.72 45.11 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.235 -175.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 17.3 m -105.61 110.14 22.35 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.912 0.387 . . . . 0.0 111.078 -178.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.43 ' O ' ' HA ' ' A' ' 37' ' ' SER . 45.4 t -77.78 128.74 38.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 176.842 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 12.3 m -60.22 -42.72 95.78 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.607 -177.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 30.2 t 178.21 129.93 0.06 Allowed 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 -178.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.522 HD11 ' OG1' ' A' ' 63' ' ' THR . 24.1 tp -108.51 117.37 33.98 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.159 0.504 . . . . 0.0 110.038 178.676 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -73.0 162.24 29.72 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.494 -175.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 2.9 p -61.5 124.35 20.4 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.329 -0.85 . . . . 0.0 111.352 179.23 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 61.01 28.62 18.4 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.854 179.014 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -108.95 156.78 19.31 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 174.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.518 ' HB3' ' HG2' ' A' ' 28' ' ' GLU . 32.5 p -114.09 125.83 54.42 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.535 179.211 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.522 ' OG1' HD11 ' A' ' 57' ' ' LEU . 53.2 m -112.78 129.44 56.43 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.975 0.417 . . . . 0.0 110.149 176.326 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.485 ' HB3' HG21 ' A' ' 24' ' ' THR . 94.1 m-20 -90.19 128.88 36.48 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.704 177.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.49 HG23 HG13 ' A' ' 40' ' ' VAL . 43.9 t -96.09 123.46 48.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.676 -177.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -86.19 97.64 10.47 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.446 -178.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -93.4 141.99 27.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.179 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 7.0 m80 -118.15 96.51 5.36 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . 0.44 ' HE3' ' SD ' ' A' ' 23' ' ' MET . 12.1 t90 -114.43 113.64 24.77 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.271 0.558 . . . . 0.0 110.621 -175.618 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.47 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 6.8 m -78.75 102.32 8.04 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.465 -0.788 . . . . 0.0 110.074 176.573 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.657 HD21 ' OD1' ' A' ' 21' ' ' ASN . 0.5 OUTLIER -61.05 113.9 2.81 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.095 0.474 . . . . 0.0 110.393 178.84 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -79.19 -32.98 44.3 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.569 -0.742 . . . . 0.0 111.075 -175.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -160.79 -146.29 4.57 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.05 -178.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 25.9 m -136.09 83.97 2.05 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.152 0.501 . . . . 0.0 110.497 179.253 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.427 ' O ' ' HB2' ' A' ' 76' ' ' ASN . . . -86.86 1.4 52.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.367 178.515 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.535 ' O ' ' HA2' ' A' ' 105' ' ' GLY . 17.0 m120 73.69 -50.4 0.69 Allowed 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.307 0.643 . . . . 0.0 112.229 -179.302 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 16.2 p -132.15 124.53 29.28 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 120.963 0.411 . . . . 0.0 111.708 -179.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -117.24 144.44 44.8 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.083 177.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.523 ' HA ' HD22 ' A' ' 103' ' ' LEU . 28.6 m -94.74 90.17 5.98 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.926 0.394 . . . . 0.0 110.094 -179.378 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.488 ' HB3' HD13 ' A' ' 42' ' ' LEU . 10.4 mp -94.18 117.23 29.8 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.308 0.575 . . . . 0.0 110.506 -178.093 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.515 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 18.8 m -114.2 119.03 35.65 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.459 -0.792 . . . . 0.0 110.394 -177.077 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 50.6 t -90.56 101.46 12.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 176.192 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -97.79 116.95 31.02 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 177.353 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.576 ' HB ' ' HB2' ' A' ' 98' ' ' ASN . 93.9 t -82.86 105.92 13.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 121.327 0.584 . . . . 0.0 111.264 -177.148 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.55 ' HB2' ' HB2' ' A' ' 38' ' ' PHE . 8.7 t70 54.42 90.86 0.08 OUTLIER Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 114.293 -1.321 . . . . 0.0 111.824 179.712 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_exo -58.17 -30.49 90.72 Favored 'Trans proline' 0 C--O 1.233 0.254 0 C-N-CA 123.052 2.501 . . . . 0.0 112.032 179.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -71.0 -25.56 62.74 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.093 177.427 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 56.48 44.98 23.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.974 -177.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -65.18 -32.16 73.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.153 -0.931 . . . . 0.0 110.439 -179.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 49.5 t -86.9 123.96 40.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.394 175.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.488 ' O ' ' HD2' ' A' ' 3' ' ' PRO . 3.9 m-20 -77.89 130.95 37.24 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.892 -0.411 . . . . 0.0 109.892 178.678 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -124.09 161.42 25.65 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.75 -173.123 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -58.21 -100.77 0.01 OUTLIER Glycine 0 CA--C 1.521 0.448 0 CA-C-N 115.033 -0.985 . . . . 0.0 112.528 172.171 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -57.94 156.37 9.24 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 176.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 -102.46 -24.93 13.78 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.15 0.5 . . . . 0.0 110.965 179.371 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 5.9 p -98.89 21.44 11.55 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.313 0.578 . . . . 0.0 110.972 -177.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.491 ' O ' ' HD2' ' A' ' 7' ' ' PRO . 26.4 p-10 -96.27 -33.82 11.84 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.106 -177.493 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.576 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 19.5 p-10 -83.7 9.77 10.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.968 -169.433 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 1.6 m -117.65 147.42 42.9 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.747 0.308 . . . . 0.0 110.22 177.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.515 ' O ' ' HA ' ' A' ' 81' ' ' THR . 50.2 tp -144.74 98.82 3.25 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.233 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 6.9 m -92.54 104.58 16.87 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.685 177.404 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -126.62 138.2 53.41 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.135 0.493 . . . . 0.0 111.359 -176.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.523 HD22 ' HA ' ' A' ' 79' ' ' THR . 74.0 mt -89.83 124.6 34.81 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.992 175.623 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.496 HG12 ' HE1' ' A' ' 23' ' ' MET . 28.3 m -108.97 141.51 24.05 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 176.219 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.535 ' HA2' ' O ' ' A' ' 76' ' ' ASN . . . -102.47 166.72 17.3 Favored Glycine 0 N--CA 1.439 -1.101 0 C-N-CA 120.273 -0.965 . . . . 0.0 111.789 -176.064 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.515 ' OG1' ' HA ' ' A' ' 76' ' ' ASN . 24.5 p -91.85 140.86 29.26 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 173.169 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.583 HD21 HG22 ' A' ' 16' ' ' VAL . 7.7 tp . . . . . 0 C--N 1.326 -0.431 0 O-C-N 123.378 0.424 . . . . 0.0 111.126 -173.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.506 HG13 ' HD2' ' A' ' 3' ' ' PRO . 4.0 tp . . . . . 0 N--CA 1.451 -0.403 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.506 ' HD2' HG13 ' A' ' 2' ' ' ILE . 11.9 Cg_exo -70.96 177.24 6.63 Favored 'Trans proline' 0 C--O 1.236 0.398 0 C-N-CA 122.498 2.132 . . . . 0.0 112.226 178.108 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . 0.473 ' HB3' ' C ' ' A' ' 30' ' ' GLN . 24.8 t70 -149.14 77.91 1.37 Allowed 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 175.536 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.549 HD22 ' HG ' ' A' ' 35' ' ' SER . 83.4 mt -75.36 109.63 9.05 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.932 -176.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 25.8 t -118.79 120.65 31.34 Favored Pre-proline 0 C--N 1.319 -0.744 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.247 -178.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.493 ' HB2' ' HB2' ' A' ' 100' ' ' LEU . 5.7 Cg_exo -73.68 111.22 3.24 Favored 'Trans proline' 0 N--CA 1.45 -1.06 0 C-N-CA 121.947 1.765 . . . . 0.0 109.726 172.43 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.0 t -80.55 -57.71 4.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.457 -169.023 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 32.8 t -144.94 167.32 22.92 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.631 -175.267 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 58.5 tp -138.62 114.61 10.1 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.149 -177.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.5 p -125.41 157.93 66.09 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.656 -179.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.63 159.51 96.43 Favored 'Cis proline' 0 N--CA 1.465 -0.185 0 C-N-CA 123.357 -1.518 . . . . 0.0 111.871 -3.356 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 29.7 m -78.31 -19.89 13.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.221 0.534 . . . . 0.0 110.249 -178.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.501 ' HA ' ' O ' ' A' ' 105' ' ' GLY . 17.3 p -124.5 130.61 52.78 Favored 'General case' 0 N--CA 1.437 -1.124 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.993 174.768 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.424 ' O ' ' HD3' ' A' ' 17' ' ' PRO . 31.3 m -113.06 146.56 17.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 120.766 0.317 . . . . 0.0 111.112 -177.02 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.585 HG23 HD21 ' A' ' 107' ' ' LEU . 18.1 t -92.13 113.0 57.76 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 116.633 -0.258 . . . . 0.0 110.963 -175.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.525 ' HA ' ' HB3' ' A' ' 71' ' ' LEU . 4.7 Cg_exo -72.44 97.86 0.9 Allowed 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 122.429 2.086 . . . . 0.0 109.934 173.727 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 -177.49 -46.07 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.417 -169.178 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 14.8 t -148.76 -169.63 3.41 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.954 -175.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.494 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 43.2 t -78.84 128.34 38.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 176.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.406 ' ND2' HD22 ' A' ' 71' ' ' LEU . 23.6 m-80 -102.82 125.19 49.47 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.64 -179.817 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.5 m -80.16 103.89 10.34 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 178.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.524 ' HB2' ' HB2' ' A' ' 67' ' ' PHE . 95.8 mmm -87.63 133.05 33.88 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.734 -174.694 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.523 ' HA ' ' O ' ' A' ' 65' ' ' VAL . 42.4 m -105.86 109.33 21.24 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.825 -177.719 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.404 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . . . -102.58 112.15 24.78 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.594 174.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 21.8 m -83.48 105.69 14.63 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.077 -178.017 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 21.5 mm -100.51 121.12 50.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 -179.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.526 ' HG3' ' HG ' ' A' ' 62' ' ' SER . 30.8 tt0 -113.1 134.78 54.38 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 -179.236 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.482 ' HB2' ' HG ' ' A' ' 57' ' ' LEU . 41.3 t30 -94.48 107.16 19.14 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.05 0.452 . . . . 0.0 109.819 177.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.473 ' C ' ' HB3' ' A' ' 4' ' ' ASP . 73.0 mt-30 -113.89 56.65 0.7 Allowed 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.243 -175.579 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -143.88 -165.65 10.97 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.36 -0.924 . . . . 0.0 112.493 -174.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.421 ' N ' HD21 ' A' ' 32' ' ' ASN . 0.9 OUTLIER -93.2 4.0 54.74 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 -169.448 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -155.41 150.19 26.43 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.785 -177.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -73.72 146.45 44.4 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 175.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.549 ' HG ' HD22 ' A' ' 5' ' ' LEU . 35.3 p -93.49 149.1 21.5 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.031 0.444 . . . . 0.0 110.807 -179.277 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.424 ' OG1' HG23 ' A' ' 90' ' ' VAL . 38.8 p -86.13 -158.9 0.43 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.885 177.057 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.447 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 37.8 t -69.71 107.95 3.69 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.752 0.31 . . . . 0.0 110.256 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.422 ' HB3' ' CG2' ' A' ' 90' ' ' VAL . 55.7 p90 -118.11 140.37 49.87 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.103 0.477 . . . . 0.0 109.878 179.723 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.499 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 65.3 t30 -90.35 128.37 36.44 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.897 -176.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.518 HG23 ' HA ' ' A' ' 84' ' ' VAL . 0.3 OUTLIER -116.62 136.91 52.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 -175.403 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.402 ' HB3' ' CG1' ' A' ' 48' ' ' VAL . 27.9 m -124.42 135.34 53.19 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.288 -173.467 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 57.8 tp -98.95 112.79 24.8 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.069 0.461 . . . . 0.0 110.168 175.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.525 ' HG ' HG21 ' A' ' 48' ' ' VAL . 5.0 mp -96.59 120.17 36.42 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.579 179.46 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 72.2 t -103.47 109.12 26.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 174.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 16.1 t70 74.39 -66.21 0.31 Allowed 'General case' 0 N--CA 1.464 0.273 0 O-C-N 124.188 0.93 . . . . 0.0 110.74 -179.516 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -162.62 14.04 0.12 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 121.144 -0.55 . . . . 0.0 112.682 179.064 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 10.8 mt -131.09 150.81 34.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 -179.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.525 HG21 ' HG ' ' A' ' 43' ' ' LEU . 29.6 t -93.12 94.9 4.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.504 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 32.8 m -70.82 -27.23 29.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.924 -173.355 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -157.93 152.85 25.32 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 178.263 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 25.2 m -139.09 128.71 24.57 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.287 -174.15 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.404 ' O ' HG12 ' A' ' 40' ' ' VAL . 2.5 tt0 -127.38 132.47 50.15 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 179.06 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.499 ' HA ' ' HA ' ' A' ' 39' ' ' ASN . 20.5 m -92.28 122.78 35.07 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 177.824 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.447 ' O ' ' HA ' ' A' ' 37' ' ' SER . 64.5 t -86.2 127.98 39.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 178.674 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 14.4 m -62.47 -45.35 93.42 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.139 -0.482 . . . . 0.0 112.087 -173.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 36.9 t -178.41 125.77 0.11 Allowed 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -177.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.49 HD23 HD21 ' A' ' 5' ' ' LEU . 25.2 tp -104.55 112.15 25.11 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.546 0.689 . . . . 0.0 110.558 178.767 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.408 ' HB3' ' HB2' ' A' ' 61' ' ' ASN . 34.5 tt0 -66.13 145.92 55.25 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.679 -179.082 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 5.9 t -64.25 137.96 58.2 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 178.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 68.87 9.67 7.5 Favored 'General case' 0 N--CA 1.464 0.231 0 O-C-N 123.741 0.651 . . . . 0.0 111.542 -178.423 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.408 ' HB2' ' HB3' ' A' ' 58' ' ' GLU . 4.7 m-20 -114.38 161.3 18.11 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.885 0.374 . . . . 0.0 110.598 177.768 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.526 ' HG ' ' HG3' ' A' ' 28' ' ' GLU . 4.3 m -123.9 124.52 42.82 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.503 179.245 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 54.5 m -104.21 124.02 48.37 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 176.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.458 ' HB3' HG23 ' A' ' 24' ' ' THR . 45.3 m-80 -87.0 126.0 34.45 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 179.599 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.523 ' O ' ' HA ' ' A' ' 24' ' ' THR . 22.1 t -96.07 136.34 27.3 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.828 -178.42 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -111.02 102.86 11.3 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.002 0.43 . . . . 0.0 110.209 -178.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.524 ' HB2' ' HB2' ' A' ' 23' ' ' MET . 66.5 m-85 -91.76 144.73 25.2 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.212 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 33.9 m-70 -99.59 87.88 3.69 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.029 179.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . 0.416 ' CZ3' HG12 ' A' ' 15' ' ' VAL . 18.2 t90 -108.02 110.45 22.16 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.276 0.56 . . . . 0.0 111.099 -173.827 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.494 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 5.5 m -80.87 122.78 27.64 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.858 177.383 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.525 ' HB3' ' HA ' ' A' ' 17' ' ' PRO . 0.9 OUTLIER -88.04 119.76 28.72 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.217 0.532 . . . . 0.0 112.09 -177.248 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -83.99 -38.69 20.62 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.827 173.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 88.4 24.87 32.43 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 121.017 -0.611 . . . . 0.0 113.501 174.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 85.5 m -64.0 -51.1 65.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.197 0.522 . . . . 0.0 110.985 177.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -110.6 146.91 35.31 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.408 179.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 17.3 p-10 -81.89 -6.91 59.49 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.033 0.444 . . . . 0.0 110.94 -177.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 8.8 t -149.23 124.97 10.48 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 176.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -112.84 156.2 23.32 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.163 0.506 . . . . 0.0 111.542 -177.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.421 ' HA ' HD22 ' A' ' 103' ' ' LEU . 6.0 m -96.78 97.51 9.38 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.279 177.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.44 HD13 HG23 ' A' ' 104' ' ' VAL . 9.4 mp -96.64 117.82 31.81 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.346 0.593 . . . . 0.0 110.592 -177.532 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.567 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 24.7 m -117.08 119.58 35.69 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.372 -177.243 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 39.8 t -94.99 109.6 22.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 177.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -99.03 125.61 44.56 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 120.419 -0.513 . . . . 0.0 110.019 178.129 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.545 ' HB ' ' HB2' ' A' ' 98' ' ' ASN . 96.6 t -98.2 111.35 27.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.917 -176.06 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 24.1 t70 66.89 92.34 0.07 OUTLIER Pre-proline 0 N--CA 1.466 0.341 0 CA-C-N 115.136 -0.938 . . . . 0.0 112.641 177.04 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -101.03 19.83 0.25 Allowed 'Trans proline' 0 N--CA 1.451 -1.008 0 C-N-CA 123.525 2.816 . . . . 0.0 111.718 171.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 58.8 mt-10 -128.17 -7.71 5.37 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.945 -174.282 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 8.1 t30 60.31 47.07 9.42 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.822 0.82 . . . . 0.0 109.882 -175.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -83.91 -37.3 22.54 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 174.075 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.424 HG23 ' OG1' ' A' ' 36' ' ' THR . 21.7 t -120.87 105.79 17.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 114.584 -1.189 . . . . 0.0 108.3 170.036 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -77.49 104.38 7.98 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.003 0.43 . . . . 0.0 110.116 -177.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 50.9 mm-40 -77.91 176.07 9.45 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.814 -177.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -57.91 -100.93 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.725 172.316 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 28.5 p-10 -87.77 174.89 8.11 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 173.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -115.21 24.71 11.43 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.117 0.484 . . . . 0.0 111.122 178.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 41.3 m -110.39 18.63 19.63 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.398 0.618 . . . . 0.0 110.003 175.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 28.3 p-10 -124.29 -24.82 4.22 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.894 -177.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.545 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 26.5 p-10 -86.6 23.57 1.62 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.744 -173.044 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.56 144.64 46.33 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.893 0.378 . . . . 0.0 110.788 -179.611 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.567 ' O ' ' HA ' ' A' ' 81' ' ' THR . 30.0 tp -136.97 115.66 12.08 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.085 178.775 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 15.0 m -104.9 102.45 11.97 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 178.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -121.65 135.35 54.98 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.974 0.416 . . . . 0.0 111.248 -176.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.421 HD22 ' HA ' ' A' ' 79' ' ' THR . 60.9 mt -87.43 125.17 34.12 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.559 175.677 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.44 HG23 HD13 ' A' ' 80' ' ' LEU . 25.6 m -112.64 155.43 13.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 175.666 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.501 ' O ' ' HA ' ' A' ' 14' ' ' THR . . . -120.49 171.34 14.63 Favored Glycine 0 N--CA 1.444 -0.787 0 C-N-CA 120.156 -1.021 . . . . 0.0 111.461 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 32.1 p -76.32 169.05 18.95 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.689 -0.485 . . . . 0.0 109.689 174.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.585 HD21 HG23 ' A' ' 16' ' ' VAL . 29.1 tp . . . . . 0 C--N 1.323 -0.587 0 CA-C-O 121.206 0.527 . . . . 0.0 110.745 -178.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.438 HG12 ' HD2' ' A' ' 3' ' ' PRO . 6.2 tt . . . . . 0 CA--C 1.535 0.386 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.44 ' HD3' ' HD3' ' A' ' 33' ' ' LYS . 2.7 Cg_exo -76.04 -174.25 1.99 Allowed 'Trans proline' 0 C--O 1.237 0.45 0 C-N-CA 122.598 2.199 . . . . 0.0 112.128 178.072 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -162.23 75.51 0.45 Allowed 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 179.296 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.408 HD21 HD21 ' A' ' 57' ' ' LEU . 73.3 mt -70.09 103.24 2.24 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.813 -177.592 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.453 ' HA ' ' HD2' ' A' ' 7' ' ' PRO . 42.7 t -110.72 110.47 57.35 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.002 -179.015 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.506 ' HD3' HG22 ' A' ' 84' ' ' VAL . 20.7 Cg_endo -63.85 114.27 2.52 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 122.271 1.981 . . . . 0.0 109.978 168.686 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 6.3 t -89.25 -58.9 3.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.25 -168.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.7 p -136.66 154.09 50.73 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.565 -174.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 62.1 tp -130.11 100.1 5.3 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.239 176.056 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.493 ' CG2' ' HA ' ' A' ' 12' ' ' PRO . 56.6 m -115.61 141.11 26.88 Favored Pre-proline 0 C--N 1.317 -0.84 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.198 -175.13 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.493 ' HA ' ' CG2' ' A' ' 11' ' ' THR . 72.1 Cg_endo -83.46 133.79 21.79 Favored 'Cis proline' 0 N--CA 1.461 -0.397 0 C-N-CA 123.383 -1.507 . . . . 0.0 113.244 1.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 35.0 m -65.75 -11.44 12.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.818 175.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.51 ' HA ' ' O ' ' A' ' 105' ' ' GLY . 0.6 OUTLIER -135.39 118.94 16.95 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 175.969 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.488 HG13 ' HG2' ' A' ' 12' ' ' PRO . 27.4 m -113.54 166.0 7.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.828 -170.106 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 1.7 t -108.09 119.72 49.07 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.166 179.107 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.492 ' HA ' ' HB3' ' A' ' 71' ' ' LEU . 36.5 Cg_exo -60.94 88.53 0.09 OUTLIER 'Trans proline' 0 C--O 1.236 0.402 0 C-N-CA 122.339 2.026 . . . . 0.0 109.719 167.013 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -158.25 -50.69 0.06 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.954 -167.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 8.9 t -153.76 -169.82 3.39 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.006 -172.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.475 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 39.0 t -77.76 114.24 18.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 174.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.518 ' OD1' HD23 ' A' ' 71' ' ' LEU . 9.6 m120 -86.84 132.81 33.72 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.479 -175.28 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 20.6 m -79.23 93.69 5.29 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.249 177.554 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.51 ' HB2' ' HB2' ' A' ' 67' ' ' PHE . 93.1 mmm -85.67 107.57 17.61 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.795 -178.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 17.7 m -97.96 113.15 24.92 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.819 -176.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -104.29 110.04 22.11 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.98 -0.554 . . . . 0.0 109.959 177.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 24.7 m -87.47 113.91 23.6 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 120.965 0.412 . . . . 0.0 110.324 -178.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 15.9 mm -100.8 122.86 53.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.708 -179.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -115.08 120.57 40.26 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 -179.21 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 32.4 t30 -82.7 98.39 9.04 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 178.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -94.18 44.24 1.11 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.353 0.596 . . . . 0.0 110.679 -175.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -143.96 147.97 19.51 Favored Glycine 0 N--CA 1.444 -0.789 0 N-CA-C 111.206 -0.758 . . . . 0.0 111.206 -177.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 14.5 t30 -84.89 61.68 6.98 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.489 0.662 . . . . 0.0 111.399 -172.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.44 ' HD3' ' HD3' ' A' ' 3' ' ' PRO . 54.4 tttm -161.69 156.85 23.57 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 170.311 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -80.7 154.57 27.22 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 120.867 0.365 . . . . 0.0 110.044 175.65 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 22.2 p -124.26 136.46 54.16 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.999 177.032 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 3.7 p -77.08 -166.53 0.72 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.889 179.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.408 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 7.5 t -60.93 113.04 2.31 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.989 0.423 . . . . 0.0 110.494 179.267 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.474 ' HB2' ' HB2' ' A' ' 85' ' ' ASP . 33.9 p90 -118.28 147.52 43.37 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.521 178.676 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.469 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 51.6 t-20 -90.29 128.59 36.46 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.368 -175.353 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.509 HG11 HG22 ' A' ' 65' ' ' VAL . 2.2 t -118.66 111.87 35.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-O 121.588 0.709 . . . . 0.0 109.821 176.144 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 8.9 m -111.77 143.15 43.17 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.807 -175.05 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 63.6 tp -102.75 113.76 27.44 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 176.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.538 ' HG ' HG21 ' A' ' 48' ' ' VAL . 4.8 mp -102.12 139.77 37.29 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.547 179.445 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 93.4 t -110.47 110.67 33.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 172.113 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 20.1 t70 67.73 -74.0 0.08 Allowed 'General case' 0 N--CA 1.464 0.273 0 O-C-N 124.042 0.839 . . . . 0.0 110.587 -174.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -150.3 6.95 0.71 Allowed Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.903 179.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 6.0 mt -116.85 147.44 20.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 117.104 0.452 . . . . 0.0 109.874 -179.319 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.538 HG21 ' HG ' ' A' ' 43' ' ' LEU . 25.5 t -94.08 114.8 31.44 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.294 -177.658 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 28.5 m -91.03 -30.0 4.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.594 -0.276 . . . . 0.0 111.47 -177.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -148.69 145.48 27.71 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 -178.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 58.3 m -137.51 114.39 10.61 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.909 -176.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -126.18 105.55 8.92 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.06 0.457 . . . . 0.0 110.24 -177.591 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.469 ' HA ' ' HA ' ' A' ' 39' ' ' ASN . 15.2 m -74.18 131.06 40.9 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.934 178.391 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.408 ' O ' ' HA ' ' A' ' 37' ' ' SER . 44.6 t -92.57 139.23 18.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 116.263 -0.426 . . . . 0.0 109.892 -179.146 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 18.6 m -59.55 -53.67 55.42 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.11 -0.495 . . . . 0.0 112.132 -177.038 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 35.3 t -176.81 149.95 0.77 Allowed 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -177.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.543 HD13 ' OG1' ' A' ' 63' ' ' THR . 25.2 tp -133.84 133.34 41.46 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.135 0.493 . . . . 0.0 110.424 178.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -89.79 174.62 7.61 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.775 -176.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 3.7 p -69.57 129.18 38.96 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.151 -179.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 50.5 mm-40 66.33 15.63 10.16 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.166 177.09 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -104.21 154.21 20.04 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 -179.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 7.3 m -113.1 143.73 43.84 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.829 0.347 . . . . 0.0 110.774 -178.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.543 ' OG1' HD13 ' A' ' 57' ' ' LEU . 95.6 m -128.86 127.91 42.8 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.078 174.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 40.1 m-80 -90.89 124.96 35.59 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.179 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.509 HG22 HG11 ' A' ' 40' ' ' VAL . 39.2 t -96.19 132.1 41.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.069 -178.335 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -101.81 97.3 7.7 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.525 -174.142 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.51 ' HB2' ' HB2' ' A' ' 23' ' ' MET . 32.2 m-85 -96.01 144.73 26.04 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.179 0.514 . . . . 0.0 111.302 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 15.9 m-70 -116.32 103.0 10.04 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.937 179.127 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . 0.402 ' CE2' HD21 ' A' ' 71' ' ' LEU . 11.3 t90 -116.51 111.2 19.61 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.516 -176.462 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.475 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 6.7 m -80.46 108.17 13.87 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.319 178.459 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.518 HD23 ' OD1' ' A' ' 21' ' ' ASN . 0.2 OUTLIER -69.25 116.02 9.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.953 0.406 . . . . 0.0 111.065 -178.302 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -84.54 -35.65 22.7 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.575 176.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 90.3 35.17 7.63 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.673 177.456 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 25.5 m -79.59 -38.63 33.53 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.023 0.44 . . . . 0.0 110.768 177.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -126.28 161.15 28.43 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.46 -174.417 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 -91.07 -12.02 36.94 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.461 178.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.491 ' HB2' HD21 ' A' ' 103' ' ' LEU . 28.4 p -147.34 137.83 23.37 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.363 177.685 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 40.3 m-85 -125.73 134.03 51.9 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.144 -178.212 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 21.4 m -89.53 92.92 9.3 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 120.927 0.394 . . . . 0.0 110.059 178.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.445 HD11 HG23 ' A' ' 104' ' ' VAL . 9.0 mp -88.37 137.92 31.9 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.194 0.521 . . . . 0.0 110.607 -179.445 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.409 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 19.1 m -131.44 114.56 15.08 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.428 -179.412 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.519 ' HB ' ' HB3' ' A' ' 100' ' ' LEU . 61.8 t -88.39 105.24 15.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 175.101 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -94.61 110.45 22.27 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.006 0.432 . . . . 0.0 110.104 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.506 HG22 ' HD3' ' A' ' 7' ' ' PRO . 85.6 t -83.19 114.47 24.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.341 -177.697 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.474 ' HB2' ' HB2' ' A' ' 38' ' ' PHE . 39.8 t0 58.74 73.66 0.69 Allowed Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 114.232 -1.349 . . . . 0.0 112.089 177.759 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.466 ' HD2' ' HB3' ' A' ' 39' ' ' ASN . 6.6 Cg_exo -74.19 -18.08 21.22 Favored 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 122.758 2.305 . . . . 0.0 111.141 176.301 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -87.77 -13.1 43.23 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.384 -177.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 62.79 45.62 5.62 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.194 177.616 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -77.12 -22.7 52.27 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.316 178.37 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 13.5 t -119.16 143.35 30.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.961 178.153 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 43.0 t-20 -89.54 105.38 17.76 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 178.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -98.82 147.21 25.14 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -174.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -57.76 -101.1 0.01 OUTLIER Glycine 0 CA--C 1.518 0.243 0 CA-C-N 114.965 -1.016 . . . . 0.0 113.195 174.124 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -73.92 106.54 5.68 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.929 0.395 . . . . 0.0 111.363 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.576 ' HA ' ' OD1' ' A' ' 98' ' ' ASN . 40.8 mt-10 -68.37 -11.71 60.0 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.089 179.418 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 8.1 m -70.82 -7.79 47.83 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.93 177.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.47 ' O ' ' HD2' ' A' ' 7' ' ' PRO . 88.6 m-20 -97.27 -21.73 17.09 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.139 -178.652 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.576 ' OD1' ' HA ' ' A' ' 95' ' ' GLU . 14.3 m120 -59.3 -34.89 72.85 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -172.234 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.49 125.0 49.8 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.258 0.551 . . . . 0.0 112.019 -178.073 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.519 ' HB3' ' HB ' ' A' ' 82' ' ' VAL . 28.5 tp -107.33 98.12 7.79 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.371 175.334 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 20.0 m -90.96 94.66 9.74 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.234 0.54 . . . . 0.0 110.105 -179.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -112.62 112.29 23.71 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.212 -178.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.491 HD21 ' HB2' ' A' ' 77' ' ' SER . 5.9 tt -80.86 104.29 11.27 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 179.681 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.445 HG23 HD11 ' A' ' 80' ' ' LEU . 18.3 m -93.83 149.86 4.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.655 -177.818 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.51 ' O ' ' HA ' ' A' ' 14' ' ' THR . . . -119.72 170.95 14.25 Favored Glycine 0 N--CA 1.443 -0.876 0 C-N-CA 119.941 -1.123 . . . . 0.0 111.876 -176.726 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 42.5 p -89.5 130.22 35.87 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 173.286 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.478 ' N ' HG23 ' A' ' 14' ' ' THR . 17.9 tp . . . . . 0 C--N 1.328 -0.332 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 -175.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.445 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 0.8 OUTLIER . . . . . 0 N--CA 1.453 -0.314 0 CA-C-O 120.676 0.274 . . . . 0.0 110.455 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.446 ' HD2' ' O ' ' A' ' 91' ' ' ASN . 12.9 Cg_endo -91.05 156.89 3.9 Favored 'Trans proline' 0 N--CA 1.445 -1.36 0 C-N-CA 122.883 2.388 . . . . 0.0 111.024 172.196 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -137.39 105.23 5.61 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 -179.126 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.507 HD21 HD21 ' A' ' 57' ' ' LEU . 27.4 mt -99.78 126.69 45.89 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 -171.145 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.521 HG21 ' HB3' ' A' ' 97' ' ' ASN . 4.6 t -125.42 140.29 35.94 Favored Pre-proline 0 C--N 1.317 -0.845 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.444 -176.52 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.459 ' HB2' ' HB2' ' A' ' 100' ' ' LEU . 6.8 Cg_endo -92.79 100.72 0.17 Allowed 'Trans proline' 0 N--CA 1.445 -1.375 0 C-N-CA 123.13 2.553 . . . . 0.0 110.054 167.514 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 27.4 m -79.53 -28.86 13.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.811 -171.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 35.4 t -156.67 147.54 21.86 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.772 0.32 . . . . 0.0 110.888 -176.452 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.509 HD13 ' HB3' ' A' ' 23' ' ' MET . 19.4 tp -127.68 126.14 41.38 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 171.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.537 ' OG1' ' HA ' ' A' ' 12' ' ' PRO . 6.5 t -122.26 152.05 60.01 Favored Pre-proline 0 C--N 1.317 -0.835 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.912 178.278 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.628 ' HD2' ' SD ' ' A' ' 23' ' ' MET . 98.5 Cg_endo -80.92 149.92 77.75 Favored 'Cis proline' 0 N--CA 1.46 -0.467 0 C-N-CA 123.483 -1.465 . . . . 0.0 112.492 -3.54 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 35.3 m -69.09 -21.57 25.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.059 177.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.55 ' HA ' ' O ' ' A' ' 105' ' ' GLY . 0.7 OUTLIER -124.71 131.19 53.48 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.152 174.288 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.0 m -114.56 149.2 16.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 121.04 0.448 . . . . 0.0 111.789 -174.381 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.9 m -98.34 117.69 64.44 Favored Pre-proline 0 N--CA 1.447 -0.577 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.346 178.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.535 ' HA ' ' HB3' ' A' ' 71' ' ' LEU . 10.0 Cg_exo -71.06 91.31 0.64 Allowed 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 122.597 2.198 . . . . 0.0 110.443 173.139 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -163.23 -41.6 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.216 -171.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 13.5 t -145.73 -170.23 3.42 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.001 -172.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.415 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 62.1 t -84.34 116.51 28.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 172.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.583 ' OD1' HD23 ' A' ' 71' ' ' LEU . 9.2 m120 -91.47 118.44 30.56 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.636 -174.177 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.62 ' HA ' ' O ' ' A' ' 67' ' ' PHE . 58.7 m -80.6 96.26 6.79 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-O 121.319 0.581 . . . . 0.0 109.873 177.34 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.628 ' SD ' ' HD2' ' A' ' 12' ' ' PRO . 93.3 mmm -79.14 126.56 30.89 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.478 -176.154 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.478 ' HA ' ' O ' ' A' ' 65' ' ' VAL . 17.5 m -105.07 112.34 25.44 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.975 0.416 . . . . 0.0 111.36 -176.208 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -104.15 130.41 51.89 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.012 176.275 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 23.7 m -95.8 108.34 20.67 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 120.695 0.283 . . . . 0.0 110.431 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.417 ' O ' ' HA ' ' A' ' 62' ' ' SER . 19.7 mm -100.06 119.95 48.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.863 -179.668 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -115.18 136.22 53.34 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.249 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 32.9 t30 -91.89 99.96 12.72 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.305 178.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -99.35 45.97 0.98 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.835 -175.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -144.01 160.08 27.73 Favored Glycine 0 N--CA 1.449 -0.463 0 N-CA-C 111.533 -0.627 . . . . 0.0 111.533 179.32 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -87.33 56.3 3.91 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.232 0.539 . . . . 0.0 110.924 -174.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.9 tptp -161.64 139.94 9.34 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 174.233 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -76.3 149.73 37.03 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 174.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.3 p -120.49 140.63 51.15 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.929 0.395 . . . . 0.0 110.498 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 3.9 p -91.84 -163.29 1.02 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.017 -178.278 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.552 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 48.5 m -49.03 115.6 1.35 Allowed 'General case' 0 C--O 1.234 0.276 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -179.482 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.426 ' CE2' HG23 ' A' ' 40' ' ' VAL . 30.4 p90 -130.57 149.52 52.2 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.12 177.632 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 11.8 m-80 -98.46 108.6 21.33 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.296 -172.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.426 HG23 ' CE2' ' A' ' 38' ' ' PHE . 2.3 t -98.32 117.88 43.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.401 0.62 . . . . 0.0 110.492 178.333 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 16.9 m -108.28 146.59 32.66 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.957 -176.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.419 HD11 ' HB3' ' A' ' 80' ' ' LEU . 47.6 tp -106.82 113.89 27.65 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 174.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.524 ' HG ' HG22 ' A' ' 48' ' ' VAL . 4.8 mp -101.07 121.01 41.03 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.277 -179.552 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 98.0 t -100.54 102.2 13.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 178.166 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 60.75 17.25 7.45 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.708 178.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 128.38 -34.45 2.92 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.943 176.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 11.5 mm -89.99 150.33 3.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.945 0.372 . . . . 0.0 110.209 -176.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.524 HG22 ' HG ' ' A' ' 43' ' ' LEU . 52.4 t -96.98 112.21 28.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 -179.375 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 24.3 m -86.01 -32.85 7.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.382 -177.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 38.4 t0 -159.68 162.32 35.06 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 120.889 0.376 . . . . 0.0 110.645 -178.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 85.0 m -149.81 129.86 13.52 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.785 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -117.69 118.82 33.14 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 110.175 -0.306 . . . . 0.0 110.175 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 27.6 m -74.86 108.35 7.54 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.034 175.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.552 ' O ' ' HA ' ' A' ' 37' ' ' SER . 40.3 t -77.53 128.37 38.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 178.196 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 7.3 m -57.44 -50.14 73.99 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 123.333 0.395 . . . . 0.0 111.763 -173.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 45.7 m -170.8 151.19 3.38 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 -177.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.507 HD21 HD21 ' A' ' 5' ' ' LEU . 23.8 tp -136.97 112.35 9.23 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.145 0.498 . . . . 0.0 110.364 177.73 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 23.9 mm-40 -76.28 174.38 10.24 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.889 -177.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 24.2 m -67.4 129.15 39.0 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.969 -179.069 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.449 ' O ' ' HG2' ' A' ' 60' ' ' GLU . 37.0 tt0 69.61 10.21 7.53 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.136 178.322 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 58.5 t30 -93.34 146.24 23.87 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.542 -0.463 . . . . 0.0 109.839 178.523 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.417 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 9.3 m -119.07 131.43 55.94 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.738 177.631 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.503 HG21 HG11 ' A' ' 54' ' ' VAL . 9.3 t -114.56 139.84 49.26 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.957 0.408 . . . . 0.0 110.42 179.014 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -92.2 114.06 26.5 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.146 178.218 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.478 ' O ' ' HA ' ' A' ' 24' ' ' THR . 10.0 t -96.4 122.88 48.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.582 -179.581 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.581 ' HB3' ' CG2' ' A' ' 22' ' ' THR . 17.3 m-20 -111.78 109.44 19.27 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.012 0.434 . . . . 0.0 110.862 -176.217 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.62 ' O ' ' HA ' ' A' ' 22' ' ' THR . 61.7 m-85 -91.5 163.93 13.98 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.372 -175.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 17.4 m80 -111.92 93.43 4.45 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.34 177.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 15.4 t90 -113.53 110.56 20.46 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.068 0.461 . . . . 0.0 110.679 -176.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.415 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 22.0 m -81.41 112.44 18.68 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.913 176.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.583 HD23 ' OD1' ' A' ' 21' ' ' ASN . 0.3 OUTLIER -71.6 119.52 15.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.121 0.486 . . . . 0.0 111.503 -177.317 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 24.5 p-10 -83.32 -33.58 25.87 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.612 175.209 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 77.38 29.62 55.63 Favored Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.87 174.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 25.6 m -80.05 -51.33 9.16 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.011 0.434 . . . . 0.0 110.501 179.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -105.85 148.29 27.73 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.302 179.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 -86.43 -9.19 56.78 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.877 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 24.4 t -137.54 119.51 15.37 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.067 179.37 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -116.58 150.37 38.13 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.956 178.264 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 26.0 m -101.36 89.73 3.86 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.012 179.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.426 HD11 HG21 ' A' ' 104' ' ' VAL . 9.2 mp -87.72 114.05 23.96 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.472 0.653 . . . . 0.0 110.493 -178.399 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.558 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 27.1 m -111.69 120.8 43.27 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.381 -177.84 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.446 ' HB ' ' HB3' ' A' ' 100' ' ' LEU . 61.8 t -89.64 103.21 13.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 176.374 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -95.83 114.04 25.74 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 178.234 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 95.7 t -81.02 104.21 9.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.129 -178.48 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.7 t70 53.49 90.85 0.08 OUTLIER Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 114.278 -1.328 . . . . 0.0 112.899 177.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -79.22 16.31 1.39 Allowed 'Trans proline' 0 N--CA 1.463 -0.323 0 C-N-CA 123.316 2.677 . . . . 0.0 111.935 177.446 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -116.18 -17.17 10.89 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.264 -177.622 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 12.2 m120 62.94 48.99 3.68 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.587 -178.009 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -66.5 -33.0 74.72 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.404 0.621 . . . . 0.0 109.752 174.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 4.1 t -107.53 169.26 2.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 174.389 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.446 ' O ' ' HD2' ' A' ' 3' ' ' PRO . 65.1 t30 -106.13 93.29 4.54 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 175.778 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 14.9 mp0 -76.51 149.7 36.7 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.772 -173.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -57.41 -100.85 0.01 OUTLIER Glycine 0 CA--C 1.522 0.5 0 CA-C-N 114.655 -1.157 . . . . 0.0 113.472 170.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 16.7 m-80 -84.71 130.72 34.66 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 122.758 -0.26 . . . . 0.0 111.351 -173.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -64.14 -32.12 73.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.076 0.465 . . . . 0.0 110.515 177.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 49.3 m -59.54 -29.41 67.88 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.82 176.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.521 ' HB3' HG21 ' A' ' 6' ' ' VAL . 7.0 m-20 -84.58 -13.25 52.26 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.913 -175.391 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -73.65 -10.67 59.93 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.011 178.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 3.7 p -130.8 125.13 32.93 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -173.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.558 ' O ' ' HA ' ' A' ' 81' ' ' THR . 46.1 tp -108.63 102.41 11.47 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.879 169.88 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 21.8 m -85.11 95.32 9.09 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 175.246 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -111.33 119.72 39.82 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.618 -177.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 41.9 mt -82.43 114.99 21.25 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.389 0.614 . . . . 0.0 110.324 176.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.426 HG21 HD11 ' A' ' 80' ' ' LEU . 27.4 m -108.13 140.05 28.03 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.319 178.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.55 ' O ' ' HA ' ' A' ' 14' ' ' THR . . . -116.75 165.35 12.33 Favored Glycine 0 N--CA 1.438 -1.199 0 C-N-CA 120.182 -1.009 . . . . 0.0 111.149 -178.346 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 27.0 p -72.35 137.25 46.48 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 175.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 49.8 tp . . . . . 0 C--N 1.326 -0.415 0 CA-C-O 120.917 0.389 . . . . 0.0 110.584 -177.73 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 7.6 tp . . . . . 0 CA--C 1.538 0.496 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.53 ' HD3' ' HD3' ' A' ' 33' ' ' LYS . 5.4 Cg_exo -75.44 157.08 41.1 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.346 2.031 . . . . 0.0 111.143 174.379 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -140.13 102.76 4.45 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 178.067 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.506 HD21 HD23 ' A' ' 57' ' ' LEU . 25.4 mt -99.74 126.72 45.85 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -172.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.484 ' O ' ' HA ' ' A' ' 27' ' ' ILE . 8.3 t -125.22 140.23 35.61 Favored Pre-proline 0 C--N 1.313 -1.002 0 C-N-CA 119.865 -0.734 . . . . 0.0 110.635 -175.182 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.515 ' HG2' ' HB2' ' A' ' 100' ' ' LEU . 11.8 Cg_endo -96.99 110.05 0.1 Allowed 'Trans proline' 0 N--CA 1.447 -1.212 0 C-N-CA 123.672 2.915 . . . . 0.0 110.478 169.398 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 19.3 m -86.5 -39.14 13.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -169.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 51.0 m -156.37 161.17 40.16 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.723 0.297 . . . . 0.0 111.099 -178.327 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.411 HD12 ' HB3' ' A' ' 23' ' ' MET . 26.9 tp -127.61 126.49 42.16 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 172.403 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.491 HG23 ' HB ' ' A' ' 24' ' ' THR . 0.7 OUTLIER -122.6 131.73 24.35 Favored Pre-proline 0 C--N 1.318 -0.773 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.978 177.101 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.522 ' HD2' ' SD ' ' A' ' 23' ' ' MET . 90.4 Cg_endo -95.2 145.76 7.99 Favored 'Cis proline' 0 N--CA 1.449 -1.125 0 C-N-CA 123.789 -1.338 . . . . 0.0 113.345 5.114 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.423 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 35.4 m -67.37 -18.04 23.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.435 175.713 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.27 151.19 39.53 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 175.645 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 16.4 m -142.93 157.17 17.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.308 0.575 . . . . 0.0 111.346 -174.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.439 ' HA ' ' HD3' ' A' ' 17' ' ' PRO . 14.4 t -99.32 131.95 24.18 Favored Pre-proline 0 C--N 1.321 -0.663 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.647 -175.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 16' ' ' VAL . 1.6 Cg_endo -84.13 18.23 1.57 Allowed 'Trans proline' 0 CA--C 1.529 0.264 0 C-N-CA 122.786 2.324 . . . . 0.0 112.856 179.244 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 56.0 m-20 -106.67 -22.91 12.6 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.669 0.271 . . . . 0.0 111.583 -174.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 8.9 t -145.54 178.23 8.28 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.136 -173.029 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.596 HG21 HG21 ' A' ' 70' ' ' THR . 51.5 t -73.29 141.89 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 172.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.653 ' ND2' HD21 ' A' ' 71' ' ' LEU . 39.7 m-80 -114.41 132.76 56.12 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.361 -173.433 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.7 m -108.19 118.88 37.9 Favored 'General case' 0 N--CA 1.437 -1.089 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 -175.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.522 ' SD ' ' HD2' ' A' ' 12' ' ' PRO . 87.2 mmm -108.93 122.99 48.39 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 113.938 -1.483 . . . . 0.0 109.855 -165.402 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.624 ' HA ' ' O ' ' A' ' 65' ' ' VAL . 17.0 m -111.99 124.44 52.4 Favored 'General case' 0 C--N 1.309 -1.152 0 CA-C-O 121.854 0.835 . . . . 0.0 109.765 -173.749 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -119.16 132.1 55.94 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 114.221 -1.354 . . . . 0.0 108.522 -175.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 19.5 m -112.35 121.01 43.65 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 121.714 0.769 . . . . 0.0 109.61 -171.063 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.484 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 8.7 mm -116.9 131.92 68.16 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 CA-C-N 114.314 -1.312 . . . . 0.0 109.236 -172.325 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -121.0 138.64 54.06 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 178.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.466 ' HB2' ' HG ' ' A' ' 57' ' ' LEU . 39.1 t30 -93.84 98.12 10.86 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 175.168 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 69.5 mt-30 -102.25 47.1 0.9 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.329 -173.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -144.18 154.65 25.83 Favored Glycine 0 N--CA 1.445 -0.743 0 N-CA-C 110.488 -1.045 . . . . 0.0 110.488 177.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -82.84 53.79 2.51 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.392 0.615 . . . . 0.0 111.466 -174.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.53 ' HD3' ' HD3' ' A' ' 3' ' ' PRO . 87.9 tttt -161.47 136.47 7.4 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 171.5 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -80.34 135.37 36.18 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 120.978 0.418 . . . . 0.0 110.756 -175.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 35.8 t -95.85 142.62 27.89 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.56 178.195 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.2 m -99.29 -129.57 0.2 Allowed 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.348 -179.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.59 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 48.5 m -82.85 108.8 16.45 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.027 0.441 . . . . 0.0 111.624 -173.641 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.527 ' HB2' ' HB2' ' A' ' 85' ' ' ASP . 52.9 p90 -122.38 146.01 47.73 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.014 177.196 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.478 ' O ' ' HA ' ' A' ' 85' ' ' ASP . 22.0 m-80 -92.56 110.58 22.01 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.794 -174.333 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -98.35 127.11 51.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 -178.46 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 37.0 m -118.72 141.65 48.41 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.297 -174.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 56.4 tp -100.24 111.51 23.79 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.575 173.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.456 ' HG ' HG22 ' A' ' 48' ' ' VAL . 4.9 mp -102.06 124.86 48.4 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.592 -178.031 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.501 HG11 ' HB3' ' A' ' 78' ' ' TYR . 86.2 t -93.68 95.96 5.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 175.485 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 64.03 5.66 2.5 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.96 -179.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 140.56 -34.99 1.92 Allowed Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.406 179.057 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.417 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 9.5 mt -82.36 147.93 5.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 -179.14 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.456 HG22 ' HG ' ' A' ' 43' ' ' LEU . 36.1 t -99.79 119.68 48.17 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.442 -176.724 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 20.3 m -97.6 -27.22 3.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 111.887 0.329 . . . . 0.0 111.887 -177.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 42.2 t0 -162.29 136.49 6.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.655 0.264 . . . . 0.0 110.332 -178.507 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 86.2 m -124.81 122.38 37.27 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.185 179.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -115.11 117.99 32.11 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 -178.445 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.435 ' HA ' ' HA ' ' A' ' 39' ' ' ASN . 22.7 m -82.86 111.18 18.51 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.327 -179.86 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.59 ' O ' ' HA ' ' A' ' 37' ' ' SER . 59.1 t -77.68 123.12 33.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 179.206 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.4 m -58.43 -39.97 81.24 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.727 -0.669 . . . . 0.0 112.128 -173.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 46.7 t -173.31 143.75 1.12 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.834 0.35 . . . . 0.0 110.486 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.506 HD23 HD21 ' A' ' 5' ' ' LEU . 23.5 tp -126.86 104.31 7.97 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.339 0.59 . . . . 0.0 109.532 175.246 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -70.75 160.68 32.24 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.525 -175.212 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 11.8 m -61.36 120.31 10.19 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.63 179.153 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 70.27 17.34 7.11 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 123.805 0.69 . . . . 0.0 110.889 -179.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -102.1 157.73 16.67 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 173.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 26.3 t -127.61 143.36 51.17 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.119 0.485 . . . . 0.0 110.71 -178.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 91.1 m -124.84 130.52 52.54 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.63 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 37.1 m-80 -101.19 117.7 35.52 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.943 177.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.624 ' O ' ' HA ' ' A' ' 24' ' ' THR . 3.7 t -102.82 125.16 57.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.911 -175.32 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -102.4 112.62 25.42 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.792 0.33 . . . . 0.0 110.914 178.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -91.62 159.01 16.1 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.953 179.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 15.8 m80 -108.64 109.74 21.02 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.727 -179.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 16.2 t90 -131.35 108.16 9.45 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.319 0.581 . . . . 0.0 111.404 -175.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.596 HG21 HG21 ' A' ' 20' ' ' VAL . 5.6 m -85.4 122.14 29.13 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.886 175.784 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.653 HD21 ' ND2' ' A' ' 21' ' ' ASN . 0.2 OUTLIER -72.3 122.33 20.94 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.19 0.519 . . . . 0.0 111.021 -177.633 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 24.2 p-10 -90.3 -41.62 11.44 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.436 179.058 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 99.07 23.62 11.27 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.81 -0.71 . . . . 0.0 113.204 175.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 92.6 m -74.96 -41.19 60.08 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.023 0.439 . . . . 0.0 110.583 177.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -128.33 162.31 27.37 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.372 178.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -100.71 -6.77 24.57 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.224 0.535 . . . . 0.0 110.183 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 22.7 t -146.95 112.26 5.53 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.508 177.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.501 ' HB3' HG11 ' A' ' 44' ' ' VAL . 83.2 m-85 -105.76 150.21 25.73 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.315 177.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.1 m -93.95 86.97 5.2 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 178.081 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.485 HD21 HG23 ' A' ' 104' ' ' VAL . 6.4 mp -81.43 114.32 20.1 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.714 0.769 . . . . 0.0 110.349 -177.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.504 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 7.3 m -116.94 117.8 30.69 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.475 -175.003 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 46.3 t -85.56 108.04 16.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 176.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.557 ' HA ' ' O ' ' A' ' 98' ' ' ASN . 6.3 t30 -101.64 116.69 33.3 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 178.696 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 58.2 t -82.64 104.42 11.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 115.615 -0.721 . . . . 0.0 111.214 -177.236 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.527 ' HB2' ' HB2' ' A' ' 38' ' ' PHE . 7.3 t70 54.5 89.66 0.1 Allowed Pre-proline 0 N--CA 1.468 0.47 0 CA-C-N 114.234 -1.348 . . . . 0.0 112.308 179.105 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -62.59 -24.43 75.1 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 123.29 2.66 . . . . 0.0 112.215 179.276 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 50.8 mm-40 -75.93 -28.81 58.13 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.812 177.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 56.2 53.84 8.47 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.812 -1.085 . . . . 0.0 109.807 -175.31 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -74.13 -25.04 59.54 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.865 -1.061 . . . . 0.0 109.706 178.24 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 17.3 t -108.31 97.49 5.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.213 -0.903 . . . . 0.0 108.897 174.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -61.15 134.31 56.89 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 -178.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.419 ' HA ' ' O ' ' A' ' 3' ' ' PRO . 3.0 mt-10 -111.22 166.22 11.27 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.966 -177.279 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -57.93 -101.04 0.01 OUTLIER Glycine 0 N--CA 1.453 -0.188 0 CA-C-N 115.588 -0.733 . . . . 0.0 112.851 174.044 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 28.4 t30 -70.17 100.74 1.72 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.683 -0.258 . . . . 0.0 110.538 179.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -75.9 53.94 0.79 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.211 0.529 . . . . 0.0 111.997 -177.207 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 13.9 t -137.64 16.1 2.91 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 174.102 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 18.1 p-10 -98.8 -27.27 14.02 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 113.58 -1.645 . . . . 0.0 111.746 -172.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.557 ' O ' ' HA ' ' A' ' 83' ' ' ASN . 17.9 m120 -55.13 -34.07 63.43 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 -168.731 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 1.5 p -107.23 123.38 48.21 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 -174.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.515 ' HB2' ' HG2' ' A' ' 7' ' ' PRO . 39.2 tp -107.26 106.63 17.17 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 170.17 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 28.3 m -89.96 102.4 15.11 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.669 -177.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -119.88 116.93 26.84 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.547 179.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 52.3 mt -74.86 119.03 18.49 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.126 175.535 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.485 HG23 HD21 ' A' ' 80' ' ' LEU . 27.6 m -113.1 133.39 59.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.693 178.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -120.9 166.55 13.95 Favored Glycine 0 N--CA 1.442 -0.956 0 C-N-CA 120.432 -0.89 . . . . 0.0 111.671 -176.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 59.3 p -69.09 146.02 52.92 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 177.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 62.4 tp . . . . . 0 C--N 1.328 -0.365 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -172.37 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 83.9 mmm . . . . . 0 N--CA 1.48 1.026 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.417 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 16.6 tt -143.72 139.24 16.01 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.301 -176.63 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.493 ' HB3' ' HB2' ' A' ' 35' ' ' SER . 12.4 Cg_exo -69.84 116.99 4.82 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.17 1.913 . . . . 0.0 111.24 175.344 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -103.16 79.94 1.79 Allowed 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 178.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.496 ' O ' ' HA ' ' A' ' 98' ' ' ASN . 61.9 mt -73.27 103.42 3.96 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.775 -173.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.534 HG21 ' HB3' ' A' ' 97' ' ' ASN . 47.1 t -114.27 111.4 47.21 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.511 -176.5 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.574 ' HD2' ' O ' ' A' ' 97' ' ' ASN . 18.2 Cg_endo -64.03 107.44 0.78 Allowed 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 122.057 1.838 . . . . 0.0 110.046 167.37 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.0 t -82.51 -55.74 7.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.126 -170.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 58.6 p -141.44 158.3 44.04 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.182 -177.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.473 HD22 HD22 ' A' ' 80' ' ' LEU . 54.0 tp -130.24 104.42 7.28 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.021 177.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 22.0 p -115.02 146.18 35.64 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.216 -175.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -78.99 152.64 89.12 Favored 'Cis proline' 0 C--N 1.341 0.183 0 C-N-CA 123.186 -1.589 . . . . 0.0 112.562 -0.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.2 m -73.57 -19.77 18.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.045 0.45 . . . . 0.0 111.206 -178.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.449 ' HB ' HD11 ' A' ' 107' ' ' LEU . 0.2 OUTLIER -126.37 128.35 46.91 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 177.178 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.46 ' HB ' ' ND2' ' A' ' 21' ' ' ASN . 18.7 m -114.13 140.14 36.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -167.447 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.429 ' HA ' ' HD3' ' A' ' 17' ' ' PRO . 5.8 m -84.17 121.4 75.49 Favored Pre-proline 0 N--CA 1.449 -0.512 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.098 176.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.438 ' HA ' ' CB ' ' A' ' 71' ' ' LEU . 4.6 Cg_exo -77.97 55.75 5.42 Favored 'Trans proline' 0 N--CA 1.463 -0.269 0 C-N-CA 123.006 2.471 . . . . 0.0 111.667 176.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -122.97 -18.26 6.48 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.161 -0.472 . . . . 0.0 112.042 -176.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 14.7 t -157.25 -173.96 4.67 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.736 -0.386 . . . . 0.0 110.938 -171.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 46.7 t -82.32 110.11 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 169.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.46 ' ND2' ' HB ' ' A' ' 15' ' ' VAL . 5.1 m-20 -84.38 108.23 17.09 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.309 0.576 . . . . 0.0 110.702 -169.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.618 ' HA ' ' O ' ' A' ' 67' ' ' PHE . 11.3 m -79.41 83.44 5.43 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.256 -0.883 . . . . 0.0 109.355 176.341 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.513 ' HE3' HG11 ' A' ' 104' ' ' VAL . 82.8 mtp -79.5 152.21 30.34 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.41 -0.813 . . . . 0.0 110.403 -176.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 30.8 m -114.11 109.58 18.65 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.065 -175.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.419 ' HB3' ' HB ' ' A' ' 65' ' ' VAL . . . -92.14 120.09 32.41 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.548 173.585 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 61.2 m -92.76 101.29 13.68 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-O 121.12 0.486 . . . . 0.0 109.769 -179.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 15.3 mm -95.17 118.98 42.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.246 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -113.74 125.15 53.79 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.481 ' HB2' ' HG ' ' A' ' 57' ' ' LEU . 29.6 t30 -81.78 90.03 6.35 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.607 178.604 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -87.11 43.99 1.14 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.559 0.695 . . . . 0.0 110.788 -173.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -143.98 145.07 14.37 Favored Glycine 0 N--CA 1.442 -0.956 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 176.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -81.17 63.65 5.6 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.526 0.679 . . . . 0.0 111.039 -173.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 50.6 tptt -161.5 121.31 2.57 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.056 171.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -69.06 124.09 22.83 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.985 0.421 . . . . 0.0 110.567 -175.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.493 ' HB2' ' HB3' ' A' ' 3' ' ' PRO . 46.4 t -87.7 147.01 25.42 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.19 -174.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 21.7 p -86.54 -163.0 0.83 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.444 178.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.448 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 15.0 m -61.68 134.09 56.37 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 120.929 0.395 . . . . 0.0 111.338 -179.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.514 ' CE1' ' HB ' ' A' ' 54' ' ' VAL . 31.1 p90 -144.9 144.35 31.05 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.294 -177.339 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.486 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 25.7 m-80 -92.62 108.67 20.16 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.219 -174.272 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.428 HG21 ' HA ' ' A' ' 84' ' ' VAL . 2.1 t -98.29 116.75 41.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 121.392 0.615 . . . . 0.0 110.289 178.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 46.3 m -109.95 144.14 38.9 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.689 -177.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 46.9 tp -98.68 108.66 21.41 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.697 175.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.476 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 5.2 mp -98.93 108.45 21.13 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.427 -179.047 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 82.4 t -88.96 101.48 12.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 60.06 18.43 7.67 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.422 -179.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 124.49 -36.04 3.02 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.785 178.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.468 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 9.8 mm -79.81 145.55 9.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.905 0.383 . . . . 0.0 110.096 -176.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.405 HG23 ' HG ' ' A' ' 43' ' ' LEU . 40.8 t -96.96 101.75 12.65 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.824 -178.036 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 28.4 m -83.59 -30.78 8.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.615 -175.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 33.7 t0 -159.56 141.37 13.19 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.915 -0.314 . . . . 0.0 111.002 -177.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 88.6 m -129.07 123.36 32.05 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.308 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -127.3 105.69 8.71 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 -178.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.486 ' HA ' ' HA ' ' A' ' 39' ' ' ASN . 7.1 t -74.52 131.02 40.64 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.068 0.461 . . . . 0.0 110.38 178.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.514 ' HB ' ' CE1' ' A' ' 38' ' ' PHE . 39.1 t -95.28 138.57 20.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.774 -179.288 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.0 m -55.07 -43.28 73.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.246 -0.434 . . . . 0.0 112.039 -177.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 47.7 t -174.76 153.51 1.77 Allowed 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 -175.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.481 ' HG ' ' HB2' ' A' ' 29' ' ' ASN . 27.6 tp -134.15 109.5 8.95 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.16 0.505 . . . . 0.0 110.066 177.092 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.448 ' HB2' ' HB3' ' A' ' 61' ' ' ASN . 35.9 mt-10 -70.98 158.78 35.92 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.542 -0.754 . . . . 0.0 112.154 -174.278 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 12.3 p -64.12 122.98 17.88 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.095 179.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 65.09 20.2 11.98 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.453 179.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.448 ' HB3' ' HB2' ' A' ' 58' ' ' GLU . 61.1 t30 -116.62 155.2 29.17 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 176.036 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 2.4 m -115.28 145.66 42.25 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.657 0.265 . . . . 0.0 110.752 -175.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 13.3 t -119.2 143.85 47.04 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 175.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -96.05 112.03 23.88 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.873 0.368 . . . . 0.0 110.261 178.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.419 ' HB ' ' HB3' ' A' ' 25' ' ' ALA . 13.2 t -96.86 118.13 42.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.911 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.444 ' HA ' ' O ' ' A' ' 23' ' ' MET . 5.3 p-10 -95.13 119.67 34.04 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.512 0.672 . . . . 0.0 110.559 -179.227 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.618 ' O ' ' HA ' ' A' ' 22' ' ' THR . 33.2 m-85 -95.67 146.8 24.22 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.726 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 15.2 m80 -110.73 90.27 3.28 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.663 -0.698 . . . . 0.0 109.485 -178.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 12.5 t90 -123.62 113.67 18.99 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.389 0.614 . . . . 0.0 111.416 -172.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 49.7 m -78.22 114.67 17.33 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.351 -0.841 . . . . 0.0 110.282 174.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.438 ' CB ' ' HA ' ' A' ' 17' ' ' PRO . 1.0 OUTLIER -63.54 118.78 8.66 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.326 0.584 . . . . 0.0 111.145 178.358 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -83.56 -36.74 23.75 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.03 -178.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 83.19 17.91 65.92 Favored Glycine 0 N--CA 1.449 -0.475 0 N-CA-C 110.99 -0.844 . . . . 0.0 110.99 -174.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 3.9 p -68.99 -29.75 68.02 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.23 -0.485 . . . . 0.0 111.332 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -145.44 168.86 19.54 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.075 -179.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 49.5 m-80 -96.98 -15.09 21.26 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.397 0.618 . . . . 0.0 109.649 178.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 20.4 m -131.97 126.6 34.4 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.781 177.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -115.12 132.88 56.46 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 177.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.454 ' HA ' HD21 ' A' ' 103' ' ' LEU . 4.3 m -90.49 83.66 5.89 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.124 0.488 . . . . 0.0 109.773 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.473 HD22 HD22 ' A' ' 10' ' ' LEU . 7.7 mp -81.41 117.2 21.66 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.515 0.674 . . . . 0.0 110.762 -176.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.551 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 32.7 m -113.85 110.61 20.39 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.545 -177.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 60.9 t -85.55 99.69 7.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 176.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -95.64 109.38 21.64 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 178.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.462 HG11 ' CD2' ' A' ' 38' ' ' PHE . 83.3 t -75.42 102.96 2.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.445 -179.595 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.0 t70 51.76 82.61 0.24 Allowed Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 114.431 -1.258 . . . . 0.0 111.427 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -64.41 -11.34 27.85 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.871 2.38 . . . . 0.0 111.923 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -87.64 -14.86 38.87 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.081 178.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 24.0 m120 56.12 43.47 26.83 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.886 -178.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.05 -34.57 77.87 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.384 0.611 . . . . 0.0 110.09 177.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 39.5 t -111.42 98.75 7.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 172.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -59.06 112.29 1.63 Allowed 'General case' 0 C--O 1.235 0.311 0 O-C-N 123.35 0.406 . . . . 0.0 110.619 -173.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.446 ' HA ' ' O ' ' A' ' 3' ' ' PRO . 3.8 mp0 -82.41 166.93 18.98 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.705 -174.007 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -58.05 -100.83 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.395 0 CA-C-N 114.919 -1.037 . . . . 0.0 113.33 176.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.408 ' HB3' ' CG ' ' A' ' 97' ' ' ASN . 53.0 t30 -76.21 141.77 41.69 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 122.626 -0.338 . . . . 0.0 110.836 -177.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -59.87 -43.1 94.9 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.979 -173.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 20.1 m -89.78 3.22 53.52 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.827 -174.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.574 ' O ' ' HD2' ' A' ' 7' ' ' PRO . 5.9 m-20 -85.97 -24.4 26.52 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 -175.286 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.496 ' HA ' ' O ' ' A' ' 5' ' ' LEU . 13.8 p-10 -82.04 -5.34 58.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.007 0.432 . . . . 0.0 111.341 -174.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 4.9 m -116.17 152.27 34.04 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.066 0.46 . . . . 0.0 110.727 -178.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.551 ' O ' ' HA ' ' A' ' 81' ' ' THR . 56.0 tp -140.66 103.63 4.56 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.84 179.18 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 15.7 m -98.83 104.5 16.54 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.123 177.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -132.48 135.72 46.21 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.895 0.378 . . . . 0.0 111.035 -178.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.454 HD21 ' HA ' ' A' ' 79' ' ' THR . 82.4 mt -80.21 127.09 31.94 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.752 177.204 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.513 HG11 ' HE3' ' A' ' 23' ' ' MET . 32.7 m -109.13 134.72 50.23 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 172.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -105.16 170.92 18.23 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.04 -1.076 . . . . 0.0 111.038 -177.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 25.0 p -85.54 125.74 33.32 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 117.485 0.642 . . . . 0.0 109.821 175.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.449 HD11 ' HB ' ' A' ' 14' ' ' THR . 30.2 tp -64.16 133.78 53.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.608 -174.457 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -62.17 -45.6 92.69 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.589 -179.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -84.51 120.59 26.51 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.162 179.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 27.1 m170 -105.83 138.93 41.19 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.284 -178.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 50.2 t-80 -68.74 -25.84 64.95 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.225 0.536 . . . . 0.0 109.662 178.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 12.1 t-80 -139.72 142.56 36.84 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 176.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 6.2 t60 -55.37 -57.57 11.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.057 0.456 . . . . 0.0 110.048 -179.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 64.2 t60 . . . . . 0 C--O 1.243 0.745 0 CA-C-O 118.171 -0.919 . . . . 0.0 109.207 173.96 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.8 mtt . . . . . 0 N--CA 1.48 1.037 0 CA-C-O 121.107 0.48 . . . . 0.0 110.809 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -114.27 142.42 28.02 Favored Pre-proline 0 C--N 1.32 -0.69 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.913 175.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.4 ' HD2' ' O ' ' A' ' 91' ' ' ASN . 72.4 Cg_endo -83.79 156.84 13.75 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 122.023 1.815 . . . . 0.0 111.175 172.242 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -139.3 113.72 9.01 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 -178.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.512 HD22 HD21 ' A' ' 57' ' ' LEU . 31.5 mt -99.83 126.88 46.0 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -173.079 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.542 ' O ' ' HA ' ' A' ' 27' ' ' ILE . 8.4 t -124.91 140.22 35.3 Favored Pre-proline 0 C--N 1.318 -0.787 0 C-N-CA 120.341 -0.544 . . . . 0.0 110.263 -176.061 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.445 ' HB2' ' HB2' ' A' ' 100' ' ' LEU . 12.2 Cg_endo -96.52 98.18 0.09 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.57 0 C-N-CA 123.548 2.832 . . . . 0.0 109.733 167.05 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 26.2 m -80.37 -28.26 11.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.53 -167.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.3 t -165.71 158.9 15.76 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-O 120.816 0.341 . . . . 0.0 111.166 -177.083 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.48 HD11 ' HE3' ' A' ' 23' ' ' MET . 29.9 tp -127.6 126.58 42.34 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.298 175.285 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 62.5 p -122.21 131.53 24.39 Favored Pre-proline 0 C--N 1.319 -0.718 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.587 179.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.652 ' HD2' ' SD ' ' A' ' 23' ' ' MET . 95.8 Cg_endo -92.02 175.01 17.81 Favored 'Cis proline' 0 N--CA 1.455 -0.753 0 C-N-CA 123.742 -1.357 . . . . 0.0 112.947 1.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 17.6 m -91.13 -10.42 9.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-O 121.347 0.594 . . . . 0.0 110.599 178.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.531 ' HA ' ' O ' ' A' ' 105' ' ' GLY . 0.8 OUTLIER -120.05 151.14 39.45 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.155 174.574 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 17.1 m -143.06 157.25 17.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.217 0.532 . . . . 0.0 111.788 -176.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.681 HG12 ' H ' ' A' ' 18' ' ' ASN . 21.8 t -99.27 132.05 24.05 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.454 -0.793 . . . . 0.0 110.287 179.092 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.507 ' HA ' ' HG ' ' A' ' 71' ' ' LEU . 95.9 Cg_endo -92.62 11.3 2.2 Favored 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 122.834 2.356 . . . . 0.0 112.65 177.085 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.681 ' H ' HG12 ' A' ' 16' ' ' VAL . 66.6 m-20 -100.6 -14.26 18.25 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.141 -175.15 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 9.1 t -158.75 173.7 16.15 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 -175.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 54.9 t -69.54 133.1 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 CA-C-O 121.64 0.733 . . . . 0.0 109.752 176.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -114.22 133.47 55.6 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 114.638 -1.165 . . . . 0.0 108.927 -176.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 18.1 m -107.8 118.76 37.57 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-O 122.444 1.116 . . . . 0.0 108.693 -170.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.652 ' SD ' ' HD2' ' A' ' 12' ' ' PRO . 97.3 mmm -109.04 123.49 49.23 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 112.868 -1.969 . . . . 0.0 110.794 -162.712 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 23.2 m -111.91 124.57 52.67 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 121.865 0.841 . . . . 0.0 109.793 -176.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -119.39 132.52 55.85 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.075 -1.42 . . . . 0.0 108.445 -175.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 45.4 m -112.31 121.01 43.68 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 121.93 0.871 . . . . 0.0 110.064 -168.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.542 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 9.4 mm -116.53 120.02 63.7 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 CA-C-N 114.001 -1.454 . . . . 0.0 109.123 -172.151 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -118.79 128.69 54.71 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 -177.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 31.2 t30 -83.82 95.04 8.33 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 177.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -95.51 57.15 1.89 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.183 -174.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -144.1 168.07 26.66 Favored Glycine 0 N--CA 1.442 -0.928 0 CA-C-N 114.879 -1.055 . . . . 0.0 110.669 178.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 44.8 m-80 -75.71 -21.34 57.64 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 111.77 0.285 . . . . 0.0 111.77 -174.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 61.7 tttp -101.32 138.55 38.19 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.944 0.402 . . . . 0.0 111.029 -177.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.403 ' HA ' ' HB3' ' A' ' 59' ' ' SER . 2.4 t70 -76.99 140.05 40.28 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.745 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 13.9 p -105.74 155.76 18.96 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.03 0.443 . . . . 0.0 111.65 -175.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 12.6 p -99.1 -161.56 0.88 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.258 -177.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 9.8 m -53.76 136.3 40.07 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 122.656 0.383 . . . . 0.0 111.638 178.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.492 ' CE1' ' HB2' ' A' ' 57' ' ' LEU . 18.2 p90 -149.44 147.04 27.77 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 177.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.563 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 42.4 t-20 -101.2 125.46 47.82 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.439 0.162 . . . . 0.0 110.673 -176.137 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.513 HG23 ' HA ' ' A' ' 84' ' ' VAL . 2.7 t -111.28 127.02 68.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 121.185 0.517 . . . . 0.0 110.013 -179.198 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 19.5 m -119.88 144.08 47.59 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.662 -177.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 58.3 tp -100.11 112.7 25.0 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.874 178.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.414 ' HG ' HG23 ' A' ' 48' ' ' VAL . 5.0 mp -101.57 121.74 42.54 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.834 -178.592 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 89.1 t -97.27 115.33 36.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 172.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 25.5 t70 67.98 -75.02 0.07 Allowed 'General case' 0 N--CA 1.469 0.509 0 O-C-N 123.736 0.648 . . . . 0.0 110.739 -174.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -158.89 17.22 0.26 Allowed Glycine 0 N--CA 1.448 -0.554 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.8 178.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 9.9 mt -123.64 149.83 27.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.414 HG23 ' HG ' ' A' ' 43' ' ' LEU . 40.0 t -93.33 122.43 44.82 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 -177.614 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 26.5 m -96.95 -28.99 3.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.351 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 37.2 t0 -149.53 151.21 33.51 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 120.768 0.318 . . . . 0.0 110.441 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 21.9 m -144.13 121.84 11.88 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.954 -174.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -135.45 125.11 25.27 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.779 0.323 . . . . 0.0 110.555 -179.229 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.563 ' HA ' ' HA ' ' A' ' 39' ' ' ASN . 23.8 m -85.5 122.78 30.12 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.252 177.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 20.1 t -86.59 136.38 23.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 -179.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 14.6 m -55.28 -51.81 65.47 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 123.494 0.496 . . . . 0.0 111.844 -176.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 8.4 t -176.87 130.86 0.18 Allowed 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.512 HD21 HD22 ' A' ' 5' ' ' LEU . 21.1 tp -96.1 112.64 24.31 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.322 0.582 . . . . 0.0 110.088 177.442 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -71.82 144.62 49.06 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.542 -0.753 . . . . 0.0 110.577 -178.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.403 ' HB3' ' HA ' ' A' ' 34' ' ' ASP . 8.5 p -61.52 132.77 54.47 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.883 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 72.66 1.13 3.88 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.223 177.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -108.17 149.6 28.32 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 2.6 p -111.44 123.19 49.71 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.063 0.458 . . . . 0.0 110.789 -178.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 27.9 m -104.05 135.86 44.76 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.725 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -94.77 128.48 41.51 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.562 179.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 40.2 t -96.16 115.79 36.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.418 -179.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -84.07 101.11 11.54 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.594 179.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.462 ' CZ ' HG12 ' A' ' 40' ' ' VAL . 8.0 m-85 -100.47 148.62 24.56 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.015 0.436 . . . . 0.0 111.143 178.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 33.1 m-70 -120.05 107.87 13.6 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 178.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 14.4 t90 -115.97 118.73 33.73 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.342 0.591 . . . . 0.0 111.205 -172.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 4.6 m -88.7 113.48 24.31 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 168.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.507 ' HG ' ' HA ' ' A' ' 17' ' ' PRO . 0.1 OUTLIER -44.64 -40.54 5.93 Favored 'General case' 0 N--CA 1.469 0.516 0 O-C-N 123.898 0.748 . . . . 0.0 112.167 -169.669 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 15.9 t70 77.52 -53.9 0.53 Allowed 'General case' 0 N--CA 1.468 0.45 0 O-C-N 123.792 0.682 . . . . 0.0 111.035 175.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -117.21 -155.92 10.34 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 121.017 -0.611 . . . . 0.0 111.61 176.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 33.0 m -153.26 91.88 1.55 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.158 0.504 . . . . 0.0 110.47 177.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.453 ' H ' ' HE2' ' A' ' 78' ' ' TYR . . . -126.25 147.6 49.65 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.354 177.263 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -63.94 -27.14 68.94 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.227 0.454 . . . . 0.0 112.227 -173.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 38.4 m -145.67 119.26 9.12 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.058 0.456 . . . . 0.0 111.185 -179.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.453 ' HE2' ' H ' ' A' ' 75' ' ' ALA . 26.5 m-85 -105.74 141.67 36.77 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.177 177.309 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 21.9 m -93.43 100.02 12.4 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.056 178.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.411 HD12 HG23 ' A' ' 104' ' ' VAL . 8.6 mp -100.43 125.07 46.67 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.274 0.559 . . . . 0.0 110.519 -178.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.516 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 32.4 m -121.24 115.69 23.48 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.938 -176.494 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 92.9 t -86.94 108.6 18.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.685 175.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -101.8 121.19 41.62 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 176.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.513 ' HA ' HG23 ' A' ' 40' ' ' VAL . 77.8 t -87.58 108.8 18.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.187 -176.605 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 46.2 t0 61.61 85.25 0.18 Allowed Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 114.555 -1.202 . . . . 0.0 111.701 178.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -72.45 -4.36 15.12 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.732 2.288 . . . . 0.0 112.088 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -99.52 -15.87 18.51 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 177.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 48.04 71.89 0.31 Allowed 'General case' 0 C--O 1.233 0.201 0 CA-C-N 114.647 -1.16 . . . . 0.0 110.911 -177.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.06 -32.12 16.85 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.251 177.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 22.0 t -89.28 134.02 29.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.658 176.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.4 ' O ' ' HD2' ' A' ' 3' ' ' PRO . 58.1 t30 -78.04 99.19 6.01 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 177.577 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -89.95 156.1 18.66 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.899 -171.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -57.47 -100.88 0.01 OUTLIER Glycine 0 CA--C 1.518 0.231 0 CA-C-N 115.088 -0.96 . . . . 0.0 112.78 171.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.607 ' HB2' ' HB3' ' A' ' 97' ' ' ASN . 78.9 m-20 -83.76 123.41 29.84 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 120.847 -0.341 . . . . 0.0 110.733 -178.088 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -72.67 -15.92 61.7 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.651 0.739 . . . . 0.0 109.724 176.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -89.03 7.18 36.19 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.826 176.141 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.607 ' HB3' ' HB2' ' A' ' 94' ' ' ASN . 1.7 t30 -116.98 -28.86 6.15 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -173.291 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 20.2 p-10 -75.69 10.99 1.47 Allowed 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.065 0.46 . . . . 0.0 111.86 -173.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -126.38 143.64 51.1 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.799 0.333 . . . . 0.0 110.399 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.516 ' O ' ' HA ' ' A' ' 81' ' ' THR . 44.1 tp -128.73 104.65 7.76 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.472 179.552 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 53.0 m -92.05 106.39 18.42 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 174.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -121.72 153.54 38.09 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.537 -177.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 88.7 mt -104.38 124.02 48.47 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.001 0.429 . . . . 0.0 110.481 179.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.411 HG23 HD12 ' A' ' 80' ' ' LEU . 22.4 m -116.17 132.42 65.77 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.618 178.534 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.531 ' O ' ' HA ' ' A' ' 14' ' ' THR . . . -110.96 166.27 12.27 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.423 -0.894 . . . . 0.0 112.01 -175.575 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 18.4 p -68.22 135.49 52.09 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.745 0.273 . . . . 0.0 110.275 177.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 61.9 tp -55.24 110.63 0.71 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.589 -176.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 -71.54 113.06 8.18 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.34 173.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 27.9 t60 -75.07 98.17 3.59 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 176.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . 0.413 ' HB3' ' O ' ' A' ' 112' ' ' HIS . 20.7 m170 -88.15 144.3 26.56 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.424 -178.201 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 76.6 m80 -69.87 -45.4 67.77 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 176.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . 0.413 ' O ' ' HB3' ' A' ' 110' ' ' HIS . 70.5 m-70 -98.98 132.99 43.89 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 171.461 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 30.0 m170 -76.47 71.45 3.12 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.634 0.73 . . . . 0.0 110.689 -176.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.245 0.842 0 CA-C-N 114.731 -1.122 . . . . 0.0 109.325 178.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.531 ' O ' ' HD2' ' A' ' 33' ' ' LYS . 66.7 mtm . . . . . 0 N--CA 1.479 1.008 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.406 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 7.5 tp -114.28 141.42 26.43 Favored Pre-proline 0 CA--C 1.537 0.458 0 CA-C-N 116.72 -0.218 . . . . 0.0 110.845 -177.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.53 ' HG3' ' HD3' ' A' ' 33' ' ' LYS . 6.5 Cg_endo -88.58 174.03 4.26 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 123.146 2.564 . . . . 0.0 112.128 173.092 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -151.42 105.91 3.23 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 179.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.528 ' O ' ' HA ' ' A' ' 98' ' ' ASN . 96.9 mt -99.57 103.3 15.01 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.192 0.52 . . . . 0.0 111.473 -168.611 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.517 HG21 ' HB3' ' A' ' 97' ' ' ASN . 11.5 t -114.57 116.58 43.5 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.653 -173.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.455 ' HB2' ' HB2' ' A' ' 100' ' ' LEU . 3.8 Cg_exo -79.33 104.07 1.7 Allowed 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 122.544 2.163 . . . . 0.0 109.76 169.006 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 31.8 m -92.14 -15.06 8.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -169.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 27.8 t -159.36 156.83 29.23 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.516 -0.474 . . . . 0.0 111.507 -177.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 60.1 tp -142.48 114.12 7.96 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.07 178.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 8.8 p -126.96 145.8 55.2 Favored Pre-proline 0 C--N 1.32 -0.708 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.99 -176.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.48 ' O ' ' HE1' ' A' ' 23' ' ' MET . 71.9 Cg_endo -77.77 155.88 95.21 Favored 'Cis proline' 0 C--N 1.341 0.18 0 C-N-CA 123.265 -1.556 . . . . 0.0 112.497 -0.68 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 30.2 m -80.16 -21.44 11.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.195 0.522 . . . . 0.0 110.282 177.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.613 ' HA ' ' O ' ' A' ' 105' ' ' GLY . 3.2 p -117.88 126.99 53.41 Favored 'General case' 0 N--CA 1.438 -1.067 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.355 176.236 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.491 ' HB ' ' ND2' ' A' ' 21' ' ' ASN . 29.2 m -113.57 140.36 34.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.134 0.492 . . . . 0.0 111.678 -173.032 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.408 ' HA ' ' HD3' ' A' ' 17' ' ' PRO . 8.1 m -90.67 124.67 61.76 Favored Pre-proline 0 N--CA 1.445 -0.698 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.425 174.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.503 ' HA ' ' HB3' ' A' ' 71' ' ' LEU . 3.0 Cg_exo -80.3 49.56 3.25 Favored 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 122.803 2.335 . . . . 0.0 111.723 178.408 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -116.71 -13.24 10.8 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.468 -175.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 15.2 t -167.98 -167.9 0.9 Allowed 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.928 -0.309 . . . . 0.0 110.799 -171.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.462 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 53.6 t -86.76 113.61 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 174.146 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.491 ' ND2' ' HB ' ' A' ' 15' ' ' VAL . 4.4 m-20 -88.08 137.07 32.65 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.237 -172.146 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 33.4 m -88.85 105.57 17.83 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.219 178.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.505 ' HB2' ' HB2' ' A' ' 67' ' ' PHE . 92.6 mmm -92.9 119.79 32.57 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.002 -178.32 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.516 ' HA ' ' O ' ' A' ' 65' ' ' VAL . 11.5 m -108.68 114.55 28.44 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.635 -176.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -105.71 133.03 51.1 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.387 -179.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 25.4 m -94.08 110.2 21.92 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.924 0.392 . . . . 0.0 110.827 -178.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 27.4 mm -102.64 116.32 46.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.789 -179.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -115.52 129.07 56.41 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.902 0.382 . . . . 0.0 110.177 178.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 24.6 t30 -92.76 98.87 11.67 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.114 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -96.22 53.85 1.38 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.707 -174.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -144.02 161.5 27.84 Favored Glycine 0 N--CA 1.448 -0.558 0 N-CA-C 111.441 -0.663 . . . . 0.0 111.441 179.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.458 ' O ' ' HB3' ' A' ' 1' ' ' MET . 5.7 t30 -86.93 46.73 1.4 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.473 0.654 . . . . 0.0 110.793 -174.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.531 ' HD2' ' O ' ' A' ' 1' ' ' MET . 31.5 tttm -161.51 146.21 13.3 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 174.203 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -76.55 149.27 36.67 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.023 0.44 . . . . 0.0 110.189 176.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.431 ' HG ' ' HB3' ' A' ' 57' ' ' LEU . 13.5 p -104.72 129.3 52.96 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 172.331 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -84.3 -148.57 0.1 Allowed 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 -176.458 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.511 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 56.4 m -65.18 108.36 1.85 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.005 0.431 . . . . 0.0 111.398 -175.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.512 ' HB2' ' HB2' ' A' ' 85' ' ' ASP . 54.0 p90 -123.09 154.9 37.96 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.032 177.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.477 ' O ' ' HA ' ' A' ' 85' ' ' ASP . 32.8 m-80 -105.27 110.92 23.47 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.107 -175.573 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.507 HG22 ' HA ' ' A' ' 84' ' ' VAL . 1.3 t -98.18 121.28 48.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 121.351 0.596 . . . . 0.0 109.716 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.561 ' HG ' HG21 ' A' ' 51' ' ' THR . 11.8 m -114.37 137.56 51.66 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.436 -175.258 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 55.0 tp -96.65 111.77 23.78 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.972 175.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.532 ' HG ' HG21 ' A' ' 48' ' ' VAL . 5.1 mp -94.46 132.29 39.26 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.336 178.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 85.5 t -105.96 97.42 5.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 173.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 70.81 -62.89 0.43 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.133 -0.94 . . . . 0.0 111.921 -179.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -147.34 -6.78 0.28 Allowed Glycine 0 CA--C 1.521 0.443 0 C-N-CA 120.886 -0.674 . . . . 0.0 113.496 179.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 6.5 mt -116.0 151.25 17.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 117.477 0.639 . . . . 0.0 110.45 -177.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.532 HG21 ' HG ' ' A' ' 43' ' ' LEU . 48.0 t -95.0 118.61 41.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 177.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 17.8 m -93.31 -33.08 5.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -176.299 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -152.98 143.07 22.33 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 110.278 -0.268 . . . . 0.0 110.278 -177.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.561 HG21 ' HG ' ' A' ' 41' ' ' SER . 39.2 m -132.86 132.55 42.24 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.318 -179.594 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -123.57 125.86 45.62 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 178.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 15.0 m -87.31 110.3 20.13 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 177.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.511 ' O ' ' HA ' ' A' ' 37' ' ' SER . 43.7 t -81.6 124.13 38.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.329 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 10.3 m -52.76 -44.18 66.3 Favored 'General case' 0 C--N 1.329 -0.287 0 O-C-N 123.543 0.527 . . . . 0.0 111.464 -177.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 34.1 t -179.95 157.76 0.72 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.598 -179.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.431 ' HB3' ' HG ' ' A' ' 35' ' ' SER . 47.9 tp -136.02 123.94 22.72 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.012 -179.458 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 44.4 mm-40 -71.98 161.12 31.39 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.817 -177.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 15.5 m -70.14 128.82 37.61 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.278 178.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 68.3 20.09 8.81 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.984 178.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -112.9 147.02 37.92 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.625 177.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 11.2 p -114.67 125.91 54.28 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.123 0.487 . . . . 0.0 110.576 179.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 50.9 m -118.21 138.7 52.14 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.208 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -94.28 133.69 37.55 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.101 0.477 . . . . 0.0 111.363 -177.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.516 ' O ' ' HA ' ' A' ' 24' ' ' THR . 21.5 t -96.77 135.36 31.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.961 179.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -104.05 97.31 7.31 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.926 -174.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.505 ' HB2' ' HB2' ' A' ' 23' ' ' MET . 57.0 m-85 -97.13 153.34 18.03 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.406 177.322 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 68.8 m-70 -128.67 116.05 18.97 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 171.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 3.5 t90 -129.69 124.23 33.08 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.657 -173.007 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.462 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 4.3 m -80.09 113.87 18.58 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.056 -178.617 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.503 ' HB3' ' HA ' ' A' ' 17' ' ' PRO . 0.8 OUTLIER -69.68 120.23 15.13 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.964 0.412 . . . . 0.0 110.973 177.409 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -87.73 -36.21 17.48 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.589 178.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 92.9 16.04 49.75 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.641 -0.79 . . . . 0.0 111.735 -178.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.5 -38.62 87.99 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.265 0.555 . . . . 0.0 110.621 -179.178 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -138.02 158.17 44.88 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.874 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.471 ' N ' HD21 ' A' ' 76' ' ' ASN . 1.0 OUTLIER -83.09 -12.3 57.21 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.027 0.441 . . . . 0.0 110.544 179.019 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 10.7 p -143.3 121.56 12.26 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.452 178.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 53.0 m-85 -105.73 149.97 25.92 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.314 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.497 ' HA ' HD21 ' A' ' 103' ' ' LEU . 8.9 m -96.46 88.27 4.66 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.906 0.384 . . . . 0.0 110.38 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 7.4 mp -88.13 120.2 29.25 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.555 0.693 . . . . 0.0 111.118 -177.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.422 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 34.5 m -118.28 117.66 29.72 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.34 -178.318 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 47.9 t -90.75 103.79 14.74 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 176.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -101.52 112.61 25.21 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 178.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.567 ' HB ' ' HB2' ' A' ' 98' ' ' ASN . 75.6 t -78.64 103.81 5.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.838 -176.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.512 ' HB2' ' HB2' ' A' ' 38' ' ' PHE . 7.9 t70 58.94 88.3 0.13 Allowed Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 114.091 -1.413 . . . . 0.0 112.019 179.58 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -72.63 -4.46 15.37 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 123.171 2.581 . . . . 0.0 111.561 176.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -83.77 -21.95 32.03 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.173 -179.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 64.09 35.3 10.53 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.581 -178.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -75.93 -34.27 59.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.56 177.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 95.2 t -99.98 112.11 31.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.173 172.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 61.8 t30 -82.74 126.0 31.9 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.509 -177.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -84.05 165.83 18.22 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.239 0.542 . . . . 0.0 111.281 178.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -57.58 -100.69 0.01 OUTLIER Glycine 0 N--CA 1.444 -0.813 0 N-CA-C 110.268 -1.133 . . . . 0.0 110.268 159.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 15.4 m-20 -72.8 88.44 1.32 Allowed 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 172.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -58.4 96.23 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.409 0 O-C-N 123.325 0.391 . . . . 0.0 110.913 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 7.8 m 173.35 -26.36 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.417 0 O-C-N 124.238 0.961 . . . . 0.0 110.072 -172.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.517 ' HB3' HG21 ' A' ' 6' ' ' VAL . 83.7 m-20 -74.68 -19.85 60.1 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.488 -177.603 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.567 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 24.9 p-10 -72.29 19.31 0.08 Allowed 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.624 0.602 . . . . 0.0 112.624 -175.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.414 ' H ' ' C ' ' A' ' 97' ' ' ASN . 1.4 m -130.36 149.03 52.23 Favored 'General case' 0 C--N 1.322 -0.625 0 O-C-N 121.881 -0.512 . . . . 0.0 111.235 -178.495 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.455 ' HB2' ' HB2' ' A' ' 7' ' ' PRO . 30.0 tp -145.45 103.46 3.82 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.686 178.114 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 15.4 m -92.37 98.26 11.37 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 177.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -116.59 127.71 54.74 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.117 0.484 . . . . 0.0 110.695 -177.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.497 HD21 ' HA ' ' A' ' 79' ' ' THR . 65.1 mt -85.77 120.12 26.84 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.649 178.555 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 26.8 m -106.46 132.92 52.44 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.409 178.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.613 ' O ' ' HA ' ' A' ' 14' ' ' THR . . . -117.32 155.6 16.07 Favored Glycine 0 N--CA 1.44 -1.097 0 C-N-CA 120.205 -0.998 . . . . 0.0 111.244 -176.325 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.464 ' HA ' ' O ' ' A' ' 15' ' ' VAL . 35.2 p -61.75 145.82 51.26 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 176.226 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.421 ' HG ' ' H ' ' A' ' 109' ' ' HIS . 49.3 tp -52.77 126.8 21.19 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.816 0.341 . . . . 0.0 111.199 -176.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.62 ' HA ' ' HD2' ' A' ' 111' ' ' HIS . 35.5 mt-10 -54.77 -31.07 58.28 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.185 -178.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . 0.421 ' H ' ' HG ' ' A' ' 107' ' ' LEU . 51.5 t60 -60.98 -24.36 66.06 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.989 -176.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 5.4 t-80 -100.66 17.94 20.56 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.06 0.457 . . . . 0.0 110.688 179.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . 0.62 ' HD2' ' HA ' ' A' ' 108' ' ' GLU . 89.2 m-70 -103.91 -37.27 7.47 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 168.197 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 13.7 t60 -77.87 -26.23 49.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.254 -0.884 . . . . 0.0 109.079 176.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 23.9 m170 -110.32 169.57 8.65 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.305 -0.862 . . . . 0.0 109.383 172.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 21.9 m-70 . . . . . 0 C--O 1.248 0.983 0 CA-C-O 118.251 -0.88 . . . . 0.0 109.844 177.178 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.448 ' O ' ' HD2' ' A' ' 33' ' ' LYS . 63.7 mtt . . . . . 0 N--CA 1.478 0.934 0 CA-C-O 120.877 0.37 . . . . 0.0 110.338 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.428 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 1.1 tt -114.27 142.46 28.08 Favored Pre-proline 0 C--N 1.319 -0.736 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 174.517 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.506 ' HD2' ' O ' ' A' ' 91' ' ' ASN . 12.6 Cg_exo -70.72 157.04 59.63 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.44 2.093 . . . . 0.0 111.012 174.362 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.601 ' HA ' ' OE1' ' A' ' 92' ' ' GLU . 13.7 t70 -132.73 91.78 2.96 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 175.566 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.515 ' O ' ' HB3' ' A' ' 97' ' ' ASN . 70.2 mt -99.76 126.45 45.84 Favored 'General case' 0 CA--C 1.499 -0.993 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 -173.105 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.0 t -125.4 140.57 36.6 Favored Pre-proline 0 C--N 1.311 -1.069 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.58 -173.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.536 ' HB2' ' HB2' ' A' ' 100' ' ' LEU . 17.2 Cg_endo -91.25 103.8 0.25 Allowed 'Trans proline' 0 N--CA 1.439 -1.688 0 C-N-CA 122.757 2.305 . . . . 0.0 109.495 168.045 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.8 t -80.02 -49.75 18.66 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 CA-C-N 114.765 -1.107 . . . . 0.0 111.306 -165.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 10.5 p -158.15 164.03 36.99 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.67 -178.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.499 HD13 ' HB3' ' A' ' 23' ' ' MET . 36.5 tp -127.73 126.51 41.97 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 176.486 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 37.0 p -122.3 131.71 24.36 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.502 176.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.529 ' HD2' ' SD ' ' A' ' 23' ' ' MET . 97.5 Cg_endo -90.83 176.4 18.03 Favored 'Cis proline' 0 N--CA 1.457 -0.619 0 C-N-CA 123.808 -1.33 . . . . 0.0 112.884 2.536 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.0 m -98.29 -12.05 8.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 121.431 0.634 . . . . 0.0 110.21 176.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.552 ' HA ' ' O ' ' A' ' 105' ' ' GLY . 0.8 OUTLIER -120.03 150.98 39.68 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.579 172.574 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.43 HG11 ' CZ3' ' A' ' 69' ' ' TRP . 7.5 m -143.14 155.15 17.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.056 0.455 . . . . 0.0 111.59 -173.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.9 m -104.33 130.26 23.63 Favored Pre-proline 0 N--CA 1.444 -0.764 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.15 -179.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.401 ' O ' ' HB2' ' A' ' 18' ' ' ASN . 4.3 Cg_exo -77.19 171.9 17.0 Favored 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 122.594 2.196 . . . . 0.0 111.648 175.164 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.401 ' HB2' ' O ' ' A' ' 17' ' ' PRO . 38.2 m-80 73.9 21.39 2.67 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.32 0.648 . . . . 0.0 111.391 178.443 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 15.1 t -167.07 -176.79 3.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.661 0.267 . . . . 0.0 110.706 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 57.8 t -102.33 132.91 47.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 178.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 32.4 m-80 -106.03 134.84 48.51 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.934 0.397 . . . . 0.0 110.362 -176.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 15.0 m -95.34 97.22 9.68 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.567 178.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.529 ' SD ' ' HD2' ' A' ' 12' ' ' PRO . 91.5 mmm -89.53 115.59 27.05 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.533 -175.087 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 25.2 m -93.44 111.28 22.91 Favored 'General case' 0 C--N 1.323 -0.576 0 O-C-N 123.563 0.54 . . . . 0.0 111.002 -178.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.514 ' HB1' ' HB ' ' A' ' 65' ' ' VAL . . . -99.01 119.53 37.95 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.09 175.236 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 5.7 m -83.5 108.81 16.88 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.082 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 28.5 mm -108.29 119.33 57.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 -179.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -117.67 133.11 56.29 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.608 0.242 . . . . 0.0 110.639 -177.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.596 ' ND2' ' HA ' ' A' ' 59' ' ' SER . 36.2 t30 -95.33 100.3 12.1 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.995 0.426 . . . . 0.0 109.889 177.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 67.5 mt-30 -104.89 52.36 0.74 Allowed 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.487 -173.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -143.99 178.19 22.18 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.11 -1.043 . . . . 0.0 113.183 -175.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -90.36 28.84 1.36 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.108 0.48 . . . . 0.0 111.711 -172.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.448 ' HD2' ' O ' ' A' ' 1' ' ' MET . 88.5 tttt -154.16 143.58 21.46 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 121.876 -0.515 . . . . 0.0 111.058 178.229 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -79.75 143.25 34.66 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 175.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.431 ' OG ' ' HB3' ' A' ' 57' ' ' LEU . 33.7 p -104.69 140.95 37.31 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.005 0.431 . . . . 0.0 111.429 -177.286 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 7.3 p -85.08 -165.49 1.22 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.052 -179.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 13.4 m -60.34 119.41 7.9 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.935 0.398 . . . . 0.0 111.547 179.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.44 ' CE2' HG23 ' A' ' 40' ' ' VAL . 26.4 p90 -137.26 153.19 50.39 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 177.574 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.584 ' O ' ' HD3' ' A' ' 86' ' ' PRO . 65.1 m-80 -94.98 138.56 32.55 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.094 0.473 . . . . 0.0 110.744 178.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.44 HG23 ' CE2' ' A' ' 38' ' ' PHE . 2.4 t -119.57 112.97 39.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 173.314 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.501 ' HB3' HG22 ' A' ' 51' ' ' THR . 33.4 p -108.79 139.28 43.84 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.24 -173.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 54.9 tp -96.46 115.85 28.1 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.403 177.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.521 ' HG ' HG21 ' A' ' 48' ' ' VAL . 5.5 mp -96.96 129.21 44.45 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.196 177.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.423 ' CG1' ' HD2' ' A' ' 78' ' ' TYR . 84.1 t -106.37 96.89 4.99 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.69 176.512 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.462 ' HA ' ' HB ' ' A' ' 79' ' ' THR . 2.9 m-20 70.9 -51.06 0.68 Allowed 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 115.156 -0.929 . . . . 0.0 112.452 178.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -166.29 14.73 0.08 OUTLIER Glycine 0 C--N 1.319 -0.391 0 C-N-CA 120.768 -0.73 . . . . 0.0 113.15 178.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 9.3 mt -136.18 152.14 29.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 -179.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.521 HG21 ' HG ' ' A' ' 43' ' ' LEU . 50.7 t -97.91 108.73 22.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 177.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 17.0 m -77.67 -37.83 24.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.592 -177.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -159.37 140.04 12.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.828 0.346 . . . . 0.0 110.175 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.501 HG22 ' HB3' ' A' ' 41' ' ' SER . 27.6 m -116.48 122.19 44.02 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.949 178.461 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 43.9 tt0 -105.13 122.7 46.44 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.014 0.435 . . . . 0.0 110.281 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 6.0 m -79.82 129.51 34.55 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.232 177.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 53.7 t -98.75 120.0 47.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 172.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.7 m -61.41 -38.01 85.54 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.629 -174.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 23.0 t -178.1 136.87 0.17 Allowed 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 178.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.458 HD22 HD22 ' A' ' 5' ' ' LEU . 39.7 tp -119.79 113.06 20.04 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.223 0.535 . . . . 0.0 109.731 176.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -67.84 156.9 36.07 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.888 -177.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.596 ' HA ' ' ND2' ' A' ' 29' ' ' ASN . 11.6 p -65.51 130.34 42.95 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.56 178.471 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 68.81 23.52 6.88 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.507 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -117.93 153.74 33.08 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.393 -0.821 . . . . 0.0 108.83 175.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 23.3 t -128.52 142.63 51.01 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 177.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 15.0 t -125.41 149.17 48.42 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.892 179.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -97.78 120.18 37.7 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.213 -178.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.514 ' HB ' ' HB1' ' A' ' 25' ' ' ALA . 21.4 t -98.7 107.02 19.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.546 -176.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -98.84 111.47 23.85 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.925 0.393 . . . . 0.0 110.666 -178.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -91.28 163.03 14.37 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.235 0.541 . . . . 0.0 111.194 -176.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 57.4 m80 -105.3 93.88 4.92 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.549 -0.751 . . . . 0.0 109.723 177.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . 0.43 ' CZ3' HG11 ' A' ' 15' ' ' VAL . 12.5 t90 -107.12 100.01 9.52 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.798 -177.201 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 12.3 t -73.82 121.96 21.71 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 172.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 15.9 tp -121.94 96.11 4.93 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.468 0.651 . . . . 0.0 111.671 -173.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -63.49 -60.71 3.0 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.876 -1.056 . . . . 0.0 109.916 172.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 128.38 67.33 0.13 Allowed Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.721 178.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 30.9 m -75.46 -69.48 0.48 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.884 0.374 . . . . 0.0 110.575 178.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -108.47 -173.19 2.21 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.456 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 -96.49 -18.21 20.0 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.866 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 20.6 m -133.7 133.93 42.44 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.995 0.426 . . . . 0.0 110.81 -179.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.423 ' HD2' ' CG1' ' A' ' 44' ' ' VAL . 49.3 m-85 -119.12 145.2 46.16 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.805 179.198 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.465 ' HA ' HD22 ' A' ' 103' ' ' LEU . 6.6 m -97.11 91.65 5.66 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.323 -179.235 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 7.9 mp -91.1 113.16 25.35 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.452 0.644 . . . . 0.0 111.265 -176.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.552 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 11.2 m -116.12 120.71 39.91 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.489 -178.05 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 85.8 t -86.96 109.63 19.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.399 178.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.547 ' HA ' ' O ' ' A' ' 98' ' ' ASN . 6.1 t30 -92.5 111.57 23.2 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.817 0.342 . . . . 0.0 110.204 176.02 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 94.0 t -92.02 124.77 44.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.338 179.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.751 ' OD2' ' HA ' ' A' ' 88' ' ' ASN . 31.2 t70 64.91 85.87 0.15 Allowed Pre-proline 0 N--CA 1.464 0.249 0 O-C-N 123.922 0.764 . . . . 0.0 111.461 176.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.584 ' HD3' ' O ' ' A' ' 39' ' ' ASN . 1.6 Cg_endo -85.15 -40.9 0.08 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 123.364 2.709 . . . . 0.0 112.754 178.69 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.486 ' OE1' ' HD2' ' A' ' 86' ' ' PRO . 27.1 mp0 -80.33 -10.28 59.75 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.174 -176.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . 0.751 ' HA ' ' OD2' ' A' ' 85' ' ' ASP . 12.9 m120 63.02 64.77 0.84 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.73 0.776 . . . . 0.0 110.273 -174.307 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -100.45 -28.58 12.85 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.641 -1.163 . . . . 0.0 109.172 178.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 54.7 t -115.81 107.67 23.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.421 175.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.506 ' O ' ' HD2' ' A' ' 3' ' ' PRO . 16.6 t-20 -66.13 106.19 1.57 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.29 -177.487 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.601 ' OE1' ' HA ' ' A' ' 4' ' ' ASP . 0.3 OUTLIER -79.95 151.48 30.05 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.439 -174.718 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -57.93 -101.11 0.01 OUTLIER Glycine 0 CA--C 1.522 0.515 0 CA-C-N 115.018 -0.992 . . . . 0.0 113.436 171.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -78.44 132.18 37.2 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.03 -0.585 . . . . 0.0 111.136 -173.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -73.78 76.77 1.58 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.172 0.511 . . . . 0.0 110.961 177.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 17.9 m -160.47 -40.27 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.564 -0.743 . . . . 0.0 109.885 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.515 ' HB3' ' O ' ' A' ' 5' ' ' LEU . 86.5 m-20 -67.47 -13.19 61.81 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.292 -0.867 . . . . 0.0 112.439 -173.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.547 ' O ' ' HA ' ' A' ' 83' ' ' ASN . 19.0 m120 -71.68 -5.01 30.67 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 111.675 0.25 . . . . 0.0 111.675 -175.616 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 2.5 p -142.41 122.54 13.77 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.552 ' O ' ' HA ' ' A' ' 81' ' ' THR . 42.2 tp -111.25 104.87 13.4 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 169.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.5 m -89.75 100.16 13.02 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.444 -178.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -120.57 128.05 52.7 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.081 0.467 . . . . 0.0 111.196 -177.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.465 HD22 ' HA ' ' A' ' 79' ' ' THR . 62.6 mt -85.51 125.82 33.36 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.57 177.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 33.3 m -116.82 142.85 28.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 177.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.552 ' O ' ' HA ' ' A' ' 14' ' ' THR . . . -122.65 155.91 17.11 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.235 -0.983 . . . . 0.0 112.291 -175.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 38.1 p -63.86 139.65 58.79 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 177.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 35.4 tp -52.48 121.29 6.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.044 -179.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -68.04 -20.83 65.01 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.918 -171.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 56.4 m170 -86.11 -5.42 59.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.278 0.561 . . . . 0.0 110.414 176.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -117.66 78.99 1.29 Allowed 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 173.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 51.5 m80 -57.47 118.45 5.19 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.367 -0.833 . . . . 0.0 112.678 -168.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 33.1 t-80 -90.87 124.44 35.18 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.175 176.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 -131.11 136.87 48.76 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.828 175.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 4.8 t60 . . . . . 0 C--O 1.247 0.946 0 CA-C-O 118.105 -0.95 . . . . 0.0 109.684 -175.782 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.477 ' HA ' ' OD1' ' A' ' 32' ' ' ASN . 83.4 mtp . . . . . 0 N--CA 1.478 0.937 0 CA-C-O 120.722 0.296 . . . . 0.0 110.354 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 13.7 tt -114.23 142.5 28.12 Favored Pre-proline 0 C--N 1.323 -0.582 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 176.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -80.63 156.81 21.55 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 122.314 2.01 . . . . 0.0 111.297 174.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.427 ' HB3' ' O ' ' A' ' 30' ' ' GLN . 13.5 t70 -146.65 104.63 3.76 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 176.234 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.532 HD22 HD22 ' A' ' 57' ' ' LEU . 14.6 mt -99.68 126.6 45.73 Favored 'General case' 0 CA--C 1.51 -0.573 0 C-N-CA 119.484 -0.886 . . . . 0.0 108.945 -172.272 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.3 t -125.55 140.69 37.04 Favored Pre-proline 0 C--N 1.318 -0.785 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.501 -176.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.65 ' HD3' ' O ' ' A' ' 97' ' ' ASN . 3.2 Cg_exo -81.89 109.39 1.96 Allowed 'Trans proline' 0 N--CA 1.446 -1.299 0 C-N-CA 122.598 2.199 . . . . 0.0 109.572 169.422 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 11.6 t -73.93 -53.59 17.19 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.037 -170.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 26.8 t -155.09 163.66 39.95 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.079 -179.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.419 HD11 ' HE1' ' A' ' 23' ' ' MET . 19.9 tp -127.64 126.56 42.21 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.156 0.503 . . . . 0.0 110.025 179.294 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.47 ' HG1' ' HB ' ' A' ' 24' ' ' THR . 41.4 p -122.17 131.47 24.4 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.558 177.299 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.494 ' HD2' ' SD ' ' A' ' 23' ' ' MET . 66.5 Cg_endo -90.68 177.19 17.19 Favored 'Cis proline' 0 N--CA 1.456 -0.72 0 C-N-CA 123.772 -1.345 . . . . 0.0 112.982 3.126 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.3 m -98.91 -13.36 8.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.376 177.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.405 ' HA ' ' O ' ' A' ' 105' ' ' GLY . 0.0 OUTLIER -120.24 151.1 39.64 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.892 173.586 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 17.0 m -143.16 157.36 17.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.574 0.226 . . . . 0.0 110.683 -177.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.491 ' HA ' ' HD3' ' A' ' 17' ' ' PRO . 2.2 t -99.25 131.84 24.44 Favored Pre-proline 0 C--N 1.325 -0.485 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 -178.173 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.539 ' HA ' ' HG ' ' A' ' 71' ' ' LEU . 3.2 Cg_exo -80.45 15.28 1.79 Allowed 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 123.3 2.667 . . . . 0.0 115.07 -171.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 29.4 p-10 -127.26 -2.47 6.31 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 -172.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 13.5 t -143.14 176.56 9.02 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.418 -172.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 62.0 t -81.01 134.46 27.13 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 CA-C-O 121.591 0.71 . . . . 0.0 109.405 174.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.546 ' ND2' HD23 ' A' ' 71' ' ' LEU . 32.7 m-80 -114.42 132.98 56.05 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 114.558 -1.201 . . . . 0.0 108.847 -173.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 23.7 m -108.2 118.88 37.93 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 108.166 -1.049 . . . . 0.0 108.166 -174.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.494 ' SD ' ' HD2' ' A' ' 12' ' ' PRO . 86.1 mmm -109.09 122.92 48.3 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 113.533 -1.667 . . . . 0.0 109.23 -166.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.524 ' HA ' ' O ' ' A' ' 65' ' ' VAL . 25.0 m -111.93 124.8 53.16 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-O 121.732 0.777 . . . . 0.0 109.531 -174.328 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -119.26 132.01 55.86 Favored 'General case' 0 N--CA 1.434 -1.248 0 CA-C-N 114.353 -1.294 . . . . 0.0 108.15 -176.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 93.6 m -112.36 121.45 44.89 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 -173.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.4 HD11 ' HA ' ' A' ' 7' ' ' PRO . 11.9 mm -116.14 131.86 67.39 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 -171.596 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -125.32 148.56 48.67 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.257 -177.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 37.6 t30 -101.15 95.99 6.92 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.442 -175.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.427 ' O ' ' HB3' ' A' ' 4' ' ' ASP . 92.8 mt-30 -88.08 62.2 6.68 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 122.048 0.927 . . . . 0.0 109.826 -179.564 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -173.5 147.14 9.31 Favored Glycine 0 N--CA 1.443 -0.841 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 178.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.477 ' OD1' ' HA ' ' A' ' 1' ' ' MET . 32.5 p-10 -85.39 8.29 19.42 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 113.661 0.986 . . . . 0.0 113.661 -162.23 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -109.19 141.17 41.82 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 120.376 -0.529 . . . . 0.0 110.648 174.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -75.24 135.56 40.99 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.864 174.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 65.5 p -93.1 -161.75 0.87 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.909 -173.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 7.0 p -131.31 -167.97 1.94 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.436 178.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 13.4 m -59.38 124.27 19.49 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.876 178.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.502 ' HB2' ' HB2' ' A' ' 85' ' ' ASP . 23.9 p90 -136.53 150.73 48.79 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.95 -179.05 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.425 ' O ' ' HA ' ' A' ' 85' ' ' ASP . 22.1 m-80 -99.44 109.84 22.38 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.364 -173.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.453 HG21 ' CE2' ' A' ' 38' ' ' PHE . 2.4 t -98.3 114.2 35.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-O 121.337 0.589 . . . . 0.0 109.797 177.509 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.435 ' HA ' ' HA ' ' A' ' 51' ' ' THR . 25.2 p -112.65 141.91 45.88 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.745 -175.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 55.9 tp -96.47 114.45 26.12 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.982 177.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.509 ' HG ' HG22 ' A' ' 48' ' ' VAL . 5.1 mp -98.26 132.57 43.64 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.225 179.196 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 98.7 t -113.78 101.72 12.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.868 177.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 58.82 19.01 6.54 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.822 179.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 128.55 -38.71 2.01 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.892 177.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 5.6 mt -87.48 150.23 3.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 -177.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.509 HG22 ' HG ' ' A' ' 43' ' ' LEU . 44.8 t -96.77 121.11 46.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 19.9 m -94.73 -33.32 4.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -177.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 34.1 t0 -156.1 138.35 14.73 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.576 0.227 . . . . 0.0 110.518 -178.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.435 ' HA ' ' HA ' ' A' ' 41' ' ' SER . 30.6 m -126.83 123.29 36.98 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.262 -179.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -114.7 112.65 23.18 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.802 0.334 . . . . 0.0 110.377 -179.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 23.7 m -77.12 113.07 14.46 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.972 0.415 . . . . 0.0 110.607 177.149 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 27.5 t -83.36 144.15 10.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.881 -179.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.3 m -62.67 -49.06 76.61 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.585 -0.279 . . . . 0.0 111.231 -178.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 22.6 t -177.75 164.45 1.97 Allowed 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -178.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.532 HD22 HD22 ' A' ' 5' ' ' LEU . 18.1 tp -139.85 110.03 6.53 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.247 0.546 . . . . 0.0 110.79 175.645 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 29.3 mp0 -74.75 174.2 9.47 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.973 -178.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 34.6 p -74.89 128.94 36.77 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.699 0.285 . . . . 0.0 110.901 -177.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 66.95 18.34 10.59 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.026 178.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.46 ' O ' HD13 ' A' ' 57' ' ' LEU . 58.5 t30 -110.64 148.65 31.79 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 175.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -117.62 153.9 32.5 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 120.964 0.411 . . . . 0.0 111.015 -175.511 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.464 ' OG1' HD11 ' A' ' 57' ' ' LEU . 92.6 m -130.07 135.24 48.02 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.715 177.254 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -96.34 123.04 39.85 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.41 176.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.524 ' O ' ' HA ' ' A' ' 24' ' ' THR . 17.6 t -105.15 120.68 56.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.732 178.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -109.42 111.27 22.72 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.114 0.483 . . . . 0.0 110.321 -179.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -91.6 157.72 16.83 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.391 -177.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 65.1 m-70 -108.94 100.03 9.29 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.327 175.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 13.5 t90 -116.67 108.23 15.66 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.077 0.465 . . . . 0.0 110.925 -175.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 10.1 m -81.78 114.03 20.14 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.636 174.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.546 HD23 ' ND2' ' A' ' 21' ' ' ASN . 0.1 OUTLIER -72.64 124.73 25.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.701 0.286 . . . . 0.0 110.46 -177.462 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -84.3 -36.62 22.48 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.765 177.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 85.8 58.58 2.0 Allowed Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 121.104 -0.569 . . . . 0.0 112.917 174.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.4 p -112.09 -32.14 6.66 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.734 0.302 . . . . 0.0 111.636 178.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -124.1 166.3 16.02 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.785 0.326 . . . . 0.0 111.083 -177.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.46 ' HA ' HG23 ' A' ' 106' ' ' THR . 51.8 m-80 -101.65 -5.09 25.47 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.046 0.45 . . . . 0.0 110.321 177.267 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 20.5 m -145.18 114.21 6.95 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.841 178.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -105.91 138.79 41.5 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.15 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.443 ' HA ' HD22 ' A' ' 103' ' ' LEU . 9.5 m -90.59 88.23 7.05 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.529 -178.005 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.415 HD12 HG23 ' A' ' 104' ' ' VAL . 8.3 mp -89.02 124.82 34.64 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.35 0.595 . . . . 0.0 111.148 -177.295 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.47 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 76.2 m -123.53 124.4 42.76 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.67 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 61.7 t -90.28 99.03 8.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 174.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.541 ' HA ' ' O ' ' A' ' 98' ' ' ASN . 4.6 t30 -93.5 114.76 27.22 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 178.583 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.418 HG12 ' HB2' ' A' ' 5' ' ' LEU . 60.8 t -80.11 108.6 13.73 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.648 -178.62 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.502 ' HB2' ' HB2' ' A' ' 38' ' ' PHE . 8.1 t70 48.57 92.09 0.06 OUTLIER Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 114.056 -1.429 . . . . 0.0 112.511 -179.242 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -64.73 -8.19 16.92 Favored 'Trans proline' 0 C--O 1.234 0.313 0 C-N-CA 123.313 2.675 . . . . 0.0 112.452 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -94.26 -24.95 17.25 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.372 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 18.9 m120 58.57 48.18 12.24 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.686 -173.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -64.21 -25.66 68.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.012 176.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 20.4 t -101.66 125.74 55.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.564 175.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -74.83 116.53 15.65 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.435 -0.579 . . . . 0.0 109.435 176.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -118.41 168.38 10.7 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -171.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -57.97 -100.96 0.01 OUTLIER Glycine 0 CA--C 1.522 0.52 0 CA-C-N 113.985 -1.461 . . . . 0.0 114.756 179.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -85.54 -163.9 0.93 Allowed 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -166.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 49.0 mm-40 -100.45 -37.84 8.66 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.282 -173.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 15.3 m -84.98 -4.4 59.13 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.824 0.345 . . . . 0.0 111.749 -171.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.65 ' O ' ' HD3' ' A' ' 7' ' ' PRO . 23.6 p-10 -70.44 -34.07 72.03 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.562 -176.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.541 ' O ' ' HA ' ' A' ' 83' ' ' ASN . 9.2 m120 -77.56 -1.46 30.77 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -175.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 1.1 p -135.83 130.94 34.72 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -177.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.47 ' O ' ' HA ' ' A' ' 81' ' ' THR . 28.3 tp -128.35 98.52 5.09 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.234 168.152 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 98.5 m -95.72 107.0 19.18 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.121 0.486 . . . . 0.0 110.501 179.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -121.57 134.83 55.03 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.948 -179.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.443 HD22 ' HA ' ' A' ' 79' ' ' THR . 78.9 mt -84.96 120.03 26.05 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.349 0.595 . . . . 0.0 110.629 179.42 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.415 HG23 HD12 ' A' ' 80' ' ' LEU . 33.2 m -106.22 132.35 53.59 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.491 177.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.405 ' O ' ' HA ' ' A' ' 14' ' ' THR . . . -108.76 173.57 17.7 Favored Glycine 0 N--CA 1.443 -0.876 0 C-N-CA 120.399 -0.905 . . . . 0.0 111.855 -175.285 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.46 HG23 ' HA ' ' A' ' 76' ' ' ASN . 22.0 p -76.43 132.54 39.72 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 120.881 0.372 . . . . 0.0 110.084 176.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 37.2 tp -63.19 123.41 18.56 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.938 -175.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -56.82 -47.11 81.04 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.872 177.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 58.6 m-70 -75.96 102.1 5.47 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.596 178.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 7.9 t60 -60.21 -26.63 66.53 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.307 -170.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 44.3 m80 -142.95 149.3 38.2 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 171.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 16.8 t-80 -79.34 74.83 5.93 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.777 0.799 . . . . 0.0 109.045 177.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -160.93 -26.65 0.06 Allowed 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.323 -1.308 . . . . 0.0 108.087 -174.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 16.5 t-80 . . . . . 0 C--O 1.245 0.855 0 CA-C-N 114.735 -1.121 . . . . 0.0 109.013 171.734 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.535 ' HG2' ' HB2' ' A' ' 33' ' ' LYS . 24.7 ttt . . . . . 0 N--CA 1.481 1.095 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 16.1 tt -130.64 148.48 70.24 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.301 -171.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -71.68 165.08 33.62 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.647 2.231 . . . . 0.0 112.501 175.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -149.85 91.21 1.77 Allowed 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 177.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.451 HD22 HD23 ' A' ' 57' ' ' LEU . 66.3 mt -84.76 117.68 23.98 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.178 -168.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.502 HG23 ' HB3' ' A' ' 97' ' ' ASN . 21.7 t -120.52 110.41 35.63 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.118 -176.248 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.553 ' HD2' ' O ' ' A' ' 97' ' ' ASN . 20.3 Cg_endo -63.74 111.68 1.59 Allowed 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 122.388 2.059 . . . . 0.0 110.55 169.361 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.3 t -85.93 -48.78 15.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.454 -169.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 18.2 t -149.32 157.66 43.52 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.924 0.392 . . . . 0.0 111.097 -174.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 53.7 tp -135.51 111.95 9.88 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.213 178.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.566 ' OG1' ' HA ' ' A' ' 12' ' ' PRO . 13.6 t -131.0 148.13 69.05 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.656 -176.555 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.566 ' HA ' ' OG1' ' A' ' 11' ' ' THR . 5.8 Cg_exo -78.77 148.76 83.79 Favored 'Cis proline' 0 N--CA 1.46 -0.446 0 C-N-CA 123.366 -1.514 . . . . 0.0 112.44 1.21 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.5 m -72.13 -5.91 6.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.271 0.557 . . . . 0.0 110.957 177.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.547 ' HB ' ' HA ' ' A' ' 107' ' ' LEU . 0.9 OUTLIER -128.27 133.01 48.7 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.834 175.43 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.48 ' O ' ' HA ' ' A' ' 106' ' ' THR . 15.3 m -124.2 156.18 31.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 120.761 0.315 . . . . 0.0 111.232 -174.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.0 m -101.83 134.0 20.41 Favored Pre-proline 0 N--CA 1.445 -0.703 0 CA-C-O 121.038 0.446 . . . . 0.0 110.823 177.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.402 ' CB ' ' HA3' ' A' ' 73' ' ' GLY . 98.6 Cg_endo -79.63 174.04 12.26 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 122.42 2.08 . . . . 0.0 112.166 178.767 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 25.1 m-80 63.14 28.77 16.09 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.32 177.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 15.2 t -169.42 170.52 8.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.761 0.315 . . . . 0.0 110.602 -177.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.443 ' HA ' ' O ' ' A' ' 69' ' ' TRP . 58.4 t -91.4 129.88 41.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.853 0.359 . . . . 0.0 110.387 178.371 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 40.4 m-80 -106.9 116.15 31.43 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.608 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.575 ' HA ' ' O ' ' A' ' 67' ' ' PHE . 10.3 m -85.36 93.39 8.71 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 175.025 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.579 ' O ' ' HA ' ' A' ' 66' ' ' ASP . 83.0 mtp -94.73 148.34 22.39 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.132 -174.197 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.449 HG22 ' HB3' ' A' ' 64' ' ' ASN . 20.9 m -109.67 114.07 27.36 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.146 -175.537 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -104.23 112.29 25.25 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 172.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 38.8 m -83.38 104.78 13.8 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 120.923 0.392 . . . . 0.0 110.044 -177.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 31.9 mm -97.05 116.62 39.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.893 -179.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -113.2 122.43 47.46 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.006 0.431 . . . . 0.0 110.135 -178.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 31.0 t30 -79.05 98.44 6.49 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.513 177.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -101.02 56.62 0.86 Allowed 'General case' 0 C--N 1.319 -0.761 0 CA-C-O 121.601 0.715 . . . . 0.0 109.976 -174.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -144.08 177.78 22.53 Favored Glycine 0 N--CA 1.444 -0.775 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.886 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.422 ' N ' HD21 ' A' ' 32' ' ' ASN . 0.9 OUTLIER -73.14 -39.17 65.91 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 -173.758 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.535 ' HB2' ' HG2' ' A' ' 1' ' ' MET . 55.7 tttp -101.21 147.58 26.1 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.424 0.631 . . . . 0.0 112.476 -170.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -65.81 138.82 58.17 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 114.523 -1.217 . . . . 0.0 110.809 173.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.414 ' OG ' HD23 ' A' ' 5' ' ' LEU . 13.8 p -105.62 137.43 43.47 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.288 176.585 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.1 m -90.14 -133.2 0.11 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.248 -179.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.491 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 26.8 m -75.62 109.47 9.22 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.085 0.469 . . . . 0.0 111.568 -175.347 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.538 ' CE2' HG21 ' A' ' 40' ' ' VAL . 19.9 p90 -122.6 148.81 44.79 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.13 178.103 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.523 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 4.2 t-20 -99.83 115.19 29.02 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 120.913 -0.315 . . . . 0.0 110.963 -173.591 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.538 HG21 ' CE2' ' A' ' 38' ' ' PHE . 2.7 t -98.48 111.96 29.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.597 0.713 . . . . 0.0 110.161 -178.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.532 ' HB3' HG22 ' A' ' 51' ' ' THR . 16.2 p -104.1 131.69 51.11 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.919 -176.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 62.9 tp -98.17 109.77 22.47 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 174.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 5.1 mp -97.78 142.05 30.03 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.669 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 81.7 t -108.56 99.23 8.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 172.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 37.3 t70 67.06 -73.95 0.07 Allowed 'General case' 0 C--N 1.329 -0.298 0 O-C-N 124.123 0.89 . . . . 0.0 111.139 -176.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -143.64 4.96 1.75 Allowed Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 121.278 -0.486 . . . . 0.0 112.314 179.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 8.4 mt -112.62 153.72 14.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -179.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 54.7 t -106.51 124.9 62.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 17.5 m -94.56 -33.05 4.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 C-N-CA 120.961 -0.295 . . . . 0.0 111.191 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -159.68 142.18 13.64 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.923 0.392 . . . . 0.0 110.673 178.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.532 HG22 ' HB3' ' A' ' 41' ' ' SER . 7.1 m -124.06 109.34 13.38 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.294 178.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 47.0 tt0 -109.08 113.01 25.5 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.104 0.478 . . . . 0.0 111.183 -172.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.523 ' HA ' ' HA ' ' A' ' 39' ' ' ASN . 10.4 m -76.32 120.0 20.97 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.358 177.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.491 ' O ' ' HA ' ' A' ' 37' ' ' SER . 25.0 t -92.58 127.18 44.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 177.091 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 27.0 m -58.05 -38.72 76.8 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.075 -0.511 . . . . 0.0 112.337 -173.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 11.2 p -169.97 163.55 9.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.671 0.272 . . . . 0.0 111.422 -177.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.481 HD13 ' O ' ' A' ' 61' ' ' ASN . 38.4 tp -156.52 114.24 3.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.869 176.195 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -77.32 169.41 18.38 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.605 -175.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 16.6 m -63.44 125.96 25.93 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.745 -0.662 . . . . 0.0 111.114 -179.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 66.27 15.8 10.21 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.96 176.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.481 ' O ' HD13 ' A' ' 57' ' ' LEU . 41.5 t-20 -97.63 143.51 28.23 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 175.277 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -114.44 115.76 27.8 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.351 -178.43 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.4 ' OG1' HD11 ' A' ' 57' ' ' LEU . 50.0 m -104.33 124.43 49.17 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.093 0.473 . . . . 0.0 110.738 -179.296 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.449 ' HB3' HG22 ' A' ' 24' ' ' THR . 94.8 m-20 -80.14 115.76 19.88 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.683 178.627 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 18.2 t -96.77 107.56 20.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.322 -178.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.579 ' HA ' ' O ' ' A' ' 23' ' ' MET . 28.5 m-20 -93.75 111.74 23.49 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.785 179.362 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.575 ' O ' ' HA ' ' A' ' 22' ' ' THR . 80.7 m-85 -91.38 167.46 12.26 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.978 179.576 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 2.5 p-80 -117.58 95.31 4.89 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.502 174.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . 0.622 ' CZ2' HD13 ' A' ' 71' ' ' LEU . 9.7 t90 -94.38 100.52 12.53 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.552 -176.324 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.436 ' HA ' HG21 ' A' ' 20' ' ' VAL . 17.8 m -73.74 91.52 1.92 Allowed 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 173.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.622 HD13 ' CZ2' ' A' ' 69' ' ' TRP . 22.2 tp -95.84 117.8 31.26 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.445 0.64 . . . . 0.0 112.102 -169.298 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -65.13 -56.86 10.51 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.807 -1.088 . . . . 0.0 109.666 171.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.402 ' HA3' ' CB ' ' A' ' 17' ' ' PRO . . . 101.22 50.31 1.24 Allowed Glycine 0 N--CA 1.446 -0.64 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.656 -179.434 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.9 m -81.65 -29.42 33.16 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.146 0.498 . . . . 0.0 110.553 -177.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -123.45 162.01 23.69 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.543 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 69.8 m-20 -97.47 -2.5 41.89 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.052 0.453 . . . . 0.0 110.668 179.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 53.6 m -149.3 112.49 4.93 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.479 176.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -105.79 149.36 26.55 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.289 178.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 89.8 m -98.7 98.06 9.24 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.876 175.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.426 HD13 ' CG2' ' A' ' 104' ' ' VAL . 6.6 mp -94.19 132.25 38.92 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.381 0.61 . . . . 0.0 110.419 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.438 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 17.3 m -129.69 113.97 15.42 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.283 -176.179 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 69.0 t -86.21 109.29 18.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 177.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -104.68 115.09 29.72 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 176.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.554 ' HB ' ' HB2' ' A' ' 98' ' ' ASN . 74.9 t -82.66 114.02 22.85 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-O 121.404 0.621 . . . . 0.0 111.304 -177.281 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 45.2 t0 63.27 90.37 0.09 OUTLIER Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 114.211 -1.359 . . . . 0.0 112.35 176.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.503 ' HD3' ' O ' ' A' ' 39' ' ' ASN . 1.9 Cg_endo -84.7 -6.93 9.7 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 123.195 2.597 . . . . 0.0 111.563 174.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -92.84 -16.67 25.02 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.738 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 57.51 54.96 6.02 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.464 -179.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -93.45 -30.17 15.19 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.008 -0.996 . . . . 0.0 109.703 179.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 47.9 t -110.03 101.51 12.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.486 173.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -64.78 129.69 40.7 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.098 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.407 ' OE1' ' HB2' ' A' ' 5' ' ' LEU . 36.0 mt-10 -108.62 164.14 12.62 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.626 -173.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -58.42 -101.06 0.01 OUTLIER Glycine 0 CA--C 1.519 0.309 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.516 168.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.427 ' C ' ' H ' ' A' ' 96' ' ' SER . 46.1 t30 -84.29 101.66 12.09 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 176.524 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -74.35 22.96 0.09 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.158 -174.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.427 ' H ' ' C ' ' A' ' 94' ' ' ASN . 16.2 m -111.82 -5.14 14.43 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.201 0.524 . . . . 0.0 109.839 174.261 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.553 ' O ' ' HD2' ' A' ' 7' ' ' PRO . 81.3 m-20 -87.52 -15.31 37.89 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.191 178.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.554 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 27.8 p-10 -77.04 1.64 17.37 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.685 -173.52 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 1.2 m -114.24 147.01 39.65 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.083 0.468 . . . . 0.0 110.984 -177.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.438 ' O ' ' HA ' ' A' ' 81' ' ' THR . 40.2 tp -143.57 102.19 3.9 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.904 179.584 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 8.5 m -95.96 110.64 22.82 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.969 178.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -128.5 138.8 52.45 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.902 -178.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 64.5 mt -87.67 121.46 30.12 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.449 177.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.509 HG13 ' HE3' ' A' ' 23' ' ' MET . 27.3 m -113.29 121.41 65.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.842 179.192 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.524 ' O ' ' HA ' ' A' ' 14' ' ' THR . . . -103.66 174.05 22.37 Favored Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 120.397 -0.906 . . . . 0.0 111.054 -177.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.48 ' HA ' ' O ' ' A' ' 15' ' ' VAL . 20.7 p -73.29 154.59 40.09 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 117.286 0.543 . . . . 0.0 109.808 175.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.547 ' HA ' ' HB ' ' A' ' 14' ' ' THR . 49.7 tp -60.58 108.01 0.77 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.184 0.516 . . . . 0.0 112.153 -172.336 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -100.69 112.08 24.42 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.438 -0.801 . . . . 0.0 108.851 172.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 18.2 t-80 -94.02 143.06 26.69 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 -174.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 13.7 t60 -72.31 140.32 48.48 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 176.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 92.1 m-70 -133.24 170.04 16.01 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 178.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 63.4 t60 -82.92 -27.26 30.73 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 174.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 77.8 m-70 67.83 -83.03 0.03 OUTLIER 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.068 -176.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 42.4 t60 . . . . . 0 C--O 1.245 0.826 0 CA-C-O 118.406 -0.807 . . . . 0.0 109.3 176.375 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 86.5 mtp . . . . . 0 N--CA 1.481 1.119 0 CA-C-O 120.865 0.364 . . . . 0.0 110.692 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 12.6 tt -140.49 138.89 19.32 Favored Pre-proline 0 C--N 1.321 -0.634 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 177.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.601 ' HD2' ' O ' ' A' ' 91' ' ' ASN . 16.9 Cg_exo -68.04 151.51 77.47 Favored 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 122.4 2.067 . . . . 0.0 111.697 175.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -141.46 90.41 2.29 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 179.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.501 HD22 HD21 ' A' ' 57' ' ' LEU . 58.4 mt -85.05 109.05 17.94 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.073 -171.401 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.521 HG21 ' HB3' ' A' ' 97' ' ' ASN . 17.7 t -117.46 123.1 30.19 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.207 -176.248 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.456 ' HG3' HG22 ' A' ' 84' ' ' VAL . 3.3 Cg_exo -79.32 101.59 1.43 Allowed 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 122.599 2.199 . . . . 0.0 110.014 170.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 29.3 m -83.66 -27.9 7.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -171.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 43.6 t -175.2 166.01 3.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.667 0.27 . . . . 0.0 110.573 -176.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.444 ' C ' HD12 ' A' ' 10' ' ' LEU . 3.2 pp -146.27 152.25 38.86 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 172.383 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 22.9 p -129.72 144.73 54.13 Favored Pre-proline 0 C--N 1.322 -0.588 0 CA-C-N 116.693 -0.231 . . . . 0.0 110.506 177.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -90.53 162.68 32.36 Favored 'Cis proline' 0 N--CA 1.457 -0.622 0 C-N-CA 123.283 -1.549 . . . . 0.0 112.365 -2.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 30.7 m -91.74 9.72 3.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.63 0.728 . . . . 0.0 110.398 177.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.522 ' HA ' ' O ' ' A' ' 105' ' ' GLY . 0.2 OUTLIER -142.29 122.22 13.61 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.223 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.419 HG23 ' CZ3' ' A' ' 69' ' ' TRP . 21.1 m -121.19 160.32 22.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -168.084 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.45 ' HA ' ' HD3' ' A' ' 17' ' ' PRO . 45.4 t -91.99 118.85 68.42 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.057 178.499 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.55 ' HA ' ' CB ' ' A' ' 71' ' ' LEU . 5.7 Cg_exo -77.79 16.14 1.17 Allowed 'Trans proline' 0 CA--C 1.53 0.318 0 C-N-CA 122.931 2.421 . . . . 0.0 113.455 -176.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 51.3 m-80 -122.61 16.16 10.33 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 121.009 -0.276 . . . . 0.0 111.628 -175.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 14.3 t -169.68 178.77 3.98 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 110.408 -0.219 . . . . 0.0 110.408 -179.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 45.2 t -85.07 125.3 40.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 176.013 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.48 ' ND2' HD23 ' A' ' 71' ' ' LEU . 28.0 m-80 -97.5 124.22 41.65 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.673 -175.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 23.8 m -80.95 105.43 12.17 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.564 -0.743 . . . . 0.0 109.52 175.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.438 ' HE2' HD11 ' A' ' 10' ' ' LEU . 42.0 mtp -102.69 136.53 42.34 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.36 -176.475 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.432 ' HA ' ' O ' ' A' ' 65' ' ' VAL . 22.0 m -115.33 103.74 11.1 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.863 -177.807 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -89.36 141.09 28.85 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.411 177.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 19.2 m -104.39 109.13 20.86 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.079 0.466 . . . . 0.0 110.376 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 14.3 mm -101.9 118.32 48.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.284 179.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -110.35 131.43 55.06 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 120.754 0.311 . . . . 0.0 110.698 -177.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 35.9 t30 -89.32 98.83 11.99 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.211 -0.449 . . . . 0.0 109.871 177.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -94.14 40.37 1.08 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.982 -174.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -143.96 147.36 18.62 Favored Glycine 0 N--CA 1.444 -0.831 0 N-CA-C 110.631 -0.987 . . . . 0.0 110.631 179.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -84.34 60.5 6.02 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.349 0.595 . . . . 0.0 111.157 -172.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.546 ' HD3' ' HD3' ' A' ' 3' ' ' PRO . 64.4 tttp -161.45 137.51 8.05 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.027 170.373 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -76.44 132.9 39.91 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.242 -176.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 58.7 p -95.69 145.1 25.54 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.144 0.497 . . . . 0.0 111.032 -176.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 24.1 p -86.47 -162.22 0.74 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.729 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.433 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 32.6 t -56.96 125.53 23.03 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 120.901 0.382 . . . . 0.0 111.085 178.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.548 ' HB2' ' HB2' ' A' ' 85' ' ' ASP . 42.6 p90 -138.32 143.66 40.04 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 177.354 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.555 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 65.2 t30 -102.55 115.56 30.83 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 121.048 -0.261 . . . . 0.0 111.422 -172.318 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.498 HG23 ' HA ' ' A' ' 84' ' ' VAL . 2.0 t -102.49 125.9 56.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.098 0.475 . . . . 0.0 110.566 -176.385 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.499 ' HB3' HG21 ' A' ' 51' ' ' THR . 52.5 p -117.66 138.27 52.09 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.914 -177.255 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 59.5 tp -96.46 107.8 20.26 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 176.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.441 ' HG ' HG21 ' A' ' 48' ' ' VAL . 4.6 mp -96.94 118.64 33.79 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.264 -179.099 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.503 HG22 ' HG ' ' A' ' 80' ' ' LEU . 95.8 t -100.87 102.08 12.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.083 178.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 59.29 22.45 10.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.374 -0.83 . . . . 0.0 112.399 176.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 121.81 -26.75 6.42 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.464 -0.874 . . . . 0.0 113.002 176.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 11.9 mm -97.85 148.6 5.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 -178.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.441 HG21 ' HG ' ' A' ' 43' ' ' LEU . 39.5 t -98.4 110.7 26.44 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 -179.383 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 28.7 m -91.53 -31.52 4.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.766 -175.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -148.95 139.82 22.85 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.676 0.274 . . . . 0.0 110.298 -177.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.499 HG21 ' HB3' ' A' ' 41' ' ' SER . 2.1 m -133.87 121.6 21.98 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.112 -0.495 . . . . 0.0 109.682 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -128.28 114.96 17.58 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.085 0.469 . . . . 0.0 110.297 -178.108 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.555 ' HA ' ' HA ' ' A' ' 39' ' ' ASN . 21.8 m -76.97 131.4 38.47 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.365 178.537 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.433 ' O ' ' HA ' ' A' ' 37' ' ' SER . 38.6 t -101.95 121.41 52.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 177.017 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.6 m -59.7 -36.16 75.96 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -174.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 21.2 t -172.53 152.46 2.63 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.959 0.409 . . . . 0.0 111.262 179.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.623 HD12 ' OG1' ' A' ' 63' ' ' THR . 23.3 tp -140.07 114.34 9.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.82 175.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -70.27 173.06 7.18 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.468 0.652 . . . . 0.0 112.035 -175.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 10.0 m -63.89 129.66 40.97 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.686 178.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 61.99 19.42 10.75 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.903 -0.59 . . . . 0.0 112.229 176.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -101.24 158.54 15.96 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 178.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 7.1 m -121.52 125.38 46.67 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.136 179.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.623 ' OG1' HD12 ' A' ' 57' ' ' LEU . 86.1 m -103.96 135.94 44.53 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.892 0.377 . . . . 0.0 110.973 -179.646 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -92.85 119.8 32.55 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.762 174.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.432 ' O ' ' HA ' ' A' ' 24' ' ' THR . 40.7 t -96.24 135.06 31.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.441 -177.34 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -96.39 112.13 23.98 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.579 -176.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.429 ' HB2' ' HB2' ' A' ' 23' ' ' MET . 36.1 m-85 -112.37 140.01 47.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.785 0.326 . . . . 0.0 111.016 177.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 22.0 m170 -115.86 97.46 6.12 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 176.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . 0.419 ' CZ3' HG23 ' A' ' 15' ' ' VAL . 18.6 t90 -108.65 114.38 28.14 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.17 0.509 . . . . 0.0 111.622 -173.511 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 9.7 m -82.88 123.9 29.83 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.05 176.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.55 ' CB ' ' HA ' ' A' ' 17' ' ' PRO . 1.0 OUTLIER -83.89 123.17 29.66 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.163 0.506 . . . . 0.0 111.756 -178.573 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 19.3 p-10 -79.19 -43.42 23.92 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.755 175.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 89.39 40.0 6.18 Favored Glycine 0 N--CA 1.45 -0.37 0 CA-C-N 115.772 -0.649 . . . . 0.0 113.152 176.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 18.2 m -99.39 -13.95 19.36 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.207 0.527 . . . . 0.0 110.524 178.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -145.04 152.5 40.22 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.567 178.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -90.09 -10.11 45.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.158 0.504 . . . . 0.0 110.645 179.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 24.7 m -140.53 121.52 14.61 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.316 179.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -116.32 153.31 32.21 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.252 179.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.405 ' HA ' HD21 ' A' ' 103' ' ' LEU . 4.4 m -96.54 89.59 5.06 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.881 179.125 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.503 ' HG ' HG22 ' A' ' 44' ' ' VAL . 10.7 mp -87.55 113.02 22.86 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.477 0.656 . . . . 0.0 110.256 -178.684 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.482 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 5.4 m -115.97 113.51 23.36 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.6 -173.209 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 59.9 t -87.55 109.16 19.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 116.311 -0.404 . . . . 0.0 109.94 177.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -105.83 120.78 42.61 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.135 0.493 . . . . 0.0 109.849 176.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.498 ' HA ' HG23 ' A' ' 40' ' ' VAL . 83.5 t -85.37 111.95 21.52 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.621 -175.601 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.548 ' HB2' ' HB2' ' A' ' 38' ' ' PHE . 20.6 t70 57.8 86.85 0.15 Allowed Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 114.294 -1.321 . . . . 0.0 112.92 173.493 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_exo -72.92 -9.0 23.18 Favored 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 122.797 2.331 . . . . 0.0 111.26 174.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -82.52 -27.12 31.9 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.27 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 10.2 m120 56.99 52.57 9.05 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.505 -177.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -83.98 -25.64 29.86 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.981 -1.009 . . . . 0.0 109.936 179.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 40.3 t -100.4 136.9 29.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.802 177.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.601 ' O ' ' HD2' ' A' ' 3' ' ' PRO . 43.8 m-80 -75.05 112.04 10.88 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 173.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.427 ' CD ' HD22 ' A' ' 98' ' ' ASN . 33.9 mt-10 -114.6 152.64 31.5 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 120.896 0.379 . . . . 0.0 111.752 -173.382 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -57.7 -101.09 0.01 OUTLIER Glycine 0 CA--C 1.519 0.326 0 CA-C-N 115.071 -0.968 . . . . 0.0 113.956 179.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -88.83 124.29 34.04 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.543 0.211 . . . . 0.0 111.015 -173.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -61.11 -33.76 73.88 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -174.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 10.9 p -75.05 -1.94 25.14 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.934 0.397 . . . . 0.0 111.398 -177.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.521 ' HB3' HG21 ' A' ' 6' ' ' VAL . 7.6 m-20 -91.7 -13.55 31.52 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.52 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.427 HD22 ' CD ' ' A' ' 92' ' ' GLU . 10.8 m120 -69.8 -18.02 63.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.903 -0.589 . . . . 0.0 112.257 -177.464 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 1.2 m -123.04 147.91 46.16 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.326 0.584 . . . . 0.0 112.102 -170.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.482 ' O ' ' HA ' ' A' ' 81' ' ' THR . 29.4 tp -131.89 104.61 6.96 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.096 -0.957 . . . . 0.0 109.694 178.52 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 7.0 m -87.98 99.47 12.18 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.277 178.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -113.62 148.85 35.49 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.91 0.386 . . . . 0.0 111.11 -178.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.405 HD21 ' HA ' ' A' ' 79' ' ' THR . 51.8 mt -112.83 120.46 41.53 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.384 178.535 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 27.8 m -110.19 156.78 11.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.371 -178.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.522 ' O ' ' HA ' ' A' ' 14' ' ' THR . . . -122.89 169.98 15.32 Favored Glycine 0 N--CA 1.442 -0.955 0 C-N-CA 120.292 -0.956 . . . . 0.0 111.468 179.153 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 27.3 p -81.47 139.28 35.29 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 174.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.483 ' HA ' HG21 ' A' ' 14' ' ' THR . 32.9 tp -54.67 120.34 6.6 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.033 0.444 . . . . 0.0 111.907 -172.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -59.69 -30.83 69.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.152 176.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . 0.453 ' H ' ' HG ' ' A' ' 107' ' ' LEU . 35.9 p-80 46.61 80.48 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.231 0 O-C-N 124.484 1.115 . . . . 0.0 110.795 -172.507 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 64.0 m170 -66.48 -18.75 65.54 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 114.909 -1.042 . . . . 0.0 110.63 -177.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 30.9 m170 -80.11 100.46 8.23 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 171.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 19.4 m80 -91.48 99.55 12.47 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.257 0.551 . . . . 0.0 111.44 -176.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 15.2 p-80 -76.33 -18.78 58.76 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 169.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 77.2 t60 . . . . . 0 C--O 1.245 0.826 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.099 175.747 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 71.8 mtm . . . . . 0 N--CA 1.48 1.03 0 CA-C-O 120.85 0.357 . . . . 0.0 110.907 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 10.7 tt -143.68 137.36 14.33 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-O 120.78 0.324 . . . . 0.0 110.479 -178.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -95.75 169.93 1.27 Allowed 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 123.09 2.527 . . . . 0.0 113.196 175.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -136.42 104.33 5.56 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.089 171.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.442 HD23 HD23 ' A' ' 57' ' ' LEU . 85.4 mt -89.69 90.79 8.38 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.34 0.59 . . . . 0.0 109.949 -176.731 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.475 ' HA ' ' HD2' ' A' ' 7' ' ' PRO . 25.0 t -104.24 111.73 65.25 Favored Pre-proline 0 C--N 1.319 -0.756 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.116 -174.155 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.495 ' HB2' HD22 ' A' ' 100' ' ' LEU . 18.5 Cg_endo -62.18 119.01 5.91 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 122.244 1.963 . . . . 0.0 109.956 169.099 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.5 t -91.0 -47.67 14.31 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.848 -168.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.9 t -160.67 173.68 15.1 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.489 -178.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 55.7 tp -136.46 127.74 28.22 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.83 -178.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.542 ' OG1' ' HA ' ' A' ' 12' ' ' PRO . 14.0 t -140.48 149.2 56.54 Favored Pre-proline 0 C--N 1.322 -0.589 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.542 ' HA ' ' OG1' ' A' ' 11' ' ' THR . 72.3 Cg_endo -76.56 148.12 88.33 Favored 'Cis proline' 0 N--CA 1.464 -0.251 0 C-N-CA 123.393 -1.503 . . . . 0.0 112.745 0.612 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 34.7 m -72.9 -22.35 19.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.724 177.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.616 ' HA ' ' O ' ' A' ' 105' ' ' GLY . 17.0 p -114.24 129.33 56.63 Favored 'General case' 0 N--CA 1.439 -1.016 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.164 174.17 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.489 HG12 ' CZ3' ' A' ' 69' ' ' TRP . 18.0 m -113.52 149.41 15.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.165 0.507 . . . . 0.0 111.923 -173.254 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 27.2 t -90.2 113.35 57.01 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.034 -179.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -83.27 42.09 1.2 Allowed 'Trans proline' 0 CA--C 1.53 0.289 0 C-N-CA 122.974 2.449 . . . . 0.0 113.384 -175.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -156.72 27.92 0.33 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.999 0.428 . . . . 0.0 110.984 177.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 11.2 t -170.99 -177.06 2.12 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.001 179.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 59.0 t -90.02 118.86 36.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.035 0.445 . . . . 0.0 109.91 177.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 44.8 m-80 -89.8 126.57 35.73 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.482 -178.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 17.8 m -80.04 89.0 5.35 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.527 175.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.521 ' HB2' ' HB2' ' A' ' 67' ' ' PHE . 91.3 mmm -79.38 113.21 17.34 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.925 -0.579 . . . . 0.0 109.607 -176.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.496 ' CG2' ' HB3' ' A' ' 64' ' ' ASN . 26.4 m -102.11 112.8 25.6 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.431 -175.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -101.21 124.05 46.3 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.38 179.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 25.0 m -86.12 110.6 19.66 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.285 179.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 19.8 mm -107.64 120.79 59.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 178.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -115.41 127.59 55.47 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.878 0.37 . . . . 0.0 110.889 -179.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 25.2 t30 -89.86 103.8 16.42 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.844 177.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 -99.51 56.73 1.01 Allowed 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.621 -175.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -144.05 170.73 25.81 Favored Glycine 0 N--CA 1.448 -0.527 0 N-CA-C 111.521 -0.632 . . . . 0.0 111.521 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 7.6 p-10 -86.84 0.97 53.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.04 0.448 . . . . 0.0 110.92 -174.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -120.91 132.33 54.9 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.51 -179.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -66.76 139.93 57.83 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.619 173.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.435 ' OG ' HD21 ' A' ' 5' ' ' LEU . 15.7 p -100.87 136.22 41.07 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.622 177.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.596 ' O ' ' HA ' ' A' ' 56' ' ' SER . 2.0 m -82.41 -128.02 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 120.91 -0.316 . . . . 0.0 110.246 -179.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 9.7 t -90.71 121.43 32.6 Favored 'General case' 0 C--N 1.323 -0.554 0 O-C-N 121.786 -0.571 . . . . 0.0 111.399 -172.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -128.92 142.04 51.08 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.624 -0.717 . . . . 0.0 109.361 176.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.654 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 64.1 t30 -90.31 120.13 31.19 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 120.832 0.349 . . . . 0.0 110.234 -176.486 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.445 HG11 HG12 ' A' ' 65' ' ' VAL . 0.3 OUTLIER -106.46 147.29 12.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -176.259 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 9.9 p -137.8 139.43 40.0 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 120.756 -0.378 . . . . 0.0 111.479 -175.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 62.2 tp -105.47 111.31 23.98 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.705 175.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.402 ' HG ' HG21 ' A' ' 48' ' ' VAL . 4.2 mp -98.55 141.49 31.33 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.936 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 87.4 t -123.83 106.09 16.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 176.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 57.53 23.49 9.25 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 115.791 -0.641 . . . . 0.0 112.083 178.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 120.99 -33.09 4.52 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.907 176.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 11.2 mm -90.89 149.25 4.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 -177.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.402 HG21 ' HG ' ' A' ' 43' ' ' LEU . 39.0 t -96.66 110.39 24.72 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 179.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 26.7 m -90.98 -25.69 5.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.686 -175.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -147.34 145.15 29.22 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 -178.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 22.1 m -141.74 113.52 7.86 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.076 0.465 . . . . 0.0 109.961 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.403 ' O ' HG13 ' A' ' 40' ' ' VAL . 0.1 OUTLIER -122.99 116.36 23.42 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.794 -174.922 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.654 ' HA ' ' HA ' ' A' ' 39' ' ' ASN . 8.6 m -80.69 112.64 18.25 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 176.499 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 49.2 t -77.6 133.27 30.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 -178.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 26.3 m -63.74 -43.74 95.59 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.614 -175.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.596 ' HA ' ' O ' ' A' ' 36' ' ' THR . 38.7 t -177.36 151.11 0.75 Allowed 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 -178.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.442 HD23 HD23 ' A' ' 5' ' ' LEU . 26.5 tp -131.04 121.76 25.58 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.836 177.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -71.16 163.07 28.34 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.52 -0.764 . . . . 0.0 112.124 -174.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 4.9 m -67.16 124.09 22.12 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.814 178.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 63.46 20.56 12.32 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.956 176.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 56.1 t30 -113.26 153.0 29.12 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 177.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.3 m -109.0 133.33 53.12 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.872 0.367 . . . . 0.0 110.286 -179.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.435 ' HB ' HD13 ' A' ' 57' ' ' LEU . 20.5 m -123.62 127.32 48.09 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.115 177.35 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.496 ' HB3' ' CG2' ' A' ' 24' ' ' THR . 56.7 m-80 -90.22 135.14 33.85 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.409 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.445 HG12 HG11 ' A' ' 40' ' ' VAL . 13.7 t -96.4 138.57 21.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.862 -176.628 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -94.55 97.2 9.97 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.921 -179.079 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.521 ' HB2' ' HB2' ' A' ' 23' ' ' MET . 67.5 m-85 -98.69 145.78 26.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.364 176.692 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 35.6 m-70 -114.99 100.95 8.57 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.221 0.534 . . . . 0.0 110.827 179.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . 0.489 ' CZ3' HG12 ' A' ' 15' ' ' VAL . 10.2 t90 -103.22 98.01 8.01 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.483 -177.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 18.8 m -74.03 100.33 3.55 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 175.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 28.5 tp -107.7 106.6 17.0 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.211 0.529 . . . . 0.0 111.391 -172.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -78.2 -19.85 53.02 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.172 175.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 89.8 87.27 1.3 Allowed Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.519 177.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 11.6 m -106.64 -33.74 7.55 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.024 0.44 . . . . 0.0 110.329 178.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -134.47 175.69 9.3 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.055 -0.521 . . . . 0.0 109.93 178.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.41 ' HA ' HG23 ' A' ' 106' ' ' THR . 31.7 p-10 -107.84 -8.88 15.87 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.03 0.443 . . . . 0.0 110.935 -179.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 3.2 p -137.2 116.81 12.94 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.345 -179.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -118.01 142.83 46.95 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.967 -178.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 25.5 m -99.21 94.32 6.42 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.051 179.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.422 HD11 HG22 ' A' ' 104' ' ' VAL . 10.2 mp -91.96 136.88 32.82 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.325 0.583 . . . . 0.0 110.777 -177.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.47 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 23.6 m -131.86 123.59 27.82 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.155 -178.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 46.8 t -95.4 108.84 21.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 177.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -100.06 119.51 38.4 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.475 HG22 ' HD3' ' A' ' 7' ' ' PRO . 88.6 t -92.52 106.36 17.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.735 -176.393 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 45.5 t0 62.38 92.67 0.06 OUTLIER Pre-proline 0 C--N 1.33 -0.272 0 O-C-N 124.276 0.985 . . . . 0.0 112.084 177.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -94.05 15.82 1.22 Allowed 'Trans proline' 0 N--CA 1.451 -0.996 0 C-N-CA 123.101 2.534 . . . . 0.0 111.839 174.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -125.5 -1.97 7.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.731 -174.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 65.5 t30 61.21 51.46 4.34 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.453 0.644 . . . . 0.0 110.714 177.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -89.33 -34.7 16.46 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.841 177.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 63.9 t -119.09 115.33 47.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.186 177.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 59.1 t30 -79.77 133.29 36.31 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 177.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -122.06 172.81 7.97 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.153 0.501 . . . . 0.0 112.27 -174.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -57.72 -100.82 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.526 0 CA-C-N 114.55 -1.205 . . . . 0.0 112.023 169.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -63.54 153.24 36.28 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.918 0.389 . . . . 0.0 110.684 178.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -98.62 -3.53 35.95 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.648 0.737 . . . . 0.0 109.817 176.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 8.3 p -87.3 -4.39 59.06 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.62 178.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.401 ' O ' ' HD2' ' A' ' 7' ' ' PRO . 55.3 m-20 -70.62 -35.54 73.01 Favored 'General case' 0 C--O 1.223 -0.303 0 CA-C-O 121.062 0.458 . . . . 0.0 110.244 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.453 ' HA ' ' HB ' ' A' ' 84' ' ' VAL . 13.1 m120 -72.34 18.87 0.08 Allowed 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 -165.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 1.8 m -150.38 149.81 30.56 Favored 'General case' 0 C--N 1.323 -0.552 0 O-C-N 121.883 -0.511 . . . . 0.0 111.345 -179.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.495 HD22 ' HB2' ' A' ' 7' ' ' PRO . 41.9 tp -152.46 100.95 2.62 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.61 176.016 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 61.8 m -92.94 113.38 25.64 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.365 178.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -130.14 134.13 47.11 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.777 -179.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 76.3 mt -85.6 126.17 33.69 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.638 178.321 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.422 HG22 HD11 ' A' ' 80' ' ' LEU . 19.1 m -116.86 147.05 20.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.581 177.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.616 ' O ' ' HA ' ' A' ' 14' ' ' THR . . . -123.72 164.08 17.05 Favored Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 120.495 -0.859 . . . . 0.0 111.389 -177.494 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.41 HG23 ' HA ' ' A' ' 76' ' ' ASN . 35.3 p -70.59 150.19 46.31 Favored 'General case' 0 C--N 1.317 -0.807 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.739 178.203 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.498 ' HA ' ' HB ' ' A' ' 14' ' ' THR . 39.1 tp -51.66 121.82 7.11 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.644 -177.316 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -62.23 -64.87 0.8 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.771 -177.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 12.3 m170 -79.39 101.36 8.09 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 173.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 54.3 m80 -65.19 131.45 46.56 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.877 -172.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 33.9 m170 -121.22 136.98 54.88 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.623 178.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 69.1 m80 -113.63 143.93 43.76 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.706 -178.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 14.8 m-70 -96.17 99.51 11.23 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.736 177.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 24.7 t60 . . . . . 0 C--O 1.245 0.82 0 CA-C-O 118.496 -0.764 . . . . 0.0 109.662 -178.94 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.5 mtt . . . . . 0 N--CA 1.479 0.98 0 CA-C-O 121.168 0.508 . . . . 0.0 111.031 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 15.9 tt -144.08 135.75 12.87 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.514 177.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.568 ' HD2' ' O ' ' A' ' 91' ' ' ASN . 8.0 Cg_exo -73.22 161.69 42.38 Favored 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 122.553 2.169 . . . . 0.0 112.309 177.004 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -145.45 92.83 2.28 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 175.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.527 HD21 HD22 ' A' ' 57' ' ' LEU . 60.8 mt -90.72 101.24 13.99 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.47 0.652 . . . . 0.0 110.801 -169.142 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 22.5 t -104.49 112.18 65.33 Favored Pre-proline 0 C--N 1.318 -0.798 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.471 -174.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.493 ' HB2' ' HB2' ' A' ' 100' ' ' LEU . 33.1 Cg_endo -67.65 103.11 0.79 Allowed 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 121.941 1.76 . . . . 0.0 109.776 166.694 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 6.6 t -80.77 -49.18 18.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.315 -167.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 55.6 m -148.64 165.96 29.74 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.877 0.37 . . . . 0.0 111.312 -177.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.548 HD12 ' HE2' ' A' ' 23' ' ' MET . 31.0 tp -139.8 104.33 4.86 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.654 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 21.5 p -123.71 145.26 46.87 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.28 -175.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.475 ' O ' ' HE1' ' A' ' 23' ' ' MET . 4.8 Cg_exo -81.89 155.96 79.79 Favored 'Cis proline' 0 C--N 1.342 0.19 0 C-N-CA 123.723 -1.366 . . . . 0.0 112.015 -2.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 33.9 m -83.62 -11.47 11.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.892 0.377 . . . . 0.0 111.52 -177.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -116.72 126.88 53.8 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.82 0.343 . . . . 0.0 110.077 173.46 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.402 HG11 ' CZ3' ' A' ' 69' ' ' TRP . 34.7 m -113.52 165.39 8.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 120.896 0.379 . . . . 0.0 111.16 -176.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.425 ' HA ' ' HD3' ' A' ' 17' ' ' PRO . 4.9 t -110.15 117.61 51.27 Favored Pre-proline 0 C--N 1.324 -0.531 0 N-CA-C 109.524 -0.546 . . . . 0.0 109.524 177.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.517 ' HA ' ' HG ' ' A' ' 71' ' ' LEU . 7.1 Cg_exo -73.59 31.27 0.32 Allowed 'Trans proline' 0 CA--C 1.533 0.465 0 C-N-CA 123.295 2.664 . . . . 0.0 112.716 -178.505 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.424 ' H ' ' C ' ' A' ' 16' ' ' VAL . 6.3 m-20 -105.82 -29.34 10.09 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.124 -176.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 8.9 t -151.21 178.62 9.05 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.159 -170.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 92.5 t -73.44 120.76 22.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 176.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 36.8 m-80 -92.49 123.91 36.14 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.345 -176.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.43 ' HA ' ' O ' ' A' ' 67' ' ' PHE . 24.9 m -89.88 96.29 10.62 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 177.567 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.548 ' HE2' HD12 ' A' ' 10' ' ' LEU . 86.5 mtp -97.23 135.87 38.55 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.459 -176.245 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.571 ' HA ' ' O ' ' A' ' 65' ' ' VAL . 31.3 m -108.46 115.78 30.74 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.873 -176.429 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -105.53 120.45 41.65 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.017 176.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 28.4 m -83.53 112.92 20.42 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 120.55 0.214 . . . . 0.0 110.458 -179.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.445 HD12 ' HA ' ' A' ' 7' ' ' PRO . 21.5 mm -103.3 120.01 52.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 177.249 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -116.22 126.47 53.67 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.772 0.32 . . . . 0.0 110.632 -177.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.417 ' HB2' ' HG ' ' A' ' 57' ' ' LEU . 33.1 t30 -90.03 101.77 14.48 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.134 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -103.39 54.3 0.75 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.515 -175.164 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -144.02 169.19 26.29 Favored Glycine 0 N--CA 1.447 -0.589 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.375 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -91.09 45.41 1.25 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.257 0.551 . . . . 0.0 110.885 -173.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 46.1 tptt -161.51 135.18 6.59 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.038 176.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -83.85 124.9 31.43 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 178.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 9.5 p -86.2 143.83 27.77 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.9 0.381 . . . . 0.0 111.402 -175.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 12.6 p -81.74 -164.13 0.75 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.967 -179.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.487 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 17.5 m -61.32 114.85 3.41 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 121.08 0.467 . . . . 0.0 111.562 -177.441 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.462 ' CE2' HG22 ' A' ' 40' ' ' VAL . 22.2 p90 -127.64 154.12 45.63 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.249 178.419 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.457 ' O ' ' HD3' ' A' ' 86' ' ' PRO . 55.1 m-80 -100.46 125.93 46.81 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.881 0.372 . . . . 0.0 110.984 -178.252 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.462 HG22 ' CE2' ' A' ' 38' ' ' PHE . 2.3 t -108.21 111.31 35.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-O 121.333 0.587 . . . . 0.0 109.453 177.399 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.492 ' HB3' HG22 ' A' ' 51' ' ' THR . 24.0 p -109.76 140.91 43.11 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.367 -174.11 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.4 HD13 ' HB3' ' A' ' 80' ' ' LEU . 52.7 tp -101.49 114.73 29.01 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.103 177.169 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.7 mp -101.18 126.45 47.9 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.243 179.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 86.2 t -104.87 104.07 16.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 116.148 -0.478 . . . . 0.0 109.873 178.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 57.18 28.89 15.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.411 178.039 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 107.46 -18.5 35.38 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.854 -0.688 . . . . 0.0 112.822 177.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 6.3 mm -95.44 148.16 5.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 -178.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 96.7 t -97.99 113.52 32.81 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-O 121.076 0.465 . . . . 0.0 110.126 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 27.9 m -96.77 -38.86 8.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.445 -177.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -153.16 143.2 22.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.855 0.359 . . . . 0.0 110.941 -175.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.492 HG22 ' HB3' ' A' ' 41' ' ' SER . 41.3 m -136.38 120.5 17.75 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.992 -179.281 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 45.8 tt0 -106.5 137.22 44.89 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.766 0.317 . . . . 0.0 110.377 -178.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 18.0 m -97.56 114.88 26.87 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.195 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.487 ' O ' ' HA ' ' A' ' 37' ' ' SER . 23.5 t -91.03 120.7 40.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.7 m -56.11 -43.15 77.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.58 -177.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 44.0 t -172.88 150.5 2.07 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.997 -0.372 . . . . 0.0 109.997 -179.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.527 HD22 HD21 ' A' ' 5' ' ' LEU . 28.3 tp -133.63 112.54 11.53 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 176.127 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -83.23 162.08 21.32 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.377 -174.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 5.8 p -65.5 138.36 58.03 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.073 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 68.66 5.72 5.06 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 123.183 0.593 . . . . 0.0 111.218 -179.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -103.48 147.56 27.0 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.874 0.369 . . . . 0.0 110.419 179.081 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 2.9 p -121.57 122.69 40.23 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.26 177.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 33.5 m -104.1 126.01 50.88 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.502 -179.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.437 ' HB3' ' CG2' ' A' ' 24' ' ' THR . 90.8 m-20 -83.15 117.87 23.2 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.894 177.353 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.571 ' O ' ' HA ' ' A' ' 24' ' ' THR . 44.8 t -96.02 115.8 36.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.964 -176.148 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 40.4 m-20 -96.67 108.21 20.79 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.748 0.309 . . . . 0.0 110.351 -179.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.43 ' O ' ' HA ' ' A' ' 22' ' ' THR . 65.3 m-85 -91.34 154.97 18.85 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 120.932 0.396 . . . . 0.0 110.097 179.463 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 50.7 m-70 -114.74 88.28 2.83 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 176.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . 0.402 ' CZ3' HG11 ' A' ' 15' ' ' VAL . 15.1 t90 -98.28 111.18 23.61 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.449 -172.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 7.3 m -86.06 118.65 25.66 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 170.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.548 HD13 ' CZ ' ' A' ' 78' ' ' TYR . 0.1 OUTLIER -55.2 -43.82 74.77 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.454 0.539 . . . . 0.0 112.454 -167.947 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.414 ' HB3' ' O ' ' A' ' 71' ' ' LEU . 31.5 t70 71.46 4.21 4.97 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.534 0.683 . . . . 0.0 110.997 176.002 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 179.18 -158.78 23.1 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 121.084 -0.579 . . . . 0.0 111.996 179.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 85.2 m -155.16 94.93 1.67 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.139 0.495 . . . . 0.0 110.344 177.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.401 ' HB2' ' CE1' ' A' ' 78' ' ' TYR . . . -112.51 172.31 7.0 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.111 175.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -79.15 -30.17 43.44 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.451 -0.5 . . . . 0.0 110.534 -178.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.464 ' HB2' HD23 ' A' ' 103' ' ' LEU . 70.7 p -150.91 157.94 43.53 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.283 -178.604 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.548 ' CZ ' HD13 ' A' ' 71' ' ' LEU . 27.9 m-85 -136.64 152.4 50.38 Favored 'General case' 0 C--N 1.328 -0.331 0 O-C-N 123.152 0.282 . . . . 0.0 110.487 -179.397 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 4.4 m -103.22 89.36 3.38 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.92 0.391 . . . . 0.0 110.219 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.449 HD13 HG23 ' A' ' 104' ' ' VAL . 9.4 mp -92.47 122.36 34.83 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.246 0.546 . . . . 0.0 111.189 -175.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.512 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 73.2 m -120.43 119.76 33.97 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.647 -179.628 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 98.9 t -85.63 107.85 16.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 174.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -95.31 113.9 25.62 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.172 177.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.534 ' HB ' ' HB2' ' A' ' 98' ' ' ASN . 96.2 t -85.48 111.25 20.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.614 179.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 56.5 t0 62.89 95.49 0.05 OUTLIER Pre-proline 0 N--CA 1.467 0.424 0 CA-C-N 114.825 -1.08 . . . . 0.0 112.236 178.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.457 ' HD3' ' O ' ' A' ' 39' ' ' ASN . 2.2 Cg_endo -85.41 1.55 8.21 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 123.167 2.578 . . . . 0.0 111.832 175.59 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -98.97 -20.29 16.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.095 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 15.3 m120 64.8 33.64 10.05 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.218 -178.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -73.23 -37.09 66.52 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.402 177.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 43.7 t -96.65 118.0 42.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.192 178.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.568 ' O ' ' HD2' ' A' ' 3' ' ' PRO . 53.6 t30 -85.7 135.7 33.65 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 175.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -115.71 159.4 21.44 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.246 0.546 . . . . 0.0 112.383 -171.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -57.96 -100.59 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 114.613 -1.176 . . . . 0.0 112.501 172.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 39.7 t30 -68.4 96.52 0.68 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.68 0.276 . . . . 0.0 110.325 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -73.97 78.76 1.67 Allowed 'General case' 0 C--O 1.233 0.226 0 CA-C-O 121.475 0.655 . . . . 0.0 110.39 -176.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 20.9 t -179.29 25.46 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.61 -1.177 . . . . 0.0 108.814 176.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 24.1 p-10 -118.68 -28.11 5.71 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.596 -170.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.534 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 22.4 p-10 -68.88 0.34 4.54 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -169.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -119.92 118.38 30.58 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.157 0.503 . . . . 0.0 111.521 178.613 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.512 ' O ' ' HA ' ' A' ' 81' ' ' THR . 26.3 tp -111.34 99.94 8.65 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.759 176.518 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 96.2 m -93.74 97.36 10.39 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.502 0.668 . . . . 0.0 110.104 178.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.484 ' HB2' HD21 ' A' ' 10' ' ' LEU . . . -107.99 115.73 30.67 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.166 -0.925 . . . . 0.0 109.589 178.628 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.464 HD23 ' HB2' ' A' ' 77' ' ' SER . 5.0 tt -78.65 101.39 7.46 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.496 HG11 ' HE3' ' A' ' 23' ' ' MET . 29.9 m -90.57 158.78 2.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.219 -176.361 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -123.58 -170.88 13.47 Favored Glycine 0 N--CA 1.436 -1.317 0 C-N-CA 120.435 -0.888 . . . . 0.0 111.519 -178.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 18.6 p -107.95 140.05 41.67 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 177.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 47.6 tp -50.38 111.53 0.55 Allowed 'General case' 0 C--N 1.33 -0.247 0 O-C-N 123.576 0.547 . . . . 0.0 110.653 -177.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -61.35 -36.73 81.02 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.169 -176.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 63.4 t60 -90.06 79.72 6.46 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.146 0.498 . . . . 0.0 109.876 177.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 46.7 t-80 -80.59 142.19 34.29 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.172 178.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 36.4 m80 -73.29 176.79 5.63 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 10.2 m-70 -108.37 13.43 25.58 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.436 0.636 . . . . 0.0 110.312 178.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -136.91 -62.39 0.64 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.427 173.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 38.9 m-70 . . . . . 0 C--O 1.246 0.9 0 CA-C-O 118.485 -0.769 . . . . 0.0 109.607 173.994 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.533 ' SD ' ' HB2' ' A' ' 33' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.479 0.98 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 . . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.415 HG13 ' HD2' ' A' ' 3' ' ' PRO . 19.2 tt -144.37 146.17 31.91 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 115.762 -0.653 . . . . 0.0 110.241 -175.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.524 ' HD3' ' HD3' ' A' ' 33' ' ' LYS . 36.0 Cg_exo -60.9 136.53 66.5 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.411 2.074 . . . . 0.0 112.389 174.456 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -117.09 86.86 2.59 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 177.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.408 HD21 HD21 ' A' ' 57' ' ' LEU . 82.5 mt -82.1 107.96 15.2 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.332 -170.687 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 18.6 t -123.32 106.33 33.15 Favored Pre-proline 0 C--N 1.32 -0.702 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.984 -177.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.556 ' HD2' ' O ' ' A' ' 97' ' ' ASN . 11.2 Cg_endo -57.75 119.44 6.7 Favored 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 122.361 2.041 . . . . 0.0 110.465 167.596 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.9 t -93.16 -54.27 7.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.099 -169.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.8 p -150.79 154.36 37.17 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.051 0.453 . . . . 0.0 111.688 -177.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 49.8 tp -121.98 110.25 15.6 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.675 177.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 16.1 p -118.2 143.94 33.94 Favored Pre-proline 0 C--N 1.32 -0.71 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.949 -178.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.411 ' O ' ' HE2' ' A' ' 23' ' ' MET . 87.1 Cg_endo -88.97 160.62 39.53 Favored 'Cis proline' 0 N--CA 1.458 -0.599 0 C-N-CA 123.372 -1.512 . . . . 0.0 112.414 -2.359 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 31.7 m -81.52 6.05 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.045 0.45 . . . . 0.0 111.343 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.4 ' HA ' ' O ' ' A' ' 105' ' ' GLY . 0.1 OUTLIER -141.96 129.77 21.71 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 176.776 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.458 HG22 HD23 ' A' ' 71' ' ' LEU . 17.3 m -121.9 153.1 25.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 -171.725 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.427 ' HA ' ' HD3' ' A' ' 17' ' ' PRO . 2.5 t -83.83 110.98 29.04 Favored Pre-proline 0 CA--C 1.533 0.296 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 -179.482 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 16' ' ' VAL . 6.3 Cg_exo -79.75 58.3 6.9 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 123.288 2.659 . . . . 0.0 113.803 -172.574 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.408 ' OD1' HG13 ' A' ' 16' ' ' VAL . 33.2 p-10 -163.0 13.43 0.07 Allowed 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 176.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 15.3 t -162.34 179.23 8.0 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.711 0.291 . . . . 0.0 110.371 -177.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.515 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 41.1 t -84.05 119.91 34.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 176.404 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 24.4 m-80 -100.33 114.29 27.68 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.27 -177.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.508 ' HA ' ' O ' ' A' ' 67' ' ' PHE . 33.5 m -79.52 90.15 5.09 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 176.636 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.62 ' O ' ' HA ' ' A' ' 66' ' ' ASP . 82.1 mtp -87.32 153.43 21.47 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.901 -176.02 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.479 ' CG2' ' HB3' ' A' ' 64' ' ' ASN . 10.9 m -115.72 112.99 22.87 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.313 -174.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -101.7 116.03 31.84 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 173.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 28.7 m -83.85 109.08 17.27 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.167 -178.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 27.7 mm -103.22 117.96 49.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.533 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 31.0 tt0 -111.09 135.5 51.52 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.147 0.498 . . . . 0.0 111.301 -177.268 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 25.5 t30 -97.17 95.07 7.5 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.536 -0.757 . . . . 0.0 109.354 176.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 64.6 mt-30 -87.96 51.06 2.11 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.362 0.601 . . . . 0.0 110.555 -175.104 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -144.39 168.17 26.77 Favored Glycine 0 N--CA 1.445 -0.755 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.196 -178.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.41 ' OD1' ' HA ' ' A' ' 1' ' ' MET . 31.4 p-10 -88.17 -1.98 58.33 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.806 0.336 . . . . 0.0 111.604 -173.105 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.533 ' HB2' ' SD ' ' A' ' 1' ' ' MET . 85.1 tttt -111.27 128.74 56.03 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.773 0.32 . . . . 0.0 110.412 179.49 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -67.84 135.18 52.15 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.841 179.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.537 ' HB3' ' HB3' ' A' ' 57' ' ' LEU . 29.5 t -89.64 139.55 30.44 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.108 -178.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -88.22 -165.7 1.39 Allowed 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.717 179.636 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.413 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 31.9 m -61.01 119.38 8.18 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.961 0.41 . . . . 0.0 111.746 -177.479 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.45 ' CE2' HG21 ' A' ' 40' ' ' VAL . 24.4 p90 -135.06 155.72 50.26 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.887 179.523 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.459 ' HB2' ' HD2' ' A' ' 86' ' ' PRO . 15.1 m120 -99.21 117.31 33.4 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.747 -0.206 . . . . 0.0 110.855 -176.449 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.45 HG21 ' CE2' ' A' ' 38' ' ' PHE . 2.3 t -104.08 114.3 43.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 121.285 0.564 . . . . 0.0 109.779 175.627 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 19.4 p -110.57 138.32 47.12 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.573 -0.739 . . . . 0.0 111.135 -175.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 51.3 tp -98.06 117.92 33.5 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.015 177.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.9 mp -104.71 127.66 52.56 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.432 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 97.9 t -99.55 103.54 14.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.822 177.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 59.93 17.88 7.0 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.565 179.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 123.55 -26.91 5.88 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.744 -0.741 . . . . 0.0 113.036 177.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 6.2 mt -91.79 147.17 5.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.995 0.397 . . . . 0.0 110.173 -178.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 61.4 t -91.18 121.26 41.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-O 120.799 0.333 . . . . 0.0 110.437 -177.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 30.9 m -104.74 -28.01 3.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.541 -0.299 . . . . 0.0 111.639 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -151.15 138.84 19.72 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 121.127 -0.229 . . . . 0.0 110.537 -177.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 28.5 m -127.49 110.82 13.14 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 175.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.19 121.4 44.79 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.14 0.495 . . . . 0.0 110.304 -175.502 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 59.1 m -82.11 110.87 17.72 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.685 178.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.413 ' O ' ' HA ' ' A' ' 37' ' ' SER . 40.9 t -85.2 121.36 36.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 177.264 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -59.37 -39.87 84.68 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.863 -173.398 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 42.7 t -175.45 155.01 1.75 Allowed 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.537 ' HB3' ' HB3' ' A' ' 35' ' ' SER . 18.7 tp -130.74 110.74 11.57 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.185 0.517 . . . . 0.0 109.946 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.51 ' HB3' ' HB2' ' A' ' 61' ' ' ASN . 26.3 tt0 -61.65 149.61 38.91 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.55 -174.592 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.3 p -60.73 128.93 38.97 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.669 -179.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 60.98 25.41 15.44 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.012 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.51 ' HB2' ' HB3' ' A' ' 58' ' ' GLU . 17.9 m-80 -121.4 160.25 24.47 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.607 178.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.533 ' HA ' ' HA ' ' A' ' 28' ' ' GLU . 0.0 OUTLIER -116.07 144.13 44.54 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.399 178.58 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 19.6 m -121.52 134.05 55.04 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.385 177.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.479 ' HB3' ' CG2' ' A' ' 24' ' ' THR . 88.7 m-20 -88.86 115.62 26.54 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.494 -179.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 6.4 t -97.66 112.58 30.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.492 -178.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.62 ' HA ' ' O ' ' A' ' 23' ' ' MET . 16.7 m-20 -97.31 115.17 27.18 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.977 0.418 . . . . 0.0 110.772 -178.553 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.508 ' O ' ' HA ' ' A' ' 22' ' ' THR . 84.4 m-85 -91.97 165.19 13.34 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.246 -177.039 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 38.5 m-70 -114.78 87.73 2.71 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 175.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 16.4 t90 -110.33 113.01 25.33 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.284 0.564 . . . . 0.0 111.224 -176.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.515 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 5.7 m -81.69 114.05 20.1 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.015 176.572 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.458 HD23 HG22 ' A' ' 15' ' ' VAL . 0.5 OUTLIER -69.09 118.23 11.74 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.058 0.456 . . . . 0.0 111.329 -178.211 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -77.53 -34.76 53.82 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.845 177.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 83.47 15.63 70.8 Favored Glycine 0 C--N 1.329 0.194 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.661 176.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 22.9 m -75.81 -27.73 58.05 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.909 0.385 . . . . 0.0 111.013 -179.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -130.92 160.93 33.06 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.526 -178.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.43 ' HA ' HG22 ' A' ' 106' ' ' THR . 36.8 m-80 -101.9 -4.0 26.94 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.235 0.541 . . . . 0.0 110.452 177.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 37.3 m -144.71 118.38 9.2 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.022 177.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 81.1 m-85 -112.41 139.46 47.96 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.903 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.3 m -92.1 85.77 5.59 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.068 0.461 . . . . 0.0 109.949 179.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 7.6 mp -81.96 117.14 21.95 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.559 0.695 . . . . 0.0 110.979 -176.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.496 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 12.9 m -115.96 118.07 31.9 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.172 -177.514 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 66.5 t -87.81 110.25 20.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 177.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -98.91 112.65 24.69 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.885 0.374 . . . . 0.0 110.257 175.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.532 ' HB ' ' HB2' ' A' ' 98' ' ' ASN . 86.6 t -84.58 111.91 20.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.826 179.591 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 18.6 t0 65.38 96.04 0.05 OUTLIER Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 114.924 -1.034 . . . . 0.0 112.779 176.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.459 ' HD2' ' HB2' ' A' ' 39' ' ' ASN . 98.4 Cg_endo -95.16 6.05 2.21 Favored 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 123.186 2.59 . . . . 0.0 111.923 173.194 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -103.05 -11.39 18.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.615 -176.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 68.22 32.64 4.68 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.708 0.766 . . . . 0.0 109.555 -176.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -73.76 -38.57 64.67 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.987 177.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 65.7 t -128.92 115.06 35.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.17 -179.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -89.1 145.32 25.53 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 175.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -80.24 162.09 24.82 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.167 0.508 . . . . 0.0 111.962 -174.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -57.49 -100.56 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.558 0 N-CA-C 109.811 -1.315 . . . . 0.0 109.811 158.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -65.6 105.49 1.23 Allowed 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 170.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -77.81 68.75 3.93 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -169.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 48.3 m -165.91 18.64 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 111.821 0.304 . . . . 0.0 111.821 179.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.556 ' O ' ' HD2' ' A' ' 7' ' ' PRO . 44.9 m-80 -115.37 -18.83 10.93 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.484 -0.487 . . . . 0.0 111.965 -173.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.532 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 18.6 p-10 -61.16 -9.54 4.94 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 -172.465 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 1.4 m -114.26 145.26 41.98 Favored 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 120.222 -0.591 . . . . 0.0 111.129 179.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.496 ' O ' ' HA ' ' A' ' 81' ' ' THR . 40.8 tp -138.81 101.64 4.36 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.674 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 26.2 m -94.28 102.48 14.48 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.801 0.334 . . . . 0.0 110.348 -179.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -119.05 163.14 17.42 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.955 -178.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 96.2 mt -112.12 129.64 56.16 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.458 178.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.522 HG13 ' HE1' ' A' ' 23' ' ' MET . 34.2 m -119.35 141.76 37.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.788 177.17 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.4 ' O ' ' HA ' ' A' ' 14' ' ' THR . . . -111.57 177.47 18.93 Favored Glycine 0 N--CA 1.443 -0.837 0 C-N-CA 120.373 -0.918 . . . . 0.0 111.685 -177.327 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.43 HG22 ' HA ' ' A' ' 76' ' ' ASN . 40.2 p -87.59 131.98 34.22 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 120.866 0.365 . . . . 0.0 110.044 176.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.456 ' HG ' ' H ' ' A' ' 109' ' ' HIS . 33.1 tp -60.44 133.94 56.58 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.663 -176.125 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -60.36 -34.19 73.5 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.326 178.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . 0.456 ' H ' ' HG ' ' A' ' 107' ' ' LEU . 96.3 m-70 -85.03 108.93 17.86 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.538 178.224 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -98.45 40.89 1.16 Allowed 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 179.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . 0.483 ' O ' ' HB2' ' A' ' 112' ' ' HIS . 30.4 m170 67.88 -169.79 0.19 Allowed 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.192 -176.159 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . 0.483 ' HB2' ' O ' ' A' ' 111' ' ' HIS . 45.2 m-70 77.31 -4.45 2.31 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.516 0.726 . . . . 0.0 110.644 -176.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 78.4 m-70 -150.42 136.55 18.59 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.442 176.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 31.0 t-80 . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.836 -0.602 . . . . 0.0 109.508 177.903 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.476 ' HA ' ' OD1' ' A' ' 32' ' ' ASN . 87.1 mtp . . . . . 0 N--CA 1.48 1.049 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.422 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 7.7 tt -144.14 141.67 18.68 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.257 -179.008 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.49 ' HD3' ' HD3' ' A' ' 33' ' ' LYS . 3.6 Cg_exo -82.11 122.69 3.82 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 122.919 2.413 . . . . 0.0 111.068 172.63 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -111.57 95.01 5.25 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 -179.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.443 HD22 HD21 ' A' ' 57' ' ' LEU . 87.5 mt -79.83 108.73 13.62 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.56 -175.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.404 ' HA ' ' HD2' ' A' ' 7' ' ' PRO . 60.3 t -116.15 109.41 44.62 Favored Pre-proline 0 C--N 1.321 -0.647 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.097 -177.311 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.492 ' HD2' ' O ' ' A' ' 97' ' ' ASN . 28.4 Cg_endo -66.21 102.47 0.57 Allowed 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 122.219 1.946 . . . . 0.0 109.929 167.3 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 15.1 t -78.64 -55.78 9.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.674 -169.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 50.7 m -150.28 155.84 40.44 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.982 0.42 . . . . 0.0 111.172 -177.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 55.2 tp -119.27 107.35 13.3 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.21 177.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.7 p -117.76 146.17 38.22 Favored Pre-proline 0 C--N 1.32 -0.68 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.524 -175.297 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -79.55 164.16 82.64 Favored 'Cis proline' 0 CA--C 1.53 0.289 0 C-N-CA 123.153 -1.603 . . . . 0.0 112.639 -0.009 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 34.8 m -80.16 -22.03 11.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.043 0.449 . . . . 0.0 110.887 -179.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.549 ' HB ' ' HA ' ' A' ' 107' ' ' LEU . 23.2 p -114.5 130.43 56.74 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.741 174.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.9 m -113.48 157.48 14.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.257 0.551 . . . . 0.0 112.153 -171.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.694 HG23 HD22 ' A' ' 107' ' ' LEU . 21.3 t -92.64 107.22 22.51 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.148 -177.714 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.51 ' HA ' ' HB3' ' A' ' 71' ' ' LEU . 7.1 Cg_exo -74.21 9.9 1.63 Allowed 'Trans proline' 0 CA--C 1.531 0.373 0 C-N-CA 123.492 2.795 . . . . 0.0 114.497 -171.391 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -127.51 27.88 5.75 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.711 0.291 . . . . 0.0 111.574 -177.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 15.0 t -167.94 167.77 12.56 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.244 179.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.521 HG21 ' HB ' ' A' ' 70' ' ' THR . 58.2 t -79.94 124.46 38.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 174.684 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.462 ' N ' HD21 ' A' ' 21' ' ' ASN . 0.9 OUTLIER -100.14 117.79 35.12 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.908 0.385 . . . . 0.0 110.244 -175.249 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.479 HG21 ' HB3' ' A' ' 66' ' ' ASP . 6.9 m -83.21 83.85 7.71 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 173.566 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.521 ' HE3' HG13 ' A' ' 104' ' ' VAL . 71.8 mtp -82.31 142.36 32.12 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.899 -174.024 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.455 HG22 ' HB2' ' A' ' 64' ' ' ASN . 26.5 m -106.93 110.52 22.7 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.094 -175.695 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.586 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . . . -91.76 122.21 34.1 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 172.389 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 24.4 m -91.24 104.67 17.19 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.236 -177.233 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 15.5 mm -102.04 117.1 46.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 179.444 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.526 ' HG2' ' HB3' ' A' ' 62' ' ' SER . 53.0 mt-10 -109.6 139.7 44.3 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.945 0.403 . . . . 0.0 110.862 179.652 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.508 ' HB2' ' HG ' ' A' ' 57' ' ' LEU . 32.5 t30 -92.31 93.88 8.87 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.766 175.264 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 83.0 mm-40 -90.06 52.1 2.2 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.683 0.754 . . . . 0.0 110.236 -178.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -144.07 157.48 27.13 Favored Glycine 0 N--CA 1.441 -0.977 0 N-CA-C 110.353 -1.099 . . . . 0.0 110.353 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.476 ' OD1' ' HA ' ' A' ' 1' ' ' MET . 33.8 p-10 -85.63 5.18 32.97 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.896 0.379 . . . . 0.0 111.76 -173.4 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.49 ' HD3' ' HD3' ' A' ' 3' ' ' PRO . 63.6 tttp -116.43 135.07 54.16 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 173.645 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -71.53 139.89 49.69 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.833 0.349 . . . . 0.0 110.161 -179.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.422 ' CB ' HD23 ' A' ' 5' ' ' LEU . 35.7 t -94.94 139.38 31.41 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.722 -177.026 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 24.3 p -83.45 -165.27 1.06 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.472 177.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 26.1 t -57.29 131.6 50.51 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.923 0.392 . . . . 0.0 110.943 178.08 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 31.3 p90 -142.46 148.62 38.03 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.395 177.211 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.458 ' O ' ' HA ' ' A' ' 85' ' ' ASP . 65.8 t30 -104.34 112.9 26.12 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.307 -172.013 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.526 HG22 ' HA ' ' A' ' 84' ' ' VAL . 2.2 t -102.77 123.47 56.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.035 0.445 . . . . 0.0 110.503 -175.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 11.2 t -114.17 144.32 43.38 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.553 -175.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.412 HD11 ' HB3' ' A' ' 80' ' ' LEU . 51.2 tp -105.9 112.58 25.69 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.232 178.414 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.8 mp -101.21 127.25 47.88 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.635 179.11 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.525 HG23 ' HG ' ' A' ' 80' ' ' LEU . 92.3 t -110.7 104.2 16.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 -177.773 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 64.49 19.2 11.72 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.049 0.452 . . . . 0.0 110.555 -176.15 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 117.74 -27.08 7.7 Favored Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.995 178.074 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.516 HG23 ' O ' ' A' ' 44' ' ' VAL . 0.1 OUTLIER -91.94 136.58 24.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.425 0.631 . . . . 0.0 112.385 -174.832 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 88.8 t -78.59 105.84 8.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.325 179.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 22.8 m -86.81 -40.64 14.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.588 179.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -155.29 154.95 32.89 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.714 0.292 . . . . 0.0 110.47 -178.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 13.6 m -143.4 130.29 20.5 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.028 -174.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -119.87 124.56 46.35 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.239 -179.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.405 ' HA ' ' HA ' ' A' ' 39' ' ' ASN . 15.5 m -90.92 116.02 28.41 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.912 0.387 . . . . 0.0 110.181 177.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.418 HG13 HG23 ' A' ' 63' ' ' THR . 43.0 t -82.34 140.32 16.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.987 -178.854 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 28.6 m -71.59 -43.35 66.42 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.82 0.343 . . . . 0.0 111.194 -177.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 32.6 t -173.14 146.94 1.52 Allowed 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 -177.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.508 ' HG ' ' HB2' ' A' ' 29' ' ' ASN . 31.5 tp -128.51 107.13 9.47 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.314 0.578 . . . . 0.0 109.963 178.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -75.34 163.04 27.87 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.986 -173.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 13.4 m -64.71 132.12 48.75 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.439 178.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 42.7 mm-40 67.12 9.41 6.91 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.522 -179.557 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -101.14 148.52 24.99 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.449 -0.342 . . . . 0.0 110.188 179.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.526 ' HB3' ' HG2' ' A' ' 28' ' ' GLU . 33.5 p -113.9 131.01 56.44 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.9 176.203 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.418 HG23 HG13 ' A' ' 54' ' ' VAL . 54.0 m -107.51 125.66 51.55 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 120.955 0.407 . . . . 0.0 110.084 175.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.455 ' HB2' HG22 ' A' ' 24' ' ' THR . 5.0 p-10 -80.34 114.76 19.47 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.093 177.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.586 ' HB ' ' HB2' ' A' ' 25' ' ' ALA . 21.9 t -96.7 105.89 17.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.773 178.227 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.513 ' HA ' ' O ' ' A' ' 23' ' ' MET . 41.8 m-20 -99.81 111.34 23.66 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.468 -175.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.466 ' O ' ' HA ' ' A' ' 22' ' ' THR . 72.1 m-85 -91.79 158.57 16.27 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.914 -176.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 30.8 m-70 -110.13 88.22 2.7 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.428 178.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 13.2 t90 -117.33 113.8 22.66 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.102 -175.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.521 ' HB ' HG21 ' A' ' 20' ' ' VAL . 5.7 t -80.12 120.49 24.33 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 171.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.51 ' HB3' ' HA ' ' A' ' 17' ' ' PRO . 0.2 OUTLIER -65.9 -45.03 83.48 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.598 -170.047 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.429 ' HB3' ' O ' ' A' ' 71' ' ' LEU . 20.9 t70 73.0 -54.27 0.7 Allowed 'General case' 0 N--CA 1.469 0.498 0 O-C-N 123.968 0.792 . . . . 0.0 110.503 -174.268 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 90.93 51.98 2.51 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 121.059 -0.591 . . . . 0.0 111.997 179.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -84.75 -38.67 19.37 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.139 0.495 . . . . 0.0 110.509 -179.23 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -134.93 171.13 14.84 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.919 -177.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 28.2 p-10 -79.15 -15.17 58.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.379 -178.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.468 ' HB3' ' CD2' ' A' ' 103' ' ' LEU . 44.2 m -154.87 147.74 24.51 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.717 0.294 . . . . 0.0 110.765 -177.733 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -126.99 142.66 51.49 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.215 178.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 5.7 m -90.58 90.95 8.21 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.769 0.319 . . . . 0.0 110.428 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.525 ' HG ' HG23 ' A' ' 44' ' ' VAL . 10.9 mp -91.64 116.22 28.7 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.354 0.597 . . . . 0.0 111.172 -176.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.456 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 52.9 m -113.75 118.86 35.48 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.473 -179.5 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.463 ' HB ' ' HB3' ' A' ' 100' ' ' LEU . 60.3 t -88.1 106.91 16.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.617 176.359 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -100.29 110.92 23.17 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 177.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.526 ' HA ' HG22 ' A' ' 40' ' ' VAL . 69.7 t -76.04 110.38 11.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.902 -179.102 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.458 ' HA ' ' O ' ' A' ' 39' ' ' ASN . 1.8 t70 56.52 94.97 0.05 OUTLIER Pre-proline 0 N--CA 1.465 0.29 0 CA-C-N 114.32 -1.309 . . . . 0.0 112.035 178.622 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -60.15 -24.74 77.94 Favored 'Trans proline' 0 N--CA 1.473 0.289 0 C-N-CA 123.369 2.713 . . . . 0.0 112.806 -178.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -92.12 -18.0 24.16 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.207 -179.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 25.6 m120 53.08 54.97 9.54 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.818 -171.034 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.85 -40.07 94.05 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.999 -178.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 41.0 t -83.71 139.36 17.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.79 178.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 60.9 t30 -75.09 95.04 2.99 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 175.234 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -93.88 177.18 6.08 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.28 -173.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -58.14 -100.78 0.01 OUTLIER Glycine 0 CA--C 1.521 0.432 0 CA-C-N 115.341 -0.845 . . . . 0.0 113.063 175.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 55.6 t30 -117.32 145.12 44.22 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.746 0.308 . . . . 0.0 110.242 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.624 ' HA ' ' OD1' ' A' ' 98' ' ' ASN . 42.3 mt-10 -75.43 -12.91 60.34 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.013 0.435 . . . . 0.0 111.567 -174.352 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 16.4 m -69.62 -9.57 54.67 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.793 -178.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.492 ' O ' ' HD2' ' A' ' 7' ' ' PRO . 2.6 p-10 -117.78 10.64 13.34 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.906 -0.318 . . . . 0.0 111.458 177.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.624 ' OD1' ' HA ' ' A' ' 95' ' ' GLU . 7.5 m120 -76.42 -27.69 56.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.859 0.361 . . . . 0.0 110.764 177.361 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -103.75 122.66 45.55 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.718 -179.484 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.463 ' HB3' ' HB ' ' A' ' 82' ' ' VAL . 38.5 tp -109.32 100.17 9.33 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.89 173.353 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 41.5 m -87.58 97.39 10.83 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.218 0.533 . . . . 0.0 110.371 179.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -113.28 107.39 15.82 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.964 179.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.468 ' CD2' ' HB3' ' A' ' 77' ' ' SER . 5.0 tt -83.81 105.67 14.89 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 108.806 -0.812 . . . . 0.0 108.806 -178.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.521 HG13 ' HE3' ' A' ' 23' ' ' MET . 21.2 m -89.64 144.13 9.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.614 -174.562 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -107.38 -179.03 22.47 Favored Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 120.793 -0.718 . . . . 0.0 111.31 -179.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.401 HG23 ' HG3' ' A' ' 17' ' ' PRO . 23.0 p -83.43 153.36 24.53 Favored 'General case' 0 C--N 1.315 -0.904 0 C-N-CA 120.904 -0.318 . . . . 0.0 110.481 178.738 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.694 HD22 HG23 ' A' ' 16' ' ' VAL . 19.2 tp -50.18 123.62 8.74 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.954 -178.235 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.39 -35.07 79.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.418 -175.425 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 77.6 m80 -126.28 108.58 11.4 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 172.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 22.4 t-80 -53.21 -32.34 47.63 Favored 'General case' 0 N--CA 1.464 0.269 0 O-C-N 123.798 0.686 . . . . 0.0 111.104 -173.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 2.8 m170 -138.2 118.74 13.89 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.964 171.028 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 10.0 m-70 -76.27 116.15 16.68 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.841 -179.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 69.2 m80 -80.19 -12.0 59.68 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.018 -178.213 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 64.9 t60 . . . . . 0 C--O 1.246 0.918 0 CA-C-N 115.332 -0.849 . . . . 0.0 108.936 172.187 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.484 ' O ' ' HD2' ' A' ' 33' ' ' LYS . 71.4 mtm . . . . . 0 N--CA 1.481 1.117 0 CA-C-O 120.885 0.374 . . . . 0.0 110.923 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 6.6 tt -114.25 142.54 28.19 Favored Pre-proline 0 C--N 1.319 -0.729 0 C-N-CA 120.596 -0.441 . . . . 0.0 110.158 179.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.447 ' HD2' ' O ' ' A' ' 91' ' ' ASN . 3.3 Cg_exo -84.26 156.94 12.86 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.804 2.336 . . . . 0.0 111.34 171.447 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -138.75 108.67 6.32 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 174.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.496 HD22 HD23 ' A' ' 57' ' ' LEU . 69.4 mt -99.81 126.96 45.98 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -173.422 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.428 HG21 ' ND2' ' A' ' 97' ' ' ASN . 2.4 t -125.36 140.39 36.12 Favored Pre-proline 0 C--N 1.317 -0.844 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.332 -176.234 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.426 ' HB2' ' HB2' ' A' ' 100' ' ' LEU . 9.3 Cg_endo -92.8 93.31 0.16 Allowed 'Trans proline' 0 N--CA 1.445 -1.367 0 C-N-CA 122.952 2.435 . . . . 0.0 109.758 166.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 28.3 m -83.84 -12.88 11.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-N 115.869 -0.605 . . . . 0.0 112.313 -169.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 31.4 t -163.43 143.42 8.71 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.124 0.487 . . . . 0.0 111.723 -176.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 62.7 tp -127.8 126.93 42.63 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.065 175.09 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.0 p -137.7 145.28 48.04 Favored Pre-proline 0 C--N 1.32 -0.709 0 CA-C-N 116.572 -0.286 . . . . 0.0 110.813 -177.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.485 ' HD2' ' SD ' ' A' ' 23' ' ' MET . 98.3 Cg_endo -80.23 163.02 82.89 Favored 'Cis proline' 0 N--CA 1.465 -0.199 0 C-N-CA 123.369 -1.513 . . . . 0.0 112.719 -1.555 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 24.5 m -85.51 -15.26 10.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.152 0.501 . . . . 0.0 110.565 177.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.563 ' HA ' ' O ' ' A' ' 105' ' ' GLY . 0.1 OUTLIER -131.61 124.94 30.98 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.647 174.718 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 20.5 m -114.57 150.47 16.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.625 -0.261 . . . . 0.0 111.141 -174.064 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 6.2 m -88.53 121.55 70.05 Favored Pre-proline 0 N--CA 1.445 -0.685 0 CA-C-O 120.957 0.408 . . . . 0.0 110.194 176.289 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.462 ' HA ' ' CB ' ' A' ' 71' ' ' LEU . 17.6 Cg_exo -68.04 172.51 10.77 Favored 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 122.497 2.132 . . . . 0.0 112.59 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 43.8 m-80 71.93 25.06 3.16 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.274 175.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 12.9 t -175.69 175.62 2.03 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.654 -0.248 . . . . 0.0 110.386 177.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.793 HG21 ' HB ' ' A' ' 70' ' ' THR . 44.4 t -91.24 135.37 27.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.343 178.51 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 21.7 m-80 -108.71 149.88 28.37 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.467 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.9 m -83.05 91.02 7.11 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.258 179.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.491 ' HB2' ' HB2' ' A' ' 67' ' ' PHE . 89.8 mmm -81.6 109.75 16.33 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.372 0.606 . . . . 0.0 110.246 -178.727 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 25.5 m -103.26 110.15 22.02 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.474 -177.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -101.33 120.13 39.79 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.072 178.062 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 28.5 m -85.88 104.43 15.53 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.62 -178.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.419 HG12 HG22 ' A' ' 65' ' ' VAL . 23.3 mm -98.5 119.35 46.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 178.691 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -120.55 139.18 53.31 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.425 -175.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.476 ' O ' ' HA ' ' A' ' 60' ' ' GLU . 54.8 t-20 -91.87 99.72 12.53 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 178.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -102.14 52.25 0.81 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.651 0.738 . . . . 0.0 110.418 -176.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -143.94 175.81 23.61 Favored Glycine 0 N--CA 1.446 -0.634 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.093 179.042 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -99.8 45.49 0.99 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.287 0.565 . . . . 0.0 111.402 -173.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.484 ' HD2' ' O ' ' A' ' 1' ' ' MET . 50.3 tttm -161.49 157.06 24.38 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.254 169.167 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.478 ' N ' ' HG2' ' A' ' 33' ' ' LYS . 8.7 p-10 -68.42 165.13 19.48 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.06 173.553 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.468 ' OG ' ' HB3' ' A' ' 57' ' ' LEU . 10.0 p -129.99 134.4 47.41 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.925 0.393 . . . . 0.0 110.703 178.164 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 11.3 p -80.66 -167.59 1.43 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.322 -177.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 18.8 t -62.61 120.78 11.82 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.058 0.456 . . . . 0.0 111.109 -177.06 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -131.46 160.19 35.87 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.685 178.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -106.08 125.63 51.23 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 121.277 -0.169 . . . . 0.0 110.617 -176.219 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.503 HG13 HG21 ' A' ' 65' ' ' VAL . 1.4 t -111.49 123.85 67.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.156 0.503 . . . . 0.0 110.546 178.216 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 18.2 m -117.83 145.5 44.51 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.912 -176.184 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 49.7 tp -104.04 108.87 20.42 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.853 176.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.7 mp -98.45 112.73 24.66 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.201 -179.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 87.8 t -97.12 107.08 19.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.113 179.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 59.08 22.21 10.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.656 178.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 116.36 -25.19 9.37 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.598 -0.81 . . . . 0.0 112.953 176.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 8.8 mt -96.39 151.31 4.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 -178.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 47.5 t -97.2 109.69 23.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 110.094 -0.335 . . . . 0.0 110.094 -178.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 28.1 m -87.18 -29.72 5.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 C-N-CA 120.904 -0.318 . . . . 0.0 111.502 -177.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -158.0 159.56 36.55 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.836 0.35 . . . . 0.0 110.537 -179.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 95.9 m -149.81 126.87 11.23 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.986 -178.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -125.04 122.85 38.42 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.93 0.395 . . . . 0.0 109.988 179.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 19.5 m -80.09 130.88 35.58 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.056 177.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 42.6 t -98.16 131.72 44.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.2 m -61.55 -47.0 87.55 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.717 -177.093 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 29.8 t -179.98 152.8 0.48 Allowed 'General case' 0 C--O 1.235 0.293 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 -178.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.496 HD23 HD22 ' A' ' 5' ' ' LEU . 40.3 tp -129.75 125.68 36.4 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.057 0.456 . . . . 0.0 110.323 178.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -76.56 160.2 29.65 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.042 -176.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 10.5 m -60.31 120.18 9.35 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.259 -177.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.476 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 44.2 mt-10 60.81 25.53 15.41 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.325 177.585 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -101.24 160.96 13.96 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 171.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -122.31 119.03 29.91 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 -176.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 54.1 m -111.5 127.17 55.62 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.072 0.463 . . . . 0.0 110.719 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -86.76 134.89 33.54 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.54 179.5 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.503 HG21 HG13 ' A' ' 40' ' ' VAL . 28.2 t -96.16 133.55 36.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.154 179.544 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -97.75 97.0 8.63 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.297 -177.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.491 ' HB2' ' HB2' ' A' ' 23' ' ' MET . 21.3 m-85 -97.66 152.38 19.15 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.669 178.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 17.1 m80 -120.77 93.7 4.12 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 178.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 24.0 t90 -114.83 118.58 33.95 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.319 -174.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.793 ' HB ' HG21 ' A' ' 20' ' ' VAL . 15.1 t -89.73 144.85 25.64 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.433 179.46 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.462 ' CB ' ' HA ' ' A' ' 17' ' ' PRO . 3.1 mm? -110.47 127.46 55.15 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.94 0.4 . . . . 0.0 111.763 179.554 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 -90.39 -28.3 18.76 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.682 172.133 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 87.44 33.91 11.07 Favored Glycine 0 N--CA 1.448 -0.517 0 N-CA-C 111.226 -0.75 . . . . 0.0 111.226 -175.268 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.63 -33.03 74.15 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.229 0.538 . . . . 0.0 110.711 -178.607 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -141.27 155.54 45.98 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.237 -178.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -67.89 -30.97 70.45 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.426 178.003 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 19.5 m -136.85 135.96 38.35 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.073 0.464 . . . . 0.0 110.898 -179.025 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -112.48 146.46 38.42 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.12 178.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.47 ' HA ' HD23 ' A' ' 103' ' ' LEU . 6.6 m -95.43 87.61 4.83 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.885 0.374 . . . . 0.0 110.499 -178.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.437 HD13 HG23 ' A' ' 104' ' ' VAL . 9.4 mp -87.7 120.16 28.74 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.184 0.516 . . . . 0.0 111.272 -176.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.575 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 73.5 m -119.64 115.7 24.49 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.606 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 46.5 t -88.16 107.8 17.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.648 175.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -97.97 117.15 31.68 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.847 0.356 . . . . 0.0 110.075 176.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.526 ' HB ' ' HB2' ' A' ' 98' ' ' ASN . 94.7 t -85.71 109.01 17.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.957 -179.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 39.2 t0 65.68 91.91 0.07 OUTLIER Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 114.583 -1.189 . . . . 0.0 112.002 178.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -89.52 6.23 4.47 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 123.021 2.481 . . . . 0.0 111.714 174.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -110.76 -8.98 14.51 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.38 -178.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 5.3 m120 56.64 53.9 7.93 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.266 178.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -88.91 -35.3 16.58 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.55 176.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 61.6 t -108.76 119.73 58.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.439 -0.801 . . . . 0.0 109.882 176.016 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.447 ' O ' ' HD2' ' A' ' 3' ' ' PRO . 53.4 m-80 -74.12 124.19 25.85 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.443 179.212 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.485 ' HB2' ' HA ' ' A' ' 95' ' ' GLU . 0.4 OUTLIER -95.93 150.51 20.36 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.587 -175.543 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -57.78 -100.87 0.01 OUTLIER Glycine 0 CA--C 1.52 0.359 0 CA-C-N 115.068 -0.969 . . . . 0.0 112.734 172.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.471 ' HB3' ' OD1' ' A' ' 97' ' ' ASN . 11.1 t30 -65.33 -24.15 67.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.644 0.259 . . . . 0.0 110.491 -177.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.485 ' HA ' ' HB2' ' A' ' 92' ' ' GLU . 29.5 tt0 76.02 -63.0 0.41 Allowed 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 168.329 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 37.0 m -64.83 -4.93 4.92 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -171.034 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.471 ' OD1' ' HB3' ' A' ' 94' ' ' ASN . 4.0 p-10 -96.01 11.06 35.4 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.808 178.4 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.526 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 24.4 p-10 -85.0 3.02 40.51 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.92 0.39 . . . . 0.0 110.487 179.031 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -119.31 118.32 30.92 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 121.215 0.531 . . . . 0.0 111.575 -178.594 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.575 ' O ' ' HA ' ' A' ' 81' ' ' THR . 25.2 tp -108.46 99.39 8.78 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.241 178.568 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 93.1 m -92.15 97.75 11.11 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 121.155 0.503 . . . . 0.0 109.717 175.304 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -114.88 126.37 54.72 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.344 -177.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.47 HD23 ' HA ' ' A' ' 79' ' ' THR . 51.2 mt -78.93 115.88 18.9 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.214 0.531 . . . . 0.0 110.573 177.641 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.437 HG23 HD13 ' A' ' 80' ' ' LEU . 23.0 m -106.36 144.56 15.39 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.01 178.279 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.563 ' O ' ' HA ' ' A' ' 14' ' ' THR . . . -118.96 169.9 13.69 Favored Glycine 0 N--CA 1.437 -1.255 0 C-N-CA 120.004 -1.094 . . . . 0.0 111.271 -177.366 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 41.6 p -77.06 129.88 36.66 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 173.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.53 ' HG ' ' H ' ' A' ' 109' ' ' HIS . 42.7 tp -57.06 129.15 40.47 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.19 -176.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.52 8.98 6.61 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.497 0.665 . . . . 0.0 110.86 -176.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . 0.53 ' H ' ' HG ' ' A' ' 107' ' ' LEU . 73.3 m80 -136.21 173.85 11.26 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.989 -1.005 . . . . 0.0 108.49 172.465 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 41.1 m80 -123.55 19.3 9.6 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.04 0.448 . . . . 0.0 111.43 -177.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -125.4 93.88 3.99 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.958 174.024 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 47.7 t-80 -91.14 86.16 6.12 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 179.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 18.7 t60 -98.24 126.21 43.63 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.449 -176.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 85.1 t60 . . . . . 0 C--O 1.246 0.884 0 CA-C-O 118.532 -0.747 . . . . 0.0 109.474 178.158 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 84.7 mtp . . . . . 0 N--CA 1.477 0.916 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.423 ' CG1' ' HD2' ' A' ' 3' ' ' PRO . 18.3 tt -114.39 142.58 28.34 Favored Pre-proline 0 C--N 1.321 -0.664 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 178.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.502 ' HD3' ' HD3' ' A' ' 33' ' ' LYS . 58.2 Cg_endo -76.0 157.1 38.68 Favored 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 122.453 2.102 . . . . 0.0 112.325 176.2 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -146.05 100.12 3.35 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 179.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.509 HD23 HD21 ' A' ' 57' ' ' LEU . 41.0 mt -99.88 126.76 46.06 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-O 121.545 0.688 . . . . 0.0 109.265 -170.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 6.0 t -125.46 140.37 36.17 Favored Pre-proline 0 N--CA 1.441 -0.92 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.638 -175.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.439 ' HB2' ' HB2' ' A' ' 100' ' ' LEU . 1.1 Cg_endo -87.34 107.09 0.65 Allowed 'Trans proline' 0 N--CA 1.446 -1.29 0 C-N-CA 122.815 2.343 . . . . 0.0 109.63 166.489 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.9 t -76.91 -60.23 2.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.566 -170.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 9.5 t -154.65 154.97 33.82 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 177.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.8 pp -127.95 127.49 43.38 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.399 0.618 . . . . 0.0 110.117 177.064 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.6 p -121.63 131.66 24.39 Favored Pre-proline 0 C--N 1.311 -1.075 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.792 -175.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.401 ' HD2' ' SD ' ' A' ' 23' ' ' MET . 84.4 Cg_endo -90.55 175.1 20.41 Favored 'Cis proline' 0 N--CA 1.461 -0.392 0 C-N-CA 123.539 -1.442 . . . . 0.0 113.5 8.723 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.5 m -99.25 -11.98 8.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.087 0.47 . . . . 0.0 111.274 178.2 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -120.09 151.0 39.69 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 174.26 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 20.9 m -143.29 157.36 17.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.029 0.442 . . . . 0.0 111.475 -177.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.8 m -99.11 144.13 27.66 Favored Pre-proline 0 N--CA 1.448 -0.564 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.114 178.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.516 ' HA ' ' CB ' ' A' ' 71' ' ' LEU . 2.9 Cg_endo -82.64 165.5 15.87 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.868 2.378 . . . . 0.0 112.589 178.79 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 34.9 m-80 71.87 24.2 3.4 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.639 175.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.5 t -163.52 162.91 24.79 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.983 -0.287 . . . . 0.0 110.592 -178.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.989 HG22 ' HB ' ' A' ' 70' ' ' THR . 21.2 t -94.56 130.81 42.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 175.464 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -119.65 152.63 36.79 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.273 179.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 90.9 m -96.83 109.22 21.96 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.332 -178.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.528 ' HB2' ' HB2' ' A' ' 67' ' ' PHE . 83.4 mmm -92.42 123.74 35.95 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.669 178.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.474 ' HA ' ' O ' ' A' ' 65' ' ' VAL . 19.3 m -106.87 103.06 12.4 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.637 0.256 . . . . 0.0 111.259 -177.577 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -97.75 123.12 41.55 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.494 176.28 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 18.8 m -87.81 121.29 30.05 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 120.813 0.34 . . . . 0.0 110.589 178.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 24.6 mm -106.88 116.37 50.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 179.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -110.27 128.91 55.77 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.918 0.389 . . . . 0.0 110.659 -178.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.431 ' ND2' ' HA ' ' A' ' 59' ' ' SER . 26.1 t30 -88.62 96.08 10.5 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.467 177.437 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 -92.74 43.98 1.14 Allowed 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.634 -174.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -144.08 150.13 22.17 Favored Glycine 0 N--CA 1.447 -0.582 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 179.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 16.1 t30 -84.47 62.77 7.46 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.497 0.665 . . . . 0.0 111.567 -172.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.502 ' HD3' ' HD3' ' A' ' 3' ' ' PRO . 62.3 tttp -161.46 136.84 7.63 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.321 166.833 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -72.16 114.39 10.23 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 177.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 16.1 p -83.56 144.77 29.26 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.054 0.454 . . . . 0.0 110.856 -178.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 3.1 p -83.4 -169.63 2.64 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.557 -178.154 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 33.0 t -54.76 132.63 46.37 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.577 -178.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 55.1 p90 -143.98 159.22 42.97 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.947 178.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 21.0 m-80 -109.04 110.5 21.79 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.483 0.182 . . . . 0.0 111.273 -175.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.445 HG13 HG22 ' A' ' 65' ' ' VAL . 1.5 t -98.43 124.85 51.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.271 0.558 . . . . 0.0 109.926 -179.594 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 18.7 m -120.56 148.18 44.2 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.047 -174.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 50.4 tp -102.21 117.36 34.59 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.787 177.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.519 ' HG ' HG21 ' A' ' 48' ' ' VAL . 5.0 mp -100.34 126.69 46.72 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.81 179.486 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 99.5 t -106.08 103.12 14.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 120.815 0.34 . . . . 0.0 110.201 179.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.48 ' HA ' ' HB ' ' A' ' 79' ' ' THR . 8.7 m-20 62.62 13.09 6.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.352 -0.84 . . . . 0.0 112.095 176.665 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 138.38 -38.63 1.67 Allowed Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.604 -0.808 . . . . 0.0 113.306 176.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 8.3 mt -98.19 150.8 4.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 120.77 0.319 . . . . 0.0 110.537 -174.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.519 HG21 ' HG ' ' A' ' 43' ' ' LEU . 55.9 t -87.43 127.17 40.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 -179.724 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 18.4 m -99.84 -39.34 7.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 111.852 0.316 . . . . 0.0 111.852 179.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -149.44 149.49 30.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.736 0.303 . . . . 0.0 110.936 -176.117 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 95.9 m -133.96 128.27 34.11 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.52 -178.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -118.97 119.28 33.85 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 177.637 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 25.6 m -80.9 126.42 31.34 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.362 178.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 47.7 t -96.6 128.92 47.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 178.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.8 p -56.4 -43.6 79.47 Favored 'General case' 0 C--N 1.329 -0.324 0 O-C-N 123.355 0.409 . . . . 0.0 111.957 -177.069 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 17.2 p -178.08 155.22 0.93 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.393 179.149 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.67 HD12 HG23 ' A' ' 63' ' ' THR . 17.4 tp -130.42 109.26 10.59 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.07 0.462 . . . . 0.0 109.783 177.44 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -63.98 160.86 16.92 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.41 -176.241 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.431 ' HA ' ' ND2' ' A' ' 29' ' ' ASN . 4.4 p -61.9 125.73 24.88 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.122 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 61.23 35.93 18.11 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.436 -179.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 13.5 m-80 -121.32 162.09 20.9 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.04 176.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 3.5 p -132.55 127.82 35.92 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.025 0.44 . . . . 0.0 111.54 -178.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.67 HG23 HD12 ' A' ' 57' ' ' LEU . 17.6 p -104.22 153.29 21.15 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.455 177.628 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -104.29 125.12 50.28 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 176.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.474 ' O ' ' HA ' ' A' ' 24' ' ' THR . 59.3 t -96.14 128.66 47.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-O 121.169 0.509 . . . . 0.0 110.963 -175.071 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -95.61 97.21 9.57 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.368 -177.097 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.528 ' HB2' ' HB2' ' A' ' 23' ' ' MET . 26.3 m-85 -92.26 147.18 23.13 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.212 0.529 . . . . 0.0 111.443 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 7.2 m80 -114.93 98.25 6.71 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.041 179.189 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 20.4 t90 -122.78 122.21 38.16 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.064 0.459 . . . . 0.0 111.444 -174.163 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.989 ' HB ' HG22 ' A' ' 20' ' ' VAL . 8.4 t -105.61 141.29 37.32 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.261 177.657 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.516 ' CB ' ' HA ' ' A' ' 17' ' ' PRO . 1.7 mm? -100.89 119.23 38.39 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.112 0.482 . . . . 0.0 111.038 176.348 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -84.37 -25.14 29.34 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.054 176.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -153.19 -155.21 7.04 Favored Glycine 0 N--CA 1.445 -0.731 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.856 -177.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 2.8 t -145.74 90.91 2.04 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-O 121.934 0.874 . . . . 0.0 111.267 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -80.87 2.45 26.47 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.882 172.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.475 ' O ' ' HA2' ' A' ' 105' ' ' GLY . 95.5 m-20 70.83 -59.11 0.55 Allowed 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.803 179.447 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 41.0 t -104.3 114.21 28.29 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 120.888 0.375 . . . . 0.0 110.415 -178.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.4 ' HB2' HG21 ' A' ' 104' ' ' VAL . 65.1 m-85 -116.92 134.0 55.31 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.323 179.105 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.48 ' HB ' ' HA ' ' A' ' 45' ' ' ASP . 7.3 m -96.69 88.05 4.52 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.911 0.386 . . . . 0.0 110.478 -177.014 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.405 HD21 HG13 ' A' ' 104' ' ' VAL . 8.1 mp -87.58 113.59 23.41 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.611 0.719 . . . . 0.0 110.56 -178.169 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.523 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 25.8 m -115.33 123.28 48.32 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.418 -177.785 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 49.5 t -90.17 112.03 24.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 176.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -108.19 117.76 34.98 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 175.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.583 ' HB ' ' HB2' ' A' ' 98' ' ' ASN . 84.8 t -83.57 103.37 10.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.995 -177.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.9 t70 59.81 89.54 0.1 Allowed Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 114.266 -1.334 . . . . 0.0 112.347 177.103 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -70.78 -12.46 30.99 Favored 'Trans proline' 0 C--O 1.232 0.215 0 C-N-CA 123.33 2.687 . . . . 0.0 112.217 179.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -89.73 -6.5 55.99 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.464 -178.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 58.41 42.1 21.82 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.61 177.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -69.26 -26.79 64.94 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.334 178.05 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 61.4 t -110.6 122.63 65.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.681 176.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 54.0 t30 -80.86 130.4 35.03 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 176.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -125.65 159.92 30.99 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.948 0.404 . . . . 0.0 112.008 -173.076 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -58.3 -100.81 0.01 OUTLIER Glycine 0 CA--C 1.522 0.489 0 CA-C-N 114.948 -1.024 . . . . 0.0 113.818 174.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -58.24 160.51 5.02 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 122.972 0.509 . . . . 0.0 111.452 -177.117 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.2 2.68 24.91 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 121.144 0.497 . . . . 0.0 111.413 -175.722 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 18.3 m -125.8 24.33 7.11 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.0 0.428 . . . . 0.0 110.465 -179.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 26.4 p-10 -98.09 -39.94 8.66 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.705 -174.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.583 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 23.9 p-10 -83.77 10.68 8.9 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.316 0.488 . . . . 0.0 112.316 -168.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 2.6 m -119.32 150.12 40.67 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.981 0.419 . . . . 0.0 110.643 -179.237 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.523 ' O ' ' HA ' ' A' ' 81' ' ' THR . 54.2 tp -148.52 106.59 3.72 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.649 178.565 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 31.0 m -93.51 98.65 11.32 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 120.9 0.381 . . . . 0.0 110.222 177.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -109.46 118.98 38.06 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.374 -179.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -81.47 111.24 17.63 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.161 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.405 HG13 HD21 ' A' ' 80' ' ' LEU . 21.5 m -103.38 162.85 3.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -179.302 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.475 ' HA2' ' O ' ' A' ' 76' ' ' ASN . . . -131.87 167.08 22.91 Favored Glycine 0 N--CA 1.439 -1.102 0 C-N-CA 119.858 -1.163 . . . . 0.0 111.955 -178.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 22.4 p -84.26 131.52 34.73 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 173.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 36.5 tp -55.02 117.88 3.84 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.634 -174.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.24 -25.01 62.3 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.957 -176.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 57.4 m80 -68.87 115.44 8.2 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 170.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 29.3 m-70 -108.73 91.42 3.63 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.069 0.461 . . . . 0.0 110.264 -177.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 -125.14 109.82 13.35 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.269 179.153 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 89.6 m-70 -91.16 -78.85 0.38 Allowed 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 172.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 89.6 m-70 -139.35 21.01 2.58 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.705 0.764 . . . . 0.0 109.285 173.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.245 0.839 0 CA-C-N 114.704 -1.134 . . . . 0.0 109.403 178.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 90.7 mtp . . . . . 0 N--CA 1.481 1.076 0 CA-C-O 120.914 0.388 . . . . 0.0 110.214 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 13.3 tt -137.31 143.38 41.25 Favored Pre-proline 0 C--N 1.32 -0.691 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -68.69 155.95 67.1 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 121.947 1.764 . . . . 0.0 111.484 176.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -147.51 76.78 1.41 Allowed 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 176.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.725 ' HG ' ' OE1' ' A' ' 92' ' ' GLU . 27.1 mt -72.8 103.66 3.74 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 114.948 -1.024 . . . . 0.0 110.856 -176.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.553 HG21 ' HB3' ' A' ' 97' ' ' ASN . 25.7 t -114.68 121.0 36.53 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.923 -177.228 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.49 ' HB2' ' HB2' ' A' ' 100' ' ' LEU . 1.9 Cg_endo -79.03 108.01 2.32 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 122.333 2.022 . . . . 0.0 109.919 171.185 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 27.3 m -93.95 -27.27 4.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 -171.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 60.7 m -146.49 145.04 30.05 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.983 0.421 . . . . 0.0 111.872 -175.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.454 HD21 ' HB1' ' A' ' 102' ' ' ALA . 50.1 tp -130.54 110.53 11.49 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.407 174.046 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.56 ' OG1' ' HA ' ' A' ' 12' ' ' PRO . 5.6 t -128.69 149.56 72.36 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.017 -177.143 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.56 ' HA ' ' OG1' ' A' ' 11' ' ' THR . 82.8 Cg_endo -77.76 154.2 94.41 Favored 'Cis proline' 0 N--CA 1.463 -0.296 0 C-N-CA 123.42 -1.492 . . . . 0.0 112.675 1.722 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.5 m -79.62 -6.64 9.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.13 178.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.411 ' HA ' ' O ' ' A' ' 105' ' ' GLY . 1.5 p -130.35 125.51 34.81 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.319 178.323 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.4 m -121.1 158.02 24.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.125 0.488 . . . . 0.0 112.115 -172.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.476 HG21 HD23 ' A' ' 107' ' ' LEU . 41.8 t -80.22 120.56 79.96 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.732 177.748 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.568 ' HA ' ' HG ' ' A' ' 71' ' ' LEU . 2.8 Cg_exo -75.5 59.28 5.47 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 123.193 2.596 . . . . 0.0 113.946 -173.286 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -176.98 -56.88 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.718 0.294 . . . . 0.0 111.506 174.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 14.6 t -80.4 178.29 8.4 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.293 -172.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.549 HG21 ' HG1' ' A' ' 70' ' ' THR . 45.2 t -80.74 124.29 38.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.106 178.42 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.561 ' ND2' HD23 ' A' ' 71' ' ' LEU . 38.7 m-80 -102.44 135.03 44.8 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.169 -179.308 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 21.2 m -82.9 97.68 8.8 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.033 -0.53 . . . . 0.0 109.95 177.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.527 ' HB2' ' HB2' ' A' ' 67' ' ' PHE . 91.5 mmm -91.56 132.26 36.42 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.269 -176.366 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.497 ' HA ' ' O ' ' A' ' 65' ' ' VAL . 10.4 m -116.27 117.07 29.0 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.638 -178.088 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -105.58 119.48 39.22 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.265 178.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 17.6 m -85.9 110.28 19.31 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.51 -178.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 24.4 mm -102.13 115.67 44.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.21 -179.065 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -103.15 132.74 49.18 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.091 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.442 ' HB2' ' HG ' ' A' ' 57' ' ' LEU . 51.9 t-20 -90.49 101.53 14.27 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 173.304 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 79.2 mm-40 -93.31 33.23 1.24 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.179 -176.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -144.09 166.87 27.0 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.024 -178.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -97.5 54.22 1.18 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.448 0.642 . . . . 0.0 111.063 -173.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 73.8 tttt -161.47 144.72 12.51 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.121 172.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.495 ' HB3' ' HA ' ' A' ' 58' ' ' GLU . 1.2 m-20 -89.19 129.71 35.73 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 -177.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 36.9 p -85.07 153.92 22.41 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 110.311 -0.255 . . . . 0.0 110.311 -179.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.409 HG22 ' H ' ' A' ' 37' ' ' SER . 0.2 OUTLIER -85.19 -167.82 1.98 Allowed 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 177.382 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.492 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 39.9 m -60.42 113.47 2.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.955 0.407 . . . . 0.0 110.701 178.692 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -124.25 154.21 40.52 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.313 -178.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -100.52 111.37 23.62 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.424 -176.072 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.468 HG11 HG23 ' A' ' 65' ' ' VAL . 1.4 t -98.34 119.11 45.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 176.356 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.42 ' HB3' HG11 ' A' ' 48' ' ' VAL . 41.2 m -113.49 138.15 50.53 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.327 -174.117 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 62.5 tp -97.89 111.82 23.97 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.58 174.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.426 ' HA ' ' O ' ' A' ' 47' ' ' ILE . 5.2 mp -96.9 140.8 30.91 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.024 -179.721 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 91.0 t -122.57 111.56 30.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 173.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 20.0 t70 67.71 -72.78 0.09 Allowed 'General case' 0 N--CA 1.47 0.542 0 O-C-N 124.036 0.835 . . . . 0.0 110.761 -176.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -153.08 9.15 0.52 Allowed Glycine 0 N--CA 1.448 -0.564 0 CA-C-N 115.969 -0.559 . . . . 0.0 112.14 177.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.426 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 3.4 mt -110.89 151.2 13.1 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.315 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 -178.603 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.42 HG11 ' HB3' ' A' ' 41' ' ' SER . 45.4 t -99.21 107.19 20.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 173.792 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 29.8 m -77.8 -33.51 18.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.304 -175.258 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -160.01 135.49 8.25 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.273 -179.101 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 95.4 m -120.88 126.41 49.97 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.832 177.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -109.83 123.27 49.27 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.068 178.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 30.3 m -81.25 104.18 11.54 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.249 -0.432 . . . . 0.0 109.905 176.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.492 ' O ' ' HA ' ' A' ' 37' ' ' SER . 21.9 t -81.4 123.26 37.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 178.632 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 20.9 m -56.14 -42.85 77.58 Favored 'General case' 0 C--N 1.329 -0.3 0 O-C-N 123.458 0.474 . . . . 0.0 111.594 -173.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 50.7 p 179.2 136.89 0.1 Allowed 'General case' 0 C--N 1.33 -0.261 0 O-C-N 123.246 0.341 . . . . 0.0 110.526 174.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.455 HD21 HD22 ' A' ' 5' ' ' LEU . 26.7 tp -105.94 110.23 22.43 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.123 0.487 . . . . 0.0 109.762 175.469 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.495 ' HA ' ' HB3' ' A' ' 34' ' ' ASP . 42.7 mt-10 -66.95 160.49 26.24 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.201 -177.044 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 2.7 p -60.73 124.87 21.68 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.372 -178.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 65.03 16.97 10.87 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.527 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -96.17 148.45 22.7 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 178.203 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 17.9 m -111.48 134.52 53.0 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.002 179.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 91.7 m -139.88 129.63 24.55 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.131 0.491 . . . . 0.0 111.123 -179.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -90.31 132.57 35.48 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.627 -179.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.497 ' O ' ' HA ' ' A' ' 24' ' ' THR . 40.2 t -96.53 133.07 39.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.448 -179.129 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -102.56 105.31 15.8 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.468 -177.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.527 ' HB2' ' HB2' ' A' ' 23' ' ' MET . 49.9 m-85 -102.03 147.83 26.1 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.912 179.046 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 35.5 m-70 -115.13 92.41 3.92 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 175.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 14.7 t90 -100.22 105.44 17.01 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.238 -173.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.549 ' HG1' HG21 ' A' ' 20' ' ' VAL . 6.8 m -73.96 108.7 6.94 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.014 171.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.568 ' HG ' ' HA ' ' A' ' 17' ' ' PRO . 0.1 OUTLIER -59.42 -69.13 0.22 Allowed 'General case' 0 C--O 1.234 0.284 0 O-C-N 123.131 0.27 . . . . 0.0 111.517 -172.645 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.436 ' HB3' ' O ' ' A' ' 71' ' ' LEU . 20.0 t70 72.87 -47.37 0.67 Allowed 'General case' 0 N--CA 1.47 0.57 0 O-C-N 123.918 0.761 . . . . 0.0 111.981 -178.126 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.556 ' HA3' ' OH ' ' A' ' 78' ' ' TYR . . . -74.34 -174.52 31.83 Favored Glycine 0 CA--C 1.518 0.244 0 C-N-CA 121.249 -0.501 . . . . 0.0 113.478 -177.511 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 9.5 t -142.43 12.82 1.95 Allowed 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.087 0.47 . . . . 0.0 111.347 -175.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.436 ' HB2' ' CE1' ' A' ' 78' ' ' TYR . . . -71.81 141.49 49.66 Favored 'General case' 0 C--N 1.33 -0.272 0 O-C-N 122.081 -0.387 . . . . 0.0 110.286 -179.446 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.462 ' HA ' HG21 ' A' ' 106' ' ' THR . 25.0 p-10 -77.73 -5.66 51.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.78 0.324 . . . . 0.0 111.514 -175.311 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 43.7 m -150.83 116.01 5.34 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.862 0.363 . . . . 0.0 110.722 -178.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.556 ' OH ' ' HA3' ' A' ' 73' ' ' GLY . 43.0 m-85 -111.47 138.26 48.21 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.89 176.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 37.2 m -92.65 97.97 11.14 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.88 179.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.429 HD11 HG22 ' A' ' 104' ' ' VAL . 10.2 mp -97.31 135.79 38.72 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.453 -179.479 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.483 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 27.4 m -130.36 116.96 19.04 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.64 -176.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.401 ' HB ' ' HB3' ' A' ' 100' ' ' LEU . 59.5 t -89.11 104.17 14.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 175.684 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -99.26 117.6 34.08 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 178.2 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.45 HG23 ' HG3' ' A' ' 7' ' ' PRO . 84.5 t -85.1 106.4 14.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.355 -176.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 51.3 t0 61.6 85.77 0.17 Allowed Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 114.563 -1.199 . . . . 0.0 111.487 178.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -74.91 -7.14 18.96 Favored 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 123.023 2.482 . . . . 0.0 111.715 178.174 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -94.57 -22.62 18.08 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 178.224 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 59.99 69.15 0.72 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.182 -179.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -93.05 -28.76 16.17 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.793 178.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.7 t -106.33 135.15 45.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.31 176.211 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -82.48 112.0 19.01 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.873 0.368 . . . . 0.0 110.008 178.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.725 ' OE1' ' HG ' ' A' ' 5' ' ' LEU . 66.6 mm-40 -100.43 173.63 6.49 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.478 -176.349 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -57.77 -101.11 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.387 0 CA-C-N 115.255 -0.884 . . . . 0.0 112.485 174.015 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.457 ' O ' ' HB2' ' A' ' 97' ' ' ASN . 60.5 m-20 -96.77 135.31 38.9 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -60.86 -29.24 69.41 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.138 0.494 . . . . 0.0 110.656 177.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 5.3 m -65.85 -19.72 65.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.252 0.548 . . . . 0.0 110.539 178.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.553 ' HB3' HG21 ' A' ' 6' ' ' VAL . 7.2 m-20 -81.24 -21.78 39.23 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.788 -178.296 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.718 HD22 ' HG3' ' A' ' 92' ' ' GLU . 16.7 m120 -78.11 -4.74 48.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.403 -177.617 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 3.2 m -110.32 154.74 23.06 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.079 0.466 . . . . 0.0 111.33 -175.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.49 ' HB2' ' HB2' ' A' ' 7' ' ' PRO . 48.8 tp -146.96 103.42 3.61 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.478 175.095 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 7.7 m -90.26 96.2 10.55 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 178.229 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.454 ' HB1' HD21 ' A' ' 10' ' ' LEU . . . -114.95 121.08 42.07 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.162 0.506 . . . . 0.0 110.82 -176.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 87.1 mt -86.26 121.21 28.52 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.215 177.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.429 HG22 HD11 ' A' ' 80' ' ' LEU . 18.5 m -111.48 137.26 44.79 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.72 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.411 ' O ' ' HA ' ' A' ' 14' ' ' THR . . . -107.61 -177.78 22.42 Favored Glycine 0 N--CA 1.439 -1.128 0 C-N-CA 120.532 -0.842 . . . . 0.0 111.22 -177.204 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.482 HG22 ' HG3' ' A' ' 17' ' ' PRO . 24.7 p -82.54 153.95 25.28 Favored 'General case' 0 C--N 1.312 -1.056 0 C-N-CA 120.856 -0.338 . . . . 0.0 110.338 178.112 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.476 HD23 HG21 ' A' ' 16' ' ' VAL . 27.1 tp -52.22 119.36 4.31 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.395 179.483 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -58.54 -51.79 68.4 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.861 -176.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 75.2 m80 -87.92 111.04 21.02 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.052 -179.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . 0.617 ' HB3' ' HA ' ' A' ' 113' ' ' HIS . 43.5 m80 -74.44 112.63 10.81 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.647 -175.385 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 43.5 t-80 -67.25 -56.27 10.53 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 168.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 7.9 t-80 -96.4 110.85 23.13 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 107.456 -1.312 . . . . 0.0 107.456 167.32 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . 0.617 ' HA ' ' HB3' ' A' ' 110' ' ' HIS . 96.0 m-70 -62.32 -40.72 97.26 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.862 -170.007 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 21.4 p80 . . . . . 0 C--O 1.245 0.855 0 CA-C-O 118.732 -0.652 . . . . 0.0 109.673 178.426 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 84.7 mmm . . . . . 0 N--CA 1.479 1.02 0 CA-C-O 120.66 0.267 . . . . 0.0 110.494 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 13.4 tt -144.14 140.56 17.07 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 116.604 -0.271 . . . . 0.0 110.424 178.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.626 ' O ' ' HA ' ' A' ' 92' ' ' GLU . 18.4 Cg_exo -68.54 148.7 73.24 Favored 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.64 2.226 . . . . 0.0 111.203 170.094 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -130.0 93.09 3.42 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 175.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.507 ' HB3' HG12 ' A' ' 84' ' ' VAL . 70.5 mt -76.08 102.18 5.6 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.108 -173.483 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 60.9 t -107.68 110.41 62.64 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.124 -179.197 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.525 ' HB2' ' HB2' ' A' ' 100' ' ' LEU . 56.8 Cg_endo -73.12 103.51 1.62 Allowed 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 121.898 1.732 . . . . 0.0 109.825 168.688 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.2 t -79.31 -51.25 16.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.573 -168.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 21.6 t -157.25 176.36 12.82 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.019 0.437 . . . . 0.0 111.028 -178.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 35.6 tp -145.44 104.32 3.9 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.071 -178.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.3 p -112.98 145.52 33.25 Favored Pre-proline 0 C--N 1.321 -0.659 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.431 -175.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.424 ' O ' ' HE3' ' A' ' 23' ' ' MET . 84.1 Cg_endo -86.0 157.22 56.85 Favored 'Cis proline' 0 N--CA 1.46 -0.474 0 C-N-CA 123.132 -1.612 . . . . 0.0 112.319 -2.691 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.467 ' HA ' HG12 ' A' ' 104' ' ' VAL . 35.9 m -83.94 13.0 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.25 0.547 . . . . 0.0 110.952 -179.756 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.52 HG23 ' HA ' ' A' ' 107' ' ' LEU . 0.3 OUTLIER -148.54 119.56 7.68 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 178.311 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.529 HG22 ' CZ3' ' A' ' 69' ' ' TRP . 24.9 m -128.41 153.53 37.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -167.21 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.451 HG23 HD21 ' A' ' 107' ' ' LEU . 7.4 t -76.01 129.77 79.97 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.052 179.086 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.553 ' HA ' ' CB ' ' A' ' 71' ' ' LEU . 6.1 Cg_exo -74.1 -173.88 1.57 Allowed 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 122.643 2.229 . . . . 0.0 111.577 174.75 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 8.1 p30 51.36 17.26 0.5 Allowed 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.349 1.059 . . . . 0.0 113.844 175.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 15.0 t -150.82 168.7 23.65 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 121.721 -0.612 . . . . 0.0 110.93 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.69 HG23 ' HG1' ' A' ' 70' ' ' THR . 25.9 t -99.0 112.39 30.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 175.144 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.445 ' ND2' ' HB ' ' A' ' 15' ' ' VAL . 26.5 p30 -101.62 162.84 12.61 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.049 -175.348 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.456 ' HA ' ' O ' ' A' ' 67' ' ' PHE . 7.9 m -113.48 95.77 5.53 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.006 -179.534 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.523 ' HE2' HG13 ' A' ' 104' ' ' VAL . 80.0 mtp -92.74 150.56 20.58 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.755 -176.814 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 3.1 m -118.02 115.91 25.82 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.424 -175.07 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -96.97 134.08 40.8 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.022 0.439 . . . . 0.0 110.457 176.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 4.1 m -91.33 100.2 13.04 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.087 179.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 21.9 mm -98.3 111.51 28.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 176.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.526 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 27.7 tt0 -119.19 132.27 55.94 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.149 0.5 . . . . 0.0 111.1 -176.557 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.54 ' HB2' ' HG ' ' A' ' 57' ' ' LEU . 54.2 t-20 -86.81 113.8 22.93 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.858 -179.471 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 83.0 mm-40 -101.13 54.92 0.84 Allowed 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.193 0.521 . . . . 0.0 110.745 179.077 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -143.99 -172.57 14.81 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.777 -0.725 . . . . 0.0 111.755 -177.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 29.9 p-10 -113.4 6.85 17.4 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.846 0.355 . . . . 0.0 111.729 -174.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -122.33 133.11 54.67 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 171.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -73.87 132.28 42.36 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.504 -179.179 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.526 ' HG ' ' HB3' ' A' ' 57' ' ' LEU . 4.5 p -93.11 138.81 31.21 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.084 0.469 . . . . 0.0 111.151 -178.199 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.0 p -83.1 -165.47 1.09 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.238 -179.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.572 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 22.4 m -56.91 121.5 10.04 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.99 0.424 . . . . 0.0 111.624 -179.073 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.415 ' CE2' HG23 ' A' ' 40' ' ' VAL . 31.3 p90 -133.87 153.73 51.54 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.295 -179.688 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.404 ' O ' ' HD3' ' A' ' 86' ' ' PRO . 89.3 m-20 -94.26 113.84 25.82 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.818 0.342 . . . . 0.0 111.245 -176.115 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.415 HG23 ' CE2' ' A' ' 38' ' ' PHE . 1.5 t -103.56 125.51 58.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.138 0.494 . . . . 0.0 109.815 176.453 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 9.7 m -113.3 139.39 48.88 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.676 -177.046 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 61.1 tp -103.01 116.97 33.55 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 174.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.484 ' HG ' HG22 ' A' ' 48' ' ' VAL . 5.1 mp -105.72 137.89 42.83 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.554 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 78.9 t -100.94 100.29 10.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 171.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 8.7 t70 69.2 -76.12 0.06 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.38 -176.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -136.95 -7.68 1.52 Allowed Glycine 0 CA--C 1.519 0.34 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.885 178.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 6.9 mt -100.03 148.75 6.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 110.029 -0.359 . . . . 0.0 110.029 -178.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.484 HG22 ' HG ' ' A' ' 43' ' ' LEU . 48.5 t -97.84 121.08 47.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.413 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 28.3 m -104.05 -28.51 2.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 C-N-CA 120.831 -0.347 . . . . 0.0 111.688 -177.213 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -144.27 150.07 37.3 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 -177.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 24.2 m -149.43 110.55 4.38 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 177.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -114.85 138.15 51.12 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.896 0.379 . . . . 0.0 110.546 -177.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 28.9 m -87.18 107.32 18.42 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 173.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.572 ' O ' ' HA ' ' A' ' 37' ' ' SER . 39.0 t -77.64 127.16 38.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 9.6 m -63.07 -39.39 94.56 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.896 -170.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 79.5 p -170.99 161.79 7.02 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.713 0.292 . . . . 0.0 110.52 178.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.54 ' HG ' ' HB2' ' A' ' 29' ' ' ASN . 37.9 tp -142.87 114.09 7.79 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.066 -0.515 . . . . 0.0 109.705 175.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -79.54 157.26 27.44 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.57 -0.741 . . . . 0.0 112.132 -172.126 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 16.5 m -59.63 119.9 8.45 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.362 -179.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.422 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 45.2 mt-10 60.5 28.65 18.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.66 179.072 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -124.9 159.64 30.68 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 172.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.526 ' HA ' ' HA ' ' A' ' 28' ' ' GLU . 33.2 p -112.76 163.86 14.07 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.059 0.457 . . . . 0.0 111.241 -176.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 79.9 m -133.97 124.46 26.36 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.918 173.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 31.4 m-80 -80.5 106.08 12.24 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.416 177.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.8 t -96.57 115.6 36.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.769 -175.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.48 ' HA ' ' O ' ' A' ' 23' ' ' MET . 19.2 m-20 -96.25 118.85 33.64 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.82 0.343 . . . . 0.0 111.223 -179.344 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.456 ' O ' ' HA ' ' A' ' 22' ' ' THR . 84.7 m-85 -102.1 174.27 6.01 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.952 178.401 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 86.3 m-70 -128.45 109.64 11.59 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 176.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . 0.529 ' CZ3' HG22 ' A' ' 15' ' ' VAL . 15.2 t90 -120.05 122.04 40.22 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.251 0.548 . . . . 0.0 111.281 -172.574 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.69 ' HG1' HG23 ' A' ' 20' ' ' VAL . 10.3 m -86.49 113.94 22.83 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.648 178.222 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.553 ' CB ' ' HA ' ' A' ' 17' ' ' PRO . 1.1 mm? -77.7 122.81 25.85 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.115 0.483 . . . . 0.0 111.678 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 16.4 p-10 -87.35 -33.72 19.07 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.154 173.063 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 82.64 19.55 63.55 Favored Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 115.589 -0.732 . . . . 0.0 113.55 172.054 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 30.0 m -70.45 -41.2 73.15 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.095 0.474 . . . . 0.0 110.401 179.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -110.25 157.24 19.67 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.041 176.382 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -97.05 -9.01 28.94 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.195 0.521 . . . . 0.0 109.734 178.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 71.9 p -137.62 110.1 7.47 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.935 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 46.5 m-85 -106.23 138.59 42.14 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.316 0.579 . . . . 0.0 111.095 -179.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.42 ' HA ' HD21 ' A' ' 103' ' ' LEU . 7.7 m -91.31 83.85 5.54 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.208 -0.906 . . . . 0.0 109.6 -179.59 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 7.9 mp -80.53 120.36 24.4 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.656 0.741 . . . . 0.0 110.267 -178.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.572 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 17.1 m -117.99 116.38 26.79 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.24 -173.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.414 ' HB ' ' HB3' ' A' ' 100' ' ' LEU . 92.8 t -87.43 110.98 21.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 177.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -96.57 117.14 30.33 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 175.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.507 HG12 ' HB3' ' A' ' 5' ' ' LEU . 47.5 t -93.47 108.14 20.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.975 -178.828 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 56.8 t0 66.38 95.91 0.05 OUTLIER Pre-proline 0 N--CA 1.466 0.374 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.447 178.005 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.404 ' HD3' ' O ' ' A' ' 39' ' ' ASN . 3.7 Cg_endo -85.1 0.56 8.81 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 123.319 2.679 . . . . 0.0 111.822 178.662 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -109.3 -14.82 14.39 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.043 -179.038 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 57.85 42.7 22.82 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.703 -178.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -80.58 -29.68 36.95 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.911 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 60.5 t -100.22 129.29 51.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.771 -0.649 . . . . 0.0 109.553 175.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -73.28 133.13 43.82 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.324 179.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.626 ' HA ' ' O ' ' A' ' 3' ' ' PRO . 0.0 OUTLIER -128.6 164.45 22.83 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.847 -179.544 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -57.72 -101.14 0.01 OUTLIER Glycine 0 CA--C 1.517 0.184 0 CA-C-N 115.251 -0.886 . . . . 0.0 112.999 173.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.487 ' O ' ' HB3' ' A' ' 97' ' ' ASN . 27.8 t-20 -89.38 126.11 35.41 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.868 0.366 . . . . 0.0 110.42 -179.446 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -76.32 -12.58 60.09 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.934 -173.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 22.3 m -92.31 -6.06 51.05 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.563 0.697 . . . . 0.0 109.774 174.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.487 ' HB3' ' O ' ' A' ' 94' ' ' ASN . 1.9 t30 -86.81 -21.66 26.32 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.082 -178.589 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.426 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 16.9 p-10 -74.24 -3.75 31.9 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.976 0.417 . . . . 0.0 111.189 -176.573 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 1.3 m -101.66 149.05 24.53 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.215 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.572 ' O ' ' HA ' ' A' ' 81' ' ' THR . 48.9 tp -136.48 111.6 9.0 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.394 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 6.2 m -90.43 89.86 7.77 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.941 178.07 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -102.69 112.02 24.6 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.04 0.448 . . . . 0.0 110.794 -177.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.42 HD21 ' HA ' ' A' ' 79' ' ' THR . 61.7 mt -83.79 116.24 22.62 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.44 178.606 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.523 HG13 ' HE2' ' A' ' 23' ' ' MET . 17.9 m -118.25 136.26 56.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.176 -177.31 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.501 ' O ' ' HA ' ' A' ' 14' ' ' THR . . . -111.6 173.74 15.99 Favored Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 120.378 -0.915 . . . . 0.0 111.858 -177.515 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 21.0 p -77.97 138.12 38.67 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.329 176.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.52 ' HA ' HG23 ' A' ' 14' ' ' THR . 32.3 tp -63.1 107.31 1.0 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.677 -0.692 . . . . 0.0 112.098 -172.637 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -121.17 90.64 3.36 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.025 174.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 61.6 m-70 -66.25 106.71 1.75 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.778 179.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 2.4 t-80 -74.24 105.01 5.23 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 177.199 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 45.0 m80 -81.31 140.04 35.04 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.761 -170.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 7.9 t-80 -97.57 116.63 30.16 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.362 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 37.4 m80 -60.52 -48.1 83.27 Favored 'General case' 0 C--N 1.327 -0.374 0 O-C-N 123.169 0.293 . . . . 0.0 111.238 -173.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 10.6 p80 . . . . . 0 C--O 1.248 0.978 0 CA-C-O 118.054 -0.974 . . . . 0.0 109.745 173.287 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.501 ' HA ' ' OD1' ' A' ' 32' ' ' ASN . 82.8 mtp . . . . . 0 N--CA 1.48 1.032 0 CA-C-O 120.749 0.309 . . . . 0.0 110.22 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.452 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 17.5 tt -144.24 139.54 15.91 Favored Pre-proline 0 C--N 1.322 -0.615 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 -179.697 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.518 ' HD3' ' HD3' ' A' ' 33' ' ' LYS . 15.9 Cg_exo -70.25 159.76 51.93 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 122.611 2.207 . . . . 0.0 112.178 176.245 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -143.62 90.36 2.15 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 176.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.472 HD21 HD21 ' A' ' 57' ' ' LEU . 78.3 mt -85.59 109.82 18.82 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.417 0.627 . . . . 0.0 110.753 -170.013 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 45.9 t -114.79 111.29 45.81 Favored Pre-proline 0 C--N 1.32 -0.68 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.602 -175.055 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.491 ' HD2' ' O ' ' A' ' 97' ' ' ASN . 34.2 Cg_endo -68.08 101.66 0.72 Allowed 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 122.2 1.933 . . . . 0.0 109.81 167.113 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.7 t -79.34 -55.37 9.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.441 -169.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.3 t -146.21 163.42 35.48 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.54 -174.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 58.8 tp -134.59 104.61 6.14 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.712 -178.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 15.6 p -107.45 143.03 26.38 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.45 -177.153 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -86.25 157.73 55.23 Favored 'Cis proline' 0 N--CA 1.457 -0.624 0 C-N-CA 122.964 -1.682 . . . . 0.0 112.021 -3.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 34.9 m -82.69 5.84 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.355 0.597 . . . . 0.0 110.257 178.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.522 ' HA ' ' O ' ' A' ' 105' ' ' GLY . 2.6 m -147.35 116.94 7.06 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 176.065 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.426 HG23 HD23 ' A' ' 71' ' ' LEU . 22.0 m -113.47 152.2 15.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.139 0.495 . . . . 0.0 111.77 -170.61 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.583 HG22 HD21 ' A' ' 107' ' ' LEU . 1.8 t -97.77 115.59 65.75 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.65 178.71 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.538 ' HA ' ' CB ' ' A' ' 71' ' ' LEU . 23.9 Cg_exo -64.93 -175.3 0.36 Allowed 'Trans proline' 0 C--O 1.234 0.277 0 C-N-CA 122.495 2.13 . . . . 0.0 112.564 179.754 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 19.5 m-80 74.25 17.77 3.19 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.474 176.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 12.1 t -164.28 166.58 20.8 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 110.532 -0.173 . . . . 0.0 110.532 -177.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.47 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 52.6 t -85.84 109.7 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 172.365 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.657 ' OD1' HD21 ' A' ' 71' ' ' LEU . 9.8 m120 -85.52 125.64 33.22 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.068 -174.054 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 53.3 m -79.19 106.09 10.98 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.572 172.311 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.496 ' HE1' HG12 ' A' ' 104' ' ' VAL . 62.1 mtp -104.88 144.13 32.2 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.956 0.407 . . . . 0.0 110.339 -179.844 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.485 HG21 ' HB3' ' A' ' 64' ' ' ASN . 31.2 m -115.02 111.4 21.05 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.055 -174.666 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -97.92 118.37 34.33 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 173.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 38.7 m -87.59 107.81 18.77 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 120.878 0.37 . . . . 0.0 110.174 -179.257 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 20.2 mm -103.11 115.13 44.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.863 -179.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.518 ' HG2' ' HB3' ' A' ' 62' ' ' SER . 46.2 mt-10 -104.14 134.07 48.0 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.751 0.31 . . . . 0.0 110.836 177.527 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.48 ' HB2' ' HG ' ' A' ' 57' ' ' LEU . 29.9 t30 -90.44 92.06 8.72 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 173.496 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 80.4 mt-30 -87.86 53.18 2.68 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.615 0.721 . . . . 0.0 110.168 -176.087 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -143.89 160.5 27.76 Favored Glycine 0 N--CA 1.444 -0.829 0 CA-C-N 114.953 -1.022 . . . . 0.0 110.638 179.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.501 ' OD1' ' HA ' ' A' ' 1' ' ' MET . 26.6 p-10 -84.9 -0.88 55.66 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 117.011 0.405 . . . . 0.0 111.91 -171.718 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.518 ' HD3' ' HD3' ' A' ' 3' ' ' PRO . 48.2 tttm -112.59 144.8 41.46 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 176.346 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 -75.15 148.77 39.34 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 176.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 35.7 p -109.12 141.99 40.52 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.95 0.405 . . . . 0.0 110.763 -178.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.9 p -76.61 -164.81 0.45 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.382 -179.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.43 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 16.8 m -65.13 129.66 40.51 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.736 0.303 . . . . 0.0 110.965 -179.16 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.55 ' HB2' ' HB2' ' A' ' 85' ' ' ASP . 49.4 p90 -141.12 152.54 44.82 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.216 179.707 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.448 ' O ' ' HA ' ' A' ' 85' ' ' ASP . 30.1 m-80 -103.35 113.32 26.72 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.561 -175.065 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.49 HG13 HG23 ' A' ' 65' ' ' VAL . 1.4 t -98.36 122.39 49.97 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-O 121.269 0.557 . . . . 0.0 109.659 178.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 10.4 m -115.35 142.79 46.22 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.057 -174.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.488 HD13 ' HB3' ' A' ' 80' ' ' LEU . 45.0 tp -102.49 110.92 23.01 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.816 176.401 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.444 ' HG ' HG23 ' A' ' 48' ' ' VAL . 4.7 mp -98.9 114.58 27.26 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.24 -179.812 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.433 HG23 ' HG ' ' A' ' 80' ' ' LEU . 96.5 t -97.51 105.53 17.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.085 178.65 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 58.74 21.49 8.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.708 177.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 122.42 -33.66 4.08 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.908 176.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 8.5 mt -91.62 150.56 3.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 O-C-N 122.737 -0.272 . . . . 0.0 110.348 -176.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.444 HG23 ' HG ' ' A' ' 43' ' ' LEU . 44.5 t -96.74 118.15 42.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -179.251 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 27.2 m -97.11 -23.23 4.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.608 -177.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -153.36 142.34 21.24 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.254 -179.028 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.2 m -133.46 108.26 8.55 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.759 178.121 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -109.19 138.72 45.11 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.235 -175.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 17.3 m -105.61 110.14 22.35 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.912 0.387 . . . . 0.0 111.078 -178.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.43 ' O ' ' HA ' ' A' ' 37' ' ' SER . 45.4 t -77.78 128.74 38.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 176.842 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 12.3 m -60.22 -42.72 95.78 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.607 -177.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 30.2 t 178.21 129.93 0.06 Allowed 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 -178.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.522 HD11 ' OG1' ' A' ' 63' ' ' THR . 24.1 tp -108.51 117.37 33.98 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.159 0.504 . . . . 0.0 110.038 178.676 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -73.0 162.24 29.72 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.494 -175.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 2.9 p -61.5 124.35 20.4 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.329 -0.85 . . . . 0.0 111.352 179.23 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 61.01 28.62 18.4 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.854 179.014 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -108.95 156.78 19.31 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 174.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.518 ' HB3' ' HG2' ' A' ' 28' ' ' GLU . 32.5 p -114.09 125.83 54.42 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.535 179.211 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.522 ' OG1' HD11 ' A' ' 57' ' ' LEU . 53.2 m -112.78 129.44 56.43 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.975 0.417 . . . . 0.0 110.149 176.326 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.485 ' HB3' HG21 ' A' ' 24' ' ' THR . 94.1 m-20 -90.19 128.88 36.48 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.704 177.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.49 HG23 HG13 ' A' ' 40' ' ' VAL . 43.9 t -96.09 123.46 48.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.676 -177.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -86.19 97.64 10.47 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.446 -178.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -93.4 141.99 27.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.179 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 7.0 m80 -118.15 96.51 5.36 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . 0.44 ' HE3' ' SD ' ' A' ' 23' ' ' MET . 12.1 t90 -114.43 113.64 24.77 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.271 0.558 . . . . 0.0 110.621 -175.618 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.47 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 6.8 m -78.75 102.32 8.04 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.465 -0.788 . . . . 0.0 110.074 176.573 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.657 HD21 ' OD1' ' A' ' 21' ' ' ASN . 0.5 OUTLIER -61.05 113.9 2.81 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.095 0.474 . . . . 0.0 110.393 178.84 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -79.19 -32.98 44.3 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.569 -0.742 . . . . 0.0 111.075 -175.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -160.79 -146.29 4.57 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.05 -178.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 25.9 m -136.09 83.97 2.05 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.152 0.501 . . . . 0.0 110.497 179.253 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.427 ' O ' ' HB2' ' A' ' 76' ' ' ASN . . . -86.86 1.4 52.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.367 178.515 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.535 ' O ' ' HA2' ' A' ' 105' ' ' GLY . 17.0 m120 73.69 -50.4 0.69 Allowed 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.307 0.643 . . . . 0.0 112.229 -179.302 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 16.2 p -132.15 124.53 29.28 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 120.963 0.411 . . . . 0.0 111.708 -179.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -117.24 144.44 44.8 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.083 177.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.523 ' HA ' HD22 ' A' ' 103' ' ' LEU . 28.6 m -94.74 90.17 5.98 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.926 0.394 . . . . 0.0 110.094 -179.378 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.488 ' HB3' HD13 ' A' ' 42' ' ' LEU . 10.4 mp -94.18 117.23 29.8 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.308 0.575 . . . . 0.0 110.506 -178.093 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.515 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 18.8 m -114.2 119.03 35.65 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.459 -0.792 . . . . 0.0 110.394 -177.077 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 50.6 t -90.56 101.46 12.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 176.192 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -97.79 116.95 31.02 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 177.353 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.576 ' HB ' ' HB2' ' A' ' 98' ' ' ASN . 93.9 t -82.86 105.92 13.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 121.327 0.584 . . . . 0.0 111.264 -177.148 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.55 ' HB2' ' HB2' ' A' ' 38' ' ' PHE . 8.7 t70 54.42 90.86 0.08 OUTLIER Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 114.293 -1.321 . . . . 0.0 111.824 179.712 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_exo -58.17 -30.49 90.72 Favored 'Trans proline' 0 C--O 1.233 0.254 0 C-N-CA 123.052 2.501 . . . . 0.0 112.032 179.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -71.0 -25.56 62.74 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.093 177.427 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 56.48 44.98 23.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.974 -177.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -65.18 -32.16 73.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.153 -0.931 . . . . 0.0 110.439 -179.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 49.5 t -86.9 123.96 40.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.394 175.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.488 ' O ' ' HD2' ' A' ' 3' ' ' PRO . 3.9 m-20 -77.89 130.95 37.24 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.892 -0.411 . . . . 0.0 109.892 178.678 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -124.09 161.42 25.65 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.75 -173.123 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -58.21 -100.77 0.01 OUTLIER Glycine 0 CA--C 1.521 0.448 0 CA-C-N 115.033 -0.985 . . . . 0.0 112.528 172.171 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -57.94 156.37 9.24 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 176.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 -102.46 -24.93 13.78 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.15 0.5 . . . . 0.0 110.965 179.371 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 5.9 p -98.89 21.44 11.55 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.313 0.578 . . . . 0.0 110.972 -177.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.491 ' O ' ' HD2' ' A' ' 7' ' ' PRO . 26.4 p-10 -96.27 -33.82 11.84 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.106 -177.493 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.576 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 19.5 p-10 -83.7 9.77 10.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.968 -169.433 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 1.6 m -117.65 147.42 42.9 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.747 0.308 . . . . 0.0 110.22 177.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.515 ' O ' ' HA ' ' A' ' 81' ' ' THR . 50.2 tp -144.74 98.82 3.25 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.233 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 6.9 m -92.54 104.58 16.87 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.685 177.404 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -126.62 138.2 53.41 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.135 0.493 . . . . 0.0 111.359 -176.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.523 HD22 ' HA ' ' A' ' 79' ' ' THR . 74.0 mt -89.83 124.6 34.81 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.992 175.623 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.496 HG12 ' HE1' ' A' ' 23' ' ' MET . 28.3 m -108.97 141.51 24.05 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 176.219 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.535 ' HA2' ' O ' ' A' ' 76' ' ' ASN . . . -102.47 166.72 17.3 Favored Glycine 0 N--CA 1.439 -1.101 0 C-N-CA 120.273 -0.965 . . . . 0.0 111.789 -176.064 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.515 ' OG1' ' HA ' ' A' ' 76' ' ' ASN . 24.5 p -91.85 140.86 29.26 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 173.169 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.583 HD21 HG22 ' A' ' 16' ' ' VAL . 7.7 tp -57.84 133.02 55.06 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 123.378 0.424 . . . . 0.0 111.126 -173.736 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 29.6 mm-40 -51.46 -38.04 51.84 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.061 -0.972 . . . . 0.0 112.058 -179.196 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 60.3 m80 -104.71 94.4 5.27 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -174.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 20.1 t60 -58.12 135.98 57.13 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 163.328 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -44.31 -50.24 9.1 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 123.589 0.556 . . . . 0.0 111.564 -167.054 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 12.1 m170 -114.67 106.83 14.69 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 167.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 58.4 t-80 -107.56 138.0 44.57 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.57 -177.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 54.3 t-80 . . . . . 0 C--O 1.245 0.82 0 CA-C-O 118.435 -0.793 . . . . 0.0 109.879 176.118 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.8 mtt . . . . . 0 N--CA 1.481 1.078 0 CA-C-O 121.152 0.501 . . . . 0.0 110.724 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.506 HG13 ' HD2' ' A' ' 3' ' ' PRO . 4.0 tp -123.25 145.74 47.24 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.09 -179.067 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.506 ' HD2' HG13 ' A' ' 2' ' ' ILE . 11.9 Cg_exo -70.96 177.24 6.63 Favored 'Trans proline' 0 C--O 1.236 0.398 0 C-N-CA 122.498 2.132 . . . . 0.0 112.226 178.108 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.473 ' HB3' ' C ' ' A' ' 30' ' ' GLN . 24.8 t70 -149.14 77.91 1.37 Allowed 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 175.536 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.549 HD22 ' HG ' ' A' ' 35' ' ' SER . 83.4 mt -75.36 109.63 9.05 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.932 -176.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 25.8 t -118.79 120.65 31.34 Favored Pre-proline 0 C--N 1.319 -0.744 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.247 -178.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.493 ' HB2' ' HB2' ' A' ' 100' ' ' LEU . 5.7 Cg_exo -73.68 111.22 3.24 Favored 'Trans proline' 0 N--CA 1.45 -1.06 0 C-N-CA 121.947 1.765 . . . . 0.0 109.726 172.43 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.0 t -80.55 -57.71 4.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.457 -169.023 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 32.8 t -144.94 167.32 22.92 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.631 -175.267 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 58.5 tp -138.62 114.61 10.1 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.149 -177.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.5 p -125.41 157.93 66.09 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.656 -179.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.63 159.51 96.43 Favored 'Cis proline' 0 N--CA 1.465 -0.185 0 C-N-CA 123.357 -1.518 . . . . 0.0 111.871 -3.356 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 29.7 m -78.31 -19.89 13.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.221 0.534 . . . . 0.0 110.249 -178.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.501 ' HA ' ' O ' ' A' ' 105' ' ' GLY . 17.3 p -124.5 130.61 52.78 Favored 'General case' 0 N--CA 1.437 -1.124 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.993 174.768 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.424 ' O ' ' HD3' ' A' ' 17' ' ' PRO . 31.3 m -113.06 146.56 17.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 120.766 0.317 . . . . 0.0 111.112 -177.02 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.585 HG23 HD21 ' A' ' 107' ' ' LEU . 18.1 t -92.13 113.0 57.76 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 116.633 -0.258 . . . . 0.0 110.963 -175.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.525 ' HA ' ' HB3' ' A' ' 71' ' ' LEU . 4.7 Cg_exo -72.44 97.86 0.9 Allowed 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 122.429 2.086 . . . . 0.0 109.934 173.727 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 -177.49 -46.07 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.417 -169.178 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 14.8 t -148.76 -169.63 3.41 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.954 -175.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.494 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 43.2 t -78.84 128.34 38.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 176.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.406 ' ND2' HD22 ' A' ' 71' ' ' LEU . 23.6 m-80 -102.82 125.19 49.47 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.64 -179.817 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.5 m -80.16 103.89 10.34 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 178.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.524 ' HB2' ' HB2' ' A' ' 67' ' ' PHE . 95.8 mmm -87.63 133.05 33.88 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.734 -174.694 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.523 ' HA ' ' O ' ' A' ' 65' ' ' VAL . 42.4 m -105.86 109.33 21.24 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.825 -177.719 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.404 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . . . -102.58 112.15 24.78 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.594 174.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 21.8 m -83.48 105.69 14.63 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.077 -178.017 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 21.5 mm -100.51 121.12 50.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 -179.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.526 ' HG3' ' HG ' ' A' ' 62' ' ' SER . 30.8 tt0 -113.1 134.78 54.38 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 -179.236 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.482 ' HB2' ' HG ' ' A' ' 57' ' ' LEU . 41.3 t30 -94.48 107.16 19.14 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.05 0.452 . . . . 0.0 109.819 177.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.473 ' C ' ' HB3' ' A' ' 4' ' ' ASP . 73.0 mt-30 -113.89 56.65 0.7 Allowed 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.243 -175.579 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -143.88 -165.65 10.97 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.36 -0.924 . . . . 0.0 112.493 -174.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.421 ' N ' HD21 ' A' ' 32' ' ' ASN . 0.9 OUTLIER -93.2 4.0 54.74 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 -169.448 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -155.41 150.19 26.43 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.785 -177.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -73.72 146.45 44.4 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 175.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.549 ' HG ' HD22 ' A' ' 5' ' ' LEU . 35.3 p -93.49 149.1 21.5 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.031 0.444 . . . . 0.0 110.807 -179.277 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.424 ' OG1' HG23 ' A' ' 90' ' ' VAL . 38.8 p -86.13 -158.9 0.43 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.885 177.057 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.447 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 37.8 t -69.71 107.95 3.69 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.752 0.31 . . . . 0.0 110.256 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.422 ' HB3' ' CG2' ' A' ' 90' ' ' VAL . 55.7 p90 -118.11 140.37 49.87 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.103 0.477 . . . . 0.0 109.878 179.723 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.499 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 65.3 t30 -90.35 128.37 36.44 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.897 -176.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.518 HG23 ' HA ' ' A' ' 84' ' ' VAL . 0.3 OUTLIER -116.62 136.91 52.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 -175.403 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.402 ' HB3' ' CG1' ' A' ' 48' ' ' VAL . 27.9 m -124.42 135.34 53.19 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.288 -173.467 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 57.8 tp -98.95 112.79 24.8 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.069 0.461 . . . . 0.0 110.168 175.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.525 ' HG ' HG21 ' A' ' 48' ' ' VAL . 5.0 mp -96.59 120.17 36.42 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.579 179.46 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 72.2 t -103.47 109.12 26.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 174.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 16.1 t70 74.39 -66.21 0.31 Allowed 'General case' 0 N--CA 1.464 0.273 0 O-C-N 124.188 0.93 . . . . 0.0 110.74 -179.516 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -162.62 14.04 0.12 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 121.144 -0.55 . . . . 0.0 112.682 179.064 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 10.8 mt -131.09 150.81 34.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 -179.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.525 HG21 ' HG ' ' A' ' 43' ' ' LEU . 29.6 t -93.12 94.9 4.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.504 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 32.8 m -70.82 -27.23 29.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.924 -173.355 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -157.93 152.85 25.32 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 178.263 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 25.2 m -139.09 128.71 24.57 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.287 -174.15 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.404 ' O ' HG12 ' A' ' 40' ' ' VAL . 2.5 tt0 -127.38 132.47 50.15 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 179.06 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.499 ' HA ' ' HA ' ' A' ' 39' ' ' ASN . 20.5 m -92.28 122.78 35.07 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 177.824 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.447 ' O ' ' HA ' ' A' ' 37' ' ' SER . 64.5 t -86.2 127.98 39.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 178.674 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 14.4 m -62.47 -45.35 93.42 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.139 -0.482 . . . . 0.0 112.087 -173.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 36.9 t -178.41 125.77 0.11 Allowed 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -177.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.49 HD23 HD21 ' A' ' 5' ' ' LEU . 25.2 tp -104.55 112.15 25.11 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.546 0.689 . . . . 0.0 110.558 178.767 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.408 ' HB3' ' HB2' ' A' ' 61' ' ' ASN . 34.5 tt0 -66.13 145.92 55.25 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.679 -179.082 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 5.9 t -64.25 137.96 58.2 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 178.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 68.87 9.67 7.5 Favored 'General case' 0 N--CA 1.464 0.231 0 O-C-N 123.741 0.651 . . . . 0.0 111.542 -178.423 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.408 ' HB2' ' HB3' ' A' ' 58' ' ' GLU . 4.7 m-20 -114.38 161.3 18.11 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.885 0.374 . . . . 0.0 110.598 177.768 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.526 ' HG ' ' HG3' ' A' ' 28' ' ' GLU . 4.3 m -123.9 124.52 42.82 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.503 179.245 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 54.5 m -104.21 124.02 48.37 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 176.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.458 ' HB3' HG23 ' A' ' 24' ' ' THR . 45.3 m-80 -87.0 126.0 34.45 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 179.599 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.523 ' O ' ' HA ' ' A' ' 24' ' ' THR . 22.1 t -96.07 136.34 27.3 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.828 -178.42 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -111.02 102.86 11.3 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.002 0.43 . . . . 0.0 110.209 -178.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.524 ' HB2' ' HB2' ' A' ' 23' ' ' MET . 66.5 m-85 -91.76 144.73 25.2 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.212 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 33.9 m-70 -99.59 87.88 3.69 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.029 179.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . 0.416 ' CZ3' HG12 ' A' ' 15' ' ' VAL . 18.2 t90 -108.02 110.45 22.16 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.276 0.56 . . . . 0.0 111.099 -173.827 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.494 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 5.5 m -80.87 122.78 27.64 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.858 177.383 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.525 ' HB3' ' HA ' ' A' ' 17' ' ' PRO . 0.9 OUTLIER -88.04 119.76 28.72 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.217 0.532 . . . . 0.0 112.09 -177.248 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -83.99 -38.69 20.62 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.827 173.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 88.4 24.87 32.43 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 121.017 -0.611 . . . . 0.0 113.501 174.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 85.5 m -64.0 -51.1 65.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.197 0.522 . . . . 0.0 110.985 177.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -110.6 146.91 35.31 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.408 179.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 17.3 p-10 -81.89 -6.91 59.49 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.033 0.444 . . . . 0.0 110.94 -177.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 8.8 t -149.23 124.97 10.48 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 176.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -112.84 156.2 23.32 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.163 0.506 . . . . 0.0 111.542 -177.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.421 ' HA ' HD22 ' A' ' 103' ' ' LEU . 6.0 m -96.78 97.51 9.38 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.279 177.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.44 HD13 HG23 ' A' ' 104' ' ' VAL . 9.4 mp -96.64 117.82 31.81 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.346 0.593 . . . . 0.0 110.592 -177.532 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.567 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 24.7 m -117.08 119.58 35.69 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.372 -177.243 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 39.8 t -94.99 109.6 22.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 177.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -99.03 125.61 44.56 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 120.419 -0.513 . . . . 0.0 110.019 178.129 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.545 ' HB ' ' HB2' ' A' ' 98' ' ' ASN . 96.6 t -98.2 111.35 27.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.917 -176.06 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 24.1 t70 66.89 92.34 0.07 OUTLIER Pre-proline 0 N--CA 1.466 0.341 0 CA-C-N 115.136 -0.938 . . . . 0.0 112.641 177.04 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -101.03 19.83 0.25 Allowed 'Trans proline' 0 N--CA 1.451 -1.008 0 C-N-CA 123.525 2.816 . . . . 0.0 111.718 171.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 58.8 mt-10 -128.17 -7.71 5.37 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.945 -174.282 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 8.1 t30 60.31 47.07 9.42 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.822 0.82 . . . . 0.0 109.882 -175.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -83.91 -37.3 22.54 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 174.075 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.424 HG23 ' OG1' ' A' ' 36' ' ' THR . 21.7 t -120.87 105.79 17.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 114.584 -1.189 . . . . 0.0 108.3 170.036 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -77.49 104.38 7.98 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.003 0.43 . . . . 0.0 110.116 -177.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 50.9 mm-40 -77.91 176.07 9.45 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.814 -177.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -57.91 -100.93 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.725 172.316 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 28.5 p-10 -87.77 174.89 8.11 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 173.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -115.21 24.71 11.43 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.117 0.484 . . . . 0.0 111.122 178.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 41.3 m -110.39 18.63 19.63 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.398 0.618 . . . . 0.0 110.003 175.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 28.3 p-10 -124.29 -24.82 4.22 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.894 -177.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.545 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 26.5 p-10 -86.6 23.57 1.62 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.744 -173.044 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.56 144.64 46.33 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.893 0.378 . . . . 0.0 110.788 -179.611 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.567 ' O ' ' HA ' ' A' ' 81' ' ' THR . 30.0 tp -136.97 115.66 12.08 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.085 178.775 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 15.0 m -104.9 102.45 11.97 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 178.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -121.65 135.35 54.98 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.974 0.416 . . . . 0.0 111.248 -176.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.421 HD22 ' HA ' ' A' ' 79' ' ' THR . 60.9 mt -87.43 125.17 34.12 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.559 175.677 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.44 HG23 HD13 ' A' ' 80' ' ' LEU . 25.6 m -112.64 155.43 13.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 175.666 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.501 ' O ' ' HA ' ' A' ' 14' ' ' THR . . . -120.49 171.34 14.63 Favored Glycine 0 N--CA 1.444 -0.787 0 C-N-CA 120.156 -1.021 . . . . 0.0 111.461 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 32.1 p -76.32 169.05 18.95 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.689 -0.485 . . . . 0.0 109.689 174.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.585 HD21 HG23 ' A' ' 16' ' ' VAL . 29.1 tp -69.02 94.44 0.64 Allowed 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.206 0.527 . . . . 0.0 110.745 -178.455 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -82.66 15.17 2.72 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.672 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 6.0 t-80 -79.43 -4.57 51.74 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 176.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 41.0 m170 -94.55 -6.58 43.34 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.42 173.441 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 4.7 t-160 -90.75 28.75 1.46 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.265 -178.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 32.1 t-80 -74.87 113.86 12.65 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.195 -176.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 28.5 t-80 -86.18 -74.38 0.42 Allowed 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 177.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 92.1 m-70 . . . . . 0 C--O 1.247 0.926 0 CA-C-O 118.384 -0.817 . . . . 0.0 109.021 175.692 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.422 ' O ' ' HD2' ' A' ' 33' ' ' LYS . 26.3 ttt . . . . . 0 N--CA 1.477 0.884 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.438 HG12 ' HD2' ' A' ' 3' ' ' PRO . 6.2 tt -140.09 147.64 51.4 Favored Pre-proline 0 CA--C 1.535 0.386 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 -175.228 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.44 ' HD3' ' HD3' ' A' ' 33' ' ' LYS . 2.7 Cg_exo -76.04 -174.25 1.99 Allowed 'Trans proline' 0 C--O 1.237 0.45 0 C-N-CA 122.598 2.199 . . . . 0.0 112.128 178.072 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -162.23 75.51 0.45 Allowed 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 179.296 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.408 HD21 HD21 ' A' ' 57' ' ' LEU . 73.3 mt -70.09 103.24 2.24 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.813 -177.592 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.453 ' HA ' ' HD2' ' A' ' 7' ' ' PRO . 42.7 t -110.72 110.47 57.35 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.002 -179.015 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.506 ' HD3' HG22 ' A' ' 84' ' ' VAL . 20.7 Cg_endo -63.85 114.27 2.52 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 122.271 1.981 . . . . 0.0 109.978 168.686 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 6.3 t -89.25 -58.9 3.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.25 -168.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.7 p -136.66 154.09 50.73 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.565 -174.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 62.1 tp -130.11 100.1 5.3 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.239 176.056 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.493 ' CG2' ' HA ' ' A' ' 12' ' ' PRO . 56.6 m -115.61 141.11 26.88 Favored Pre-proline 0 C--N 1.317 -0.84 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.198 -175.13 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.493 ' HA ' ' CG2' ' A' ' 11' ' ' THR . 72.1 Cg_endo -83.46 133.79 21.79 Favored 'Cis proline' 0 N--CA 1.461 -0.397 0 C-N-CA 123.383 -1.507 . . . . 0.0 113.244 1.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 35.0 m -65.75 -11.44 12.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.818 175.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.51 ' HA ' ' O ' ' A' ' 105' ' ' GLY . 0.6 OUTLIER -135.39 118.94 16.95 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 175.969 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.488 HG13 ' HG2' ' A' ' 12' ' ' PRO . 27.4 m -113.54 166.0 7.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.828 -170.106 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 1.7 t -108.09 119.72 49.07 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.166 179.107 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.611 ' HD2' ' O ' ' A' ' 111' ' ' HIS . 36.5 Cg_exo -60.94 88.53 0.09 OUTLIER 'Trans proline' 0 C--O 1.236 0.402 0 C-N-CA 122.339 2.026 . . . . 0.0 109.719 167.013 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -158.25 -50.69 0.06 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.954 -167.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 8.9 t -153.76 -169.82 3.39 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.006 -172.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.475 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 39.0 t -77.76 114.24 18.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 174.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.518 ' OD1' HD23 ' A' ' 71' ' ' LEU . 9.6 m120 -86.84 132.81 33.72 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.479 -175.28 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 20.6 m -79.23 93.69 5.29 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.249 177.554 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.51 ' HB2' ' HB2' ' A' ' 67' ' ' PHE . 93.1 mmm -85.67 107.57 17.61 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.795 -178.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 17.7 m -97.96 113.15 24.92 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.819 -176.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -104.29 110.04 22.11 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.98 -0.554 . . . . 0.0 109.959 177.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 24.7 m -87.47 113.91 23.6 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 120.965 0.412 . . . . 0.0 110.324 -178.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 15.9 mm -100.8 122.86 53.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.708 -179.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -115.08 120.57 40.26 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 -179.21 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 32.4 t30 -82.7 98.39 9.04 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 178.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -94.18 44.24 1.11 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.353 0.596 . . . . 0.0 110.679 -175.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -143.96 147.97 19.51 Favored Glycine 0 N--CA 1.444 -0.789 0 N-CA-C 111.206 -0.758 . . . . 0.0 111.206 -177.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 14.5 t30 -84.89 61.68 6.98 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.489 0.662 . . . . 0.0 111.399 -172.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.44 ' HD3' ' HD3' ' A' ' 3' ' ' PRO . 54.4 tttm -161.69 156.85 23.57 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 170.311 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -80.7 154.57 27.22 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 120.867 0.365 . . . . 0.0 110.044 175.65 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 22.2 p -124.26 136.46 54.16 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.999 177.032 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 3.7 p -77.08 -166.53 0.72 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.889 179.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.408 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 7.5 t -60.93 113.04 2.31 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.989 0.423 . . . . 0.0 110.494 179.267 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.474 ' HB2' ' HB2' ' A' ' 85' ' ' ASP . 33.9 p90 -118.28 147.52 43.37 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.521 178.676 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.469 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 51.6 t-20 -90.29 128.59 36.46 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.368 -175.353 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.509 HG11 HG22 ' A' ' 65' ' ' VAL . 2.2 t -118.66 111.87 35.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-O 121.588 0.709 . . . . 0.0 109.821 176.144 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 8.9 m -111.77 143.15 43.17 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.807 -175.05 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 63.6 tp -102.75 113.76 27.44 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 176.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.538 ' HG ' HG21 ' A' ' 48' ' ' VAL . 4.8 mp -102.12 139.77 37.29 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.547 179.445 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 93.4 t -110.47 110.67 33.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 172.113 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 20.1 t70 67.73 -74.0 0.08 Allowed 'General case' 0 N--CA 1.464 0.273 0 O-C-N 124.042 0.839 . . . . 0.0 110.587 -174.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -150.3 6.95 0.71 Allowed Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.903 179.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 6.0 mt -116.85 147.44 20.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 117.104 0.452 . . . . 0.0 109.874 -179.319 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.538 HG21 ' HG ' ' A' ' 43' ' ' LEU . 25.5 t -94.08 114.8 31.44 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.294 -177.658 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 28.5 m -91.03 -30.0 4.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.594 -0.276 . . . . 0.0 111.47 -177.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -148.69 145.48 27.71 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 -178.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 58.3 m -137.51 114.39 10.61 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.909 -176.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -126.18 105.55 8.92 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.06 0.457 . . . . 0.0 110.24 -177.591 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.469 ' HA ' ' HA ' ' A' ' 39' ' ' ASN . 15.2 m -74.18 131.06 40.9 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.934 178.391 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.408 ' O ' ' HA ' ' A' ' 37' ' ' SER . 44.6 t -92.57 139.23 18.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 116.263 -0.426 . . . . 0.0 109.892 -179.146 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 18.6 m -59.55 -53.67 55.42 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.11 -0.495 . . . . 0.0 112.132 -177.038 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 35.3 t -176.81 149.95 0.77 Allowed 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -177.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.543 HD13 ' OG1' ' A' ' 63' ' ' THR . 25.2 tp -133.84 133.34 41.46 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.135 0.493 . . . . 0.0 110.424 178.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -89.79 174.62 7.61 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.775 -176.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 3.7 p -69.57 129.18 38.96 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.151 -179.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 50.5 mm-40 66.33 15.63 10.16 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.166 177.09 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -104.21 154.21 20.04 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 -179.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 7.3 m -113.1 143.73 43.84 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.829 0.347 . . . . 0.0 110.774 -178.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.543 ' OG1' HD13 ' A' ' 57' ' ' LEU . 95.6 m -128.86 127.91 42.8 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.078 174.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 40.1 m-80 -90.89 124.96 35.59 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.179 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.509 HG22 HG11 ' A' ' 40' ' ' VAL . 39.2 t -96.19 132.1 41.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.069 -178.335 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -101.81 97.3 7.7 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.525 -174.142 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.51 ' HB2' ' HB2' ' A' ' 23' ' ' MET . 32.2 m-85 -96.01 144.73 26.04 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.179 0.514 . . . . 0.0 111.302 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 15.9 m-70 -116.32 103.0 10.04 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.937 179.127 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . 0.402 ' CE2' HD21 ' A' ' 71' ' ' LEU . 11.3 t90 -116.51 111.2 19.61 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.516 -176.462 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.475 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 6.7 m -80.46 108.17 13.87 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.319 178.459 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.518 HD23 ' OD1' ' A' ' 21' ' ' ASN . 0.2 OUTLIER -69.25 116.02 9.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.953 0.406 . . . . 0.0 111.065 -178.302 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -84.54 -35.65 22.7 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.575 176.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 90.3 35.17 7.63 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.673 177.456 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 25.5 m -79.59 -38.63 33.53 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.023 0.44 . . . . 0.0 110.768 177.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -126.28 161.15 28.43 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.46 -174.417 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 -91.07 -12.02 36.94 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.461 178.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.491 ' HB2' HD21 ' A' ' 103' ' ' LEU . 28.4 p -147.34 137.83 23.37 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.363 177.685 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 40.3 m-85 -125.73 134.03 51.9 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.144 -178.212 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 21.4 m -89.53 92.92 9.3 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 120.927 0.394 . . . . 0.0 110.059 178.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.445 HD11 HG23 ' A' ' 104' ' ' VAL . 9.0 mp -88.37 137.92 31.9 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.194 0.521 . . . . 0.0 110.607 -179.445 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.409 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 19.1 m -131.44 114.56 15.08 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.428 -179.412 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.519 ' HB ' ' HB3' ' A' ' 100' ' ' LEU . 61.8 t -88.39 105.24 15.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 175.101 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -94.61 110.45 22.27 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.006 0.432 . . . . 0.0 110.104 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.506 HG22 ' HD3' ' A' ' 7' ' ' PRO . 85.6 t -83.19 114.47 24.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.341 -177.697 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.474 ' HB2' ' HB2' ' A' ' 38' ' ' PHE . 39.8 t0 58.74 73.66 0.69 Allowed Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 114.232 -1.349 . . . . 0.0 112.089 177.759 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.466 ' HD2' ' HB3' ' A' ' 39' ' ' ASN . 6.6 Cg_exo -74.19 -18.08 21.22 Favored 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 122.758 2.305 . . . . 0.0 111.141 176.301 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -87.77 -13.1 43.23 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.384 -177.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 62.79 45.62 5.62 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.194 177.616 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -77.12 -22.7 52.27 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.316 178.37 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 13.5 t -119.16 143.35 30.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.961 178.153 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 43.0 t-20 -89.54 105.38 17.76 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 178.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -98.82 147.21 25.14 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -174.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -57.76 -101.1 0.01 OUTLIER Glycine 0 CA--C 1.518 0.243 0 CA-C-N 114.965 -1.016 . . . . 0.0 113.195 174.124 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -73.92 106.54 5.68 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.929 0.395 . . . . 0.0 111.363 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.576 ' HA ' ' OD1' ' A' ' 98' ' ' ASN . 40.8 mt-10 -68.37 -11.71 60.0 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.089 179.418 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 8.1 m -70.82 -7.79 47.83 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.93 177.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.47 ' O ' ' HD2' ' A' ' 7' ' ' PRO . 88.6 m-20 -97.27 -21.73 17.09 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.139 -178.652 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.576 ' OD1' ' HA ' ' A' ' 95' ' ' GLU . 14.3 m120 -59.3 -34.89 72.85 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -172.234 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.49 125.0 49.8 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.258 0.551 . . . . 0.0 112.019 -178.073 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.519 ' HB3' ' HB ' ' A' ' 82' ' ' VAL . 28.5 tp -107.33 98.12 7.79 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.371 175.334 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 20.0 m -90.96 94.66 9.74 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.234 0.54 . . . . 0.0 110.105 -179.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -112.62 112.29 23.71 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.212 -178.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.491 HD21 ' HB2' ' A' ' 77' ' ' SER . 5.9 tt -80.86 104.29 11.27 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 179.681 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.445 HG23 HD11 ' A' ' 80' ' ' LEU . 18.3 m -93.83 149.86 4.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.655 -177.818 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.51 ' O ' ' HA ' ' A' ' 14' ' ' THR . . . -119.72 170.95 14.25 Favored Glycine 0 N--CA 1.443 -0.876 0 C-N-CA 119.941 -1.123 . . . . 0.0 111.876 -176.726 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 42.5 p -89.5 130.22 35.87 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 173.286 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.757 HD21 ' HB2' ' A' ' 110' ' ' HIS . 17.9 tp -56.64 130.22 44.35 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 -175.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -82.17 -55.04 4.79 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.666 -0.414 . . . . 0.0 111.666 -170.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 10.4 t-160 -69.26 -19.33 63.93 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 120.891 0.377 . . . . 0.0 111.137 -177.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . 0.757 ' HB2' HD21 ' A' ' 107' ' ' LEU . 5.3 m-70 -128.15 81.85 2.05 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 169.535 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . 0.611 ' O ' ' HD2' ' A' ' 17' ' ' PRO . 0.8 OUTLIER -92.8 -73.55 0.55 Allowed 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.759 -0.377 . . . . 0.0 111.612 -169.1 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 56.0 t60 -105.2 83.87 2.03 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 119.852 -0.739 . . . . 0.0 110.607 -179.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 43.5 t-80 -79.64 149.47 31.29 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.601 176.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 16.6 p-80 . . . . . 0 C--O 1.244 0.802 0 CA-C-O 118.593 -0.718 . . . . 0.0 109.627 174.235 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 83.0 mmm . . . . . 0 N--CA 1.478 0.928 0 CA-C-O 121.079 0.466 . . . . 0.0 110.106 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.445 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 0.8 OUTLIER -114.48 142.36 28.03 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.455 179.286 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.446 ' HD2' ' O ' ' A' ' 91' ' ' ASN . 12.9 Cg_endo -91.05 156.89 3.9 Favored 'Trans proline' 0 N--CA 1.445 -1.36 0 C-N-CA 122.883 2.388 . . . . 0.0 111.024 172.196 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -137.39 105.23 5.61 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 -179.126 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.507 HD21 HD21 ' A' ' 57' ' ' LEU . 27.4 mt -99.78 126.69 45.89 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 -171.145 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.521 HG21 ' HB3' ' A' ' 97' ' ' ASN . 4.6 t -125.42 140.29 35.94 Favored Pre-proline 0 C--N 1.317 -0.845 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.444 -176.52 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.459 ' HB2' ' HB2' ' A' ' 100' ' ' LEU . 6.8 Cg_endo -92.79 100.72 0.17 Allowed 'Trans proline' 0 N--CA 1.445 -1.375 0 C-N-CA 123.13 2.553 . . . . 0.0 110.054 167.514 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 27.4 m -79.53 -28.86 13.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.811 -171.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 35.4 t -156.67 147.54 21.86 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.772 0.32 . . . . 0.0 110.888 -176.452 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.509 HD13 ' HB3' ' A' ' 23' ' ' MET . 19.4 tp -127.68 126.14 41.38 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 171.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.537 ' OG1' ' HA ' ' A' ' 12' ' ' PRO . 6.5 t -122.26 152.05 60.01 Favored Pre-proline 0 C--N 1.317 -0.835 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.912 178.278 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.628 ' HD2' ' SD ' ' A' ' 23' ' ' MET . 98.5 Cg_endo -80.92 149.92 77.75 Favored 'Cis proline' 0 N--CA 1.46 -0.467 0 C-N-CA 123.483 -1.465 . . . . 0.0 112.492 -3.54 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 35.3 m -69.09 -21.57 25.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.059 177.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.55 ' HA ' ' O ' ' A' ' 105' ' ' GLY . 0.7 OUTLIER -124.71 131.19 53.48 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.152 174.288 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.0 m -114.56 149.2 16.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 121.04 0.448 . . . . 0.0 111.789 -174.381 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.9 m -98.34 117.69 64.44 Favored Pre-proline 0 N--CA 1.447 -0.577 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.346 178.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.535 ' HA ' ' HB3' ' A' ' 71' ' ' LEU . 10.0 Cg_exo -71.06 91.31 0.64 Allowed 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 122.597 2.198 . . . . 0.0 110.443 173.139 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -163.23 -41.6 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.216 -171.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 13.5 t -145.73 -170.23 3.42 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.001 -172.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.415 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 62.1 t -84.34 116.51 28.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 172.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.583 ' OD1' HD23 ' A' ' 71' ' ' LEU . 9.2 m120 -91.47 118.44 30.56 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.636 -174.177 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.62 ' HA ' ' O ' ' A' ' 67' ' ' PHE . 58.7 m -80.6 96.26 6.79 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-O 121.319 0.581 . . . . 0.0 109.873 177.34 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.628 ' SD ' ' HD2' ' A' ' 12' ' ' PRO . 93.3 mmm -79.14 126.56 30.89 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.478 -176.154 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.478 ' HA ' ' O ' ' A' ' 65' ' ' VAL . 17.5 m -105.07 112.34 25.44 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.975 0.416 . . . . 0.0 111.36 -176.208 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -104.15 130.41 51.89 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.012 176.275 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 23.7 m -95.8 108.34 20.67 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 120.695 0.283 . . . . 0.0 110.431 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.417 ' O ' ' HA ' ' A' ' 62' ' ' SER . 19.7 mm -100.06 119.95 48.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.863 -179.668 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -115.18 136.22 53.34 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.249 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 32.9 t30 -91.89 99.96 12.72 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.305 178.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -99.35 45.97 0.98 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.835 -175.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -144.01 160.08 27.73 Favored Glycine 0 N--CA 1.449 -0.463 0 N-CA-C 111.533 -0.627 . . . . 0.0 111.533 179.32 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -87.33 56.3 3.91 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.232 0.539 . . . . 0.0 110.924 -174.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.9 tptp -161.64 139.94 9.34 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 174.233 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -76.3 149.73 37.03 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 174.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.3 p -120.49 140.63 51.15 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.929 0.395 . . . . 0.0 110.498 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 3.9 p -91.84 -163.29 1.02 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.017 -178.278 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.552 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 48.5 m -49.03 115.6 1.35 Allowed 'General case' 0 C--O 1.234 0.276 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -179.482 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.426 ' CE2' HG23 ' A' ' 40' ' ' VAL . 30.4 p90 -130.57 149.52 52.2 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.12 177.632 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 11.8 m-80 -98.46 108.6 21.33 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.296 -172.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.426 HG23 ' CE2' ' A' ' 38' ' ' PHE . 2.3 t -98.32 117.88 43.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.401 0.62 . . . . 0.0 110.492 178.333 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 16.9 m -108.28 146.59 32.66 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.957 -176.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.419 HD11 ' HB3' ' A' ' 80' ' ' LEU . 47.6 tp -106.82 113.89 27.65 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 174.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.524 ' HG ' HG22 ' A' ' 48' ' ' VAL . 4.8 mp -101.07 121.01 41.03 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.277 -179.552 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 98.0 t -100.54 102.2 13.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 178.166 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 60.75 17.25 7.45 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.708 178.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 128.38 -34.45 2.92 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.943 176.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 11.5 mm -89.99 150.33 3.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.945 0.372 . . . . 0.0 110.209 -176.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.524 HG22 ' HG ' ' A' ' 43' ' ' LEU . 52.4 t -96.98 112.21 28.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 -179.375 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 24.3 m -86.01 -32.85 7.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.382 -177.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 38.4 t0 -159.68 162.32 35.06 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 120.889 0.376 . . . . 0.0 110.645 -178.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 85.0 m -149.81 129.86 13.52 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.785 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -117.69 118.82 33.14 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 110.175 -0.306 . . . . 0.0 110.175 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 27.6 m -74.86 108.35 7.54 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.034 175.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.552 ' O ' ' HA ' ' A' ' 37' ' ' SER . 40.3 t -77.53 128.37 38.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 178.196 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 7.3 m -57.44 -50.14 73.99 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 123.333 0.395 . . . . 0.0 111.763 -173.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 45.7 m -170.8 151.19 3.38 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 -177.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.507 HD21 HD21 ' A' ' 5' ' ' LEU . 23.8 tp -136.97 112.35 9.23 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.145 0.498 . . . . 0.0 110.364 177.73 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 23.9 mm-40 -76.28 174.38 10.24 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.889 -177.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 24.2 m -67.4 129.15 39.0 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.969 -179.069 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.449 ' O ' ' HG2' ' A' ' 60' ' ' GLU . 37.0 tt0 69.61 10.21 7.53 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.136 178.322 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 58.5 t30 -93.34 146.24 23.87 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.542 -0.463 . . . . 0.0 109.839 178.523 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.417 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 9.3 m -119.07 131.43 55.94 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.738 177.631 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.503 HG21 HG11 ' A' ' 54' ' ' VAL . 9.3 t -114.56 139.84 49.26 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.957 0.408 . . . . 0.0 110.42 179.014 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -92.2 114.06 26.5 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.146 178.218 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.478 ' O ' ' HA ' ' A' ' 24' ' ' THR . 10.0 t -96.4 122.88 48.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.582 -179.581 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.581 ' HB3' ' CG2' ' A' ' 22' ' ' THR . 17.3 m-20 -111.78 109.44 19.27 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.012 0.434 . . . . 0.0 110.862 -176.217 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.62 ' O ' ' HA ' ' A' ' 22' ' ' THR . 61.7 m-85 -91.5 163.93 13.98 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.372 -175.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 17.4 m80 -111.92 93.43 4.45 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.34 177.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 15.4 t90 -113.53 110.56 20.46 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.068 0.461 . . . . 0.0 110.679 -176.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.415 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 22.0 m -81.41 112.44 18.68 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.913 176.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.583 HD23 ' OD1' ' A' ' 21' ' ' ASN . 0.3 OUTLIER -71.6 119.52 15.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.121 0.486 . . . . 0.0 111.503 -177.317 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 24.5 p-10 -83.32 -33.58 25.87 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.612 175.209 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 77.38 29.62 55.63 Favored Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.87 174.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 25.6 m -80.05 -51.33 9.16 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.011 0.434 . . . . 0.0 110.501 179.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -105.85 148.29 27.73 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.302 179.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 -86.43 -9.19 56.78 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.877 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 24.4 t -137.54 119.51 15.37 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.067 179.37 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -116.58 150.37 38.13 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.956 178.264 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 26.0 m -101.36 89.73 3.86 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.012 179.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.426 HD11 HG21 ' A' ' 104' ' ' VAL . 9.2 mp -87.72 114.05 23.96 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.472 0.653 . . . . 0.0 110.493 -178.399 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.558 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 27.1 m -111.69 120.8 43.27 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.381 -177.84 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.446 ' HB ' ' HB3' ' A' ' 100' ' ' LEU . 61.8 t -89.64 103.21 13.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 176.374 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -95.83 114.04 25.74 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 178.234 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 95.7 t -81.02 104.21 9.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.129 -178.48 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.7 t70 53.49 90.85 0.08 OUTLIER Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 114.278 -1.328 . . . . 0.0 112.899 177.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -79.22 16.31 1.39 Allowed 'Trans proline' 0 N--CA 1.463 -0.323 0 C-N-CA 123.316 2.677 . . . . 0.0 111.935 177.446 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -116.18 -17.17 10.89 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.264 -177.622 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 12.2 m120 62.94 48.99 3.68 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.587 -178.009 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -66.5 -33.0 74.72 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.404 0.621 . . . . 0.0 109.752 174.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 4.1 t -107.53 169.26 2.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 174.389 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.446 ' O ' ' HD2' ' A' ' 3' ' ' PRO . 65.1 t30 -106.13 93.29 4.54 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 175.778 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 14.9 mp0 -76.51 149.7 36.7 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.772 -173.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -57.41 -100.85 0.01 OUTLIER Glycine 0 CA--C 1.522 0.5 0 CA-C-N 114.655 -1.157 . . . . 0.0 113.472 170.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 16.7 m-80 -84.71 130.72 34.66 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 122.758 -0.26 . . . . 0.0 111.351 -173.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -64.14 -32.12 73.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.076 0.465 . . . . 0.0 110.515 177.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 49.3 m -59.54 -29.41 67.88 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.82 176.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.521 ' HB3' HG21 ' A' ' 6' ' ' VAL . 7.0 m-20 -84.58 -13.25 52.26 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.913 -175.391 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -73.65 -10.67 59.93 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.011 178.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 3.7 p -130.8 125.13 32.93 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -173.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.558 ' O ' ' HA ' ' A' ' 81' ' ' THR . 46.1 tp -108.63 102.41 11.47 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.879 169.88 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 21.8 m -85.11 95.32 9.09 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 175.246 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -111.33 119.72 39.82 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.618 -177.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 41.9 mt -82.43 114.99 21.25 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.389 0.614 . . . . 0.0 110.324 176.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.426 HG21 HD11 ' A' ' 80' ' ' LEU . 27.4 m -108.13 140.05 28.03 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.319 178.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.55 ' O ' ' HA ' ' A' ' 14' ' ' THR . . . -116.75 165.35 12.33 Favored Glycine 0 N--CA 1.438 -1.199 0 C-N-CA 120.182 -1.009 . . . . 0.0 111.149 -178.346 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 27.0 p -72.35 137.25 46.48 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 175.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.513 ' HG ' ' H ' ' A' ' 109' ' ' HIS . 49.8 tp -59.31 147.24 36.66 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.917 0.389 . . . . 0.0 110.584 -177.73 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.429 ' O ' ' HB3' ' A' ' 109' ' ' HIS . 34.2 mt-10 -58.48 -34.15 70.57 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.079 -178.431 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . 0.513 ' H ' ' HG ' ' A' ' 107' ' ' LEU . 86.0 t60 69.31 13.77 8.52 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 122.132 0.968 . . . . 0.0 109.197 -179.499 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 21.2 m170 -105.98 140.19 39.36 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.03 -0.986 . . . . 0.0 109.149 179.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 8.8 m-70 -80.13 -10.2 59.75 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.194 0.521 . . . . 0.0 110.467 179.292 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 20.8 m170 -105.13 90.12 3.34 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 167.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 65.7 t-80 -80.53 150.01 29.77 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.628 -173.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 70.6 m80 . . . . . 0 C--O 1.245 0.864 0 CA-C-O 118.91 -0.567 . . . . 0.0 109.585 174.59 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.447 ' O ' ' HD2' ' A' ' 33' ' ' LYS . 58.7 mtm . . . . . 0 N--CA 1.479 1.002 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 7.6 tp -114.46 142.58 28.37 Favored Pre-proline 0 C--N 1.321 -0.662 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 -179.21 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.53 ' HD3' ' HD3' ' A' ' 33' ' ' LYS . 5.4 Cg_exo -75.44 157.08 41.1 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.346 2.031 . . . . 0.0 111.143 174.379 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -140.13 102.76 4.45 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 178.067 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.506 HD21 HD23 ' A' ' 57' ' ' LEU . 25.4 mt -99.74 126.72 45.85 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -172.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.484 ' O ' ' HA ' ' A' ' 27' ' ' ILE . 8.3 t -125.22 140.23 35.61 Favored Pre-proline 0 C--N 1.313 -1.002 0 C-N-CA 119.865 -0.734 . . . . 0.0 110.635 -175.182 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.515 ' HG2' ' HB2' ' A' ' 100' ' ' LEU . 11.8 Cg_endo -96.99 110.05 0.1 Allowed 'Trans proline' 0 N--CA 1.447 -1.212 0 C-N-CA 123.672 2.915 . . . . 0.0 110.478 169.398 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 19.3 m -86.5 -39.14 13.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -169.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 51.0 m -156.37 161.17 40.16 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.723 0.297 . . . . 0.0 111.099 -178.327 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.411 HD12 ' HB3' ' A' ' 23' ' ' MET . 26.9 tp -127.61 126.49 42.16 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 172.403 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.491 HG23 ' HB ' ' A' ' 24' ' ' THR . 0.7 OUTLIER -122.6 131.73 24.35 Favored Pre-proline 0 C--N 1.318 -0.773 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.978 177.101 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.522 ' HD2' ' SD ' ' A' ' 23' ' ' MET . 90.4 Cg_endo -95.2 145.76 7.99 Favored 'Cis proline' 0 N--CA 1.449 -1.125 0 C-N-CA 123.789 -1.338 . . . . 0.0 113.345 5.114 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.423 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 35.4 m -67.37 -18.04 23.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.435 175.713 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.27 151.19 39.53 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 175.645 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 16.4 m -142.93 157.17 17.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.308 0.575 . . . . 0.0 111.346 -174.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.439 ' HA ' ' HD3' ' A' ' 17' ' ' PRO . 14.4 t -99.32 131.95 24.18 Favored Pre-proline 0 C--N 1.321 -0.663 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.647 -175.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 16' ' ' VAL . 1.6 Cg_endo -84.13 18.23 1.57 Allowed 'Trans proline' 0 CA--C 1.529 0.264 0 C-N-CA 122.786 2.324 . . . . 0.0 112.856 179.244 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 56.0 m-20 -106.67 -22.91 12.6 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.669 0.271 . . . . 0.0 111.583 -174.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 8.9 t -145.54 178.23 8.28 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.136 -173.029 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.596 HG21 HG21 ' A' ' 70' ' ' THR . 51.5 t -73.29 141.89 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 172.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.653 ' ND2' HD21 ' A' ' 71' ' ' LEU . 39.7 m-80 -114.41 132.76 56.12 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.361 -173.433 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.7 m -108.19 118.88 37.9 Favored 'General case' 0 N--CA 1.437 -1.089 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 -175.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.522 ' SD ' ' HD2' ' A' ' 12' ' ' PRO . 87.2 mmm -108.93 122.99 48.39 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 113.938 -1.483 . . . . 0.0 109.855 -165.402 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.624 ' HA ' ' O ' ' A' ' 65' ' ' VAL . 17.0 m -111.99 124.44 52.4 Favored 'General case' 0 C--N 1.309 -1.152 0 CA-C-O 121.854 0.835 . . . . 0.0 109.765 -173.749 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -119.16 132.1 55.94 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 114.221 -1.354 . . . . 0.0 108.522 -175.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 19.5 m -112.35 121.01 43.65 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 121.714 0.769 . . . . 0.0 109.61 -171.063 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.484 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 8.7 mm -116.9 131.92 68.16 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 CA-C-N 114.314 -1.312 . . . . 0.0 109.236 -172.325 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -121.0 138.64 54.06 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 178.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.466 ' HB2' ' HG ' ' A' ' 57' ' ' LEU . 39.1 t30 -93.84 98.12 10.86 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 175.168 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 69.5 mt-30 -102.25 47.1 0.9 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.329 -173.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -144.18 154.65 25.83 Favored Glycine 0 N--CA 1.445 -0.743 0 N-CA-C 110.488 -1.045 . . . . 0.0 110.488 177.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -82.84 53.79 2.51 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.392 0.615 . . . . 0.0 111.466 -174.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.53 ' HD3' ' HD3' ' A' ' 3' ' ' PRO . 87.9 tttt -161.47 136.47 7.4 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 171.5 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -80.34 135.37 36.18 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 120.978 0.418 . . . . 0.0 110.756 -175.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 35.8 t -95.85 142.62 27.89 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.56 178.195 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.2 m -99.29 -129.57 0.2 Allowed 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.348 -179.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.59 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 48.5 m -82.85 108.8 16.45 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.027 0.441 . . . . 0.0 111.624 -173.641 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.527 ' HB2' ' HB2' ' A' ' 85' ' ' ASP . 52.9 p90 -122.38 146.01 47.73 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.014 177.196 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.478 ' O ' ' HA ' ' A' ' 85' ' ' ASP . 22.0 m-80 -92.56 110.58 22.01 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.794 -174.333 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -98.35 127.11 51.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 -178.46 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 37.0 m -118.72 141.65 48.41 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.297 -174.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 56.4 tp -100.24 111.51 23.79 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.575 173.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.456 ' HG ' HG22 ' A' ' 48' ' ' VAL . 4.9 mp -102.06 124.86 48.4 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.592 -178.031 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.501 HG11 ' HB3' ' A' ' 78' ' ' TYR . 86.2 t -93.68 95.96 5.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 175.485 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 64.03 5.66 2.5 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.96 -179.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 140.56 -34.99 1.92 Allowed Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.406 179.057 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.417 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 9.5 mt -82.36 147.93 5.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 -179.14 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.456 HG22 ' HG ' ' A' ' 43' ' ' LEU . 36.1 t -99.79 119.68 48.17 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.442 -176.724 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 20.3 m -97.6 -27.22 3.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 111.887 0.329 . . . . 0.0 111.887 -177.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 42.2 t0 -162.29 136.49 6.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.655 0.264 . . . . 0.0 110.332 -178.507 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 86.2 m -124.81 122.38 37.27 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.185 179.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -115.11 117.99 32.11 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 -178.445 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.435 ' HA ' ' HA ' ' A' ' 39' ' ' ASN . 22.7 m -82.86 111.18 18.51 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.327 -179.86 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.59 ' O ' ' HA ' ' A' ' 37' ' ' SER . 59.1 t -77.68 123.12 33.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 179.206 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.4 m -58.43 -39.97 81.24 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.727 -0.669 . . . . 0.0 112.128 -173.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 46.7 t -173.31 143.75 1.12 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.834 0.35 . . . . 0.0 110.486 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.506 HD23 HD21 ' A' ' 5' ' ' LEU . 23.5 tp -126.86 104.31 7.97 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.339 0.59 . . . . 0.0 109.532 175.246 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -70.75 160.68 32.24 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.525 -175.212 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 11.8 m -61.36 120.31 10.19 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.63 179.153 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 70.27 17.34 7.11 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 123.805 0.69 . . . . 0.0 110.889 -179.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -102.1 157.73 16.67 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 173.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 26.3 t -127.61 143.36 51.17 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.119 0.485 . . . . 0.0 110.71 -178.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 91.1 m -124.84 130.52 52.54 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.63 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 37.1 m-80 -101.19 117.7 35.52 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.943 177.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.624 ' O ' ' HA ' ' A' ' 24' ' ' THR . 3.7 t -102.82 125.16 57.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.911 -175.32 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -102.4 112.62 25.42 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.792 0.33 . . . . 0.0 110.914 178.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -91.62 159.01 16.1 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.953 179.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 15.8 m80 -108.64 109.74 21.02 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.727 -179.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 16.2 t90 -131.35 108.16 9.45 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.319 0.581 . . . . 0.0 111.404 -175.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.596 HG21 HG21 ' A' ' 20' ' ' VAL . 5.6 m -85.4 122.14 29.13 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.886 175.784 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.653 HD21 ' ND2' ' A' ' 21' ' ' ASN . 0.2 OUTLIER -72.3 122.33 20.94 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.19 0.519 . . . . 0.0 111.021 -177.633 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 24.2 p-10 -90.3 -41.62 11.44 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.436 179.058 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 99.07 23.62 11.27 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.81 -0.71 . . . . 0.0 113.204 175.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 92.6 m -74.96 -41.19 60.08 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.023 0.439 . . . . 0.0 110.583 177.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -128.33 162.31 27.37 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.372 178.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -100.71 -6.77 24.57 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.224 0.535 . . . . 0.0 110.183 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 22.7 t -146.95 112.26 5.53 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.508 177.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.501 ' HB3' HG11 ' A' ' 44' ' ' VAL . 83.2 m-85 -105.76 150.21 25.73 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.315 177.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.1 m -93.95 86.97 5.2 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 178.081 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.485 HD21 HG23 ' A' ' 104' ' ' VAL . 6.4 mp -81.43 114.32 20.1 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.714 0.769 . . . . 0.0 110.349 -177.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.504 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 7.3 m -116.94 117.8 30.69 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.475 -175.003 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 46.3 t -85.56 108.04 16.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 176.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.557 ' HA ' ' O ' ' A' ' 98' ' ' ASN . 6.3 t30 -101.64 116.69 33.3 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 178.696 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 58.2 t -82.64 104.42 11.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 115.615 -0.721 . . . . 0.0 111.214 -177.236 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.527 ' HB2' ' HB2' ' A' ' 38' ' ' PHE . 7.3 t70 54.5 89.66 0.1 Allowed Pre-proline 0 N--CA 1.468 0.47 0 CA-C-N 114.234 -1.348 . . . . 0.0 112.308 179.105 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -62.59 -24.43 75.1 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 123.29 2.66 . . . . 0.0 112.215 179.276 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 50.8 mm-40 -75.93 -28.81 58.13 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.812 177.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 56.2 53.84 8.47 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.812 -1.085 . . . . 0.0 109.807 -175.31 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -74.13 -25.04 59.54 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.865 -1.061 . . . . 0.0 109.706 178.24 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 17.3 t -108.31 97.49 5.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.213 -0.903 . . . . 0.0 108.897 174.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -61.15 134.31 56.89 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 -178.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.419 ' HA ' ' O ' ' A' ' 3' ' ' PRO . 3.0 mt-10 -111.22 166.22 11.27 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.966 -177.279 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -57.93 -101.04 0.01 OUTLIER Glycine 0 N--CA 1.453 -0.188 0 CA-C-N 115.588 -0.733 . . . . 0.0 112.851 174.044 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 28.4 t30 -70.17 100.74 1.72 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.683 -0.258 . . . . 0.0 110.538 179.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -75.9 53.94 0.79 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.211 0.529 . . . . 0.0 111.997 -177.207 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 13.9 t -137.64 16.1 2.91 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 174.102 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 18.1 p-10 -98.8 -27.27 14.02 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 113.58 -1.645 . . . . 0.0 111.746 -172.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.557 ' O ' ' HA ' ' A' ' 83' ' ' ASN . 17.9 m120 -55.13 -34.07 63.43 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 -168.731 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 1.5 p -107.23 123.38 48.21 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 -174.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.515 ' HB2' ' HG2' ' A' ' 7' ' ' PRO . 39.2 tp -107.26 106.63 17.17 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 170.17 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 28.3 m -89.96 102.4 15.11 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.669 -177.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -119.88 116.93 26.84 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.547 179.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 52.3 mt -74.86 119.03 18.49 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.126 175.535 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.485 HG23 HD21 ' A' ' 80' ' ' LEU . 27.6 m -113.1 133.39 59.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.693 178.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -120.9 166.55 13.95 Favored Glycine 0 N--CA 1.442 -0.956 0 C-N-CA 120.432 -0.89 . . . . 0.0 111.671 -176.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 59.3 p -69.09 146.02 52.92 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 177.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 62.4 tp -53.68 104.51 0.1 Allowed 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -172.37 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -82.71 126.5 32.43 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 107.734 -1.209 . . . . 0.0 107.734 171.073 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -71.55 -23.68 61.8 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -167.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 74.7 m80 -85.82 -72.65 0.48 Allowed 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.943 -0.303 . . . . 0.0 111.466 -176.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 18.4 m170 -87.05 122.8 31.37 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.307 0.575 . . . . 0.0 111.286 -174.008 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 5.4 m-70 -116.27 165.27 13.37 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.321 175.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 15.7 t60 -103.16 73.58 1.24 Allowed 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 172.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 66.0 t60 . . . . . 0 C--O 1.249 1.065 0 CA-C-N 115.173 -0.922 . . . . 0.0 109.19 -175.625 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.437 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 16.6 tt . . . . . 0 N--CA 1.451 -0.382 0 N-CA-C 110.301 -0.259 . . . . 0.0 110.301 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.521 ' HB3' ' HB2' ' A' ' 35' ' ' SER . 12.4 Cg_exo -69.84 116.99 4.82 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.17 1.913 . . . . 0.0 111.24 175.344 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -103.16 79.94 1.79 Allowed 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 178.593 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.517 HD22 HD23 ' A' ' 57' ' ' LEU . 61.9 mt -73.27 103.42 3.96 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.775 -173.551 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.548 HG22 ' HB3' ' A' ' 97' ' ' ASN . 47.1 t -114.27 111.4 47.21 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.511 -176.5 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.584 ' HD2' ' O ' ' A' ' 97' ' ' ASN . 18.2 Cg_endo -64.03 107.44 0.78 Allowed 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 122.057 1.838 . . . . 0.0 110.046 167.37 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.0 t -82.51 -55.74 7.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.126 -170.521 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 58.6 p -141.44 158.3 44.04 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.182 -177.41 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.481 HD21 HD23 ' A' ' 80' ' ' LEU . 54.0 tp -130.24 104.42 7.28 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.021 177.787 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 22.0 p -115.02 146.18 35.64 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.216 -175.743 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.403 ' HD2' ' HG2' ' A' ' 23' ' ' MET . 88.1 Cg_endo -78.99 152.64 89.12 Favored 'Cis proline' 0 C--N 1.341 0.183 0 C-N-CA 123.186 -1.589 . . . . 0.0 112.562 -0.795 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.2 m -73.57 -19.77 18.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.045 0.45 . . . . 0.0 111.206 -178.865 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.458 ' HB ' HD13 ' A' ' 107' ' ' LEU . 0.2 OUTLIER -126.37 128.35 46.91 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 177.178 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.468 ' HB ' ' ND2' ' A' ' 21' ' ' ASN . 18.7 m -114.13 140.14 36.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -167.447 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.439 ' HA ' ' HD3' ' A' ' 17' ' ' PRO . 5.8 m -84.17 121.4 75.49 Favored Pre-proline 0 N--CA 1.449 -0.512 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.098 176.765 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 16' ' ' VAL . 4.6 Cg_exo -77.97 55.75 5.42 Favored 'Trans proline' 0 N--CA 1.463 -0.269 0 C-N-CA 123.006 2.471 . . . . 0.0 111.667 176.692 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -122.97 -18.26 6.48 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.161 -0.472 . . . . 0.0 112.042 -176.769 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 14.7 t -157.25 -173.96 4.67 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.736 -0.386 . . . . 0.0 110.938 -171.434 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.402 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 46.7 t -82.32 110.11 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 169.841 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.468 ' ND2' ' HB ' ' A' ' 15' ' ' VAL . 5.1 m-20 -84.38 108.23 17.09 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.309 0.576 . . . . 0.0 110.702 -169.827 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.622 ' HA ' ' O ' ' A' ' 67' ' ' PHE . 11.3 m -79.41 83.44 5.43 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.256 -0.883 . . . . 0.0 109.355 176.341 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' MET . . . . . 0.449 ' O ' ' HA ' ' A' ' 66' ' ' ASP . 82.8 mtp -79.5 152.21 30.34 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.41 -0.813 . . . . 0.0 110.403 -176.692 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 30.8 m -114.11 109.58 18.65 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.065 -175.768 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.441 ' HB3' ' HB ' ' A' ' 65' ' ' VAL . . . -92.14 120.09 32.41 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.548 173.585 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 61.2 m -92.76 101.29 13.68 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-O 121.12 0.486 . . . . 0.0 109.769 -179.638 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 15.3 mm -95.17 118.98 42.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.246 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -113.74 125.15 53.79 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.51 ' HB2' ' HG ' ' A' ' 57' ' ' LEU . 29.6 t30 -81.78 90.03 6.35 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.607 178.604 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -87.11 43.99 1.14 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.559 0.695 . . . . 0.0 110.788 -173.654 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -143.98 145.07 14.37 Favored Glycine 0 N--CA 1.442 -0.956 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 176.568 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -81.17 63.65 5.6 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.526 0.679 . . . . 0.0 111.039 -173.324 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.413 ' HA ' ' HD2' ' A' ' 33' ' ' LYS . 50.6 tptt -161.5 121.31 2.57 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.056 171.481 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -69.06 124.09 22.83 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.985 0.421 . . . . 0.0 110.567 -175.631 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.521 ' HB2' ' HB3' ' A' ' 3' ' ' PRO . 46.4 t -87.7 147.01 25.42 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.19 -174.73 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 21.7 p -86.54 -163.0 0.83 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.444 178.236 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.463 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 15.0 m -61.68 134.09 56.37 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 120.929 0.395 . . . . 0.0 111.338 -179.568 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.52 ' CE1' ' HB ' ' A' ' 54' ' ' VAL . 31.1 p90 -144.9 144.35 31.05 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.294 -177.339 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.515 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 25.7 m-80 -92.62 108.67 20.16 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.219 -174.272 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.452 HG22 ' HA ' ' A' ' 84' ' ' VAL . 2.1 t -98.29 116.75 41.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 121.392 0.615 . . . . 0.0 110.289 178.897 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 46.3 m -109.95 144.14 38.9 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.689 -177.569 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 46.9 tp -98.68 108.66 21.41 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.697 175.038 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.498 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 5.2 mp -98.93 108.45 21.13 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.427 -179.047 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 82.4 t -88.96 101.48 12.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.203 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 60.06 18.43 7.67 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.422 -179.097 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 124.49 -36.04 3.02 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.785 178.078 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.474 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 9.8 mm -79.81 145.55 9.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.905 0.383 . . . . 0.0 110.096 -176.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.42 HG22 ' HG ' ' A' ' 43' ' ' LEU . 40.8 t -96.96 101.75 12.65 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.824 -178.036 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 28.4 m -83.59 -30.78 8.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.615 -175.882 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 33.7 t0 -159.56 141.37 13.19 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.915 -0.314 . . . . 0.0 111.002 -177.425 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 88.6 m -129.07 123.36 32.05 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.308 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -127.3 105.69 8.71 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 -178.758 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.515 ' HA ' ' HA ' ' A' ' 39' ' ' ASN . 7.1 t -74.52 131.02 40.64 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.068 0.461 . . . . 0.0 110.38 178.679 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.52 ' HB ' ' CE1' ' A' ' 38' ' ' PHE . 39.1 t -95.28 138.57 20.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.774 -179.288 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.0 m -55.07 -43.28 73.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.246 -0.434 . . . . 0.0 112.039 -177.058 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 47.7 t -174.76 153.51 1.77 Allowed 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 -175.844 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.517 HD23 HD22 ' A' ' 5' ' ' LEU . 27.6 tp -134.15 109.5 8.95 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.16 0.505 . . . . 0.0 110.066 177.092 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.473 ' HB2' ' HB3' ' A' ' 61' ' ' ASN . 35.9 mt-10 -70.98 158.78 35.92 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.542 -0.754 . . . . 0.0 112.154 -174.278 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 12.3 p -64.12 122.98 17.88 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.095 179.45 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 65.09 20.2 11.98 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.453 179.131 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.473 ' HB3' ' HB2' ' A' ' 58' ' ' GLU . 61.1 t30 -116.62 155.2 29.17 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 176.036 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 2.4 m -115.28 145.66 42.25 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.657 0.265 . . . . 0.0 110.752 -175.764 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 13.3 t -119.2 143.85 47.04 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 175.271 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -96.05 112.03 23.88 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.873 0.368 . . . . 0.0 110.261 178.679 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.441 ' HB ' ' HB3' ' A' ' 25' ' ' ALA . 13.2 t -96.86 118.13 42.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.911 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.452 ' HB2' ' CG2' ' A' ' 22' ' ' THR . 5.3 p-10 -95.13 119.67 34.04 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.512 0.672 . . . . 0.0 110.559 -179.227 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.622 ' O ' ' HA ' ' A' ' 22' ' ' THR . 33.2 m-85 -95.67 146.8 24.22 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.726 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 15.2 m80 -110.73 90.27 3.28 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.663 -0.698 . . . . 0.0 109.485 -178.749 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 12.5 t90 -123.62 113.67 18.99 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.389 0.614 . . . . 0.0 111.416 -172.865 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.402 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 49.7 m -78.22 114.67 17.33 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.351 -0.841 . . . . 0.0 110.282 174.734 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.428 ' CB ' ' HA ' ' A' ' 17' ' ' PRO . 1.0 OUTLIER -63.54 118.78 8.66 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.326 0.584 . . . . 0.0 111.145 178.358 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -83.56 -36.74 23.75 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.03 -178.822 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 83.19 17.91 65.92 Favored Glycine 0 N--CA 1.449 -0.475 0 N-CA-C 110.99 -0.844 . . . . 0.0 110.99 -174.086 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 3.9 p -68.99 -29.75 68.02 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.23 -0.485 . . . . 0.0 111.332 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -145.44 168.86 19.54 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.075 -179.713 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 49.5 m-80 -96.98 -15.09 21.26 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.397 0.618 . . . . 0.0 109.649 178.468 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 20.4 m -131.97 126.6 34.4 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.781 177.812 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -115.12 132.88 56.46 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 177.652 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.48 ' HA ' HD23 ' A' ' 103' ' ' LEU . 4.3 m -90.49 83.66 5.89 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.124 0.488 . . . . 0.0 109.773 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.481 HD23 HD21 ' A' ' 10' ' ' LEU . 7.7 mp -81.41 117.2 21.66 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.515 0.674 . . . . 0.0 110.762 -176.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.562 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 32.7 m -113.85 110.61 20.39 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.545 -177.872 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 60.9 t -85.55 99.69 7.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 176.782 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -95.64 109.38 21.64 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 178.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.483 HG11 ' HB3' ' A' ' 5' ' ' LEU . 83.3 t -75.42 102.96 2.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.445 -179.595 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.0 t70 51.76 82.61 0.24 Allowed Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 114.431 -1.258 . . . . 0.0 111.427 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -64.41 -11.34 27.85 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.871 2.38 . . . . 0.0 111.923 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -87.64 -14.86 38.87 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.081 178.521 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 24.0 m120 56.12 43.47 26.83 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.886 -178.261 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.05 -34.57 77.87 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.384 0.611 . . . . 0.0 110.09 177.337 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 39.5 t -111.42 98.75 7.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 172.276 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -59.06 112.29 1.63 Allowed 'General case' 0 C--O 1.235 0.311 0 O-C-N 123.35 0.406 . . . . 0.0 110.619 -173.527 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.449 ' HA ' ' O ' ' A' ' 3' ' ' PRO . 3.8 mp0 -82.41 166.93 18.98 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.705 -174.007 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -58.05 -100.83 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.395 0 CA-C-N 114.919 -1.037 . . . . 0.0 113.33 176.072 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.418 ' HB3' ' CG ' ' A' ' 97' ' ' ASN . 53.0 t30 -76.21 141.77 41.69 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 122.626 -0.338 . . . . 0.0 110.836 -177.735 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -59.87 -43.1 94.9 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.979 -173.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 20.1 m -89.78 3.22 53.52 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.827 -174.637 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.584 ' O ' ' HD2' ' A' ' 7' ' ' PRO . 5.9 m-20 -85.97 -24.4 26.52 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 -175.286 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.507 ' HA ' ' O ' ' A' ' 5' ' ' LEU . 13.8 p-10 -82.04 -5.34 58.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.007 0.432 . . . . 0.0 111.341 -174.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 4.9 m -116.17 152.27 34.04 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.066 0.46 . . . . 0.0 110.727 -178.358 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.562 ' O ' ' HA ' ' A' ' 81' ' ' THR . 56.0 tp -140.66 103.63 4.56 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.84 179.18 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 15.7 m -98.83 104.5 16.54 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.123 177.889 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -132.48 135.72 46.21 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.895 0.378 . . . . 0.0 111.035 -178.055 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.48 HD23 ' HA ' ' A' ' 79' ' ' THR . 82.4 mt -80.21 127.09 31.94 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.752 177.204 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.442 HG22 HD13 ' A' ' 80' ' ' LEU . 32.7 m -109.13 134.72 50.23 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 172.879 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -105.16 170.92 18.23 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.04 -1.076 . . . . 0.0 111.038 -177.207 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 25.0 p -85.54 125.74 33.32 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 117.485 0.642 . . . . 0.0 109.821 175.436 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.458 HD13 ' HB ' ' A' ' 14' ' ' THR . 30.2 tp . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.608 -174.457 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.449 -0.494 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -83.79 156.84 13.75 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 122.023 1.815 . . . . 0.0 111.175 172.242 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -139.3 113.72 9.01 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 -178.763 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.674 HD22 HD23 ' A' ' 57' ' ' LEU . 31.5 mt -99.83 126.88 46.0 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -173.079 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.539 ' O ' ' HA ' ' A' ' 27' ' ' ILE . 8.4 t -124.91 140.22 35.3 Favored Pre-proline 0 C--N 1.318 -0.787 0 C-N-CA 120.341 -0.544 . . . . 0.0 110.263 -176.061 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.47 ' HB2' ' HB2' ' A' ' 100' ' ' LEU . 12.2 Cg_endo -96.52 98.18 0.09 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.57 0 C-N-CA 123.548 2.832 . . . . 0.0 109.733 167.05 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 26.2 m -80.37 -28.26 11.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.53 -167.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.3 t -165.71 158.9 15.76 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-O 120.816 0.341 . . . . 0.0 111.166 -177.083 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 29.9 tp -127.6 126.58 42.34 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.298 175.285 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.44 ' HA ' ' HA ' ' A' ' 12' ' ' PRO . 62.5 p -122.21 131.53 24.39 Favored Pre-proline 0 C--N 1.319 -0.718 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.587 179.46 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.672 ' HD2' ' SD ' ' A' ' 23' ' ' MET . 95.8 Cg_endo -92.02 175.01 17.81 Favored 'Cis proline' 0 N--CA 1.455 -0.753 0 C-N-CA 123.742 -1.357 . . . . 0.0 112.947 1.917 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 17.6 m -91.13 -10.42 9.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-O 121.347 0.594 . . . . 0.0 110.599 178.507 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.54 ' HA ' ' O ' ' A' ' 105' ' ' GLY . 0.8 OUTLIER -120.05 151.14 39.45 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.155 174.574 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 17.1 m -143.06 157.25 17.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.217 0.532 . . . . 0.0 111.788 -176.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.761 HG12 ' H ' ' A' ' 18' ' ' ASN . 21.8 t -99.27 132.05 24.05 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.454 -0.793 . . . . 0.0 110.287 179.092 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.441 ' HA ' ' HG ' ' A' ' 71' ' ' LEU . 95.9 Cg_endo -92.62 11.3 2.2 Favored 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 122.834 2.356 . . . . 0.0 112.65 177.085 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.761 ' H ' HG12 ' A' ' 16' ' ' VAL . 66.6 m-20 -100.6 -14.26 18.25 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.141 -175.15 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 9.1 t -158.75 173.7 16.15 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 -175.309 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 54.9 t -69.54 133.1 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 CA-C-O 121.64 0.733 . . . . 0.0 109.752 176.468 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.444 HD22 ' HE3' ' A' ' 69' ' ' TRP . 2.5 p-10 -114.22 133.47 55.6 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 114.638 -1.165 . . . . 0.0 108.927 -176.013 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 18.1 m -107.8 118.76 37.57 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-O 122.444 1.116 . . . . 0.0 108.693 -170.053 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' MET . . . . . 0.672 ' SD ' ' HD2' ' A' ' 12' ' ' PRO . 97.3 mmm -109.04 123.49 49.23 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 112.868 -1.969 . . . . 0.0 110.794 -162.712 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 23.2 m -111.91 124.57 52.67 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 121.865 0.841 . . . . 0.0 109.793 -176.485 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -119.39 132.52 55.85 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.075 -1.42 . . . . 0.0 108.445 -175.63 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 45.4 m -112.31 121.01 43.68 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 121.93 0.871 . . . . 0.0 110.064 -168.777 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.539 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 9.4 mm -116.53 120.02 63.7 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 CA-C-N 114.001 -1.454 . . . . 0.0 109.123 -172.151 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -118.79 128.69 54.71 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 -177.523 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 31.2 t30 -83.82 95.04 8.33 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 177.227 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -95.51 57.15 1.89 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.183 -174.492 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -144.1 168.07 26.66 Favored Glycine 0 N--CA 1.442 -0.928 0 CA-C-N 114.879 -1.055 . . . . 0.0 110.669 178.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 44.8 m-80 -75.71 -21.34 57.64 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 111.77 0.285 . . . . 0.0 111.77 -174.372 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 61.7 tttp -101.32 138.55 38.19 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.944 0.402 . . . . 0.0 111.029 -177.346 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -76.99 140.05 40.28 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.745 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 13.9 p -105.74 155.76 18.96 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.03 0.443 . . . . 0.0 111.65 -175.746 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 12.6 p -99.1 -161.56 0.88 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.258 -177.017 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 9.8 m -53.76 136.3 40.07 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 122.656 0.383 . . . . 0.0 111.638 178.563 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.506 ' CE1' ' HB2' ' A' ' 57' ' ' LEU . 18.2 p90 -149.44 147.04 27.77 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 177.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.579 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 42.4 t-20 -101.2 125.46 47.82 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.439 0.162 . . . . 0.0 110.673 -176.137 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.53 HG22 ' HA ' ' A' ' 84' ' ' VAL . 2.7 t -111.28 127.02 68.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 121.185 0.517 . . . . 0.0 110.013 -179.198 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 19.5 m -119.88 144.08 47.59 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.662 -177.155 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 58.3 tp -100.11 112.7 25.0 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.874 178.187 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.429 ' HG ' HG22 ' A' ' 48' ' ' VAL . 5.0 mp -101.57 121.74 42.54 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.834 -178.592 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 89.1 t -97.27 115.33 36.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 172.809 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 25.5 t70 67.98 -75.02 0.07 Allowed 'General case' 0 N--CA 1.469 0.509 0 O-C-N 123.736 0.648 . . . . 0.0 110.739 -174.855 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -158.89 17.22 0.26 Allowed Glycine 0 N--CA 1.448 -0.554 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.8 178.072 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 9.9 mt -123.64 149.83 27.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.429 HG22 ' HG ' ' A' ' 43' ' ' LEU . 40.0 t -93.33 122.43 44.82 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 -177.614 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 26.5 m -96.95 -28.99 3.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.351 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 37.2 t0 -149.53 151.21 33.51 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 120.768 0.318 . . . . 0.0 110.441 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 21.9 m -144.13 121.84 11.88 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.954 -174.477 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -135.45 125.11 25.27 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.779 0.323 . . . . 0.0 110.555 -179.229 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.579 ' HA ' ' HA ' ' A' ' 39' ' ' ASN . 23.8 m -85.5 122.78 30.12 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.252 177.736 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 20.1 t -86.59 136.38 23.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 -179.506 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 14.6 m -55.28 -51.81 65.47 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 123.494 0.496 . . . . 0.0 111.844 -176.182 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 8.4 t -176.87 130.86 0.18 Allowed 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.674 HD23 HD22 ' A' ' 5' ' ' LEU . 21.1 tp -96.1 112.64 24.31 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.322 0.582 . . . . 0.0 110.088 177.442 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.41 ' HB2' ' HB3' ' A' ' 61' ' ' ASN . 38.3 mt-10 -71.82 144.62 49.06 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.542 -0.753 . . . . 0.0 110.577 -178.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 8.5 p -61.52 132.77 54.47 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.883 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 72.66 1.13 3.88 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.223 177.819 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.41 ' HB3' ' HB2' ' A' ' 58' ' ' GLU . 53.9 t30 -108.17 149.6 28.32 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.151 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 2.6 p -111.44 123.19 49.71 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.063 0.458 . . . . 0.0 110.789 -178.153 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 27.9 m -104.05 135.86 44.76 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.725 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -94.77 128.48 41.51 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.562 179.245 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 40.2 t -96.16 115.79 36.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.418 -179.578 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -84.07 101.11 11.54 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.594 179.388 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.481 ' CZ ' HG12 ' A' ' 40' ' ' VAL . 8.0 m-85 -100.47 148.62 24.56 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.015 0.436 . . . . 0.0 111.143 178.812 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 33.1 m-70 -120.05 107.87 13.6 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 178.302 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' TRP . . . . . 0.444 ' HE3' HD22 ' A' ' 21' ' ' ASN . 14.4 t90 -115.97 118.73 33.73 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.342 0.591 . . . . 0.0 111.205 -172.807 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 4.6 m -88.7 113.48 24.31 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 168.709 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.441 ' HG ' ' HA ' ' A' ' 17' ' ' PRO . 0.1 OUTLIER -44.64 -40.54 5.93 Favored 'General case' 0 N--CA 1.469 0.516 0 O-C-N 123.898 0.748 . . . . 0.0 112.167 -169.669 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 15.9 t70 77.52 -53.9 0.53 Allowed 'General case' 0 N--CA 1.468 0.45 0 O-C-N 123.792 0.682 . . . . 0.0 111.035 175.259 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -117.21 -155.92 10.34 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 121.017 -0.611 . . . . 0.0 111.61 176.888 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 33.0 m -153.26 91.88 1.55 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.158 0.504 . . . . 0.0 110.47 177.633 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.523 ' H ' ' HE2' ' A' ' 78' ' ' TYR . . . -126.25 147.6 49.65 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.354 177.263 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -63.94 -27.14 68.94 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.227 0.454 . . . . 0.0 112.227 -173.08 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 38.4 m -145.67 119.26 9.12 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.058 0.456 . . . . 0.0 111.185 -179.54 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.523 ' HE2' ' H ' ' A' ' 75' ' ' ALA . 26.5 m-85 -105.74 141.67 36.77 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.177 177.309 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 21.9 m -93.43 100.02 12.4 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.056 178.583 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.452 HD13 HG22 ' A' ' 104' ' ' VAL . 8.6 mp -100.43 125.07 46.67 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.274 0.559 . . . . 0.0 110.519 -178.832 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.527 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 32.4 m -121.24 115.69 23.48 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.938 -176.494 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 92.9 t -86.94 108.6 18.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.685 175.403 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -101.8 121.19 41.62 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 176.288 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.53 ' HA ' HG22 ' A' ' 40' ' ' VAL . 77.8 t -87.58 108.8 18.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.187 -176.605 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 46.2 t0 61.61 85.25 0.18 Allowed Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 114.555 -1.202 . . . . 0.0 111.701 178.066 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -72.45 -4.36 15.12 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.732 2.288 . . . . 0.0 112.088 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -99.52 -15.87 18.51 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 177.295 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 48.04 71.89 0.31 Allowed 'General case' 0 C--O 1.233 0.201 0 CA-C-N 114.647 -1.16 . . . . 0.0 110.911 -177.656 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.06 -32.12 16.85 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.251 177.368 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 22.0 t -89.28 134.02 29.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.658 176.547 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -78.04 99.19 6.01 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 177.577 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -89.95 156.1 18.66 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.899 -171.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -57.47 -100.88 0.01 OUTLIER Glycine 0 CA--C 1.518 0.231 0 CA-C-N 115.088 -0.96 . . . . 0.0 112.78 171.886 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.645 ' HB2' ' HB3' ' A' ' 97' ' ' ASN . 78.9 m-20 -83.76 123.41 29.84 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 120.847 -0.341 . . . . 0.0 110.733 -178.088 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -72.67 -15.92 61.7 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.651 0.739 . . . . 0.0 109.724 176.712 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -89.03 7.18 36.19 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.826 176.141 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.645 ' HB3' ' HB2' ' A' ' 94' ' ' ASN . 1.7 t30 -116.98 -28.86 6.15 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -173.291 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 20.2 p-10 -75.69 10.99 1.47 Allowed 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.065 0.46 . . . . 0.0 111.86 -173.638 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -126.38 143.64 51.1 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.799 0.333 . . . . 0.0 110.399 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.527 ' O ' ' HA ' ' A' ' 81' ' ' THR . 44.1 tp -128.73 104.65 7.76 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.472 179.552 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 53.0 m -92.05 106.39 18.42 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 174.753 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -121.72 153.54 38.09 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.537 -177.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 88.7 mt -104.38 124.02 48.47 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.001 0.429 . . . . 0.0 110.481 179.157 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.452 HG22 HD13 ' A' ' 80' ' ' LEU . 22.4 m -116.17 132.42 65.77 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.618 178.534 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.54 ' O ' ' HA ' ' A' ' 14' ' ' THR . . . -110.96 166.27 12.27 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.423 -0.894 . . . . 0.0 112.01 -175.575 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 18.4 p -68.22 135.49 52.09 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.745 0.273 . . . . 0.0 110.275 177.014 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 61.9 tp . . . . . 0 C--N 1.327 -0.388 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.589 -176.827 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.435 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 7.5 tp . . . . . 0 CA--C 1.537 0.458 0 CA-C-O 120.488 0.185 . . . . 0.0 110.845 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.539 ' HG3' ' HD3' ' A' ' 33' ' ' LYS . 6.5 Cg_endo -88.58 174.03 4.26 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 123.146 2.564 . . . . 0.0 112.128 173.092 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ASP . . . . . 0.402 ' O ' ' HA ' ' A' ' 29' ' ' ASN . 17.8 t70 -151.42 105.91 3.23 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 179.315 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.537 ' O ' ' HA ' ' A' ' 98' ' ' ASN . 96.9 mt -99.57 103.3 15.01 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.192 0.52 . . . . 0.0 111.473 -168.611 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.536 HG22 ' HB3' ' A' ' 97' ' ' ASN . 11.5 t -114.57 116.58 43.5 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.653 -173.49 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.478 ' HB2' ' HB2' ' A' ' 100' ' ' LEU . 3.8 Cg_exo -79.33 104.07 1.7 Allowed 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 122.544 2.163 . . . . 0.0 109.76 169.006 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 31.8 m -92.14 -15.06 8.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -169.802 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 27.8 t -159.36 156.83 29.23 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.516 -0.474 . . . . 0.0 111.507 -177.054 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 60.1 tp -142.48 114.12 7.96 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.07 178.241 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 8.8 p -126.96 145.8 55.2 Favored Pre-proline 0 C--N 1.32 -0.708 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.99 -176.266 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -77.77 155.88 95.21 Favored 'Cis proline' 0 C--N 1.341 0.18 0 C-N-CA 123.265 -1.556 . . . . 0.0 112.497 -0.68 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 30.2 m -80.16 -21.44 11.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.195 0.522 . . . . 0.0 110.282 177.122 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.627 ' HA ' ' O ' ' A' ' 105' ' ' GLY . 3.2 p -117.88 126.99 53.41 Favored 'General case' 0 N--CA 1.438 -1.067 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.355 176.236 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.497 ' HB ' ' ND2' ' A' ' 21' ' ' ASN . 29.2 m -113.57 140.36 34.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.134 0.492 . . . . 0.0 111.678 -173.032 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.417 ' HA ' ' HD3' ' A' ' 17' ' ' PRO . 8.1 m -90.67 124.67 61.76 Favored Pre-proline 0 N--CA 1.445 -0.698 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.425 174.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.496 ' HA ' ' HB3' ' A' ' 71' ' ' LEU . 3.0 Cg_exo -80.3 49.56 3.25 Favored 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 122.803 2.335 . . . . 0.0 111.723 178.408 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -116.71 -13.24 10.8 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.468 -175.549 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 15.2 t -167.98 -167.9 0.9 Allowed 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.928 -0.309 . . . . 0.0 110.799 -171.394 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.494 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 53.6 t -86.76 113.61 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 174.146 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.497 ' ND2' ' HB ' ' A' ' 15' ' ' VAL . 4.4 m-20 -88.08 137.07 32.65 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.237 -172.146 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 33.4 m -88.85 105.57 17.83 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.219 178.069 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' MET . . . . . 0.52 ' HB2' ' HB2' ' A' ' 67' ' ' PHE . 92.6 mmm -92.9 119.79 32.57 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.002 -178.32 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.526 ' HA ' ' O ' ' A' ' 65' ' ' VAL . 11.5 m -108.68 114.55 28.44 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.635 -176.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -105.71 133.03 51.1 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.387 -179.618 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 25.4 m -94.08 110.2 21.92 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.924 0.392 . . . . 0.0 110.827 -178.368 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 27.4 mm -102.64 116.32 46.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.789 -179.399 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -115.52 129.07 56.41 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.902 0.382 . . . . 0.0 110.177 178.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.402 ' HA ' ' O ' ' A' ' 4' ' ' ASP . 24.6 t30 -92.76 98.87 11.67 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.114 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -96.22 53.85 1.38 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.707 -174.707 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -144.02 161.5 27.84 Favored Glycine 0 N--CA 1.448 -0.558 0 N-CA-C 111.441 -0.663 . . . . 0.0 111.441 179.273 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -86.93 46.73 1.4 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.473 0.654 . . . . 0.0 110.793 -174.657 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.539 ' HD3' ' HG3' ' A' ' 3' ' ' PRO . 31.5 tttm -161.51 146.21 13.3 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 174.203 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -76.55 149.27 36.67 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.023 0.44 . . . . 0.0 110.189 176.716 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.424 ' OG ' ' HB3' ' A' ' 57' ' ' LEU . 13.5 p -104.72 129.3 52.96 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 172.331 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -84.3 -148.57 0.1 Allowed 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 -176.458 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.526 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 56.4 m -65.18 108.36 1.85 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.005 0.431 . . . . 0.0 111.398 -175.685 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.526 ' HB2' ' HB2' ' A' ' 85' ' ' ASP . 54.0 p90 -123.09 154.9 37.96 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.032 177.8 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.483 ' O ' ' HA ' ' A' ' 85' ' ' ASP . 32.8 m-80 -105.27 110.92 23.47 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.107 -175.573 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.606 HG22 ' HA ' ' A' ' 84' ' ' VAL . 1.3 t -98.18 121.28 48.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 121.351 0.596 . . . . 0.0 109.716 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 11.8 m -114.37 137.56 51.66 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.436 -175.258 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 55.0 tp -96.65 111.77 23.78 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.972 175.617 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.557 ' HG ' HG22 ' A' ' 48' ' ' VAL . 5.1 mp -94.46 132.29 39.26 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.336 178.54 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 85.5 t -105.96 97.42 5.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 173.62 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 70.81 -62.89 0.43 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.133 -0.94 . . . . 0.0 111.921 -179.516 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -147.34 -6.78 0.28 Allowed Glycine 0 CA--C 1.521 0.443 0 C-N-CA 120.886 -0.674 . . . . 0.0 113.496 179.264 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 6.5 mt -116.0 151.25 17.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 117.477 0.639 . . . . 0.0 110.45 -177.133 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.557 HG22 ' HG ' ' A' ' 43' ' ' LEU . 48.0 t -95.0 118.61 41.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 177.873 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 17.8 m -93.31 -33.08 5.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -176.299 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -152.98 143.07 22.33 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 110.278 -0.268 . . . . 0.0 110.278 -177.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 39.2 m -132.86 132.55 42.24 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.318 -179.594 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -123.57 125.86 45.62 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 178.563 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 15.0 m -87.31 110.3 20.13 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 177.188 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.526 ' O ' ' HA ' ' A' ' 37' ' ' SER . 43.7 t -81.6 124.13 38.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.329 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 10.3 m -52.76 -44.18 66.3 Favored 'General case' 0 C--N 1.329 -0.287 0 O-C-N 123.543 0.527 . . . . 0.0 111.464 -177.259 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 34.1 t -179.95 157.76 0.72 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.598 -179.502 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.424 ' HB3' ' OG ' ' A' ' 35' ' ' SER . 47.9 tp -136.02 123.94 22.72 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.012 -179.458 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 44.4 mm-40 -71.98 161.12 31.39 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.817 -177.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 15.5 m -70.14 128.82 37.61 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.278 178.004 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 68.3 20.09 8.81 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.984 178.278 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -112.9 147.02 37.92 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.625 177.149 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 11.2 p -114.67 125.91 54.28 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.123 0.487 . . . . 0.0 110.576 179.092 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 50.9 m -118.21 138.7 52.14 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.208 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -94.28 133.69 37.55 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.101 0.477 . . . . 0.0 111.363 -177.224 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.535 HG21 HG11 ' A' ' 40' ' ' VAL . 21.5 t -96.77 135.36 31.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.961 179.54 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -104.05 97.31 7.31 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.926 -174.826 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.52 ' HB2' ' HB2' ' A' ' 23' ' ' MET . 57.0 m-85 -97.13 153.34 18.03 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.406 177.322 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 68.8 m-70 -128.67 116.05 18.97 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 171.226 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 3.5 t90 -129.69 124.23 33.08 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.657 -173.007 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.494 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 4.3 m -80.09 113.87 18.58 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.056 -178.617 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.496 ' HB3' ' HA ' ' A' ' 17' ' ' PRO . 0.8 OUTLIER -69.68 120.23 15.13 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.964 0.412 . . . . 0.0 110.973 177.409 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -87.73 -36.21 17.48 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.589 178.76 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 92.9 16.04 49.75 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.641 -0.79 . . . . 0.0 111.735 -178.314 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.5 -38.62 87.99 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.265 0.555 . . . . 0.0 110.621 -179.178 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -138.02 158.17 44.88 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.874 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -83.09 -12.3 57.21 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.027 0.441 . . . . 0.0 110.544 179.019 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 10.7 p -143.3 121.56 12.26 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.452 178.606 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 53.0 m-85 -105.73 149.97 25.92 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.314 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.518 ' HA ' HD23 ' A' ' 103' ' ' LEU . 8.9 m -96.46 88.27 4.66 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.906 0.384 . . . . 0.0 110.38 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.412 HD13 HG22 ' A' ' 104' ' ' VAL . 7.4 mp -88.13 120.2 29.25 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.555 0.693 . . . . 0.0 111.118 -177.341 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.444 ' HB ' ' HB2' ' A' ' 43' ' ' LEU . 34.5 m -118.28 117.66 29.72 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.34 -178.318 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 47.9 t -90.75 103.79 14.74 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 176.562 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -101.52 112.61 25.21 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 178.533 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.606 ' HA ' HG22 ' A' ' 40' ' ' VAL . 75.6 t -78.64 103.81 5.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.838 -176.782 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.526 ' HB2' ' HB2' ' A' ' 38' ' ' PHE . 7.9 t70 58.94 88.3 0.13 Allowed Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 114.091 -1.413 . . . . 0.0 112.019 179.58 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -72.63 -4.46 15.37 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 123.171 2.581 . . . . 0.0 111.561 176.665 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -83.77 -21.95 32.03 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.173 -179.388 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 64.09 35.3 10.53 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.581 -178.074 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -75.93 -34.27 59.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.56 177.557 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 95.2 t -99.98 112.11 31.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.173 172.43 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 61.8 t30 -82.74 126.0 31.9 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.509 -177.376 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -84.05 165.83 18.22 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.239 0.542 . . . . 0.0 111.281 178.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -57.58 -100.69 0.01 OUTLIER Glycine 0 N--CA 1.444 -0.813 0 N-CA-C 110.268 -1.133 . . . . 0.0 110.268 159.24 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 15.4 m-20 -72.8 88.44 1.32 Allowed 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 172.084 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -58.4 96.23 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.409 0 O-C-N 123.325 0.391 . . . . 0.0 110.913 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 7.8 m 173.35 -26.36 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.417 0 O-C-N 124.238 0.961 . . . . 0.0 110.072 -172.222 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.536 ' HB3' HG22 ' A' ' 6' ' ' VAL . 83.7 m-20 -74.68 -19.85 60.1 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.488 -177.603 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.597 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 24.9 p-10 -72.29 19.31 0.08 Allowed 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.624 0.602 . . . . 0.0 112.624 -175.926 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 1.4 m -130.36 149.03 52.23 Favored 'General case' 0 C--N 1.322 -0.625 0 O-C-N 121.881 -0.512 . . . . 0.0 111.235 -178.495 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.478 ' HB2' ' HB2' ' A' ' 7' ' ' PRO . 30.0 tp -145.45 103.46 3.82 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.686 178.114 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 15.4 m -92.37 98.26 11.37 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 177.042 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -116.59 127.71 54.74 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.117 0.484 . . . . 0.0 110.695 -177.131 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.518 HD23 ' HA ' ' A' ' 79' ' ' THR . 65.1 mt -85.77 120.12 26.84 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.649 178.555 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.412 HG22 HD13 ' A' ' 80' ' ' LEU . 26.8 m -106.46 132.92 52.44 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.409 178.476 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.627 ' O ' ' HA ' ' A' ' 14' ' ' THR . . . -117.32 155.6 16.07 Favored Glycine 0 N--CA 1.44 -1.097 0 C-N-CA 120.205 -0.998 . . . . 0.0 111.244 -176.325 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.473 ' HA ' ' O ' ' A' ' 15' ' ' VAL . 35.2 p -61.75 145.82 51.26 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 176.226 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.442 ' HA ' ' HB ' ' A' ' 14' ' ' THR . 49.3 tp . . . . . 0 C--N 1.327 -0.401 0 CA-C-O 120.816 0.341 . . . . 0.0 111.199 -176.707 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.434 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 1.1 tt . . . . . 0 N--CA 1.448 -0.553 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.519 ' HD2' ' O ' ' A' ' 91' ' ' ASN . 12.6 Cg_exo -70.72 157.04 59.63 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.44 2.093 . . . . 0.0 111.012 174.362 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ASP . . . . . 0.571 ' HA ' ' OE1' ' A' ' 92' ' ' GLU . 13.7 t70 -132.73 91.78 2.96 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 175.566 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.529 ' O ' ' HB3' ' A' ' 97' ' ' ASN . 70.2 mt -99.76 126.45 45.84 Favored 'General case' 0 CA--C 1.499 -0.993 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 -173.105 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.4 ' HA ' ' HD3' ' A' ' 7' ' ' PRO . 11.0 t -125.4 140.57 36.6 Favored Pre-proline 0 C--N 1.311 -1.069 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.58 -173.132 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.573 ' HB2' ' HB2' ' A' ' 100' ' ' LEU . 17.2 Cg_endo -91.25 103.8 0.25 Allowed 'Trans proline' 0 N--CA 1.439 -1.688 0 C-N-CA 122.757 2.305 . . . . 0.0 109.495 168.045 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.8 t -80.02 -49.75 18.66 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 CA-C-N 114.765 -1.107 . . . . 0.0 111.306 -165.208 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 10.5 p -158.15 164.03 36.99 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.67 -178.646 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.53 HD11 ' HB3' ' A' ' 23' ' ' MET . 36.5 tp -127.73 126.51 41.97 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 176.486 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 37.0 p -122.3 131.71 24.36 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.502 176.688 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.543 ' HD2' ' SD ' ' A' ' 23' ' ' MET . 97.5 Cg_endo -90.83 176.4 18.03 Favored 'Cis proline' 0 N--CA 1.457 -0.619 0 C-N-CA 123.808 -1.33 . . . . 0.0 112.884 2.536 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.0 m -98.29 -12.05 8.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 121.431 0.634 . . . . 0.0 110.21 176.678 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.561 ' HA ' ' O ' ' A' ' 105' ' ' GLY . 0.8 OUTLIER -120.03 150.98 39.68 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.579 172.574 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.435 HG11 ' CZ3' ' A' ' 69' ' ' TRP . 7.5 m -143.14 155.15 17.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.056 0.455 . . . . 0.0 111.59 -173.699 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.9 m -104.33 130.26 23.63 Favored Pre-proline 0 N--CA 1.444 -0.764 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.15 -179.271 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -77.19 171.9 17.0 Favored 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 122.594 2.196 . . . . 0.0 111.648 175.164 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 73.9 21.39 2.67 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.32 0.648 . . . . 0.0 111.391 178.443 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 15.1 t -167.07 -176.79 3.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.661 0.267 . . . . 0.0 110.706 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 57.8 t -102.33 132.91 47.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 178.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 32.4 m-80 -106.03 134.84 48.51 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.934 0.397 . . . . 0.0 110.362 -176.242 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 15.0 m -95.34 97.22 9.68 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.567 178.79 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' MET . . . . . 0.543 ' SD ' ' HD2' ' A' ' 12' ' ' PRO . 91.5 mmm -89.53 115.59 27.05 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.533 -175.087 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 25.2 m -93.44 111.28 22.91 Favored 'General case' 0 C--N 1.323 -0.576 0 O-C-N 123.563 0.54 . . . . 0.0 111.002 -178.088 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.537 ' HB3' ' HB ' ' A' ' 65' ' ' VAL . . . -99.01 119.53 37.95 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.09 175.236 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 5.7 m -83.5 108.81 16.88 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.082 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 28.5 mm -108.29 119.33 57.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 -179.524 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -117.67 133.11 56.29 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.608 0.242 . . . . 0.0 110.639 -177.074 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.595 ' ND2' ' HA ' ' A' ' 59' ' ' SER . 36.2 t30 -95.33 100.3 12.1 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.995 0.426 . . . . 0.0 109.889 177.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 67.5 mt-30 -104.89 52.36 0.74 Allowed 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.487 -173.439 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -143.99 178.19 22.18 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.11 -1.043 . . . . 0.0 113.183 -175.263 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -90.36 28.84 1.36 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.108 0.48 . . . . 0.0 111.711 -172.083 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.446 ' HD3' ' HD3' ' A' ' 3' ' ' PRO . 88.5 tttt -154.16 143.58 21.46 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 121.876 -0.515 . . . . 0.0 111.058 178.229 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -79.75 143.25 34.66 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 175.465 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.438 ' OG ' ' HB3' ' A' ' 57' ' ' LEU . 33.7 p -104.69 140.95 37.31 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.005 0.431 . . . . 0.0 111.429 -177.286 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 7.3 p -85.08 -165.49 1.22 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.052 -179.412 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.414 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 13.4 m -60.34 119.41 7.9 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.935 0.398 . . . . 0.0 111.547 179.59 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.507 ' CE2' HG23 ' A' ' 40' ' ' VAL . 26.4 p90 -137.26 153.19 50.39 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 177.574 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.597 ' O ' ' HD3' ' A' ' 86' ' ' PRO . 65.1 m-80 -94.98 138.56 32.55 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.094 0.473 . . . . 0.0 110.744 178.935 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.507 HG23 ' CE2' ' A' ' 38' ' ' PHE . 2.4 t -119.57 112.97 39.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 173.314 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.523 ' HB3' HG23 ' A' ' 51' ' ' THR . 33.4 p -108.79 139.28 43.84 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.24 -173.806 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 54.9 tp -96.46 115.85 28.1 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.403 177.332 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.55 ' HG ' HG22 ' A' ' 48' ' ' VAL . 5.5 mp -96.96 129.21 44.45 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.196 177.593 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.424 ' CG1' ' HD2' ' A' ' 78' ' ' TYR . 84.1 t -106.37 96.89 4.99 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.69 176.512 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.471 ' HA ' ' HB ' ' A' ' 79' ' ' THR . 2.9 m-20 70.9 -51.06 0.68 Allowed 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 115.156 -0.929 . . . . 0.0 112.452 178.606 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -166.29 14.73 0.08 OUTLIER Glycine 0 C--N 1.319 -0.391 0 C-N-CA 120.768 -0.73 . . . . 0.0 113.15 178.716 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 9.3 mt -136.18 152.14 29.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 -179.543 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.55 HG22 ' HG ' ' A' ' 43' ' ' LEU . 50.7 t -97.91 108.73 22.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 177.929 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 17.0 m -77.67 -37.83 24.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.592 -177.209 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -159.37 140.04 12.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.828 0.346 . . . . 0.0 110.175 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.523 HG23 ' HB3' ' A' ' 41' ' ' SER . 27.6 m -116.48 122.19 44.02 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.949 178.461 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 43.9 tt0 -105.13 122.7 46.44 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.014 0.435 . . . . 0.0 110.281 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 6.0 m -79.82 129.51 34.55 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.232 177.3 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.414 ' O ' ' HA ' ' A' ' 37' ' ' SER . 53.7 t -98.75 120.0 47.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 172.757 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.7 m -61.41 -38.01 85.54 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.629 -174.169 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 23.0 t -178.1 136.87 0.17 Allowed 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 178.826 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.467 HD23 HD22 ' A' ' 5' ' ' LEU . 39.7 tp -119.79 113.06 20.04 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.223 0.535 . . . . 0.0 109.731 176.75 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -67.84 156.9 36.07 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.888 -177.335 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.595 ' HA ' ' ND2' ' A' ' 29' ' ' ASN . 11.6 p -65.51 130.34 42.95 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.56 178.471 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 68.81 23.52 6.88 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.507 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -117.93 153.74 33.08 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.393 -0.821 . . . . 0.0 108.83 175.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 23.3 t -128.52 142.63 51.01 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 177.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 15.0 t -125.41 149.17 48.42 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.892 179.297 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -97.78 120.18 37.7 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.213 -178.237 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.537 ' HB ' ' HB3' ' A' ' 25' ' ' ALA . 21.4 t -98.7 107.02 19.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.546 -176.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -98.84 111.47 23.85 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.925 0.393 . . . . 0.0 110.666 -178.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -91.28 163.03 14.37 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.235 0.541 . . . . 0.0 111.194 -176.707 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 57.4 m80 -105.3 93.88 4.92 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.549 -0.751 . . . . 0.0 109.723 177.212 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' TRP . . . . . 0.435 ' CZ3' HG11 ' A' ' 15' ' ' VAL . 12.5 t90 -107.12 100.01 9.52 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.798 -177.201 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 12.3 t -73.82 121.96 21.71 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 172.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 15.9 tp -121.94 96.11 4.93 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.468 0.651 . . . . 0.0 111.671 -173.407 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -63.49 -60.71 3.0 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.876 -1.056 . . . . 0.0 109.916 172.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 128.38 67.33 0.13 Allowed Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.721 178.608 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 30.9 m -75.46 -69.48 0.48 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.884 0.374 . . . . 0.0 110.575 178.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -108.47 -173.19 2.21 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.456 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 -96.49 -18.21 20.0 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.866 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 20.6 m -133.7 133.93 42.44 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.995 0.426 . . . . 0.0 110.81 -179.186 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.424 ' HD2' ' CG1' ' A' ' 44' ' ' VAL . 49.3 m-85 -119.12 145.2 46.16 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.805 179.198 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.484 ' HA ' HD23 ' A' ' 103' ' ' LEU . 6.6 m -97.11 91.65 5.66 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.323 -179.235 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.411 HD13 HG22 ' A' ' 104' ' ' VAL . 7.9 mp -91.1 113.16 25.35 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.452 0.644 . . . . 0.0 111.265 -176.919 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.561 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 11.2 m -116.12 120.71 39.91 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.489 -178.05 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 85.8 t -86.96 109.63 19.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.399 178.413 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.551 ' HA ' ' O ' ' A' ' 98' ' ' ASN . 6.1 t30 -92.5 111.57 23.2 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.817 0.342 . . . . 0.0 110.204 176.02 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 94.0 t -92.02 124.77 44.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.338 179.579 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.755 ' OD2' ' HA ' ' A' ' 88' ' ' ASN . 31.2 t70 64.91 85.87 0.15 Allowed Pre-proline 0 N--CA 1.464 0.249 0 O-C-N 123.922 0.764 . . . . 0.0 111.461 176.842 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.597 ' HD3' ' O ' ' A' ' 39' ' ' ASN . 1.6 Cg_endo -85.15 -40.9 0.08 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 123.364 2.709 . . . . 0.0 112.754 178.69 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.482 ' OE1' ' HD2' ' A' ' 86' ' ' PRO . 27.1 mp0 -80.33 -10.28 59.75 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.174 -176.827 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ASN . . . . . 0.755 ' HA ' ' OD2' ' A' ' 85' ' ' ASP . 12.9 m120 63.02 64.77 0.84 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.73 0.776 . . . . 0.0 110.273 -174.307 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -100.45 -28.58 12.85 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.641 -1.163 . . . . 0.0 109.172 178.167 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 54.7 t -115.81 107.67 23.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.421 175.553 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.519 ' O ' ' HD2' ' A' ' 3' ' ' PRO . 16.6 t-20 -66.13 106.19 1.57 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.29 -177.487 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.571 ' OE1' ' HA ' ' A' ' 4' ' ' ASP . 0.3 OUTLIER -79.95 151.48 30.05 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.439 -174.718 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.401 ' HA2' HD13 ' A' ' 2' ' ' ILE . . . -57.93 -101.11 0.01 OUTLIER Glycine 0 CA--C 1.522 0.515 0 CA-C-N 115.018 -0.992 . . . . 0.0 113.436 171.378 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -78.44 132.18 37.2 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.03 -0.585 . . . . 0.0 111.136 -173.671 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -73.78 76.77 1.58 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.172 0.511 . . . . 0.0 110.961 177.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 17.9 m -160.47 -40.27 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.564 -0.743 . . . . 0.0 109.885 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.529 ' HB3' ' O ' ' A' ' 5' ' ' LEU . 86.5 m-20 -67.47 -13.19 61.81 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.292 -0.867 . . . . 0.0 112.439 -173.609 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.551 ' O ' ' HA ' ' A' ' 83' ' ' ASN . 19.0 m120 -71.68 -5.01 30.67 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 111.675 0.25 . . . . 0.0 111.675 -175.616 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 2.5 p -142.41 122.54 13.77 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.573 ' HB2' ' HB2' ' A' ' 7' ' ' PRO . 42.2 tp -111.25 104.87 13.4 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 169.683 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.5 m -89.75 100.16 13.02 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.444 -178.278 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -120.57 128.05 52.7 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.081 0.467 . . . . 0.0 111.196 -177.703 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.484 HD23 ' HA ' ' A' ' 79' ' ' THR . 62.6 mt -85.51 125.82 33.36 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.57 177.56 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.411 HG22 HD13 ' A' ' 80' ' ' LEU . 33.3 m -116.82 142.85 28.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 177.368 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.561 ' O ' ' HA ' ' A' ' 14' ' ' THR . . . -122.65 155.91 17.11 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.235 -0.983 . . . . 0.0 112.291 -175.815 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 38.1 p -63.86 139.65 58.79 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 177.13 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 35.4 tp . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.044 -179.563 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 13.7 tt . . . . . 0 N--CA 1.451 -0.375 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -80.63 156.81 21.55 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 122.314 2.01 . . . . 0.0 111.297 174.156 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ASP . . . . . 0.441 ' HB3' ' O ' ' A' ' 30' ' ' GLN . 13.5 t70 -146.65 104.63 3.76 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 176.234 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.593 HD22 HD23 ' A' ' 57' ' ' LEU . 14.6 mt -99.68 126.6 45.73 Favored 'General case' 0 CA--C 1.51 -0.573 0 C-N-CA 119.484 -0.886 . . . . 0.0 108.945 -172.272 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.3 t -125.55 140.69 37.04 Favored Pre-proline 0 C--N 1.318 -0.785 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.501 -176.528 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.675 ' HD3' ' O ' ' A' ' 97' ' ' ASN . 3.2 Cg_exo -81.89 109.39 1.96 Allowed 'Trans proline' 0 N--CA 1.446 -1.299 0 C-N-CA 122.598 2.199 . . . . 0.0 109.572 169.422 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 11.6 t -73.93 -53.59 17.19 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.037 -170.284 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 26.8 t -155.09 163.66 39.95 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.079 -179.484 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 19.9 tp -127.64 126.56 42.21 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.156 0.503 . . . . 0.0 110.025 179.294 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.412 ' HA ' ' HA ' ' A' ' 12' ' ' PRO . 41.4 p -122.17 131.47 24.4 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.558 177.299 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.513 ' HD2' ' SD ' ' A' ' 23' ' ' MET . 66.5 Cg_endo -90.68 177.19 17.19 Favored 'Cis proline' 0 N--CA 1.456 -0.72 0 C-N-CA 123.772 -1.345 . . . . 0.0 112.982 3.126 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.3 m -98.91 -13.36 8.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.376 177.697 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.412 ' HA ' ' O ' ' A' ' 105' ' ' GLY . 0.0 OUTLIER -120.24 151.1 39.64 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.892 173.586 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 17.0 m -143.16 157.36 17.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.574 0.226 . . . . 0.0 110.683 -177.745 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.505 ' HA ' ' HD3' ' A' ' 17' ' ' PRO . 2.2 t -99.25 131.84 24.44 Favored Pre-proline 0 C--N 1.325 -0.485 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 -178.173 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.585 ' HA ' ' HG ' ' A' ' 71' ' ' LEU . 3.2 Cg_exo -80.45 15.28 1.79 Allowed 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 123.3 2.667 . . . . 0.0 115.07 -171.543 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 29.4 p-10 -127.26 -2.47 6.31 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 -172.409 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 13.5 t -143.14 176.56 9.02 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.418 -172.655 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 62.0 t -81.01 134.46 27.13 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 CA-C-O 121.591 0.71 . . . . 0.0 109.405 174.278 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.547 ' ND2' HD23 ' A' ' 71' ' ' LEU . 32.7 m-80 -114.42 132.98 56.05 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 114.558 -1.201 . . . . 0.0 108.847 -173.956 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 23.7 m -108.2 118.88 37.93 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 108.166 -1.049 . . . . 0.0 108.166 -174.154 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' MET . . . . . 0.513 ' SD ' ' HD2' ' A' ' 12' ' ' PRO . 86.1 mmm -109.09 122.92 48.3 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 113.533 -1.667 . . . . 0.0 109.23 -166.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.529 ' HA ' ' O ' ' A' ' 65' ' ' VAL . 25.0 m -111.93 124.8 53.16 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-O 121.732 0.777 . . . . 0.0 109.531 -174.328 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -119.26 132.01 55.86 Favored 'General case' 0 N--CA 1.434 -1.248 0 CA-C-N 114.353 -1.294 . . . . 0.0 108.15 -176.82 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 93.6 m -112.36 121.45 44.89 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 -173.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 11.9 mm -116.14 131.86 67.39 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 -171.596 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -125.32 148.56 48.67 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.257 -177.738 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 37.6 t30 -101.15 95.99 6.92 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.442 -175.639 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.441 ' O ' ' HB3' ' A' ' 4' ' ' ASP . 92.8 mt-30 -88.08 62.2 6.68 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 122.048 0.927 . . . . 0.0 109.826 -179.564 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -173.5 147.14 9.31 Favored Glycine 0 N--CA 1.443 -0.841 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 178.583 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 32.5 p-10 -85.39 8.29 19.42 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 113.661 0.986 . . . . 0.0 113.661 -162.23 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -109.19 141.17 41.82 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 120.376 -0.529 . . . . 0.0 110.648 174.16 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -75.24 135.56 40.99 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.864 174.828 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 65.5 p -93.1 -161.75 0.87 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.909 -173.707 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 7.0 p -131.31 -167.97 1.94 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.436 178.192 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 13.4 m -59.38 124.27 19.49 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.876 178.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.523 ' HB2' ' HB2' ' A' ' 85' ' ' ASP . 23.9 p90 -136.53 150.73 48.79 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.95 -179.05 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.435 ' O ' ' HA ' ' A' ' 85' ' ' ASP . 22.1 m-80 -99.44 109.84 22.38 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.364 -173.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.479 HG23 ' CE2' ' A' ' 38' ' ' PHE . 2.4 t -98.3 114.2 35.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-O 121.337 0.589 . . . . 0.0 109.797 177.509 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.447 ' HA ' ' HA ' ' A' ' 51' ' ' THR . 25.2 p -112.65 141.91 45.88 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.745 -175.866 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 55.9 tp -96.47 114.45 26.12 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.982 177.205 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.528 ' HG ' HG22 ' A' ' 48' ' ' VAL . 5.1 mp -98.26 132.57 43.64 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.225 179.196 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 98.7 t -113.78 101.72 12.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.868 177.751 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 58.82 19.01 6.54 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.822 179.358 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 128.55 -38.71 2.01 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.892 177.19 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 5.6 mt -87.48 150.23 3.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 -177.085 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.528 HG22 ' HG ' ' A' ' 43' ' ' LEU . 44.8 t -96.77 121.11 46.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 19.9 m -94.73 -33.32 4.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -177.125 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 34.1 t0 -156.1 138.35 14.73 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.576 0.227 . . . . 0.0 110.518 -178.134 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.447 ' HA ' ' HA ' ' A' ' 41' ' ' SER . 30.6 m -126.83 123.29 36.98 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.262 -179.712 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -114.7 112.65 23.18 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.802 0.334 . . . . 0.0 110.377 -179.158 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 23.7 m -77.12 113.07 14.46 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.972 0.415 . . . . 0.0 110.607 177.149 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 27.5 t -83.36 144.15 10.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.881 -179.584 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.3 m -62.67 -49.06 76.61 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.585 -0.279 . . . . 0.0 111.231 -178.527 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 22.6 t -177.75 164.45 1.97 Allowed 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -178.247 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.593 HD23 HD22 ' A' ' 5' ' ' LEU . 18.1 tp -139.85 110.03 6.53 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.247 0.546 . . . . 0.0 110.79 175.645 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 29.3 mp0 -74.75 174.2 9.47 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.973 -178.644 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 34.6 p -74.89 128.94 36.77 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.699 0.285 . . . . 0.0 110.901 -177.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 66.95 18.34 10.59 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.026 178.808 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.457 ' O ' HD11 ' A' ' 57' ' ' LEU . 58.5 t30 -110.64 148.65 31.79 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 175.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -117.62 153.9 32.5 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 120.964 0.411 . . . . 0.0 111.015 -175.511 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.472 ' OG1' HD13 ' A' ' 57' ' ' LEU . 92.6 m -130.07 135.24 48.02 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.715 177.254 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -96.34 123.04 39.85 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.41 176.451 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.529 ' O ' ' HA ' ' A' ' 24' ' ' THR . 17.6 t -105.15 120.68 56.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.732 178.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -109.42 111.27 22.72 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.114 0.483 . . . . 0.0 110.321 -179.38 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -91.6 157.72 16.83 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.391 -177.11 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 65.1 m-70 -108.94 100.03 9.29 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.327 175.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 13.5 t90 -116.67 108.23 15.66 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.077 0.465 . . . . 0.0 110.925 -175.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 10.1 m -81.78 114.03 20.14 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.636 174.71 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.585 ' HG ' ' HA ' ' A' ' 17' ' ' PRO . 0.1 OUTLIER -72.64 124.73 25.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.701 0.286 . . . . 0.0 110.46 -177.462 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -84.3 -36.62 22.48 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.765 177.285 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 85.8 58.58 2.0 Allowed Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 121.104 -0.569 . . . . 0.0 112.917 174.488 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.4 p -112.09 -32.14 6.66 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.734 0.302 . . . . 0.0 111.636 178.416 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -124.1 166.3 16.02 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.785 0.326 . . . . 0.0 111.083 -177.613 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.499 ' HA ' HG23 ' A' ' 106' ' ' THR . 51.8 m-80 -101.65 -5.09 25.47 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.046 0.45 . . . . 0.0 110.321 177.267 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 20.5 m -145.18 114.21 6.95 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.841 178.828 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -105.91 138.79 41.5 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.15 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.456 ' HA ' HD23 ' A' ' 103' ' ' LEU . 9.5 m -90.59 88.23 7.05 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.529 -178.005 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.475 HD13 HG22 ' A' ' 104' ' ' VAL . 8.3 mp -89.02 124.82 34.64 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.35 0.595 . . . . 0.0 111.148 -177.295 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.473 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 76.2 m -123.53 124.4 42.76 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.67 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 61.7 t -90.28 99.03 8.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 174.782 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.538 ' HA ' ' O ' ' A' ' 98' ' ' ASN . 4.6 t30 -93.5 114.76 27.22 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 178.583 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.438 HG11 ' HB2' ' A' ' 5' ' ' LEU . 60.8 t -80.11 108.6 13.73 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.648 -178.62 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.523 ' HB2' ' HB2' ' A' ' 38' ' ' PHE . 8.1 t70 48.57 92.09 0.06 OUTLIER Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 114.056 -1.429 . . . . 0.0 112.511 -179.242 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -64.73 -8.19 16.92 Favored 'Trans proline' 0 C--O 1.234 0.313 0 C-N-CA 123.313 2.675 . . . . 0.0 112.452 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -94.26 -24.95 17.25 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.372 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 18.9 m120 58.57 48.18 12.24 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.686 -173.548 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -64.21 -25.66 68.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.012 176.73 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 20.4 t -101.66 125.74 55.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.564 175.508 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -74.83 116.53 15.65 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.435 -0.579 . . . . 0.0 109.435 176.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -118.41 168.38 10.7 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -171.695 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -57.97 -100.96 0.01 OUTLIER Glycine 0 CA--C 1.522 0.52 0 CA-C-N 113.985 -1.461 . . . . 0.0 114.756 179.153 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -85.54 -163.9 0.93 Allowed 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -166.03 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 49.0 mm-40 -100.45 -37.84 8.66 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.282 -173.486 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 15.3 m -84.98 -4.4 59.13 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.824 0.345 . . . . 0.0 111.749 -171.202 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.675 ' O ' ' HD3' ' A' ' 7' ' ' PRO . 23.6 p-10 -70.44 -34.07 72.03 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.562 -176.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.538 ' O ' ' HA ' ' A' ' 83' ' ' ASN . 9.2 m120 -77.56 -1.46 30.77 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -175.629 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 1.1 p -135.83 130.94 34.72 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -177.505 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.473 ' O ' ' HA ' ' A' ' 81' ' ' THR . 28.3 tp -128.35 98.52 5.09 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.234 168.152 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 98.5 m -95.72 107.0 19.18 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.121 0.486 . . . . 0.0 110.501 179.032 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -121.57 134.83 55.03 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.948 -179.344 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.456 HD23 ' HA ' ' A' ' 79' ' ' THR . 78.9 mt -84.96 120.03 26.05 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.349 0.595 . . . . 0.0 110.629 179.42 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.475 HG22 HD13 ' A' ' 80' ' ' LEU . 33.2 m -106.22 132.35 53.59 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.491 177.777 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.412 ' O ' ' HA ' ' A' ' 14' ' ' THR . . . -108.76 173.57 17.7 Favored Glycine 0 N--CA 1.443 -0.876 0 C-N-CA 120.399 -0.905 . . . . 0.0 111.855 -175.285 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.499 HG23 ' HA ' ' A' ' 76' ' ' ASN . 22.0 p -76.43 132.54 39.72 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 120.881 0.372 . . . . 0.0 110.084 176.76 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 37.2 tp . . . . . 0 C--N 1.322 -0.598 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.938 -175.718 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 16.1 tt . . . . . 0 CA--C 1.538 0.518 0 N-CA-C 110.301 -0.259 . . . . 0.0 110.301 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -71.68 165.08 33.62 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.647 2.231 . . . . 0.0 112.501 175.549 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -149.85 91.21 1.77 Allowed 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 177.028 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.474 HD22 HD23 ' A' ' 57' ' ' LEU . 66.3 mt -84.76 117.68 23.98 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.178 -168.756 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.536 HG22 ' HB3' ' A' ' 97' ' ' ASN . 21.7 t -120.52 110.41 35.63 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.118 -176.248 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.561 ' HD2' ' O ' ' A' ' 97' ' ' ASN . 20.3 Cg_endo -63.74 111.68 1.59 Allowed 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 122.388 2.059 . . . . 0.0 110.55 169.361 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.3 t -85.93 -48.78 15.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.454 -169.542 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 18.2 t -149.32 157.66 43.52 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.924 0.392 . . . . 0.0 111.097 -174.778 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 53.7 tp -135.51 111.95 9.88 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.213 178.184 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.56 ' OG1' ' HA ' ' A' ' 12' ' ' PRO . 13.6 t -131.0 148.13 69.05 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.656 -176.555 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.56 ' HA ' ' OG1' ' A' ' 11' ' ' THR . 5.8 Cg_exo -78.77 148.76 83.79 Favored 'Cis proline' 0 N--CA 1.46 -0.446 0 C-N-CA 123.366 -1.514 . . . . 0.0 112.44 1.21 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.5 m -72.13 -5.91 6.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.271 0.557 . . . . 0.0 110.957 177.244 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.575 ' HB ' ' HA ' ' A' ' 107' ' ' LEU . 0.9 OUTLIER -128.27 133.01 48.7 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.834 175.43 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.496 ' O ' ' HA ' ' A' ' 106' ' ' THR . 15.3 m -124.2 156.18 31.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 120.761 0.315 . . . . 0.0 111.232 -174.869 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.0 m -101.83 134.0 20.41 Favored Pre-proline 0 N--CA 1.445 -0.703 0 CA-C-O 121.038 0.446 . . . . 0.0 110.823 177.604 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.425 ' CB ' ' HA3' ' A' ' 73' ' ' GLY . 98.6 Cg_endo -79.63 174.04 12.26 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 122.42 2.08 . . . . 0.0 112.166 178.767 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 25.1 m-80 63.14 28.77 16.09 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.32 177.393 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 15.2 t -169.42 170.52 8.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.761 0.315 . . . . 0.0 110.602 -177.755 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.467 HG22 ' HA ' ' A' ' 70' ' ' THR . 58.4 t -91.4 129.88 41.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.853 0.359 . . . . 0.0 110.387 178.371 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 40.4 m-80 -106.9 116.15 31.43 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.608 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.587 ' HA ' ' O ' ' A' ' 67' ' ' PHE . 10.3 m -85.36 93.39 8.71 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 175.025 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' MET . . . . . 0.582 ' O ' ' HA ' ' A' ' 66' ' ' ASP . 83.0 mtp -94.73 148.34 22.39 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.132 -174.197 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.459 HG23 ' HB3' ' A' ' 64' ' ' ASN . 20.9 m -109.67 114.07 27.36 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.146 -175.537 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -104.23 112.29 25.25 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 172.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 38.8 m -83.38 104.78 13.8 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 120.923 0.392 . . . . 0.0 110.044 -177.543 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 31.9 mm -97.05 116.62 39.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.893 -179.17 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -113.2 122.43 47.46 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.006 0.431 . . . . 0.0 110.135 -178.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 31.0 t30 -79.05 98.44 6.49 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.513 177.841 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -101.02 56.62 0.86 Allowed 'General case' 0 C--N 1.319 -0.761 0 CA-C-O 121.601 0.715 . . . . 0.0 109.976 -174.451 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -144.08 177.78 22.53 Favored Glycine 0 N--CA 1.444 -0.775 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.886 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -73.14 -39.17 65.91 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 -173.758 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.402 ' HG2' ' O ' ' A' ' 34' ' ' ASP . 55.7 tttp -101.21 147.58 26.1 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.424 0.631 . . . . 0.0 112.476 -170.71 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.402 ' O ' ' HG2' ' A' ' 33' ' ' LYS . 1.7 t70 -65.81 138.82 58.17 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 114.523 -1.217 . . . . 0.0 110.809 173.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.423 ' OG ' HD21 ' A' ' 5' ' ' LEU . 13.8 p -105.62 137.43 43.47 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.288 176.585 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.1 m -90.14 -133.2 0.11 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.248 -179.369 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.509 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 26.8 m -75.62 109.47 9.22 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.085 0.469 . . . . 0.0 111.568 -175.347 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.552 ' CE2' HG23 ' A' ' 40' ' ' VAL . 19.9 p90 -122.6 148.81 44.79 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.13 178.103 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.543 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 4.2 t-20 -99.83 115.19 29.02 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 120.913 -0.315 . . . . 0.0 110.963 -173.591 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.552 HG23 ' CE2' ' A' ' 38' ' ' PHE . 2.7 t -98.48 111.96 29.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.597 0.713 . . . . 0.0 110.161 -178.779 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.577 ' HB3' HG23 ' A' ' 51' ' ' THR . 16.2 p -104.1 131.69 51.11 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.919 -176.935 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 62.9 tp -98.17 109.77 22.47 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 174.632 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 5.1 mp -97.78 142.05 30.03 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.669 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 81.7 t -108.56 99.23 8.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 172.261 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 37.3 t70 67.06 -73.95 0.07 Allowed 'General case' 0 C--N 1.329 -0.298 0 O-C-N 124.123 0.89 . . . . 0.0 111.139 -176.637 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -143.64 4.96 1.75 Allowed Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 121.278 -0.486 . . . . 0.0 112.314 179.505 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 8.4 mt -112.62 153.72 14.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -179.538 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 54.7 t -106.51 124.9 62.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.228 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 17.5 m -94.56 -33.05 4.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 C-N-CA 120.961 -0.295 . . . . 0.0 111.191 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -159.68 142.18 13.64 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.923 0.392 . . . . 0.0 110.673 178.207 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.577 HG23 ' HB3' ' A' ' 41' ' ' SER . 7.1 m -124.06 109.34 13.38 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.294 178.852 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 47.0 tt0 -109.08 113.01 25.5 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.104 0.478 . . . . 0.0 111.183 -172.664 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.543 ' HA ' ' HA ' ' A' ' 39' ' ' ASN . 10.4 m -76.32 120.0 20.97 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.358 177.733 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.509 ' O ' ' HA ' ' A' ' 37' ' ' SER . 25.0 t -92.58 127.18 44.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 177.091 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 27.0 m -58.05 -38.72 76.8 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.075 -0.511 . . . . 0.0 112.337 -173.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 11.2 p -169.97 163.55 9.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.671 0.272 . . . . 0.0 111.422 -177.331 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.483 HD11 ' O ' ' A' ' 61' ' ' ASN . 38.4 tp -156.52 114.24 3.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.869 176.195 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -77.32 169.41 18.38 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.605 -175.599 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 16.6 m -63.44 125.96 25.93 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.745 -0.662 . . . . 0.0 111.114 -179.412 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 66.27 15.8 10.21 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.96 176.702 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.483 ' O ' HD11 ' A' ' 57' ' ' LEU . 41.5 t-20 -97.63 143.51 28.23 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 175.277 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -114.44 115.76 27.8 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.351 -178.43 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.412 ' OG1' HD13 ' A' ' 57' ' ' LEU . 50.0 m -104.33 124.43 49.17 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.093 0.473 . . . . 0.0 110.738 -179.296 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.459 ' HB3' HG23 ' A' ' 24' ' ' THR . 94.8 m-20 -80.14 115.76 19.88 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.683 178.627 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 18.2 t -96.77 107.56 20.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.322 -178.641 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.582 ' HA ' ' O ' ' A' ' 23' ' ' MET . 28.5 m-20 -93.75 111.74 23.49 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.785 179.362 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.587 ' O ' ' HA ' ' A' ' 22' ' ' THR . 80.7 m-85 -91.38 167.46 12.26 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.978 179.576 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 2.5 p-80 -117.58 95.31 4.89 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.502 174.213 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' TRP . . . . . 0.618 ' CZ2' HD13 ' A' ' 71' ' ' LEU . 9.7 t90 -94.38 100.52 12.53 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.552 -176.324 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.467 ' HA ' HG22 ' A' ' 20' ' ' VAL . 17.8 m -73.74 91.52 1.92 Allowed 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 173.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.618 HD13 ' CZ2' ' A' ' 69' ' ' TRP . 22.2 tp -95.84 117.8 31.26 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.445 0.64 . . . . 0.0 112.102 -169.298 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -65.13 -56.86 10.51 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.807 -1.088 . . . . 0.0 109.666 171.767 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.425 ' HA3' ' CB ' ' A' ' 17' ' ' PRO . . . 101.22 50.31 1.24 Allowed Glycine 0 N--CA 1.446 -0.64 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.656 -179.434 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.9 m -81.65 -29.42 33.16 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.146 0.498 . . . . 0.0 110.553 -177.419 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -123.45 162.01 23.69 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.543 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 69.8 m-20 -97.47 -2.5 41.89 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.052 0.453 . . . . 0.0 110.668 179.153 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.416 ' HA ' ' HA2' ' A' ' 105' ' ' GLY . 53.6 m -149.3 112.49 4.93 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.479 176.862 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -105.79 149.36 26.55 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.289 178.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 89.8 m -98.7 98.06 9.24 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.876 175.751 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.438 HD13 ' CG2' ' A' ' 104' ' ' VAL . 6.6 mp -94.19 132.25 38.92 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.381 0.61 . . . . 0.0 110.419 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.446 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 17.3 m -129.69 113.97 15.42 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.283 -176.179 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 69.0 t -86.21 109.29 18.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 177.013 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -104.68 115.09 29.72 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 176.713 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.587 ' HB ' ' HB2' ' A' ' 98' ' ' ASN . 74.9 t -82.66 114.02 22.85 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-O 121.404 0.621 . . . . 0.0 111.304 -177.281 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 45.2 t0 63.27 90.37 0.09 OUTLIER Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 114.211 -1.359 . . . . 0.0 112.35 176.826 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.528 ' HD3' ' O ' ' A' ' 39' ' ' ASN . 1.9 Cg_endo -84.7 -6.93 9.7 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 123.195 2.597 . . . . 0.0 111.563 174.697 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -92.84 -16.67 25.02 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.738 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 57.51 54.96 6.02 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.464 -179.172 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -93.45 -30.17 15.19 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.008 -0.996 . . . . 0.0 109.703 179.579 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 47.9 t -110.03 101.51 12.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.486 173.696 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -64.78 129.69 40.7 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.098 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.403 ' OE1' ' HB2' ' A' ' 5' ' ' LEU . 36.0 mt-10 -108.62 164.14 12.62 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.626 -173.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -58.42 -101.06 0.01 OUTLIER Glycine 0 CA--C 1.519 0.309 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.516 168.502 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -84.29 101.66 12.09 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 176.524 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -74.35 22.96 0.09 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.158 -174.373 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 16.2 m -111.82 -5.14 14.43 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.201 0.524 . . . . 0.0 109.839 174.261 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.561 ' O ' ' HD2' ' A' ' 7' ' ' PRO . 81.3 m-20 -87.52 -15.31 37.89 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.191 178.659 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.587 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 27.8 p-10 -77.04 1.64 17.37 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.685 -173.52 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 1.2 m -114.24 147.01 39.65 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.083 0.468 . . . . 0.0 110.984 -177.506 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.446 ' O ' ' HA ' ' A' ' 81' ' ' THR . 40.2 tp -143.57 102.19 3.9 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.904 179.584 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 8.5 m -95.96 110.64 22.82 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.969 178.419 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -128.5 138.8 52.45 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.902 -178.454 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 64.5 mt -87.67 121.46 30.12 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.449 177.679 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.438 ' CG2' HD13 ' A' ' 80' ' ' LEU . 27.3 m -113.29 121.41 65.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.842 179.192 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.538 ' O ' ' HA ' ' A' ' 14' ' ' THR . . . -103.66 174.05 22.37 Favored Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 120.397 -0.906 . . . . 0.0 111.054 -177.877 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.496 ' HA ' ' O ' ' A' ' 15' ' ' VAL . 20.7 p -73.29 154.59 40.09 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 117.286 0.543 . . . . 0.0 109.808 175.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.575 ' HA ' ' HB ' ' A' ' 14' ' ' THR . 49.7 tp . . . . . 0 C--N 1.327 -0.403 0 CA-C-O 121.184 0.516 . . . . 0.0 112.153 -172.336 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 12.6 tt . . . . . 0 N--CA 1.451 -0.395 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.603 ' HD2' ' O ' ' A' ' 91' ' ' ASN . 16.9 Cg_exo -68.04 151.51 77.47 Favored 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 122.4 2.067 . . . . 0.0 111.697 175.844 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -141.46 90.41 2.29 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 179.512 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.523 HD22 HD23 ' A' ' 57' ' ' LEU . 58.4 mt -85.05 109.05 17.94 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.073 -171.401 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.538 HG22 ' HB3' ' A' ' 97' ' ' ASN . 17.7 t -117.46 123.1 30.19 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.207 -176.248 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.556 ' HG3' HG23 ' A' ' 84' ' ' VAL . 3.3 Cg_exo -79.32 101.59 1.43 Allowed 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 122.599 2.199 . . . . 0.0 110.014 170.735 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 29.3 m -83.66 -27.9 7.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -171.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 43.6 t -175.2 166.01 3.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.667 0.27 . . . . 0.0 110.573 -176.103 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.478 ' C ' HD12 ' A' ' 10' ' ' LEU . 3.2 pp -146.27 152.25 38.86 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 172.383 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 22.9 p -129.72 144.73 54.13 Favored Pre-proline 0 C--N 1.322 -0.588 0 CA-C-N 116.693 -0.231 . . . . 0.0 110.506 177.233 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -90.53 162.68 32.36 Favored 'Cis proline' 0 N--CA 1.457 -0.622 0 C-N-CA 123.283 -1.549 . . . . 0.0 112.365 -2.627 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 30.7 m -91.74 9.72 3.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.63 0.728 . . . . 0.0 110.398 177.399 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.545 HG22 ' HA ' ' A' ' 107' ' ' LEU . 0.2 OUTLIER -142.29 122.22 13.61 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.223 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.43 HG21 ' CZ3' ' A' ' 69' ' ' TRP . 21.1 m -121.19 160.32 22.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -168.084 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.457 ' HA ' ' HD3' ' A' ' 17' ' ' PRO . 45.4 t -91.99 118.85 68.42 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.057 178.499 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.577 ' HA ' ' CB ' ' A' ' 71' ' ' LEU . 5.7 Cg_exo -77.79 16.14 1.17 Allowed 'Trans proline' 0 CA--C 1.53 0.318 0 C-N-CA 122.931 2.421 . . . . 0.0 113.455 -176.9 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.452 ' H ' HG12 ' A' ' 16' ' ' VAL . 51.3 m-80 -122.61 16.16 10.33 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 121.009 -0.276 . . . . 0.0 111.628 -175.277 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 14.3 t -169.68 178.77 3.98 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 110.408 -0.219 . . . . 0.0 110.408 -179.65 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 45.2 t -85.07 125.3 40.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 176.013 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.492 ' ND2' HD23 ' A' ' 71' ' ' LEU . 28.0 m-80 -97.5 124.22 41.65 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.673 -175.855 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 23.8 m -80.95 105.43 12.17 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.564 -0.743 . . . . 0.0 109.52 175.572 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' MET . . . . . 0.439 ' HB2' ' HB2' ' A' ' 67' ' ' PHE . 42.0 mtp -102.69 136.53 42.34 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.36 -176.475 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.444 ' HA ' ' O ' ' A' ' 65' ' ' VAL . 22.0 m -115.33 103.74 11.1 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.863 -177.807 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -89.36 141.09 28.85 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.411 177.284 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 19.2 m -104.39 109.13 20.86 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.079 0.466 . . . . 0.0 110.376 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 14.3 mm -101.9 118.32 48.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.284 179.195 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -110.35 131.43 55.06 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 120.754 0.311 . . . . 0.0 110.698 -177.265 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 35.9 t30 -89.32 98.83 11.99 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.211 -0.449 . . . . 0.0 109.871 177.492 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -94.14 40.37 1.08 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.982 -174.369 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -143.96 147.36 18.62 Favored Glycine 0 N--CA 1.444 -0.831 0 N-CA-C 110.631 -0.987 . . . . 0.0 110.631 179.117 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -84.34 60.5 6.02 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.349 0.595 . . . . 0.0 111.157 -172.666 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.563 ' HD3' ' HD3' ' A' ' 3' ' ' PRO . 64.4 tttp -161.45 137.51 8.05 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.027 170.373 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -76.44 132.9 39.91 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.242 -176.521 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 58.7 p -95.69 145.1 25.54 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.144 0.497 . . . . 0.0 111.032 -176.41 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 24.1 p -86.47 -162.22 0.74 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.729 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.449 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 32.6 t -56.96 125.53 23.03 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 120.901 0.382 . . . . 0.0 111.085 178.867 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.558 ' HB2' ' HB2' ' A' ' 85' ' ' ASP . 42.6 p90 -138.32 143.66 40.04 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 177.354 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.568 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 65.2 t30 -102.55 115.56 30.83 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 121.048 -0.261 . . . . 0.0 111.422 -172.318 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.568 HG22 ' HA ' ' A' ' 84' ' ' VAL . 2.0 t -102.49 125.9 56.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.098 0.475 . . . . 0.0 110.566 -176.385 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.533 ' HB3' HG23 ' A' ' 51' ' ' THR . 52.5 p -117.66 138.27 52.09 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.914 -177.255 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 59.5 tp -96.46 107.8 20.26 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 176.412 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.456 ' HG ' HG22 ' A' ' 48' ' ' VAL . 4.6 mp -96.94 118.64 33.79 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.264 -179.099 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.527 HG22 ' HG ' ' A' ' 80' ' ' LEU . 95.8 t -100.87 102.08 12.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.083 178.732 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 59.29 22.45 10.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.374 -0.83 . . . . 0.0 112.399 176.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 121.81 -26.75 6.42 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.464 -0.874 . . . . 0.0 113.002 176.81 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 11.9 mm -97.85 148.6 5.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 -178.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.456 HG22 ' HG ' ' A' ' 43' ' ' LEU . 39.5 t -98.4 110.7 26.44 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 -179.383 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 28.7 m -91.53 -31.52 4.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.766 -175.619 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -148.95 139.82 22.85 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.676 0.274 . . . . 0.0 110.298 -177.107 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.533 HG23 ' HB3' ' A' ' 41' ' ' SER . 2.1 m -133.87 121.6 21.98 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.112 -0.495 . . . . 0.0 109.682 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -128.28 114.96 17.58 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.085 0.469 . . . . 0.0 110.297 -178.108 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.568 ' HA ' ' HA ' ' A' ' 39' ' ' ASN . 21.8 m -76.97 131.4 38.47 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.365 178.537 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.449 ' O ' ' HA ' ' A' ' 37' ' ' SER . 38.6 t -101.95 121.41 52.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 177.017 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.6 m -59.7 -36.16 75.96 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -174.406 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 21.2 t -172.53 152.46 2.63 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.959 0.409 . . . . 0.0 111.262 179.651 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.633 HD13 ' OG1' ' A' ' 63' ' ' THR . 23.3 tp -140.07 114.34 9.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.82 175.765 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -70.27 173.06 7.18 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.468 0.652 . . . . 0.0 112.035 -175.756 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 10.0 m -63.89 129.66 40.97 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.686 178.85 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 61.99 19.42 10.75 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.903 -0.59 . . . . 0.0 112.229 176.447 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -101.24 158.54 15.96 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 178.595 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 7.1 m -121.52 125.38 46.67 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.136 179.572 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.633 ' OG1' HD13 ' A' ' 57' ' ' LEU . 86.1 m -103.96 135.94 44.53 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.892 0.377 . . . . 0.0 110.973 -179.646 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -92.85 119.8 32.55 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.762 174.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.444 ' O ' ' HA ' ' A' ' 24' ' ' THR . 40.7 t -96.24 135.06 31.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.441 -177.34 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -96.39 112.13 23.98 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.579 -176.25 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.439 ' HB2' ' HB2' ' A' ' 23' ' ' MET . 36.1 m-85 -112.37 140.01 47.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.785 0.326 . . . . 0.0 111.016 177.856 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 22.0 m170 -115.86 97.46 6.12 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 176.364 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' TRP . . . . . 0.43 ' CZ3' HG21 ' A' ' 15' ' ' VAL . 18.6 t90 -108.65 114.38 28.14 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.17 0.509 . . . . 0.0 111.622 -173.511 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 9.7 m -82.88 123.9 29.83 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.05 176.075 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.577 ' CB ' ' HA ' ' A' ' 17' ' ' PRO . 1.0 OUTLIER -83.89 123.17 29.66 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.163 0.506 . . . . 0.0 111.756 -178.573 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 19.3 p-10 -79.19 -43.42 23.92 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.755 175.437 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 89.39 40.0 6.18 Favored Glycine 0 N--CA 1.45 -0.37 0 CA-C-N 115.772 -0.649 . . . . 0.0 113.152 176.22 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 18.2 m -99.39 -13.95 19.36 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.207 0.527 . . . . 0.0 110.524 178.632 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -145.04 152.5 40.22 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.567 178.295 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -90.09 -10.11 45.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.158 0.504 . . . . 0.0 110.645 179.581 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 24.7 m -140.53 121.52 14.61 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.316 179.516 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -116.32 153.31 32.21 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.252 179.489 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.422 ' HA ' HD23 ' A' ' 103' ' ' LEU . 4.4 m -96.54 89.59 5.06 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.881 179.125 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.527 ' HG ' HG22 ' A' ' 44' ' ' VAL . 10.7 mp -87.55 113.02 22.86 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.477 0.656 . . . . 0.0 110.256 -178.684 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.495 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 5.4 m -115.97 113.51 23.36 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.6 -173.209 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 59.9 t -87.55 109.16 19.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 116.311 -0.404 . . . . 0.0 109.94 177.757 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -105.83 120.78 42.61 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.135 0.493 . . . . 0.0 109.849 176.3 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.568 ' HA ' HG22 ' A' ' 40' ' ' VAL . 83.5 t -85.37 111.95 21.52 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.621 -175.601 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.558 ' HB2' ' HB2' ' A' ' 38' ' ' PHE . 20.6 t70 57.8 86.85 0.15 Allowed Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 114.294 -1.321 . . . . 0.0 112.92 173.493 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_exo -72.92 -9.0 23.18 Favored 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 122.797 2.331 . . . . 0.0 111.26 174.635 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -82.52 -27.12 31.9 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.27 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 56.99 52.57 9.05 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.505 -177.761 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -83.98 -25.64 29.86 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.981 -1.009 . . . . 0.0 109.936 179.059 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 40.3 t -100.4 136.9 29.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.802 177.736 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.603 ' O ' ' HD2' ' A' ' 3' ' ' PRO . 43.8 m-80 -75.05 112.04 10.88 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 173.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.442 ' CD ' HD21 ' A' ' 98' ' ' ASN . 33.9 mt-10 -114.6 152.64 31.5 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 120.896 0.379 . . . . 0.0 111.752 -173.382 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -57.7 -101.09 0.01 OUTLIER Glycine 0 CA--C 1.519 0.326 0 CA-C-N 115.071 -0.968 . . . . 0.0 113.956 179.004 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -88.83 124.29 34.04 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.543 0.211 . . . . 0.0 111.015 -173.232 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -61.11 -33.76 73.88 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -174.774 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 10.9 p -75.05 -1.94 25.14 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.934 0.397 . . . . 0.0 111.398 -177.307 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.538 ' HB3' HG22 ' A' ' 6' ' ' VAL . 7.6 m-20 -91.7 -13.55 31.52 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.52 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.442 HD21 ' CD ' ' A' ' 92' ' ' GLU . 10.8 m120 -69.8 -18.02 63.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.903 -0.589 . . . . 0.0 112.257 -177.464 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 1.2 m -123.04 147.91 46.16 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.326 0.584 . . . . 0.0 112.102 -170.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.495 ' O ' ' HA ' ' A' ' 81' ' ' THR . 29.4 tp -131.89 104.61 6.96 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.096 -0.957 . . . . 0.0 109.694 178.52 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 7.0 m -87.98 99.47 12.18 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.277 178.837 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -113.62 148.85 35.49 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.91 0.386 . . . . 0.0 111.11 -178.271 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.422 HD23 ' HA ' ' A' ' 79' ' ' THR . 51.8 mt -112.83 120.46 41.53 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.384 178.535 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.446 HG22 HD13 ' A' ' 80' ' ' LEU . 27.8 m -110.19 156.78 11.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.371 -178.86 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.53 ' O ' ' HA ' ' A' ' 14' ' ' THR . . . -122.89 169.98 15.32 Favored Glycine 0 N--CA 1.442 -0.955 0 C-N-CA 120.292 -0.956 . . . . 0.0 111.468 179.153 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 27.3 p -81.47 139.28 35.29 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 174.681 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.545 ' HA ' HG22 ' A' ' 14' ' ' THR . 32.9 tp . . . . . 0 C--N 1.327 -0.381 0 CA-C-O 121.033 0.444 . . . . 0.0 111.907 -172.734 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 10.7 tt . . . . . 0 N--CA 1.452 -0.356 0 CA-C-O 120.78 0.324 . . . . 0.0 110.479 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.444 ' HA ' ' HA3' ' A' ' 31' ' ' GLY . 88.2 Cg_endo -95.75 169.93 1.27 Allowed 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 123.09 2.527 . . . . 0.0 113.196 175.628 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ASP . . . . . 0.402 ' O ' ' HA ' ' A' ' 29' ' ' ASN . 5.5 m-20 -136.42 104.33 5.56 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.089 171.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.475 HD22 HD23 ' A' ' 57' ' ' LEU . 85.4 mt -89.69 90.79 8.38 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.34 0.59 . . . . 0.0 109.949 -176.731 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.489 ' HA ' ' HD2' ' A' ' 7' ' ' PRO . 25.0 t -104.24 111.73 65.25 Favored Pre-proline 0 C--N 1.319 -0.756 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.116 -174.155 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.524 ' HB2' HD22 ' A' ' 100' ' ' LEU . 18.5 Cg_endo -62.18 119.01 5.91 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 122.244 1.963 . . . . 0.0 109.956 169.099 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.5 t -91.0 -47.67 14.31 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.848 -168.443 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.9 t -160.67 173.68 15.1 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.489 -178.46 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 55.7 tp -136.46 127.74 28.22 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.83 -178.565 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.536 ' OG1' ' HA ' ' A' ' 12' ' ' PRO . 14.0 t -140.48 149.2 56.54 Favored Pre-proline 0 C--N 1.322 -0.589 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.536 ' HA ' ' OG1' ' A' ' 11' ' ' THR . 72.3 Cg_endo -76.56 148.12 88.33 Favored 'Cis proline' 0 N--CA 1.464 -0.251 0 C-N-CA 123.393 -1.503 . . . . 0.0 112.745 0.612 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 34.7 m -72.9 -22.35 19.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.724 177.656 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.622 ' HA ' ' O ' ' A' ' 105' ' ' GLY . 17.0 p -114.24 129.33 56.63 Favored 'General case' 0 N--CA 1.439 -1.016 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.164 174.17 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.499 HG11 ' CZ3' ' A' ' 69' ' ' TRP . 18.0 m -113.52 149.41 15.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.165 0.507 . . . . 0.0 111.923 -173.254 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 27.2 t -90.2 113.35 57.01 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.034 -179.459 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -83.27 42.09 1.2 Allowed 'Trans proline' 0 CA--C 1.53 0.289 0 C-N-CA 122.974 2.449 . . . . 0.0 113.384 -175.423 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -156.72 27.92 0.33 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.999 0.428 . . . . 0.0 110.984 177.055 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 11.2 t -170.99 -177.06 2.12 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.001 179.031 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 59.0 t -90.02 118.86 36.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.035 0.445 . . . . 0.0 109.91 177.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 44.8 m-80 -89.8 126.57 35.73 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.482 -178.529 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 17.8 m -80.04 89.0 5.35 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.527 175.706 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' MET . . . . . 0.558 ' HB2' ' HB2' ' A' ' 67' ' ' PHE . 91.3 mmm -79.38 113.21 17.34 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.925 -0.579 . . . . 0.0 109.607 -176.828 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.5 ' CG2' ' HB3' ' A' ' 64' ' ' ASN . 26.4 m -102.11 112.8 25.6 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.431 -175.695 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -101.21 124.05 46.3 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.38 179.073 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 25.0 m -86.12 110.6 19.66 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.285 179.644 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 19.8 mm -107.64 120.79 59.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 178.11 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -115.41 127.59 55.47 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.878 0.37 . . . . 0.0 110.889 -179.435 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.402 ' HA ' ' O ' ' A' ' 4' ' ' ASP . 25.2 t30 -89.86 103.8 16.42 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.844 177.293 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 -99.51 56.73 1.01 Allowed 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.621 -175.444 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.444 ' HA3' ' HA ' ' A' ' 3' ' ' PRO . . . -144.05 170.73 25.81 Favored Glycine 0 N--CA 1.448 -0.527 0 N-CA-C 111.521 -0.632 . . . . 0.0 111.521 -179.679 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 7.6 p-10 -86.84 0.97 53.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.04 0.448 . . . . 0.0 110.92 -174.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -120.91 132.33 54.9 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.51 -179.124 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -66.76 139.93 57.83 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.619 173.124 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.448 ' OG ' HD21 ' A' ' 5' ' ' LEU . 15.7 p -100.87 136.22 41.07 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.622 177.781 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.602 ' O ' ' HA ' ' A' ' 56' ' ' SER . 2.0 m -82.41 -128.02 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 120.91 -0.316 . . . . 0.0 110.246 -179.618 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.406 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 9.7 t -90.71 121.43 32.6 Favored 'General case' 0 C--N 1.323 -0.554 0 O-C-N 121.786 -0.571 . . . . 0.0 111.399 -172.222 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -128.92 142.04 51.08 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.624 -0.717 . . . . 0.0 109.361 176.443 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.676 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 64.1 t30 -90.31 120.13 31.19 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 120.832 0.349 . . . . 0.0 110.234 -176.486 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.483 HG11 HG11 ' A' ' 65' ' ' VAL . 0.3 OUTLIER -106.46 147.29 12.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -176.259 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 9.9 p -137.8 139.43 40.0 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 120.756 -0.378 . . . . 0.0 111.479 -175.03 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 62.2 tp -105.47 111.31 23.98 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.705 175.445 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.416 ' HG ' HG22 ' A' ' 48' ' ' VAL . 4.2 mp -98.55 141.49 31.33 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.936 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.412 HG22 ' HG ' ' A' ' 80' ' ' LEU . 87.4 t -123.83 106.09 16.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 176.885 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 57.53 23.49 9.25 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 115.791 -0.641 . . . . 0.0 112.083 178.668 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 120.99 -33.09 4.52 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.907 176.257 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 11.2 mm -90.89 149.25 4.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 -177.66 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.416 HG22 ' HG ' ' A' ' 43' ' ' LEU . 39.0 t -96.66 110.39 24.72 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 179.607 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 26.7 m -90.98 -25.69 5.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.686 -175.486 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -147.34 145.15 29.22 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 -178.807 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 22.1 m -141.74 113.52 7.86 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.076 0.465 . . . . 0.0 109.961 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.407 ' O ' HG12 ' A' ' 40' ' ' VAL . 0.1 OUTLIER -122.99 116.36 23.42 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.794 -174.922 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.676 ' HA ' ' HA ' ' A' ' 39' ' ' ASN . 8.6 m -80.69 112.64 18.25 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 176.499 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.406 ' O ' ' HA ' ' A' ' 37' ' ' SER . 49.2 t -77.6 133.27 30.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 -178.53 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 26.3 m -63.74 -43.74 95.59 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.614 -175.344 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.602 ' HA ' ' O ' ' A' ' 36' ' ' THR . 38.7 t -177.36 151.11 0.75 Allowed 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 -178.66 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.475 HD23 HD22 ' A' ' 5' ' ' LEU . 26.5 tp -131.04 121.76 25.58 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.836 177.93 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.414 ' HB2' ' HB3' ' A' ' 61' ' ' ASN . 24.5 mt-10 -71.16 163.07 28.34 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.52 -0.764 . . . . 0.0 112.124 -174.274 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 4.9 m -67.16 124.09 22.12 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.814 178.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 63.46 20.56 12.32 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.956 176.653 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.414 ' HB3' ' HB2' ' A' ' 58' ' ' GLU . 56.1 t30 -113.26 153.0 29.12 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 177.868 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.3 m -109.0 133.33 53.12 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.872 0.367 . . . . 0.0 110.286 -179.317 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.42 ' HB ' HD13 ' A' ' 57' ' ' LEU . 20.5 m -123.62 127.32 48.09 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.115 177.35 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.5 ' HB3' ' CG2' ' A' ' 24' ' ' THR . 56.7 m-80 -90.22 135.14 33.85 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.409 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.483 HG11 HG11 ' A' ' 40' ' ' VAL . 13.7 t -96.4 138.57 21.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.862 -176.628 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -94.55 97.2 9.97 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.921 -179.079 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.558 ' HB2' ' HB2' ' A' ' 23' ' ' MET . 67.5 m-85 -98.69 145.78 26.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.364 176.692 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 35.6 m-70 -114.99 100.95 8.57 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.221 0.534 . . . . 0.0 110.827 179.536 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' TRP . . . . . 0.499 ' CZ3' HG11 ' A' ' 15' ' ' VAL . 10.2 t90 -103.22 98.01 8.01 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.483 -177.859 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 18.8 m -74.03 100.33 3.55 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 175.083 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 28.5 tp -107.7 106.6 17.0 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.211 0.529 . . . . 0.0 111.391 -172.768 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -78.2 -19.85 53.02 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.172 175.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 89.8 87.27 1.3 Allowed Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.519 177.858 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 11.6 m -106.64 -33.74 7.55 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.024 0.44 . . . . 0.0 110.329 178.337 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -134.47 175.69 9.3 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.055 -0.521 . . . . 0.0 109.93 178.489 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.454 ' HA ' HG23 ' A' ' 106' ' ' THR . 31.7 p-10 -107.84 -8.88 15.87 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.03 0.443 . . . . 0.0 110.935 -179.691 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 3.2 p -137.2 116.81 12.94 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.345 -179.043 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -118.01 142.83 46.95 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.967 -178.609 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 25.5 m -99.21 94.32 6.42 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.051 179.172 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.497 HD13 HG22 ' A' ' 104' ' ' VAL . 10.2 mp -91.96 136.88 32.82 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.325 0.583 . . . . 0.0 110.777 -177.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.477 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 23.6 m -131.86 123.59 27.82 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.155 -178.695 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 46.8 t -95.4 108.84 21.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 177.122 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -100.06 119.51 38.4 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.47 HG21 ' HD3' ' A' ' 7' ' ' PRO . 88.6 t -92.52 106.36 17.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.735 -176.393 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 45.5 t0 62.38 92.67 0.06 OUTLIER Pre-proline 0 C--N 1.33 -0.272 0 O-C-N 124.276 0.985 . . . . 0.0 112.084 177.015 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -94.05 15.82 1.22 Allowed 'Trans proline' 0 N--CA 1.451 -0.996 0 C-N-CA 123.101 2.534 . . . . 0.0 111.839 174.452 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -125.5 -1.97 7.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.731 -174.342 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 65.5 t30 61.21 51.46 4.34 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.453 0.644 . . . . 0.0 110.714 177.026 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -89.33 -34.7 16.46 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.841 177.666 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 63.9 t -119.09 115.33 47.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.186 177.122 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 59.1 t30 -79.77 133.29 36.31 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 177.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -122.06 172.81 7.97 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.153 0.501 . . . . 0.0 112.27 -174.223 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -57.72 -100.82 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.526 0 CA-C-N 114.55 -1.205 . . . . 0.0 112.023 169.323 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -63.54 153.24 36.28 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.918 0.389 . . . . 0.0 110.684 178.668 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -98.62 -3.53 35.95 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.648 0.737 . . . . 0.0 109.817 176.86 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 8.3 p -87.3 -4.39 59.06 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.62 178.361 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.419 ' O ' ' HD2' ' A' ' 7' ' ' PRO . 55.3 m-20 -70.62 -35.54 73.01 Favored 'General case' 0 C--O 1.223 -0.303 0 CA-C-O 121.062 0.458 . . . . 0.0 110.244 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.467 ' HA ' ' HB ' ' A' ' 84' ' ' VAL . 13.1 m120 -72.34 18.87 0.08 Allowed 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 -165.766 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 1.8 m -150.38 149.81 30.56 Favored 'General case' 0 C--N 1.323 -0.552 0 O-C-N 121.883 -0.511 . . . . 0.0 111.345 -179.556 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.524 HD22 ' HB2' ' A' ' 7' ' ' PRO . 41.9 tp -152.46 100.95 2.62 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.61 176.016 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 61.8 m -92.94 113.38 25.64 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.365 178.405 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -130.14 134.13 47.11 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.777 -179.336 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 76.3 mt -85.6 126.17 33.69 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.638 178.321 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.497 HG22 HD13 ' A' ' 80' ' ' LEU . 19.1 m -116.86 147.05 20.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.581 177.551 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.622 ' O ' ' HA ' ' A' ' 14' ' ' THR . . . -123.72 164.08 17.05 Favored Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 120.495 -0.859 . . . . 0.0 111.389 -177.494 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.454 HG23 ' HA ' ' A' ' 76' ' ' ASN . 35.3 p -70.59 150.19 46.31 Favored 'General case' 0 C--N 1.317 -0.807 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.739 178.203 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.522 ' HA ' ' HB ' ' A' ' 14' ' ' THR . 39.1 tp . . . . . 0 C--N 1.326 -0.442 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.644 -177.316 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 15.9 tt . . . . . 0 N--CA 1.45 -0.439 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.57 ' HD2' ' O ' ' A' ' 91' ' ' ASN . 8.0 Cg_exo -73.22 161.69 42.38 Favored 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 122.553 2.169 . . . . 0.0 112.309 177.004 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -145.45 92.83 2.28 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 175.705 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.566 HD22 HD23 ' A' ' 57' ' ' LEU . 60.8 mt -90.72 101.24 13.99 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.47 0.652 . . . . 0.0 110.801 -169.142 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 22.5 t -104.49 112.18 65.33 Favored Pre-proline 0 C--N 1.318 -0.798 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.471 -174.201 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.518 ' HB2' ' HB2' ' A' ' 100' ' ' LEU . 33.1 Cg_endo -67.65 103.11 0.79 Allowed 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 121.941 1.76 . . . . 0.0 109.776 166.694 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 6.6 t -80.77 -49.18 18.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.315 -167.89 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 55.6 m -148.64 165.96 29.74 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.877 0.37 . . . . 0.0 111.312 -177.558 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.511 HD23 ' HB3' ' A' ' 102' ' ' ALA . 31.0 tp -139.8 104.33 4.86 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.654 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 21.5 p -123.71 145.26 46.87 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.28 -175.789 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -81.89 155.96 79.79 Favored 'Cis proline' 0 C--N 1.342 0.19 0 C-N-CA 123.723 -1.366 . . . . 0.0 112.015 -2.726 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 33.9 m -83.62 -11.47 11.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.892 0.377 . . . . 0.0 111.52 -177.567 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -116.72 126.88 53.8 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.82 0.343 . . . . 0.0 110.077 173.46 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.413 HG11 ' CZ3' ' A' ' 69' ' ' TRP . 34.7 m -113.52 165.39 8.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 120.896 0.379 . . . . 0.0 111.16 -176.695 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.432 ' HA ' ' HD3' ' A' ' 17' ' ' PRO . 4.9 t -110.15 117.61 51.27 Favored Pre-proline 0 C--N 1.324 -0.531 0 N-CA-C 109.524 -0.546 . . . . 0.0 109.524 177.728 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.471 ' HA ' ' HG ' ' A' ' 71' ' ' LEU . 7.1 Cg_exo -73.59 31.27 0.32 Allowed 'Trans proline' 0 CA--C 1.533 0.465 0 C-N-CA 123.295 2.664 . . . . 0.0 112.716 -178.505 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -105.82 -29.34 10.09 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.124 -176.813 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 8.9 t -151.21 178.62 9.05 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.159 -170.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 92.5 t -73.44 120.76 22.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 176.843 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 36.8 m-80 -92.49 123.91 36.14 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.345 -176.465 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.435 ' HA ' ' O ' ' A' ' 67' ' ' PHE . 24.9 m -89.88 96.29 10.62 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 177.567 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 86.5 mtp -97.23 135.87 38.55 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.459 -176.245 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.584 ' HA ' ' O ' ' A' ' 65' ' ' VAL . 31.3 m -108.46 115.78 30.74 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.873 -176.429 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -105.53 120.45 41.65 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.017 176.67 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 28.4 m -83.53 112.92 20.42 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 120.55 0.214 . . . . 0.0 110.458 -179.248 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.425 HD13 ' HA ' ' A' ' 7' ' ' PRO . 21.5 mm -103.3 120.01 52.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 177.249 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -116.22 126.47 53.67 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.772 0.32 . . . . 0.0 110.632 -177.377 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.438 ' HB2' ' HG ' ' A' ' 57' ' ' LEU . 33.1 t30 -90.03 101.77 14.48 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.134 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -103.39 54.3 0.75 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.515 -175.164 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -144.02 169.19 26.29 Favored Glycine 0 N--CA 1.447 -0.589 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.375 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -91.09 45.41 1.25 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.257 0.551 . . . . 0.0 110.885 -173.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 46.1 tptt -161.51 135.18 6.59 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.038 176.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -83.85 124.9 31.43 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 178.195 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 9.5 p -86.2 143.83 27.77 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.9 0.381 . . . . 0.0 111.402 -175.712 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 12.6 p -81.74 -164.13 0.75 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.967 -179.693 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.498 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 17.5 m -61.32 114.85 3.41 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 121.08 0.467 . . . . 0.0 111.562 -177.441 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.512 ' CE2' HG23 ' A' ' 40' ' ' VAL . 22.2 p90 -127.64 154.12 45.63 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.249 178.419 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.474 ' O ' ' HD3' ' A' ' 86' ' ' PRO . 55.1 m-80 -100.46 125.93 46.81 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.881 0.372 . . . . 0.0 110.984 -178.252 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.512 HG23 ' CE2' ' A' ' 38' ' ' PHE . 2.3 t -108.21 111.31 35.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-O 121.333 0.587 . . . . 0.0 109.453 177.399 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.517 ' HB3' HG23 ' A' ' 51' ' ' THR . 24.0 p -109.76 140.91 43.11 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.367 -174.11 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.403 HD11 ' HB3' ' A' ' 80' ' ' LEU . 52.7 tp -101.49 114.73 29.01 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.103 177.169 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.7 mp -101.18 126.45 47.9 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.243 179.524 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 86.2 t -104.87 104.07 16.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 116.148 -0.478 . . . . 0.0 109.873 178.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 57.18 28.89 15.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.411 178.039 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 107.46 -18.5 35.38 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.854 -0.688 . . . . 0.0 112.822 177.473 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 6.3 mm -95.44 148.16 5.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 -178.589 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 96.7 t -97.99 113.52 32.81 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-O 121.076 0.465 . . . . 0.0 110.126 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 27.9 m -96.77 -38.86 8.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.445 -177.681 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -153.16 143.2 22.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.855 0.359 . . . . 0.0 110.941 -175.813 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.517 HG23 ' HB3' ' A' ' 41' ' ' SER . 41.3 m -136.38 120.5 17.75 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.992 -179.281 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 45.8 tt0 -106.5 137.22 44.89 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.766 0.317 . . . . 0.0 110.377 -178.009 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 18.0 m -97.56 114.88 26.87 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.195 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.498 ' O ' ' HA ' ' A' ' 37' ' ' SER . 23.5 t -91.03 120.7 40.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.7 m -56.11 -43.15 77.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.58 -177.772 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 44.0 t -172.88 150.5 2.07 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.997 -0.372 . . . . 0.0 109.997 -179.542 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.566 HD23 HD22 ' A' ' 5' ' ' LEU . 28.3 tp -133.63 112.54 11.53 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 176.127 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -83.23 162.08 21.32 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.377 -174.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 5.8 p -65.5 138.36 58.03 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.073 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 68.66 5.72 5.06 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 123.183 0.593 . . . . 0.0 111.218 -179.297 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -103.48 147.56 27.0 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.874 0.369 . . . . 0.0 110.419 179.081 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 2.9 p -121.57 122.69 40.23 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.26 177.557 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 33.5 m -104.1 126.01 50.88 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.502 -179.539 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.436 ' HB3' ' CG2' ' A' ' 24' ' ' THR . 90.8 m-20 -83.15 117.87 23.2 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.894 177.353 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.584 ' O ' ' HA ' ' A' ' 24' ' ' THR . 44.8 t -96.02 115.8 36.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.964 -176.148 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 40.4 m-20 -96.67 108.21 20.79 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.748 0.309 . . . . 0.0 110.351 -179.033 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.435 ' O ' ' HA ' ' A' ' 22' ' ' THR . 65.3 m-85 -91.34 154.97 18.85 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 120.932 0.396 . . . . 0.0 110.097 179.463 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 50.7 m-70 -114.74 88.28 2.83 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 176.557 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' TRP . . . . . 0.413 ' CZ3' HG11 ' A' ' 15' ' ' VAL . 15.1 t90 -98.28 111.18 23.61 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.449 -172.611 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 7.3 m -86.06 118.65 25.66 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 170.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.561 HD11 ' CZ ' ' A' ' 78' ' ' TYR . 0.1 OUTLIER -55.2 -43.82 74.77 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.454 0.539 . . . . 0.0 112.454 -167.947 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.42 ' HB3' ' O ' ' A' ' 71' ' ' LEU . 31.5 t70 71.46 4.21 4.97 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.534 0.683 . . . . 0.0 110.997 176.002 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 179.18 -158.78 23.1 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 121.084 -0.579 . . . . 0.0 111.996 179.588 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 85.2 m -155.16 94.93 1.67 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.139 0.495 . . . . 0.0 110.344 177.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.412 ' HB3' ' CE1' ' A' ' 78' ' ' TYR . . . -112.51 172.31 7.0 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.111 175.818 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -79.15 -30.17 43.44 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.451 -0.5 . . . . 0.0 110.534 -178.538 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.499 ' HB2' HD21 ' A' ' 103' ' ' LEU . 70.7 p -150.91 157.94 43.53 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.283 -178.604 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.561 ' CZ ' HD11 ' A' ' 71' ' ' LEU . 27.9 m-85 -136.64 152.4 50.38 Favored 'General case' 0 C--N 1.328 -0.331 0 O-C-N 123.152 0.282 . . . . 0.0 110.487 -179.397 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 4.4 m -103.22 89.36 3.38 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.92 0.391 . . . . 0.0 110.219 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.523 HD13 HG22 ' A' ' 104' ' ' VAL . 9.4 mp -92.47 122.36 34.83 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.246 0.546 . . . . 0.0 111.189 -175.885 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.515 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 73.2 m -120.43 119.76 33.97 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.647 -179.628 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.417 ' HB ' ' HB3' ' A' ' 100' ' ' LEU . 98.9 t -85.63 107.85 16.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 174.859 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -95.31 113.9 25.62 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.172 177.576 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.569 ' HB ' ' HB2' ' A' ' 98' ' ' ASN . 96.2 t -85.48 111.25 20.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.614 179.782 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 56.5 t0 62.89 95.49 0.05 OUTLIER Pre-proline 0 N--CA 1.467 0.424 0 CA-C-N 114.825 -1.08 . . . . 0.0 112.236 178.143 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.474 ' HD3' ' O ' ' A' ' 39' ' ' ASN . 2.2 Cg_endo -85.41 1.55 8.21 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 123.167 2.578 . . . . 0.0 111.832 175.59 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -98.97 -20.29 16.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.095 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 15.3 m120 64.8 33.64 10.05 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.218 -178.582 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -73.23 -37.09 66.52 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.402 177.208 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 43.7 t -96.65 118.0 42.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.192 178.175 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.57 ' O ' ' HD2' ' A' ' 3' ' ' PRO . 53.6 t30 -85.7 135.7 33.65 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 175.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.4 ' OE2' ' HB3' ' A' ' 98' ' ' ASN . 40.6 mt-10 -115.71 159.4 21.44 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.246 0.546 . . . . 0.0 112.383 -171.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -57.96 -100.59 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 114.613 -1.176 . . . . 0.0 112.501 172.208 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 39.7 t30 -68.4 96.52 0.68 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.68 0.276 . . . . 0.0 110.325 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -73.97 78.76 1.67 Allowed 'General case' 0 C--O 1.233 0.226 0 CA-C-O 121.475 0.655 . . . . 0.0 110.39 -176.555 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 20.9 t -179.29 25.46 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.61 -1.177 . . . . 0.0 108.814 176.838 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 24.1 p-10 -118.68 -28.11 5.71 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.596 -170.03 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.569 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 22.4 p-10 -68.88 0.34 4.54 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -169.811 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -119.92 118.38 30.58 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.157 0.503 . . . . 0.0 111.521 178.613 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.518 ' HB2' ' HB2' ' A' ' 7' ' ' PRO . 26.3 tp -111.34 99.94 8.65 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.759 176.518 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 96.2 m -93.74 97.36 10.39 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.502 0.668 . . . . 0.0 110.104 178.626 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.511 ' HB3' HD23 ' A' ' 10' ' ' LEU . . . -107.99 115.73 30.67 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.166 -0.925 . . . . 0.0 109.589 178.628 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.499 HD21 ' HB2' ' A' ' 77' ' ' SER . 5.0 tt -78.65 101.39 7.46 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.523 HG22 HD13 ' A' ' 80' ' ' LEU . 29.9 m -90.57 158.78 2.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.219 -176.361 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -123.58 -170.88 13.47 Favored Glycine 0 N--CA 1.436 -1.317 0 C-N-CA 120.435 -0.888 . . . . 0.0 111.519 -178.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 18.6 p -107.95 140.05 41.67 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 177.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 47.6 tp . . . . . 0 C--N 1.33 -0.247 0 O-C-N 123.576 0.547 . . . . 0.0 110.653 -177.25 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.466 HG13 ' HD2' ' A' ' 3' ' ' PRO . 19.2 tt . . . . . 0 CA--C 1.534 0.346 0 N-CA-C 110.241 -0.281 . . . . 0.0 110.241 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.542 ' HD3' ' HD3' ' A' ' 33' ' ' LYS . 36.0 Cg_exo -60.9 136.53 66.5 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.411 2.074 . . . . 0.0 112.389 174.456 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -117.09 86.86 2.59 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 177.424 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.422 HD22 HD23 ' A' ' 57' ' ' LEU . 82.5 mt -82.1 107.96 15.2 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.332 -170.687 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.407 ' HA ' ' HD2' ' A' ' 7' ' ' PRO . 18.6 t -123.32 106.33 33.15 Favored Pre-proline 0 C--N 1.32 -0.702 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.984 -177.287 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.552 ' HD2' ' O ' ' A' ' 97' ' ' ASN . 11.2 Cg_endo -57.75 119.44 6.7 Favored 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 122.361 2.041 . . . . 0.0 110.465 167.596 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.9 t -93.16 -54.27 7.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.099 -169.758 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.8 p -150.79 154.36 37.17 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.051 0.453 . . . . 0.0 111.688 -177.609 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 49.8 tp -121.98 110.25 15.6 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.675 177.124 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 16.1 p -118.2 143.94 33.94 Favored Pre-proline 0 C--N 1.32 -0.71 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.949 -178.388 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -88.97 160.62 39.53 Favored 'Cis proline' 0 N--CA 1.458 -0.599 0 C-N-CA 123.372 -1.512 . . . . 0.0 112.414 -2.359 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 31.7 m -81.52 6.05 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.045 0.45 . . . . 0.0 111.343 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.406 ' HA ' ' O ' ' A' ' 105' ' ' GLY . 0.1 OUTLIER -141.96 129.77 21.71 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 176.776 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.488 HG21 HD21 ' A' ' 71' ' ' LEU . 17.3 m -121.9 153.1 25.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 -171.725 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.435 ' HA ' ' HD3' ' A' ' 17' ' ' PRO . 2.5 t -83.83 110.98 29.04 Favored Pre-proline 0 CA--C 1.533 0.296 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 -179.482 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 16' ' ' VAL . 6.3 Cg_exo -79.75 58.3 6.9 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 123.288 2.659 . . . . 0.0 113.803 -172.574 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.405 ' OD1' HG12 ' A' ' 16' ' ' VAL . 33.2 p-10 -163.0 13.43 0.07 Allowed 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 176.827 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 15.3 t -162.34 179.23 8.0 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.711 0.291 . . . . 0.0 110.371 -177.305 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.556 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 41.1 t -84.05 119.91 34.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 176.404 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.404 ' ND2' HD23 ' A' ' 71' ' ' LEU . 24.4 m-80 -100.33 114.29 27.68 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.27 -177.779 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.52 ' HA ' ' O ' ' A' ' 67' ' ' PHE . 33.5 m -79.52 90.15 5.09 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 176.636 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' MET . . . . . 0.633 ' O ' ' HA ' ' A' ' 66' ' ' ASP . 82.1 mtp -87.32 153.43 21.47 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.901 -176.02 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.476 ' CG2' ' HB3' ' A' ' 64' ' ' ASN . 10.9 m -115.72 112.99 22.87 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.313 -174.876 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -101.7 116.03 31.84 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 173.759 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 28.7 m -83.85 109.08 17.27 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.167 -178.591 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.426 HD11 HG11 ' A' ' 82' ' ' VAL . 27.7 mm -103.22 117.96 49.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.54 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 31.0 tt0 -111.09 135.5 51.52 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.147 0.498 . . . . 0.0 111.301 -177.268 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 25.5 t30 -97.17 95.07 7.5 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.536 -0.757 . . . . 0.0 109.354 176.521 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 64.6 mt-30 -87.96 51.06 2.11 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.362 0.601 . . . . 0.0 110.555 -175.104 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -144.39 168.17 26.77 Favored Glycine 0 N--CA 1.445 -0.755 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.196 -178.781 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 31.4 p-10 -88.17 -1.98 58.33 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.806 0.336 . . . . 0.0 111.604 -173.105 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.542 ' HD3' ' HD3' ' A' ' 3' ' ' PRO . 85.1 tttt -111.27 128.74 56.03 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.773 0.32 . . . . 0.0 110.412 179.49 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -67.84 135.18 52.15 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.841 179.533 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.567 ' HB3' ' HB3' ' A' ' 57' ' ' LEU . 29.5 t -89.64 139.55 30.44 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.108 -178.861 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -88.22 -165.7 1.39 Allowed 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.717 179.636 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.428 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 31.9 m -61.01 119.38 8.18 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.961 0.41 . . . . 0.0 111.746 -177.479 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.497 ' CE2' HG23 ' A' ' 40' ' ' VAL . 24.4 p90 -135.06 155.72 50.26 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.887 179.523 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.5 ' HB2' ' HD2' ' A' ' 86' ' ' PRO . 84.6 m-20 -99.21 117.31 33.4 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.747 -0.206 . . . . 0.0 110.855 -176.449 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.497 HG23 ' CE2' ' A' ' 38' ' ' PHE . 2.3 t -104.08 114.3 43.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 121.285 0.564 . . . . 0.0 109.779 175.627 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 19.4 p -110.57 138.32 47.12 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.573 -0.739 . . . . 0.0 111.135 -175.362 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 51.3 tp -98.06 117.92 33.5 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.015 177.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.9 mp -104.71 127.66 52.56 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.432 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 97.9 t -99.55 103.54 14.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.822 177.083 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 59.93 17.88 7.0 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.565 179.384 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 123.55 -26.91 5.88 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.744 -0.741 . . . . 0.0 113.036 177.499 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 6.2 mt -91.79 147.17 5.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.995 0.397 . . . . 0.0 110.173 -178.271 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 61.4 t -91.18 121.26 41.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-O 120.799 0.333 . . . . 0.0 110.437 -177.726 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 30.9 m -104.74 -28.01 3.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.541 -0.299 . . . . 0.0 111.639 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -151.15 138.84 19.72 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 121.127 -0.229 . . . . 0.0 110.537 -177.893 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 28.5 m -127.49 110.82 13.14 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 175.317 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.19 121.4 44.79 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.14 0.495 . . . . 0.0 110.304 -175.502 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 59.1 m -82.11 110.87 17.72 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.685 178.789 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.428 ' O ' ' HA ' ' A' ' 37' ' ' SER . 40.9 t -85.2 121.36 36.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 177.264 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -59.37 -39.87 84.68 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.863 -173.398 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 42.7 t -175.45 155.01 1.75 Allowed 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.567 ' HB3' ' HB3' ' A' ' 35' ' ' SER . 18.7 tp -130.74 110.74 11.57 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.185 0.517 . . . . 0.0 109.946 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.521 ' HB3' ' HB2' ' A' ' 61' ' ' ASN . 26.3 tt0 -61.65 149.61 38.91 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.55 -174.592 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.3 p -60.73 128.93 38.97 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.669 -179.358 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 60.98 25.41 15.44 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.012 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.521 ' HB2' ' HB3' ' A' ' 58' ' ' GLU . 17.9 m-80 -121.4 160.25 24.47 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.607 178.719 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.54 ' HA ' ' HA ' ' A' ' 28' ' ' GLU . 0.0 OUTLIER -116.07 144.13 44.54 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.399 178.58 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 19.6 m -121.52 134.05 55.04 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.385 177.401 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.476 ' HB3' ' CG2' ' A' ' 24' ' ' THR . 88.7 m-20 -88.86 115.62 26.54 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.494 -179.712 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 6.4 t -97.66 112.58 30.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.492 -178.211 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.633 ' HA ' ' O ' ' A' ' 23' ' ' MET . 16.7 m-20 -97.31 115.17 27.18 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.977 0.418 . . . . 0.0 110.772 -178.553 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.52 ' O ' ' HA ' ' A' ' 22' ' ' THR . 84.4 m-85 -91.97 165.19 13.34 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.246 -177.039 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 38.5 m-70 -114.78 87.73 2.71 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 175.717 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 16.4 t90 -110.33 113.01 25.33 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.284 0.564 . . . . 0.0 111.224 -176.435 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.556 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 5.7 m -81.69 114.05 20.1 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.015 176.572 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.488 HD21 HG21 ' A' ' 15' ' ' VAL . 0.5 OUTLIER -69.09 118.23 11.74 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.058 0.456 . . . . 0.0 111.329 -178.211 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -77.53 -34.76 53.82 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.845 177.783 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 83.47 15.63 70.8 Favored Glycine 0 C--N 1.329 0.194 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.661 176.587 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 22.9 m -75.81 -27.73 58.05 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.909 0.385 . . . . 0.0 111.013 -179.4 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -130.92 160.93 33.06 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.526 -178.435 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.437 ' HA ' HG23 ' A' ' 106' ' ' THR . 36.8 m-80 -101.9 -4.0 26.94 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.235 0.541 . . . . 0.0 110.452 177.9 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 37.3 m -144.71 118.38 9.2 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.022 177.498 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 81.1 m-85 -112.41 139.46 47.96 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.903 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.416 ' HA ' HD23 ' A' ' 103' ' ' LEU . 8.3 m -92.1 85.77 5.59 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.068 0.461 . . . . 0.0 109.949 179.184 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.437 HD13 HG22 ' A' ' 104' ' ' VAL . 7.6 mp -81.96 117.14 21.95 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.559 0.695 . . . . 0.0 110.979 -176.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.508 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 12.9 m -115.96 118.07 31.9 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.172 -177.514 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.426 HG11 HD11 ' A' ' 27' ' ' ILE . 66.5 t -87.81 110.25 20.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 177.852 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -98.91 112.65 24.69 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.885 0.374 . . . . 0.0 110.257 175.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.554 ' HB ' ' HB2' ' A' ' 98' ' ' ASN . 86.6 t -84.58 111.91 20.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.826 179.591 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 18.6 t0 65.38 96.04 0.05 OUTLIER Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 114.924 -1.034 . . . . 0.0 112.779 176.13 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.5 ' HD2' ' HB2' ' A' ' 39' ' ' ASN . 98.4 Cg_endo -95.16 6.05 2.21 Favored 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 123.186 2.59 . . . . 0.0 111.923 173.194 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -103.05 -11.39 18.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.615 -176.431 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 65.7 t30 68.22 32.64 4.68 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.708 0.766 . . . . 0.0 109.555 -176.101 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -73.76 -38.57 64.67 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.987 177.621 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 65.7 t -128.92 115.06 35.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.17 -179.173 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -89.1 145.32 25.53 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 175.707 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -80.24 162.09 24.82 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.167 0.508 . . . . 0.0 111.962 -174.168 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -57.49 -100.56 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.558 0 N-CA-C 109.811 -1.315 . . . . 0.0 109.811 158.117 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -65.6 105.49 1.23 Allowed 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 170.797 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -77.81 68.75 3.93 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -169.645 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 48.3 m -165.91 18.64 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 111.821 0.304 . . . . 0.0 111.821 179.389 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.552 ' O ' ' HD2' ' A' ' 7' ' ' PRO . 44.9 m-80 -115.37 -18.83 10.93 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.484 -0.487 . . . . 0.0 111.965 -173.832 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.554 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 18.6 p-10 -61.16 -9.54 4.94 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 -172.465 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 1.4 m -114.26 145.26 41.98 Favored 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 120.222 -0.591 . . . . 0.0 111.129 179.395 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.508 ' O ' ' HA ' ' A' ' 81' ' ' THR . 40.8 tp -138.81 101.64 4.36 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.674 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 26.2 m -94.28 102.48 14.48 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.801 0.334 . . . . 0.0 110.348 -179.551 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -119.05 163.14 17.42 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.955 -178.036 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.416 HD23 ' HA ' ' A' ' 79' ' ' THR . 96.2 mt -112.12 129.64 56.16 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.458 178.329 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.437 HG22 HD13 ' A' ' 80' ' ' LEU . 34.2 m -119.35 141.76 37.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.788 177.17 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.406 ' O ' ' HA ' ' A' ' 14' ' ' THR . . . -111.57 177.47 18.93 Favored Glycine 0 N--CA 1.443 -0.837 0 C-N-CA 120.373 -0.918 . . . . 0.0 111.685 -177.327 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.437 HG23 ' HA ' ' A' ' 76' ' ' ASN . 40.2 p -87.59 131.98 34.22 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 120.866 0.365 . . . . 0.0 110.044 176.806 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 33.1 tp . . . . . 0 C--N 1.325 -0.481 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.663 -176.125 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.432 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 7.7 tt . . . . . 0 C--O 1.236 0.38 0 N-CA-C 110.257 -0.275 . . . . 0.0 110.257 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.486 ' HD3' ' HD3' ' A' ' 33' ' ' LYS . 3.6 Cg_exo -82.11 122.69 3.82 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 122.919 2.413 . . . . 0.0 111.068 172.63 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -111.57 95.01 5.25 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 -179.607 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.484 HD22 HD23 ' A' ' 57' ' ' LEU . 87.5 mt -79.83 108.73 13.62 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.56 -175.923 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.416 ' HA ' ' HD2' ' A' ' 7' ' ' PRO . 60.3 t -116.15 109.41 44.62 Favored Pre-proline 0 C--N 1.321 -0.647 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.097 -177.311 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.501 ' HD2' ' O ' ' A' ' 97' ' ' ASN . 28.4 Cg_endo -66.21 102.47 0.57 Allowed 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 122.219 1.946 . . . . 0.0 109.929 167.3 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 15.1 t -78.64 -55.78 9.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.674 -169.846 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 50.7 m -150.28 155.84 40.44 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.982 0.42 . . . . 0.0 111.172 -177.441 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 55.2 tp -119.27 107.35 13.3 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.21 177.296 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.7 p -117.76 146.17 38.22 Favored Pre-proline 0 C--N 1.32 -0.68 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.524 -175.297 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -79.55 164.16 82.64 Favored 'Cis proline' 0 CA--C 1.53 0.289 0 C-N-CA 123.153 -1.603 . . . . 0.0 112.639 -0.009 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 34.8 m -80.16 -22.03 11.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.043 0.449 . . . . 0.0 110.887 -179.173 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.574 ' HB ' ' HA ' ' A' ' 107' ' ' LEU . 23.2 p -114.5 130.43 56.74 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.741 174.79 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.9 m -113.48 157.48 14.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.257 0.551 . . . . 0.0 112.153 -171.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.712 HG22 HD22 ' A' ' 107' ' ' LEU . 21.3 t -92.64 107.22 22.51 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.148 -177.714 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.572 ' HA ' ' HB3' ' A' ' 71' ' ' LEU . 7.1 Cg_exo -74.21 9.9 1.63 Allowed 'Trans proline' 0 CA--C 1.531 0.373 0 C-N-CA 123.492 2.795 . . . . 0.0 114.497 -171.391 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -127.51 27.88 5.75 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.711 0.291 . . . . 0.0 111.574 -177.511 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 15.0 t -167.94 167.77 12.56 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.244 179.323 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.531 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 58.2 t -79.94 124.46 38.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 174.684 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.473 HD22 ' N ' ' A' ' 21' ' ' ASN . 0.9 OUTLIER -100.14 117.79 35.12 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.908 0.385 . . . . 0.0 110.244 -175.249 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.494 HG22 ' HB3' ' A' ' 66' ' ' ASP . 6.9 m -83.21 83.85 7.71 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 173.566 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' MET . . . . . 0.521 ' O ' ' HA ' ' A' ' 66' ' ' ASP . 71.8 mtp -82.31 142.36 32.12 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.899 -174.024 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.483 HG23 ' HB2' ' A' ' 64' ' ' ASN . 26.5 m -106.93 110.52 22.7 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.094 -175.695 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.605 ' HB3' ' HB ' ' A' ' 65' ' ' VAL . . . -91.76 122.21 34.1 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 172.389 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 24.4 m -91.24 104.67 17.19 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.236 -177.233 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 15.5 mm -102.04 117.1 46.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 179.444 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.569 ' HG2' ' HB3' ' A' ' 62' ' ' SER . 53.0 mt-10 -109.6 139.7 44.3 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.945 0.403 . . . . 0.0 110.862 179.652 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.539 ' HB2' ' HG ' ' A' ' 57' ' ' LEU . 32.5 t30 -92.31 93.88 8.87 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.766 175.264 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 83.0 mm-40 -90.06 52.1 2.2 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.683 0.754 . . . . 0.0 110.236 -178.526 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -144.07 157.48 27.13 Favored Glycine 0 N--CA 1.441 -0.977 0 N-CA-C 110.353 -1.099 . . . . 0.0 110.353 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 33.8 p-10 -85.63 5.18 32.97 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.896 0.379 . . . . 0.0 111.76 -173.4 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.486 ' HD3' ' HD3' ' A' ' 3' ' ' PRO . 63.6 tttp -116.43 135.07 54.16 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 173.645 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -71.53 139.89 49.69 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.833 0.349 . . . . 0.0 110.161 -179.052 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.423 ' CB ' HD21 ' A' ' 5' ' ' LEU . 35.7 t -94.94 139.38 31.41 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.722 -177.026 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 24.3 p -83.45 -165.27 1.06 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.472 177.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 26.1 t -57.29 131.6 50.51 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.923 0.392 . . . . 0.0 110.943 178.08 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.421 ' CE2' HG23 ' A' ' 40' ' ' VAL . 31.3 p90 -142.46 148.62 38.03 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.395 177.211 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.465 ' O ' ' HA ' ' A' ' 85' ' ' ASP . 65.8 t30 -104.34 112.9 26.12 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.307 -172.013 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.587 HG22 ' HA ' ' A' ' 84' ' ' VAL . 2.2 t -102.77 123.47 56.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.035 0.445 . . . . 0.0 110.503 -175.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 11.2 t -114.17 144.32 43.38 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.553 -175.783 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.421 HD11 ' HB3' ' A' ' 80' ' ' LEU . 51.2 tp -105.9 112.58 25.69 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.232 178.414 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.8 mp -101.21 127.25 47.88 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.635 179.11 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.545 HG22 ' HG ' ' A' ' 80' ' ' LEU . 92.3 t -110.7 104.2 16.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 -177.773 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 64.49 19.2 11.72 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.049 0.452 . . . . 0.0 110.555 -176.15 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 117.74 -27.08 7.7 Favored Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.995 178.074 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.528 HG23 ' O ' ' A' ' 44' ' ' VAL . 0.1 OUTLIER -91.94 136.58 24.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.425 0.631 . . . . 0.0 112.385 -174.832 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 88.8 t -78.59 105.84 8.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.325 179.054 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 22.8 m -86.81 -40.64 14.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.588 179.621 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -155.29 154.95 32.89 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.714 0.292 . . . . 0.0 110.47 -178.195 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 13.6 m -143.4 130.29 20.5 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.028 -174.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -119.87 124.56 46.35 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.239 -179.235 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.427 ' HA ' ' HA ' ' A' ' 39' ' ' ASN . 15.5 m -90.92 116.02 28.41 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.912 0.387 . . . . 0.0 110.181 177.828 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.431 HG13 HG21 ' A' ' 63' ' ' THR . 43.0 t -82.34 140.32 16.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.987 -178.854 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 28.6 m -71.59 -43.35 66.42 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.82 0.343 . . . . 0.0 111.194 -177.48 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 32.6 t -173.14 146.94 1.52 Allowed 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 -177.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.539 ' HG ' ' HB2' ' A' ' 29' ' ' ASN . 31.5 tp -128.51 107.13 9.47 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.314 0.578 . . . . 0.0 109.963 178.924 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -75.34 163.04 27.87 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.986 -173.699 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 13.4 m -64.71 132.12 48.75 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.439 178.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 42.7 mm-40 67.12 9.41 6.91 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.522 -179.557 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -101.14 148.52 24.99 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.449 -0.342 . . . . 0.0 110.188 179.695 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.569 ' HB3' ' HG2' ' A' ' 28' ' ' GLU . 33.5 p -113.9 131.01 56.44 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.9 176.203 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.431 HG21 HG13 ' A' ' 54' ' ' VAL . 54.0 m -107.51 125.66 51.55 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 120.955 0.407 . . . . 0.0 110.084 175.914 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.483 ' HB2' HG23 ' A' ' 24' ' ' THR . 5.0 p-10 -80.34 114.76 19.47 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.093 177.935 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.605 ' HB ' ' HB3' ' A' ' 25' ' ' ALA . 21.9 t -96.7 105.89 17.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.773 178.227 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.521 ' HA ' ' O ' ' A' ' 23' ' ' MET . 41.8 m-20 -99.81 111.34 23.66 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.468 -175.844 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.474 ' O ' ' HA ' ' A' ' 22' ' ' THR . 72.1 m-85 -91.79 158.57 16.27 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.914 -176.864 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 30.8 m-70 -110.13 88.22 2.7 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.428 178.859 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 13.2 t90 -117.33 113.8 22.66 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.102 -175.332 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.531 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 5.7 t -80.12 120.49 24.33 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 171.789 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.572 ' HB3' ' HA ' ' A' ' 17' ' ' PRO . 0.2 OUTLIER -65.9 -45.03 83.48 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.598 -170.047 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.439 ' HB3' ' O ' ' A' ' 71' ' ' LEU . 20.9 t70 73.0 -54.27 0.7 Allowed 'General case' 0 N--CA 1.469 0.498 0 O-C-N 123.968 0.792 . . . . 0.0 110.503 -174.268 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 90.93 51.98 2.51 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 121.059 -0.591 . . . . 0.0 111.997 179.675 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -84.75 -38.67 19.37 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.139 0.495 . . . . 0.0 110.509 -179.23 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -134.93 171.13 14.84 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.919 -177.357 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.412 ' O ' HG23 ' A' ' 106' ' ' THR . 28.2 p-10 -79.15 -15.17 58.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.379 -178.309 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.489 ' HB3' ' CD2' ' A' ' 103' ' ' LEU . 44.2 m -154.87 147.74 24.51 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.717 0.294 . . . . 0.0 110.765 -177.733 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -126.99 142.66 51.49 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.215 178.44 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 5.7 m -90.58 90.95 8.21 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.769 0.319 . . . . 0.0 110.428 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.554 HD13 HG22 ' A' ' 104' ' ' VAL . 10.9 mp -91.64 116.22 28.7 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.354 0.597 . . . . 0.0 111.172 -176.937 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.46 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 52.9 m -113.75 118.86 35.48 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.473 -179.5 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.486 ' HB ' ' HB3' ' A' ' 100' ' ' LEU . 60.3 t -88.1 106.91 16.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.617 176.359 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -100.29 110.92 23.17 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 177.388 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.587 ' HA ' HG22 ' A' ' 40' ' ' VAL . 69.7 t -76.04 110.38 11.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.902 -179.102 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.465 ' HA ' ' O ' ' A' ' 39' ' ' ASN . 1.8 t70 56.52 94.97 0.05 OUTLIER Pre-proline 0 N--CA 1.465 0.29 0 CA-C-N 114.32 -1.309 . . . . 0.0 112.035 178.622 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -60.15 -24.74 77.94 Favored 'Trans proline' 0 N--CA 1.473 0.289 0 C-N-CA 123.369 2.713 . . . . 0.0 112.806 -178.192 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -92.12 -18.0 24.16 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.207 -179.416 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 25.6 m120 53.08 54.97 9.54 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.818 -171.034 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.85 -40.07 94.05 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.999 -178.701 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 41.0 t -83.71 139.36 17.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.79 178.334 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 60.9 t30 -75.09 95.04 2.99 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 175.234 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.411 ' CD ' HD21 ' A' ' 98' ' ' ASN . 20.5 mt-10 -93.88 177.18 6.08 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.28 -173.529 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -58.14 -100.78 0.01 OUTLIER Glycine 0 CA--C 1.521 0.432 0 CA-C-N 115.341 -0.845 . . . . 0.0 113.063 175.709 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 55.6 t30 -117.32 145.12 44.22 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.746 0.308 . . . . 0.0 110.242 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.638 ' HA ' ' OD1' ' A' ' 98' ' ' ASN . 42.3 mt-10 -75.43 -12.91 60.34 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.013 0.435 . . . . 0.0 111.567 -174.352 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 16.4 m -69.62 -9.57 54.67 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.793 -178.167 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.501 ' O ' ' HD2' ' A' ' 7' ' ' PRO . 2.6 p-10 -117.78 10.64 13.34 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.906 -0.318 . . . . 0.0 111.458 177.935 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.638 ' OD1' ' HA ' ' A' ' 95' ' ' GLU . 7.5 m120 -76.42 -27.69 56.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.859 0.361 . . . . 0.0 110.764 177.361 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -103.75 122.66 45.55 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.718 -179.484 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.486 ' HB3' ' HB ' ' A' ' 82' ' ' VAL . 38.5 tp -109.32 100.17 9.33 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.89 173.353 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 41.5 m -87.58 97.39 10.83 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.218 0.533 . . . . 0.0 110.371 179.32 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -113.28 107.39 15.82 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.964 179.472 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.489 ' CD2' ' HB3' ' A' ' 77' ' ' SER . 5.0 tt -83.81 105.67 14.89 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 108.806 -0.812 . . . . 0.0 108.806 -178.813 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.554 HG22 HD13 ' A' ' 80' ' ' LEU . 21.2 m -89.64 144.13 9.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.614 -174.562 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -107.38 -179.03 22.47 Favored Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 120.793 -0.718 . . . . 0.0 111.31 -179.767 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.412 HG23 ' O ' ' A' ' 76' ' ' ASN . 23.0 p -83.43 153.36 24.53 Favored 'General case' 0 C--N 1.315 -0.904 0 C-N-CA 120.904 -0.318 . . . . 0.0 110.481 178.738 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.712 HD22 HG22 ' A' ' 16' ' ' VAL . 19.2 tp . . . . . 0 C--N 1.331 -0.211 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.954 -178.235 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.415 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 6.6 tt . . . . . 0 N--CA 1.452 -0.334 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.451 ' HD2' ' O ' ' A' ' 91' ' ' ASN . 3.3 Cg_exo -84.26 156.94 12.86 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.804 2.336 . . . . 0.0 111.34 171.447 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -138.75 108.67 6.32 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 174.305 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.533 HD22 HD23 ' A' ' 57' ' ' LEU . 69.4 mt -99.81 126.96 45.98 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -173.422 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.441 HG22 ' ND2' ' A' ' 97' ' ' ASN . 2.4 t -125.36 140.39 36.12 Favored Pre-proline 0 C--N 1.317 -0.844 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.332 -176.234 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.443 ' HB2' ' HB2' ' A' ' 100' ' ' LEU . 9.3 Cg_endo -92.8 93.31 0.16 Allowed 'Trans proline' 0 N--CA 1.445 -1.367 0 C-N-CA 122.952 2.435 . . . . 0.0 109.758 166.955 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 28.3 m -83.84 -12.88 11.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-N 115.869 -0.605 . . . . 0.0 112.313 -169.233 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 31.4 t -163.43 143.42 8.71 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.124 0.487 . . . . 0.0 111.723 -176.452 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 62.7 tp -127.8 126.93 42.63 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.065 175.09 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.0 p -137.7 145.28 48.04 Favored Pre-proline 0 C--N 1.32 -0.709 0 CA-C-N 116.572 -0.286 . . . . 0.0 110.813 -177.521 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.493 ' HD2' ' SD ' ' A' ' 23' ' ' MET . 98.3 Cg_endo -80.23 163.02 82.89 Favored 'Cis proline' 0 N--CA 1.465 -0.199 0 C-N-CA 123.369 -1.513 . . . . 0.0 112.719 -1.555 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 24.5 m -85.51 -15.26 10.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.152 0.501 . . . . 0.0 110.565 177.828 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.567 ' HA ' ' O ' ' A' ' 105' ' ' GLY . 0.1 OUTLIER -131.61 124.94 30.98 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.647 174.718 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.411 HG12 ' HG2' ' A' ' 12' ' ' PRO . 20.5 m -114.57 150.47 16.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.625 -0.261 . . . . 0.0 111.141 -174.064 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.411 ' HA ' ' HD3' ' A' ' 17' ' ' PRO . 6.2 m -88.53 121.55 70.05 Favored Pre-proline 0 N--CA 1.445 -0.685 0 CA-C-O 120.957 0.408 . . . . 0.0 110.194 176.289 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.467 ' HA ' ' CB ' ' A' ' 71' ' ' LEU . 17.6 Cg_exo -68.04 172.51 10.77 Favored 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 122.497 2.132 . . . . 0.0 112.59 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 43.8 m-80 71.93 25.06 3.16 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.274 175.474 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 12.9 t -175.69 175.62 2.03 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.654 -0.248 . . . . 0.0 110.386 177.229 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.814 HG22 ' HB ' ' A' ' 70' ' ' THR . 44.4 t -91.24 135.37 27.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.343 178.51 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 21.7 m-80 -108.71 149.88 28.37 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.467 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.9 m -83.05 91.02 7.11 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.258 179.444 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' MET . . . . . 0.526 ' HB2' ' HB2' ' A' ' 67' ' ' PHE . 89.8 mmm -81.6 109.75 16.33 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.372 0.606 . . . . 0.0 110.246 -178.727 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 25.5 m -103.26 110.15 22.02 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.474 -177.491 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -101.33 120.13 39.79 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.072 178.062 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 28.5 m -85.88 104.43 15.53 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.62 -178.538 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.423 HG12 HG23 ' A' ' 65' ' ' VAL . 23.3 mm -98.5 119.35 46.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 178.691 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -120.55 139.18 53.31 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.425 -175.174 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.474 ' O ' ' HA ' ' A' ' 60' ' ' GLU . 54.8 t-20 -91.87 99.72 12.53 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 178.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -102.14 52.25 0.81 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.651 0.738 . . . . 0.0 110.418 -176.808 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -143.94 175.81 23.61 Favored Glycine 0 N--CA 1.446 -0.634 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.093 179.042 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -99.8 45.49 0.99 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.287 0.565 . . . . 0.0 111.402 -173.88 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.486 ' HG2' ' N ' ' A' ' 34' ' ' ASP . 50.3 tttm -161.49 157.06 24.38 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.254 169.167 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.486 ' N ' ' HG2' ' A' ' 33' ' ' LYS . 8.7 p-10 -68.42 165.13 19.48 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.06 173.553 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.474 ' OG ' ' HB3' ' A' ' 57' ' ' LEU . 10.0 p -129.99 134.4 47.41 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.925 0.393 . . . . 0.0 110.703 178.164 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 11.3 p -80.66 -167.59 1.43 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.322 -177.098 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 18.8 t -62.61 120.78 11.82 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.058 0.456 . . . . 0.0 111.109 -177.06 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -131.46 160.19 35.87 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.685 178.842 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -106.08 125.63 51.23 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 121.277 -0.169 . . . . 0.0 110.617 -176.219 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.573 HG11 HG21 ' A' ' 65' ' ' VAL . 1.4 t -111.49 123.85 67.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.156 0.503 . . . . 0.0 110.546 178.216 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 18.2 m -117.83 145.5 44.51 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.912 -176.184 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 49.7 tp -104.04 108.87 20.42 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.853 176.536 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.7 mp -98.45 112.73 24.66 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.201 -179.11 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 87.8 t -97.12 107.08 19.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.113 179.7 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 59.08 22.21 10.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.656 178.026 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 116.36 -25.19 9.37 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.598 -0.81 . . . . 0.0 112.953 176.358 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 8.8 mt -96.39 151.31 4.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 -178.663 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 47.5 t -97.2 109.69 23.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 110.094 -0.335 . . . . 0.0 110.094 -178.503 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 28.1 m -87.18 -29.72 5.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 C-N-CA 120.904 -0.318 . . . . 0.0 111.502 -177.26 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -158.0 159.56 36.55 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.836 0.35 . . . . 0.0 110.537 -179.175 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 95.9 m -149.81 126.87 11.23 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.986 -178.375 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -125.04 122.85 38.42 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.93 0.395 . . . . 0.0 109.988 179.182 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 19.5 m -80.09 130.88 35.58 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.056 177.742 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 42.6 t -98.16 131.72 44.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.2 m -61.55 -47.0 87.55 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.717 -177.093 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 29.8 t -179.98 152.8 0.48 Allowed 'General case' 0 C--O 1.235 0.293 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 -178.469 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.533 HD23 HD22 ' A' ' 5' ' ' LEU . 40.3 tp -129.75 125.68 36.4 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.057 0.456 . . . . 0.0 110.323 178.816 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -76.56 160.2 29.65 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.042 -176.364 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 10.5 m -60.31 120.18 9.35 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.259 -177.26 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.474 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 44.2 mt-10 60.81 25.53 15.41 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.325 177.585 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -101.24 160.96 13.96 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 171.663 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -122.31 119.03 29.91 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 -176.706 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 54.1 m -111.5 127.17 55.62 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.072 0.463 . . . . 0.0 110.719 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -86.76 134.89 33.54 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.54 179.5 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.573 HG21 HG11 ' A' ' 40' ' ' VAL . 28.2 t -96.16 133.55 36.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.154 179.544 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -97.75 97.0 8.63 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.297 -177.641 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.526 ' HB2' ' HB2' ' A' ' 23' ' ' MET . 21.3 m-85 -97.66 152.38 19.15 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.669 178.979 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 17.1 m80 -120.77 93.7 4.12 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 178.713 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 24.0 t90 -114.83 118.58 33.95 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.319 -174.084 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.814 ' HB ' HG22 ' A' ' 20' ' ' VAL . 15.1 t -89.73 144.85 25.64 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.433 179.46 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.467 ' CB ' ' HA ' ' A' ' 17' ' ' PRO . 3.1 mm? -110.47 127.46 55.15 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.94 0.4 . . . . 0.0 111.763 179.554 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 -90.39 -28.3 18.76 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.682 172.133 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 87.44 33.91 11.07 Favored Glycine 0 N--CA 1.448 -0.517 0 N-CA-C 111.226 -0.75 . . . . 0.0 111.226 -175.268 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.63 -33.03 74.15 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.229 0.538 . . . . 0.0 110.711 -178.607 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -141.27 155.54 45.98 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.237 -178.821 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -67.89 -30.97 70.45 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.426 178.003 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 19.5 m -136.85 135.96 38.35 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.073 0.464 . . . . 0.0 110.898 -179.025 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -112.48 146.46 38.42 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.12 178.399 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.488 ' HA ' HD23 ' A' ' 103' ' ' LEU . 6.6 m -95.43 87.61 4.83 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.885 0.374 . . . . 0.0 110.499 -178.996 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.513 HD13 HG22 ' A' ' 104' ' ' VAL . 9.4 mp -87.7 120.16 28.74 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.184 0.516 . . . . 0.0 111.272 -176.855 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.58 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 73.5 m -119.64 115.7 24.49 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.606 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 46.5 t -88.16 107.8 17.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.648 175.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -97.97 117.15 31.68 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.847 0.356 . . . . 0.0 110.075 176.908 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.542 ' HB ' ' HB2' ' A' ' 98' ' ' ASN . 94.7 t -85.71 109.01 17.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.957 -179.706 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 39.2 t0 65.68 91.91 0.07 OUTLIER Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 114.583 -1.189 . . . . 0.0 112.002 178.221 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -89.52 6.23 4.47 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 123.021 2.481 . . . . 0.0 111.714 174.521 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -110.76 -8.98 14.51 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.38 -178.123 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 56.64 53.9 7.93 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.266 178.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -88.91 -35.3 16.58 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.55 176.545 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 61.6 t -108.76 119.73 58.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.439 -0.801 . . . . 0.0 109.882 176.016 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.451 ' O ' ' HD2' ' A' ' 3' ' ' PRO . 53.4 m-80 -74.12 124.19 25.85 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.443 179.212 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.492 ' HB2' ' HA ' ' A' ' 95' ' ' GLU . 0.4 OUTLIER -95.93 150.51 20.36 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.587 -175.543 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -57.78 -100.87 0.01 OUTLIER Glycine 0 CA--C 1.52 0.359 0 CA-C-N 115.068 -0.969 . . . . 0.0 112.734 172.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.467 ' HB3' ' OD1' ' A' ' 97' ' ' ASN . 11.1 t30 -65.33 -24.15 67.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.644 0.259 . . . . 0.0 110.491 -177.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.492 ' HA ' ' HB2' ' A' ' 92' ' ' GLU . 29.5 tt0 76.02 -63.0 0.41 Allowed 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 168.329 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 37.0 m -64.83 -4.93 4.92 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -171.034 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.467 ' OD1' ' HB3' ' A' ' 94' ' ' ASN . 4.0 p-10 -96.01 11.06 35.4 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.808 178.4 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.542 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 24.4 p-10 -85.0 3.02 40.51 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.92 0.39 . . . . 0.0 110.487 179.031 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -119.31 118.32 30.92 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 121.215 0.531 . . . . 0.0 111.575 -178.594 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.58 ' O ' ' HA ' ' A' ' 81' ' ' THR . 25.2 tp -108.46 99.39 8.78 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.241 178.568 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 93.1 m -92.15 97.75 11.11 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 121.155 0.503 . . . . 0.0 109.717 175.304 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -114.88 126.37 54.72 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.344 -177.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.488 HD23 ' HA ' ' A' ' 79' ' ' THR . 51.2 mt -78.93 115.88 18.9 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.214 0.531 . . . . 0.0 110.573 177.641 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.513 HG22 HD13 ' A' ' 80' ' ' LEU . 23.0 m -106.36 144.56 15.39 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.01 178.279 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.567 ' O ' ' HA ' ' A' ' 14' ' ' THR . . . -118.96 169.9 13.69 Favored Glycine 0 N--CA 1.437 -1.255 0 C-N-CA 120.004 -1.094 . . . . 0.0 111.271 -177.366 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 41.6 p -77.06 129.88 36.66 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 173.484 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 42.7 tp . . . . . 0 C--N 1.324 -0.505 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.19 -176.927 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.459 HG13 ' HD2' ' A' ' 3' ' ' PRO . 18.3 tt . . . . . 0 N--CA 1.451 -0.392 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.53 ' HD3' ' HD3' ' A' ' 33' ' ' LYS . 58.2 Cg_endo -76.0 157.1 38.68 Favored 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 122.453 2.102 . . . . 0.0 112.325 176.2 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -146.05 100.12 3.35 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 179.474 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.539 HD22 HD23 ' A' ' 57' ' ' LEU . 41.0 mt -99.88 126.76 46.06 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-O 121.545 0.688 . . . . 0.0 109.265 -170.939 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 6.0 t -125.46 140.37 36.17 Favored Pre-proline 0 N--CA 1.441 -0.92 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.638 -175.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.458 ' HB2' ' HB2' ' A' ' 100' ' ' LEU . 1.1 Cg_endo -87.34 107.09 0.65 Allowed 'Trans proline' 0 N--CA 1.446 -1.29 0 C-N-CA 122.815 2.343 . . . . 0.0 109.63 166.489 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.9 t -76.91 -60.23 2.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.566 -170.552 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 9.5 t -154.65 154.97 33.82 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 177.663 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.411 ' HA ' ' O ' ' A' ' 24' ' ' THR . 1.8 pp -127.95 127.49 43.38 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.399 0.618 . . . . 0.0 110.117 177.064 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.6 p -121.63 131.66 24.39 Favored Pre-proline 0 C--N 1.311 -1.075 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.792 -175.526 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.413 ' HD2' ' SD ' ' A' ' 23' ' ' MET . 84.4 Cg_endo -90.55 175.1 20.41 Favored 'Cis proline' 0 N--CA 1.461 -0.392 0 C-N-CA 123.539 -1.442 . . . . 0.0 113.5 8.723 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.5 m -99.25 -11.98 8.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.087 0.47 . . . . 0.0 111.274 178.2 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -120.09 151.0 39.69 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 174.26 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 20.9 m -143.29 157.36 17.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.029 0.442 . . . . 0.0 111.475 -177.75 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.4 ' HA ' ' HD3' ' A' ' 17' ' ' PRO . 2.8 m -99.11 144.13 27.66 Favored Pre-proline 0 N--CA 1.448 -0.564 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.114 178.606 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.531 ' HA ' ' CB ' ' A' ' 71' ' ' LEU . 2.9 Cg_endo -82.64 165.5 15.87 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.868 2.378 . . . . 0.0 112.589 178.79 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 18.5 m120 71.87 24.2 3.4 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.639 175.428 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.5 t -163.52 162.91 24.79 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.983 -0.287 . . . . 0.0 110.592 -178.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 1.005 HG22 ' HB ' ' A' ' 70' ' ' THR . 21.2 t -94.56 130.81 42.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 175.464 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -119.65 152.63 36.79 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.273 179.694 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 90.9 m -96.83 109.22 21.96 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.332 -178.541 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' MET . . . . . 0.55 ' HB2' ' HB2' ' A' ' 67' ' ' PHE . 83.4 mmm -92.42 123.74 35.95 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.669 178.911 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.486 ' HA ' ' O ' ' A' ' 65' ' ' VAL . 19.3 m -106.87 103.06 12.4 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.637 0.256 . . . . 0.0 111.259 -177.577 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -97.75 123.12 41.55 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.494 176.28 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 18.8 m -87.81 121.29 30.05 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 120.813 0.34 . . . . 0.0 110.589 178.806 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 24.6 mm -106.88 116.37 50.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 179.67 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -110.27 128.91 55.77 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.918 0.389 . . . . 0.0 110.659 -178.547 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.431 ' ND2' ' HA ' ' A' ' 59' ' ' SER . 26.1 t30 -88.62 96.08 10.5 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.467 177.437 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 -92.74 43.98 1.14 Allowed 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.634 -174.522 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -144.08 150.13 22.17 Favored Glycine 0 N--CA 1.447 -0.582 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 179.157 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 16.1 t30 -84.47 62.77 7.46 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.497 0.665 . . . . 0.0 111.567 -172.677 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.53 ' HD3' ' HD3' ' A' ' 3' ' ' PRO . 62.3 tttp -161.46 136.84 7.63 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.321 166.833 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -72.16 114.39 10.23 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 177.633 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 16.1 p -83.56 144.77 29.26 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.054 0.454 . . . . 0.0 110.856 -178.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 3.1 p -83.4 -169.63 2.64 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.557 -178.154 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 33.0 t -54.76 132.63 46.37 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.577 -178.837 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 55.1 p90 -143.98 159.22 42.97 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.947 178.749 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 21.0 m-80 -109.04 110.5 21.79 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.483 0.182 . . . . 0.0 111.273 -175.691 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.487 HG22 ' HA ' ' A' ' 84' ' ' VAL . 1.5 t -98.43 124.85 51.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.271 0.558 . . . . 0.0 109.926 -179.594 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 18.7 m -120.56 148.18 44.2 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.047 -174.453 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 50.4 tp -102.21 117.36 34.59 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.787 177.106 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.574 ' HG ' HG22 ' A' ' 48' ' ' VAL . 5.0 mp -100.34 126.69 46.72 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.81 179.486 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 99.5 t -106.08 103.12 14.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 120.815 0.34 . . . . 0.0 110.201 179.366 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.489 ' HA ' ' HB ' ' A' ' 79' ' ' THR . 8.7 m-20 62.62 13.09 6.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.352 -0.84 . . . . 0.0 112.095 176.665 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 138.38 -38.63 1.67 Allowed Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.604 -0.808 . . . . 0.0 113.306 176.695 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 8.3 mt -98.19 150.8 4.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 120.77 0.319 . . . . 0.0 110.537 -174.874 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.574 HG22 ' HG ' ' A' ' 43' ' ' LEU . 55.9 t -87.43 127.17 40.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 -179.724 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 18.4 m -99.84 -39.34 7.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 111.852 0.316 . . . . 0.0 111.852 179.676 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -149.44 149.49 30.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.736 0.303 . . . . 0.0 110.936 -176.117 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 95.9 m -133.96 128.27 34.11 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.52 -178.157 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -118.97 119.28 33.85 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 177.637 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 25.6 m -80.9 126.42 31.34 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.362 178.922 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 47.7 t -96.6 128.92 47.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 178.443 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.8 p -56.4 -43.6 79.47 Favored 'General case' 0 C--N 1.329 -0.324 0 O-C-N 123.355 0.409 . . . . 0.0 111.957 -177.069 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 17.2 p -178.08 155.22 0.93 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.393 179.149 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.672 HD13 HG23 ' A' ' 63' ' ' THR . 17.4 tp -130.42 109.26 10.59 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.07 0.462 . . . . 0.0 109.783 177.44 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -63.98 160.86 16.92 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.41 -176.241 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.431 ' HA ' ' ND2' ' A' ' 29' ' ' ASN . 4.4 p -61.9 125.73 24.88 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.122 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 61.23 35.93 18.11 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.436 -179.623 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 13.5 m-80 -121.32 162.09 20.9 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.04 176.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 3.5 p -132.55 127.82 35.92 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.025 0.44 . . . . 0.0 111.54 -178.375 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.672 HG23 HD13 ' A' ' 57' ' ' LEU . 17.6 p -104.22 153.29 21.15 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.455 177.628 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -104.29 125.12 50.28 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 176.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.486 ' O ' ' HA ' ' A' ' 24' ' ' THR . 59.3 t -96.14 128.66 47.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-O 121.169 0.509 . . . . 0.0 110.963 -175.071 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -95.61 97.21 9.57 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.368 -177.097 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.55 ' HB2' ' HB2' ' A' ' 23' ' ' MET . 26.3 m-85 -92.26 147.18 23.13 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.212 0.529 . . . . 0.0 111.443 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 7.2 m80 -114.93 98.25 6.71 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.041 179.189 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 20.4 t90 -122.78 122.21 38.16 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.064 0.459 . . . . 0.0 111.444 -174.163 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' THR . . . . . 1.005 ' HB ' HG22 ' A' ' 20' ' ' VAL . 8.4 t -105.61 141.29 37.32 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.261 177.657 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.531 ' CB ' ' HA ' ' A' ' 17' ' ' PRO . 1.7 mm? -100.89 119.23 38.39 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.112 0.482 . . . . 0.0 111.038 176.348 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -84.37 -25.14 29.34 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.054 176.818 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -153.19 -155.21 7.04 Favored Glycine 0 N--CA 1.445 -0.731 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.856 -177.865 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 2.8 t -145.74 90.91 2.04 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-O 121.934 0.874 . . . . 0.0 111.267 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -80.87 2.45 26.47 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.882 172.772 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.487 ' O ' ' HA2' ' A' ' 105' ' ' GLY . 95.5 m-20 70.83 -59.11 0.55 Allowed 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.803 179.447 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 41.0 t -104.3 114.21 28.29 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 120.888 0.375 . . . . 0.0 110.415 -178.375 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.423 ' HB2' HG23 ' A' ' 104' ' ' VAL . 65.1 m-85 -116.92 134.0 55.31 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.323 179.105 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.489 ' HB ' ' HA ' ' A' ' 45' ' ' ASP . 7.3 m -96.69 88.05 4.52 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.911 0.386 . . . . 0.0 110.478 -177.014 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.41 HD22 HG11 ' A' ' 104' ' ' VAL . 8.1 mp -87.58 113.59 23.41 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.611 0.719 . . . . 0.0 110.56 -178.169 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.532 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 25.8 m -115.33 123.28 48.32 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.418 -177.785 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 49.5 t -90.17 112.03 24.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 176.47 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -108.19 117.76 34.98 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 175.394 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.614 ' HB ' ' HB2' ' A' ' 98' ' ' ASN . 84.8 t -83.57 103.37 10.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.995 -177.897 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.9 t70 59.81 89.54 0.1 Allowed Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 114.266 -1.334 . . . . 0.0 112.347 177.103 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -70.78 -12.46 30.99 Favored 'Trans proline' 0 C--O 1.232 0.215 0 C-N-CA 123.33 2.687 . . . . 0.0 112.217 179.487 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -89.73 -6.5 55.99 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.464 -178.79 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 65.8 t30 58.41 42.1 21.82 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.61 177.402 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -69.26 -26.79 64.94 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.334 178.05 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 61.4 t -110.6 122.63 65.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.681 176.582 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 54.0 t30 -80.86 130.4 35.03 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 176.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -125.65 159.92 30.99 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.948 0.404 . . . . 0.0 112.008 -173.076 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -58.3 -100.81 0.01 OUTLIER Glycine 0 CA--C 1.522 0.489 0 CA-C-N 114.948 -1.024 . . . . 0.0 113.818 174.293 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -58.24 160.51 5.02 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 122.972 0.509 . . . . 0.0 111.452 -177.117 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.2 2.68 24.91 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 121.144 0.497 . . . . 0.0 111.413 -175.722 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 18.3 m -125.8 24.33 7.11 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.0 0.428 . . . . 0.0 110.465 -179.657 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 26.4 p-10 -98.09 -39.94 8.66 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.705 -174.881 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.614 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 23.9 p-10 -83.77 10.68 8.9 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.316 0.488 . . . . 0.0 112.316 -168.877 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 2.6 m -119.32 150.12 40.67 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.981 0.419 . . . . 0.0 110.643 -179.237 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.532 ' O ' ' HA ' ' A' ' 81' ' ' THR . 54.2 tp -148.52 106.59 3.72 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.649 178.565 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 31.0 m -93.51 98.65 11.32 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 120.9 0.381 . . . . 0.0 110.222 177.914 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -109.46 118.98 38.06 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.374 -179.32 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.44 HD22 ' HA ' ' A' ' 103' ' ' LEU . 1.8 tm? -81.47 111.24 17.63 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.161 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.423 HG23 ' HB2' ' A' ' 78' ' ' TYR . 21.5 m -103.38 162.85 3.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -179.302 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.487 ' HA2' ' O ' ' A' ' 76' ' ' ASN . . . -131.87 167.08 22.91 Favored Glycine 0 N--CA 1.439 -1.102 0 C-N-CA 119.858 -1.163 . . . . 0.0 111.955 -178.907 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 22.4 p -84.26 131.52 34.73 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 173.123 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 36.5 tp . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.634 -174.366 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 13.3 tt . . . . . 0 N--CA 1.454 -0.227 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -68.69 155.95 67.1 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 121.947 1.764 . . . . 0.0 111.484 176.262 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -147.51 76.78 1.41 Allowed 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 176.477 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.741 ' HG ' ' OE1' ' A' ' 92' ' ' GLU . 27.1 mt -72.8 103.66 3.74 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 114.948 -1.024 . . . . 0.0 110.856 -176.845 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.584 HG22 ' HB3' ' A' ' 97' ' ' ASN . 25.7 t -114.68 121.0 36.53 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.923 -177.228 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.509 ' HB2' ' HB2' ' A' ' 100' ' ' LEU . 1.9 Cg_endo -79.03 108.01 2.32 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 122.333 2.022 . . . . 0.0 109.919 171.185 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 27.3 m -93.95 -27.27 4.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 -171.892 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 60.7 m -146.49 145.04 30.05 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.983 0.421 . . . . 0.0 111.872 -175.811 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.477 HD23 ' HB3' ' A' ' 102' ' ' ALA . 50.1 tp -130.54 110.53 11.49 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.407 174.046 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.573 ' OG1' ' HA ' ' A' ' 12' ' ' PRO . 5.6 t -128.69 149.56 72.36 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.017 -177.143 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.573 ' HA ' ' OG1' ' A' ' 11' ' ' THR . 82.8 Cg_endo -77.76 154.2 94.41 Favored 'Cis proline' 0 N--CA 1.463 -0.296 0 C-N-CA 123.42 -1.492 . . . . 0.0 112.675 1.722 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.5 m -79.62 -6.64 9.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.13 178.193 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.427 ' HA ' ' O ' ' A' ' 105' ' ' GLY . 1.5 p -130.35 125.51 34.81 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.319 178.323 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.4 m -121.1 158.02 24.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.125 0.488 . . . . 0.0 112.115 -172.775 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.488 HG22 HD22 ' A' ' 107' ' ' LEU . 41.8 t -80.22 120.56 79.96 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.732 177.748 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.658 ' HA ' ' HG ' ' A' ' 71' ' ' LEU . 2.8 Cg_exo -75.5 59.28 5.47 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 123.193 2.596 . . . . 0.0 113.946 -173.286 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -176.98 -56.88 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.718 0.294 . . . . 0.0 111.506 174.27 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 14.6 t -80.4 178.29 8.4 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.293 -172.832 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 45.2 t -80.74 124.29 38.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.106 178.42 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.571 ' ND2' HD23 ' A' ' 71' ' ' LEU . 38.7 m-80 -102.44 135.03 44.8 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.169 -179.308 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 21.2 m -82.9 97.68 8.8 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.033 -0.53 . . . . 0.0 109.95 177.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' MET . . . . . 0.553 ' HB2' ' HB2' ' A' ' 67' ' ' PHE . 91.5 mmm -91.56 132.26 36.42 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.269 -176.366 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.508 ' HA ' ' O ' ' A' ' 65' ' ' VAL . 10.4 m -116.27 117.07 29.0 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.638 -178.088 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.414 ' HB3' ' HB ' ' A' ' 65' ' ' VAL . . . -105.58 119.48 39.22 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.265 178.358 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 17.6 m -85.9 110.28 19.31 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.51 -178.772 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 24.4 mm -102.13 115.67 44.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.21 -179.065 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -103.15 132.74 49.18 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.091 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.458 ' HB2' ' HG ' ' A' ' 57' ' ' LEU . 51.9 t-20 -90.49 101.53 14.27 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 173.304 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 11.5 mm100 -93.31 33.23 1.24 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.179 -176.819 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -144.09 166.87 27.0 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.024 -178.269 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -97.5 54.22 1.18 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.448 0.642 . . . . 0.0 111.063 -173.789 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 73.8 tttt -161.47 144.72 12.51 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.121 172.709 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.495 ' HB3' ' HA ' ' A' ' 58' ' ' GLU . 1.2 m-20 -89.19 129.71 35.73 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 -177.823 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 36.9 p -85.07 153.92 22.41 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 110.311 -0.255 . . . . 0.0 110.311 -179.261 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.407 HG22 ' H ' ' A' ' 37' ' ' SER . 0.2 OUTLIER -85.19 -167.82 1.98 Allowed 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 177.382 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.51 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 39.9 m -60.42 113.47 2.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.955 0.407 . . . . 0.0 110.701 178.692 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.4 ' CE2' HG23 ' A' ' 40' ' ' VAL . 41.4 p90 -124.25 154.21 40.52 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.313 -178.422 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.412 ' O ' ' HD3' ' A' ' 86' ' ' PRO . 79.7 m-20 -100.52 111.37 23.62 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.424 -176.072 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.53 HG11 HG21 ' A' ' 65' ' ' VAL . 1.4 t -98.34 119.11 45.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 176.356 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.447 ' HB3' HG13 ' A' ' 48' ' ' VAL . 41.2 m -113.49 138.15 50.53 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.327 -174.117 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 62.5 tp -97.89 111.82 23.97 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.58 174.194 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.427 ' HA ' ' O ' ' A' ' 47' ' ' ILE . 5.2 mp -96.9 140.8 30.91 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.024 -179.721 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 91.0 t -122.57 111.56 30.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 173.488 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 20.0 t70 67.71 -72.78 0.09 Allowed 'General case' 0 N--CA 1.47 0.542 0 O-C-N 124.036 0.835 . . . . 0.0 110.761 -176.06 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -153.08 9.15 0.52 Allowed Glycine 0 N--CA 1.448 -0.564 0 CA-C-N 115.969 -0.559 . . . . 0.0 112.14 177.334 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.427 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 3.4 mt -110.89 151.2 13.1 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.315 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 -178.603 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.447 HG13 ' HB3' ' A' ' 41' ' ' SER . 45.4 t -99.21 107.19 20.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 173.792 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 29.8 m -77.8 -33.51 18.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.304 -175.258 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -160.01 135.49 8.25 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.273 -179.101 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 95.4 m -120.88 126.41 49.97 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.832 177.369 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -109.83 123.27 49.27 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.068 178.722 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 30.3 m -81.25 104.18 11.54 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.249 -0.432 . . . . 0.0 109.905 176.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.51 ' O ' ' HA ' ' A' ' 37' ' ' SER . 21.9 t -81.4 123.26 37.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 178.632 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 20.9 m -56.14 -42.85 77.58 Favored 'General case' 0 C--N 1.329 -0.3 0 O-C-N 123.458 0.474 . . . . 0.0 111.594 -173.873 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 50.7 p 179.2 136.89 0.1 Allowed 'General case' 0 C--N 1.33 -0.261 0 O-C-N 123.246 0.341 . . . . 0.0 110.526 174.355 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.576 HD23 HD22 ' A' ' 5' ' ' LEU . 26.7 tp -105.94 110.23 22.43 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.123 0.487 . . . . 0.0 109.762 175.469 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.495 ' HA ' ' HB3' ' A' ' 34' ' ' ASP . 42.7 mt-10 -66.95 160.49 26.24 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.201 -177.044 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 2.7 p -60.73 124.87 21.68 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.372 -178.584 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 65.03 16.97 10.87 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.527 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -96.17 148.45 22.7 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 178.203 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 17.9 m -111.48 134.52 53.0 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.002 179.455 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 91.7 m -139.88 129.63 24.55 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.131 0.491 . . . . 0.0 111.123 -179.453 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -90.31 132.57 35.48 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.627 -179.246 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.53 HG21 HG11 ' A' ' 40' ' ' VAL . 40.2 t -96.53 133.07 39.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.448 -179.129 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -102.56 105.31 15.8 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.468 -177.251 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.553 ' HB2' ' HB2' ' A' ' 23' ' ' MET . 49.9 m-85 -102.03 147.83 26.1 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.912 179.046 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 35.5 m-70 -115.13 92.41 3.92 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 175.281 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 14.7 t90 -100.22 105.44 17.01 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.238 -173.615 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 6.8 m -73.96 108.7 6.94 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.014 171.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.658 ' HG ' ' HA ' ' A' ' 17' ' ' PRO . 0.1 OUTLIER -59.42 -69.13 0.22 Allowed 'General case' 0 C--O 1.234 0.284 0 O-C-N 123.131 0.27 . . . . 0.0 111.517 -172.645 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.446 ' HB3' ' O ' ' A' ' 71' ' ' LEU . 20.0 t70 72.87 -47.37 0.67 Allowed 'General case' 0 N--CA 1.47 0.57 0 O-C-N 123.918 0.761 . . . . 0.0 111.981 -178.126 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.558 ' HA3' ' OH ' ' A' ' 78' ' ' TYR . . . -74.34 -174.52 31.83 Favored Glycine 0 CA--C 1.518 0.244 0 C-N-CA 121.249 -0.501 . . . . 0.0 113.478 -177.511 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 9.5 t -142.43 12.82 1.95 Allowed 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.087 0.47 . . . . 0.0 111.347 -175.717 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.45 ' HB3' ' CE1' ' A' ' 78' ' ' TYR . . . -71.81 141.49 49.66 Favored 'General case' 0 C--N 1.33 -0.272 0 O-C-N 122.081 -0.387 . . . . 0.0 110.286 -179.446 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.551 ' HA ' HG23 ' A' ' 106' ' ' THR . 25.0 p-10 -77.73 -5.66 51.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.78 0.324 . . . . 0.0 111.514 -175.311 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 43.7 m -150.83 116.01 5.34 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.862 0.363 . . . . 0.0 110.722 -178.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.558 ' OH ' ' HA3' ' A' ' 73' ' ' GLY . 43.0 m-85 -111.47 138.26 48.21 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.89 176.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.405 ' HA ' HD23 ' A' ' 103' ' ' LEU . 37.2 m -92.65 97.97 11.14 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.88 179.133 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.517 HD13 HG22 ' A' ' 104' ' ' VAL . 10.2 mp -97.31 135.79 38.72 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.453 -179.479 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.491 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 27.4 m -130.36 116.96 19.04 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.64 -176.921 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.425 ' HB ' ' HB3' ' A' ' 100' ' ' LEU . 59.5 t -89.11 104.17 14.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 175.684 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -99.26 117.6 34.08 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 178.2 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.504 HG23 ' HG3' ' A' ' 7' ' ' PRO . 84.5 t -85.1 106.4 14.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.355 -176.84 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 51.3 t0 61.6 85.77 0.17 Allowed Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 114.563 -1.199 . . . . 0.0 111.487 178.813 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.412 ' HD3' ' O ' ' A' ' 39' ' ' ASN . 4.6 Cg_exo -74.91 -7.14 18.96 Favored 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 123.023 2.482 . . . . 0.0 111.715 178.174 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -94.57 -22.62 18.08 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 178.224 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 59.99 69.15 0.72 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.182 -179.717 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -93.05 -28.76 16.17 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.793 178.131 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.7 t -106.33 135.15 45.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.31 176.211 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -82.48 112.0 19.01 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.873 0.368 . . . . 0.0 110.008 178.686 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.741 ' OE1' ' HG ' ' A' ' 5' ' ' LEU . 66.6 mm-40 -100.43 173.63 6.49 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.478 -176.349 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -57.77 -101.11 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.387 0 CA-C-N 115.255 -0.884 . . . . 0.0 112.485 174.015 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.45 ' O ' ' HB2' ' A' ' 97' ' ' ASN . 60.5 m-20 -96.77 135.31 38.9 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.522 ' HA ' HD21 ' A' ' 98' ' ' ASN . 40.4 tt0 -60.86 -29.24 69.41 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.138 0.494 . . . . 0.0 110.656 177.755 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 5.3 m -65.85 -19.72 65.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.252 0.548 . . . . 0.0 110.539 178.497 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.584 ' HB3' HG22 ' A' ' 6' ' ' VAL . 7.2 m-20 -81.24 -21.78 39.23 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.788 -178.296 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.522 HD21 ' HA ' ' A' ' 95' ' ' GLU . 29.4 m-80 -78.11 -4.74 48.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.403 -177.617 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 3.2 m -110.32 154.74 23.06 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.079 0.466 . . . . 0.0 111.33 -175.372 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.509 ' HB2' ' HB2' ' A' ' 7' ' ' PRO . 48.8 tp -146.96 103.42 3.61 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.478 175.095 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 7.7 m -90.26 96.2 10.55 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 178.229 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.477 ' HB3' HD23 ' A' ' 10' ' ' LEU . . . -114.95 121.08 42.07 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.162 0.506 . . . . 0.0 110.82 -176.83 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.405 HD23 ' HA ' ' A' ' 79' ' ' THR . 87.1 mt -86.26 121.21 28.52 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.215 177.787 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.517 HG22 HD13 ' A' ' 80' ' ' LEU . 18.5 m -111.48 137.26 44.79 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.72 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.427 ' O ' ' HA ' ' A' ' 14' ' ' THR . . . -107.61 -177.78 22.42 Favored Glycine 0 N--CA 1.439 -1.128 0 C-N-CA 120.532 -0.842 . . . . 0.0 111.22 -177.204 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.551 HG23 ' HA ' ' A' ' 76' ' ' ASN . 24.7 p -82.54 153.95 25.28 Favored 'General case' 0 C--N 1.312 -1.056 0 C-N-CA 120.856 -0.338 . . . . 0.0 110.338 178.112 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.488 HD22 HG22 ' A' ' 16' ' ' VAL . 27.1 tp . . . . . 0 C--N 1.326 -0.448 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.395 179.483 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 13.4 tt . . . . . 0 C--O 1.237 0.396 0 N-CA-C 110.424 -0.213 . . . . 0.0 110.424 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.634 ' O ' ' HA ' ' A' ' 92' ' ' GLU . 18.4 Cg_exo -68.54 148.7 73.24 Favored 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.64 2.226 . . . . 0.0 111.203 170.094 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -130.0 93.09 3.42 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 175.793 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.549 ' HB3' HG11 ' A' ' 84' ' ' VAL . 70.5 mt -76.08 102.18 5.6 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.108 -173.483 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.488 HG22 HD21 ' A' ' 97' ' ' ASN . 60.9 t -107.68 110.41 62.64 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.124 -179.197 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.556 ' HB2' ' HB2' ' A' ' 100' ' ' LEU . 56.8 Cg_endo -73.12 103.51 1.62 Allowed 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 121.898 1.732 . . . . 0.0 109.825 168.688 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.2 t -79.31 -51.25 16.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.573 -168.474 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 21.6 t -157.25 176.36 12.82 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.019 0.437 . . . . 0.0 111.028 -178.404 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 35.6 tp -145.44 104.32 3.9 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.071 -178.72 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.3 p -112.98 145.52 33.25 Favored Pre-proline 0 C--N 1.321 -0.659 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.431 -175.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -86.0 157.22 56.85 Favored 'Cis proline' 0 N--CA 1.46 -0.474 0 C-N-CA 123.132 -1.612 . . . . 0.0 112.319 -2.691 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.462 ' HA ' HG12 ' A' ' 104' ' ' VAL . 35.9 m -83.94 13.0 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.25 0.547 . . . . 0.0 110.952 -179.756 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.704 HG22 ' HA ' ' A' ' 107' ' ' LEU . 0.3 OUTLIER -148.54 119.56 7.68 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 178.311 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.537 HG21 ' CZ3' ' A' ' 69' ' ' TRP . 24.9 m -128.41 153.53 37.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -167.21 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.471 HG22 HD23 ' A' ' 107' ' ' LEU . 7.4 t -76.01 129.77 79.97 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.052 179.086 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.59 ' HA ' ' CB ' ' A' ' 71' ' ' LEU . 6.1 Cg_exo -74.1 -173.88 1.57 Allowed 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 122.643 2.229 . . . . 0.0 111.577 174.75 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 8.1 p30 51.36 17.26 0.5 Allowed 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.349 1.059 . . . . 0.0 113.844 175.592 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 15.0 t -150.82 168.7 23.65 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 121.721 -0.612 . . . . 0.0 110.93 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 25.9 t -99.0 112.39 30.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 175.144 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.449 ' ND2' ' HB ' ' A' ' 15' ' ' VAL . 26.5 p30 -101.62 162.84 12.61 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.049 -175.348 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.465 ' HA ' ' O ' ' A' ' 67' ' ' PHE . 7.9 m -113.48 95.77 5.53 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.006 -179.534 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' MET . . . . . 0.485 ' O ' ' HA ' ' A' ' 66' ' ' ASP . 80.0 mtp -92.74 150.56 20.58 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.755 -176.814 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.405 ' HA ' ' O ' ' A' ' 65' ' ' VAL . 3.1 m -118.02 115.91 25.82 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.424 -175.07 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -96.97 134.08 40.8 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.022 0.439 . . . . 0.0 110.457 176.035 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 4.1 m -91.33 100.2 13.04 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.087 179.718 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 21.9 mm -98.3 111.51 28.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 176.732 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.526 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 27.7 tt0 -119.19 132.27 55.94 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.149 0.5 . . . . 0.0 111.1 -176.557 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.578 ' HB2' ' HG ' ' A' ' 57' ' ' LEU . 54.2 t-20 -86.81 113.8 22.93 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.858 -179.471 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 83.0 mm-40 -101.13 54.92 0.84 Allowed 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.193 0.521 . . . . 0.0 110.745 179.077 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -143.99 -172.57 14.81 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.777 -0.725 . . . . 0.0 111.755 -177.524 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 29.9 p-10 -113.4 6.85 17.4 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.846 0.355 . . . . 0.0 111.729 -174.568 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.404 ' HD3' ' HD3' ' A' ' 3' ' ' PRO . 87.6 tttt -122.33 133.11 54.67 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 171.928 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -73.87 132.28 42.36 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.504 -179.179 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.491 ' OG ' ' HB3' ' A' ' 57' ' ' LEU . 4.5 p -93.11 138.81 31.21 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.084 0.469 . . . . 0.0 111.151 -178.199 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.0 p -83.1 -165.47 1.09 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.238 -179.23 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.586 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 22.4 m -56.91 121.5 10.04 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.99 0.424 . . . . 0.0 111.624 -179.073 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.46 ' CE2' HG23 ' A' ' 40' ' ' VAL . 31.3 p90 -133.87 153.73 51.54 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.295 -179.688 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.424 ' O ' ' HD3' ' A' ' 86' ' ' PRO . 89.3 m-20 -94.26 113.84 25.82 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.818 0.342 . . . . 0.0 111.245 -176.115 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.46 HG23 ' CE2' ' A' ' 38' ' ' PHE . 1.5 t -103.56 125.51 58.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.138 0.494 . . . . 0.0 109.815 176.453 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 9.7 m -113.3 139.39 48.88 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.676 -177.046 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 61.1 tp -103.01 116.97 33.55 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 174.521 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.494 ' HG ' HG22 ' A' ' 48' ' ' VAL . 5.1 mp -105.72 137.89 42.83 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.554 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 78.9 t -100.94 100.29 10.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 171.657 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 8.7 t70 69.2 -76.12 0.06 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.38 -176.765 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -136.95 -7.68 1.52 Allowed Glycine 0 CA--C 1.519 0.34 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.885 178.91 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 6.9 mt -100.03 148.75 6.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 110.029 -0.359 . . . . 0.0 110.029 -178.485 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.494 HG22 ' HG ' ' A' ' 43' ' ' LEU . 48.5 t -97.84 121.08 47.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.413 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 28.3 m -104.05 -28.51 2.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 C-N-CA 120.831 -0.347 . . . . 0.0 111.688 -177.213 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -144.27 150.07 37.3 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 -177.82 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 24.2 m -149.43 110.55 4.38 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 177.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -114.85 138.15 51.12 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.896 0.379 . . . . 0.0 110.546 -177.274 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 28.9 m -87.18 107.32 18.42 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 173.894 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.586 ' O ' ' HA ' ' A' ' 37' ' ' SER . 39.0 t -77.64 127.16 38.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 9.6 m -63.07 -39.39 94.56 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.896 -170.814 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 79.5 p -170.99 161.79 7.02 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.713 0.292 . . . . 0.0 110.52 178.374 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.578 ' HG ' ' HB2' ' A' ' 29' ' ' ASN . 37.9 tp -142.87 114.09 7.79 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.066 -0.515 . . . . 0.0 109.705 175.876 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -79.54 157.26 27.44 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.57 -0.741 . . . . 0.0 112.132 -172.126 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 16.5 m -59.63 119.9 8.45 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.362 -179.22 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.407 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 45.2 mt-10 60.5 28.65 18.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.66 179.072 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -124.9 159.64 30.68 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 172.63 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.526 ' HA ' ' HA ' ' A' ' 28' ' ' GLU . 33.2 p -112.76 163.86 14.07 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.059 0.457 . . . . 0.0 111.241 -176.877 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 79.9 m -133.97 124.46 26.36 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.918 173.207 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 31.4 m-80 -80.5 106.08 12.24 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.416 177.748 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.405 ' O ' ' HA ' ' A' ' 24' ' ' THR . 3.8 t -96.57 115.6 36.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.769 -175.702 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.485 ' HA ' ' O ' ' A' ' 23' ' ' MET . 19.2 m-20 -96.25 118.85 33.64 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.82 0.343 . . . . 0.0 111.223 -179.344 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.465 ' O ' ' HA ' ' A' ' 22' ' ' THR . 84.7 m-85 -102.1 174.27 6.01 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.952 178.401 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 86.3 m-70 -128.45 109.64 11.59 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 176.664 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' TRP . . . . . 0.537 ' CZ3' HG21 ' A' ' 15' ' ' VAL . 15.2 t90 -120.05 122.04 40.22 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.251 0.548 . . . . 0.0 111.281 -172.574 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 10.3 m -86.49 113.94 22.83 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.648 178.222 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.59 ' CB ' ' HA ' ' A' ' 17' ' ' PRO . 1.1 mm? -77.7 122.81 25.85 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.115 0.483 . . . . 0.0 111.678 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 16.4 p-10 -87.35 -33.72 19.07 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.154 173.063 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 82.64 19.55 63.55 Favored Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 115.589 -0.732 . . . . 0.0 113.55 172.054 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 30.0 m -70.45 -41.2 73.15 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.095 0.474 . . . . 0.0 110.401 179.558 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -110.25 157.24 19.67 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.041 176.382 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -97.05 -9.01 28.94 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.195 0.521 . . . . 0.0 109.734 178.783 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 71.9 p -137.62 110.1 7.47 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.935 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 46.5 m-85 -106.23 138.59 42.14 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.316 0.579 . . . . 0.0 111.095 -179.681 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.442 ' HA ' HD23 ' A' ' 103' ' ' LEU . 7.7 m -91.31 83.85 5.54 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.208 -0.906 . . . . 0.0 109.6 -179.59 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.435 HD13 HG22 ' A' ' 104' ' ' VAL . 7.9 mp -80.53 120.36 24.4 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.656 0.741 . . . . 0.0 110.267 -178.289 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.582 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 17.1 m -117.99 116.38 26.79 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.24 -173.84 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.437 ' HB ' ' HB3' ' A' ' 100' ' ' LEU . 92.8 t -87.43 110.98 21.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 177.77 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -96.57 117.14 30.33 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 175.627 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.549 HG11 ' HB3' ' A' ' 5' ' ' LEU . 47.5 t -93.47 108.14 20.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.975 -178.828 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 56.8 t0 66.38 95.91 0.05 OUTLIER Pre-proline 0 N--CA 1.466 0.374 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.447 178.005 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.424 ' HD3' ' O ' ' A' ' 39' ' ' ASN . 3.7 Cg_endo -85.1 0.56 8.81 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 123.319 2.679 . . . . 0.0 111.822 178.662 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -109.3 -14.82 14.39 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.043 -179.038 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 64.6 t30 57.85 42.7 22.82 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.703 -178.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -80.58 -29.68 36.95 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.911 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 60.5 t -100.22 129.29 51.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.771 -0.649 . . . . 0.0 109.553 175.302 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -73.28 133.13 43.82 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.324 179.636 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.634 ' HA ' ' O ' ' A' ' 3' ' ' PRO . 0.0 OUTLIER -128.6 164.45 22.83 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.847 -179.544 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -57.72 -101.14 0.01 OUTLIER Glycine 0 CA--C 1.517 0.184 0 CA-C-N 115.251 -0.886 . . . . 0.0 112.999 173.542 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.495 ' O ' ' HB3' ' A' ' 97' ' ' ASN . 27.8 t-20 -89.38 126.11 35.41 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.868 0.366 . . . . 0.0 110.42 -179.446 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -76.32 -12.58 60.09 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.934 -173.571 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 22.3 m -92.31 -6.06 51.05 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.563 0.697 . . . . 0.0 109.774 174.097 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.495 ' HB3' ' O ' ' A' ' 94' ' ' ASN . 1.9 t30 -86.81 -21.66 26.32 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.082 -178.589 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.443 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 16.9 p-10 -74.24 -3.75 31.9 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.976 0.417 . . . . 0.0 111.189 -176.573 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 1.3 m -101.66 149.05 24.53 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.215 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.582 ' O ' ' HA ' ' A' ' 81' ' ' THR . 48.9 tp -136.48 111.6 9.0 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.394 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 6.2 m -90.43 89.86 7.77 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.941 178.07 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -102.69 112.02 24.6 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.04 0.448 . . . . 0.0 110.794 -177.583 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.442 HD23 ' HA ' ' A' ' 79' ' ' THR . 61.7 mt -83.79 116.24 22.62 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.44 178.606 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.462 HG12 ' HA ' ' A' ' 13' ' ' VAL . 17.9 m -118.25 136.26 56.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.176 -177.31 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.514 ' O ' ' HA ' ' A' ' 14' ' ' THR . . . -111.6 173.74 15.99 Favored Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 120.378 -0.915 . . . . 0.0 111.858 -177.515 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 21.0 p -77.97 138.12 38.67 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.329 176.372 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.704 ' HA ' HG22 ' A' ' 14' ' ' THR . 32.3 tp . . . . . 0 C--N 1.326 -0.419 0 CA-C-N 115.677 -0.692 . . . . 0.0 112.098 -172.637 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.469 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 17.5 tt . . . . . 0 N--CA 1.452 -0.329 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.529 ' HD3' ' HD3' ' A' ' 33' ' ' LYS . 15.9 Cg_exo -70.25 159.76 51.93 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 122.611 2.207 . . . . 0.0 112.178 176.245 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -143.62 90.36 2.15 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 176.908 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.496 HD22 HD23 ' A' ' 57' ' ' LEU . 78.3 mt -85.59 109.82 18.82 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.417 0.627 . . . . 0.0 110.753 -170.013 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.407 ' HA ' ' HD2' ' A' ' 7' ' ' PRO . 45.9 t -114.79 111.29 45.81 Favored Pre-proline 0 C--N 1.32 -0.68 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.602 -175.055 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.505 ' HD2' ' O ' ' A' ' 97' ' ' ASN . 34.2 Cg_endo -68.08 101.66 0.72 Allowed 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 122.2 1.933 . . . . 0.0 109.81 167.113 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.7 t -79.34 -55.37 9.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.441 -169.55 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.3 t -146.21 163.42 35.48 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.54 -174.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 58.8 tp -134.59 104.61 6.14 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.712 -178.655 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 15.6 p -107.45 143.03 26.38 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.45 -177.153 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -86.25 157.73 55.23 Favored 'Cis proline' 0 N--CA 1.457 -0.624 0 C-N-CA 122.964 -1.682 . . . . 0.0 112.021 -3.556 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 34.9 m -82.69 5.84 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.355 0.597 . . . . 0.0 110.257 178.568 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.522 ' HA ' ' O ' ' A' ' 105' ' ' GLY . 2.6 m -147.35 116.94 7.06 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 176.065 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.442 HG21 HD21 ' A' ' 71' ' ' LEU . 22.0 m -113.47 152.2 15.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.139 0.495 . . . . 0.0 111.77 -170.61 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.608 HG22 HD22 ' A' ' 107' ' ' LEU . 1.8 t -97.77 115.59 65.75 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.65 178.71 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.523 ' HA ' ' CB ' ' A' ' 71' ' ' LEU . 23.9 Cg_exo -64.93 -175.3 0.36 Allowed 'Trans proline' 0 C--O 1.234 0.277 0 C-N-CA 122.495 2.13 . . . . 0.0 112.564 179.754 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 19.5 m-80 74.25 17.77 3.19 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.474 176.476 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 12.1 t -164.28 166.58 20.8 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 110.532 -0.173 . . . . 0.0 110.532 -177.699 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.508 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 52.6 t -85.84 109.7 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 172.365 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.669 ' OD1' HD23 ' A' ' 71' ' ' LEU . 9.8 m120 -85.52 125.64 33.22 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.068 -174.054 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 53.3 m -79.19 106.09 10.98 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.572 172.311 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' MET . . . . . 0.435 ' SD ' ' HE3' ' A' ' 69' ' ' TRP . 62.1 mtp -104.88 144.13 32.2 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.956 0.407 . . . . 0.0 110.339 -179.844 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.498 HG23 ' HB3' ' A' ' 64' ' ' ASN . 31.2 m -115.02 111.4 21.05 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.055 -174.666 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.4 ' HB3' ' HB ' ' A' ' 65' ' ' VAL . . . -97.92 118.37 34.33 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 173.819 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 38.7 m -87.59 107.81 18.77 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 120.878 0.37 . . . . 0.0 110.174 -179.257 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 20.2 mm -103.11 115.13 44.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.863 -179.551 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.555 ' HG2' ' HB3' ' A' ' 62' ' ' SER . 46.2 mt-10 -104.14 134.07 48.0 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.751 0.31 . . . . 0.0 110.836 177.527 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.493 ' HB2' ' HG ' ' A' ' 57' ' ' LEU . 29.9 t30 -90.44 92.06 8.72 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 173.496 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 80.4 mt-30 -87.86 53.18 2.68 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.615 0.721 . . . . 0.0 110.168 -176.087 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -143.89 160.5 27.76 Favored Glycine 0 N--CA 1.444 -0.829 0 CA-C-N 114.953 -1.022 . . . . 0.0 110.638 179.593 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 26.6 p-10 -84.9 -0.88 55.66 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 117.011 0.405 . . . . 0.0 111.91 -171.718 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.529 ' HD3' ' HD3' ' A' ' 3' ' ' PRO . 48.2 tttm -112.59 144.8 41.46 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 176.346 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 -75.15 148.77 39.34 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 176.362 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 35.7 p -109.12 141.99 40.52 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.95 0.405 . . . . 0.0 110.763 -178.672 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.9 p -76.61 -164.81 0.45 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.382 -179.756 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.443 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 16.8 m -65.13 129.66 40.51 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.736 0.303 . . . . 0.0 110.965 -179.16 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.569 ' HB2' ' HB2' ' A' ' 85' ' ' ASP . 49.4 p90 -141.12 152.54 44.82 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.216 179.707 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.457 ' O ' ' HA ' ' A' ' 85' ' ' ASP . 30.1 m-80 -103.35 113.32 26.72 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.561 -175.065 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.503 HG11 HG21 ' A' ' 65' ' ' VAL . 1.4 t -98.36 122.39 49.97 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-O 121.269 0.557 . . . . 0.0 109.659 178.948 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 10.4 m -115.35 142.79 46.22 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.057 -174.597 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.49 HD11 ' HB3' ' A' ' 80' ' ' LEU . 45.0 tp -102.49 110.92 23.01 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.816 176.401 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.457 ' HG ' HG22 ' A' ' 48' ' ' VAL . 4.7 mp -98.9 114.58 27.26 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.24 -179.812 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.451 HG22 ' HG ' ' A' ' 80' ' ' LEU . 96.5 t -97.51 105.53 17.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.085 178.65 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 58.74 21.49 8.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.708 177.895 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 122.42 -33.66 4.08 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.908 176.899 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 8.5 mt -91.62 150.56 3.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 O-C-N 122.737 -0.272 . . . . 0.0 110.348 -176.884 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.457 HG22 ' HG ' ' A' ' 43' ' ' LEU . 44.5 t -96.74 118.15 42.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -179.251 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 27.2 m -97.11 -23.23 4.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.608 -177.39 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -153.36 142.34 21.24 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.254 -179.028 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.2 m -133.46 108.26 8.55 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.759 178.121 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -109.19 138.72 45.11 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.235 -175.678 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 17.3 m -105.61 110.14 22.35 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.912 0.387 . . . . 0.0 111.078 -178.691 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.443 ' O ' ' HA ' ' A' ' 37' ' ' SER . 45.4 t -77.78 128.74 38.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 176.842 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 12.3 m -60.22 -42.72 95.78 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.607 -177.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 30.2 t 178.21 129.93 0.06 Allowed 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 -178.058 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.529 HD13 ' OG1' ' A' ' 63' ' ' THR . 24.1 tp -108.51 117.37 33.98 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.159 0.504 . . . . 0.0 110.038 178.676 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -73.0 162.24 29.72 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.494 -175.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 2.9 p -61.5 124.35 20.4 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.329 -0.85 . . . . 0.0 111.352 179.23 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 61.01 28.62 18.4 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.854 179.014 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -108.95 156.78 19.31 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 174.541 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.555 ' HB3' ' HG2' ' A' ' 28' ' ' GLU . 32.5 p -114.09 125.83 54.42 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.535 179.211 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.529 ' OG1' HD13 ' A' ' 57' ' ' LEU . 53.2 m -112.78 129.44 56.43 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.975 0.417 . . . . 0.0 110.149 176.326 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.498 ' HB3' HG23 ' A' ' 24' ' ' THR . 94.1 m-20 -90.19 128.88 36.48 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.704 177.869 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.503 HG21 HG11 ' A' ' 40' ' ' VAL . 43.9 t -96.09 123.46 48.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.676 -177.979 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -86.19 97.64 10.47 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.446 -178.711 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -93.4 141.99 27.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.179 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 7.0 m80 -118.15 96.51 5.36 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.52 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' TRP . . . . . 0.435 ' HE3' ' SD ' ' A' ' 23' ' ' MET . 12.1 t90 -114.43 113.64 24.77 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.271 0.558 . . . . 0.0 110.621 -175.618 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.508 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 6.8 m -78.75 102.32 8.04 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.465 -0.788 . . . . 0.0 110.074 176.573 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.669 HD23 ' OD1' ' A' ' 21' ' ' ASN . 0.5 OUTLIER -61.05 113.9 2.81 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.095 0.474 . . . . 0.0 110.393 178.84 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -79.19 -32.98 44.3 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.569 -0.742 . . . . 0.0 111.075 -175.211 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -160.79 -146.29 4.57 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.05 -178.855 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 25.9 m -136.09 83.97 2.05 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.152 0.501 . . . . 0.0 110.497 179.253 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.422 ' O ' ' HB2' ' A' ' 76' ' ' ASN . . . -86.86 1.4 52.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.367 178.515 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.545 ' O ' ' HA2' ' A' ' 105' ' ' GLY . 17.0 m120 73.69 -50.4 0.69 Allowed 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.307 0.643 . . . . 0.0 112.229 -179.302 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 16.2 p -132.15 124.53 29.28 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 120.963 0.411 . . . . 0.0 111.708 -179.758 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -117.24 144.44 44.8 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.083 177.951 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.557 ' HA ' HD23 ' A' ' 103' ' ' LEU . 28.6 m -94.74 90.17 5.98 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.926 0.394 . . . . 0.0 110.094 -179.378 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.55 HD13 HG22 ' A' ' 104' ' ' VAL . 10.4 mp -94.18 117.23 29.8 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.308 0.575 . . . . 0.0 110.506 -178.093 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.525 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 18.8 m -114.2 119.03 35.65 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.459 -0.792 . . . . 0.0 110.394 -177.077 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 50.6 t -90.56 101.46 12.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 176.192 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -97.79 116.95 31.02 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 177.353 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.595 ' HB ' ' HB2' ' A' ' 98' ' ' ASN . 93.9 t -82.86 105.92 13.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 121.327 0.584 . . . . 0.0 111.264 -177.148 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.569 ' HB2' ' HB2' ' A' ' 38' ' ' PHE . 8.7 t70 54.42 90.86 0.08 OUTLIER Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 114.293 -1.321 . . . . 0.0 111.824 179.712 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_exo -58.17 -30.49 90.72 Favored 'Trans proline' 0 C--O 1.233 0.254 0 C-N-CA 123.052 2.501 . . . . 0.0 112.032 179.75 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -71.0 -25.56 62.74 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.093 177.427 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 43.0 t30 56.48 44.98 23.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.974 -177.575 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -65.18 -32.16 73.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.153 -0.931 . . . . 0.0 110.439 -179.729 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 49.5 t -86.9 123.96 40.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.394 175.376 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.493 ' O ' ' HD2' ' A' ' 3' ' ' PRO . 3.9 m-20 -77.89 130.95 37.24 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.892 -0.411 . . . . 0.0 109.892 178.678 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -124.09 161.42 25.65 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.75 -173.123 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -58.21 -100.77 0.01 OUTLIER Glycine 0 CA--C 1.521 0.448 0 CA-C-N 115.033 -0.985 . . . . 0.0 112.528 172.171 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -57.94 156.37 9.24 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 176.459 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 -102.46 -24.93 13.78 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.15 0.5 . . . . 0.0 110.965 179.371 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 5.9 p -98.89 21.44 11.55 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.313 0.578 . . . . 0.0 110.972 -177.522 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.505 ' O ' ' HD2' ' A' ' 7' ' ' PRO . 26.4 p-10 -96.27 -33.82 11.84 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.106 -177.493 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.595 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 19.5 p-10 -83.7 9.77 10.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.968 -169.433 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 1.6 m -117.65 147.42 42.9 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.747 0.308 . . . . 0.0 110.22 177.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.525 ' O ' ' HA ' ' A' ' 81' ' ' THR . 50.2 tp -144.74 98.82 3.25 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.233 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 6.9 m -92.54 104.58 16.87 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.685 177.404 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -126.62 138.2 53.41 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.135 0.493 . . . . 0.0 111.359 -176.818 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.557 HD23 ' HA ' ' A' ' 79' ' ' THR . 74.0 mt -89.83 124.6 34.81 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.992 175.623 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.55 HG22 HD13 ' A' ' 80' ' ' LEU . 28.3 m -108.97 141.51 24.05 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 176.219 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.545 ' HA2' ' O ' ' A' ' 76' ' ' ASN . . . -102.47 166.72 17.3 Favored Glycine 0 N--CA 1.439 -1.101 0 C-N-CA 120.273 -0.965 . . . . 0.0 111.789 -176.064 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.529 ' OG1' ' HA ' ' A' ' 76' ' ' ASN . 24.5 p -91.85 140.86 29.26 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 173.169 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.608 HD22 HG22 ' A' ' 16' ' ' VAL . 7.7 tp . . . . . 0 C--N 1.326 -0.431 0 O-C-N 123.378 0.424 . . . . 0.0 111.126 -173.736 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.529 HG13 ' HD2' ' A' ' 3' ' ' PRO . 4.0 tp . . . . . 0 N--CA 1.451 -0.403 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.529 ' HD2' HG13 ' A' ' 2' ' ' ILE . 11.9 Cg_exo -70.96 177.24 6.63 Favored 'Trans proline' 0 C--O 1.236 0.398 0 C-N-CA 122.498 2.132 . . . . 0.0 112.226 178.108 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' ASP . . . . . 0.487 ' HB3' ' C ' ' A' ' 30' ' ' GLN . 24.8 t70 -149.14 77.91 1.37 Allowed 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 175.536 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.539 HD22 HD23 ' A' ' 57' ' ' LEU . 83.4 mt -75.36 109.63 9.05 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.932 -176.863 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 25.8 t -118.79 120.65 31.34 Favored Pre-proline 0 C--N 1.319 -0.744 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.247 -178.476 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.522 ' HB2' ' HB2' ' A' ' 100' ' ' LEU . 5.7 Cg_exo -73.68 111.22 3.24 Favored 'Trans proline' 0 N--CA 1.45 -1.06 0 C-N-CA 121.947 1.765 . . . . 0.0 109.726 172.43 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.0 t -80.55 -57.71 4.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.457 -169.023 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 32.8 t -144.94 167.32 22.92 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.631 -175.267 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 58.5 tp -138.62 114.61 10.1 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.149 -177.462 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.5 p -125.41 157.93 66.09 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.656 -179.725 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.63 159.51 96.43 Favored 'Cis proline' 0 N--CA 1.465 -0.185 0 C-N-CA 123.357 -1.518 . . . . 0.0 111.871 -3.356 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 29.7 m -78.31 -19.89 13.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.221 0.534 . . . . 0.0 110.249 -178.856 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.511 ' HA ' ' O ' ' A' ' 105' ' ' GLY . 17.3 p -124.5 130.61 52.78 Favored 'General case' 0 N--CA 1.437 -1.124 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.993 174.768 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.425 HG11 ' CZ3' ' A' ' 69' ' ' TRP . 31.3 m -113.06 146.56 17.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 120.766 0.317 . . . . 0.0 111.112 -177.02 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.603 HG22 HD22 ' A' ' 107' ' ' LEU . 18.1 t -92.13 113.0 57.76 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 116.633 -0.258 . . . . 0.0 110.963 -175.854 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.532 ' HA ' ' HB3' ' A' ' 71' ' ' LEU . 4.7 Cg_exo -72.44 97.86 0.9 Allowed 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 122.429 2.086 . . . . 0.0 109.934 173.727 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 -177.49 -46.07 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.417 -169.178 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 14.8 t -148.76 -169.63 3.41 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.954 -175.425 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.516 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 43.2 t -78.84 128.34 38.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 176.965 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.417 ' ND2' HD23 ' A' ' 71' ' ' LEU . 23.6 m-80 -102.82 125.19 49.47 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.64 -179.817 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.5 m -80.16 103.89 10.34 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 178.396 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' MET . . . . . 0.553 ' HB2' ' HB2' ' A' ' 67' ' ' PHE . 95.8 mmm -87.63 133.05 33.88 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.734 -174.694 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.534 ' HA ' ' O ' ' A' ' 65' ' ' VAL . 42.4 m -105.86 109.33 21.24 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.825 -177.719 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.429 ' HB3' ' HB ' ' A' ' 65' ' ' VAL . . . -102.58 112.15 24.78 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.594 174.962 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 21.8 m -83.48 105.69 14.63 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.077 -178.017 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 21.5 mm -100.51 121.12 50.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 -179.59 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -113.1 134.78 54.38 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 -179.236 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.499 ' HB2' ' HG ' ' A' ' 57' ' ' LEU . 41.3 t30 -94.48 107.16 19.14 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.05 0.452 . . . . 0.0 109.819 177.863 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.487 ' C ' ' HB3' ' A' ' 4' ' ' ASP . 73.0 mt-30 -113.89 56.65 0.7 Allowed 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.243 -175.579 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -143.88 -165.65 10.97 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.36 -0.924 . . . . 0.0 112.493 -174.661 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -93.2 4.0 54.74 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 -169.448 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -155.41 150.19 26.43 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.785 -177.827 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -73.72 146.45 44.4 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 175.648 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.491 ' OG ' ' HB3' ' A' ' 57' ' ' LEU . 35.3 p -93.49 149.1 21.5 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.031 0.444 . . . . 0.0 110.807 -179.277 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.435 ' OG1' HG22 ' A' ' 90' ' ' VAL . 38.8 p -86.13 -158.9 0.43 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.885 177.057 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.461 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 37.8 t -69.71 107.95 3.69 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.752 0.31 . . . . 0.0 110.256 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.433 ' HB3' ' CG2' ' A' ' 90' ' ' VAL . 55.7 p90 -118.11 140.37 49.87 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.103 0.477 . . . . 0.0 109.878 179.723 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.514 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 65.3 t30 -90.35 128.37 36.44 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.897 -176.965 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.539 HG23 ' HA ' ' A' ' 84' ' ' VAL . 0.3 OUTLIER -116.62 136.91 52.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 -175.403 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.406 ' HB3' ' CG1' ' A' ' 48' ' ' VAL . 27.9 m -124.42 135.34 53.19 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.288 -173.467 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 57.8 tp -98.95 112.79 24.8 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.069 0.461 . . . . 0.0 110.168 175.714 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.552 ' HG ' HG22 ' A' ' 48' ' ' VAL . 5.0 mp -96.59 120.17 36.42 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.579 179.46 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 72.2 t -103.47 109.12 26.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 174.184 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 16.1 t70 74.39 -66.21 0.31 Allowed 'General case' 0 N--CA 1.464 0.273 0 O-C-N 124.188 0.93 . . . . 0.0 110.74 -179.516 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -162.62 14.04 0.12 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 121.144 -0.55 . . . . 0.0 112.682 179.064 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 10.8 mt -131.09 150.81 34.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 -179.217 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.552 HG22 ' HG ' ' A' ' 43' ' ' LEU . 29.6 t -93.12 94.9 4.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.504 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 32.8 m -70.82 -27.23 29.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.924 -173.355 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -157.93 152.85 25.32 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 178.263 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 25.2 m -139.09 128.71 24.57 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.287 -174.15 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.412 ' O ' HG12 ' A' ' 40' ' ' VAL . 2.5 tt0 -127.38 132.47 50.15 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 179.06 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.514 ' HA ' ' HA ' ' A' ' 39' ' ' ASN . 20.5 m -92.28 122.78 35.07 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 177.824 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.461 ' O ' ' HA ' ' A' ' 37' ' ' SER . 64.5 t -86.2 127.98 39.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 178.674 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 14.4 m -62.47 -45.35 93.42 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.139 -0.482 . . . . 0.0 112.087 -173.731 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 36.9 t -178.41 125.77 0.11 Allowed 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -177.823 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.539 HD23 HD22 ' A' ' 5' ' ' LEU . 25.2 tp -104.55 112.15 25.11 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.546 0.689 . . . . 0.0 110.558 178.767 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.41 ' HB3' ' HB2' ' A' ' 61' ' ' ASN . 34.5 tt0 -66.13 145.92 55.25 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.679 -179.082 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 5.9 t -64.25 137.96 58.2 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 178.719 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 68.87 9.67 7.5 Favored 'General case' 0 N--CA 1.464 0.231 0 O-C-N 123.741 0.651 . . . . 0.0 111.542 -178.423 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.41 ' HB2' ' HB3' ' A' ' 58' ' ' GLU . 4.7 m-20 -114.38 161.3 18.11 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.885 0.374 . . . . 0.0 110.598 177.768 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.3 m -123.9 124.52 42.82 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.503 179.245 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 54.5 m -104.21 124.02 48.37 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 176.765 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.469 ' HB3' HG23 ' A' ' 24' ' ' THR . 45.3 m-80 -87.0 126.0 34.45 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 179.599 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.534 ' O ' ' HA ' ' A' ' 24' ' ' THR . 22.1 t -96.07 136.34 27.3 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.828 -178.42 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -111.02 102.86 11.3 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.002 0.43 . . . . 0.0 110.209 -178.108 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.553 ' HB2' ' HB2' ' A' ' 23' ' ' MET . 66.5 m-85 -91.76 144.73 25.2 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.212 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 33.9 m-70 -99.59 87.88 3.69 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.029 179.605 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' TRP . . . . . 0.425 ' CZ3' HG11 ' A' ' 15' ' ' VAL . 18.2 t90 -108.02 110.45 22.16 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.276 0.56 . . . . 0.0 111.099 -173.827 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.516 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 5.5 m -80.87 122.78 27.64 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.858 177.383 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.532 ' HB3' ' HA ' ' A' ' 17' ' ' PRO . 0.9 OUTLIER -88.04 119.76 28.72 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.217 0.532 . . . . 0.0 112.09 -177.248 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -83.99 -38.69 20.62 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.827 173.0 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 88.4 24.87 32.43 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 121.017 -0.611 . . . . 0.0 113.501 174.546 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 85.5 m -64.0 -51.1 65.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.197 0.522 . . . . 0.0 110.985 177.783 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -110.6 146.91 35.31 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.408 179.424 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 17.3 p-10 -81.89 -6.91 59.49 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.033 0.444 . . . . 0.0 110.94 -177.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 8.8 t -149.23 124.97 10.48 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 176.662 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -112.84 156.2 23.32 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.163 0.506 . . . . 0.0 111.542 -177.823 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.445 ' HA ' HD23 ' A' ' 103' ' ' LEU . 6.0 m -96.78 97.51 9.38 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.279 177.936 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.519 HD13 HG22 ' A' ' 104' ' ' VAL . 9.4 mp -96.64 117.82 31.81 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.346 0.593 . . . . 0.0 110.592 -177.532 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.574 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 24.7 m -117.08 119.58 35.69 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.372 -177.243 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 39.8 t -94.99 109.6 22.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 177.939 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -99.03 125.61 44.56 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 120.419 -0.513 . . . . 0.0 110.019 178.129 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.577 ' HB ' ' HB2' ' A' ' 98' ' ' ASN . 96.6 t -98.2 111.35 27.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.917 -176.06 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 24.1 t70 66.89 92.34 0.07 OUTLIER Pre-proline 0 N--CA 1.466 0.341 0 CA-C-N 115.136 -0.938 . . . . 0.0 112.641 177.04 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -101.03 19.83 0.25 Allowed 'Trans proline' 0 N--CA 1.451 -1.008 0 C-N-CA 123.525 2.816 . . . . 0.0 111.718 171.73 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 58.8 mt-10 -128.17 -7.71 5.37 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.945 -174.282 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 8.1 t30 60.31 47.07 9.42 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.822 0.82 . . . . 0.0 109.882 -175.747 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -83.91 -37.3 22.54 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 174.075 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.435 HG22 ' OG1' ' A' ' 36' ' ' THR . 21.7 t -120.87 105.79 17.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 114.584 -1.189 . . . . 0.0 108.3 170.036 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -77.49 104.38 7.98 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.003 0.43 . . . . 0.0 110.116 -177.668 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 50.9 mm-40 -77.91 176.07 9.45 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.814 -177.701 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -57.91 -100.93 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.725 172.316 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 28.5 p-10 -87.77 174.89 8.11 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 173.756 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -115.21 24.71 11.43 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.117 0.484 . . . . 0.0 111.122 178.448 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 41.3 m -110.39 18.63 19.63 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.398 0.618 . . . . 0.0 110.003 175.783 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 28.3 p-10 -124.29 -24.82 4.22 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.894 -177.813 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.577 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 26.5 p-10 -86.6 23.57 1.62 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.744 -173.044 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.56 144.64 46.33 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.893 0.378 . . . . 0.0 110.788 -179.611 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.574 ' O ' ' HA ' ' A' ' 81' ' ' THR . 30.0 tp -136.97 115.66 12.08 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.085 178.775 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 15.0 m -104.9 102.45 11.97 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 178.753 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -121.65 135.35 54.98 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.974 0.416 . . . . 0.0 111.248 -176.742 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.445 HD23 ' HA ' ' A' ' 79' ' ' THR . 60.9 mt -87.43 125.17 34.12 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.559 175.677 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.519 HG22 HD13 ' A' ' 80' ' ' LEU . 25.6 m -112.64 155.43 13.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 175.666 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.511 ' O ' ' HA ' ' A' ' 14' ' ' THR . . . -120.49 171.34 14.63 Favored Glycine 0 N--CA 1.444 -0.787 0 C-N-CA 120.156 -1.021 . . . . 0.0 111.461 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 32.1 p -76.32 169.05 18.95 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.689 -0.485 . . . . 0.0 109.689 174.464 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.603 HD22 HG22 ' A' ' 16' ' ' VAL . 29.1 tp . . . . . 0 C--N 1.323 -0.587 0 CA-C-O 121.206 0.527 . . . . 0.0 110.745 -178.455 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.485 HG12 ' HD2' ' A' ' 3' ' ' PRO . 6.2 tt . . . . . 0 CA--C 1.535 0.386 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.485 ' HD2' HG12 ' A' ' 2' ' ' ILE . 2.7 Cg_exo -76.04 -174.25 1.99 Allowed 'Trans proline' 0 C--O 1.237 0.45 0 C-N-CA 122.598 2.199 . . . . 0.0 112.128 178.072 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -162.23 75.51 0.45 Allowed 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 179.296 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.421 HD22 HD23 ' A' ' 57' ' ' LEU . 73.3 mt -70.09 103.24 2.24 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.813 -177.592 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.462 ' HA ' ' HD2' ' A' ' 7' ' ' PRO . 42.7 t -110.72 110.47 57.35 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.002 -179.015 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.524 ' HD3' HG21 ' A' ' 84' ' ' VAL . 20.7 Cg_endo -63.85 114.27 2.52 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 122.271 1.981 . . . . 0.0 109.978 168.686 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 6.3 t -89.25 -58.9 3.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.25 -168.613 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.7 p -136.66 154.09 50.73 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.565 -174.922 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 62.1 tp -130.11 100.1 5.3 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.239 176.056 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.527 HG23 ' HA ' ' A' ' 12' ' ' PRO . 56.6 m -115.61 141.11 26.88 Favored Pre-proline 0 C--N 1.317 -0.84 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.198 -175.13 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.533 ' HG2' HG12 ' A' ' 15' ' ' VAL . 72.1 Cg_endo -83.46 133.79 21.79 Favored 'Cis proline' 0 N--CA 1.461 -0.397 0 C-N-CA 123.383 -1.507 . . . . 0.0 113.244 1.767 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 35.0 m -65.75 -11.44 12.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.818 175.757 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.517 ' HA ' ' O ' ' A' ' 105' ' ' GLY . 0.6 OUTLIER -135.39 118.94 16.95 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 175.969 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.533 HG12 ' HG2' ' A' ' 12' ' ' PRO . 27.4 m -113.54 166.0 7.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.828 -170.106 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 1.7 t -108.09 119.72 49.07 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.166 179.107 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.514 ' HA ' ' HB3' ' A' ' 71' ' ' LEU . 36.5 Cg_exo -60.94 88.53 0.09 OUTLIER 'Trans proline' 0 C--O 1.236 0.402 0 C-N-CA 122.339 2.026 . . . . 0.0 109.719 167.013 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 32.5 t30 -158.25 -50.69 0.06 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.954 -167.3 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 8.9 t -153.76 -169.82 3.39 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.006 -172.809 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.508 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 39.0 t -77.76 114.24 18.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 174.891 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.529 ' OD1' HD23 ' A' ' 71' ' ' LEU . 9.6 m120 -86.84 132.81 33.72 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.479 -175.28 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 20.6 m -79.23 93.69 5.29 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.249 177.554 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' MET . . . . . 0.549 ' HB2' ' HB2' ' A' ' 67' ' ' PHE . 93.1 mmm -85.67 107.57 17.61 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.795 -178.979 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 17.7 m -97.96 113.15 24.92 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.819 -176.965 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -104.29 110.04 22.11 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.98 -0.554 . . . . 0.0 109.959 177.545 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 24.7 m -87.47 113.91 23.6 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 120.965 0.412 . . . . 0.0 110.324 -178.811 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 15.9 mm -100.8 122.86 53.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.708 -179.227 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -115.08 120.57 40.26 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 -179.21 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 32.4 t30 -82.7 98.39 9.04 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 178.276 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -94.18 44.24 1.11 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.353 0.596 . . . . 0.0 110.679 -175.684 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -143.96 147.97 19.51 Favored Glycine 0 N--CA 1.444 -0.789 0 N-CA-C 111.206 -0.758 . . . . 0.0 111.206 -177.629 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 14.5 t30 -84.89 61.68 6.98 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.489 0.662 . . . . 0.0 111.399 -172.371 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.448 ' HD3' ' HD3' ' A' ' 3' ' ' PRO . 54.4 tttm -161.69 156.85 23.57 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 170.311 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -80.7 154.57 27.22 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 120.867 0.365 . . . . 0.0 110.044 175.65 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 22.2 p -124.26 136.46 54.16 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.999 177.032 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 3.7 p -77.08 -166.53 0.72 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.889 179.306 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.425 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 7.5 t -60.93 113.04 2.31 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.989 0.423 . . . . 0.0 110.494 179.267 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.475 ' HB2' ' HB2' ' A' ' 85' ' ' ASP . 33.9 p90 -118.28 147.52 43.37 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.521 178.676 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.495 ' HB3' ' HD2' ' A' ' 86' ' ' PRO . 51.6 t-20 -90.29 128.59 36.46 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.368 -175.353 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.557 HG11 HG21 ' A' ' 65' ' ' VAL . 2.2 t -118.66 111.87 35.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-O 121.588 0.709 . . . . 0.0 109.821 176.144 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 8.9 m -111.77 143.15 43.17 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.807 -175.05 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 63.6 tp -102.75 113.76 27.44 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 176.735 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.553 ' HG ' HG22 ' A' ' 48' ' ' VAL . 4.8 mp -102.12 139.77 37.29 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.547 179.445 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 93.4 t -110.47 110.67 33.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 172.113 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 20.1 t70 67.73 -74.0 0.08 Allowed 'General case' 0 N--CA 1.464 0.273 0 O-C-N 124.042 0.839 . . . . 0.0 110.587 -174.855 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -150.3 6.95 0.71 Allowed Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.903 179.003 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 6.0 mt -116.85 147.44 20.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 117.104 0.452 . . . . 0.0 109.874 -179.319 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.553 HG22 ' HG ' ' A' ' 43' ' ' LEU . 25.5 t -94.08 114.8 31.44 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.294 -177.658 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 28.5 m -91.03 -30.0 4.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.594 -0.276 . . . . 0.0 111.47 -177.848 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -148.69 145.48 27.71 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 -178.785 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 58.3 m -137.51 114.39 10.61 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.909 -176.433 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -126.18 105.55 8.92 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.06 0.457 . . . . 0.0 110.24 -177.591 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.492 ' HA ' ' HA ' ' A' ' 39' ' ' ASN . 15.2 m -74.18 131.06 40.9 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.934 178.391 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.425 ' O ' ' HA ' ' A' ' 37' ' ' SER . 44.6 t -92.57 139.23 18.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 116.263 -0.426 . . . . 0.0 109.892 -179.146 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 18.6 m -59.55 -53.67 55.42 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.11 -0.495 . . . . 0.0 112.132 -177.038 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 35.3 t -176.81 149.95 0.77 Allowed 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -177.451 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.554 HD13 ' OG1' ' A' ' 63' ' ' THR . 25.2 tp -133.84 133.34 41.46 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.135 0.493 . . . . 0.0 110.424 178.946 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -89.79 174.62 7.61 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.775 -176.441 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 3.7 p -69.57 129.18 38.96 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.151 -179.775 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 50.5 mm-40 66.33 15.63 10.16 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.166 177.09 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -104.21 154.21 20.04 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 -179.623 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 7.3 m -113.1 143.73 43.84 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.829 0.347 . . . . 0.0 110.774 -178.816 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.554 ' OG1' HD13 ' A' ' 57' ' ' LEU . 95.6 m -128.86 127.91 42.8 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.078 174.934 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 40.1 m-80 -90.89 124.96 35.59 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.179 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.557 HG21 HG11 ' A' ' 40' ' ' VAL . 39.2 t -96.19 132.1 41.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.069 -178.335 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -101.81 97.3 7.7 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.525 -174.142 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.549 ' HB2' ' HB2' ' A' ' 23' ' ' MET . 32.2 m-85 -96.01 144.73 26.04 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.179 0.514 . . . . 0.0 111.302 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 15.9 m-70 -116.32 103.0 10.04 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.937 179.127 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' TRP . . . . . 0.41 ' CE2' HD22 ' A' ' 71' ' ' LEU . 11.3 t90 -116.51 111.2 19.61 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.516 -176.462 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.508 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 6.7 m -80.46 108.17 13.87 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.319 178.459 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.529 HD23 ' OD1' ' A' ' 21' ' ' ASN . 0.2 OUTLIER -69.25 116.02 9.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.953 0.406 . . . . 0.0 111.065 -178.302 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -84.54 -35.65 22.7 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.575 176.939 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 90.3 35.17 7.63 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.673 177.456 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 25.5 m -79.59 -38.63 33.53 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.023 0.44 . . . . 0.0 110.768 177.276 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -126.28 161.15 28.43 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.46 -174.417 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 -91.07 -12.02 36.94 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.461 178.146 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.562 ' HB2' HD21 ' A' ' 103' ' ' LEU . 28.4 p -147.34 137.83 23.37 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.363 177.685 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 40.3 m-85 -125.73 134.03 51.9 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.144 -178.212 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 21.4 m -89.53 92.92 9.3 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 120.927 0.394 . . . . 0.0 110.059 178.24 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.491 HD13 HG22 ' A' ' 104' ' ' VAL . 9.0 mp -88.37 137.92 31.9 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.194 0.521 . . . . 0.0 110.607 -179.445 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.416 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 19.1 m -131.44 114.56 15.08 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.428 -179.412 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.546 ' HB ' ' HB3' ' A' ' 100' ' ' LEU . 61.8 t -88.39 105.24 15.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 175.101 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -94.61 110.45 22.27 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.006 0.432 . . . . 0.0 110.104 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.524 HG21 ' HD3' ' A' ' 7' ' ' PRO . 85.6 t -83.19 114.47 24.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.341 -177.697 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.475 ' HB2' ' HB2' ' A' ' 38' ' ' PHE . 39.8 t0 58.74 73.66 0.69 Allowed Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 114.232 -1.349 . . . . 0.0 112.089 177.759 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.495 ' HD2' ' HB3' ' A' ' 39' ' ' ASN . 6.6 Cg_exo -74.19 -18.08 21.22 Favored 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 122.758 2.305 . . . . 0.0 111.141 176.301 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -87.77 -13.1 43.23 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.384 -177.616 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 62.79 45.62 5.62 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.194 177.616 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -77.12 -22.7 52.27 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.316 178.37 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 13.5 t -119.16 143.35 30.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.961 178.153 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 43.0 t-20 -89.54 105.38 17.76 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 178.596 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -98.82 147.21 25.14 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -174.474 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -57.76 -101.1 0.01 OUTLIER Glycine 0 CA--C 1.518 0.243 0 CA-C-N 114.965 -1.016 . . . . 0.0 113.195 174.124 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -73.92 106.54 5.68 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.929 0.395 . . . . 0.0 111.363 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.585 ' HA ' ' OD1' ' A' ' 98' ' ' ASN . 40.8 mt-10 -68.37 -11.71 60.0 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.089 179.418 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 8.1 m -70.82 -7.79 47.83 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.93 177.928 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.483 ' O ' ' HD2' ' A' ' 7' ' ' PRO . 88.6 m-20 -97.27 -21.73 17.09 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.139 -178.652 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.585 ' OD1' ' HA ' ' A' ' 95' ' ' GLU . 14.3 m120 -59.3 -34.89 72.85 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -172.234 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.49 125.0 49.8 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.258 0.551 . . . . 0.0 112.019 -178.073 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.546 ' HB3' ' HB ' ' A' ' 82' ' ' VAL . 28.5 tp -107.33 98.12 7.79 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.371 175.334 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 20.0 m -90.96 94.66 9.74 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.234 0.54 . . . . 0.0 110.105 -179.652 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -112.62 112.29 23.71 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.212 -178.89 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.562 HD21 ' HB2' ' A' ' 77' ' ' SER . 5.9 tt -80.86 104.29 11.27 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 179.681 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.491 HG22 HD13 ' A' ' 80' ' ' LEU . 18.3 m -93.83 149.86 4.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.655 -177.818 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.517 ' O ' ' HA ' ' A' ' 14' ' ' THR . . . -119.72 170.95 14.25 Favored Glycine 0 N--CA 1.443 -0.876 0 C-N-CA 119.941 -1.123 . . . . 0.0 111.876 -176.726 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 42.5 p -89.5 130.22 35.87 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 173.286 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.485 ' N ' HG22 ' A' ' 14' ' ' THR . 17.9 tp . . . . . 0 C--N 1.328 -0.332 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 -175.965 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.459 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 0.8 OUTLIER . . . . . 0 N--CA 1.453 -0.314 0 CA-C-O 120.676 0.274 . . . . 0.0 110.455 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.462 ' HD2' ' O ' ' A' ' 91' ' ' ASN . 12.9 Cg_endo -91.05 156.89 3.9 Favored 'Trans proline' 0 N--CA 1.445 -1.36 0 C-N-CA 122.883 2.388 . . . . 0.0 111.024 172.196 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -137.39 105.23 5.61 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 -179.126 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.531 HD22 HD23 ' A' ' 57' ' ' LEU . 27.4 mt -99.78 126.69 45.89 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 -171.145 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.532 HG22 ' HB3' ' A' ' 97' ' ' ASN . 4.6 t -125.42 140.29 35.94 Favored Pre-proline 0 C--N 1.317 -0.845 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.444 -176.52 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.473 ' HD3' ' O ' ' A' ' 97' ' ' ASN . 6.8 Cg_endo -92.79 100.72 0.17 Allowed 'Trans proline' 0 N--CA 1.445 -1.375 0 C-N-CA 123.13 2.553 . . . . 0.0 110.054 167.514 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 27.4 m -79.53 -28.86 13.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.811 -171.414 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 35.4 t -156.67 147.54 21.86 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.772 0.32 . . . . 0.0 110.888 -176.452 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.541 HD11 ' HB3' ' A' ' 23' ' ' MET . 19.4 tp -127.68 126.14 41.38 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 171.813 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.519 ' OG1' ' HA ' ' A' ' 12' ' ' PRO . 6.5 t -122.26 152.05 60.01 Favored Pre-proline 0 C--N 1.317 -0.835 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.912 178.278 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.64 ' HD2' ' SD ' ' A' ' 23' ' ' MET . 98.5 Cg_endo -80.92 149.92 77.75 Favored 'Cis proline' 0 N--CA 1.46 -0.467 0 C-N-CA 123.483 -1.465 . . . . 0.0 112.492 -3.54 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 35.3 m -69.09 -21.57 25.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.059 177.649 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.558 ' HA ' ' O ' ' A' ' 105' ' ' GLY . 0.7 OUTLIER -124.71 131.19 53.48 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.152 174.288 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.0 m -114.56 149.2 16.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 121.04 0.448 . . . . 0.0 111.789 -174.381 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.9 m -98.34 117.69 64.44 Favored Pre-proline 0 N--CA 1.447 -0.577 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.346 178.942 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.553 ' HA ' ' HB3' ' A' ' 71' ' ' LEU . 10.0 Cg_exo -71.06 91.31 0.64 Allowed 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 122.597 2.198 . . . . 0.0 110.443 173.139 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -163.23 -41.6 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.216 -171.489 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 13.5 t -145.73 -170.23 3.42 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.001 -172.874 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.439 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 62.1 t -84.34 116.51 28.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 172.853 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.587 ' OD1' HD23 ' A' ' 71' ' ' LEU . 9.2 m120 -91.47 118.44 30.56 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.636 -174.177 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.628 ' HA ' ' O ' ' A' ' 67' ' ' PHE . 58.7 m -80.6 96.26 6.79 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-O 121.319 0.581 . . . . 0.0 109.873 177.34 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' MET . . . . . 0.64 ' SD ' ' HD2' ' A' ' 12' ' ' PRO . 93.3 mmm -79.14 126.56 30.89 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.478 -176.154 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.49 ' HA ' ' O ' ' A' ' 65' ' ' VAL . 17.5 m -105.07 112.34 25.44 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.975 0.416 . . . . 0.0 111.36 -176.208 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -104.15 130.41 51.89 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.012 176.275 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 23.7 m -95.8 108.34 20.67 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 120.695 0.283 . . . . 0.0 110.431 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.429 ' O ' ' HA ' ' A' ' 62' ' ' SER . 19.7 mm -100.06 119.95 48.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.863 -179.668 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -115.18 136.22 53.34 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.249 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 32.9 t30 -91.89 99.96 12.72 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.305 178.392 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -99.35 45.97 0.98 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.835 -175.281 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -144.01 160.08 27.73 Favored Glycine 0 N--CA 1.449 -0.463 0 N-CA-C 111.533 -0.627 . . . . 0.0 111.533 179.32 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -87.33 56.3 3.91 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.232 0.539 . . . . 0.0 110.924 -174.421 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.9 tptp -161.64 139.94 9.34 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 174.233 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -76.3 149.73 37.03 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 174.965 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.3 p -120.49 140.63 51.15 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.929 0.395 . . . . 0.0 110.498 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 3.9 p -91.84 -163.29 1.02 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.017 -178.278 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.557 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 48.5 m -49.03 115.6 1.35 Allowed 'General case' 0 C--O 1.234 0.276 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -179.482 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.463 ' CE2' HG23 ' A' ' 40' ' ' VAL . 30.4 p90 -130.57 149.52 52.2 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.12 177.632 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 11.8 m-80 -98.46 108.6 21.33 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.296 -172.71 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.463 HG23 ' CE2' ' A' ' 38' ' ' PHE . 2.3 t -98.32 117.88 43.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.401 0.62 . . . . 0.0 110.492 178.333 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 16.9 m -108.28 146.59 32.66 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.957 -176.372 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.42 HD11 ' HB3' ' A' ' 80' ' ' LEU . 47.6 tp -106.82 113.89 27.65 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 174.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.545 ' HG ' HG22 ' A' ' 48' ' ' VAL . 4.8 mp -101.07 121.01 41.03 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.277 -179.552 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 98.0 t -100.54 102.2 13.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 178.166 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 60.75 17.25 7.45 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.708 178.797 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 128.38 -34.45 2.92 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.943 176.87 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 11.5 mm -89.99 150.33 3.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.945 0.372 . . . . 0.0 110.209 -176.719 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.545 HG22 ' HG ' ' A' ' 43' ' ' LEU . 52.4 t -96.98 112.21 28.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 -179.375 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 24.3 m -86.01 -32.85 7.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.382 -177.724 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 38.4 t0 -159.68 162.32 35.06 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 120.889 0.376 . . . . 0.0 110.645 -178.901 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 85.0 m -149.81 129.86 13.52 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.785 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -117.69 118.82 33.14 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 110.175 -0.306 . . . . 0.0 110.175 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 27.6 m -74.86 108.35 7.54 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.034 175.715 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.557 ' O ' ' HA ' ' A' ' 37' ' ' SER . 40.3 t -77.53 128.37 38.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 178.196 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 7.3 m -57.44 -50.14 73.99 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 123.333 0.395 . . . . 0.0 111.763 -173.907 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 45.7 m -170.8 151.19 3.38 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 -177.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.531 HD23 HD22 ' A' ' 5' ' ' LEU . 23.8 tp -136.97 112.35 9.23 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.145 0.498 . . . . 0.0 110.364 177.73 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 23.9 mm-40 -76.28 174.38 10.24 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.889 -177.97 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 24.2 m -67.4 129.15 39.0 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.969 -179.069 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.457 ' O ' ' HG2' ' A' ' 60' ' ' GLU . 37.0 tt0 69.61 10.21 7.53 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.136 178.322 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 58.5 t30 -93.34 146.24 23.87 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.542 -0.463 . . . . 0.0 109.839 178.523 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.429 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 9.3 m -119.07 131.43 55.94 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.738 177.631 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.552 HG21 HG11 ' A' ' 54' ' ' VAL . 9.3 t -114.56 139.84 49.26 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.957 0.408 . . . . 0.0 110.42 179.014 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 30.7 m-80 -92.2 114.06 26.5 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.146 178.218 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.49 ' O ' ' HA ' ' A' ' 24' ' ' THR . 10.0 t -96.4 122.88 48.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.582 -179.581 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.581 ' HB3' ' CG2' ' A' ' 22' ' ' THR . 17.3 m-20 -111.78 109.44 19.27 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.012 0.434 . . . . 0.0 110.862 -176.217 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.628 ' O ' ' HA ' ' A' ' 22' ' ' THR . 61.7 m-85 -91.5 163.93 13.98 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.372 -175.914 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 17.4 m80 -111.92 93.43 4.45 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.34 177.948 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 15.4 t90 -113.53 110.56 20.46 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.068 0.461 . . . . 0.0 110.679 -176.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.439 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 22.0 m -81.41 112.44 18.68 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.913 176.894 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.587 HD23 ' OD1' ' A' ' 21' ' ' ASN . 0.3 OUTLIER -71.6 119.52 15.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.121 0.486 . . . . 0.0 111.503 -177.317 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 24.5 p-10 -83.32 -33.58 25.87 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.612 175.209 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 77.38 29.62 55.63 Favored Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.87 174.832 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 25.6 m -80.05 -51.33 9.16 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.011 0.434 . . . . 0.0 110.501 179.756 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -105.85 148.29 27.73 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.302 179.372 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 -86.43 -9.19 56.78 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.877 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 24.4 t -137.54 119.51 15.37 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.067 179.37 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -116.58 150.37 38.13 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.956 178.264 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.41 ' HA ' HD23 ' A' ' 103' ' ' LEU . 26.0 m -101.36 89.73 3.86 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.012 179.295 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.484 HD13 HG22 ' A' ' 104' ' ' VAL . 9.2 mp -87.72 114.05 23.96 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.472 0.653 . . . . 0.0 110.493 -178.399 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.564 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 27.1 m -111.69 120.8 43.27 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.381 -177.84 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.467 ' HB ' ' HB3' ' A' ' 100' ' ' LEU . 61.8 t -89.64 103.21 13.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 176.374 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -95.83 114.04 25.74 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 178.234 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.417 ' HA ' HG22 ' A' ' 40' ' ' VAL . 95.7 t -81.02 104.21 9.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.129 -178.48 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.7 t70 53.49 90.85 0.08 OUTLIER Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 114.278 -1.328 . . . . 0.0 112.899 177.407 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -79.22 16.31 1.39 Allowed 'Trans proline' 0 N--CA 1.463 -0.323 0 C-N-CA 123.316 2.677 . . . . 0.0 111.935 177.446 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -116.18 -17.17 10.89 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.264 -177.622 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 62.94 48.99 3.68 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.587 -178.009 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -66.5 -33.0 74.72 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.404 0.621 . . . . 0.0 109.752 174.537 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 4.1 t -107.53 169.26 2.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 174.389 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.462 ' O ' ' HD2' ' A' ' 3' ' ' PRO . 65.1 t30 -106.13 93.29 4.54 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 175.778 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 14.9 mp0 -76.51 149.7 36.7 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.772 -173.467 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -57.41 -100.85 0.01 OUTLIER Glycine 0 CA--C 1.522 0.5 0 CA-C-N 114.655 -1.157 . . . . 0.0 113.472 170.95 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 16.7 m-80 -84.71 130.72 34.66 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 122.758 -0.26 . . . . 0.0 111.351 -173.946 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -64.14 -32.12 73.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.076 0.465 . . . . 0.0 110.515 177.769 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 49.3 m -59.54 -29.41 67.88 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.82 176.925 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.532 ' HB3' HG22 ' A' ' 6' ' ' VAL . 7.0 m-20 -84.58 -13.25 52.26 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.913 -175.391 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -73.65 -10.67 59.93 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.011 178.203 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 3.7 p -130.8 125.13 32.93 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -173.655 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.564 ' O ' ' HA ' ' A' ' 81' ' ' THR . 46.1 tp -108.63 102.41 11.47 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.879 169.88 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 21.8 m -85.11 95.32 9.09 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 175.246 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -111.33 119.72 39.82 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.618 -177.827 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.41 HD23 ' HA ' ' A' ' 79' ' ' THR . 41.9 mt -82.43 114.99 21.25 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.389 0.614 . . . . 0.0 110.324 176.943 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.484 HG22 HD13 ' A' ' 80' ' ' LEU . 27.4 m -108.13 140.05 28.03 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.319 178.882 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.558 ' O ' ' HA ' ' A' ' 14' ' ' THR . . . -116.75 165.35 12.33 Favored Glycine 0 N--CA 1.438 -1.199 0 C-N-CA 120.182 -1.009 . . . . 0.0 111.149 -178.346 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 27.0 p -72.35 137.25 46.48 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 175.341 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 49.8 tp . . . . . 0 C--N 1.326 -0.415 0 CA-C-O 120.917 0.389 . . . . 0.0 110.584 -177.73 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 7.6 tp . . . . . 0 CA--C 1.538 0.496 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.538 ' HD3' ' HD3' ' A' ' 33' ' ' LYS . 5.4 Cg_exo -75.44 157.08 41.1 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.346 2.031 . . . . 0.0 111.143 174.379 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -140.13 102.76 4.45 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 178.067 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.552 HD22 HD23 ' A' ' 57' ' ' LEU . 25.4 mt -99.74 126.72 45.85 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -172.974 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.48 ' O ' ' HA ' ' A' ' 27' ' ' ILE . 8.3 t -125.22 140.23 35.61 Favored Pre-proline 0 C--N 1.313 -1.002 0 C-N-CA 119.865 -0.734 . . . . 0.0 110.635 -175.182 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.518 ' HG2' ' HB2' ' A' ' 100' ' ' LEU . 11.8 Cg_endo -96.99 110.05 0.1 Allowed 'Trans proline' 0 N--CA 1.447 -1.212 0 C-N-CA 123.672 2.915 . . . . 0.0 110.478 169.398 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 19.3 m -86.5 -39.14 13.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -169.88 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 51.0 m -156.37 161.17 40.16 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.723 0.297 . . . . 0.0 111.099 -178.327 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.436 HD11 ' HB3' ' A' ' 23' ' ' MET . 26.9 tp -127.61 126.49 42.16 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 172.403 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.511 HG22 ' HB ' ' A' ' 24' ' ' THR . 0.7 OUTLIER -122.6 131.73 24.35 Favored Pre-proline 0 C--N 1.318 -0.773 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.978 177.101 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.541 ' HD2' ' SD ' ' A' ' 23' ' ' MET . 90.4 Cg_endo -95.2 145.76 7.99 Favored 'Cis proline' 0 N--CA 1.449 -1.125 0 C-N-CA 123.789 -1.338 . . . . 0.0 113.345 5.114 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.432 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 35.4 m -67.37 -18.04 23.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.435 175.713 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.27 151.19 39.53 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 175.645 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 16.4 m -142.93 157.17 17.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.308 0.575 . . . . 0.0 111.346 -174.662 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.46 ' HA ' ' HD3' ' A' ' 17' ' ' PRO . 14.4 t -99.32 131.95 24.18 Favored Pre-proline 0 C--N 1.321 -0.663 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.647 -175.936 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 16' ' ' VAL . 1.6 Cg_endo -84.13 18.23 1.57 Allowed 'Trans proline' 0 CA--C 1.529 0.264 0 C-N-CA 122.786 2.324 . . . . 0.0 112.856 179.244 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 56.0 m-20 -106.67 -22.91 12.6 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.669 0.271 . . . . 0.0 111.583 -174.646 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 8.9 t -145.54 178.23 8.28 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.136 -173.029 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.626 HG22 HG23 ' A' ' 70' ' ' THR . 51.5 t -73.29 141.89 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 172.908 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.66 ' ND2' HD23 ' A' ' 71' ' ' LEU . 39.7 m-80 -114.41 132.76 56.12 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.361 -173.433 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.7 m -108.19 118.88 37.9 Favored 'General case' 0 N--CA 1.437 -1.089 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 -175.748 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' MET . . . . . 0.541 ' SD ' ' HD2' ' A' ' 12' ' ' PRO . 87.2 mmm -108.93 122.99 48.39 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 113.938 -1.483 . . . . 0.0 109.855 -165.402 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.632 ' HA ' ' O ' ' A' ' 65' ' ' VAL . 17.0 m -111.99 124.44 52.4 Favored 'General case' 0 C--N 1.309 -1.152 0 CA-C-O 121.854 0.835 . . . . 0.0 109.765 -173.749 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -119.16 132.1 55.94 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 114.221 -1.354 . . . . 0.0 108.522 -175.82 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 19.5 m -112.35 121.01 43.65 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 121.714 0.769 . . . . 0.0 109.61 -171.063 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.48 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 8.7 mm -116.9 131.92 68.16 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 CA-C-N 114.314 -1.312 . . . . 0.0 109.236 -172.325 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -121.0 138.64 54.06 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 178.889 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.499 ' HB2' ' HG ' ' A' ' 57' ' ' LEU . 39.1 t30 -93.84 98.12 10.86 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 175.168 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 69.5 mt-30 -102.25 47.1 0.9 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.329 -173.977 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -144.18 154.65 25.83 Favored Glycine 0 N--CA 1.445 -0.743 0 N-CA-C 110.488 -1.045 . . . . 0.0 110.488 177.658 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -82.84 53.79 2.51 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.392 0.615 . . . . 0.0 111.466 -174.016 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.538 ' HD3' ' HD3' ' A' ' 3' ' ' PRO . 87.9 tttt -161.47 136.47 7.4 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 171.5 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -80.34 135.37 36.18 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 120.978 0.418 . . . . 0.0 110.756 -175.836 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 35.8 t -95.85 142.62 27.89 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.56 178.195 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.405 ' O ' ' HA ' ' A' ' 56' ' ' SER . 2.2 m -99.29 -129.57 0.2 Allowed 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.348 -179.631 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.605 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 48.5 m -82.85 108.8 16.45 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.027 0.441 . . . . 0.0 111.624 -173.641 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.547 ' HB2' ' HB2' ' A' ' 85' ' ' ASP . 52.9 p90 -122.38 146.01 47.73 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.014 177.196 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.485 ' O ' ' HA ' ' A' ' 85' ' ' ASP . 22.0 m-80 -92.56 110.58 22.01 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.794 -174.333 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -98.35 127.11 51.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 -178.46 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 37.0 m -118.72 141.65 48.41 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.297 -174.227 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 56.4 tp -100.24 111.51 23.79 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.575 173.516 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.472 ' HG ' HG22 ' A' ' 48' ' ' VAL . 4.9 mp -102.06 124.86 48.4 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.592 -178.031 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.511 HG13 ' HB3' ' A' ' 78' ' ' TYR . 86.2 t -93.68 95.96 5.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 175.485 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 64.03 5.66 2.5 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.96 -179.689 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 140.56 -34.99 1.92 Allowed Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.406 179.057 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.42 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 9.5 mt -82.36 147.93 5.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 -179.14 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.472 HG22 ' HG ' ' A' ' 43' ' ' LEU . 36.1 t -99.79 119.68 48.17 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.442 -176.724 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 20.3 m -97.6 -27.22 3.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 111.887 0.329 . . . . 0.0 111.887 -177.835 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 42.2 t0 -162.29 136.49 6.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.655 0.264 . . . . 0.0 110.332 -178.507 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 86.2 m -124.81 122.38 37.27 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.185 179.481 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -115.11 117.99 32.11 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 -178.445 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.454 ' HA ' ' HA ' ' A' ' 39' ' ' ASN . 22.7 m -82.86 111.18 18.51 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.327 -179.86 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.605 ' O ' ' HA ' ' A' ' 37' ' ' SER . 59.1 t -77.68 123.12 33.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 179.206 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.4 m -58.43 -39.97 81.24 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.727 -0.669 . . . . 0.0 112.128 -173.814 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.405 ' HA ' ' O ' ' A' ' 36' ' ' THR . 46.7 t -173.31 143.75 1.12 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.834 0.35 . . . . 0.0 110.486 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.552 HD23 HD22 ' A' ' 5' ' ' LEU . 23.5 tp -126.86 104.31 7.97 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.339 0.59 . . . . 0.0 109.532 175.246 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -70.75 160.68 32.24 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.525 -175.212 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 11.8 m -61.36 120.31 10.19 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.63 179.153 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 70.27 17.34 7.11 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 123.805 0.69 . . . . 0.0 110.889 -179.644 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -102.1 157.73 16.67 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 173.662 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 26.3 t -127.61 143.36 51.17 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.119 0.485 . . . . 0.0 110.71 -178.909 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 91.1 m -124.84 130.52 52.54 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.63 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 37.1 m-80 -101.19 117.7 35.52 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.943 177.697 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.632 ' O ' ' HA ' ' A' ' 24' ' ' THR . 3.7 t -102.82 125.16 57.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.911 -175.32 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -102.4 112.62 25.42 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.792 0.33 . . . . 0.0 110.914 178.595 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.402 ' HB2' ' HB2' ' A' ' 23' ' ' MET . 96.0 m-85 -91.62 159.01 16.1 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.953 179.467 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 15.8 m80 -108.64 109.74 21.02 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.727 -179.825 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 16.2 t90 -131.35 108.16 9.45 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.319 0.581 . . . . 0.0 111.404 -175.915 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.626 HG23 HG22 ' A' ' 20' ' ' VAL . 5.6 m -85.4 122.14 29.13 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.886 175.784 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.66 HD23 ' ND2' ' A' ' 21' ' ' ASN . 0.2 OUTLIER -72.3 122.33 20.94 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.19 0.519 . . . . 0.0 111.021 -177.633 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 24.2 p-10 -90.3 -41.62 11.44 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.436 179.058 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 99.07 23.62 11.27 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.81 -0.71 . . . . 0.0 113.204 175.792 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 92.6 m -74.96 -41.19 60.08 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.023 0.439 . . . . 0.0 110.583 177.558 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -128.33 162.31 27.37 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.372 178.526 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -100.71 -6.77 24.57 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.224 0.535 . . . . 0.0 110.183 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 22.7 t -146.95 112.26 5.53 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.508 177.984 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.511 ' HB3' HG13 ' A' ' 44' ' ' VAL . 83.2 m-85 -105.76 150.21 25.73 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.315 177.983 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.1 m -93.95 86.97 5.2 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 178.081 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.487 HD22 HG21 ' A' ' 104' ' ' VAL . 6.4 mp -81.43 114.32 20.1 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.714 0.769 . . . . 0.0 110.349 -177.883 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.513 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 7.3 m -116.94 117.8 30.69 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.475 -175.003 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 46.3 t -85.56 108.04 16.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 176.647 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.551 ' HA ' ' O ' ' A' ' 98' ' ' ASN . 6.3 t30 -101.64 116.69 33.3 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 178.696 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 58.2 t -82.64 104.42 11.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 115.615 -0.721 . . . . 0.0 111.214 -177.236 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.547 ' HB2' ' HB2' ' A' ' 38' ' ' PHE . 7.3 t70 54.5 89.66 0.1 Allowed Pre-proline 0 N--CA 1.468 0.47 0 CA-C-N 114.234 -1.348 . . . . 0.0 112.308 179.105 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -62.59 -24.43 75.1 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 123.29 2.66 . . . . 0.0 112.215 179.276 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 50.8 mm-40 -75.93 -28.81 58.13 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.812 177.706 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 56.2 53.84 8.47 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.812 -1.085 . . . . 0.0 109.807 -175.31 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -74.13 -25.04 59.54 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.865 -1.061 . . . . 0.0 109.706 178.24 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 17.3 t -108.31 97.49 5.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.213 -0.903 . . . . 0.0 108.897 174.392 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -61.15 134.31 56.89 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 -178.809 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.43 ' HA ' ' O ' ' A' ' 3' ' ' PRO . 3.0 mt-10 -111.22 166.22 11.27 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.966 -177.279 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -57.93 -101.04 0.01 OUTLIER Glycine 0 N--CA 1.453 -0.188 0 CA-C-N 115.588 -0.733 . . . . 0.0 112.851 174.044 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 28.4 t30 -70.17 100.74 1.72 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.683 -0.258 . . . . 0.0 110.538 179.855 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -75.9 53.94 0.79 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.211 0.529 . . . . 0.0 111.997 -177.207 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 13.9 t -137.64 16.1 2.91 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 174.102 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 18.1 p-10 -98.8 -27.27 14.02 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 113.58 -1.645 . . . . 0.0 111.746 -172.448 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.551 ' O ' ' HA ' ' A' ' 83' ' ' ASN . 17.9 m120 -55.13 -34.07 63.43 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 -168.731 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 1.5 p -107.23 123.38 48.21 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 -174.718 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.518 ' HB2' ' HG2' ' A' ' 7' ' ' PRO . 39.2 tp -107.26 106.63 17.17 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 170.17 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 28.3 m -89.96 102.4 15.11 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.669 -177.603 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -119.88 116.93 26.84 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.547 179.771 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 52.3 mt -74.86 119.03 18.49 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.126 175.535 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.487 HG21 HD22 ' A' ' 80' ' ' LEU . 27.6 m -113.1 133.39 59.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.693 178.789 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -120.9 166.55 13.95 Favored Glycine 0 N--CA 1.442 -0.956 0 C-N-CA 120.432 -0.89 . . . . 0.0 111.671 -176.676 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 59.3 p -69.09 146.02 52.92 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 177.518 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 62.4 tp . . . . . 0 C--N 1.328 -0.365 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -172.37 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 83.9 mmm . . . . . 0 N--CA 1.48 1.026 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.437 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 16.6 tt -143.72 139.24 16.01 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.301 -176.63 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.521 ' HB3' ' HB2' ' A' ' 35' ' ' SER . 12.4 Cg_exo -69.84 116.99 4.82 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.17 1.913 . . . . 0.0 111.24 175.344 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -103.16 79.94 1.79 Allowed 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 178.593 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.517 HD22 HD23 ' A' ' 57' ' ' LEU . 61.9 mt -73.27 103.42 3.96 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.775 -173.551 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.548 HG22 ' HB3' ' A' ' 97' ' ' ASN . 47.1 t -114.27 111.4 47.21 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.511 -176.5 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.584 ' HD2' ' O ' ' A' ' 97' ' ' ASN . 18.2 Cg_endo -64.03 107.44 0.78 Allowed 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 122.057 1.838 . . . . 0.0 110.046 167.37 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.0 t -82.51 -55.74 7.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.126 -170.521 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 58.6 p -141.44 158.3 44.04 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.182 -177.41 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.481 HD21 HD23 ' A' ' 80' ' ' LEU . 54.0 tp -130.24 104.42 7.28 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.021 177.787 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 22.0 p -115.02 146.18 35.64 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.216 -175.743 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.403 ' HD2' ' HG2' ' A' ' 23' ' ' MET . 88.1 Cg_endo -78.99 152.64 89.12 Favored 'Cis proline' 0 C--N 1.341 0.183 0 C-N-CA 123.186 -1.589 . . . . 0.0 112.562 -0.795 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.2 m -73.57 -19.77 18.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.045 0.45 . . . . 0.0 111.206 -178.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.458 ' HB ' HD13 ' A' ' 107' ' ' LEU . 0.2 OUTLIER -126.37 128.35 46.91 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 177.178 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.468 ' HB ' ' ND2' ' A' ' 21' ' ' ASN . 18.7 m -114.13 140.14 36.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -167.447 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.439 ' HA ' ' HD3' ' A' ' 17' ' ' PRO . 5.8 m -84.17 121.4 75.49 Favored Pre-proline 0 N--CA 1.449 -0.512 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.098 176.765 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 16' ' ' VAL . 4.6 Cg_exo -77.97 55.75 5.42 Favored 'Trans proline' 0 N--CA 1.463 -0.269 0 C-N-CA 123.006 2.471 . . . . 0.0 111.667 176.692 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -122.97 -18.26 6.48 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.161 -0.472 . . . . 0.0 112.042 -176.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 14.7 t -157.25 -173.96 4.67 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.736 -0.386 . . . . 0.0 110.938 -171.434 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.402 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 46.7 t -82.32 110.11 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 169.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.468 ' ND2' ' HB ' ' A' ' 15' ' ' VAL . 5.1 m-20 -84.38 108.23 17.09 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.309 0.576 . . . . 0.0 110.702 -169.827 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.622 ' HA ' ' O ' ' A' ' 67' ' ' PHE . 11.3 m -79.41 83.44 5.43 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.256 -0.883 . . . . 0.0 109.355 176.341 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.449 ' O ' ' HA ' ' A' ' 66' ' ' ASP . 82.8 mtp -79.5 152.21 30.34 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.41 -0.813 . . . . 0.0 110.403 -176.692 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 30.8 m -114.11 109.58 18.65 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.065 -175.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.441 ' HB3' ' HB ' ' A' ' 65' ' ' VAL . . . -92.14 120.09 32.41 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.548 173.585 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 61.2 m -92.76 101.29 13.68 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-O 121.12 0.486 . . . . 0.0 109.769 -179.638 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 15.3 mm -95.17 118.98 42.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.246 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -113.74 125.15 53.79 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.51 ' HB2' ' HG ' ' A' ' 57' ' ' LEU . 29.6 t30 -81.78 90.03 6.35 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.607 178.604 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -87.11 43.99 1.14 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.559 0.695 . . . . 0.0 110.788 -173.654 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -143.98 145.07 14.37 Favored Glycine 0 N--CA 1.442 -0.956 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 176.568 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -81.17 63.65 5.6 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.526 0.679 . . . . 0.0 111.039 -173.324 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.413 ' HA ' ' HD2' ' A' ' 33' ' ' LYS . 50.6 tptt -161.5 121.31 2.57 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.056 171.481 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -69.06 124.09 22.83 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.985 0.421 . . . . 0.0 110.567 -175.631 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.521 ' HB2' ' HB3' ' A' ' 3' ' ' PRO . 46.4 t -87.7 147.01 25.42 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.19 -174.73 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 21.7 p -86.54 -163.0 0.83 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.444 178.236 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.463 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 15.0 m -61.68 134.09 56.37 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 120.929 0.395 . . . . 0.0 111.338 -179.568 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.52 ' CE1' ' HB ' ' A' ' 54' ' ' VAL . 31.1 p90 -144.9 144.35 31.05 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.294 -177.339 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.515 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 25.7 m-80 -92.62 108.67 20.16 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.219 -174.272 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.452 HG22 ' HA ' ' A' ' 84' ' ' VAL . 2.1 t -98.29 116.75 41.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 121.392 0.615 . . . . 0.0 110.289 178.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 46.3 m -109.95 144.14 38.9 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.689 -177.569 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 46.9 tp -98.68 108.66 21.41 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.697 175.038 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.498 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 5.2 mp -98.93 108.45 21.13 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.427 -179.047 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 82.4 t -88.96 101.48 12.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.203 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 60.06 18.43 7.67 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.422 -179.097 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 124.49 -36.04 3.02 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.785 178.078 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.474 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 9.8 mm -79.81 145.55 9.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.905 0.383 . . . . 0.0 110.096 -176.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.42 HG22 ' HG ' ' A' ' 43' ' ' LEU . 40.8 t -96.96 101.75 12.65 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.824 -178.036 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 28.4 m -83.59 -30.78 8.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.615 -175.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 33.7 t0 -159.56 141.37 13.19 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.915 -0.314 . . . . 0.0 111.002 -177.425 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 88.6 m -129.07 123.36 32.05 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.308 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -127.3 105.69 8.71 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 -178.758 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.515 ' HA ' ' HA ' ' A' ' 39' ' ' ASN . 7.1 t -74.52 131.02 40.64 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.068 0.461 . . . . 0.0 110.38 178.679 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.52 ' HB ' ' CE1' ' A' ' 38' ' ' PHE . 39.1 t -95.28 138.57 20.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.774 -179.288 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.0 m -55.07 -43.28 73.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.246 -0.434 . . . . 0.0 112.039 -177.058 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 47.7 t -174.76 153.51 1.77 Allowed 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 -175.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.517 HD23 HD22 ' A' ' 5' ' ' LEU . 27.6 tp -134.15 109.5 8.95 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.16 0.505 . . . . 0.0 110.066 177.092 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.473 ' HB2' ' HB3' ' A' ' 61' ' ' ASN . 35.9 mt-10 -70.98 158.78 35.92 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.542 -0.754 . . . . 0.0 112.154 -174.278 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 12.3 p -64.12 122.98 17.88 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.095 179.45 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 65.09 20.2 11.98 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.453 179.131 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.473 ' HB3' ' HB2' ' A' ' 58' ' ' GLU . 61.1 t30 -116.62 155.2 29.17 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 176.036 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 2.4 m -115.28 145.66 42.25 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.657 0.265 . . . . 0.0 110.752 -175.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 13.3 t -119.2 143.85 47.04 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 175.271 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -96.05 112.03 23.88 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.873 0.368 . . . . 0.0 110.261 178.679 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.441 ' HB ' ' HB3' ' A' ' 25' ' ' ALA . 13.2 t -96.86 118.13 42.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.911 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.452 ' HB2' ' CG2' ' A' ' 22' ' ' THR . 5.3 p-10 -95.13 119.67 34.04 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.512 0.672 . . . . 0.0 110.559 -179.227 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.622 ' O ' ' HA ' ' A' ' 22' ' ' THR . 33.2 m-85 -95.67 146.8 24.22 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.726 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 15.2 m80 -110.73 90.27 3.28 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.663 -0.698 . . . . 0.0 109.485 -178.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 12.5 t90 -123.62 113.67 18.99 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.389 0.614 . . . . 0.0 111.416 -172.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.402 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 49.7 m -78.22 114.67 17.33 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.351 -0.841 . . . . 0.0 110.282 174.734 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.428 ' CB ' ' HA ' ' A' ' 17' ' ' PRO . 1.0 OUTLIER -63.54 118.78 8.66 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.326 0.584 . . . . 0.0 111.145 178.358 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -83.56 -36.74 23.75 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.03 -178.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 83.19 17.91 65.92 Favored Glycine 0 N--CA 1.449 -0.475 0 N-CA-C 110.99 -0.844 . . . . 0.0 110.99 -174.086 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 3.9 p -68.99 -29.75 68.02 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.23 -0.485 . . . . 0.0 111.332 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -145.44 168.86 19.54 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.075 -179.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 49.5 m-80 -96.98 -15.09 21.26 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.397 0.618 . . . . 0.0 109.649 178.468 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 20.4 m -131.97 126.6 34.4 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.781 177.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -115.12 132.88 56.46 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 177.652 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.48 ' HA ' HD23 ' A' ' 103' ' ' LEU . 4.3 m -90.49 83.66 5.89 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.124 0.488 . . . . 0.0 109.773 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.481 HD23 HD21 ' A' ' 10' ' ' LEU . 7.7 mp -81.41 117.2 21.66 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.515 0.674 . . . . 0.0 110.762 -176.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.562 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 32.7 m -113.85 110.61 20.39 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.545 -177.872 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 60.9 t -85.55 99.69 7.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 176.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -95.64 109.38 21.64 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 178.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.483 HG11 ' HB3' ' A' ' 5' ' ' LEU . 83.3 t -75.42 102.96 2.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.445 -179.595 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.0 t70 51.76 82.61 0.24 Allowed Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 114.431 -1.258 . . . . 0.0 111.427 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -64.41 -11.34 27.85 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.871 2.38 . . . . 0.0 111.923 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -87.64 -14.86 38.87 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.081 178.521 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 24.0 m120 56.12 43.47 26.83 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.886 -178.261 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.05 -34.57 77.87 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.384 0.611 . . . . 0.0 110.09 177.337 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 39.5 t -111.42 98.75 7.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 172.276 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -59.06 112.29 1.63 Allowed 'General case' 0 C--O 1.235 0.311 0 O-C-N 123.35 0.406 . . . . 0.0 110.619 -173.527 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.449 ' HA ' ' O ' ' A' ' 3' ' ' PRO . 3.8 mp0 -82.41 166.93 18.98 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.705 -174.007 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -58.05 -100.83 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.395 0 CA-C-N 114.919 -1.037 . . . . 0.0 113.33 176.072 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.418 ' HB3' ' CG ' ' A' ' 97' ' ' ASN . 53.0 t30 -76.21 141.77 41.69 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 122.626 -0.338 . . . . 0.0 110.836 -177.735 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -59.87 -43.1 94.9 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.979 -173.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 20.1 m -89.78 3.22 53.52 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.827 -174.637 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.584 ' O ' ' HD2' ' A' ' 7' ' ' PRO . 5.9 m-20 -85.97 -24.4 26.52 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 -175.286 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.507 ' HA ' ' O ' ' A' ' 5' ' ' LEU . 13.8 p-10 -82.04 -5.34 58.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.007 0.432 . . . . 0.0 111.341 -174.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 4.9 m -116.17 152.27 34.04 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.066 0.46 . . . . 0.0 110.727 -178.358 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.562 ' O ' ' HA ' ' A' ' 81' ' ' THR . 56.0 tp -140.66 103.63 4.56 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.84 179.18 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 15.7 m -98.83 104.5 16.54 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.123 177.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -132.48 135.72 46.21 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.895 0.378 . . . . 0.0 111.035 -178.055 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.48 HD23 ' HA ' ' A' ' 79' ' ' THR . 82.4 mt -80.21 127.09 31.94 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.752 177.204 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.442 HG22 HD13 ' A' ' 80' ' ' LEU . 32.7 m -109.13 134.72 50.23 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 172.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -105.16 170.92 18.23 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.04 -1.076 . . . . 0.0 111.038 -177.207 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 25.0 p -85.54 125.74 33.32 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 117.485 0.642 . . . . 0.0 109.821 175.436 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.458 HD13 ' HB ' ' A' ' 14' ' ' THR . 30.2 tp -64.16 133.78 53.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.608 -174.457 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -62.17 -45.6 92.69 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.589 -179.339 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -84.51 120.59 26.51 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.162 179.587 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 27.1 m170 -105.83 138.93 41.19 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.284 -178.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 50.2 t-80 -68.74 -25.84 64.95 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.225 0.536 . . . . 0.0 109.662 178.631 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 12.1 t-80 -139.72 142.56 36.84 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 176.26 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 6.2 t60 -55.37 -57.57 11.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.057 0.456 . . . . 0.0 110.048 -179.552 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 64.2 t60 . . . . . 0 C--O 1.243 0.745 0 CA-C-O 118.171 -0.919 . . . . 0.0 109.207 173.96 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.8 mtt . . . . . 0 N--CA 1.48 1.037 0 CA-C-O 121.107 0.48 . . . . 0.0 110.809 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -114.27 142.42 28.02 Favored Pre-proline 0 C--N 1.32 -0.69 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.913 175.885 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -83.79 156.84 13.75 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 122.023 1.815 . . . . 0.0 111.175 172.242 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -139.3 113.72 9.01 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 -178.763 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.674 HD22 HD23 ' A' ' 57' ' ' LEU . 31.5 mt -99.83 126.88 46.0 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -173.079 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.539 ' O ' ' HA ' ' A' ' 27' ' ' ILE . 8.4 t -124.91 140.22 35.3 Favored Pre-proline 0 C--N 1.318 -0.787 0 C-N-CA 120.341 -0.544 . . . . 0.0 110.263 -176.061 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.47 ' HB2' ' HB2' ' A' ' 100' ' ' LEU . 12.2 Cg_endo -96.52 98.18 0.09 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.57 0 C-N-CA 123.548 2.832 . . . . 0.0 109.733 167.05 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 26.2 m -80.37 -28.26 11.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.53 -167.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.3 t -165.71 158.9 15.76 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-O 120.816 0.341 . . . . 0.0 111.166 -177.083 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 29.9 tp -127.6 126.58 42.34 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.298 175.285 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.44 ' HA ' ' HA ' ' A' ' 12' ' ' PRO . 62.5 p -122.21 131.53 24.39 Favored Pre-proline 0 C--N 1.319 -0.718 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.587 179.46 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.672 ' HD2' ' SD ' ' A' ' 23' ' ' MET . 95.8 Cg_endo -92.02 175.01 17.81 Favored 'Cis proline' 0 N--CA 1.455 -0.753 0 C-N-CA 123.742 -1.357 . . . . 0.0 112.947 1.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 17.6 m -91.13 -10.42 9.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-O 121.347 0.594 . . . . 0.0 110.599 178.507 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.54 ' HA ' ' O ' ' A' ' 105' ' ' GLY . 0.8 OUTLIER -120.05 151.14 39.45 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.155 174.574 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 17.1 m -143.06 157.25 17.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.217 0.532 . . . . 0.0 111.788 -176.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.761 HG12 ' H ' ' A' ' 18' ' ' ASN . 21.8 t -99.27 132.05 24.05 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.454 -0.793 . . . . 0.0 110.287 179.092 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.441 ' HA ' ' HG ' ' A' ' 71' ' ' LEU . 95.9 Cg_endo -92.62 11.3 2.2 Favored 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 122.834 2.356 . . . . 0.0 112.65 177.085 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.761 ' H ' HG12 ' A' ' 16' ' ' VAL . 66.6 m-20 -100.6 -14.26 18.25 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.141 -175.15 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 9.1 t -158.75 173.7 16.15 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 -175.309 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 54.9 t -69.54 133.1 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 CA-C-O 121.64 0.733 . . . . 0.0 109.752 176.468 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.444 HD22 ' HE3' ' A' ' 69' ' ' TRP . 2.5 p-10 -114.22 133.47 55.6 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 114.638 -1.165 . . . . 0.0 108.927 -176.013 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 18.1 m -107.8 118.76 37.57 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-O 122.444 1.116 . . . . 0.0 108.693 -170.053 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.672 ' SD ' ' HD2' ' A' ' 12' ' ' PRO . 97.3 mmm -109.04 123.49 49.23 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 112.868 -1.969 . . . . 0.0 110.794 -162.712 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 23.2 m -111.91 124.57 52.67 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 121.865 0.841 . . . . 0.0 109.793 -176.485 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -119.39 132.52 55.85 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.075 -1.42 . . . . 0.0 108.445 -175.63 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 45.4 m -112.31 121.01 43.68 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 121.93 0.871 . . . . 0.0 110.064 -168.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.539 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 9.4 mm -116.53 120.02 63.7 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 CA-C-N 114.001 -1.454 . . . . 0.0 109.123 -172.151 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -118.79 128.69 54.71 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 -177.523 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 31.2 t30 -83.82 95.04 8.33 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 177.227 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -95.51 57.15 1.89 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.183 -174.492 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -144.1 168.07 26.66 Favored Glycine 0 N--CA 1.442 -0.928 0 CA-C-N 114.879 -1.055 . . . . 0.0 110.669 178.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 44.8 m-80 -75.71 -21.34 57.64 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 111.77 0.285 . . . . 0.0 111.77 -174.372 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 61.7 tttp -101.32 138.55 38.19 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.944 0.402 . . . . 0.0 111.029 -177.346 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -76.99 140.05 40.28 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.745 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 13.9 p -105.74 155.76 18.96 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.03 0.443 . . . . 0.0 111.65 -175.746 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 12.6 p -99.1 -161.56 0.88 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.258 -177.017 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 9.8 m -53.76 136.3 40.07 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 122.656 0.383 . . . . 0.0 111.638 178.563 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.506 ' CE1' ' HB2' ' A' ' 57' ' ' LEU . 18.2 p90 -149.44 147.04 27.77 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 177.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.579 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 42.4 t-20 -101.2 125.46 47.82 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.439 0.162 . . . . 0.0 110.673 -176.137 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.53 HG22 ' HA ' ' A' ' 84' ' ' VAL . 2.7 t -111.28 127.02 68.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 121.185 0.517 . . . . 0.0 110.013 -179.198 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 19.5 m -119.88 144.08 47.59 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.662 -177.155 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 58.3 tp -100.11 112.7 25.0 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.874 178.187 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.429 ' HG ' HG22 ' A' ' 48' ' ' VAL . 5.0 mp -101.57 121.74 42.54 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.834 -178.592 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 89.1 t -97.27 115.33 36.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 172.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 25.5 t70 67.98 -75.02 0.07 Allowed 'General case' 0 N--CA 1.469 0.509 0 O-C-N 123.736 0.648 . . . . 0.0 110.739 -174.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -158.89 17.22 0.26 Allowed Glycine 0 N--CA 1.448 -0.554 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.8 178.072 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 9.9 mt -123.64 149.83 27.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.429 HG22 ' HG ' ' A' ' 43' ' ' LEU . 40.0 t -93.33 122.43 44.82 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 -177.614 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 26.5 m -96.95 -28.99 3.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.351 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 37.2 t0 -149.53 151.21 33.51 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 120.768 0.318 . . . . 0.0 110.441 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 21.9 m -144.13 121.84 11.88 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.954 -174.477 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -135.45 125.11 25.27 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.779 0.323 . . . . 0.0 110.555 -179.229 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.579 ' HA ' ' HA ' ' A' ' 39' ' ' ASN . 23.8 m -85.5 122.78 30.12 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.252 177.736 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 20.1 t -86.59 136.38 23.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 -179.506 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 14.6 m -55.28 -51.81 65.47 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 123.494 0.496 . . . . 0.0 111.844 -176.182 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 8.4 t -176.87 130.86 0.18 Allowed 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.674 HD23 HD22 ' A' ' 5' ' ' LEU . 21.1 tp -96.1 112.64 24.31 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.322 0.582 . . . . 0.0 110.088 177.442 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.41 ' HB2' ' HB3' ' A' ' 61' ' ' ASN . 38.3 mt-10 -71.82 144.62 49.06 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.542 -0.753 . . . . 0.0 110.577 -178.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 8.5 p -61.52 132.77 54.47 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.883 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 72.66 1.13 3.88 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.223 177.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.41 ' HB3' ' HB2' ' A' ' 58' ' ' GLU . 53.9 t30 -108.17 149.6 28.32 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.151 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 2.6 p -111.44 123.19 49.71 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.063 0.458 . . . . 0.0 110.789 -178.153 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 27.9 m -104.05 135.86 44.76 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.725 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -94.77 128.48 41.51 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.562 179.245 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 40.2 t -96.16 115.79 36.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.418 -179.578 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -84.07 101.11 11.54 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.594 179.388 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.481 ' CZ ' HG12 ' A' ' 40' ' ' VAL . 8.0 m-85 -100.47 148.62 24.56 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.015 0.436 . . . . 0.0 111.143 178.812 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 33.1 m-70 -120.05 107.87 13.6 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 178.302 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' TRP . . . . . 0.444 ' HE3' HD22 ' A' ' 21' ' ' ASN . 14.4 t90 -115.97 118.73 33.73 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.342 0.591 . . . . 0.0 111.205 -172.807 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 4.6 m -88.7 113.48 24.31 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 168.709 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.441 ' HG ' ' HA ' ' A' ' 17' ' ' PRO . 0.1 OUTLIER -44.64 -40.54 5.93 Favored 'General case' 0 N--CA 1.469 0.516 0 O-C-N 123.898 0.748 . . . . 0.0 112.167 -169.669 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 15.9 t70 77.52 -53.9 0.53 Allowed 'General case' 0 N--CA 1.468 0.45 0 O-C-N 123.792 0.682 . . . . 0.0 111.035 175.259 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -117.21 -155.92 10.34 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 121.017 -0.611 . . . . 0.0 111.61 176.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 33.0 m -153.26 91.88 1.55 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.158 0.504 . . . . 0.0 110.47 177.633 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.523 ' H ' ' HE2' ' A' ' 78' ' ' TYR . . . -126.25 147.6 49.65 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.354 177.263 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -63.94 -27.14 68.94 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.227 0.454 . . . . 0.0 112.227 -173.08 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 38.4 m -145.67 119.26 9.12 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.058 0.456 . . . . 0.0 111.185 -179.54 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.523 ' HE2' ' H ' ' A' ' 75' ' ' ALA . 26.5 m-85 -105.74 141.67 36.77 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.177 177.309 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 21.9 m -93.43 100.02 12.4 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.056 178.583 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.452 HD13 HG22 ' A' ' 104' ' ' VAL . 8.6 mp -100.43 125.07 46.67 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.274 0.559 . . . . 0.0 110.519 -178.832 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.527 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 32.4 m -121.24 115.69 23.48 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.938 -176.494 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 92.9 t -86.94 108.6 18.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.685 175.403 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -101.8 121.19 41.62 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 176.288 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.53 ' HA ' HG22 ' A' ' 40' ' ' VAL . 77.8 t -87.58 108.8 18.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.187 -176.605 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 46.2 t0 61.61 85.25 0.18 Allowed Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 114.555 -1.202 . . . . 0.0 111.701 178.066 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -72.45 -4.36 15.12 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.732 2.288 . . . . 0.0 112.088 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -99.52 -15.87 18.51 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 177.295 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 48.04 71.89 0.31 Allowed 'General case' 0 C--O 1.233 0.201 0 CA-C-N 114.647 -1.16 . . . . 0.0 110.911 -177.656 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.06 -32.12 16.85 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.251 177.368 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 22.0 t -89.28 134.02 29.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.658 176.547 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -78.04 99.19 6.01 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 177.577 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -89.95 156.1 18.66 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.899 -171.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -57.47 -100.88 0.01 OUTLIER Glycine 0 CA--C 1.518 0.231 0 CA-C-N 115.088 -0.96 . . . . 0.0 112.78 171.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.645 ' HB2' ' HB3' ' A' ' 97' ' ' ASN . 78.9 m-20 -83.76 123.41 29.84 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 120.847 -0.341 . . . . 0.0 110.733 -178.088 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -72.67 -15.92 61.7 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.651 0.739 . . . . 0.0 109.724 176.712 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -89.03 7.18 36.19 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.826 176.141 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.645 ' HB3' ' HB2' ' A' ' 94' ' ' ASN . 1.7 t30 -116.98 -28.86 6.15 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -173.291 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 20.2 p-10 -75.69 10.99 1.47 Allowed 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.065 0.46 . . . . 0.0 111.86 -173.638 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -126.38 143.64 51.1 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.799 0.333 . . . . 0.0 110.399 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.527 ' O ' ' HA ' ' A' ' 81' ' ' THR . 44.1 tp -128.73 104.65 7.76 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.472 179.552 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 53.0 m -92.05 106.39 18.42 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 174.753 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -121.72 153.54 38.09 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.537 -177.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 88.7 mt -104.38 124.02 48.47 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.001 0.429 . . . . 0.0 110.481 179.157 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.452 HG22 HD13 ' A' ' 80' ' ' LEU . 22.4 m -116.17 132.42 65.77 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.618 178.534 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.54 ' O ' ' HA ' ' A' ' 14' ' ' THR . . . -110.96 166.27 12.27 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.423 -0.894 . . . . 0.0 112.01 -175.575 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 18.4 p -68.22 135.49 52.09 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.745 0.273 . . . . 0.0 110.275 177.014 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 61.9 tp -55.24 110.63 0.71 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.589 -176.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 -71.54 113.06 8.18 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.34 173.541 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 27.9 t60 -75.07 98.17 3.59 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 176.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' HIS . . . . . 0.432 ' HB3' ' O ' ' A' ' 112' ' ' HIS . 20.7 m170 -88.15 144.3 26.56 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.424 -178.201 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 76.6 m80 -69.87 -45.4 67.77 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 176.028 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' HIS . . . . . 0.432 ' O ' ' HB3' ' A' ' 110' ' ' HIS . 70.5 m-70 -98.98 132.99 43.89 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 171.461 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 30.0 m170 -76.47 71.45 3.12 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.634 0.73 . . . . 0.0 110.689 -176.476 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.245 0.842 0 CA-C-N 114.731 -1.122 . . . . 0.0 109.325 178.629 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.539 ' O ' ' HD2' ' A' ' 33' ' ' LYS . 66.7 mtm . . . . . 0 N--CA 1.479 1.008 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.435 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 7.5 tp -114.28 141.42 26.43 Favored Pre-proline 0 CA--C 1.537 0.458 0 CA-C-N 116.72 -0.218 . . . . 0.0 110.845 -177.852 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.539 ' HG3' ' HD3' ' A' ' 33' ' ' LYS . 6.5 Cg_endo -88.58 174.03 4.26 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 123.146 2.564 . . . . 0.0 112.128 173.092 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.402 ' O ' ' HA ' ' A' ' 29' ' ' ASN . 17.8 t70 -151.42 105.91 3.23 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 179.315 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.537 ' O ' ' HA ' ' A' ' 98' ' ' ASN . 96.9 mt -99.57 103.3 15.01 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.192 0.52 . . . . 0.0 111.473 -168.611 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.536 HG22 ' HB3' ' A' ' 97' ' ' ASN . 11.5 t -114.57 116.58 43.5 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.653 -173.49 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.478 ' HB2' ' HB2' ' A' ' 100' ' ' LEU . 3.8 Cg_exo -79.33 104.07 1.7 Allowed 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 122.544 2.163 . . . . 0.0 109.76 169.006 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 31.8 m -92.14 -15.06 8.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -169.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 27.8 t -159.36 156.83 29.23 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.516 -0.474 . . . . 0.0 111.507 -177.054 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 60.1 tp -142.48 114.12 7.96 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.07 178.241 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 8.8 p -126.96 145.8 55.2 Favored Pre-proline 0 C--N 1.32 -0.708 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.99 -176.266 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -77.77 155.88 95.21 Favored 'Cis proline' 0 C--N 1.341 0.18 0 C-N-CA 123.265 -1.556 . . . . 0.0 112.497 -0.68 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 30.2 m -80.16 -21.44 11.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.195 0.522 . . . . 0.0 110.282 177.122 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.627 ' HA ' ' O ' ' A' ' 105' ' ' GLY . 3.2 p -117.88 126.99 53.41 Favored 'General case' 0 N--CA 1.438 -1.067 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.355 176.236 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.497 ' HB ' ' ND2' ' A' ' 21' ' ' ASN . 29.2 m -113.57 140.36 34.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.134 0.492 . . . . 0.0 111.678 -173.032 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.417 ' HA ' ' HD3' ' A' ' 17' ' ' PRO . 8.1 m -90.67 124.67 61.76 Favored Pre-proline 0 N--CA 1.445 -0.698 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.425 174.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.496 ' HA ' ' HB3' ' A' ' 71' ' ' LEU . 3.0 Cg_exo -80.3 49.56 3.25 Favored 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 122.803 2.335 . . . . 0.0 111.723 178.408 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -116.71 -13.24 10.8 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.468 -175.549 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 15.2 t -167.98 -167.9 0.9 Allowed 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.928 -0.309 . . . . 0.0 110.799 -171.394 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.494 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 53.6 t -86.76 113.61 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 174.146 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.497 ' ND2' ' HB ' ' A' ' 15' ' ' VAL . 4.4 m-20 -88.08 137.07 32.65 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.237 -172.146 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 33.4 m -88.85 105.57 17.83 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.219 178.069 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.52 ' HB2' ' HB2' ' A' ' 67' ' ' PHE . 92.6 mmm -92.9 119.79 32.57 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.002 -178.32 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.526 ' HA ' ' O ' ' A' ' 65' ' ' VAL . 11.5 m -108.68 114.55 28.44 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.635 -176.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -105.71 133.03 51.1 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.387 -179.618 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 25.4 m -94.08 110.2 21.92 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.924 0.392 . . . . 0.0 110.827 -178.368 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 27.4 mm -102.64 116.32 46.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.789 -179.399 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -115.52 129.07 56.41 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.902 0.382 . . . . 0.0 110.177 178.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.402 ' HA ' ' O ' ' A' ' 4' ' ' ASP . 24.6 t30 -92.76 98.87 11.67 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.114 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -96.22 53.85 1.38 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.707 -174.707 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -144.02 161.5 27.84 Favored Glycine 0 N--CA 1.448 -0.558 0 N-CA-C 111.441 -0.663 . . . . 0.0 111.441 179.273 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.466 ' O ' ' HB3' ' A' ' 1' ' ' MET . 5.7 t30 -86.93 46.73 1.4 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.473 0.654 . . . . 0.0 110.793 -174.657 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.539 ' HD3' ' HG3' ' A' ' 3' ' ' PRO . 31.5 tttm -161.51 146.21 13.3 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 174.203 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -76.55 149.27 36.67 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.023 0.44 . . . . 0.0 110.189 176.716 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.424 ' OG ' ' HB3' ' A' ' 57' ' ' LEU . 13.5 p -104.72 129.3 52.96 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 172.331 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -84.3 -148.57 0.1 Allowed 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 -176.458 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.526 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 56.4 m -65.18 108.36 1.85 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.005 0.431 . . . . 0.0 111.398 -175.685 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.526 ' HB2' ' HB2' ' A' ' 85' ' ' ASP . 54.0 p90 -123.09 154.9 37.96 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.032 177.8 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.483 ' O ' ' HA ' ' A' ' 85' ' ' ASP . 32.8 m-80 -105.27 110.92 23.47 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.107 -175.573 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.606 HG22 ' HA ' ' A' ' 84' ' ' VAL . 1.3 t -98.18 121.28 48.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 121.351 0.596 . . . . 0.0 109.716 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 11.8 m -114.37 137.56 51.66 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.436 -175.258 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 55.0 tp -96.65 111.77 23.78 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.972 175.617 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.557 ' HG ' HG22 ' A' ' 48' ' ' VAL . 5.1 mp -94.46 132.29 39.26 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.336 178.54 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 85.5 t -105.96 97.42 5.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 173.62 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 70.81 -62.89 0.43 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.133 -0.94 . . . . 0.0 111.921 -179.516 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -147.34 -6.78 0.28 Allowed Glycine 0 CA--C 1.521 0.443 0 C-N-CA 120.886 -0.674 . . . . 0.0 113.496 179.264 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 6.5 mt -116.0 151.25 17.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 117.477 0.639 . . . . 0.0 110.45 -177.133 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.557 HG22 ' HG ' ' A' ' 43' ' ' LEU . 48.0 t -95.0 118.61 41.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 177.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 17.8 m -93.31 -33.08 5.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -176.299 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -152.98 143.07 22.33 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 110.278 -0.268 . . . . 0.0 110.278 -177.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 39.2 m -132.86 132.55 42.24 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.318 -179.594 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -123.57 125.86 45.62 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 178.563 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 15.0 m -87.31 110.3 20.13 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 177.188 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.526 ' O ' ' HA ' ' A' ' 37' ' ' SER . 43.7 t -81.6 124.13 38.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.329 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 10.3 m -52.76 -44.18 66.3 Favored 'General case' 0 C--N 1.329 -0.287 0 O-C-N 123.543 0.527 . . . . 0.0 111.464 -177.259 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 34.1 t -179.95 157.76 0.72 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.598 -179.502 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.424 ' HB3' ' OG ' ' A' ' 35' ' ' SER . 47.9 tp -136.02 123.94 22.72 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.012 -179.458 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 44.4 mm-40 -71.98 161.12 31.39 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.817 -177.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 15.5 m -70.14 128.82 37.61 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.278 178.004 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 68.3 20.09 8.81 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.984 178.278 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -112.9 147.02 37.92 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.625 177.149 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 11.2 p -114.67 125.91 54.28 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.123 0.487 . . . . 0.0 110.576 179.092 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 50.9 m -118.21 138.7 52.14 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.208 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -94.28 133.69 37.55 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.101 0.477 . . . . 0.0 111.363 -177.224 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.535 HG21 HG11 ' A' ' 40' ' ' VAL . 21.5 t -96.77 135.36 31.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.961 179.54 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -104.05 97.31 7.31 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.926 -174.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.52 ' HB2' ' HB2' ' A' ' 23' ' ' MET . 57.0 m-85 -97.13 153.34 18.03 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.406 177.322 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 68.8 m-70 -128.67 116.05 18.97 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 171.226 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 3.5 t90 -129.69 124.23 33.08 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.657 -173.007 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.494 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 4.3 m -80.09 113.87 18.58 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.056 -178.617 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.496 ' HB3' ' HA ' ' A' ' 17' ' ' PRO . 0.8 OUTLIER -69.68 120.23 15.13 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.964 0.412 . . . . 0.0 110.973 177.409 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -87.73 -36.21 17.48 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.589 178.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 92.9 16.04 49.75 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.641 -0.79 . . . . 0.0 111.735 -178.314 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.5 -38.62 87.99 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.265 0.555 . . . . 0.0 110.621 -179.178 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -138.02 158.17 44.88 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.874 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.482 HD22 ' N ' ' A' ' 76' ' ' ASN . 1.0 OUTLIER -83.09 -12.3 57.21 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.027 0.441 . . . . 0.0 110.544 179.019 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 10.7 p -143.3 121.56 12.26 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.452 178.606 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 53.0 m-85 -105.73 149.97 25.92 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.314 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.518 ' HA ' HD23 ' A' ' 103' ' ' LEU . 8.9 m -96.46 88.27 4.66 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.906 0.384 . . . . 0.0 110.38 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.412 HD13 HG22 ' A' ' 104' ' ' VAL . 7.4 mp -88.13 120.2 29.25 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.555 0.693 . . . . 0.0 111.118 -177.341 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.444 ' HB ' ' HB2' ' A' ' 43' ' ' LEU . 34.5 m -118.28 117.66 29.72 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.34 -178.318 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 47.9 t -90.75 103.79 14.74 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 176.562 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -101.52 112.61 25.21 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 178.533 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.606 ' HA ' HG22 ' A' ' 40' ' ' VAL . 75.6 t -78.64 103.81 5.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.838 -176.782 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.526 ' HB2' ' HB2' ' A' ' 38' ' ' PHE . 7.9 t70 58.94 88.3 0.13 Allowed Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 114.091 -1.413 . . . . 0.0 112.019 179.58 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -72.63 -4.46 15.37 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 123.171 2.581 . . . . 0.0 111.561 176.665 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -83.77 -21.95 32.03 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.173 -179.388 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 64.09 35.3 10.53 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.581 -178.074 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -75.93 -34.27 59.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.56 177.557 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 95.2 t -99.98 112.11 31.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.173 172.43 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 61.8 t30 -82.74 126.0 31.9 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.509 -177.376 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -84.05 165.83 18.22 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.239 0.542 . . . . 0.0 111.281 178.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -57.58 -100.69 0.01 OUTLIER Glycine 0 N--CA 1.444 -0.813 0 N-CA-C 110.268 -1.133 . . . . 0.0 110.268 159.24 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 15.4 m-20 -72.8 88.44 1.32 Allowed 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 172.084 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -58.4 96.23 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.409 0 O-C-N 123.325 0.391 . . . . 0.0 110.913 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 7.8 m 173.35 -26.36 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.417 0 O-C-N 124.238 0.961 . . . . 0.0 110.072 -172.222 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.536 ' HB3' HG22 ' A' ' 6' ' ' VAL . 83.7 m-20 -74.68 -19.85 60.1 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.488 -177.603 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.597 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 24.9 p-10 -72.29 19.31 0.08 Allowed 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.624 0.602 . . . . 0.0 112.624 -175.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 1.4 m -130.36 149.03 52.23 Favored 'General case' 0 C--N 1.322 -0.625 0 O-C-N 121.881 -0.512 . . . . 0.0 111.235 -178.495 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.478 ' HB2' ' HB2' ' A' ' 7' ' ' PRO . 30.0 tp -145.45 103.46 3.82 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.686 178.114 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 15.4 m -92.37 98.26 11.37 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 177.042 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -116.59 127.71 54.74 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.117 0.484 . . . . 0.0 110.695 -177.131 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.518 HD23 ' HA ' ' A' ' 79' ' ' THR . 65.1 mt -85.77 120.12 26.84 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.649 178.555 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.412 HG22 HD13 ' A' ' 80' ' ' LEU . 26.8 m -106.46 132.92 52.44 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.409 178.476 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.627 ' O ' ' HA ' ' A' ' 14' ' ' THR . . . -117.32 155.6 16.07 Favored Glycine 0 N--CA 1.44 -1.097 0 C-N-CA 120.205 -0.998 . . . . 0.0 111.244 -176.325 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.473 ' HA ' ' O ' ' A' ' 15' ' ' VAL . 35.2 p -61.75 145.82 51.26 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 176.226 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.494 ' HG ' ' H ' ' A' ' 109' ' ' HIS . 49.3 tp -52.77 126.8 21.19 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.816 0.341 . . . . 0.0 111.199 -176.707 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -54.77 -31.07 58.28 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.185 -178.776 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' HIS . . . . . 0.494 ' H ' ' HG ' ' A' ' 107' ' ' LEU . 51.5 t60 -60.98 -24.36 66.06 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.989 -176.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 5.4 t-80 -100.66 17.94 20.56 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.06 0.457 . . . . 0.0 110.688 179.221 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 38.2 m80 -103.91 -37.27 7.47 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 168.197 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 13.7 t60 -77.87 -26.23 49.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.254 -0.884 . . . . 0.0 109.079 176.14 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 23.9 m170 -110.32 169.57 8.65 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.305 -0.862 . . . . 0.0 109.383 172.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 21.9 m-70 . . . . . 0 C--O 1.248 0.983 0 CA-C-O 118.251 -0.88 . . . . 0.0 109.844 177.178 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.468 ' O ' ' HD2' ' A' ' 33' ' ' LYS . 63.7 mtt . . . . . 0 N--CA 1.478 0.934 0 CA-C-O 120.877 0.37 . . . . 0.0 110.338 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.434 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 1.1 tt -114.27 142.46 28.08 Favored Pre-proline 0 C--N 1.319 -0.736 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 174.517 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.519 ' HD2' ' O ' ' A' ' 91' ' ' ASN . 12.6 Cg_exo -70.72 157.04 59.63 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.44 2.093 . . . . 0.0 111.012 174.362 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.571 ' HA ' ' OE1' ' A' ' 92' ' ' GLU . 13.7 t70 -132.73 91.78 2.96 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 175.566 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.529 ' O ' ' HB3' ' A' ' 97' ' ' ASN . 70.2 mt -99.76 126.45 45.84 Favored 'General case' 0 CA--C 1.499 -0.993 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 -173.105 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.4 ' HA ' ' HD3' ' A' ' 7' ' ' PRO . 11.0 t -125.4 140.57 36.6 Favored Pre-proline 0 C--N 1.311 -1.069 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.58 -173.132 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.573 ' HB2' ' HB2' ' A' ' 100' ' ' LEU . 17.2 Cg_endo -91.25 103.8 0.25 Allowed 'Trans proline' 0 N--CA 1.439 -1.688 0 C-N-CA 122.757 2.305 . . . . 0.0 109.495 168.045 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.8 t -80.02 -49.75 18.66 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 CA-C-N 114.765 -1.107 . . . . 0.0 111.306 -165.208 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 10.5 p -158.15 164.03 36.99 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.67 -178.646 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.53 HD11 ' HB3' ' A' ' 23' ' ' MET . 36.5 tp -127.73 126.51 41.97 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 176.486 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 37.0 p -122.3 131.71 24.36 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.502 176.688 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.543 ' HD2' ' SD ' ' A' ' 23' ' ' MET . 97.5 Cg_endo -90.83 176.4 18.03 Favored 'Cis proline' 0 N--CA 1.457 -0.619 0 C-N-CA 123.808 -1.33 . . . . 0.0 112.884 2.536 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.0 m -98.29 -12.05 8.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 121.431 0.634 . . . . 0.0 110.21 176.678 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.561 ' HA ' ' O ' ' A' ' 105' ' ' GLY . 0.8 OUTLIER -120.03 150.98 39.68 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.579 172.574 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.435 HG11 ' CZ3' ' A' ' 69' ' ' TRP . 7.5 m -143.14 155.15 17.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.056 0.455 . . . . 0.0 111.59 -173.699 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.9 m -104.33 130.26 23.63 Favored Pre-proline 0 N--CA 1.444 -0.764 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.15 -179.271 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -77.19 171.9 17.0 Favored 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 122.594 2.196 . . . . 0.0 111.648 175.164 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 73.9 21.39 2.67 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.32 0.648 . . . . 0.0 111.391 178.443 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 15.1 t -167.07 -176.79 3.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.661 0.267 . . . . 0.0 110.706 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 57.8 t -102.33 132.91 47.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 178.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 32.4 m-80 -106.03 134.84 48.51 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.934 0.397 . . . . 0.0 110.362 -176.242 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 15.0 m -95.34 97.22 9.68 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.567 178.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.543 ' SD ' ' HD2' ' A' ' 12' ' ' PRO . 91.5 mmm -89.53 115.59 27.05 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.533 -175.087 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 25.2 m -93.44 111.28 22.91 Favored 'General case' 0 C--N 1.323 -0.576 0 O-C-N 123.563 0.54 . . . . 0.0 111.002 -178.088 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.537 ' HB3' ' HB ' ' A' ' 65' ' ' VAL . . . -99.01 119.53 37.95 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.09 175.236 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 5.7 m -83.5 108.81 16.88 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.082 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 28.5 mm -108.29 119.33 57.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 -179.524 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -117.67 133.11 56.29 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.608 0.242 . . . . 0.0 110.639 -177.074 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.595 ' ND2' ' HA ' ' A' ' 59' ' ' SER . 36.2 t30 -95.33 100.3 12.1 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.995 0.426 . . . . 0.0 109.889 177.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 67.5 mt-30 -104.89 52.36 0.74 Allowed 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.487 -173.439 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -143.99 178.19 22.18 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.11 -1.043 . . . . 0.0 113.183 -175.263 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -90.36 28.84 1.36 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.108 0.48 . . . . 0.0 111.711 -172.083 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.468 ' HD2' ' O ' ' A' ' 1' ' ' MET . 88.5 tttt -154.16 143.58 21.46 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 121.876 -0.515 . . . . 0.0 111.058 178.229 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -79.75 143.25 34.66 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 175.465 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.438 ' OG ' ' HB3' ' A' ' 57' ' ' LEU . 33.7 p -104.69 140.95 37.31 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.005 0.431 . . . . 0.0 111.429 -177.286 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 7.3 p -85.08 -165.49 1.22 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.052 -179.412 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.414 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 13.4 m -60.34 119.41 7.9 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.935 0.398 . . . . 0.0 111.547 179.59 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.507 ' CE2' HG23 ' A' ' 40' ' ' VAL . 26.4 p90 -137.26 153.19 50.39 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 177.574 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.597 ' O ' ' HD3' ' A' ' 86' ' ' PRO . 65.1 m-80 -94.98 138.56 32.55 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.094 0.473 . . . . 0.0 110.744 178.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.507 HG23 ' CE2' ' A' ' 38' ' ' PHE . 2.4 t -119.57 112.97 39.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 173.314 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.523 ' HB3' HG23 ' A' ' 51' ' ' THR . 33.4 p -108.79 139.28 43.84 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.24 -173.806 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 54.9 tp -96.46 115.85 28.1 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.403 177.332 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.55 ' HG ' HG22 ' A' ' 48' ' ' VAL . 5.5 mp -96.96 129.21 44.45 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.196 177.593 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.424 ' CG1' ' HD2' ' A' ' 78' ' ' TYR . 84.1 t -106.37 96.89 4.99 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.69 176.512 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.471 ' HA ' ' HB ' ' A' ' 79' ' ' THR . 2.9 m-20 70.9 -51.06 0.68 Allowed 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 115.156 -0.929 . . . . 0.0 112.452 178.606 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -166.29 14.73 0.08 OUTLIER Glycine 0 C--N 1.319 -0.391 0 C-N-CA 120.768 -0.73 . . . . 0.0 113.15 178.716 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 9.3 mt -136.18 152.14 29.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 -179.543 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.55 HG22 ' HG ' ' A' ' 43' ' ' LEU . 50.7 t -97.91 108.73 22.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 177.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 17.0 m -77.67 -37.83 24.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.592 -177.209 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -159.37 140.04 12.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.828 0.346 . . . . 0.0 110.175 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.523 HG23 ' HB3' ' A' ' 41' ' ' SER . 27.6 m -116.48 122.19 44.02 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.949 178.461 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 43.9 tt0 -105.13 122.7 46.44 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.014 0.435 . . . . 0.0 110.281 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 6.0 m -79.82 129.51 34.55 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.232 177.3 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.414 ' O ' ' HA ' ' A' ' 37' ' ' SER . 53.7 t -98.75 120.0 47.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 172.757 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.7 m -61.41 -38.01 85.54 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.629 -174.169 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 23.0 t -178.1 136.87 0.17 Allowed 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 178.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.467 HD23 HD22 ' A' ' 5' ' ' LEU . 39.7 tp -119.79 113.06 20.04 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.223 0.535 . . . . 0.0 109.731 176.75 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -67.84 156.9 36.07 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.888 -177.335 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.595 ' HA ' ' ND2' ' A' ' 29' ' ' ASN . 11.6 p -65.51 130.34 42.95 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.56 178.471 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 68.81 23.52 6.88 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.507 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -117.93 153.74 33.08 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.393 -0.821 . . . . 0.0 108.83 175.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 23.3 t -128.52 142.63 51.01 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 177.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 15.0 t -125.41 149.17 48.42 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.892 179.297 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -97.78 120.18 37.7 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.213 -178.237 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.537 ' HB ' ' HB3' ' A' ' 25' ' ' ALA . 21.4 t -98.7 107.02 19.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.546 -176.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -98.84 111.47 23.85 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.925 0.393 . . . . 0.0 110.666 -178.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -91.28 163.03 14.37 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.235 0.541 . . . . 0.0 111.194 -176.707 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 57.4 m80 -105.3 93.88 4.92 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.549 -0.751 . . . . 0.0 109.723 177.212 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' TRP . . . . . 0.435 ' CZ3' HG11 ' A' ' 15' ' ' VAL . 12.5 t90 -107.12 100.01 9.52 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.798 -177.201 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 12.3 t -73.82 121.96 21.71 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 172.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 15.9 tp -121.94 96.11 4.93 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.468 0.651 . . . . 0.0 111.671 -173.407 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -63.49 -60.71 3.0 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.876 -1.056 . . . . 0.0 109.916 172.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 128.38 67.33 0.13 Allowed Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.721 178.608 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 30.9 m -75.46 -69.48 0.48 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.884 0.374 . . . . 0.0 110.575 178.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -108.47 -173.19 2.21 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.456 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 -96.49 -18.21 20.0 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.866 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 20.6 m -133.7 133.93 42.44 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.995 0.426 . . . . 0.0 110.81 -179.186 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.424 ' HD2' ' CG1' ' A' ' 44' ' ' VAL . 49.3 m-85 -119.12 145.2 46.16 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.805 179.198 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.484 ' HA ' HD23 ' A' ' 103' ' ' LEU . 6.6 m -97.11 91.65 5.66 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.323 -179.235 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.411 HD13 HG22 ' A' ' 104' ' ' VAL . 7.9 mp -91.1 113.16 25.35 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.452 0.644 . . . . 0.0 111.265 -176.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.561 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 11.2 m -116.12 120.71 39.91 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.489 -178.05 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 85.8 t -86.96 109.63 19.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.399 178.413 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.551 ' HA ' ' O ' ' A' ' 98' ' ' ASN . 6.1 t30 -92.5 111.57 23.2 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.817 0.342 . . . . 0.0 110.204 176.02 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 94.0 t -92.02 124.77 44.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.338 179.579 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.755 ' OD2' ' HA ' ' A' ' 88' ' ' ASN . 31.2 t70 64.91 85.87 0.15 Allowed Pre-proline 0 N--CA 1.464 0.249 0 O-C-N 123.922 0.764 . . . . 0.0 111.461 176.842 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.597 ' HD3' ' O ' ' A' ' 39' ' ' ASN . 1.6 Cg_endo -85.15 -40.9 0.08 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 123.364 2.709 . . . . 0.0 112.754 178.69 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.482 ' OE1' ' HD2' ' A' ' 86' ' ' PRO . 27.1 mp0 -80.33 -10.28 59.75 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.174 -176.827 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ASN . . . . . 0.755 ' HA ' ' OD2' ' A' ' 85' ' ' ASP . 12.9 m120 63.02 64.77 0.84 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.73 0.776 . . . . 0.0 110.273 -174.307 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -100.45 -28.58 12.85 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.641 -1.163 . . . . 0.0 109.172 178.167 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 54.7 t -115.81 107.67 23.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.421 175.553 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.519 ' O ' ' HD2' ' A' ' 3' ' ' PRO . 16.6 t-20 -66.13 106.19 1.57 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.29 -177.487 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.571 ' OE1' ' HA ' ' A' ' 4' ' ' ASP . 0.3 OUTLIER -79.95 151.48 30.05 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.439 -174.718 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.401 ' HA2' HD13 ' A' ' 2' ' ' ILE . . . -57.93 -101.11 0.01 OUTLIER Glycine 0 CA--C 1.522 0.515 0 CA-C-N 115.018 -0.992 . . . . 0.0 113.436 171.378 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -78.44 132.18 37.2 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.03 -0.585 . . . . 0.0 111.136 -173.671 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -73.78 76.77 1.58 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.172 0.511 . . . . 0.0 110.961 177.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 17.9 m -160.47 -40.27 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.564 -0.743 . . . . 0.0 109.885 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.529 ' HB3' ' O ' ' A' ' 5' ' ' LEU . 86.5 m-20 -67.47 -13.19 61.81 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.292 -0.867 . . . . 0.0 112.439 -173.609 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.551 ' O ' ' HA ' ' A' ' 83' ' ' ASN . 19.0 m120 -71.68 -5.01 30.67 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 111.675 0.25 . . . . 0.0 111.675 -175.616 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 2.5 p -142.41 122.54 13.77 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.573 ' HB2' ' HB2' ' A' ' 7' ' ' PRO . 42.2 tp -111.25 104.87 13.4 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 169.683 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.5 m -89.75 100.16 13.02 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.444 -178.278 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -120.57 128.05 52.7 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.081 0.467 . . . . 0.0 111.196 -177.703 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.484 HD23 ' HA ' ' A' ' 79' ' ' THR . 62.6 mt -85.51 125.82 33.36 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.57 177.56 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.411 HG22 HD13 ' A' ' 80' ' ' LEU . 33.3 m -116.82 142.85 28.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 177.368 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.561 ' O ' ' HA ' ' A' ' 14' ' ' THR . . . -122.65 155.91 17.11 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.235 -0.983 . . . . 0.0 112.291 -175.815 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 38.1 p -63.86 139.65 58.79 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 177.13 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 35.4 tp -52.48 121.29 6.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.044 -179.563 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -68.04 -20.83 65.01 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.918 -171.726 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 56.4 m170 -86.11 -5.42 59.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.278 0.561 . . . . 0.0 110.414 176.639 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -117.66 78.99 1.29 Allowed 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 173.25 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 51.5 m80 -57.47 118.45 5.19 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.367 -0.833 . . . . 0.0 112.678 -168.58 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 33.1 t-80 -90.87 124.44 35.18 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.175 176.57 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 -131.11 136.87 48.76 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.828 175.062 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 4.8 t60 . . . . . 0 C--O 1.247 0.946 0 CA-C-O 118.105 -0.95 . . . . 0.0 109.684 -175.782 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.482 ' HA ' ' OD1' ' A' ' 32' ' ' ASN . 83.4 mtp . . . . . 0 N--CA 1.478 0.937 0 CA-C-O 120.722 0.296 . . . . 0.0 110.354 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 13.7 tt -114.23 142.5 28.12 Favored Pre-proline 0 C--N 1.323 -0.582 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 176.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -80.63 156.81 21.55 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 122.314 2.01 . . . . 0.0 111.297 174.156 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.441 ' HB3' ' O ' ' A' ' 30' ' ' GLN . 13.5 t70 -146.65 104.63 3.76 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 176.234 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.593 HD22 HD23 ' A' ' 57' ' ' LEU . 14.6 mt -99.68 126.6 45.73 Favored 'General case' 0 CA--C 1.51 -0.573 0 C-N-CA 119.484 -0.886 . . . . 0.0 108.945 -172.272 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.3 t -125.55 140.69 37.04 Favored Pre-proline 0 C--N 1.318 -0.785 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.501 -176.528 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.675 ' HD3' ' O ' ' A' ' 97' ' ' ASN . 3.2 Cg_exo -81.89 109.39 1.96 Allowed 'Trans proline' 0 N--CA 1.446 -1.299 0 C-N-CA 122.598 2.199 . . . . 0.0 109.572 169.422 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 11.6 t -73.93 -53.59 17.19 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.037 -170.284 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 26.8 t -155.09 163.66 39.95 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.079 -179.484 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 19.9 tp -127.64 126.56 42.21 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.156 0.503 . . . . 0.0 110.025 179.294 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.412 ' HA ' ' HA ' ' A' ' 12' ' ' PRO . 41.4 p -122.17 131.47 24.4 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.558 177.299 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.513 ' HD2' ' SD ' ' A' ' 23' ' ' MET . 66.5 Cg_endo -90.68 177.19 17.19 Favored 'Cis proline' 0 N--CA 1.456 -0.72 0 C-N-CA 123.772 -1.345 . . . . 0.0 112.982 3.126 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.3 m -98.91 -13.36 8.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.376 177.697 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.412 ' HA ' ' O ' ' A' ' 105' ' ' GLY . 0.0 OUTLIER -120.24 151.1 39.64 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.892 173.586 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 17.0 m -143.16 157.36 17.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.574 0.226 . . . . 0.0 110.683 -177.745 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.505 ' HA ' ' HD3' ' A' ' 17' ' ' PRO . 2.2 t -99.25 131.84 24.44 Favored Pre-proline 0 C--N 1.325 -0.485 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 -178.173 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.585 ' HA ' ' HG ' ' A' ' 71' ' ' LEU . 3.2 Cg_exo -80.45 15.28 1.79 Allowed 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 123.3 2.667 . . . . 0.0 115.07 -171.543 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 29.4 p-10 -127.26 -2.47 6.31 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 -172.409 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 13.5 t -143.14 176.56 9.02 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.418 -172.655 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 62.0 t -81.01 134.46 27.13 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 CA-C-O 121.591 0.71 . . . . 0.0 109.405 174.278 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.547 ' ND2' HD23 ' A' ' 71' ' ' LEU . 32.7 m-80 -114.42 132.98 56.05 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 114.558 -1.201 . . . . 0.0 108.847 -173.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 23.7 m -108.2 118.88 37.93 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 108.166 -1.049 . . . . 0.0 108.166 -174.154 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.513 ' SD ' ' HD2' ' A' ' 12' ' ' PRO . 86.1 mmm -109.09 122.92 48.3 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 113.533 -1.667 . . . . 0.0 109.23 -166.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.529 ' HA ' ' O ' ' A' ' 65' ' ' VAL . 25.0 m -111.93 124.8 53.16 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-O 121.732 0.777 . . . . 0.0 109.531 -174.328 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -119.26 132.01 55.86 Favored 'General case' 0 N--CA 1.434 -1.248 0 CA-C-N 114.353 -1.294 . . . . 0.0 108.15 -176.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 93.6 m -112.36 121.45 44.89 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 -173.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 11.9 mm -116.14 131.86 67.39 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 -171.596 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -125.32 148.56 48.67 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.257 -177.738 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 37.6 t30 -101.15 95.99 6.92 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.442 -175.639 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.441 ' O ' ' HB3' ' A' ' 4' ' ' ASP . 92.8 mt-30 -88.08 62.2 6.68 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 122.048 0.927 . . . . 0.0 109.826 -179.564 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -173.5 147.14 9.31 Favored Glycine 0 N--CA 1.443 -0.841 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 178.583 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.482 ' OD1' ' HA ' ' A' ' 1' ' ' MET . 32.5 p-10 -85.39 8.29 19.42 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 113.661 0.986 . . . . 0.0 113.661 -162.23 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -109.19 141.17 41.82 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 120.376 -0.529 . . . . 0.0 110.648 174.16 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -75.24 135.56 40.99 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.864 174.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 65.5 p -93.1 -161.75 0.87 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.909 -173.707 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 7.0 p -131.31 -167.97 1.94 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.436 178.192 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 13.4 m -59.38 124.27 19.49 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.876 178.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.523 ' HB2' ' HB2' ' A' ' 85' ' ' ASP . 23.9 p90 -136.53 150.73 48.79 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.95 -179.05 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.435 ' O ' ' HA ' ' A' ' 85' ' ' ASP . 22.1 m-80 -99.44 109.84 22.38 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.364 -173.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.479 HG23 ' CE2' ' A' ' 38' ' ' PHE . 2.4 t -98.3 114.2 35.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-O 121.337 0.589 . . . . 0.0 109.797 177.509 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.447 ' HA ' ' HA ' ' A' ' 51' ' ' THR . 25.2 p -112.65 141.91 45.88 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.745 -175.866 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 55.9 tp -96.47 114.45 26.12 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.982 177.205 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.528 ' HG ' HG22 ' A' ' 48' ' ' VAL . 5.1 mp -98.26 132.57 43.64 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.225 179.196 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 98.7 t -113.78 101.72 12.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.868 177.751 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 58.82 19.01 6.54 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.822 179.358 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 128.55 -38.71 2.01 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.892 177.19 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 5.6 mt -87.48 150.23 3.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 -177.085 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.528 HG22 ' HG ' ' A' ' 43' ' ' LEU . 44.8 t -96.77 121.11 46.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 19.9 m -94.73 -33.32 4.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -177.125 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 34.1 t0 -156.1 138.35 14.73 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.576 0.227 . . . . 0.0 110.518 -178.134 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.447 ' HA ' ' HA ' ' A' ' 41' ' ' SER . 30.6 m -126.83 123.29 36.98 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.262 -179.712 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -114.7 112.65 23.18 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.802 0.334 . . . . 0.0 110.377 -179.158 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 23.7 m -77.12 113.07 14.46 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.972 0.415 . . . . 0.0 110.607 177.149 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 27.5 t -83.36 144.15 10.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.881 -179.584 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.3 m -62.67 -49.06 76.61 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.585 -0.279 . . . . 0.0 111.231 -178.527 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 22.6 t -177.75 164.45 1.97 Allowed 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -178.247 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.593 HD23 HD22 ' A' ' 5' ' ' LEU . 18.1 tp -139.85 110.03 6.53 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.247 0.546 . . . . 0.0 110.79 175.645 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 29.3 mp0 -74.75 174.2 9.47 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.973 -178.644 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 34.6 p -74.89 128.94 36.77 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.699 0.285 . . . . 0.0 110.901 -177.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 66.95 18.34 10.59 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.026 178.808 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.457 ' O ' HD11 ' A' ' 57' ' ' LEU . 58.5 t30 -110.64 148.65 31.79 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 175.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -117.62 153.9 32.5 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 120.964 0.411 . . . . 0.0 111.015 -175.511 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.472 ' OG1' HD13 ' A' ' 57' ' ' LEU . 92.6 m -130.07 135.24 48.02 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.715 177.254 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -96.34 123.04 39.85 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.41 176.451 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.529 ' O ' ' HA ' ' A' ' 24' ' ' THR . 17.6 t -105.15 120.68 56.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.732 178.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -109.42 111.27 22.72 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.114 0.483 . . . . 0.0 110.321 -179.38 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -91.6 157.72 16.83 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.391 -177.11 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 65.1 m-70 -108.94 100.03 9.29 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.327 175.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 13.5 t90 -116.67 108.23 15.66 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.077 0.465 . . . . 0.0 110.925 -175.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 10.1 m -81.78 114.03 20.14 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.636 174.71 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.585 ' HG ' ' HA ' ' A' ' 17' ' ' PRO . 0.1 OUTLIER -72.64 124.73 25.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.701 0.286 . . . . 0.0 110.46 -177.462 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -84.3 -36.62 22.48 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.765 177.285 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 85.8 58.58 2.0 Allowed Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 121.104 -0.569 . . . . 0.0 112.917 174.488 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.4 p -112.09 -32.14 6.66 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.734 0.302 . . . . 0.0 111.636 178.416 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -124.1 166.3 16.02 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.785 0.326 . . . . 0.0 111.083 -177.613 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.499 ' HA ' HG23 ' A' ' 106' ' ' THR . 51.8 m-80 -101.65 -5.09 25.47 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.046 0.45 . . . . 0.0 110.321 177.267 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 20.5 m -145.18 114.21 6.95 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.841 178.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -105.91 138.79 41.5 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.15 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.456 ' HA ' HD23 ' A' ' 103' ' ' LEU . 9.5 m -90.59 88.23 7.05 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.529 -178.005 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.475 HD13 HG22 ' A' ' 104' ' ' VAL . 8.3 mp -89.02 124.82 34.64 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.35 0.595 . . . . 0.0 111.148 -177.295 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.473 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 76.2 m -123.53 124.4 42.76 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.67 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 61.7 t -90.28 99.03 8.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 174.782 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.538 ' HA ' ' O ' ' A' ' 98' ' ' ASN . 4.6 t30 -93.5 114.76 27.22 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 178.583 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.438 HG11 ' HB2' ' A' ' 5' ' ' LEU . 60.8 t -80.11 108.6 13.73 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.648 -178.62 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.523 ' HB2' ' HB2' ' A' ' 38' ' ' PHE . 8.1 t70 48.57 92.09 0.06 OUTLIER Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 114.056 -1.429 . . . . 0.0 112.511 -179.242 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -64.73 -8.19 16.92 Favored 'Trans proline' 0 C--O 1.234 0.313 0 C-N-CA 123.313 2.675 . . . . 0.0 112.452 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -94.26 -24.95 17.25 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.372 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 18.9 m120 58.57 48.18 12.24 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.686 -173.548 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -64.21 -25.66 68.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.012 176.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 20.4 t -101.66 125.74 55.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.564 175.508 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -74.83 116.53 15.65 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.435 -0.579 . . . . 0.0 109.435 176.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -118.41 168.38 10.7 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -171.695 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -57.97 -100.96 0.01 OUTLIER Glycine 0 CA--C 1.522 0.52 0 CA-C-N 113.985 -1.461 . . . . 0.0 114.756 179.153 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -85.54 -163.9 0.93 Allowed 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -166.03 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 49.0 mm-40 -100.45 -37.84 8.66 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.282 -173.486 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 15.3 m -84.98 -4.4 59.13 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.824 0.345 . . . . 0.0 111.749 -171.202 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.675 ' O ' ' HD3' ' A' ' 7' ' ' PRO . 23.6 p-10 -70.44 -34.07 72.03 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.562 -176.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.538 ' O ' ' HA ' ' A' ' 83' ' ' ASN . 9.2 m120 -77.56 -1.46 30.77 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -175.629 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 1.1 p -135.83 130.94 34.72 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -177.505 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.473 ' O ' ' HA ' ' A' ' 81' ' ' THR . 28.3 tp -128.35 98.52 5.09 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.234 168.152 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 98.5 m -95.72 107.0 19.18 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.121 0.486 . . . . 0.0 110.501 179.032 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -121.57 134.83 55.03 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.948 -179.344 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.456 HD23 ' HA ' ' A' ' 79' ' ' THR . 78.9 mt -84.96 120.03 26.05 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.349 0.595 . . . . 0.0 110.629 179.42 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.475 HG22 HD13 ' A' ' 80' ' ' LEU . 33.2 m -106.22 132.35 53.59 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.491 177.777 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.412 ' O ' ' HA ' ' A' ' 14' ' ' THR . . . -108.76 173.57 17.7 Favored Glycine 0 N--CA 1.443 -0.876 0 C-N-CA 120.399 -0.905 . . . . 0.0 111.855 -175.285 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.499 HG23 ' HA ' ' A' ' 76' ' ' ASN . 22.0 p -76.43 132.54 39.72 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 120.881 0.372 . . . . 0.0 110.084 176.76 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 37.2 tp -63.19 123.41 18.56 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.938 -175.718 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -56.82 -47.11 81.04 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.872 177.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 58.6 m-70 -75.96 102.1 5.47 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.596 178.391 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 7.9 t60 -60.21 -26.63 66.53 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.307 -170.636 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 44.3 m80 -142.95 149.3 38.2 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 171.181 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 16.8 t-80 -79.34 74.83 5.93 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.777 0.799 . . . . 0.0 109.045 177.425 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -160.93 -26.65 0.06 Allowed 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.323 -1.308 . . . . 0.0 108.087 -174.305 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 16.5 t-80 . . . . . 0 C--O 1.245 0.855 0 CA-C-N 114.735 -1.121 . . . . 0.0 109.013 171.734 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.552 ' HG2' ' HB2' ' A' ' 33' ' ' LYS . 24.7 ttt . . . . . 0 N--CA 1.481 1.095 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 16.1 tt -130.64 148.48 70.24 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.301 -171.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -71.68 165.08 33.62 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.647 2.231 . . . . 0.0 112.501 175.549 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -149.85 91.21 1.77 Allowed 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 177.028 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.474 HD22 HD23 ' A' ' 57' ' ' LEU . 66.3 mt -84.76 117.68 23.98 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.178 -168.756 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.536 HG22 ' HB3' ' A' ' 97' ' ' ASN . 21.7 t -120.52 110.41 35.63 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.118 -176.248 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.561 ' HD2' ' O ' ' A' ' 97' ' ' ASN . 20.3 Cg_endo -63.74 111.68 1.59 Allowed 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 122.388 2.059 . . . . 0.0 110.55 169.361 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.3 t -85.93 -48.78 15.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.454 -169.542 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 18.2 t -149.32 157.66 43.52 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.924 0.392 . . . . 0.0 111.097 -174.778 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 53.7 tp -135.51 111.95 9.88 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.213 178.184 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.56 ' OG1' ' HA ' ' A' ' 12' ' ' PRO . 13.6 t -131.0 148.13 69.05 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.656 -176.555 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.56 ' HA ' ' OG1' ' A' ' 11' ' ' THR . 5.8 Cg_exo -78.77 148.76 83.79 Favored 'Cis proline' 0 N--CA 1.46 -0.446 0 C-N-CA 123.366 -1.514 . . . . 0.0 112.44 1.21 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.5 m -72.13 -5.91 6.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.271 0.557 . . . . 0.0 110.957 177.244 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.575 ' HB ' ' HA ' ' A' ' 107' ' ' LEU . 0.9 OUTLIER -128.27 133.01 48.7 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.834 175.43 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.496 ' O ' ' HA ' ' A' ' 106' ' ' THR . 15.3 m -124.2 156.18 31.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 120.761 0.315 . . . . 0.0 111.232 -174.869 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.0 m -101.83 134.0 20.41 Favored Pre-proline 0 N--CA 1.445 -0.703 0 CA-C-O 121.038 0.446 . . . . 0.0 110.823 177.604 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.425 ' CB ' ' HA3' ' A' ' 73' ' ' GLY . 98.6 Cg_endo -79.63 174.04 12.26 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 122.42 2.08 . . . . 0.0 112.166 178.767 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 25.1 m-80 63.14 28.77 16.09 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.32 177.393 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 15.2 t -169.42 170.52 8.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.761 0.315 . . . . 0.0 110.602 -177.755 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.467 HG22 ' HA ' ' A' ' 70' ' ' THR . 58.4 t -91.4 129.88 41.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.853 0.359 . . . . 0.0 110.387 178.371 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 40.4 m-80 -106.9 116.15 31.43 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.608 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.587 ' HA ' ' O ' ' A' ' 67' ' ' PHE . 10.3 m -85.36 93.39 8.71 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 175.025 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.582 ' O ' ' HA ' ' A' ' 66' ' ' ASP . 83.0 mtp -94.73 148.34 22.39 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.132 -174.197 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.459 HG23 ' HB3' ' A' ' 64' ' ' ASN . 20.9 m -109.67 114.07 27.36 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.146 -175.537 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -104.23 112.29 25.25 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 172.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 38.8 m -83.38 104.78 13.8 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 120.923 0.392 . . . . 0.0 110.044 -177.543 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 31.9 mm -97.05 116.62 39.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.893 -179.17 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -113.2 122.43 47.46 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.006 0.431 . . . . 0.0 110.135 -178.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 31.0 t30 -79.05 98.44 6.49 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.513 177.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -101.02 56.62 0.86 Allowed 'General case' 0 C--N 1.319 -0.761 0 CA-C-O 121.601 0.715 . . . . 0.0 109.976 -174.451 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -144.08 177.78 22.53 Favored Glycine 0 N--CA 1.444 -0.775 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.886 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.457 ' HB3' ' HG3' ' A' ' 1' ' ' MET . 3.5 m-20 -73.14 -39.17 65.91 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 -173.758 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.552 ' HB2' ' HG2' ' A' ' 1' ' ' MET . 55.7 tttp -101.21 147.58 26.1 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.424 0.631 . . . . 0.0 112.476 -170.71 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.402 ' O ' ' HG2' ' A' ' 33' ' ' LYS . 1.7 t70 -65.81 138.82 58.17 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 114.523 -1.217 . . . . 0.0 110.809 173.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.423 ' OG ' HD21 ' A' ' 5' ' ' LEU . 13.8 p -105.62 137.43 43.47 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.288 176.585 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.1 m -90.14 -133.2 0.11 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.248 -179.369 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.509 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 26.8 m -75.62 109.47 9.22 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.085 0.469 . . . . 0.0 111.568 -175.347 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.552 ' CE2' HG23 ' A' ' 40' ' ' VAL . 19.9 p90 -122.6 148.81 44.79 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.13 178.103 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.543 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 4.2 t-20 -99.83 115.19 29.02 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 120.913 -0.315 . . . . 0.0 110.963 -173.591 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.552 HG23 ' CE2' ' A' ' 38' ' ' PHE . 2.7 t -98.48 111.96 29.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.597 0.713 . . . . 0.0 110.161 -178.779 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.577 ' HB3' HG23 ' A' ' 51' ' ' THR . 16.2 p -104.1 131.69 51.11 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.919 -176.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 62.9 tp -98.17 109.77 22.47 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 174.632 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 5.1 mp -97.78 142.05 30.03 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.669 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 81.7 t -108.56 99.23 8.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 172.261 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 37.3 t70 67.06 -73.95 0.07 Allowed 'General case' 0 C--N 1.329 -0.298 0 O-C-N 124.123 0.89 . . . . 0.0 111.139 -176.637 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -143.64 4.96 1.75 Allowed Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 121.278 -0.486 . . . . 0.0 112.314 179.505 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 8.4 mt -112.62 153.72 14.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -179.538 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 54.7 t -106.51 124.9 62.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.228 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 17.5 m -94.56 -33.05 4.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 C-N-CA 120.961 -0.295 . . . . 0.0 111.191 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -159.68 142.18 13.64 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.923 0.392 . . . . 0.0 110.673 178.207 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.577 HG23 ' HB3' ' A' ' 41' ' ' SER . 7.1 m -124.06 109.34 13.38 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.294 178.852 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 47.0 tt0 -109.08 113.01 25.5 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.104 0.478 . . . . 0.0 111.183 -172.664 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.543 ' HA ' ' HA ' ' A' ' 39' ' ' ASN . 10.4 m -76.32 120.0 20.97 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.358 177.733 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.509 ' O ' ' HA ' ' A' ' 37' ' ' SER . 25.0 t -92.58 127.18 44.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 177.091 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 27.0 m -58.05 -38.72 76.8 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.075 -0.511 . . . . 0.0 112.337 -173.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 11.2 p -169.97 163.55 9.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.671 0.272 . . . . 0.0 111.422 -177.331 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.483 HD11 ' O ' ' A' ' 61' ' ' ASN . 38.4 tp -156.52 114.24 3.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.869 176.195 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -77.32 169.41 18.38 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.605 -175.599 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 16.6 m -63.44 125.96 25.93 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.745 -0.662 . . . . 0.0 111.114 -179.412 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 66.27 15.8 10.21 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.96 176.702 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.483 ' O ' HD11 ' A' ' 57' ' ' LEU . 41.5 t-20 -97.63 143.51 28.23 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 175.277 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -114.44 115.76 27.8 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.351 -178.43 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.412 ' OG1' HD13 ' A' ' 57' ' ' LEU . 50.0 m -104.33 124.43 49.17 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.093 0.473 . . . . 0.0 110.738 -179.296 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.459 ' HB3' HG23 ' A' ' 24' ' ' THR . 94.8 m-20 -80.14 115.76 19.88 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.683 178.627 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 18.2 t -96.77 107.56 20.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.322 -178.641 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.582 ' HA ' ' O ' ' A' ' 23' ' ' MET . 28.5 m-20 -93.75 111.74 23.49 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.785 179.362 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.587 ' O ' ' HA ' ' A' ' 22' ' ' THR . 80.7 m-85 -91.38 167.46 12.26 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.978 179.576 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 2.5 p-80 -117.58 95.31 4.89 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.502 174.213 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' TRP . . . . . 0.618 ' CZ2' HD13 ' A' ' 71' ' ' LEU . 9.7 t90 -94.38 100.52 12.53 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.552 -176.324 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.467 ' HA ' HG22 ' A' ' 20' ' ' VAL . 17.8 m -73.74 91.52 1.92 Allowed 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 173.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.618 HD13 ' CZ2' ' A' ' 69' ' ' TRP . 22.2 tp -95.84 117.8 31.26 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.445 0.64 . . . . 0.0 112.102 -169.298 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -65.13 -56.86 10.51 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.807 -1.088 . . . . 0.0 109.666 171.767 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.425 ' HA3' ' CB ' ' A' ' 17' ' ' PRO . . . 101.22 50.31 1.24 Allowed Glycine 0 N--CA 1.446 -0.64 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.656 -179.434 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.9 m -81.65 -29.42 33.16 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.146 0.498 . . . . 0.0 110.553 -177.419 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -123.45 162.01 23.69 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.543 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 69.8 m-20 -97.47 -2.5 41.89 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.052 0.453 . . . . 0.0 110.668 179.153 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.416 ' HA ' ' HA2' ' A' ' 105' ' ' GLY . 53.6 m -149.3 112.49 4.93 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.479 176.862 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -105.79 149.36 26.55 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.289 178.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 89.8 m -98.7 98.06 9.24 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.876 175.751 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.438 HD13 ' CG2' ' A' ' 104' ' ' VAL . 6.6 mp -94.19 132.25 38.92 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.381 0.61 . . . . 0.0 110.419 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.446 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 17.3 m -129.69 113.97 15.42 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.283 -176.179 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 69.0 t -86.21 109.29 18.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 177.013 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -104.68 115.09 29.72 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 176.713 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.587 ' HB ' ' HB2' ' A' ' 98' ' ' ASN . 74.9 t -82.66 114.02 22.85 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-O 121.404 0.621 . . . . 0.0 111.304 -177.281 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 45.2 t0 63.27 90.37 0.09 OUTLIER Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 114.211 -1.359 . . . . 0.0 112.35 176.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.528 ' HD3' ' O ' ' A' ' 39' ' ' ASN . 1.9 Cg_endo -84.7 -6.93 9.7 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 123.195 2.597 . . . . 0.0 111.563 174.697 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -92.84 -16.67 25.02 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.738 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 57.51 54.96 6.02 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.464 -179.172 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -93.45 -30.17 15.19 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.008 -0.996 . . . . 0.0 109.703 179.579 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 47.9 t -110.03 101.51 12.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.486 173.696 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -64.78 129.69 40.7 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.098 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.403 ' OE1' ' HB2' ' A' ' 5' ' ' LEU . 36.0 mt-10 -108.62 164.14 12.62 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.626 -173.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -58.42 -101.06 0.01 OUTLIER Glycine 0 CA--C 1.519 0.309 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.516 168.502 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -84.29 101.66 12.09 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 176.524 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -74.35 22.96 0.09 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.158 -174.373 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 16.2 m -111.82 -5.14 14.43 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.201 0.524 . . . . 0.0 109.839 174.261 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.561 ' O ' ' HD2' ' A' ' 7' ' ' PRO . 81.3 m-20 -87.52 -15.31 37.89 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.191 178.659 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.587 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 27.8 p-10 -77.04 1.64 17.37 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.685 -173.52 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 1.2 m -114.24 147.01 39.65 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.083 0.468 . . . . 0.0 110.984 -177.506 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.446 ' O ' ' HA ' ' A' ' 81' ' ' THR . 40.2 tp -143.57 102.19 3.9 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.904 179.584 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 8.5 m -95.96 110.64 22.82 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.969 178.419 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -128.5 138.8 52.45 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.902 -178.454 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 64.5 mt -87.67 121.46 30.12 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.449 177.679 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.438 ' CG2' HD13 ' A' ' 80' ' ' LEU . 27.3 m -113.29 121.41 65.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.842 179.192 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.538 ' O ' ' HA ' ' A' ' 14' ' ' THR . . . -103.66 174.05 22.37 Favored Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 120.397 -0.906 . . . . 0.0 111.054 -177.877 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.496 ' HA ' ' O ' ' A' ' 15' ' ' VAL . 20.7 p -73.29 154.59 40.09 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 117.286 0.543 . . . . 0.0 109.808 175.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.575 ' HA ' ' HB ' ' A' ' 14' ' ' THR . 49.7 tp -60.58 108.01 0.77 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.184 0.516 . . . . 0.0 112.153 -172.336 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -100.69 112.08 24.42 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.438 -0.801 . . . . 0.0 108.851 172.783 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 18.2 t-80 -94.02 143.06 26.69 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 -174.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 13.7 t60 -72.31 140.32 48.48 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 176.489 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 92.1 m-70 -133.24 170.04 16.01 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 178.73 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 63.4 t60 -82.92 -27.26 30.73 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 174.38 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 77.8 m-70 67.83 -83.03 0.03 OUTLIER 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.068 -176.536 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 42.4 t60 . . . . . 0 C--O 1.245 0.826 0 CA-C-O 118.406 -0.807 . . . . 0.0 109.3 176.375 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 86.5 mtp . . . . . 0 N--CA 1.481 1.119 0 CA-C-O 120.865 0.364 . . . . 0.0 110.692 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 12.6 tt -140.49 138.89 19.32 Favored Pre-proline 0 C--N 1.321 -0.634 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 177.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.603 ' HD2' ' O ' ' A' ' 91' ' ' ASN . 16.9 Cg_exo -68.04 151.51 77.47 Favored 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 122.4 2.067 . . . . 0.0 111.697 175.844 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -141.46 90.41 2.29 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 179.512 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.523 HD22 HD23 ' A' ' 57' ' ' LEU . 58.4 mt -85.05 109.05 17.94 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.073 -171.401 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.538 HG22 ' HB3' ' A' ' 97' ' ' ASN . 17.7 t -117.46 123.1 30.19 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.207 -176.248 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.556 ' HG3' HG23 ' A' ' 84' ' ' VAL . 3.3 Cg_exo -79.32 101.59 1.43 Allowed 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 122.599 2.199 . . . . 0.0 110.014 170.735 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 29.3 m -83.66 -27.9 7.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -171.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 43.6 t -175.2 166.01 3.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.667 0.27 . . . . 0.0 110.573 -176.103 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.478 ' C ' HD12 ' A' ' 10' ' ' LEU . 3.2 pp -146.27 152.25 38.86 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 172.383 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 22.9 p -129.72 144.73 54.13 Favored Pre-proline 0 C--N 1.322 -0.588 0 CA-C-N 116.693 -0.231 . . . . 0.0 110.506 177.233 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -90.53 162.68 32.36 Favored 'Cis proline' 0 N--CA 1.457 -0.622 0 C-N-CA 123.283 -1.549 . . . . 0.0 112.365 -2.627 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 30.7 m -91.74 9.72 3.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.63 0.728 . . . . 0.0 110.398 177.399 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.545 HG22 ' HA ' ' A' ' 107' ' ' LEU . 0.2 OUTLIER -142.29 122.22 13.61 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.223 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.43 HG21 ' CZ3' ' A' ' 69' ' ' TRP . 21.1 m -121.19 160.32 22.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -168.084 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.457 ' HA ' ' HD3' ' A' ' 17' ' ' PRO . 45.4 t -91.99 118.85 68.42 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.057 178.499 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.577 ' HA ' ' CB ' ' A' ' 71' ' ' LEU . 5.7 Cg_exo -77.79 16.14 1.17 Allowed 'Trans proline' 0 CA--C 1.53 0.318 0 C-N-CA 122.931 2.421 . . . . 0.0 113.455 -176.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.452 ' H ' HG12 ' A' ' 16' ' ' VAL . 51.3 m-80 -122.61 16.16 10.33 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 121.009 -0.276 . . . . 0.0 111.628 -175.277 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 14.3 t -169.68 178.77 3.98 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 110.408 -0.219 . . . . 0.0 110.408 -179.65 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 45.2 t -85.07 125.3 40.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 176.013 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.492 ' ND2' HD23 ' A' ' 71' ' ' LEU . 28.0 m-80 -97.5 124.22 41.65 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.673 -175.855 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 23.8 m -80.95 105.43 12.17 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.564 -0.743 . . . . 0.0 109.52 175.572 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.439 ' HB2' ' HB2' ' A' ' 67' ' ' PHE . 42.0 mtp -102.69 136.53 42.34 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.36 -176.475 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.444 ' HA ' ' O ' ' A' ' 65' ' ' VAL . 22.0 m -115.33 103.74 11.1 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.863 -177.807 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -89.36 141.09 28.85 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.411 177.284 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 19.2 m -104.39 109.13 20.86 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.079 0.466 . . . . 0.0 110.376 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 14.3 mm -101.9 118.32 48.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.284 179.195 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -110.35 131.43 55.06 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 120.754 0.311 . . . . 0.0 110.698 -177.265 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 35.9 t30 -89.32 98.83 11.99 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.211 -0.449 . . . . 0.0 109.871 177.492 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -94.14 40.37 1.08 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.982 -174.369 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -143.96 147.36 18.62 Favored Glycine 0 N--CA 1.444 -0.831 0 N-CA-C 110.631 -0.987 . . . . 0.0 110.631 179.117 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -84.34 60.5 6.02 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.349 0.595 . . . . 0.0 111.157 -172.666 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.563 ' HD3' ' HD3' ' A' ' 3' ' ' PRO . 64.4 tttp -161.45 137.51 8.05 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.027 170.373 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -76.44 132.9 39.91 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.242 -176.521 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 58.7 p -95.69 145.1 25.54 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.144 0.497 . . . . 0.0 111.032 -176.41 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 24.1 p -86.47 -162.22 0.74 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.729 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.449 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 32.6 t -56.96 125.53 23.03 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 120.901 0.382 . . . . 0.0 111.085 178.867 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.558 ' HB2' ' HB2' ' A' ' 85' ' ' ASP . 42.6 p90 -138.32 143.66 40.04 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 177.354 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.568 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 65.2 t30 -102.55 115.56 30.83 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 121.048 -0.261 . . . . 0.0 111.422 -172.318 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.568 HG22 ' HA ' ' A' ' 84' ' ' VAL . 2.0 t -102.49 125.9 56.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.098 0.475 . . . . 0.0 110.566 -176.385 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.533 ' HB3' HG23 ' A' ' 51' ' ' THR . 52.5 p -117.66 138.27 52.09 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.914 -177.255 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 59.5 tp -96.46 107.8 20.26 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 176.412 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.456 ' HG ' HG22 ' A' ' 48' ' ' VAL . 4.6 mp -96.94 118.64 33.79 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.264 -179.099 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.527 HG22 ' HG ' ' A' ' 80' ' ' LEU . 95.8 t -100.87 102.08 12.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.083 178.732 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 59.29 22.45 10.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.374 -0.83 . . . . 0.0 112.399 176.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 121.81 -26.75 6.42 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.464 -0.874 . . . . 0.0 113.002 176.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 11.9 mm -97.85 148.6 5.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 -178.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.456 HG22 ' HG ' ' A' ' 43' ' ' LEU . 39.5 t -98.4 110.7 26.44 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 -179.383 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 28.7 m -91.53 -31.52 4.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.766 -175.619 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -148.95 139.82 22.85 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.676 0.274 . . . . 0.0 110.298 -177.107 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.533 HG23 ' HB3' ' A' ' 41' ' ' SER . 2.1 m -133.87 121.6 21.98 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.112 -0.495 . . . . 0.0 109.682 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -128.28 114.96 17.58 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.085 0.469 . . . . 0.0 110.297 -178.108 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.568 ' HA ' ' HA ' ' A' ' 39' ' ' ASN . 21.8 m -76.97 131.4 38.47 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.365 178.537 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.449 ' O ' ' HA ' ' A' ' 37' ' ' SER . 38.6 t -101.95 121.41 52.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 177.017 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.6 m -59.7 -36.16 75.96 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -174.406 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 21.2 t -172.53 152.46 2.63 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.959 0.409 . . . . 0.0 111.262 179.651 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.633 HD13 ' OG1' ' A' ' 63' ' ' THR . 23.3 tp -140.07 114.34 9.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.82 175.765 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -70.27 173.06 7.18 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.468 0.652 . . . . 0.0 112.035 -175.756 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 10.0 m -63.89 129.66 40.97 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.686 178.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 61.99 19.42 10.75 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.903 -0.59 . . . . 0.0 112.229 176.447 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -101.24 158.54 15.96 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 178.595 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 7.1 m -121.52 125.38 46.67 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.136 179.572 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.633 ' OG1' HD13 ' A' ' 57' ' ' LEU . 86.1 m -103.96 135.94 44.53 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.892 0.377 . . . . 0.0 110.973 -179.646 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -92.85 119.8 32.55 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.762 174.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.444 ' O ' ' HA ' ' A' ' 24' ' ' THR . 40.7 t -96.24 135.06 31.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.441 -177.34 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -96.39 112.13 23.98 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.579 -176.25 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.439 ' HB2' ' HB2' ' A' ' 23' ' ' MET . 36.1 m-85 -112.37 140.01 47.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.785 0.326 . . . . 0.0 111.016 177.856 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 22.0 m170 -115.86 97.46 6.12 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 176.364 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' TRP . . . . . 0.43 ' CZ3' HG21 ' A' ' 15' ' ' VAL . 18.6 t90 -108.65 114.38 28.14 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.17 0.509 . . . . 0.0 111.622 -173.511 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 9.7 m -82.88 123.9 29.83 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.05 176.075 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.577 ' CB ' ' HA ' ' A' ' 17' ' ' PRO . 1.0 OUTLIER -83.89 123.17 29.66 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.163 0.506 . . . . 0.0 111.756 -178.573 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 19.3 p-10 -79.19 -43.42 23.92 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.755 175.437 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 89.39 40.0 6.18 Favored Glycine 0 N--CA 1.45 -0.37 0 CA-C-N 115.772 -0.649 . . . . 0.0 113.152 176.22 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 18.2 m -99.39 -13.95 19.36 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.207 0.527 . . . . 0.0 110.524 178.632 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -145.04 152.5 40.22 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.567 178.295 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -90.09 -10.11 45.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.158 0.504 . . . . 0.0 110.645 179.581 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 24.7 m -140.53 121.52 14.61 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.316 179.516 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -116.32 153.31 32.21 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.252 179.489 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.422 ' HA ' HD23 ' A' ' 103' ' ' LEU . 4.4 m -96.54 89.59 5.06 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.881 179.125 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.527 ' HG ' HG22 ' A' ' 44' ' ' VAL . 10.7 mp -87.55 113.02 22.86 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.477 0.656 . . . . 0.0 110.256 -178.684 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.495 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 5.4 m -115.97 113.51 23.36 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.6 -173.209 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 59.9 t -87.55 109.16 19.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 116.311 -0.404 . . . . 0.0 109.94 177.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -105.83 120.78 42.61 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.135 0.493 . . . . 0.0 109.849 176.3 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.568 ' HA ' HG22 ' A' ' 40' ' ' VAL . 83.5 t -85.37 111.95 21.52 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.621 -175.601 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.558 ' HB2' ' HB2' ' A' ' 38' ' ' PHE . 20.6 t70 57.8 86.85 0.15 Allowed Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 114.294 -1.321 . . . . 0.0 112.92 173.493 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_exo -72.92 -9.0 23.18 Favored 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 122.797 2.331 . . . . 0.0 111.26 174.635 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -82.52 -27.12 31.9 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.27 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 56.99 52.57 9.05 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.505 -177.761 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -83.98 -25.64 29.86 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.981 -1.009 . . . . 0.0 109.936 179.059 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 40.3 t -100.4 136.9 29.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.802 177.736 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.603 ' O ' ' HD2' ' A' ' 3' ' ' PRO . 43.8 m-80 -75.05 112.04 10.88 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 173.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.442 ' CD ' HD21 ' A' ' 98' ' ' ASN . 33.9 mt-10 -114.6 152.64 31.5 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 120.896 0.379 . . . . 0.0 111.752 -173.382 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -57.7 -101.09 0.01 OUTLIER Glycine 0 CA--C 1.519 0.326 0 CA-C-N 115.071 -0.968 . . . . 0.0 113.956 179.004 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -88.83 124.29 34.04 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.543 0.211 . . . . 0.0 111.015 -173.232 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -61.11 -33.76 73.88 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -174.774 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 10.9 p -75.05 -1.94 25.14 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.934 0.397 . . . . 0.0 111.398 -177.307 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.538 ' HB3' HG22 ' A' ' 6' ' ' VAL . 7.6 m-20 -91.7 -13.55 31.52 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.52 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.442 HD21 ' CD ' ' A' ' 92' ' ' GLU . 10.8 m120 -69.8 -18.02 63.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.903 -0.589 . . . . 0.0 112.257 -177.464 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 1.2 m -123.04 147.91 46.16 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.326 0.584 . . . . 0.0 112.102 -170.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.495 ' O ' ' HA ' ' A' ' 81' ' ' THR . 29.4 tp -131.89 104.61 6.96 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.096 -0.957 . . . . 0.0 109.694 178.52 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 7.0 m -87.98 99.47 12.18 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.277 178.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -113.62 148.85 35.49 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.91 0.386 . . . . 0.0 111.11 -178.271 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.422 HD23 ' HA ' ' A' ' 79' ' ' THR . 51.8 mt -112.83 120.46 41.53 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.384 178.535 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.446 HG22 HD13 ' A' ' 80' ' ' LEU . 27.8 m -110.19 156.78 11.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.371 -178.86 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.53 ' O ' ' HA ' ' A' ' 14' ' ' THR . . . -122.89 169.98 15.32 Favored Glycine 0 N--CA 1.442 -0.955 0 C-N-CA 120.292 -0.956 . . . . 0.0 111.468 179.153 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 27.3 p -81.47 139.28 35.29 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 174.681 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.545 ' HA ' HG22 ' A' ' 14' ' ' THR . 32.9 tp -54.67 120.34 6.6 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.033 0.444 . . . . 0.0 111.907 -172.734 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -59.69 -30.83 69.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.152 176.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' HIS . . . . . 0.541 ' H ' ' HG ' ' A' ' 107' ' ' LEU . 35.9 p-80 46.61 80.48 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.231 0 O-C-N 124.484 1.115 . . . . 0.0 110.795 -172.507 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 64.0 m170 -66.48 -18.75 65.54 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 114.909 -1.042 . . . . 0.0 110.63 -177.749 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 30.9 m170 -80.11 100.46 8.23 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 171.367 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 19.4 m80 -91.48 99.55 12.47 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.257 0.551 . . . . 0.0 111.44 -176.453 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 15.2 p-80 -76.33 -18.78 58.76 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 169.388 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 77.2 t60 . . . . . 0 C--O 1.245 0.826 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.099 175.747 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 71.8 mtm . . . . . 0 N--CA 1.48 1.03 0 CA-C-O 120.85 0.357 . . . . 0.0 110.907 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 10.7 tt -143.68 137.36 14.33 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-O 120.78 0.324 . . . . 0.0 110.479 -178.36 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.444 ' HA ' ' HA3' ' A' ' 31' ' ' GLY . 88.2 Cg_endo -95.75 169.93 1.27 Allowed 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 123.09 2.527 . . . . 0.0 113.196 175.628 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.402 ' O ' ' HA ' ' A' ' 29' ' ' ASN . 5.5 m-20 -136.42 104.33 5.56 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.089 171.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.475 HD22 HD23 ' A' ' 57' ' ' LEU . 85.4 mt -89.69 90.79 8.38 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.34 0.59 . . . . 0.0 109.949 -176.731 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.489 ' HA ' ' HD2' ' A' ' 7' ' ' PRO . 25.0 t -104.24 111.73 65.25 Favored Pre-proline 0 C--N 1.319 -0.756 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.116 -174.155 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.524 ' HB2' HD22 ' A' ' 100' ' ' LEU . 18.5 Cg_endo -62.18 119.01 5.91 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 122.244 1.963 . . . . 0.0 109.956 169.099 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.5 t -91.0 -47.67 14.31 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.848 -168.443 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.9 t -160.67 173.68 15.1 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.489 -178.46 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 55.7 tp -136.46 127.74 28.22 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.83 -178.565 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.536 ' OG1' ' HA ' ' A' ' 12' ' ' PRO . 14.0 t -140.48 149.2 56.54 Favored Pre-proline 0 C--N 1.322 -0.589 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.536 ' HA ' ' OG1' ' A' ' 11' ' ' THR . 72.3 Cg_endo -76.56 148.12 88.33 Favored 'Cis proline' 0 N--CA 1.464 -0.251 0 C-N-CA 123.393 -1.503 . . . . 0.0 112.745 0.612 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 34.7 m -72.9 -22.35 19.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.724 177.656 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.622 ' HA ' ' O ' ' A' ' 105' ' ' GLY . 17.0 p -114.24 129.33 56.63 Favored 'General case' 0 N--CA 1.439 -1.016 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.164 174.17 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.499 HG11 ' CZ3' ' A' ' 69' ' ' TRP . 18.0 m -113.52 149.41 15.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.165 0.507 . . . . 0.0 111.923 -173.254 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 27.2 t -90.2 113.35 57.01 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.034 -179.459 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -83.27 42.09 1.2 Allowed 'Trans proline' 0 CA--C 1.53 0.289 0 C-N-CA 122.974 2.449 . . . . 0.0 113.384 -175.423 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -156.72 27.92 0.33 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.999 0.428 . . . . 0.0 110.984 177.055 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 11.2 t -170.99 -177.06 2.12 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.001 179.031 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 59.0 t -90.02 118.86 36.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.035 0.445 . . . . 0.0 109.91 177.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 44.8 m-80 -89.8 126.57 35.73 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.482 -178.529 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 17.8 m -80.04 89.0 5.35 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.527 175.706 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.558 ' HB2' ' HB2' ' A' ' 67' ' ' PHE . 91.3 mmm -79.38 113.21 17.34 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.925 -0.579 . . . . 0.0 109.607 -176.828 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.5 ' CG2' ' HB3' ' A' ' 64' ' ' ASN . 26.4 m -102.11 112.8 25.6 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.431 -175.695 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -101.21 124.05 46.3 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.38 179.073 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 25.0 m -86.12 110.6 19.66 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.285 179.644 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 19.8 mm -107.64 120.79 59.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 178.11 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -115.41 127.59 55.47 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.878 0.37 . . . . 0.0 110.889 -179.435 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.402 ' HA ' ' O ' ' A' ' 4' ' ' ASP . 25.2 t30 -89.86 103.8 16.42 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.844 177.293 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 -99.51 56.73 1.01 Allowed 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.621 -175.444 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.444 ' HA3' ' HA ' ' A' ' 3' ' ' PRO . . . -144.05 170.73 25.81 Favored Glycine 0 N--CA 1.448 -0.527 0 N-CA-C 111.521 -0.632 . . . . 0.0 111.521 -179.679 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 7.6 p-10 -86.84 0.97 53.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.04 0.448 . . . . 0.0 110.92 -174.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -120.91 132.33 54.9 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.51 -179.124 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -66.76 139.93 57.83 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.619 173.124 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.448 ' OG ' HD21 ' A' ' 5' ' ' LEU . 15.7 p -100.87 136.22 41.07 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.622 177.781 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.602 ' O ' ' HA ' ' A' ' 56' ' ' SER . 2.0 m -82.41 -128.02 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 120.91 -0.316 . . . . 0.0 110.246 -179.618 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.406 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 9.7 t -90.71 121.43 32.6 Favored 'General case' 0 C--N 1.323 -0.554 0 O-C-N 121.786 -0.571 . . . . 0.0 111.399 -172.222 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -128.92 142.04 51.08 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.624 -0.717 . . . . 0.0 109.361 176.443 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.676 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 64.1 t30 -90.31 120.13 31.19 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 120.832 0.349 . . . . 0.0 110.234 -176.486 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.483 HG11 HG11 ' A' ' 65' ' ' VAL . 0.3 OUTLIER -106.46 147.29 12.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -176.259 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 9.9 p -137.8 139.43 40.0 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 120.756 -0.378 . . . . 0.0 111.479 -175.03 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 62.2 tp -105.47 111.31 23.98 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.705 175.445 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.416 ' HG ' HG22 ' A' ' 48' ' ' VAL . 4.2 mp -98.55 141.49 31.33 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.936 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.412 HG22 ' HG ' ' A' ' 80' ' ' LEU . 87.4 t -123.83 106.09 16.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 176.885 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 57.53 23.49 9.25 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 115.791 -0.641 . . . . 0.0 112.083 178.668 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 120.99 -33.09 4.52 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.907 176.257 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 11.2 mm -90.89 149.25 4.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 -177.66 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.416 HG22 ' HG ' ' A' ' 43' ' ' LEU . 39.0 t -96.66 110.39 24.72 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 179.607 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 26.7 m -90.98 -25.69 5.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.686 -175.486 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -147.34 145.15 29.22 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 -178.807 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 22.1 m -141.74 113.52 7.86 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.076 0.465 . . . . 0.0 109.961 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.407 ' O ' HG12 ' A' ' 40' ' ' VAL . 0.1 OUTLIER -122.99 116.36 23.42 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.794 -174.922 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.676 ' HA ' ' HA ' ' A' ' 39' ' ' ASN . 8.6 m -80.69 112.64 18.25 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 176.499 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.406 ' O ' ' HA ' ' A' ' 37' ' ' SER . 49.2 t -77.6 133.27 30.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 -178.53 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 26.3 m -63.74 -43.74 95.59 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.614 -175.344 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.602 ' HA ' ' O ' ' A' ' 36' ' ' THR . 38.7 t -177.36 151.11 0.75 Allowed 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 -178.66 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.475 HD23 HD22 ' A' ' 5' ' ' LEU . 26.5 tp -131.04 121.76 25.58 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.836 177.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.414 ' HB2' ' HB3' ' A' ' 61' ' ' ASN . 24.5 mt-10 -71.16 163.07 28.34 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.52 -0.764 . . . . 0.0 112.124 -174.274 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 4.9 m -67.16 124.09 22.12 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.814 178.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 63.46 20.56 12.32 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.956 176.653 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.414 ' HB3' ' HB2' ' A' ' 58' ' ' GLU . 56.1 t30 -113.26 153.0 29.12 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 177.868 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.3 m -109.0 133.33 53.12 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.872 0.367 . . . . 0.0 110.286 -179.317 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.42 ' HB ' HD13 ' A' ' 57' ' ' LEU . 20.5 m -123.62 127.32 48.09 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.115 177.35 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.5 ' HB3' ' CG2' ' A' ' 24' ' ' THR . 56.7 m-80 -90.22 135.14 33.85 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.409 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.483 HG11 HG11 ' A' ' 40' ' ' VAL . 13.7 t -96.4 138.57 21.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.862 -176.628 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -94.55 97.2 9.97 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.921 -179.079 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.558 ' HB2' ' HB2' ' A' ' 23' ' ' MET . 67.5 m-85 -98.69 145.78 26.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.364 176.692 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 35.6 m-70 -114.99 100.95 8.57 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.221 0.534 . . . . 0.0 110.827 179.536 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' TRP . . . . . 0.499 ' CZ3' HG11 ' A' ' 15' ' ' VAL . 10.2 t90 -103.22 98.01 8.01 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.483 -177.859 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 18.8 m -74.03 100.33 3.55 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 175.083 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 28.5 tp -107.7 106.6 17.0 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.211 0.529 . . . . 0.0 111.391 -172.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -78.2 -19.85 53.02 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.172 175.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 89.8 87.27 1.3 Allowed Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.519 177.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 11.6 m -106.64 -33.74 7.55 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.024 0.44 . . . . 0.0 110.329 178.337 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -134.47 175.69 9.3 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.055 -0.521 . . . . 0.0 109.93 178.489 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.454 ' HA ' HG23 ' A' ' 106' ' ' THR . 31.7 p-10 -107.84 -8.88 15.87 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.03 0.443 . . . . 0.0 110.935 -179.691 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 3.2 p -137.2 116.81 12.94 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.345 -179.043 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -118.01 142.83 46.95 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.967 -178.609 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 25.5 m -99.21 94.32 6.42 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.051 179.172 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.497 HD13 HG22 ' A' ' 104' ' ' VAL . 10.2 mp -91.96 136.88 32.82 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.325 0.583 . . . . 0.0 110.777 -177.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.477 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 23.6 m -131.86 123.59 27.82 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.155 -178.695 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 46.8 t -95.4 108.84 21.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 177.122 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -100.06 119.51 38.4 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.47 HG21 ' HD3' ' A' ' 7' ' ' PRO . 88.6 t -92.52 106.36 17.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.735 -176.393 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 45.5 t0 62.38 92.67 0.06 OUTLIER Pre-proline 0 C--N 1.33 -0.272 0 O-C-N 124.276 0.985 . . . . 0.0 112.084 177.015 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -94.05 15.82 1.22 Allowed 'Trans proline' 0 N--CA 1.451 -0.996 0 C-N-CA 123.101 2.534 . . . . 0.0 111.839 174.452 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -125.5 -1.97 7.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.731 -174.342 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 65.5 t30 61.21 51.46 4.34 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.453 0.644 . . . . 0.0 110.714 177.026 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -89.33 -34.7 16.46 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.841 177.666 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 63.9 t -119.09 115.33 47.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.186 177.122 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 59.1 t30 -79.77 133.29 36.31 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 177.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -122.06 172.81 7.97 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.153 0.501 . . . . 0.0 112.27 -174.223 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -57.72 -100.82 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.526 0 CA-C-N 114.55 -1.205 . . . . 0.0 112.023 169.323 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -63.54 153.24 36.28 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.918 0.389 . . . . 0.0 110.684 178.668 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -98.62 -3.53 35.95 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.648 0.737 . . . . 0.0 109.817 176.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 8.3 p -87.3 -4.39 59.06 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.62 178.361 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.419 ' O ' ' HD2' ' A' ' 7' ' ' PRO . 55.3 m-20 -70.62 -35.54 73.01 Favored 'General case' 0 C--O 1.223 -0.303 0 CA-C-O 121.062 0.458 . . . . 0.0 110.244 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.467 ' HA ' ' HB ' ' A' ' 84' ' ' VAL . 13.1 m120 -72.34 18.87 0.08 Allowed 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 -165.766 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 1.8 m -150.38 149.81 30.56 Favored 'General case' 0 C--N 1.323 -0.552 0 O-C-N 121.883 -0.511 . . . . 0.0 111.345 -179.556 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.524 HD22 ' HB2' ' A' ' 7' ' ' PRO . 41.9 tp -152.46 100.95 2.62 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.61 176.016 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 61.8 m -92.94 113.38 25.64 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.365 178.405 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -130.14 134.13 47.11 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.777 -179.336 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 76.3 mt -85.6 126.17 33.69 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.638 178.321 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.497 HG22 HD13 ' A' ' 80' ' ' LEU . 19.1 m -116.86 147.05 20.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.581 177.551 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.622 ' O ' ' HA ' ' A' ' 14' ' ' THR . . . -123.72 164.08 17.05 Favored Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 120.495 -0.859 . . . . 0.0 111.389 -177.494 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.454 HG23 ' HA ' ' A' ' 76' ' ' ASN . 35.3 p -70.59 150.19 46.31 Favored 'General case' 0 C--N 1.317 -0.807 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.739 178.203 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.522 ' HA ' ' HB ' ' A' ' 14' ' ' THR . 39.1 tp -51.66 121.82 7.11 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.644 -177.316 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -62.23 -64.87 0.8 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.771 -177.747 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 12.3 m170 -79.39 101.36 8.09 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 173.39 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 54.3 m80 -65.19 131.45 46.56 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.877 -172.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 33.9 m170 -121.22 136.98 54.88 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.623 178.152 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 69.1 m80 -113.63 143.93 43.76 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.706 -178.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 14.8 m-70 -96.17 99.51 11.23 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.736 177.689 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 24.7 t60 . . . . . 0 C--O 1.245 0.82 0 CA-C-O 118.496 -0.764 . . . . 0.0 109.662 -178.94 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.5 mtt . . . . . 0 N--CA 1.479 0.98 0 CA-C-O 121.168 0.508 . . . . 0.0 111.031 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 15.9 tt -144.08 135.75 12.87 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.514 177.191 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.57 ' HD2' ' O ' ' A' ' 91' ' ' ASN . 8.0 Cg_exo -73.22 161.69 42.38 Favored 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 122.553 2.169 . . . . 0.0 112.309 177.004 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -145.45 92.83 2.28 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 175.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.566 HD22 HD23 ' A' ' 57' ' ' LEU . 60.8 mt -90.72 101.24 13.99 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.47 0.652 . . . . 0.0 110.801 -169.142 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 22.5 t -104.49 112.18 65.33 Favored Pre-proline 0 C--N 1.318 -0.798 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.471 -174.201 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.518 ' HB2' ' HB2' ' A' ' 100' ' ' LEU . 33.1 Cg_endo -67.65 103.11 0.79 Allowed 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 121.941 1.76 . . . . 0.0 109.776 166.694 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 6.6 t -80.77 -49.18 18.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.315 -167.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 55.6 m -148.64 165.96 29.74 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.877 0.37 . . . . 0.0 111.312 -177.558 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.511 HD23 ' HB3' ' A' ' 102' ' ' ALA . 31.0 tp -139.8 104.33 4.86 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.654 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 21.5 p -123.71 145.26 46.87 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.28 -175.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -81.89 155.96 79.79 Favored 'Cis proline' 0 C--N 1.342 0.19 0 C-N-CA 123.723 -1.366 . . . . 0.0 112.015 -2.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 33.9 m -83.62 -11.47 11.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.892 0.377 . . . . 0.0 111.52 -177.567 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -116.72 126.88 53.8 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.82 0.343 . . . . 0.0 110.077 173.46 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.413 HG11 ' CZ3' ' A' ' 69' ' ' TRP . 34.7 m -113.52 165.39 8.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 120.896 0.379 . . . . 0.0 111.16 -176.695 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.432 ' HA ' ' HD3' ' A' ' 17' ' ' PRO . 4.9 t -110.15 117.61 51.27 Favored Pre-proline 0 C--N 1.324 -0.531 0 N-CA-C 109.524 -0.546 . . . . 0.0 109.524 177.728 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.471 ' HA ' ' HG ' ' A' ' 71' ' ' LEU . 7.1 Cg_exo -73.59 31.27 0.32 Allowed 'Trans proline' 0 CA--C 1.533 0.465 0 C-N-CA 123.295 2.664 . . . . 0.0 112.716 -178.505 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -105.82 -29.34 10.09 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.124 -176.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 8.9 t -151.21 178.62 9.05 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.159 -170.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 92.5 t -73.44 120.76 22.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 176.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 36.8 m-80 -92.49 123.91 36.14 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.345 -176.465 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.435 ' HA ' ' O ' ' A' ' 67' ' ' PHE . 24.9 m -89.88 96.29 10.62 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 177.567 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 86.5 mtp -97.23 135.87 38.55 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.459 -176.245 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.584 ' HA ' ' O ' ' A' ' 65' ' ' VAL . 31.3 m -108.46 115.78 30.74 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.873 -176.429 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -105.53 120.45 41.65 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.017 176.67 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 28.4 m -83.53 112.92 20.42 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 120.55 0.214 . . . . 0.0 110.458 -179.248 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.425 HD13 ' HA ' ' A' ' 7' ' ' PRO . 21.5 mm -103.3 120.01 52.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 177.249 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -116.22 126.47 53.67 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.772 0.32 . . . . 0.0 110.632 -177.377 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.438 ' HB2' ' HG ' ' A' ' 57' ' ' LEU . 33.1 t30 -90.03 101.77 14.48 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.134 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -103.39 54.3 0.75 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.515 -175.164 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -144.02 169.19 26.29 Favored Glycine 0 N--CA 1.447 -0.589 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.375 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -91.09 45.41 1.25 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.257 0.551 . . . . 0.0 110.885 -173.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 46.1 tptt -161.51 135.18 6.59 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.038 176.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -83.85 124.9 31.43 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 178.195 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 9.5 p -86.2 143.83 27.77 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.9 0.381 . . . . 0.0 111.402 -175.712 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 12.6 p -81.74 -164.13 0.75 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.967 -179.693 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.498 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 17.5 m -61.32 114.85 3.41 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 121.08 0.467 . . . . 0.0 111.562 -177.441 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.512 ' CE2' HG23 ' A' ' 40' ' ' VAL . 22.2 p90 -127.64 154.12 45.63 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.249 178.419 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.474 ' O ' ' HD3' ' A' ' 86' ' ' PRO . 55.1 m-80 -100.46 125.93 46.81 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.881 0.372 . . . . 0.0 110.984 -178.252 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.512 HG23 ' CE2' ' A' ' 38' ' ' PHE . 2.3 t -108.21 111.31 35.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-O 121.333 0.587 . . . . 0.0 109.453 177.399 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.517 ' HB3' HG23 ' A' ' 51' ' ' THR . 24.0 p -109.76 140.91 43.11 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.367 -174.11 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.403 HD11 ' HB3' ' A' ' 80' ' ' LEU . 52.7 tp -101.49 114.73 29.01 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.103 177.169 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.7 mp -101.18 126.45 47.9 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.243 179.524 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 86.2 t -104.87 104.07 16.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 116.148 -0.478 . . . . 0.0 109.873 178.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 57.18 28.89 15.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.411 178.039 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 107.46 -18.5 35.38 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.854 -0.688 . . . . 0.0 112.822 177.473 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 6.3 mm -95.44 148.16 5.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 -178.589 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 96.7 t -97.99 113.52 32.81 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-O 121.076 0.465 . . . . 0.0 110.126 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 27.9 m -96.77 -38.86 8.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.445 -177.681 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -153.16 143.2 22.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.855 0.359 . . . . 0.0 110.941 -175.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.517 HG23 ' HB3' ' A' ' 41' ' ' SER . 41.3 m -136.38 120.5 17.75 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.992 -179.281 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 45.8 tt0 -106.5 137.22 44.89 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.766 0.317 . . . . 0.0 110.377 -178.009 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 18.0 m -97.56 114.88 26.87 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.195 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.498 ' O ' ' HA ' ' A' ' 37' ' ' SER . 23.5 t -91.03 120.7 40.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.7 m -56.11 -43.15 77.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.58 -177.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 44.0 t -172.88 150.5 2.07 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.997 -0.372 . . . . 0.0 109.997 -179.542 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.566 HD23 HD22 ' A' ' 5' ' ' LEU . 28.3 tp -133.63 112.54 11.53 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 176.127 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -83.23 162.08 21.32 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.377 -174.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 5.8 p -65.5 138.36 58.03 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.073 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 68.66 5.72 5.06 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 123.183 0.593 . . . . 0.0 111.218 -179.297 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -103.48 147.56 27.0 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.874 0.369 . . . . 0.0 110.419 179.081 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 2.9 p -121.57 122.69 40.23 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.26 177.557 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 33.5 m -104.1 126.01 50.88 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.502 -179.539 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.436 ' HB3' ' CG2' ' A' ' 24' ' ' THR . 90.8 m-20 -83.15 117.87 23.2 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.894 177.353 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.584 ' O ' ' HA ' ' A' ' 24' ' ' THR . 44.8 t -96.02 115.8 36.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.964 -176.148 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 40.4 m-20 -96.67 108.21 20.79 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.748 0.309 . . . . 0.0 110.351 -179.033 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.435 ' O ' ' HA ' ' A' ' 22' ' ' THR . 65.3 m-85 -91.34 154.97 18.85 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 120.932 0.396 . . . . 0.0 110.097 179.463 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 50.7 m-70 -114.74 88.28 2.83 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 176.557 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' TRP . . . . . 0.413 ' CZ3' HG11 ' A' ' 15' ' ' VAL . 15.1 t90 -98.28 111.18 23.61 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.449 -172.611 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 7.3 m -86.06 118.65 25.66 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 170.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.561 HD11 ' CZ ' ' A' ' 78' ' ' TYR . 0.1 OUTLIER -55.2 -43.82 74.77 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.454 0.539 . . . . 0.0 112.454 -167.947 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.42 ' HB3' ' O ' ' A' ' 71' ' ' LEU . 31.5 t70 71.46 4.21 4.97 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.534 0.683 . . . . 0.0 110.997 176.002 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 179.18 -158.78 23.1 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 121.084 -0.579 . . . . 0.0 111.996 179.588 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 85.2 m -155.16 94.93 1.67 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.139 0.495 . . . . 0.0 110.344 177.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.412 ' HB3' ' CE1' ' A' ' 78' ' ' TYR . . . -112.51 172.31 7.0 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.111 175.818 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -79.15 -30.17 43.44 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.451 -0.5 . . . . 0.0 110.534 -178.538 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.499 ' HB2' HD21 ' A' ' 103' ' ' LEU . 70.7 p -150.91 157.94 43.53 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.283 -178.604 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.561 ' CZ ' HD11 ' A' ' 71' ' ' LEU . 27.9 m-85 -136.64 152.4 50.38 Favored 'General case' 0 C--N 1.328 -0.331 0 O-C-N 123.152 0.282 . . . . 0.0 110.487 -179.397 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 4.4 m -103.22 89.36 3.38 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.92 0.391 . . . . 0.0 110.219 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.523 HD13 HG22 ' A' ' 104' ' ' VAL . 9.4 mp -92.47 122.36 34.83 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.246 0.546 . . . . 0.0 111.189 -175.885 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.515 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 73.2 m -120.43 119.76 33.97 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.647 -179.628 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.417 ' HB ' ' HB3' ' A' ' 100' ' ' LEU . 98.9 t -85.63 107.85 16.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 174.859 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -95.31 113.9 25.62 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.172 177.576 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.569 ' HB ' ' HB2' ' A' ' 98' ' ' ASN . 96.2 t -85.48 111.25 20.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.614 179.782 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 56.5 t0 62.89 95.49 0.05 OUTLIER Pre-proline 0 N--CA 1.467 0.424 0 CA-C-N 114.825 -1.08 . . . . 0.0 112.236 178.143 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.474 ' HD3' ' O ' ' A' ' 39' ' ' ASN . 2.2 Cg_endo -85.41 1.55 8.21 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 123.167 2.578 . . . . 0.0 111.832 175.59 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -98.97 -20.29 16.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.095 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 15.3 m120 64.8 33.64 10.05 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.218 -178.582 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -73.23 -37.09 66.52 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.402 177.208 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 43.7 t -96.65 118.0 42.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.192 178.175 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.57 ' O ' ' HD2' ' A' ' 3' ' ' PRO . 53.6 t30 -85.7 135.7 33.65 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 175.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.4 ' OE2' ' HB3' ' A' ' 98' ' ' ASN . 40.6 mt-10 -115.71 159.4 21.44 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.246 0.546 . . . . 0.0 112.383 -171.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -57.96 -100.59 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 114.613 -1.176 . . . . 0.0 112.501 172.208 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 39.7 t30 -68.4 96.52 0.68 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.68 0.276 . . . . 0.0 110.325 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -73.97 78.76 1.67 Allowed 'General case' 0 C--O 1.233 0.226 0 CA-C-O 121.475 0.655 . . . . 0.0 110.39 -176.555 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 20.9 t -179.29 25.46 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.61 -1.177 . . . . 0.0 108.814 176.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 24.1 p-10 -118.68 -28.11 5.71 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.596 -170.03 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.569 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 22.4 p-10 -68.88 0.34 4.54 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -169.811 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -119.92 118.38 30.58 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.157 0.503 . . . . 0.0 111.521 178.613 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.518 ' HB2' ' HB2' ' A' ' 7' ' ' PRO . 26.3 tp -111.34 99.94 8.65 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.759 176.518 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 96.2 m -93.74 97.36 10.39 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.502 0.668 . . . . 0.0 110.104 178.626 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.511 ' HB3' HD23 ' A' ' 10' ' ' LEU . . . -107.99 115.73 30.67 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.166 -0.925 . . . . 0.0 109.589 178.628 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.499 HD21 ' HB2' ' A' ' 77' ' ' SER . 5.0 tt -78.65 101.39 7.46 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.523 HG22 HD13 ' A' ' 80' ' ' LEU . 29.9 m -90.57 158.78 2.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.219 -176.361 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -123.58 -170.88 13.47 Favored Glycine 0 N--CA 1.436 -1.317 0 C-N-CA 120.435 -0.888 . . . . 0.0 111.519 -178.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 18.6 p -107.95 140.05 41.67 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 177.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 47.6 tp -50.38 111.53 0.55 Allowed 'General case' 0 C--N 1.33 -0.247 0 O-C-N 123.576 0.547 . . . . 0.0 110.653 -177.25 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -61.35 -36.73 81.02 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.169 -176.106 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 63.4 t60 -90.06 79.72 6.46 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.146 0.498 . . . . 0.0 109.876 177.167 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 46.7 t-80 -80.59 142.19 34.29 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.172 178.659 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 36.4 m80 -73.29 176.79 5.63 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.702 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 10.2 m-70 -108.37 13.43 25.58 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.436 0.636 . . . . 0.0 110.312 178.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -136.91 -62.39 0.64 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.427 173.757 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 38.9 m-70 . . . . . 0 C--O 1.246 0.9 0 CA-C-O 118.485 -0.769 . . . . 0.0 109.607 173.994 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.532 ' SD ' ' HB2' ' A' ' 33' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.479 0.98 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 . . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.466 HG13 ' HD2' ' A' ' 3' ' ' PRO . 19.2 tt -144.37 146.17 31.91 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 115.762 -0.653 . . . . 0.0 110.241 -175.637 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.542 ' HD3' ' HD3' ' A' ' 33' ' ' LYS . 36.0 Cg_exo -60.9 136.53 66.5 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.411 2.074 . . . . 0.0 112.389 174.456 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -117.09 86.86 2.59 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 177.424 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.422 HD22 HD23 ' A' ' 57' ' ' LEU . 82.5 mt -82.1 107.96 15.2 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.332 -170.687 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.407 ' HA ' ' HD2' ' A' ' 7' ' ' PRO . 18.6 t -123.32 106.33 33.15 Favored Pre-proline 0 C--N 1.32 -0.702 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.984 -177.287 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.552 ' HD2' ' O ' ' A' ' 97' ' ' ASN . 11.2 Cg_endo -57.75 119.44 6.7 Favored 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 122.361 2.041 . . . . 0.0 110.465 167.596 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.9 t -93.16 -54.27 7.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.099 -169.758 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.8 p -150.79 154.36 37.17 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.051 0.453 . . . . 0.0 111.688 -177.609 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 49.8 tp -121.98 110.25 15.6 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.675 177.124 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 16.1 p -118.2 143.94 33.94 Favored Pre-proline 0 C--N 1.32 -0.71 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.949 -178.388 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -88.97 160.62 39.53 Favored 'Cis proline' 0 N--CA 1.458 -0.599 0 C-N-CA 123.372 -1.512 . . . . 0.0 112.414 -2.359 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 31.7 m -81.52 6.05 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.045 0.45 . . . . 0.0 111.343 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.406 ' HA ' ' O ' ' A' ' 105' ' ' GLY . 0.1 OUTLIER -141.96 129.77 21.71 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 176.776 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.488 HG21 HD21 ' A' ' 71' ' ' LEU . 17.3 m -121.9 153.1 25.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 -171.725 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.435 ' HA ' ' HD3' ' A' ' 17' ' ' PRO . 2.5 t -83.83 110.98 29.04 Favored Pre-proline 0 CA--C 1.533 0.296 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 -179.482 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 16' ' ' VAL . 6.3 Cg_exo -79.75 58.3 6.9 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 123.288 2.659 . . . . 0.0 113.803 -172.574 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.405 ' OD1' HG12 ' A' ' 16' ' ' VAL . 33.2 p-10 -163.0 13.43 0.07 Allowed 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 176.827 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 15.3 t -162.34 179.23 8.0 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.711 0.291 . . . . 0.0 110.371 -177.305 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.556 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 41.1 t -84.05 119.91 34.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 176.404 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.404 ' ND2' HD23 ' A' ' 71' ' ' LEU . 24.4 m-80 -100.33 114.29 27.68 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.27 -177.779 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.52 ' HA ' ' O ' ' A' ' 67' ' ' PHE . 33.5 m -79.52 90.15 5.09 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 176.636 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.633 ' O ' ' HA ' ' A' ' 66' ' ' ASP . 82.1 mtp -87.32 153.43 21.47 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.901 -176.02 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.476 ' CG2' ' HB3' ' A' ' 64' ' ' ASN . 10.9 m -115.72 112.99 22.87 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.313 -174.876 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -101.7 116.03 31.84 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 173.759 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 28.7 m -83.85 109.08 17.27 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.167 -178.591 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.426 HD11 HG11 ' A' ' 82' ' ' VAL . 27.7 mm -103.22 117.96 49.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.54 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 31.0 tt0 -111.09 135.5 51.52 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.147 0.498 . . . . 0.0 111.301 -177.268 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 25.5 t30 -97.17 95.07 7.5 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.536 -0.757 . . . . 0.0 109.354 176.521 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 64.6 mt-30 -87.96 51.06 2.11 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.362 0.601 . . . . 0.0 110.555 -175.104 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -144.39 168.17 26.77 Favored Glycine 0 N--CA 1.445 -0.755 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.196 -178.781 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.412 ' OD1' ' HA ' ' A' ' 1' ' ' MET . 31.4 p-10 -88.17 -1.98 58.33 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.806 0.336 . . . . 0.0 111.604 -173.105 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.542 ' HD3' ' HD3' ' A' ' 3' ' ' PRO . 85.1 tttt -111.27 128.74 56.03 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.773 0.32 . . . . 0.0 110.412 179.49 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -67.84 135.18 52.15 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.841 179.533 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.567 ' HB3' ' HB3' ' A' ' 57' ' ' LEU . 29.5 t -89.64 139.55 30.44 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.108 -178.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -88.22 -165.7 1.39 Allowed 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.717 179.636 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.428 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 31.9 m -61.01 119.38 8.18 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.961 0.41 . . . . 0.0 111.746 -177.479 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.497 ' CE2' HG23 ' A' ' 40' ' ' VAL . 24.4 p90 -135.06 155.72 50.26 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.887 179.523 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.5 ' HB2' ' HD2' ' A' ' 86' ' ' PRO . 84.6 m-20 -99.21 117.31 33.4 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.747 -0.206 . . . . 0.0 110.855 -176.449 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.497 HG23 ' CE2' ' A' ' 38' ' ' PHE . 2.3 t -104.08 114.3 43.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 121.285 0.564 . . . . 0.0 109.779 175.627 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 19.4 p -110.57 138.32 47.12 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.573 -0.739 . . . . 0.0 111.135 -175.362 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 51.3 tp -98.06 117.92 33.5 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.015 177.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.9 mp -104.71 127.66 52.56 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.432 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 97.9 t -99.55 103.54 14.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.822 177.083 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 59.93 17.88 7.0 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.565 179.384 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 123.55 -26.91 5.88 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.744 -0.741 . . . . 0.0 113.036 177.499 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 6.2 mt -91.79 147.17 5.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.995 0.397 . . . . 0.0 110.173 -178.271 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 61.4 t -91.18 121.26 41.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-O 120.799 0.333 . . . . 0.0 110.437 -177.726 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 30.9 m -104.74 -28.01 3.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.541 -0.299 . . . . 0.0 111.639 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -151.15 138.84 19.72 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 121.127 -0.229 . . . . 0.0 110.537 -177.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 28.5 m -127.49 110.82 13.14 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 175.317 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.19 121.4 44.79 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.14 0.495 . . . . 0.0 110.304 -175.502 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 59.1 m -82.11 110.87 17.72 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.685 178.789 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.428 ' O ' ' HA ' ' A' ' 37' ' ' SER . 40.9 t -85.2 121.36 36.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 177.264 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -59.37 -39.87 84.68 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.863 -173.398 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 42.7 t -175.45 155.01 1.75 Allowed 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.567 ' HB3' ' HB3' ' A' ' 35' ' ' SER . 18.7 tp -130.74 110.74 11.57 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.185 0.517 . . . . 0.0 109.946 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.521 ' HB3' ' HB2' ' A' ' 61' ' ' ASN . 26.3 tt0 -61.65 149.61 38.91 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.55 -174.592 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.3 p -60.73 128.93 38.97 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.669 -179.358 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 60.98 25.41 15.44 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.012 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.521 ' HB2' ' HB3' ' A' ' 58' ' ' GLU . 17.9 m-80 -121.4 160.25 24.47 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.607 178.719 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.54 ' HA ' ' HA ' ' A' ' 28' ' ' GLU . 0.0 OUTLIER -116.07 144.13 44.54 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.399 178.58 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 19.6 m -121.52 134.05 55.04 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.385 177.401 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.476 ' HB3' ' CG2' ' A' ' 24' ' ' THR . 88.7 m-20 -88.86 115.62 26.54 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.494 -179.712 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 6.4 t -97.66 112.58 30.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.492 -178.211 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.633 ' HA ' ' O ' ' A' ' 23' ' ' MET . 16.7 m-20 -97.31 115.17 27.18 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.977 0.418 . . . . 0.0 110.772 -178.553 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.52 ' O ' ' HA ' ' A' ' 22' ' ' THR . 84.4 m-85 -91.97 165.19 13.34 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.246 -177.039 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 38.5 m-70 -114.78 87.73 2.71 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 175.717 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 16.4 t90 -110.33 113.01 25.33 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.284 0.564 . . . . 0.0 111.224 -176.435 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.556 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 5.7 m -81.69 114.05 20.1 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.015 176.572 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.488 HD21 HG21 ' A' ' 15' ' ' VAL . 0.5 OUTLIER -69.09 118.23 11.74 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.058 0.456 . . . . 0.0 111.329 -178.211 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -77.53 -34.76 53.82 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.845 177.783 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 83.47 15.63 70.8 Favored Glycine 0 C--N 1.329 0.194 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.661 176.587 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 22.9 m -75.81 -27.73 58.05 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.909 0.385 . . . . 0.0 111.013 -179.4 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -130.92 160.93 33.06 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.526 -178.435 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.437 ' HA ' HG23 ' A' ' 106' ' ' THR . 36.8 m-80 -101.9 -4.0 26.94 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.235 0.541 . . . . 0.0 110.452 177.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 37.3 m -144.71 118.38 9.2 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.022 177.498 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 81.1 m-85 -112.41 139.46 47.96 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.903 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.416 ' HA ' HD23 ' A' ' 103' ' ' LEU . 8.3 m -92.1 85.77 5.59 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.068 0.461 . . . . 0.0 109.949 179.184 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.437 HD13 HG22 ' A' ' 104' ' ' VAL . 7.6 mp -81.96 117.14 21.95 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.559 0.695 . . . . 0.0 110.979 -176.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.508 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 12.9 m -115.96 118.07 31.9 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.172 -177.514 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.426 HG11 HD11 ' A' ' 27' ' ' ILE . 66.5 t -87.81 110.25 20.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 177.852 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -98.91 112.65 24.69 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.885 0.374 . . . . 0.0 110.257 175.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.554 ' HB ' ' HB2' ' A' ' 98' ' ' ASN . 86.6 t -84.58 111.91 20.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.826 179.591 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 18.6 t0 65.38 96.04 0.05 OUTLIER Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 114.924 -1.034 . . . . 0.0 112.779 176.13 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.5 ' HD2' ' HB2' ' A' ' 39' ' ' ASN . 98.4 Cg_endo -95.16 6.05 2.21 Favored 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 123.186 2.59 . . . . 0.0 111.923 173.194 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -103.05 -11.39 18.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.615 -176.431 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 65.7 t30 68.22 32.64 4.68 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.708 0.766 . . . . 0.0 109.555 -176.101 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -73.76 -38.57 64.67 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.987 177.621 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 65.7 t -128.92 115.06 35.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.17 -179.173 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -89.1 145.32 25.53 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 175.707 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -80.24 162.09 24.82 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.167 0.508 . . . . 0.0 111.962 -174.168 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -57.49 -100.56 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.558 0 N-CA-C 109.811 -1.315 . . . . 0.0 109.811 158.117 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -65.6 105.49 1.23 Allowed 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 170.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -77.81 68.75 3.93 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -169.645 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 48.3 m -165.91 18.64 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 111.821 0.304 . . . . 0.0 111.821 179.389 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.552 ' O ' ' HD2' ' A' ' 7' ' ' PRO . 44.9 m-80 -115.37 -18.83 10.93 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.484 -0.487 . . . . 0.0 111.965 -173.832 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.554 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 18.6 p-10 -61.16 -9.54 4.94 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 -172.465 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 1.4 m -114.26 145.26 41.98 Favored 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 120.222 -0.591 . . . . 0.0 111.129 179.395 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.508 ' O ' ' HA ' ' A' ' 81' ' ' THR . 40.8 tp -138.81 101.64 4.36 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.674 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 26.2 m -94.28 102.48 14.48 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.801 0.334 . . . . 0.0 110.348 -179.551 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -119.05 163.14 17.42 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.955 -178.036 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.416 HD23 ' HA ' ' A' ' 79' ' ' THR . 96.2 mt -112.12 129.64 56.16 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.458 178.329 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.437 HG22 HD13 ' A' ' 80' ' ' LEU . 34.2 m -119.35 141.76 37.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.788 177.17 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.406 ' O ' ' HA ' ' A' ' 14' ' ' THR . . . -111.57 177.47 18.93 Favored Glycine 0 N--CA 1.443 -0.837 0 C-N-CA 120.373 -0.918 . . . . 0.0 111.685 -177.327 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.437 HG23 ' HA ' ' A' ' 76' ' ' ASN . 40.2 p -87.59 131.98 34.22 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 120.866 0.365 . . . . 0.0 110.044 176.806 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.51 ' HG ' ' H ' ' A' ' 109' ' ' HIS . 33.1 tp -60.44 133.94 56.58 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.663 -176.125 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -60.36 -34.19 73.5 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.326 178.216 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' HIS . . . . . 0.51 ' H ' ' HG ' ' A' ' 107' ' ' LEU . 96.3 m-70 -85.03 108.93 17.86 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.538 178.224 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -98.45 40.89 1.16 Allowed 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 179.061 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' HIS . . . . . 0.485 ' O ' ' HB2' ' A' ' 112' ' ' HIS . 30.4 m170 67.88 -169.79 0.19 Allowed 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.192 -176.159 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' HIS . . . . . 0.485 ' HB2' ' O ' ' A' ' 111' ' ' HIS . 45.2 m-70 77.31 -4.45 2.31 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.516 0.726 . . . . 0.0 110.644 -176.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 78.4 m-70 -150.42 136.55 18.59 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.442 176.599 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 31.0 t-80 . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.836 -0.602 . . . . 0.0 109.508 177.903 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.479 ' HA ' ' OD1' ' A' ' 32' ' ' ASN . 87.1 mtp . . . . . 0 N--CA 1.48 1.049 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.432 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 7.7 tt -144.14 141.67 18.68 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.257 -179.008 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.486 ' HD3' ' HD3' ' A' ' 33' ' ' LYS . 3.6 Cg_exo -82.11 122.69 3.82 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 122.919 2.413 . . . . 0.0 111.068 172.63 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -111.57 95.01 5.25 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 -179.607 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.484 HD22 HD23 ' A' ' 57' ' ' LEU . 87.5 mt -79.83 108.73 13.62 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.56 -175.923 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.416 ' HA ' ' HD2' ' A' ' 7' ' ' PRO . 60.3 t -116.15 109.41 44.62 Favored Pre-proline 0 C--N 1.321 -0.647 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.097 -177.311 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.501 ' HD2' ' O ' ' A' ' 97' ' ' ASN . 28.4 Cg_endo -66.21 102.47 0.57 Allowed 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 122.219 1.946 . . . . 0.0 109.929 167.3 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 15.1 t -78.64 -55.78 9.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.674 -169.846 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 50.7 m -150.28 155.84 40.44 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.982 0.42 . . . . 0.0 111.172 -177.441 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 55.2 tp -119.27 107.35 13.3 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.21 177.296 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.7 p -117.76 146.17 38.22 Favored Pre-proline 0 C--N 1.32 -0.68 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.524 -175.297 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -79.55 164.16 82.64 Favored 'Cis proline' 0 CA--C 1.53 0.289 0 C-N-CA 123.153 -1.603 . . . . 0.0 112.639 -0.009 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 34.8 m -80.16 -22.03 11.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.043 0.449 . . . . 0.0 110.887 -179.173 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.574 ' HB ' ' HA ' ' A' ' 107' ' ' LEU . 23.2 p -114.5 130.43 56.74 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.741 174.79 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.9 m -113.48 157.48 14.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.257 0.551 . . . . 0.0 112.153 -171.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.712 HG22 HD22 ' A' ' 107' ' ' LEU . 21.3 t -92.64 107.22 22.51 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.148 -177.714 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.572 ' HA ' ' HB3' ' A' ' 71' ' ' LEU . 7.1 Cg_exo -74.21 9.9 1.63 Allowed 'Trans proline' 0 CA--C 1.531 0.373 0 C-N-CA 123.492 2.795 . . . . 0.0 114.497 -171.391 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -127.51 27.88 5.75 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.711 0.291 . . . . 0.0 111.574 -177.511 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 15.0 t -167.94 167.77 12.56 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.244 179.323 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.531 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 58.2 t -79.94 124.46 38.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 174.684 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.473 HD22 ' N ' ' A' ' 21' ' ' ASN . 0.9 OUTLIER -100.14 117.79 35.12 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.908 0.385 . . . . 0.0 110.244 -175.249 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.494 HG22 ' HB3' ' A' ' 66' ' ' ASP . 6.9 m -83.21 83.85 7.71 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 173.566 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.521 ' O ' ' HA ' ' A' ' 66' ' ' ASP . 71.8 mtp -82.31 142.36 32.12 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.899 -174.024 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.483 HG23 ' HB2' ' A' ' 64' ' ' ASN . 26.5 m -106.93 110.52 22.7 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.094 -175.695 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.605 ' HB3' ' HB ' ' A' ' 65' ' ' VAL . . . -91.76 122.21 34.1 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 172.389 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 24.4 m -91.24 104.67 17.19 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.236 -177.233 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 15.5 mm -102.04 117.1 46.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 179.444 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.569 ' HG2' ' HB3' ' A' ' 62' ' ' SER . 53.0 mt-10 -109.6 139.7 44.3 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.945 0.403 . . . . 0.0 110.862 179.652 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.539 ' HB2' ' HG ' ' A' ' 57' ' ' LEU . 32.5 t30 -92.31 93.88 8.87 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.766 175.264 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 83.0 mm-40 -90.06 52.1 2.2 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.683 0.754 . . . . 0.0 110.236 -178.526 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -144.07 157.48 27.13 Favored Glycine 0 N--CA 1.441 -0.977 0 N-CA-C 110.353 -1.099 . . . . 0.0 110.353 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.479 ' OD1' ' HA ' ' A' ' 1' ' ' MET . 33.8 p-10 -85.63 5.18 32.97 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.896 0.379 . . . . 0.0 111.76 -173.4 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.486 ' HD3' ' HD3' ' A' ' 3' ' ' PRO . 63.6 tttp -116.43 135.07 54.16 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 173.645 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -71.53 139.89 49.69 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.833 0.349 . . . . 0.0 110.161 -179.052 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.423 ' CB ' HD21 ' A' ' 5' ' ' LEU . 35.7 t -94.94 139.38 31.41 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.722 -177.026 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 24.3 p -83.45 -165.27 1.06 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.472 177.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 26.1 t -57.29 131.6 50.51 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.923 0.392 . . . . 0.0 110.943 178.08 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.421 ' CE2' HG23 ' A' ' 40' ' ' VAL . 31.3 p90 -142.46 148.62 38.03 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.395 177.211 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.465 ' O ' ' HA ' ' A' ' 85' ' ' ASP . 65.8 t30 -104.34 112.9 26.12 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.307 -172.013 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.587 HG22 ' HA ' ' A' ' 84' ' ' VAL . 2.2 t -102.77 123.47 56.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.035 0.445 . . . . 0.0 110.503 -175.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 11.2 t -114.17 144.32 43.38 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.553 -175.783 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.421 HD11 ' HB3' ' A' ' 80' ' ' LEU . 51.2 tp -105.9 112.58 25.69 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.232 178.414 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.8 mp -101.21 127.25 47.88 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.635 179.11 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.545 HG22 ' HG ' ' A' ' 80' ' ' LEU . 92.3 t -110.7 104.2 16.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 -177.773 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 64.49 19.2 11.72 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.049 0.452 . . . . 0.0 110.555 -176.15 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 117.74 -27.08 7.7 Favored Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.995 178.074 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.528 HG23 ' O ' ' A' ' 44' ' ' VAL . 0.1 OUTLIER -91.94 136.58 24.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.425 0.631 . . . . 0.0 112.385 -174.832 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 88.8 t -78.59 105.84 8.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.325 179.054 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 22.8 m -86.81 -40.64 14.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.588 179.621 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -155.29 154.95 32.89 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.714 0.292 . . . . 0.0 110.47 -178.195 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 13.6 m -143.4 130.29 20.5 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.028 -174.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -119.87 124.56 46.35 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.239 -179.235 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.427 ' HA ' ' HA ' ' A' ' 39' ' ' ASN . 15.5 m -90.92 116.02 28.41 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.912 0.387 . . . . 0.0 110.181 177.828 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.431 HG13 HG21 ' A' ' 63' ' ' THR . 43.0 t -82.34 140.32 16.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.987 -178.854 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 28.6 m -71.59 -43.35 66.42 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.82 0.343 . . . . 0.0 111.194 -177.48 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 32.6 t -173.14 146.94 1.52 Allowed 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 -177.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.539 ' HG ' ' HB2' ' A' ' 29' ' ' ASN . 31.5 tp -128.51 107.13 9.47 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.314 0.578 . . . . 0.0 109.963 178.924 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -75.34 163.04 27.87 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.986 -173.699 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 13.4 m -64.71 132.12 48.75 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.439 178.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 42.7 mm-40 67.12 9.41 6.91 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.522 -179.557 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -101.14 148.52 24.99 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.449 -0.342 . . . . 0.0 110.188 179.695 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.569 ' HB3' ' HG2' ' A' ' 28' ' ' GLU . 33.5 p -113.9 131.01 56.44 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.9 176.203 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.431 HG21 HG13 ' A' ' 54' ' ' VAL . 54.0 m -107.51 125.66 51.55 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 120.955 0.407 . . . . 0.0 110.084 175.914 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.483 ' HB2' HG23 ' A' ' 24' ' ' THR . 5.0 p-10 -80.34 114.76 19.47 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.093 177.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.605 ' HB ' ' HB3' ' A' ' 25' ' ' ALA . 21.9 t -96.7 105.89 17.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.773 178.227 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.521 ' HA ' ' O ' ' A' ' 23' ' ' MET . 41.8 m-20 -99.81 111.34 23.66 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.468 -175.844 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.474 ' O ' ' HA ' ' A' ' 22' ' ' THR . 72.1 m-85 -91.79 158.57 16.27 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.914 -176.864 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 30.8 m-70 -110.13 88.22 2.7 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.428 178.859 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 13.2 t90 -117.33 113.8 22.66 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.102 -175.332 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.531 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 5.7 t -80.12 120.49 24.33 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 171.789 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.572 ' HB3' ' HA ' ' A' ' 17' ' ' PRO . 0.2 OUTLIER -65.9 -45.03 83.48 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.598 -170.047 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.439 ' HB3' ' O ' ' A' ' 71' ' ' LEU . 20.9 t70 73.0 -54.27 0.7 Allowed 'General case' 0 N--CA 1.469 0.498 0 O-C-N 123.968 0.792 . . . . 0.0 110.503 -174.268 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 90.93 51.98 2.51 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 121.059 -0.591 . . . . 0.0 111.997 179.675 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -84.75 -38.67 19.37 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.139 0.495 . . . . 0.0 110.509 -179.23 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -134.93 171.13 14.84 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.919 -177.357 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.412 ' O ' HG23 ' A' ' 106' ' ' THR . 28.2 p-10 -79.15 -15.17 58.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.379 -178.309 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.489 ' HB3' ' CD2' ' A' ' 103' ' ' LEU . 44.2 m -154.87 147.74 24.51 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.717 0.294 . . . . 0.0 110.765 -177.733 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -126.99 142.66 51.49 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.215 178.44 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 5.7 m -90.58 90.95 8.21 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.769 0.319 . . . . 0.0 110.428 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.554 HD13 HG22 ' A' ' 104' ' ' VAL . 10.9 mp -91.64 116.22 28.7 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.354 0.597 . . . . 0.0 111.172 -176.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.46 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 52.9 m -113.75 118.86 35.48 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.473 -179.5 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.486 ' HB ' ' HB3' ' A' ' 100' ' ' LEU . 60.3 t -88.1 106.91 16.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.617 176.359 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -100.29 110.92 23.17 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 177.388 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.587 ' HA ' HG22 ' A' ' 40' ' ' VAL . 69.7 t -76.04 110.38 11.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.902 -179.102 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.465 ' HA ' ' O ' ' A' ' 39' ' ' ASN . 1.8 t70 56.52 94.97 0.05 OUTLIER Pre-proline 0 N--CA 1.465 0.29 0 CA-C-N 114.32 -1.309 . . . . 0.0 112.035 178.622 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -60.15 -24.74 77.94 Favored 'Trans proline' 0 N--CA 1.473 0.289 0 C-N-CA 123.369 2.713 . . . . 0.0 112.806 -178.192 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -92.12 -18.0 24.16 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.207 -179.416 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 25.6 m120 53.08 54.97 9.54 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.818 -171.034 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.85 -40.07 94.05 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.999 -178.701 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 41.0 t -83.71 139.36 17.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.79 178.334 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 60.9 t30 -75.09 95.04 2.99 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 175.234 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.411 ' CD ' HD21 ' A' ' 98' ' ' ASN . 20.5 mt-10 -93.88 177.18 6.08 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.28 -173.529 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -58.14 -100.78 0.01 OUTLIER Glycine 0 CA--C 1.521 0.432 0 CA-C-N 115.341 -0.845 . . . . 0.0 113.063 175.709 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 55.6 t30 -117.32 145.12 44.22 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.746 0.308 . . . . 0.0 110.242 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.638 ' HA ' ' OD1' ' A' ' 98' ' ' ASN . 42.3 mt-10 -75.43 -12.91 60.34 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.013 0.435 . . . . 0.0 111.567 -174.352 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 16.4 m -69.62 -9.57 54.67 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.793 -178.167 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.501 ' O ' ' HD2' ' A' ' 7' ' ' PRO . 2.6 p-10 -117.78 10.64 13.34 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.906 -0.318 . . . . 0.0 111.458 177.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.638 ' OD1' ' HA ' ' A' ' 95' ' ' GLU . 7.5 m120 -76.42 -27.69 56.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.859 0.361 . . . . 0.0 110.764 177.361 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -103.75 122.66 45.55 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.718 -179.484 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.486 ' HB3' ' HB ' ' A' ' 82' ' ' VAL . 38.5 tp -109.32 100.17 9.33 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.89 173.353 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 41.5 m -87.58 97.39 10.83 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.218 0.533 . . . . 0.0 110.371 179.32 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -113.28 107.39 15.82 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.964 179.472 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.489 ' CD2' ' HB3' ' A' ' 77' ' ' SER . 5.0 tt -83.81 105.67 14.89 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 108.806 -0.812 . . . . 0.0 108.806 -178.813 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.554 HG22 HD13 ' A' ' 80' ' ' LEU . 21.2 m -89.64 144.13 9.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.614 -174.562 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -107.38 -179.03 22.47 Favored Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 120.793 -0.718 . . . . 0.0 111.31 -179.767 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.412 HG23 ' O ' ' A' ' 76' ' ' ASN . 23.0 p -83.43 153.36 24.53 Favored 'General case' 0 C--N 1.315 -0.904 0 C-N-CA 120.904 -0.318 . . . . 0.0 110.481 178.738 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.712 HD22 HG22 ' A' ' 16' ' ' VAL . 19.2 tp -50.18 123.62 8.74 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.954 -178.235 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.425 ' HG3' ' H ' ' A' ' 108' ' ' GLU . 0.0 OUTLIER -65.39 -35.07 79.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.418 -175.425 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 77.6 m80 -126.28 108.58 11.4 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 172.713 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 22.4 t-80 -53.21 -32.34 47.63 Favored 'General case' 0 N--CA 1.464 0.269 0 O-C-N 123.798 0.686 . . . . 0.0 111.104 -173.776 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 2.8 m170 -138.2 118.74 13.89 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.964 171.028 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 10.0 m-70 -76.27 116.15 16.68 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.841 -179.669 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 69.2 m80 -80.19 -12.0 59.68 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.018 -178.213 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 64.9 t60 . . . . . 0 C--O 1.246 0.918 0 CA-C-N 115.332 -0.849 . . . . 0.0 108.936 172.187 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.503 ' O ' ' HD2' ' A' ' 33' ' ' LYS . 71.4 mtm . . . . . 0 N--CA 1.481 1.117 0 CA-C-O 120.885 0.374 . . . . 0.0 110.923 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.415 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 6.6 tt -114.25 142.54 28.19 Favored Pre-proline 0 C--N 1.319 -0.729 0 C-N-CA 120.596 -0.441 . . . . 0.0 110.158 179.612 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.451 ' HD2' ' O ' ' A' ' 91' ' ' ASN . 3.3 Cg_exo -84.26 156.94 12.86 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.804 2.336 . . . . 0.0 111.34 171.447 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -138.75 108.67 6.32 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 174.305 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.533 HD22 HD23 ' A' ' 57' ' ' LEU . 69.4 mt -99.81 126.96 45.98 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -173.422 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.441 HG22 ' ND2' ' A' ' 97' ' ' ASN . 2.4 t -125.36 140.39 36.12 Favored Pre-proline 0 C--N 1.317 -0.844 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.332 -176.234 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.443 ' HB2' ' HB2' ' A' ' 100' ' ' LEU . 9.3 Cg_endo -92.8 93.31 0.16 Allowed 'Trans proline' 0 N--CA 1.445 -1.367 0 C-N-CA 122.952 2.435 . . . . 0.0 109.758 166.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 28.3 m -83.84 -12.88 11.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-N 115.869 -0.605 . . . . 0.0 112.313 -169.233 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 31.4 t -163.43 143.42 8.71 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.124 0.487 . . . . 0.0 111.723 -176.452 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 62.7 tp -127.8 126.93 42.63 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.065 175.09 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.0 p -137.7 145.28 48.04 Favored Pre-proline 0 C--N 1.32 -0.709 0 CA-C-N 116.572 -0.286 . . . . 0.0 110.813 -177.521 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.493 ' HD2' ' SD ' ' A' ' 23' ' ' MET . 98.3 Cg_endo -80.23 163.02 82.89 Favored 'Cis proline' 0 N--CA 1.465 -0.199 0 C-N-CA 123.369 -1.513 . . . . 0.0 112.719 -1.555 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 24.5 m -85.51 -15.26 10.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.152 0.501 . . . . 0.0 110.565 177.828 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.567 ' HA ' ' O ' ' A' ' 105' ' ' GLY . 0.1 OUTLIER -131.61 124.94 30.98 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.647 174.718 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.411 HG12 ' HG2' ' A' ' 12' ' ' PRO . 20.5 m -114.57 150.47 16.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.625 -0.261 . . . . 0.0 111.141 -174.064 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.411 ' HA ' ' HD3' ' A' ' 17' ' ' PRO . 6.2 m -88.53 121.55 70.05 Favored Pre-proline 0 N--CA 1.445 -0.685 0 CA-C-O 120.957 0.408 . . . . 0.0 110.194 176.289 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.467 ' HA ' ' CB ' ' A' ' 71' ' ' LEU . 17.6 Cg_exo -68.04 172.51 10.77 Favored 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 122.497 2.132 . . . . 0.0 112.59 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 43.8 m-80 71.93 25.06 3.16 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.274 175.474 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 12.9 t -175.69 175.62 2.03 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.654 -0.248 . . . . 0.0 110.386 177.229 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.814 HG22 ' HB ' ' A' ' 70' ' ' THR . 44.4 t -91.24 135.37 27.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.343 178.51 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 21.7 m-80 -108.71 149.88 28.37 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.467 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.9 m -83.05 91.02 7.11 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.258 179.444 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.526 ' HB2' ' HB2' ' A' ' 67' ' ' PHE . 89.8 mmm -81.6 109.75 16.33 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.372 0.606 . . . . 0.0 110.246 -178.727 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 25.5 m -103.26 110.15 22.02 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.474 -177.491 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -101.33 120.13 39.79 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.072 178.062 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 28.5 m -85.88 104.43 15.53 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.62 -178.538 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.423 HG12 HG23 ' A' ' 65' ' ' VAL . 23.3 mm -98.5 119.35 46.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 178.691 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -120.55 139.18 53.31 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.425 -175.174 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.474 ' O ' ' HA ' ' A' ' 60' ' ' GLU . 54.8 t-20 -91.87 99.72 12.53 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 178.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -102.14 52.25 0.81 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.651 0.738 . . . . 0.0 110.418 -176.808 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -143.94 175.81 23.61 Favored Glycine 0 N--CA 1.446 -0.634 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.093 179.042 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -99.8 45.49 0.99 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.287 0.565 . . . . 0.0 111.402 -173.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.503 ' HD2' ' O ' ' A' ' 1' ' ' MET . 50.3 tttm -161.49 157.06 24.38 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.254 169.167 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.486 ' N ' ' HG2' ' A' ' 33' ' ' LYS . 8.7 p-10 -68.42 165.13 19.48 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.06 173.553 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.474 ' OG ' ' HB3' ' A' ' 57' ' ' LEU . 10.0 p -129.99 134.4 47.41 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.925 0.393 . . . . 0.0 110.703 178.164 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 11.3 p -80.66 -167.59 1.43 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.322 -177.098 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 18.8 t -62.61 120.78 11.82 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.058 0.456 . . . . 0.0 111.109 -177.06 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -131.46 160.19 35.87 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.685 178.842 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -106.08 125.63 51.23 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 121.277 -0.169 . . . . 0.0 110.617 -176.219 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.573 HG11 HG21 ' A' ' 65' ' ' VAL . 1.4 t -111.49 123.85 67.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.156 0.503 . . . . 0.0 110.546 178.216 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 18.2 m -117.83 145.5 44.51 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.912 -176.184 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 49.7 tp -104.04 108.87 20.42 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.853 176.536 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.7 mp -98.45 112.73 24.66 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.201 -179.11 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 87.8 t -97.12 107.08 19.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.113 179.7 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 59.08 22.21 10.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.656 178.026 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 116.36 -25.19 9.37 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.598 -0.81 . . . . 0.0 112.953 176.358 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 8.8 mt -96.39 151.31 4.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 -178.663 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 47.5 t -97.2 109.69 23.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 110.094 -0.335 . . . . 0.0 110.094 -178.503 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 28.1 m -87.18 -29.72 5.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 C-N-CA 120.904 -0.318 . . . . 0.0 111.502 -177.26 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -158.0 159.56 36.55 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.836 0.35 . . . . 0.0 110.537 -179.175 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 95.9 m -149.81 126.87 11.23 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.986 -178.375 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -125.04 122.85 38.42 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.93 0.395 . . . . 0.0 109.988 179.182 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 19.5 m -80.09 130.88 35.58 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.056 177.742 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 42.6 t -98.16 131.72 44.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.2 m -61.55 -47.0 87.55 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.717 -177.093 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 29.8 t -179.98 152.8 0.48 Allowed 'General case' 0 C--O 1.235 0.293 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 -178.469 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.533 HD23 HD22 ' A' ' 5' ' ' LEU . 40.3 tp -129.75 125.68 36.4 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.057 0.456 . . . . 0.0 110.323 178.816 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -76.56 160.2 29.65 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.042 -176.364 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 10.5 m -60.31 120.18 9.35 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.259 -177.26 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.474 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 44.2 mt-10 60.81 25.53 15.41 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.325 177.585 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -101.24 160.96 13.96 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 171.663 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -122.31 119.03 29.91 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 -176.706 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 54.1 m -111.5 127.17 55.62 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.072 0.463 . . . . 0.0 110.719 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -86.76 134.89 33.54 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.54 179.5 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.573 HG21 HG11 ' A' ' 40' ' ' VAL . 28.2 t -96.16 133.55 36.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.154 179.544 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -97.75 97.0 8.63 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.297 -177.641 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.526 ' HB2' ' HB2' ' A' ' 23' ' ' MET . 21.3 m-85 -97.66 152.38 19.15 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.669 178.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 17.1 m80 -120.77 93.7 4.12 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 178.713 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 24.0 t90 -114.83 118.58 33.95 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.319 -174.084 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.814 ' HB ' HG22 ' A' ' 20' ' ' VAL . 15.1 t -89.73 144.85 25.64 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.433 179.46 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.467 ' CB ' ' HA ' ' A' ' 17' ' ' PRO . 3.1 mm? -110.47 127.46 55.15 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.94 0.4 . . . . 0.0 111.763 179.554 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 -90.39 -28.3 18.76 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.682 172.133 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 87.44 33.91 11.07 Favored Glycine 0 N--CA 1.448 -0.517 0 N-CA-C 111.226 -0.75 . . . . 0.0 111.226 -175.268 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.63 -33.03 74.15 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.229 0.538 . . . . 0.0 110.711 -178.607 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -141.27 155.54 45.98 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.237 -178.821 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -67.89 -30.97 70.45 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.426 178.003 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 19.5 m -136.85 135.96 38.35 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.073 0.464 . . . . 0.0 110.898 -179.025 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -112.48 146.46 38.42 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.12 178.399 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.488 ' HA ' HD23 ' A' ' 103' ' ' LEU . 6.6 m -95.43 87.61 4.83 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.885 0.374 . . . . 0.0 110.499 -178.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.513 HD13 HG22 ' A' ' 104' ' ' VAL . 9.4 mp -87.7 120.16 28.74 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.184 0.516 . . . . 0.0 111.272 -176.855 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.58 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 73.5 m -119.64 115.7 24.49 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.606 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 46.5 t -88.16 107.8 17.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.648 175.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -97.97 117.15 31.68 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.847 0.356 . . . . 0.0 110.075 176.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.542 ' HB ' ' HB2' ' A' ' 98' ' ' ASN . 94.7 t -85.71 109.01 17.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.957 -179.706 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 39.2 t0 65.68 91.91 0.07 OUTLIER Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 114.583 -1.189 . . . . 0.0 112.002 178.221 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -89.52 6.23 4.47 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 123.021 2.481 . . . . 0.0 111.714 174.521 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -110.76 -8.98 14.51 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.38 -178.123 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 56.64 53.9 7.93 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.266 178.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -88.91 -35.3 16.58 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.55 176.545 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 61.6 t -108.76 119.73 58.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.439 -0.801 . . . . 0.0 109.882 176.016 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.451 ' O ' ' HD2' ' A' ' 3' ' ' PRO . 53.4 m-80 -74.12 124.19 25.85 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.443 179.212 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.492 ' HB2' ' HA ' ' A' ' 95' ' ' GLU . 0.4 OUTLIER -95.93 150.51 20.36 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.587 -175.543 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -57.78 -100.87 0.01 OUTLIER Glycine 0 CA--C 1.52 0.359 0 CA-C-N 115.068 -0.969 . . . . 0.0 112.734 172.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.467 ' HB3' ' OD1' ' A' ' 97' ' ' ASN . 11.1 t30 -65.33 -24.15 67.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.644 0.259 . . . . 0.0 110.491 -177.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.492 ' HA ' ' HB2' ' A' ' 92' ' ' GLU . 29.5 tt0 76.02 -63.0 0.41 Allowed 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 168.329 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 37.0 m -64.83 -4.93 4.92 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -171.034 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.467 ' OD1' ' HB3' ' A' ' 94' ' ' ASN . 4.0 p-10 -96.01 11.06 35.4 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.808 178.4 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.542 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 24.4 p-10 -85.0 3.02 40.51 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.92 0.39 . . . . 0.0 110.487 179.031 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -119.31 118.32 30.92 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 121.215 0.531 . . . . 0.0 111.575 -178.594 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.58 ' O ' ' HA ' ' A' ' 81' ' ' THR . 25.2 tp -108.46 99.39 8.78 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.241 178.568 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 93.1 m -92.15 97.75 11.11 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 121.155 0.503 . . . . 0.0 109.717 175.304 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -114.88 126.37 54.72 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.344 -177.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.488 HD23 ' HA ' ' A' ' 79' ' ' THR . 51.2 mt -78.93 115.88 18.9 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.214 0.531 . . . . 0.0 110.573 177.641 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.513 HG22 HD13 ' A' ' 80' ' ' LEU . 23.0 m -106.36 144.56 15.39 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.01 178.279 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.567 ' O ' ' HA ' ' A' ' 14' ' ' THR . . . -118.96 169.9 13.69 Favored Glycine 0 N--CA 1.437 -1.255 0 C-N-CA 120.004 -1.094 . . . . 0.0 111.271 -177.366 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 41.6 p -77.06 129.88 36.66 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 173.484 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.629 ' HG ' ' H ' ' A' ' 109' ' ' HIS . 42.7 tp -57.06 129.15 40.47 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.19 -176.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.52 8.98 6.61 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.497 0.665 . . . . 0.0 110.86 -176.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' HIS . . . . . 0.629 ' H ' ' HG ' ' A' ' 107' ' ' LEU . 73.3 m80 -136.21 173.85 11.26 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.989 -1.005 . . . . 0.0 108.49 172.465 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 41.1 m80 -123.55 19.3 9.6 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.04 0.448 . . . . 0.0 111.43 -177.693 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -125.4 93.88 3.99 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.958 174.024 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 47.7 t-80 -91.14 86.16 6.12 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 179.644 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 18.7 t60 -98.24 126.21 43.63 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.449 -176.815 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 85.1 t60 . . . . . 0 C--O 1.246 0.884 0 CA-C-O 118.532 -0.747 . . . . 0.0 109.474 178.158 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.416 ' O ' ' HD2' ' A' ' 33' ' ' LYS . 84.7 mtp . . . . . 0 N--CA 1.477 0.916 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.459 HG13 ' HD2' ' A' ' 3' ' ' PRO . 18.3 tt -114.39 142.58 28.34 Favored Pre-proline 0 C--N 1.321 -0.664 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 178.83 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.53 ' HD3' ' HD3' ' A' ' 33' ' ' LYS . 58.2 Cg_endo -76.0 157.1 38.68 Favored 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 122.453 2.102 . . . . 0.0 112.325 176.2 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -146.05 100.12 3.35 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 179.474 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.539 HD22 HD23 ' A' ' 57' ' ' LEU . 41.0 mt -99.88 126.76 46.06 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-O 121.545 0.688 . . . . 0.0 109.265 -170.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 6.0 t -125.46 140.37 36.17 Favored Pre-proline 0 N--CA 1.441 -0.92 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.638 -175.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.458 ' HB2' ' HB2' ' A' ' 100' ' ' LEU . 1.1 Cg_endo -87.34 107.09 0.65 Allowed 'Trans proline' 0 N--CA 1.446 -1.29 0 C-N-CA 122.815 2.343 . . . . 0.0 109.63 166.489 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.9 t -76.91 -60.23 2.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.566 -170.552 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 9.5 t -154.65 154.97 33.82 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 177.663 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.411 ' HA ' ' O ' ' A' ' 24' ' ' THR . 1.8 pp -127.95 127.49 43.38 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.399 0.618 . . . . 0.0 110.117 177.064 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.6 p -121.63 131.66 24.39 Favored Pre-proline 0 C--N 1.311 -1.075 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.792 -175.526 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.413 ' HD2' ' SD ' ' A' ' 23' ' ' MET . 84.4 Cg_endo -90.55 175.1 20.41 Favored 'Cis proline' 0 N--CA 1.461 -0.392 0 C-N-CA 123.539 -1.442 . . . . 0.0 113.5 8.723 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.5 m -99.25 -11.98 8.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.087 0.47 . . . . 0.0 111.274 178.2 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -120.09 151.0 39.69 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 174.26 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 20.9 m -143.29 157.36 17.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.029 0.442 . . . . 0.0 111.475 -177.75 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.4 ' HA ' ' HD3' ' A' ' 17' ' ' PRO . 2.8 m -99.11 144.13 27.66 Favored Pre-proline 0 N--CA 1.448 -0.564 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.114 178.606 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.531 ' HA ' ' CB ' ' A' ' 71' ' ' LEU . 2.9 Cg_endo -82.64 165.5 15.87 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.868 2.378 . . . . 0.0 112.589 178.79 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 18.5 m120 71.87 24.2 3.4 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.639 175.428 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.5 t -163.52 162.91 24.79 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.983 -0.287 . . . . 0.0 110.592 -178.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 1.005 HG22 ' HB ' ' A' ' 70' ' ' THR . 21.2 t -94.56 130.81 42.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 175.464 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -119.65 152.63 36.79 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.273 179.694 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 90.9 m -96.83 109.22 21.96 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.332 -178.541 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.55 ' HB2' ' HB2' ' A' ' 67' ' ' PHE . 83.4 mmm -92.42 123.74 35.95 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.669 178.911 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.486 ' HA ' ' O ' ' A' ' 65' ' ' VAL . 19.3 m -106.87 103.06 12.4 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.637 0.256 . . . . 0.0 111.259 -177.577 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -97.75 123.12 41.55 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.494 176.28 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 18.8 m -87.81 121.29 30.05 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 120.813 0.34 . . . . 0.0 110.589 178.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 24.6 mm -106.88 116.37 50.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 179.67 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -110.27 128.91 55.77 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.918 0.389 . . . . 0.0 110.659 -178.547 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.431 ' ND2' ' HA ' ' A' ' 59' ' ' SER . 26.1 t30 -88.62 96.08 10.5 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.467 177.437 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 -92.74 43.98 1.14 Allowed 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.634 -174.522 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -144.08 150.13 22.17 Favored Glycine 0 N--CA 1.447 -0.582 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 179.157 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -84.47 62.77 7.46 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.497 0.665 . . . . 0.0 111.567 -172.677 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.53 ' HD3' ' HD3' ' A' ' 3' ' ' PRO . 62.3 tttp -161.46 136.84 7.63 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.321 166.833 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -72.16 114.39 10.23 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 177.633 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 16.1 p -83.56 144.77 29.26 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.054 0.454 . . . . 0.0 110.856 -178.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 3.1 p -83.4 -169.63 2.64 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.557 -178.154 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 33.0 t -54.76 132.63 46.37 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.577 -178.837 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 55.1 p90 -143.98 159.22 42.97 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.947 178.749 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 21.0 m-80 -109.04 110.5 21.79 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.483 0.182 . . . . 0.0 111.273 -175.691 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.487 HG22 ' HA ' ' A' ' 84' ' ' VAL . 1.5 t -98.43 124.85 51.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.271 0.558 . . . . 0.0 109.926 -179.594 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 18.7 m -120.56 148.18 44.2 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.047 -174.453 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 50.4 tp -102.21 117.36 34.59 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.787 177.106 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.574 ' HG ' HG22 ' A' ' 48' ' ' VAL . 5.0 mp -100.34 126.69 46.72 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.81 179.486 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 99.5 t -106.08 103.12 14.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 120.815 0.34 . . . . 0.0 110.201 179.366 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.489 ' HA ' ' HB ' ' A' ' 79' ' ' THR . 8.7 m-20 62.62 13.09 6.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.352 -0.84 . . . . 0.0 112.095 176.665 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 138.38 -38.63 1.67 Allowed Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.604 -0.808 . . . . 0.0 113.306 176.695 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 8.3 mt -98.19 150.8 4.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 120.77 0.319 . . . . 0.0 110.537 -174.874 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.574 HG22 ' HG ' ' A' ' 43' ' ' LEU . 55.9 t -87.43 127.17 40.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 -179.724 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 18.4 m -99.84 -39.34 7.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 111.852 0.316 . . . . 0.0 111.852 179.676 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -149.44 149.49 30.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.736 0.303 . . . . 0.0 110.936 -176.117 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 95.9 m -133.96 128.27 34.11 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.52 -178.157 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -118.97 119.28 33.85 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 177.637 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 25.6 m -80.9 126.42 31.34 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.362 178.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 47.7 t -96.6 128.92 47.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 178.443 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.8 p -56.4 -43.6 79.47 Favored 'General case' 0 C--N 1.329 -0.324 0 O-C-N 123.355 0.409 . . . . 0.0 111.957 -177.069 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 17.2 p -178.08 155.22 0.93 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.393 179.149 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.672 HD13 HG23 ' A' ' 63' ' ' THR . 17.4 tp -130.42 109.26 10.59 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.07 0.462 . . . . 0.0 109.783 177.44 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -63.98 160.86 16.92 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.41 -176.241 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.431 ' HA ' ' ND2' ' A' ' 29' ' ' ASN . 4.4 p -61.9 125.73 24.88 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.122 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 61.23 35.93 18.11 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.436 -179.623 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 13.5 m-80 -121.32 162.09 20.9 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.04 176.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 3.5 p -132.55 127.82 35.92 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.025 0.44 . . . . 0.0 111.54 -178.375 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.672 HG23 HD13 ' A' ' 57' ' ' LEU . 17.6 p -104.22 153.29 21.15 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.455 177.628 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -104.29 125.12 50.28 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 176.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.486 ' O ' ' HA ' ' A' ' 24' ' ' THR . 59.3 t -96.14 128.66 47.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-O 121.169 0.509 . . . . 0.0 110.963 -175.071 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -95.61 97.21 9.57 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.368 -177.097 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.55 ' HB2' ' HB2' ' A' ' 23' ' ' MET . 26.3 m-85 -92.26 147.18 23.13 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.212 0.529 . . . . 0.0 111.443 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 7.2 m80 -114.93 98.25 6.71 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.041 179.189 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 20.4 t90 -122.78 122.21 38.16 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.064 0.459 . . . . 0.0 111.444 -174.163 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' THR . . . . . 1.005 ' HB ' HG22 ' A' ' 20' ' ' VAL . 8.4 t -105.61 141.29 37.32 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.261 177.657 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.531 ' CB ' ' HA ' ' A' ' 17' ' ' PRO . 1.7 mm? -100.89 119.23 38.39 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.112 0.482 . . . . 0.0 111.038 176.348 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -84.37 -25.14 29.34 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.054 176.818 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -153.19 -155.21 7.04 Favored Glycine 0 N--CA 1.445 -0.731 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.856 -177.865 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 2.8 t -145.74 90.91 2.04 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-O 121.934 0.874 . . . . 0.0 111.267 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -80.87 2.45 26.47 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.882 172.772 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.487 ' O ' ' HA2' ' A' ' 105' ' ' GLY . 95.5 m-20 70.83 -59.11 0.55 Allowed 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.803 179.447 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 41.0 t -104.3 114.21 28.29 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 120.888 0.375 . . . . 0.0 110.415 -178.375 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.423 ' HB2' HG23 ' A' ' 104' ' ' VAL . 65.1 m-85 -116.92 134.0 55.31 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.323 179.105 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.489 ' HB ' ' HA ' ' A' ' 45' ' ' ASP . 7.3 m -96.69 88.05 4.52 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.911 0.386 . . . . 0.0 110.478 -177.014 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.41 HD22 HG11 ' A' ' 104' ' ' VAL . 8.1 mp -87.58 113.59 23.41 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.611 0.719 . . . . 0.0 110.56 -178.169 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.532 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 25.8 m -115.33 123.28 48.32 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.418 -177.785 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 49.5 t -90.17 112.03 24.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 176.47 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -108.19 117.76 34.98 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 175.394 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.614 ' HB ' ' HB2' ' A' ' 98' ' ' ASN . 84.8 t -83.57 103.37 10.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.995 -177.897 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.9 t70 59.81 89.54 0.1 Allowed Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 114.266 -1.334 . . . . 0.0 112.347 177.103 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -70.78 -12.46 30.99 Favored 'Trans proline' 0 C--O 1.232 0.215 0 C-N-CA 123.33 2.687 . . . . 0.0 112.217 179.487 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -89.73 -6.5 55.99 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.464 -178.79 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 65.8 t30 58.41 42.1 21.82 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.61 177.402 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -69.26 -26.79 64.94 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.334 178.05 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 61.4 t -110.6 122.63 65.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.681 176.582 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 54.0 t30 -80.86 130.4 35.03 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 176.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -125.65 159.92 30.99 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.948 0.404 . . . . 0.0 112.008 -173.076 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -58.3 -100.81 0.01 OUTLIER Glycine 0 CA--C 1.522 0.489 0 CA-C-N 114.948 -1.024 . . . . 0.0 113.818 174.293 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -58.24 160.51 5.02 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 122.972 0.509 . . . . 0.0 111.452 -177.117 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.2 2.68 24.91 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 121.144 0.497 . . . . 0.0 111.413 -175.722 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 18.3 m -125.8 24.33 7.11 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.0 0.428 . . . . 0.0 110.465 -179.657 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 26.4 p-10 -98.09 -39.94 8.66 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.705 -174.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.614 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 23.9 p-10 -83.77 10.68 8.9 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.316 0.488 . . . . 0.0 112.316 -168.877 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 2.6 m -119.32 150.12 40.67 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.981 0.419 . . . . 0.0 110.643 -179.237 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.532 ' O ' ' HA ' ' A' ' 81' ' ' THR . 54.2 tp -148.52 106.59 3.72 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.649 178.565 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 31.0 m -93.51 98.65 11.32 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 120.9 0.381 . . . . 0.0 110.222 177.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -109.46 118.98 38.06 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.374 -179.32 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.44 HD22 ' HA ' ' A' ' 103' ' ' LEU . 1.8 tm? -81.47 111.24 17.63 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.161 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.423 HG23 ' HB2' ' A' ' 78' ' ' TYR . 21.5 m -103.38 162.85 3.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -179.302 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.487 ' HA2' ' O ' ' A' ' 76' ' ' ASN . . . -131.87 167.08 22.91 Favored Glycine 0 N--CA 1.439 -1.102 0 C-N-CA 119.858 -1.163 . . . . 0.0 111.955 -178.907 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 22.4 p -84.26 131.52 34.73 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 173.123 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 36.5 tp -55.02 117.88 3.84 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.634 -174.366 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.24 -25.01 62.3 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.957 -176.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 57.4 m80 -68.87 115.44 8.2 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 170.576 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 29.3 m-70 -108.73 91.42 3.63 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.069 0.461 . . . . 0.0 110.264 -177.224 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 -125.14 109.82 13.35 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.269 179.153 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 89.6 m-70 -91.16 -78.85 0.38 Allowed 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 172.859 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 89.6 m-70 -139.35 21.01 2.58 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.705 0.764 . . . . 0.0 109.285 173.868 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.245 0.839 0 CA-C-N 114.704 -1.134 . . . . 0.0 109.403 178.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 90.7 mtp . . . . . 0 N--CA 1.481 1.076 0 CA-C-O 120.914 0.388 . . . . 0.0 110.214 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 13.3 tt -137.31 143.38 41.25 Favored Pre-proline 0 C--N 1.32 -0.691 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -68.69 155.95 67.1 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 121.947 1.764 . . . . 0.0 111.484 176.262 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -147.51 76.78 1.41 Allowed 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 176.477 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.741 ' HG ' ' OE1' ' A' ' 92' ' ' GLU . 27.1 mt -72.8 103.66 3.74 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 114.948 -1.024 . . . . 0.0 110.856 -176.845 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.584 HG22 ' HB3' ' A' ' 97' ' ' ASN . 25.7 t -114.68 121.0 36.53 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.923 -177.228 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.509 ' HB2' ' HB2' ' A' ' 100' ' ' LEU . 1.9 Cg_endo -79.03 108.01 2.32 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 122.333 2.022 . . . . 0.0 109.919 171.185 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 27.3 m -93.95 -27.27 4.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 -171.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 60.7 m -146.49 145.04 30.05 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.983 0.421 . . . . 0.0 111.872 -175.811 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.477 HD23 ' HB3' ' A' ' 102' ' ' ALA . 50.1 tp -130.54 110.53 11.49 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.407 174.046 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.573 ' OG1' ' HA ' ' A' ' 12' ' ' PRO . 5.6 t -128.69 149.56 72.36 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.017 -177.143 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.573 ' HA ' ' OG1' ' A' ' 11' ' ' THR . 82.8 Cg_endo -77.76 154.2 94.41 Favored 'Cis proline' 0 N--CA 1.463 -0.296 0 C-N-CA 123.42 -1.492 . . . . 0.0 112.675 1.722 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.5 m -79.62 -6.64 9.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.13 178.193 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.427 ' HA ' ' O ' ' A' ' 105' ' ' GLY . 1.5 p -130.35 125.51 34.81 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.319 178.323 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.4 m -121.1 158.02 24.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.125 0.488 . . . . 0.0 112.115 -172.775 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.488 HG22 HD22 ' A' ' 107' ' ' LEU . 41.8 t -80.22 120.56 79.96 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.732 177.748 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.658 ' HA ' ' HG ' ' A' ' 71' ' ' LEU . 2.8 Cg_exo -75.5 59.28 5.47 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 123.193 2.596 . . . . 0.0 113.946 -173.286 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -176.98 -56.88 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.718 0.294 . . . . 0.0 111.506 174.27 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 14.6 t -80.4 178.29 8.4 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.293 -172.832 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 45.2 t -80.74 124.29 38.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.106 178.42 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.571 ' ND2' HD23 ' A' ' 71' ' ' LEU . 38.7 m-80 -102.44 135.03 44.8 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.169 -179.308 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 21.2 m -82.9 97.68 8.8 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.033 -0.53 . . . . 0.0 109.95 177.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.553 ' HB2' ' HB2' ' A' ' 67' ' ' PHE . 91.5 mmm -91.56 132.26 36.42 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.269 -176.366 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.508 ' HA ' ' O ' ' A' ' 65' ' ' VAL . 10.4 m -116.27 117.07 29.0 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.638 -178.088 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.414 ' HB3' ' HB ' ' A' ' 65' ' ' VAL . . . -105.58 119.48 39.22 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.265 178.358 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 17.6 m -85.9 110.28 19.31 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.51 -178.772 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 24.4 mm -102.13 115.67 44.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.21 -179.065 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -103.15 132.74 49.18 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.091 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.458 ' HB2' ' HG ' ' A' ' 57' ' ' LEU . 51.9 t-20 -90.49 101.53 14.27 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 173.304 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 11.5 mm100 -93.31 33.23 1.24 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.179 -176.819 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -144.09 166.87 27.0 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.024 -178.269 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -97.5 54.22 1.18 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.448 0.642 . . . . 0.0 111.063 -173.789 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 73.8 tttt -161.47 144.72 12.51 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.121 172.709 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.495 ' HB3' ' HA ' ' A' ' 58' ' ' GLU . 1.2 m-20 -89.19 129.71 35.73 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 -177.823 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 36.9 p -85.07 153.92 22.41 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 110.311 -0.255 . . . . 0.0 110.311 -179.261 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.407 HG22 ' H ' ' A' ' 37' ' ' SER . 0.2 OUTLIER -85.19 -167.82 1.98 Allowed 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 177.382 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.51 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 39.9 m -60.42 113.47 2.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.955 0.407 . . . . 0.0 110.701 178.692 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.4 ' CE2' HG23 ' A' ' 40' ' ' VAL . 41.4 p90 -124.25 154.21 40.52 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.313 -178.422 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.412 ' O ' ' HD3' ' A' ' 86' ' ' PRO . 79.7 m-20 -100.52 111.37 23.62 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.424 -176.072 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.53 HG11 HG21 ' A' ' 65' ' ' VAL . 1.4 t -98.34 119.11 45.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 176.356 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.447 ' HB3' HG13 ' A' ' 48' ' ' VAL . 41.2 m -113.49 138.15 50.53 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.327 -174.117 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 62.5 tp -97.89 111.82 23.97 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.58 174.194 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.427 ' HA ' ' O ' ' A' ' 47' ' ' ILE . 5.2 mp -96.9 140.8 30.91 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.024 -179.721 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 91.0 t -122.57 111.56 30.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 173.488 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 20.0 t70 67.71 -72.78 0.09 Allowed 'General case' 0 N--CA 1.47 0.542 0 O-C-N 124.036 0.835 . . . . 0.0 110.761 -176.06 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -153.08 9.15 0.52 Allowed Glycine 0 N--CA 1.448 -0.564 0 CA-C-N 115.969 -0.559 . . . . 0.0 112.14 177.334 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.427 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 3.4 mt -110.89 151.2 13.1 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.315 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 -178.603 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.447 HG13 ' HB3' ' A' ' 41' ' ' SER . 45.4 t -99.21 107.19 20.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 173.792 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 29.8 m -77.8 -33.51 18.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.304 -175.258 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -160.01 135.49 8.25 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.273 -179.101 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 95.4 m -120.88 126.41 49.97 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.832 177.369 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -109.83 123.27 49.27 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.068 178.722 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 30.3 m -81.25 104.18 11.54 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.249 -0.432 . . . . 0.0 109.905 176.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.51 ' O ' ' HA ' ' A' ' 37' ' ' SER . 21.9 t -81.4 123.26 37.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 178.632 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 20.9 m -56.14 -42.85 77.58 Favored 'General case' 0 C--N 1.329 -0.3 0 O-C-N 123.458 0.474 . . . . 0.0 111.594 -173.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 50.7 p 179.2 136.89 0.1 Allowed 'General case' 0 C--N 1.33 -0.261 0 O-C-N 123.246 0.341 . . . . 0.0 110.526 174.355 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.576 HD23 HD22 ' A' ' 5' ' ' LEU . 26.7 tp -105.94 110.23 22.43 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.123 0.487 . . . . 0.0 109.762 175.469 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.495 ' HA ' ' HB3' ' A' ' 34' ' ' ASP . 42.7 mt-10 -66.95 160.49 26.24 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.201 -177.044 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 2.7 p -60.73 124.87 21.68 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.372 -178.584 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 65.03 16.97 10.87 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.527 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -96.17 148.45 22.7 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 178.203 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 17.9 m -111.48 134.52 53.0 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.002 179.455 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 91.7 m -139.88 129.63 24.55 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.131 0.491 . . . . 0.0 111.123 -179.453 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -90.31 132.57 35.48 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.627 -179.246 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.53 HG21 HG11 ' A' ' 40' ' ' VAL . 40.2 t -96.53 133.07 39.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.448 -179.129 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -102.56 105.31 15.8 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.468 -177.251 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.553 ' HB2' ' HB2' ' A' ' 23' ' ' MET . 49.9 m-85 -102.03 147.83 26.1 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.912 179.046 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 35.5 m-70 -115.13 92.41 3.92 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 175.281 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 14.7 t90 -100.22 105.44 17.01 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.238 -173.615 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 6.8 m -73.96 108.7 6.94 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.014 171.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.658 ' HG ' ' HA ' ' A' ' 17' ' ' PRO . 0.1 OUTLIER -59.42 -69.13 0.22 Allowed 'General case' 0 C--O 1.234 0.284 0 O-C-N 123.131 0.27 . . . . 0.0 111.517 -172.645 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.446 ' HB3' ' O ' ' A' ' 71' ' ' LEU . 20.0 t70 72.87 -47.37 0.67 Allowed 'General case' 0 N--CA 1.47 0.57 0 O-C-N 123.918 0.761 . . . . 0.0 111.981 -178.126 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.558 ' HA3' ' OH ' ' A' ' 78' ' ' TYR . . . -74.34 -174.52 31.83 Favored Glycine 0 CA--C 1.518 0.244 0 C-N-CA 121.249 -0.501 . . . . 0.0 113.478 -177.511 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 9.5 t -142.43 12.82 1.95 Allowed 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.087 0.47 . . . . 0.0 111.347 -175.717 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.45 ' HB3' ' CE1' ' A' ' 78' ' ' TYR . . . -71.81 141.49 49.66 Favored 'General case' 0 C--N 1.33 -0.272 0 O-C-N 122.081 -0.387 . . . . 0.0 110.286 -179.446 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.551 ' HA ' HG23 ' A' ' 106' ' ' THR . 25.0 p-10 -77.73 -5.66 51.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.78 0.324 . . . . 0.0 111.514 -175.311 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 43.7 m -150.83 116.01 5.34 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.862 0.363 . . . . 0.0 110.722 -178.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.558 ' OH ' ' HA3' ' A' ' 73' ' ' GLY . 43.0 m-85 -111.47 138.26 48.21 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.89 176.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.405 ' HA ' HD23 ' A' ' 103' ' ' LEU . 37.2 m -92.65 97.97 11.14 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.88 179.133 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.517 HD13 HG22 ' A' ' 104' ' ' VAL . 10.2 mp -97.31 135.79 38.72 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.453 -179.479 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.491 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 27.4 m -130.36 116.96 19.04 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.64 -176.921 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.425 ' HB ' ' HB3' ' A' ' 100' ' ' LEU . 59.5 t -89.11 104.17 14.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 175.684 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -99.26 117.6 34.08 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 178.2 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.504 HG23 ' HG3' ' A' ' 7' ' ' PRO . 84.5 t -85.1 106.4 14.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.355 -176.84 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 51.3 t0 61.6 85.77 0.17 Allowed Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 114.563 -1.199 . . . . 0.0 111.487 178.813 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.412 ' HD3' ' O ' ' A' ' 39' ' ' ASN . 4.6 Cg_exo -74.91 -7.14 18.96 Favored 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 123.023 2.482 . . . . 0.0 111.715 178.174 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -94.57 -22.62 18.08 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 178.224 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 59.99 69.15 0.72 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.182 -179.717 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -93.05 -28.76 16.17 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.793 178.131 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.7 t -106.33 135.15 45.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.31 176.211 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -82.48 112.0 19.01 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.873 0.368 . . . . 0.0 110.008 178.686 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.741 ' OE1' ' HG ' ' A' ' 5' ' ' LEU . 66.6 mm-40 -100.43 173.63 6.49 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.478 -176.349 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -57.77 -101.11 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.387 0 CA-C-N 115.255 -0.884 . . . . 0.0 112.485 174.015 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.45 ' O ' ' HB2' ' A' ' 97' ' ' ASN . 60.5 m-20 -96.77 135.31 38.9 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.522 ' HA ' HD21 ' A' ' 98' ' ' ASN . 40.4 tt0 -60.86 -29.24 69.41 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.138 0.494 . . . . 0.0 110.656 177.755 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 5.3 m -65.85 -19.72 65.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.252 0.548 . . . . 0.0 110.539 178.497 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.584 ' HB3' HG22 ' A' ' 6' ' ' VAL . 7.2 m-20 -81.24 -21.78 39.23 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.788 -178.296 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.522 HD21 ' HA ' ' A' ' 95' ' ' GLU . 29.4 m-80 -78.11 -4.74 48.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.403 -177.617 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 3.2 m -110.32 154.74 23.06 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.079 0.466 . . . . 0.0 111.33 -175.372 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.509 ' HB2' ' HB2' ' A' ' 7' ' ' PRO . 48.8 tp -146.96 103.42 3.61 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.478 175.095 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 7.7 m -90.26 96.2 10.55 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 178.229 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.477 ' HB3' HD23 ' A' ' 10' ' ' LEU . . . -114.95 121.08 42.07 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.162 0.506 . . . . 0.0 110.82 -176.83 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.405 HD23 ' HA ' ' A' ' 79' ' ' THR . 87.1 mt -86.26 121.21 28.52 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.215 177.787 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.517 HG22 HD13 ' A' ' 80' ' ' LEU . 18.5 m -111.48 137.26 44.79 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.72 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.427 ' O ' ' HA ' ' A' ' 14' ' ' THR . . . -107.61 -177.78 22.42 Favored Glycine 0 N--CA 1.439 -1.128 0 C-N-CA 120.532 -0.842 . . . . 0.0 111.22 -177.204 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.551 HG23 ' HA ' ' A' ' 76' ' ' ASN . 24.7 p -82.54 153.95 25.28 Favored 'General case' 0 C--N 1.312 -1.056 0 C-N-CA 120.856 -0.338 . . . . 0.0 110.338 178.112 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.488 HD22 HG22 ' A' ' 16' ' ' VAL . 27.1 tp -52.22 119.36 4.31 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.395 179.483 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -58.54 -51.79 68.4 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.861 -176.785 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 75.2 m80 -87.92 111.04 21.02 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.052 -179.427 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' HIS . . . . . 0.635 ' HB3' ' HA ' ' A' ' 113' ' ' HIS . 43.5 m80 -74.44 112.63 10.81 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.647 -175.385 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 43.5 t-80 -67.25 -56.27 10.53 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 168.767 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 7.9 t-80 -96.4 110.85 23.13 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 107.456 -1.312 . . . . 0.0 107.456 167.32 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' HIS . . . . . 0.635 ' HA ' ' HB3' ' A' ' 110' ' ' HIS . 96.0 m-70 -62.32 -40.72 97.26 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.862 -170.007 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 21.4 p80 . . . . . 0 C--O 1.245 0.855 0 CA-C-O 118.732 -0.652 . . . . 0.0 109.673 178.426 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 84.7 mmm . . . . . 0 N--CA 1.479 1.02 0 CA-C-O 120.66 0.267 . . . . 0.0 110.494 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 13.4 tt -144.14 140.56 17.07 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 116.604 -0.271 . . . . 0.0 110.424 178.61 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.634 ' O ' ' HA ' ' A' ' 92' ' ' GLU . 18.4 Cg_exo -68.54 148.7 73.24 Favored 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.64 2.226 . . . . 0.0 111.203 170.094 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -130.0 93.09 3.42 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 175.793 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.549 ' HB3' HG11 ' A' ' 84' ' ' VAL . 70.5 mt -76.08 102.18 5.6 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.108 -173.483 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.488 HG22 HD21 ' A' ' 97' ' ' ASN . 60.9 t -107.68 110.41 62.64 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.124 -179.197 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.556 ' HB2' ' HB2' ' A' ' 100' ' ' LEU . 56.8 Cg_endo -73.12 103.51 1.62 Allowed 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 121.898 1.732 . . . . 0.0 109.825 168.688 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.2 t -79.31 -51.25 16.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.573 -168.474 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 21.6 t -157.25 176.36 12.82 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.019 0.437 . . . . 0.0 111.028 -178.404 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 35.6 tp -145.44 104.32 3.9 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.071 -178.72 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.3 p -112.98 145.52 33.25 Favored Pre-proline 0 C--N 1.321 -0.659 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.431 -175.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -86.0 157.22 56.85 Favored 'Cis proline' 0 N--CA 1.46 -0.474 0 C-N-CA 123.132 -1.612 . . . . 0.0 112.319 -2.691 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.462 ' HA ' HG12 ' A' ' 104' ' ' VAL . 35.9 m -83.94 13.0 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.25 0.547 . . . . 0.0 110.952 -179.756 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.704 HG22 ' HA ' ' A' ' 107' ' ' LEU . 0.3 OUTLIER -148.54 119.56 7.68 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 178.311 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.537 HG21 ' CZ3' ' A' ' 69' ' ' TRP . 24.9 m -128.41 153.53 37.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -167.21 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.471 HG22 HD23 ' A' ' 107' ' ' LEU . 7.4 t -76.01 129.77 79.97 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.052 179.086 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.59 ' HA ' ' CB ' ' A' ' 71' ' ' LEU . 6.1 Cg_exo -74.1 -173.88 1.57 Allowed 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 122.643 2.229 . . . . 0.0 111.577 174.75 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 8.1 p30 51.36 17.26 0.5 Allowed 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.349 1.059 . . . . 0.0 113.844 175.592 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 15.0 t -150.82 168.7 23.65 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 121.721 -0.612 . . . . 0.0 110.93 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 25.9 t -99.0 112.39 30.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 175.144 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.449 ' ND2' ' HB ' ' A' ' 15' ' ' VAL . 26.5 p30 -101.62 162.84 12.61 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.049 -175.348 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.465 ' HA ' ' O ' ' A' ' 67' ' ' PHE . 7.9 m -113.48 95.77 5.53 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.006 -179.534 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.485 ' O ' ' HA ' ' A' ' 66' ' ' ASP . 80.0 mtp -92.74 150.56 20.58 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.755 -176.814 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.405 ' HA ' ' O ' ' A' ' 65' ' ' VAL . 3.1 m -118.02 115.91 25.82 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.424 -175.07 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -96.97 134.08 40.8 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.022 0.439 . . . . 0.0 110.457 176.035 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 4.1 m -91.33 100.2 13.04 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.087 179.718 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 21.9 mm -98.3 111.51 28.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 176.732 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.526 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 27.7 tt0 -119.19 132.27 55.94 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.149 0.5 . . . . 0.0 111.1 -176.557 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.578 ' HB2' ' HG ' ' A' ' 57' ' ' LEU . 54.2 t-20 -86.81 113.8 22.93 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.858 -179.471 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 83.0 mm-40 -101.13 54.92 0.84 Allowed 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.193 0.521 . . . . 0.0 110.745 179.077 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -143.99 -172.57 14.81 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.777 -0.725 . . . . 0.0 111.755 -177.524 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 29.9 p-10 -113.4 6.85 17.4 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.846 0.355 . . . . 0.0 111.729 -174.568 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.404 ' HD3' ' HD3' ' A' ' 3' ' ' PRO . 87.6 tttt -122.33 133.11 54.67 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 171.928 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -73.87 132.28 42.36 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.504 -179.179 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.491 ' OG ' ' HB3' ' A' ' 57' ' ' LEU . 4.5 p -93.11 138.81 31.21 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.084 0.469 . . . . 0.0 111.151 -178.199 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.0 p -83.1 -165.47 1.09 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.238 -179.23 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.586 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 22.4 m -56.91 121.5 10.04 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.99 0.424 . . . . 0.0 111.624 -179.073 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.46 ' CE2' HG23 ' A' ' 40' ' ' VAL . 31.3 p90 -133.87 153.73 51.54 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.295 -179.688 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.424 ' O ' ' HD3' ' A' ' 86' ' ' PRO . 89.3 m-20 -94.26 113.84 25.82 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.818 0.342 . . . . 0.0 111.245 -176.115 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.46 HG23 ' CE2' ' A' ' 38' ' ' PHE . 1.5 t -103.56 125.51 58.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.138 0.494 . . . . 0.0 109.815 176.453 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 9.7 m -113.3 139.39 48.88 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.676 -177.046 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 61.1 tp -103.01 116.97 33.55 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 174.521 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.494 ' HG ' HG22 ' A' ' 48' ' ' VAL . 5.1 mp -105.72 137.89 42.83 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.554 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 78.9 t -100.94 100.29 10.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 171.657 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 8.7 t70 69.2 -76.12 0.06 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.38 -176.765 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -136.95 -7.68 1.52 Allowed Glycine 0 CA--C 1.519 0.34 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.885 178.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 6.9 mt -100.03 148.75 6.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 110.029 -0.359 . . . . 0.0 110.029 -178.485 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.494 HG22 ' HG ' ' A' ' 43' ' ' LEU . 48.5 t -97.84 121.08 47.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.413 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 28.3 m -104.05 -28.51 2.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 C-N-CA 120.831 -0.347 . . . . 0.0 111.688 -177.213 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -144.27 150.07 37.3 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 -177.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 24.2 m -149.43 110.55 4.38 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 177.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -114.85 138.15 51.12 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.896 0.379 . . . . 0.0 110.546 -177.274 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 28.9 m -87.18 107.32 18.42 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 173.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.586 ' O ' ' HA ' ' A' ' 37' ' ' SER . 39.0 t -77.64 127.16 38.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 9.6 m -63.07 -39.39 94.56 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.896 -170.814 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 79.5 p -170.99 161.79 7.02 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.713 0.292 . . . . 0.0 110.52 178.374 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.578 ' HG ' ' HB2' ' A' ' 29' ' ' ASN . 37.9 tp -142.87 114.09 7.79 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.066 -0.515 . . . . 0.0 109.705 175.876 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -79.54 157.26 27.44 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.57 -0.741 . . . . 0.0 112.132 -172.126 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 16.5 m -59.63 119.9 8.45 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.362 -179.22 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.407 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 45.2 mt-10 60.5 28.65 18.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.66 179.072 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -124.9 159.64 30.68 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 172.63 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.526 ' HA ' ' HA ' ' A' ' 28' ' ' GLU . 33.2 p -112.76 163.86 14.07 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.059 0.457 . . . . 0.0 111.241 -176.877 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 79.9 m -133.97 124.46 26.36 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.918 173.207 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 31.4 m-80 -80.5 106.08 12.24 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.416 177.748 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.405 ' O ' ' HA ' ' A' ' 24' ' ' THR . 3.8 t -96.57 115.6 36.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.769 -175.702 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.485 ' HA ' ' O ' ' A' ' 23' ' ' MET . 19.2 m-20 -96.25 118.85 33.64 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.82 0.343 . . . . 0.0 111.223 -179.344 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.465 ' O ' ' HA ' ' A' ' 22' ' ' THR . 84.7 m-85 -102.1 174.27 6.01 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.952 178.401 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 86.3 m-70 -128.45 109.64 11.59 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 176.664 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' TRP . . . . . 0.537 ' CZ3' HG21 ' A' ' 15' ' ' VAL . 15.2 t90 -120.05 122.04 40.22 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.251 0.548 . . . . 0.0 111.281 -172.574 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 10.3 m -86.49 113.94 22.83 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.648 178.222 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.59 ' CB ' ' HA ' ' A' ' 17' ' ' PRO . 1.1 mm? -77.7 122.81 25.85 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.115 0.483 . . . . 0.0 111.678 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 16.4 p-10 -87.35 -33.72 19.07 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.154 173.063 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 82.64 19.55 63.55 Favored Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 115.589 -0.732 . . . . 0.0 113.55 172.054 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 30.0 m -70.45 -41.2 73.15 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.095 0.474 . . . . 0.0 110.401 179.558 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -110.25 157.24 19.67 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.041 176.382 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -97.05 -9.01 28.94 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.195 0.521 . . . . 0.0 109.734 178.783 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 71.9 p -137.62 110.1 7.47 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.935 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 46.5 m-85 -106.23 138.59 42.14 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.316 0.579 . . . . 0.0 111.095 -179.681 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.442 ' HA ' HD23 ' A' ' 103' ' ' LEU . 7.7 m -91.31 83.85 5.54 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.208 -0.906 . . . . 0.0 109.6 -179.59 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.435 HD13 HG22 ' A' ' 104' ' ' VAL . 7.9 mp -80.53 120.36 24.4 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.656 0.741 . . . . 0.0 110.267 -178.289 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.582 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 17.1 m -117.99 116.38 26.79 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.24 -173.84 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.437 ' HB ' ' HB3' ' A' ' 100' ' ' LEU . 92.8 t -87.43 110.98 21.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 177.77 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -96.57 117.14 30.33 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 175.627 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.549 HG11 ' HB3' ' A' ' 5' ' ' LEU . 47.5 t -93.47 108.14 20.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.975 -178.828 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 56.8 t0 66.38 95.91 0.05 OUTLIER Pre-proline 0 N--CA 1.466 0.374 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.447 178.005 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.424 ' HD3' ' O ' ' A' ' 39' ' ' ASN . 3.7 Cg_endo -85.1 0.56 8.81 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 123.319 2.679 . . . . 0.0 111.822 178.662 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -109.3 -14.82 14.39 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.043 -179.038 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 64.6 t30 57.85 42.7 22.82 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.703 -178.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -80.58 -29.68 36.95 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.911 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 60.5 t -100.22 129.29 51.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.771 -0.649 . . . . 0.0 109.553 175.302 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -73.28 133.13 43.82 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.324 179.636 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.634 ' HA ' ' O ' ' A' ' 3' ' ' PRO . 0.0 OUTLIER -128.6 164.45 22.83 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.847 -179.544 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -57.72 -101.14 0.01 OUTLIER Glycine 0 CA--C 1.517 0.184 0 CA-C-N 115.251 -0.886 . . . . 0.0 112.999 173.542 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.495 ' O ' ' HB3' ' A' ' 97' ' ' ASN . 27.8 t-20 -89.38 126.11 35.41 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.868 0.366 . . . . 0.0 110.42 -179.446 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -76.32 -12.58 60.09 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.934 -173.571 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 22.3 m -92.31 -6.06 51.05 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.563 0.697 . . . . 0.0 109.774 174.097 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.495 ' HB3' ' O ' ' A' ' 94' ' ' ASN . 1.9 t30 -86.81 -21.66 26.32 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.082 -178.589 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.443 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 16.9 p-10 -74.24 -3.75 31.9 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.976 0.417 . . . . 0.0 111.189 -176.573 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 1.3 m -101.66 149.05 24.53 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.215 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.582 ' O ' ' HA ' ' A' ' 81' ' ' THR . 48.9 tp -136.48 111.6 9.0 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.394 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 6.2 m -90.43 89.86 7.77 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.941 178.07 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -102.69 112.02 24.6 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.04 0.448 . . . . 0.0 110.794 -177.583 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.442 HD23 ' HA ' ' A' ' 79' ' ' THR . 61.7 mt -83.79 116.24 22.62 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.44 178.606 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.462 HG12 ' HA ' ' A' ' 13' ' ' VAL . 17.9 m -118.25 136.26 56.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.176 -177.31 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.514 ' O ' ' HA ' ' A' ' 14' ' ' THR . . . -111.6 173.74 15.99 Favored Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 120.378 -0.915 . . . . 0.0 111.858 -177.515 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 21.0 p -77.97 138.12 38.67 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.329 176.372 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.704 ' HA ' HG22 ' A' ' 14' ' ' THR . 32.3 tp -63.1 107.31 1.0 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.677 -0.692 . . . . 0.0 112.098 -172.637 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -121.17 90.64 3.36 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.025 174.666 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 61.6 m-70 -66.25 106.71 1.75 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.778 179.451 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 2.4 t-80 -74.24 105.01 5.23 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 177.199 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 45.0 m80 -81.31 140.04 35.04 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.761 -170.03 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 7.9 t-80 -97.57 116.63 30.16 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.362 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 37.4 m80 -60.52 -48.1 83.27 Favored 'General case' 0 C--N 1.327 -0.374 0 O-C-N 123.169 0.293 . . . . 0.0 111.238 -173.665 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 10.6 p80 . . . . . 0 C--O 1.248 0.978 0 CA-C-O 118.054 -0.974 . . . . 0.0 109.745 173.287 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.506 ' HA ' ' OD1' ' A' ' 32' ' ' ASN . 82.8 mtp . . . . . 0 N--CA 1.48 1.032 0 CA-C-O 120.749 0.309 . . . . 0.0 110.22 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.469 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 17.5 tt -144.24 139.54 15.91 Favored Pre-proline 0 C--N 1.322 -0.615 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 -179.697 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.529 ' HD3' ' HD3' ' A' ' 33' ' ' LYS . 15.9 Cg_exo -70.25 159.76 51.93 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 122.611 2.207 . . . . 0.0 112.178 176.245 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -143.62 90.36 2.15 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 176.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.496 HD22 HD23 ' A' ' 57' ' ' LEU . 78.3 mt -85.59 109.82 18.82 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.417 0.627 . . . . 0.0 110.753 -170.013 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.407 ' HA ' ' HD2' ' A' ' 7' ' ' PRO . 45.9 t -114.79 111.29 45.81 Favored Pre-proline 0 C--N 1.32 -0.68 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.602 -175.055 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.505 ' HD2' ' O ' ' A' ' 97' ' ' ASN . 34.2 Cg_endo -68.08 101.66 0.72 Allowed 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 122.2 1.933 . . . . 0.0 109.81 167.113 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.7 t -79.34 -55.37 9.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.441 -169.55 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.3 t -146.21 163.42 35.48 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.54 -174.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 58.8 tp -134.59 104.61 6.14 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.712 -178.655 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 15.6 p -107.45 143.03 26.38 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.45 -177.153 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -86.25 157.73 55.23 Favored 'Cis proline' 0 N--CA 1.457 -0.624 0 C-N-CA 122.964 -1.682 . . . . 0.0 112.021 -3.556 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 34.9 m -82.69 5.84 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.355 0.597 . . . . 0.0 110.257 178.568 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.522 ' HA ' ' O ' ' A' ' 105' ' ' GLY . 2.6 m -147.35 116.94 7.06 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 176.065 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.442 HG21 HD21 ' A' ' 71' ' ' LEU . 22.0 m -113.47 152.2 15.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.139 0.495 . . . . 0.0 111.77 -170.61 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.608 HG22 HD22 ' A' ' 107' ' ' LEU . 1.8 t -97.77 115.59 65.75 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.65 178.71 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.523 ' HA ' ' CB ' ' A' ' 71' ' ' LEU . 23.9 Cg_exo -64.93 -175.3 0.36 Allowed 'Trans proline' 0 C--O 1.234 0.277 0 C-N-CA 122.495 2.13 . . . . 0.0 112.564 179.754 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 12.1 m120 74.25 17.77 3.19 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.474 176.476 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 12.1 t -164.28 166.58 20.8 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 110.532 -0.173 . . . . 0.0 110.532 -177.699 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.508 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 52.6 t -85.84 109.7 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 172.365 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.669 ' OD1' HD23 ' A' ' 71' ' ' LEU . 9.8 m120 -85.52 125.64 33.22 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.068 -174.054 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 53.3 m -79.19 106.09 10.98 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.572 172.311 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.435 ' SD ' ' HE3' ' A' ' 69' ' ' TRP . 62.1 mtp -104.88 144.13 32.2 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.956 0.407 . . . . 0.0 110.339 -179.844 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.498 HG23 ' HB3' ' A' ' 64' ' ' ASN . 31.2 m -115.02 111.4 21.05 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.055 -174.666 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.4 ' HB3' ' HB ' ' A' ' 65' ' ' VAL . . . -97.92 118.37 34.33 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 173.819 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 38.7 m -87.59 107.81 18.77 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 120.878 0.37 . . . . 0.0 110.174 -179.257 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 20.2 mm -103.11 115.13 44.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.863 -179.551 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.555 ' HG2' ' HB3' ' A' ' 62' ' ' SER . 46.2 mt-10 -104.14 134.07 48.0 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.751 0.31 . . . . 0.0 110.836 177.527 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.493 ' HB2' ' HG ' ' A' ' 57' ' ' LEU . 29.9 t30 -90.44 92.06 8.72 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 173.496 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 80.4 mt-30 -87.86 53.18 2.68 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.615 0.721 . . . . 0.0 110.168 -176.087 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -143.89 160.5 27.76 Favored Glycine 0 N--CA 1.444 -0.829 0 CA-C-N 114.953 -1.022 . . . . 0.0 110.638 179.593 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.506 ' OD1' ' HA ' ' A' ' 1' ' ' MET . 26.6 p-10 -84.9 -0.88 55.66 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 117.011 0.405 . . . . 0.0 111.91 -171.718 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.529 ' HD3' ' HD3' ' A' ' 3' ' ' PRO . 48.2 tttm -112.59 144.8 41.46 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 176.346 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 -75.15 148.77 39.34 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 176.362 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 35.7 p -109.12 141.99 40.52 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.95 0.405 . . . . 0.0 110.763 -178.672 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.9 p -76.61 -164.81 0.45 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.382 -179.756 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.443 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 16.8 m -65.13 129.66 40.51 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.736 0.303 . . . . 0.0 110.965 -179.16 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.569 ' HB2' ' HB2' ' A' ' 85' ' ' ASP . 49.4 p90 -141.12 152.54 44.82 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.216 179.707 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.457 ' O ' ' HA ' ' A' ' 85' ' ' ASP . 30.1 m-80 -103.35 113.32 26.72 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.561 -175.065 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.503 HG11 HG21 ' A' ' 65' ' ' VAL . 1.4 t -98.36 122.39 49.97 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-O 121.269 0.557 . . . . 0.0 109.659 178.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 10.4 m -115.35 142.79 46.22 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.057 -174.597 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.49 HD11 ' HB3' ' A' ' 80' ' ' LEU . 45.0 tp -102.49 110.92 23.01 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.816 176.401 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.457 ' HG ' HG22 ' A' ' 48' ' ' VAL . 4.7 mp -98.9 114.58 27.26 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.24 -179.812 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.451 HG22 ' HG ' ' A' ' 80' ' ' LEU . 96.5 t -97.51 105.53 17.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.085 178.65 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 58.74 21.49 8.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.708 177.895 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 122.42 -33.66 4.08 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.908 176.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 8.5 mt -91.62 150.56 3.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 O-C-N 122.737 -0.272 . . . . 0.0 110.348 -176.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.457 HG22 ' HG ' ' A' ' 43' ' ' LEU . 44.5 t -96.74 118.15 42.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -179.251 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 27.2 m -97.11 -23.23 4.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.608 -177.39 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -153.36 142.34 21.24 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.254 -179.028 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.2 m -133.46 108.26 8.55 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.759 178.121 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -109.19 138.72 45.11 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.235 -175.678 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 17.3 m -105.61 110.14 22.35 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.912 0.387 . . . . 0.0 111.078 -178.691 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.443 ' O ' ' HA ' ' A' ' 37' ' ' SER . 45.4 t -77.78 128.74 38.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 176.842 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 12.3 m -60.22 -42.72 95.78 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.607 -177.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 30.2 t 178.21 129.93 0.06 Allowed 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 -178.058 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.529 HD13 ' OG1' ' A' ' 63' ' ' THR . 24.1 tp -108.51 117.37 33.98 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.159 0.504 . . . . 0.0 110.038 178.676 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -73.0 162.24 29.72 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.494 -175.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 2.9 p -61.5 124.35 20.4 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.329 -0.85 . . . . 0.0 111.352 179.23 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 61.01 28.62 18.4 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.854 179.014 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -108.95 156.78 19.31 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 174.541 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.555 ' HB3' ' HG2' ' A' ' 28' ' ' GLU . 32.5 p -114.09 125.83 54.42 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.535 179.211 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.529 ' OG1' HD13 ' A' ' 57' ' ' LEU . 53.2 m -112.78 129.44 56.43 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.975 0.417 . . . . 0.0 110.149 176.326 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.498 ' HB3' HG23 ' A' ' 24' ' ' THR . 94.1 m-20 -90.19 128.88 36.48 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.704 177.869 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.503 HG21 HG11 ' A' ' 40' ' ' VAL . 43.9 t -96.09 123.46 48.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.676 -177.979 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -86.19 97.64 10.47 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.446 -178.711 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -93.4 141.99 27.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.179 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 7.0 m80 -118.15 96.51 5.36 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.52 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' TRP . . . . . 0.435 ' HE3' ' SD ' ' A' ' 23' ' ' MET . 12.1 t90 -114.43 113.64 24.77 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.271 0.558 . . . . 0.0 110.621 -175.618 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.508 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 6.8 m -78.75 102.32 8.04 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.465 -0.788 . . . . 0.0 110.074 176.573 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.669 HD23 ' OD1' ' A' ' 21' ' ' ASN . 0.5 OUTLIER -61.05 113.9 2.81 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.095 0.474 . . . . 0.0 110.393 178.84 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -79.19 -32.98 44.3 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.569 -0.742 . . . . 0.0 111.075 -175.211 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -160.79 -146.29 4.57 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.05 -178.855 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 25.9 m -136.09 83.97 2.05 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.152 0.501 . . . . 0.0 110.497 179.253 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.422 ' O ' ' HB2' ' A' ' 76' ' ' ASN . . . -86.86 1.4 52.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.367 178.515 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.545 ' O ' ' HA2' ' A' ' 105' ' ' GLY . 17.0 m120 73.69 -50.4 0.69 Allowed 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.307 0.643 . . . . 0.0 112.229 -179.302 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 16.2 p -132.15 124.53 29.28 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 120.963 0.411 . . . . 0.0 111.708 -179.758 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -117.24 144.44 44.8 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.083 177.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.557 ' HA ' HD23 ' A' ' 103' ' ' LEU . 28.6 m -94.74 90.17 5.98 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.926 0.394 . . . . 0.0 110.094 -179.378 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.55 HD13 HG22 ' A' ' 104' ' ' VAL . 10.4 mp -94.18 117.23 29.8 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.308 0.575 . . . . 0.0 110.506 -178.093 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.525 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 18.8 m -114.2 119.03 35.65 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.459 -0.792 . . . . 0.0 110.394 -177.077 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 50.6 t -90.56 101.46 12.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 176.192 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -97.79 116.95 31.02 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 177.353 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.595 ' HB ' ' HB2' ' A' ' 98' ' ' ASN . 93.9 t -82.86 105.92 13.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 121.327 0.584 . . . . 0.0 111.264 -177.148 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.569 ' HB2' ' HB2' ' A' ' 38' ' ' PHE . 8.7 t70 54.42 90.86 0.08 OUTLIER Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 114.293 -1.321 . . . . 0.0 111.824 179.712 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_exo -58.17 -30.49 90.72 Favored 'Trans proline' 0 C--O 1.233 0.254 0 C-N-CA 123.052 2.501 . . . . 0.0 112.032 179.75 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -71.0 -25.56 62.74 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.093 177.427 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 43.0 t30 56.48 44.98 23.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.974 -177.575 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -65.18 -32.16 73.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.153 -0.931 . . . . 0.0 110.439 -179.729 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 49.5 t -86.9 123.96 40.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.394 175.376 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.493 ' O ' ' HD2' ' A' ' 3' ' ' PRO . 3.9 m-20 -77.89 130.95 37.24 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.892 -0.411 . . . . 0.0 109.892 178.678 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -124.09 161.42 25.65 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.75 -173.123 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -58.21 -100.77 0.01 OUTLIER Glycine 0 CA--C 1.521 0.448 0 CA-C-N 115.033 -0.985 . . . . 0.0 112.528 172.171 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -57.94 156.37 9.24 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 176.459 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 -102.46 -24.93 13.78 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.15 0.5 . . . . 0.0 110.965 179.371 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 5.9 p -98.89 21.44 11.55 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.313 0.578 . . . . 0.0 110.972 -177.522 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.505 ' O ' ' HD2' ' A' ' 7' ' ' PRO . 26.4 p-10 -96.27 -33.82 11.84 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.106 -177.493 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.595 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 19.5 p-10 -83.7 9.77 10.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.968 -169.433 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 1.6 m -117.65 147.42 42.9 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.747 0.308 . . . . 0.0 110.22 177.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.525 ' O ' ' HA ' ' A' ' 81' ' ' THR . 50.2 tp -144.74 98.82 3.25 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.233 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 6.9 m -92.54 104.58 16.87 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.685 177.404 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -126.62 138.2 53.41 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.135 0.493 . . . . 0.0 111.359 -176.818 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.557 HD23 ' HA ' ' A' ' 79' ' ' THR . 74.0 mt -89.83 124.6 34.81 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.992 175.623 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.55 HG22 HD13 ' A' ' 80' ' ' LEU . 28.3 m -108.97 141.51 24.05 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 176.219 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.545 ' HA2' ' O ' ' A' ' 76' ' ' ASN . . . -102.47 166.72 17.3 Favored Glycine 0 N--CA 1.439 -1.101 0 C-N-CA 120.273 -0.965 . . . . 0.0 111.789 -176.064 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.529 ' OG1' ' HA ' ' A' ' 76' ' ' ASN . 24.5 p -91.85 140.86 29.26 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 173.169 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.608 HD22 HG22 ' A' ' 16' ' ' VAL . 7.7 tp -57.84 133.02 55.06 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 123.378 0.424 . . . . 0.0 111.126 -173.736 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 29.6 mm-40 -51.46 -38.04 51.84 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.061 -0.972 . . . . 0.0 112.058 -179.196 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 60.3 m80 -104.71 94.4 5.27 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -174.867 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 62.6 t-80 -58.12 135.98 57.13 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 163.328 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -44.31 -50.24 9.1 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 123.589 0.556 . . . . 0.0 111.564 -167.054 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 12.1 m170 -114.67 106.83 14.69 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 167.252 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 58.4 t-80 -107.56 138.0 44.57 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.57 -177.646 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 54.3 t-80 . . . . . 0 C--O 1.245 0.82 0 CA-C-O 118.435 -0.793 . . . . 0.0 109.879 176.118 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.8 mtt . . . . . 0 N--CA 1.481 1.078 0 CA-C-O 121.152 0.501 . . . . 0.0 110.724 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.529 HG13 ' HD2' ' A' ' 3' ' ' PRO . 4.0 tp -123.25 145.74 47.24 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.09 -179.067 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.529 ' HD2' HG13 ' A' ' 2' ' ' ILE . 11.9 Cg_exo -70.96 177.24 6.63 Favored 'Trans proline' 0 C--O 1.236 0.398 0 C-N-CA 122.498 2.132 . . . . 0.0 112.226 178.108 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.487 ' HB3' ' C ' ' A' ' 30' ' ' GLN . 24.8 t70 -149.14 77.91 1.37 Allowed 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 175.536 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.539 HD22 HD23 ' A' ' 57' ' ' LEU . 83.4 mt -75.36 109.63 9.05 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.932 -176.863 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 25.8 t -118.79 120.65 31.34 Favored Pre-proline 0 C--N 1.319 -0.744 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.247 -178.476 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.522 ' HB2' ' HB2' ' A' ' 100' ' ' LEU . 5.7 Cg_exo -73.68 111.22 3.24 Favored 'Trans proline' 0 N--CA 1.45 -1.06 0 C-N-CA 121.947 1.765 . . . . 0.0 109.726 172.43 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.0 t -80.55 -57.71 4.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.457 -169.023 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 32.8 t -144.94 167.32 22.92 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.631 -175.267 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 58.5 tp -138.62 114.61 10.1 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.149 -177.462 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.5 p -125.41 157.93 66.09 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.656 -179.725 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.63 159.51 96.43 Favored 'Cis proline' 0 N--CA 1.465 -0.185 0 C-N-CA 123.357 -1.518 . . . . 0.0 111.871 -3.356 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 29.7 m -78.31 -19.89 13.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.221 0.534 . . . . 0.0 110.249 -178.856 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.511 ' HA ' ' O ' ' A' ' 105' ' ' GLY . 17.3 p -124.5 130.61 52.78 Favored 'General case' 0 N--CA 1.437 -1.124 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.993 174.768 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.425 HG11 ' CZ3' ' A' ' 69' ' ' TRP . 31.3 m -113.06 146.56 17.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 120.766 0.317 . . . . 0.0 111.112 -177.02 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.603 HG22 HD22 ' A' ' 107' ' ' LEU . 18.1 t -92.13 113.0 57.76 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 116.633 -0.258 . . . . 0.0 110.963 -175.854 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.532 ' HA ' ' HB3' ' A' ' 71' ' ' LEU . 4.7 Cg_exo -72.44 97.86 0.9 Allowed 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 122.429 2.086 . . . . 0.0 109.934 173.727 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 -177.49 -46.07 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.417 -169.178 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 14.8 t -148.76 -169.63 3.41 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.954 -175.425 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.516 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 43.2 t -78.84 128.34 38.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 176.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.417 ' ND2' HD23 ' A' ' 71' ' ' LEU . 23.6 m-80 -102.82 125.19 49.47 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.64 -179.817 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.5 m -80.16 103.89 10.34 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 178.396 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.553 ' HB2' ' HB2' ' A' ' 67' ' ' PHE . 95.8 mmm -87.63 133.05 33.88 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.734 -174.694 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.534 ' HA ' ' O ' ' A' ' 65' ' ' VAL . 42.4 m -105.86 109.33 21.24 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.825 -177.719 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.429 ' HB3' ' HB ' ' A' ' 65' ' ' VAL . . . -102.58 112.15 24.78 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.594 174.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 21.8 m -83.48 105.69 14.63 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.077 -178.017 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 21.5 mm -100.51 121.12 50.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 -179.59 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -113.1 134.78 54.38 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 -179.236 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.499 ' HB2' ' HG ' ' A' ' 57' ' ' LEU . 41.3 t30 -94.48 107.16 19.14 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.05 0.452 . . . . 0.0 109.819 177.863 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.487 ' C ' ' HB3' ' A' ' 4' ' ' ASP . 73.0 mt-30 -113.89 56.65 0.7 Allowed 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.243 -175.579 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -143.88 -165.65 10.97 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.36 -0.924 . . . . 0.0 112.493 -174.661 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -93.2 4.0 54.74 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 -169.448 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -155.41 150.19 26.43 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.785 -177.827 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -73.72 146.45 44.4 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 175.648 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.491 ' OG ' ' HB3' ' A' ' 57' ' ' LEU . 35.3 p -93.49 149.1 21.5 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.031 0.444 . . . . 0.0 110.807 -179.277 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.435 ' OG1' HG22 ' A' ' 90' ' ' VAL . 38.8 p -86.13 -158.9 0.43 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.885 177.057 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.461 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 37.8 t -69.71 107.95 3.69 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.752 0.31 . . . . 0.0 110.256 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.433 ' HB3' ' CG2' ' A' ' 90' ' ' VAL . 55.7 p90 -118.11 140.37 49.87 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.103 0.477 . . . . 0.0 109.878 179.723 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.514 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 65.3 t30 -90.35 128.37 36.44 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.897 -176.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.539 HG23 ' HA ' ' A' ' 84' ' ' VAL . 0.3 OUTLIER -116.62 136.91 52.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 -175.403 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.406 ' HB3' ' CG1' ' A' ' 48' ' ' VAL . 27.9 m -124.42 135.34 53.19 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.288 -173.467 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 57.8 tp -98.95 112.79 24.8 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.069 0.461 . . . . 0.0 110.168 175.714 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.552 ' HG ' HG22 ' A' ' 48' ' ' VAL . 5.0 mp -96.59 120.17 36.42 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.579 179.46 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 72.2 t -103.47 109.12 26.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 174.184 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 16.1 t70 74.39 -66.21 0.31 Allowed 'General case' 0 N--CA 1.464 0.273 0 O-C-N 124.188 0.93 . . . . 0.0 110.74 -179.516 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -162.62 14.04 0.12 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 121.144 -0.55 . . . . 0.0 112.682 179.064 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 10.8 mt -131.09 150.81 34.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 -179.217 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.552 HG22 ' HG ' ' A' ' 43' ' ' LEU . 29.6 t -93.12 94.9 4.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.504 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 32.8 m -70.82 -27.23 29.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.924 -173.355 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -157.93 152.85 25.32 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 178.263 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 25.2 m -139.09 128.71 24.57 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.287 -174.15 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.412 ' O ' HG12 ' A' ' 40' ' ' VAL . 2.5 tt0 -127.38 132.47 50.15 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 179.06 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.514 ' HA ' ' HA ' ' A' ' 39' ' ' ASN . 20.5 m -92.28 122.78 35.07 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 177.824 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.461 ' O ' ' HA ' ' A' ' 37' ' ' SER . 64.5 t -86.2 127.98 39.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 178.674 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 14.4 m -62.47 -45.35 93.42 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.139 -0.482 . . . . 0.0 112.087 -173.731 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 36.9 t -178.41 125.77 0.11 Allowed 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -177.823 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.539 HD23 HD22 ' A' ' 5' ' ' LEU . 25.2 tp -104.55 112.15 25.11 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.546 0.689 . . . . 0.0 110.558 178.767 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.41 ' HB3' ' HB2' ' A' ' 61' ' ' ASN . 34.5 tt0 -66.13 145.92 55.25 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.679 -179.082 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 5.9 t -64.25 137.96 58.2 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 178.719 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 68.87 9.67 7.5 Favored 'General case' 0 N--CA 1.464 0.231 0 O-C-N 123.741 0.651 . . . . 0.0 111.542 -178.423 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.41 ' HB2' ' HB3' ' A' ' 58' ' ' GLU . 4.7 m-20 -114.38 161.3 18.11 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.885 0.374 . . . . 0.0 110.598 177.768 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.3 m -123.9 124.52 42.82 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.503 179.245 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 54.5 m -104.21 124.02 48.37 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 176.765 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.469 ' HB3' HG23 ' A' ' 24' ' ' THR . 45.3 m-80 -87.0 126.0 34.45 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 179.599 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.534 ' O ' ' HA ' ' A' ' 24' ' ' THR . 22.1 t -96.07 136.34 27.3 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.828 -178.42 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -111.02 102.86 11.3 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.002 0.43 . . . . 0.0 110.209 -178.108 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.553 ' HB2' ' HB2' ' A' ' 23' ' ' MET . 66.5 m-85 -91.76 144.73 25.2 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.212 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 33.9 m-70 -99.59 87.88 3.69 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.029 179.605 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' TRP . . . . . 0.425 ' CZ3' HG11 ' A' ' 15' ' ' VAL . 18.2 t90 -108.02 110.45 22.16 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.276 0.56 . . . . 0.0 111.099 -173.827 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.516 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 5.5 m -80.87 122.78 27.64 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.858 177.383 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.532 ' HB3' ' HA ' ' A' ' 17' ' ' PRO . 0.9 OUTLIER -88.04 119.76 28.72 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.217 0.532 . . . . 0.0 112.09 -177.248 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -83.99 -38.69 20.62 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.827 173.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 88.4 24.87 32.43 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 121.017 -0.611 . . . . 0.0 113.501 174.546 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 85.5 m -64.0 -51.1 65.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.197 0.522 . . . . 0.0 110.985 177.783 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -110.6 146.91 35.31 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.408 179.424 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 17.3 p-10 -81.89 -6.91 59.49 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.033 0.444 . . . . 0.0 110.94 -177.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 8.8 t -149.23 124.97 10.48 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 176.662 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -112.84 156.2 23.32 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.163 0.506 . . . . 0.0 111.542 -177.823 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.445 ' HA ' HD23 ' A' ' 103' ' ' LEU . 6.0 m -96.78 97.51 9.38 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.279 177.936 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.519 HD13 HG22 ' A' ' 104' ' ' VAL . 9.4 mp -96.64 117.82 31.81 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.346 0.593 . . . . 0.0 110.592 -177.532 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.574 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 24.7 m -117.08 119.58 35.69 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.372 -177.243 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 39.8 t -94.99 109.6 22.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 177.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -99.03 125.61 44.56 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 120.419 -0.513 . . . . 0.0 110.019 178.129 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.577 ' HB ' ' HB2' ' A' ' 98' ' ' ASN . 96.6 t -98.2 111.35 27.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.917 -176.06 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 24.1 t70 66.89 92.34 0.07 OUTLIER Pre-proline 0 N--CA 1.466 0.341 0 CA-C-N 115.136 -0.938 . . . . 0.0 112.641 177.04 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -101.03 19.83 0.25 Allowed 'Trans proline' 0 N--CA 1.451 -1.008 0 C-N-CA 123.525 2.816 . . . . 0.0 111.718 171.73 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 58.8 mt-10 -128.17 -7.71 5.37 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.945 -174.282 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 8.1 t30 60.31 47.07 9.42 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.822 0.82 . . . . 0.0 109.882 -175.747 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -83.91 -37.3 22.54 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 174.075 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.435 HG22 ' OG1' ' A' ' 36' ' ' THR . 21.7 t -120.87 105.79 17.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 114.584 -1.189 . . . . 0.0 108.3 170.036 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -77.49 104.38 7.98 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.003 0.43 . . . . 0.0 110.116 -177.668 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 50.9 mm-40 -77.91 176.07 9.45 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.814 -177.701 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -57.91 -100.93 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.725 172.316 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 28.5 p-10 -87.77 174.89 8.11 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 173.756 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -115.21 24.71 11.43 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.117 0.484 . . . . 0.0 111.122 178.448 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 41.3 m -110.39 18.63 19.63 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.398 0.618 . . . . 0.0 110.003 175.783 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 28.3 p-10 -124.29 -24.82 4.22 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.894 -177.813 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.577 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 26.5 p-10 -86.6 23.57 1.62 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.744 -173.044 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.56 144.64 46.33 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.893 0.378 . . . . 0.0 110.788 -179.611 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.574 ' O ' ' HA ' ' A' ' 81' ' ' THR . 30.0 tp -136.97 115.66 12.08 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.085 178.775 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 15.0 m -104.9 102.45 11.97 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 178.753 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -121.65 135.35 54.98 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.974 0.416 . . . . 0.0 111.248 -176.742 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.445 HD23 ' HA ' ' A' ' 79' ' ' THR . 60.9 mt -87.43 125.17 34.12 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.559 175.677 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.519 HG22 HD13 ' A' ' 80' ' ' LEU . 25.6 m -112.64 155.43 13.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 175.666 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.511 ' O ' ' HA ' ' A' ' 14' ' ' THR . . . -120.49 171.34 14.63 Favored Glycine 0 N--CA 1.444 -0.787 0 C-N-CA 120.156 -1.021 . . . . 0.0 111.461 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 32.1 p -76.32 169.05 18.95 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.689 -0.485 . . . . 0.0 109.689 174.464 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.603 HD22 HG22 ' A' ' 16' ' ' VAL . 29.1 tp -69.02 94.44 0.64 Allowed 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.206 0.527 . . . . 0.0 110.745 -178.455 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -82.66 15.17 2.72 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.672 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 6.0 t-80 -79.43 -4.57 51.74 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 176.419 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 41.0 m170 -94.55 -6.58 43.34 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.42 173.441 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 4.7 t-160 -90.75 28.75 1.46 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.265 -178.446 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 32.1 t-80 -74.87 113.86 12.65 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.195 -176.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 28.5 t-80 -86.18 -74.38 0.42 Allowed 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 177.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 92.1 m-70 . . . . . 0 C--O 1.247 0.926 0 CA-C-O 118.384 -0.817 . . . . 0.0 109.021 175.692 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.43 ' O ' ' HD2' ' A' ' 33' ' ' LYS . 26.3 ttt . . . . . 0 N--CA 1.477 0.884 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.485 HG12 ' HD2' ' A' ' 3' ' ' PRO . 6.2 tt -140.09 147.64 51.4 Favored Pre-proline 0 CA--C 1.535 0.386 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 -175.228 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.485 ' HD2' HG12 ' A' ' 2' ' ' ILE . 2.7 Cg_exo -76.04 -174.25 1.99 Allowed 'Trans proline' 0 C--O 1.237 0.45 0 C-N-CA 122.598 2.199 . . . . 0.0 112.128 178.072 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -162.23 75.51 0.45 Allowed 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 179.296 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.421 HD22 HD23 ' A' ' 57' ' ' LEU . 73.3 mt -70.09 103.24 2.24 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.813 -177.592 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.462 ' HA ' ' HD2' ' A' ' 7' ' ' PRO . 42.7 t -110.72 110.47 57.35 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.002 -179.015 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.524 ' HD3' HG21 ' A' ' 84' ' ' VAL . 20.7 Cg_endo -63.85 114.27 2.52 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 122.271 1.981 . . . . 0.0 109.978 168.686 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 6.3 t -89.25 -58.9 3.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.25 -168.613 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.7 p -136.66 154.09 50.73 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.565 -174.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 62.1 tp -130.11 100.1 5.3 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.239 176.056 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.527 HG23 ' HA ' ' A' ' 12' ' ' PRO . 56.6 m -115.61 141.11 26.88 Favored Pre-proline 0 C--N 1.317 -0.84 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.198 -175.13 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.533 ' HG2' HG12 ' A' ' 15' ' ' VAL . 72.1 Cg_endo -83.46 133.79 21.79 Favored 'Cis proline' 0 N--CA 1.461 -0.397 0 C-N-CA 123.383 -1.507 . . . . 0.0 113.244 1.767 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 35.0 m -65.75 -11.44 12.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.818 175.757 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.517 ' HA ' ' O ' ' A' ' 105' ' ' GLY . 0.6 OUTLIER -135.39 118.94 16.95 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 175.969 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.533 HG12 ' HG2' ' A' ' 12' ' ' PRO . 27.4 m -113.54 166.0 7.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.828 -170.106 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 1.7 t -108.09 119.72 49.07 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.166 179.107 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.607 ' HD2' ' O ' ' A' ' 111' ' ' HIS . 36.5 Cg_exo -60.94 88.53 0.09 OUTLIER 'Trans proline' 0 C--O 1.236 0.402 0 C-N-CA 122.339 2.026 . . . . 0.0 109.719 167.013 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -158.25 -50.69 0.06 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.954 -167.3 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 8.9 t -153.76 -169.82 3.39 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.006 -172.809 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.508 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 39.0 t -77.76 114.24 18.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 174.891 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.529 ' OD1' HD23 ' A' ' 71' ' ' LEU . 9.6 m120 -86.84 132.81 33.72 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.479 -175.28 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 20.6 m -79.23 93.69 5.29 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.249 177.554 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.549 ' HB2' ' HB2' ' A' ' 67' ' ' PHE . 93.1 mmm -85.67 107.57 17.61 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.795 -178.979 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 17.7 m -97.96 113.15 24.92 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.819 -176.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -104.29 110.04 22.11 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.98 -0.554 . . . . 0.0 109.959 177.545 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 24.7 m -87.47 113.91 23.6 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 120.965 0.412 . . . . 0.0 110.324 -178.811 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 15.9 mm -100.8 122.86 53.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.708 -179.227 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -115.08 120.57 40.26 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 -179.21 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 32.4 t30 -82.7 98.39 9.04 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 178.276 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -94.18 44.24 1.11 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.353 0.596 . . . . 0.0 110.679 -175.684 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -143.96 147.97 19.51 Favored Glycine 0 N--CA 1.444 -0.789 0 N-CA-C 111.206 -0.758 . . . . 0.0 111.206 -177.629 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 14.5 t30 -84.89 61.68 6.98 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.489 0.662 . . . . 0.0 111.399 -172.371 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.448 ' HD3' ' HD3' ' A' ' 3' ' ' PRO . 54.4 tttm -161.69 156.85 23.57 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 170.311 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -80.7 154.57 27.22 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 120.867 0.365 . . . . 0.0 110.044 175.65 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 22.2 p -124.26 136.46 54.16 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.999 177.032 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 3.7 p -77.08 -166.53 0.72 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.889 179.306 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.425 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 7.5 t -60.93 113.04 2.31 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.989 0.423 . . . . 0.0 110.494 179.267 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.475 ' HB2' ' HB2' ' A' ' 85' ' ' ASP . 33.9 p90 -118.28 147.52 43.37 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.521 178.676 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.495 ' HB3' ' HD2' ' A' ' 86' ' ' PRO . 51.6 t-20 -90.29 128.59 36.46 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.368 -175.353 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.557 HG11 HG21 ' A' ' 65' ' ' VAL . 2.2 t -118.66 111.87 35.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-O 121.588 0.709 . . . . 0.0 109.821 176.144 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 8.9 m -111.77 143.15 43.17 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.807 -175.05 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 63.6 tp -102.75 113.76 27.44 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 176.735 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.553 ' HG ' HG22 ' A' ' 48' ' ' VAL . 4.8 mp -102.12 139.77 37.29 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.547 179.445 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 93.4 t -110.47 110.67 33.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 172.113 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 20.1 t70 67.73 -74.0 0.08 Allowed 'General case' 0 N--CA 1.464 0.273 0 O-C-N 124.042 0.839 . . . . 0.0 110.587 -174.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -150.3 6.95 0.71 Allowed Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.903 179.003 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 6.0 mt -116.85 147.44 20.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 117.104 0.452 . . . . 0.0 109.874 -179.319 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.553 HG22 ' HG ' ' A' ' 43' ' ' LEU . 25.5 t -94.08 114.8 31.44 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.294 -177.658 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 28.5 m -91.03 -30.0 4.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.594 -0.276 . . . . 0.0 111.47 -177.848 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -148.69 145.48 27.71 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 -178.785 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 58.3 m -137.51 114.39 10.61 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.909 -176.433 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -126.18 105.55 8.92 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.06 0.457 . . . . 0.0 110.24 -177.591 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.492 ' HA ' ' HA ' ' A' ' 39' ' ' ASN . 15.2 m -74.18 131.06 40.9 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.934 178.391 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.425 ' O ' ' HA ' ' A' ' 37' ' ' SER . 44.6 t -92.57 139.23 18.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 116.263 -0.426 . . . . 0.0 109.892 -179.146 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 18.6 m -59.55 -53.67 55.42 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.11 -0.495 . . . . 0.0 112.132 -177.038 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 35.3 t -176.81 149.95 0.77 Allowed 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -177.451 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.554 HD13 ' OG1' ' A' ' 63' ' ' THR . 25.2 tp -133.84 133.34 41.46 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.135 0.493 . . . . 0.0 110.424 178.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -89.79 174.62 7.61 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.775 -176.441 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 3.7 p -69.57 129.18 38.96 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.151 -179.775 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 50.5 mm-40 66.33 15.63 10.16 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.166 177.09 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -104.21 154.21 20.04 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 -179.623 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 7.3 m -113.1 143.73 43.84 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.829 0.347 . . . . 0.0 110.774 -178.816 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.554 ' OG1' HD13 ' A' ' 57' ' ' LEU . 95.6 m -128.86 127.91 42.8 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.078 174.934 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 40.1 m-80 -90.89 124.96 35.59 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.179 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.557 HG21 HG11 ' A' ' 40' ' ' VAL . 39.2 t -96.19 132.1 41.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.069 -178.335 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -101.81 97.3 7.7 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.525 -174.142 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.549 ' HB2' ' HB2' ' A' ' 23' ' ' MET . 32.2 m-85 -96.01 144.73 26.04 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.179 0.514 . . . . 0.0 111.302 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 15.9 m-70 -116.32 103.0 10.04 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.937 179.127 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' TRP . . . . . 0.41 ' CE2' HD22 ' A' ' 71' ' ' LEU . 11.3 t90 -116.51 111.2 19.61 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.516 -176.462 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.508 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 6.7 m -80.46 108.17 13.87 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.319 178.459 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.529 HD23 ' OD1' ' A' ' 21' ' ' ASN . 0.2 OUTLIER -69.25 116.02 9.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.953 0.406 . . . . 0.0 111.065 -178.302 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -84.54 -35.65 22.7 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.575 176.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 90.3 35.17 7.63 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.673 177.456 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 25.5 m -79.59 -38.63 33.53 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.023 0.44 . . . . 0.0 110.768 177.276 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -126.28 161.15 28.43 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.46 -174.417 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 -91.07 -12.02 36.94 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.461 178.146 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.562 ' HB2' HD21 ' A' ' 103' ' ' LEU . 28.4 p -147.34 137.83 23.37 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.363 177.685 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 40.3 m-85 -125.73 134.03 51.9 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.144 -178.212 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 21.4 m -89.53 92.92 9.3 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 120.927 0.394 . . . . 0.0 110.059 178.24 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.491 HD13 HG22 ' A' ' 104' ' ' VAL . 9.0 mp -88.37 137.92 31.9 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.194 0.521 . . . . 0.0 110.607 -179.445 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.416 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 19.1 m -131.44 114.56 15.08 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.428 -179.412 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.546 ' HB ' ' HB3' ' A' ' 100' ' ' LEU . 61.8 t -88.39 105.24 15.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 175.101 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -94.61 110.45 22.27 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.006 0.432 . . . . 0.0 110.104 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.524 HG21 ' HD3' ' A' ' 7' ' ' PRO . 85.6 t -83.19 114.47 24.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.341 -177.697 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.475 ' HB2' ' HB2' ' A' ' 38' ' ' PHE . 39.8 t0 58.74 73.66 0.69 Allowed Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 114.232 -1.349 . . . . 0.0 112.089 177.759 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.495 ' HD2' ' HB3' ' A' ' 39' ' ' ASN . 6.6 Cg_exo -74.19 -18.08 21.22 Favored 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 122.758 2.305 . . . . 0.0 111.141 176.301 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -87.77 -13.1 43.23 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.384 -177.616 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 62.79 45.62 5.62 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.194 177.616 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -77.12 -22.7 52.27 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.316 178.37 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 13.5 t -119.16 143.35 30.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.961 178.153 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 43.0 t-20 -89.54 105.38 17.76 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 178.596 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -98.82 147.21 25.14 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -174.474 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -57.76 -101.1 0.01 OUTLIER Glycine 0 CA--C 1.518 0.243 0 CA-C-N 114.965 -1.016 . . . . 0.0 113.195 174.124 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -73.92 106.54 5.68 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.929 0.395 . . . . 0.0 111.363 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.585 ' HA ' ' OD1' ' A' ' 98' ' ' ASN . 40.8 mt-10 -68.37 -11.71 60.0 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.089 179.418 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 8.1 m -70.82 -7.79 47.83 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.93 177.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.483 ' O ' ' HD2' ' A' ' 7' ' ' PRO . 88.6 m-20 -97.27 -21.73 17.09 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.139 -178.652 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.585 ' OD1' ' HA ' ' A' ' 95' ' ' GLU . 14.3 m120 -59.3 -34.89 72.85 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -172.234 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.49 125.0 49.8 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.258 0.551 . . . . 0.0 112.019 -178.073 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.546 ' HB3' ' HB ' ' A' ' 82' ' ' VAL . 28.5 tp -107.33 98.12 7.79 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.371 175.334 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 20.0 m -90.96 94.66 9.74 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.234 0.54 . . . . 0.0 110.105 -179.652 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -112.62 112.29 23.71 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.212 -178.89 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.562 HD21 ' HB2' ' A' ' 77' ' ' SER . 5.9 tt -80.86 104.29 11.27 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 179.681 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.491 HG22 HD13 ' A' ' 80' ' ' LEU . 18.3 m -93.83 149.86 4.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.655 -177.818 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.517 ' O ' ' HA ' ' A' ' 14' ' ' THR . . . -119.72 170.95 14.25 Favored Glycine 0 N--CA 1.443 -0.876 0 C-N-CA 119.941 -1.123 . . . . 0.0 111.876 -176.726 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 42.5 p -89.5 130.22 35.87 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 173.286 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.773 HD23 ' HB2' ' A' ' 110' ' ' HIS . 17.9 tp -56.64 130.22 44.35 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 -175.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -82.17 -55.04 4.79 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.666 -0.414 . . . . 0.0 111.666 -170.396 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 10.4 t-160 -69.26 -19.33 63.93 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 120.891 0.377 . . . . 0.0 111.137 -177.597 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' HIS . . . . . 0.773 ' HB2' HD23 ' A' ' 107' ' ' LEU . 5.3 m-70 -128.15 81.85 2.05 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 169.535 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' HIS . . . . . 0.607 ' O ' ' HD2' ' A' ' 17' ' ' PRO . 0.8 OUTLIER -92.8 -73.55 0.55 Allowed 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.759 -0.377 . . . . 0.0 111.612 -169.1 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 56.0 t60 -105.2 83.87 2.03 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 119.852 -0.739 . . . . 0.0 110.607 -179.231 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 43.5 t-80 -79.64 149.47 31.29 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.601 176.462 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 27.1 p80 . . . . . 0 C--O 1.244 0.802 0 CA-C-O 118.593 -0.718 . . . . 0.0 109.627 174.235 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 83.0 mmm . . . . . 0 N--CA 1.478 0.928 0 CA-C-O 121.079 0.466 . . . . 0.0 110.106 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.459 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 0.8 OUTLIER -114.48 142.36 28.03 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.455 179.286 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.462 ' HD2' ' O ' ' A' ' 91' ' ' ASN . 12.9 Cg_endo -91.05 156.89 3.9 Favored 'Trans proline' 0 N--CA 1.445 -1.36 0 C-N-CA 122.883 2.388 . . . . 0.0 111.024 172.196 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -137.39 105.23 5.61 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 -179.126 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.531 HD22 HD23 ' A' ' 57' ' ' LEU . 27.4 mt -99.78 126.69 45.89 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 -171.145 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.532 HG22 ' HB3' ' A' ' 97' ' ' ASN . 4.6 t -125.42 140.29 35.94 Favored Pre-proline 0 C--N 1.317 -0.845 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.444 -176.52 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.473 ' HD3' ' O ' ' A' ' 97' ' ' ASN . 6.8 Cg_endo -92.79 100.72 0.17 Allowed 'Trans proline' 0 N--CA 1.445 -1.375 0 C-N-CA 123.13 2.553 . . . . 0.0 110.054 167.514 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 27.4 m -79.53 -28.86 13.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.811 -171.414 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 35.4 t -156.67 147.54 21.86 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.772 0.32 . . . . 0.0 110.888 -176.452 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.541 HD11 ' HB3' ' A' ' 23' ' ' MET . 19.4 tp -127.68 126.14 41.38 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 171.813 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.519 ' OG1' ' HA ' ' A' ' 12' ' ' PRO . 6.5 t -122.26 152.05 60.01 Favored Pre-proline 0 C--N 1.317 -0.835 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.912 178.278 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.64 ' HD2' ' SD ' ' A' ' 23' ' ' MET . 98.5 Cg_endo -80.92 149.92 77.75 Favored 'Cis proline' 0 N--CA 1.46 -0.467 0 C-N-CA 123.483 -1.465 . . . . 0.0 112.492 -3.54 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 35.3 m -69.09 -21.57 25.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.059 177.649 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.558 ' HA ' ' O ' ' A' ' 105' ' ' GLY . 0.7 OUTLIER -124.71 131.19 53.48 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.152 174.288 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.0 m -114.56 149.2 16.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 121.04 0.448 . . . . 0.0 111.789 -174.381 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.9 m -98.34 117.69 64.44 Favored Pre-proline 0 N--CA 1.447 -0.577 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.346 178.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.553 ' HA ' ' HB3' ' A' ' 71' ' ' LEU . 10.0 Cg_exo -71.06 91.31 0.64 Allowed 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 122.597 2.198 . . . . 0.0 110.443 173.139 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -163.23 -41.6 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.216 -171.489 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 13.5 t -145.73 -170.23 3.42 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.001 -172.874 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.439 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 62.1 t -84.34 116.51 28.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 172.853 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.587 ' OD1' HD23 ' A' ' 71' ' ' LEU . 9.2 m120 -91.47 118.44 30.56 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.636 -174.177 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.628 ' HA ' ' O ' ' A' ' 67' ' ' PHE . 58.7 m -80.6 96.26 6.79 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-O 121.319 0.581 . . . . 0.0 109.873 177.34 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.64 ' SD ' ' HD2' ' A' ' 12' ' ' PRO . 93.3 mmm -79.14 126.56 30.89 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.478 -176.154 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.49 ' HA ' ' O ' ' A' ' 65' ' ' VAL . 17.5 m -105.07 112.34 25.44 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.975 0.416 . . . . 0.0 111.36 -176.208 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -104.15 130.41 51.89 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.012 176.275 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 23.7 m -95.8 108.34 20.67 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 120.695 0.283 . . . . 0.0 110.431 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.429 ' O ' ' HA ' ' A' ' 62' ' ' SER . 19.7 mm -100.06 119.95 48.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.863 -179.668 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -115.18 136.22 53.34 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.249 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 32.9 t30 -91.89 99.96 12.72 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.305 178.392 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -99.35 45.97 0.98 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.835 -175.281 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -144.01 160.08 27.73 Favored Glycine 0 N--CA 1.449 -0.463 0 N-CA-C 111.533 -0.627 . . . . 0.0 111.533 179.32 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -87.33 56.3 3.91 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.232 0.539 . . . . 0.0 110.924 -174.421 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.9 tptp -161.64 139.94 9.34 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 174.233 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -76.3 149.73 37.03 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 174.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.3 p -120.49 140.63 51.15 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.929 0.395 . . . . 0.0 110.498 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 3.9 p -91.84 -163.29 1.02 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.017 -178.278 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.557 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 48.5 m -49.03 115.6 1.35 Allowed 'General case' 0 C--O 1.234 0.276 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -179.482 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.463 ' CE2' HG23 ' A' ' 40' ' ' VAL . 30.4 p90 -130.57 149.52 52.2 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.12 177.632 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 11.8 m-80 -98.46 108.6 21.33 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.296 -172.71 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.463 HG23 ' CE2' ' A' ' 38' ' ' PHE . 2.3 t -98.32 117.88 43.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.401 0.62 . . . . 0.0 110.492 178.333 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 16.9 m -108.28 146.59 32.66 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.957 -176.372 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.42 HD11 ' HB3' ' A' ' 80' ' ' LEU . 47.6 tp -106.82 113.89 27.65 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 174.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.545 ' HG ' HG22 ' A' ' 48' ' ' VAL . 4.8 mp -101.07 121.01 41.03 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.277 -179.552 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 98.0 t -100.54 102.2 13.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 178.166 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 60.75 17.25 7.45 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.708 178.797 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 128.38 -34.45 2.92 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.943 176.87 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 11.5 mm -89.99 150.33 3.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.945 0.372 . . . . 0.0 110.209 -176.719 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.545 HG22 ' HG ' ' A' ' 43' ' ' LEU . 52.4 t -96.98 112.21 28.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 -179.375 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 24.3 m -86.01 -32.85 7.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.382 -177.724 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 38.4 t0 -159.68 162.32 35.06 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 120.889 0.376 . . . . 0.0 110.645 -178.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 85.0 m -149.81 129.86 13.52 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.785 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -117.69 118.82 33.14 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 110.175 -0.306 . . . . 0.0 110.175 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 27.6 m -74.86 108.35 7.54 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.034 175.715 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.557 ' O ' ' HA ' ' A' ' 37' ' ' SER . 40.3 t -77.53 128.37 38.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 178.196 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 7.3 m -57.44 -50.14 73.99 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 123.333 0.395 . . . . 0.0 111.763 -173.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 45.7 m -170.8 151.19 3.38 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 -177.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.531 HD23 HD22 ' A' ' 5' ' ' LEU . 23.8 tp -136.97 112.35 9.23 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.145 0.498 . . . . 0.0 110.364 177.73 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 23.9 mm-40 -76.28 174.38 10.24 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.889 -177.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 24.2 m -67.4 129.15 39.0 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.969 -179.069 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.457 ' O ' ' HG2' ' A' ' 60' ' ' GLU . 37.0 tt0 69.61 10.21 7.53 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.136 178.322 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 58.5 t30 -93.34 146.24 23.87 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.542 -0.463 . . . . 0.0 109.839 178.523 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.429 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 9.3 m -119.07 131.43 55.94 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.738 177.631 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.552 HG21 HG11 ' A' ' 54' ' ' VAL . 9.3 t -114.56 139.84 49.26 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.957 0.408 . . . . 0.0 110.42 179.014 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 30.7 m-80 -92.2 114.06 26.5 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.146 178.218 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.49 ' O ' ' HA ' ' A' ' 24' ' ' THR . 10.0 t -96.4 122.88 48.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.582 -179.581 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.581 ' HB3' ' CG2' ' A' ' 22' ' ' THR . 17.3 m-20 -111.78 109.44 19.27 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.012 0.434 . . . . 0.0 110.862 -176.217 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.628 ' O ' ' HA ' ' A' ' 22' ' ' THR . 61.7 m-85 -91.5 163.93 13.98 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.372 -175.914 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 17.4 m80 -111.92 93.43 4.45 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.34 177.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 15.4 t90 -113.53 110.56 20.46 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.068 0.461 . . . . 0.0 110.679 -176.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.439 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 22.0 m -81.41 112.44 18.68 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.913 176.894 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.587 HD23 ' OD1' ' A' ' 21' ' ' ASN . 0.3 OUTLIER -71.6 119.52 15.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.121 0.486 . . . . 0.0 111.503 -177.317 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 24.5 p-10 -83.32 -33.58 25.87 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.612 175.209 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 77.38 29.62 55.63 Favored Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.87 174.832 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 25.6 m -80.05 -51.33 9.16 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.011 0.434 . . . . 0.0 110.501 179.756 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -105.85 148.29 27.73 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.302 179.372 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 -86.43 -9.19 56.78 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.877 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 24.4 t -137.54 119.51 15.37 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.067 179.37 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -116.58 150.37 38.13 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.956 178.264 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.41 ' HA ' HD23 ' A' ' 103' ' ' LEU . 26.0 m -101.36 89.73 3.86 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.012 179.295 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.484 HD13 HG22 ' A' ' 104' ' ' VAL . 9.2 mp -87.72 114.05 23.96 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.472 0.653 . . . . 0.0 110.493 -178.399 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.564 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 27.1 m -111.69 120.8 43.27 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.381 -177.84 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.467 ' HB ' ' HB3' ' A' ' 100' ' ' LEU . 61.8 t -89.64 103.21 13.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 176.374 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -95.83 114.04 25.74 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 178.234 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.417 ' HA ' HG22 ' A' ' 40' ' ' VAL . 95.7 t -81.02 104.21 9.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.129 -178.48 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.7 t70 53.49 90.85 0.08 OUTLIER Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 114.278 -1.328 . . . . 0.0 112.899 177.407 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -79.22 16.31 1.39 Allowed 'Trans proline' 0 N--CA 1.463 -0.323 0 C-N-CA 123.316 2.677 . . . . 0.0 111.935 177.446 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -116.18 -17.17 10.89 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.264 -177.622 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 62.94 48.99 3.68 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.587 -178.009 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -66.5 -33.0 74.72 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.404 0.621 . . . . 0.0 109.752 174.537 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 4.1 t -107.53 169.26 2.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 174.389 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.462 ' O ' ' HD2' ' A' ' 3' ' ' PRO . 65.1 t30 -106.13 93.29 4.54 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 175.778 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 14.9 mp0 -76.51 149.7 36.7 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.772 -173.467 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -57.41 -100.85 0.01 OUTLIER Glycine 0 CA--C 1.522 0.5 0 CA-C-N 114.655 -1.157 . . . . 0.0 113.472 170.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 16.7 m-80 -84.71 130.72 34.66 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 122.758 -0.26 . . . . 0.0 111.351 -173.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -64.14 -32.12 73.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.076 0.465 . . . . 0.0 110.515 177.769 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 49.3 m -59.54 -29.41 67.88 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.82 176.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.532 ' HB3' HG22 ' A' ' 6' ' ' VAL . 7.0 m-20 -84.58 -13.25 52.26 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.913 -175.391 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -73.65 -10.67 59.93 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.011 178.203 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 3.7 p -130.8 125.13 32.93 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -173.655 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.564 ' O ' ' HA ' ' A' ' 81' ' ' THR . 46.1 tp -108.63 102.41 11.47 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.879 169.88 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 21.8 m -85.11 95.32 9.09 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 175.246 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -111.33 119.72 39.82 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.618 -177.827 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.41 HD23 ' HA ' ' A' ' 79' ' ' THR . 41.9 mt -82.43 114.99 21.25 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.389 0.614 . . . . 0.0 110.324 176.943 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.484 HG22 HD13 ' A' ' 80' ' ' LEU . 27.4 m -108.13 140.05 28.03 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.319 178.882 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.558 ' O ' ' HA ' ' A' ' 14' ' ' THR . . . -116.75 165.35 12.33 Favored Glycine 0 N--CA 1.438 -1.199 0 C-N-CA 120.182 -1.009 . . . . 0.0 111.149 -178.346 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 27.0 p -72.35 137.25 46.48 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 175.341 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.57 ' HG ' ' H ' ' A' ' 109' ' ' HIS . 49.8 tp -59.31 147.24 36.66 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.917 0.389 . . . . 0.0 110.584 -177.73 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.438 ' O ' ' HB3' ' A' ' 109' ' ' HIS . 34.2 mt-10 -58.48 -34.15 70.57 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.079 -178.431 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' HIS . . . . . 0.57 ' H ' ' HG ' ' A' ' 107' ' ' LEU . 86.0 t60 69.31 13.77 8.52 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 122.132 0.968 . . . . 0.0 109.197 -179.499 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 21.2 m170 -105.98 140.19 39.36 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.03 -0.986 . . . . 0.0 109.149 179.648 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 8.8 m-70 -80.13 -10.2 59.75 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.194 0.521 . . . . 0.0 110.467 179.292 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 20.8 m170 -105.13 90.12 3.34 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 167.747 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 65.7 t-80 -80.53 150.01 29.77 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.628 -173.458 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 70.6 m80 . . . . . 0 C--O 1.245 0.864 0 CA-C-O 118.91 -0.567 . . . . 0.0 109.585 174.59 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.467 ' O ' ' HD2' ' A' ' 33' ' ' LYS . 58.7 mtm . . . . . 0 N--CA 1.479 1.002 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 7.6 tp -114.46 142.58 28.37 Favored Pre-proline 0 C--N 1.321 -0.662 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 -179.21 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.538 ' HD3' ' HD3' ' A' ' 33' ' ' LYS . 5.4 Cg_exo -75.44 157.08 41.1 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.346 2.031 . . . . 0.0 111.143 174.379 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -140.13 102.76 4.45 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 178.067 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.552 HD22 HD23 ' A' ' 57' ' ' LEU . 25.4 mt -99.74 126.72 45.85 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -172.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.48 ' O ' ' HA ' ' A' ' 27' ' ' ILE . 8.3 t -125.22 140.23 35.61 Favored Pre-proline 0 C--N 1.313 -1.002 0 C-N-CA 119.865 -0.734 . . . . 0.0 110.635 -175.182 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.518 ' HG2' ' HB2' ' A' ' 100' ' ' LEU . 11.8 Cg_endo -96.99 110.05 0.1 Allowed 'Trans proline' 0 N--CA 1.447 -1.212 0 C-N-CA 123.672 2.915 . . . . 0.0 110.478 169.398 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 19.3 m -86.5 -39.14 13.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -169.88 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 51.0 m -156.37 161.17 40.16 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.723 0.297 . . . . 0.0 111.099 -178.327 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.436 HD11 ' HB3' ' A' ' 23' ' ' MET . 26.9 tp -127.61 126.49 42.16 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 172.403 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.511 HG22 ' HB ' ' A' ' 24' ' ' THR . 0.7 OUTLIER -122.6 131.73 24.35 Favored Pre-proline 0 C--N 1.318 -0.773 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.978 177.101 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.541 ' HD2' ' SD ' ' A' ' 23' ' ' MET . 90.4 Cg_endo -95.2 145.76 7.99 Favored 'Cis proline' 0 N--CA 1.449 -1.125 0 C-N-CA 123.789 -1.338 . . . . 0.0 113.345 5.114 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.432 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 35.4 m -67.37 -18.04 23.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.435 175.713 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.27 151.19 39.53 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 175.645 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 16.4 m -142.93 157.17 17.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.308 0.575 . . . . 0.0 111.346 -174.662 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.46 ' HA ' ' HD3' ' A' ' 17' ' ' PRO . 14.4 t -99.32 131.95 24.18 Favored Pre-proline 0 C--N 1.321 -0.663 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.647 -175.936 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 16' ' ' VAL . 1.6 Cg_endo -84.13 18.23 1.57 Allowed 'Trans proline' 0 CA--C 1.529 0.264 0 C-N-CA 122.786 2.324 . . . . 0.0 112.856 179.244 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 56.0 m-20 -106.67 -22.91 12.6 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.669 0.271 . . . . 0.0 111.583 -174.646 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 8.9 t -145.54 178.23 8.28 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.136 -173.029 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.626 HG22 HG23 ' A' ' 70' ' ' THR . 51.5 t -73.29 141.89 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 172.908 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.66 ' ND2' HD23 ' A' ' 71' ' ' LEU . 39.7 m-80 -114.41 132.76 56.12 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.361 -173.433 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.7 m -108.19 118.88 37.9 Favored 'General case' 0 N--CA 1.437 -1.089 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 -175.748 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.541 ' SD ' ' HD2' ' A' ' 12' ' ' PRO . 87.2 mmm -108.93 122.99 48.39 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 113.938 -1.483 . . . . 0.0 109.855 -165.402 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.632 ' HA ' ' O ' ' A' ' 65' ' ' VAL . 17.0 m -111.99 124.44 52.4 Favored 'General case' 0 C--N 1.309 -1.152 0 CA-C-O 121.854 0.835 . . . . 0.0 109.765 -173.749 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -119.16 132.1 55.94 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 114.221 -1.354 . . . . 0.0 108.522 -175.82 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 19.5 m -112.35 121.01 43.65 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 121.714 0.769 . . . . 0.0 109.61 -171.063 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.48 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 8.7 mm -116.9 131.92 68.16 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 CA-C-N 114.314 -1.312 . . . . 0.0 109.236 -172.325 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -121.0 138.64 54.06 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 178.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.499 ' HB2' ' HG ' ' A' ' 57' ' ' LEU . 39.1 t30 -93.84 98.12 10.86 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 175.168 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 69.5 mt-30 -102.25 47.1 0.9 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.329 -173.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -144.18 154.65 25.83 Favored Glycine 0 N--CA 1.445 -0.743 0 N-CA-C 110.488 -1.045 . . . . 0.0 110.488 177.658 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -82.84 53.79 2.51 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.392 0.615 . . . . 0.0 111.466 -174.016 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.538 ' HD3' ' HD3' ' A' ' 3' ' ' PRO . 87.9 tttt -161.47 136.47 7.4 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 171.5 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -80.34 135.37 36.18 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 120.978 0.418 . . . . 0.0 110.756 -175.836 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 35.8 t -95.85 142.62 27.89 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.56 178.195 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.405 ' O ' ' HA ' ' A' ' 56' ' ' SER . 2.2 m -99.29 -129.57 0.2 Allowed 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.348 -179.631 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.605 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 48.5 m -82.85 108.8 16.45 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.027 0.441 . . . . 0.0 111.624 -173.641 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.547 ' HB2' ' HB2' ' A' ' 85' ' ' ASP . 52.9 p90 -122.38 146.01 47.73 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.014 177.196 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.485 ' O ' ' HA ' ' A' ' 85' ' ' ASP . 22.0 m-80 -92.56 110.58 22.01 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.794 -174.333 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -98.35 127.11 51.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 -178.46 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 37.0 m -118.72 141.65 48.41 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.297 -174.227 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 56.4 tp -100.24 111.51 23.79 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.575 173.516 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.472 ' HG ' HG22 ' A' ' 48' ' ' VAL . 4.9 mp -102.06 124.86 48.4 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.592 -178.031 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.511 HG13 ' HB3' ' A' ' 78' ' ' TYR . 86.2 t -93.68 95.96 5.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 175.485 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 64.03 5.66 2.5 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.96 -179.689 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 140.56 -34.99 1.92 Allowed Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.406 179.057 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.42 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 9.5 mt -82.36 147.93 5.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 -179.14 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.472 HG22 ' HG ' ' A' ' 43' ' ' LEU . 36.1 t -99.79 119.68 48.17 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.442 -176.724 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 20.3 m -97.6 -27.22 3.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 111.887 0.329 . . . . 0.0 111.887 -177.835 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 42.2 t0 -162.29 136.49 6.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.655 0.264 . . . . 0.0 110.332 -178.507 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 86.2 m -124.81 122.38 37.27 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.185 179.481 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -115.11 117.99 32.11 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 -178.445 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.454 ' HA ' ' HA ' ' A' ' 39' ' ' ASN . 22.7 m -82.86 111.18 18.51 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.327 -179.86 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.605 ' O ' ' HA ' ' A' ' 37' ' ' SER . 59.1 t -77.68 123.12 33.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 179.206 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.4 m -58.43 -39.97 81.24 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.727 -0.669 . . . . 0.0 112.128 -173.814 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.405 ' HA ' ' O ' ' A' ' 36' ' ' THR . 46.7 t -173.31 143.75 1.12 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.834 0.35 . . . . 0.0 110.486 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.552 HD23 HD22 ' A' ' 5' ' ' LEU . 23.5 tp -126.86 104.31 7.97 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.339 0.59 . . . . 0.0 109.532 175.246 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -70.75 160.68 32.24 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.525 -175.212 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 11.8 m -61.36 120.31 10.19 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.63 179.153 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 70.27 17.34 7.11 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 123.805 0.69 . . . . 0.0 110.889 -179.644 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -102.1 157.73 16.67 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 173.662 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 26.3 t -127.61 143.36 51.17 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.119 0.485 . . . . 0.0 110.71 -178.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 91.1 m -124.84 130.52 52.54 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.63 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 37.1 m-80 -101.19 117.7 35.52 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.943 177.697 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.632 ' O ' ' HA ' ' A' ' 24' ' ' THR . 3.7 t -102.82 125.16 57.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.911 -175.32 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -102.4 112.62 25.42 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.792 0.33 . . . . 0.0 110.914 178.595 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.402 ' HB2' ' HB2' ' A' ' 23' ' ' MET . 96.0 m-85 -91.62 159.01 16.1 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.953 179.467 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 15.8 m80 -108.64 109.74 21.02 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.727 -179.825 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 16.2 t90 -131.35 108.16 9.45 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.319 0.581 . . . . 0.0 111.404 -175.915 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.626 HG23 HG22 ' A' ' 20' ' ' VAL . 5.6 m -85.4 122.14 29.13 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.886 175.784 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.66 HD23 ' ND2' ' A' ' 21' ' ' ASN . 0.2 OUTLIER -72.3 122.33 20.94 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.19 0.519 . . . . 0.0 111.021 -177.633 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 24.2 p-10 -90.3 -41.62 11.44 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.436 179.058 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 99.07 23.62 11.27 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.81 -0.71 . . . . 0.0 113.204 175.792 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 92.6 m -74.96 -41.19 60.08 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.023 0.439 . . . . 0.0 110.583 177.558 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -128.33 162.31 27.37 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.372 178.526 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -100.71 -6.77 24.57 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.224 0.535 . . . . 0.0 110.183 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 22.7 t -146.95 112.26 5.53 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.508 177.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.511 ' HB3' HG13 ' A' ' 44' ' ' VAL . 83.2 m-85 -105.76 150.21 25.73 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.315 177.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.1 m -93.95 86.97 5.2 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 178.081 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.487 HD22 HG21 ' A' ' 104' ' ' VAL . 6.4 mp -81.43 114.32 20.1 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.714 0.769 . . . . 0.0 110.349 -177.883 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.513 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 7.3 m -116.94 117.8 30.69 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.475 -175.003 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 46.3 t -85.56 108.04 16.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 176.647 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.551 ' HA ' ' O ' ' A' ' 98' ' ' ASN . 6.3 t30 -101.64 116.69 33.3 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 178.696 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 58.2 t -82.64 104.42 11.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 115.615 -0.721 . . . . 0.0 111.214 -177.236 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.547 ' HB2' ' HB2' ' A' ' 38' ' ' PHE . 7.3 t70 54.5 89.66 0.1 Allowed Pre-proline 0 N--CA 1.468 0.47 0 CA-C-N 114.234 -1.348 . . . . 0.0 112.308 179.105 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -62.59 -24.43 75.1 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 123.29 2.66 . . . . 0.0 112.215 179.276 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 50.8 mm-40 -75.93 -28.81 58.13 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.812 177.706 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 56.2 53.84 8.47 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.812 -1.085 . . . . 0.0 109.807 -175.31 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -74.13 -25.04 59.54 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.865 -1.061 . . . . 0.0 109.706 178.24 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 17.3 t -108.31 97.49 5.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.213 -0.903 . . . . 0.0 108.897 174.392 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -61.15 134.31 56.89 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 -178.809 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.43 ' HA ' ' O ' ' A' ' 3' ' ' PRO . 3.0 mt-10 -111.22 166.22 11.27 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.966 -177.279 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -57.93 -101.04 0.01 OUTLIER Glycine 0 N--CA 1.453 -0.188 0 CA-C-N 115.588 -0.733 . . . . 0.0 112.851 174.044 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 28.4 t30 -70.17 100.74 1.72 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.683 -0.258 . . . . 0.0 110.538 179.855 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -75.9 53.94 0.79 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.211 0.529 . . . . 0.0 111.997 -177.207 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 13.9 t -137.64 16.1 2.91 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 174.102 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 18.1 p-10 -98.8 -27.27 14.02 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 113.58 -1.645 . . . . 0.0 111.746 -172.448 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.551 ' O ' ' HA ' ' A' ' 83' ' ' ASN . 17.9 m120 -55.13 -34.07 63.43 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 -168.731 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 1.5 p -107.23 123.38 48.21 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 -174.718 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.518 ' HB2' ' HG2' ' A' ' 7' ' ' PRO . 39.2 tp -107.26 106.63 17.17 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 170.17 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 28.3 m -89.96 102.4 15.11 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.669 -177.603 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -119.88 116.93 26.84 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.547 179.771 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 52.3 mt -74.86 119.03 18.49 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.126 175.535 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.487 HG21 HD22 ' A' ' 80' ' ' LEU . 27.6 m -113.1 133.39 59.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.693 178.789 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -120.9 166.55 13.95 Favored Glycine 0 N--CA 1.442 -0.956 0 C-N-CA 120.432 -0.89 . . . . 0.0 111.671 -176.676 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 59.3 p -69.09 146.02 52.92 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 177.518 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 62.4 tp -53.68 104.51 0.1 Allowed 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -172.37 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -82.71 126.5 32.43 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 107.734 -1.209 . . . . 0.0 107.734 171.073 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -71.55 -23.68 61.8 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -167.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 74.7 m80 -85.82 -72.65 0.48 Allowed 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.943 -0.303 . . . . 0.0 111.466 -176.686 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 18.4 m170 -87.05 122.8 31.37 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.307 0.575 . . . . 0.0 111.286 -174.008 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 5.4 m-70 -116.27 165.27 13.37 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.321 175.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 15.7 t60 -103.16 73.58 1.24 Allowed 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 172.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 66.0 t60 . . . . . 0 C--O 1.249 1.065 0 CA-C-N 115.173 -0.922 . . . . 0.0 109.19 -175.625 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.437 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 16.6 tt . . . . . 0 N--CA 1.451 -0.382 0 N-CA-C 110.301 -0.259 . . . . 0.0 110.301 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.521 ' HB3' ' HB2' ' A' ' 35' ' ' SER . 12.4 Cg_exo -69.84 116.99 4.82 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.17 1.913 . . . . 0.0 111.24 175.344 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -103.16 79.94 1.79 Allowed 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 178.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.517 HD22 HD23 ' A' ' 57' ' ' LEU . 61.9 mt -73.27 103.42 3.96 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.775 -173.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.548 HG22 ' HB3' ' A' ' 97' ' ' ASN . 47.1 t -114.27 111.4 47.21 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.511 -176.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.584 ' HD2' ' O ' ' A' ' 97' ' ' ASN . 18.2 Cg_endo -64.03 107.44 0.78 Allowed 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 122.057 1.838 . . . . 0.0 110.046 167.37 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.0 t -82.51 -55.74 7.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.126 -170.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 58.6 p -141.44 158.3 44.04 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.182 -177.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.481 HD21 HD23 ' A' ' 80' ' ' LEU . 54.0 tp -130.24 104.42 7.28 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.021 177.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 22.0 p -115.02 146.18 35.64 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.216 -175.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.403 ' HD2' ' HG2' ' A' ' 23' ' ' MET . 88.1 Cg_endo -78.99 152.64 89.12 Favored 'Cis proline' 0 C--N 1.341 0.183 0 C-N-CA 123.186 -1.589 . . . . 0.0 112.562 -0.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.2 m -73.57 -19.77 18.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.045 0.45 . . . . 0.0 111.206 -178.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.458 ' HB ' HD13 ' A' ' 107' ' ' LEU . 0.2 OUTLIER -126.37 128.35 46.91 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 177.178 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.468 ' HB ' ' ND2' ' A' ' 21' ' ' ASN . 18.7 m -114.13 140.14 36.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -167.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.439 ' HA ' ' HD3' ' A' ' 17' ' ' PRO . 5.8 m -84.17 121.4 75.49 Favored Pre-proline 0 N--CA 1.449 -0.512 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.098 176.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 16' ' ' VAL . 4.6 Cg_exo -77.97 55.75 5.42 Favored 'Trans proline' 0 N--CA 1.463 -0.269 0 C-N-CA 123.006 2.471 . . . . 0.0 111.667 176.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -122.97 -18.26 6.48 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.161 -0.472 . . . . 0.0 112.042 -176.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 14.7 t -157.25 -173.96 4.67 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.736 -0.386 . . . . 0.0 110.938 -171.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.402 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 46.7 t -82.32 110.11 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 169.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.468 ' ND2' ' HB ' ' A' ' 15' ' ' VAL . 5.1 m-20 -84.38 108.23 17.09 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.309 0.576 . . . . 0.0 110.702 -169.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.622 ' HA ' ' O ' ' A' ' 67' ' ' PHE . 11.3 m -79.41 83.44 5.43 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.256 -0.883 . . . . 0.0 109.355 176.341 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . 0.449 ' O ' ' HA ' ' A' ' 66' ' ' ASP . 82.8 mtp -79.5 152.21 30.34 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.41 -0.813 . . . . 0.0 110.403 -176.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 30.8 m -114.11 109.58 18.65 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.065 -175.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.441 ' HB3' ' HB ' ' A' ' 65' ' ' VAL . . . -92.14 120.09 32.41 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.548 173.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 61.2 m -92.76 101.29 13.68 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-O 121.12 0.486 . . . . 0.0 109.769 -179.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 15.3 mm -95.17 118.98 42.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.246 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -113.74 125.15 53.79 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.51 ' HB2' ' HG ' ' A' ' 57' ' ' LEU . 29.6 t30 -81.78 90.03 6.35 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.607 178.604 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -87.11 43.99 1.14 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.559 0.695 . . . . 0.0 110.788 -173.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -143.98 145.07 14.37 Favored Glycine 0 N--CA 1.442 -0.956 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 176.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -81.17 63.65 5.6 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.526 0.679 . . . . 0.0 111.039 -173.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.413 ' HA ' ' HD2' ' A' ' 33' ' ' LYS . 50.6 tptt -161.5 121.31 2.57 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.056 171.481 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -69.06 124.09 22.83 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.985 0.421 . . . . 0.0 110.567 -175.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.521 ' HB2' ' HB3' ' A' ' 3' ' ' PRO . 46.4 t -87.7 147.01 25.42 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.19 -174.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 21.7 p -86.54 -163.0 0.83 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.444 178.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.463 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 15.0 m -61.68 134.09 56.37 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 120.929 0.395 . . . . 0.0 111.338 -179.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.52 ' CE1' ' HB ' ' A' ' 54' ' ' VAL . 31.1 p90 -144.9 144.35 31.05 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.294 -177.339 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.515 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 25.7 m-80 -92.62 108.67 20.16 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.219 -174.272 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.452 HG22 ' HA ' ' A' ' 84' ' ' VAL . 2.1 t -98.29 116.75 41.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 121.392 0.615 . . . . 0.0 110.289 178.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 46.3 m -109.95 144.14 38.9 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.689 -177.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 46.9 tp -98.68 108.66 21.41 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.697 175.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.498 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 5.2 mp -98.93 108.45 21.13 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.427 -179.047 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 82.4 t -88.96 101.48 12.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 60.06 18.43 7.67 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.422 -179.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 124.49 -36.04 3.02 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.785 178.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.474 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 9.8 mm -79.81 145.55 9.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.905 0.383 . . . . 0.0 110.096 -176.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.42 HG22 ' HG ' ' A' ' 43' ' ' LEU . 40.8 t -96.96 101.75 12.65 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.824 -178.036 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 28.4 m -83.59 -30.78 8.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.615 -175.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 33.7 t0 -159.56 141.37 13.19 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.915 -0.314 . . . . 0.0 111.002 -177.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 88.6 m -129.07 123.36 32.05 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.308 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -127.3 105.69 8.71 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 -178.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.515 ' HA ' ' HA ' ' A' ' 39' ' ' ASN . 7.1 t -74.52 131.02 40.64 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.068 0.461 . . . . 0.0 110.38 178.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.52 ' HB ' ' CE1' ' A' ' 38' ' ' PHE . 39.1 t -95.28 138.57 20.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.774 -179.288 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.0 m -55.07 -43.28 73.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.246 -0.434 . . . . 0.0 112.039 -177.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 47.7 t -174.76 153.51 1.77 Allowed 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 -175.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.517 HD23 HD22 ' A' ' 5' ' ' LEU . 27.6 tp -134.15 109.5 8.95 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.16 0.505 . . . . 0.0 110.066 177.092 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.473 ' HB2' ' HB3' ' A' ' 61' ' ' ASN . 35.9 mt-10 -70.98 158.78 35.92 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.542 -0.754 . . . . 0.0 112.154 -174.278 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 12.3 p -64.12 122.98 17.88 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.095 179.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 65.09 20.2 11.98 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.453 179.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.473 ' HB3' ' HB2' ' A' ' 58' ' ' GLU . 61.1 t30 -116.62 155.2 29.17 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 176.036 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 2.4 m -115.28 145.66 42.25 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.657 0.265 . . . . 0.0 110.752 -175.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 13.3 t -119.2 143.85 47.04 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 175.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -96.05 112.03 23.88 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.873 0.368 . . . . 0.0 110.261 178.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.441 ' HB ' ' HB3' ' A' ' 25' ' ' ALA . 13.2 t -96.86 118.13 42.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.911 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.452 ' HB2' ' CG2' ' A' ' 22' ' ' THR . 5.3 p-10 -95.13 119.67 34.04 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.512 0.672 . . . . 0.0 110.559 -179.227 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.622 ' O ' ' HA ' ' A' ' 22' ' ' THR . 33.2 m-85 -95.67 146.8 24.22 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.726 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 15.2 m80 -110.73 90.27 3.28 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.663 -0.698 . . . . 0.0 109.485 -178.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 12.5 t90 -123.62 113.67 18.99 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.389 0.614 . . . . 0.0 111.416 -172.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.402 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 49.7 m -78.22 114.67 17.33 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.351 -0.841 . . . . 0.0 110.282 174.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.428 ' CB ' ' HA ' ' A' ' 17' ' ' PRO . 1.0 OUTLIER -63.54 118.78 8.66 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.326 0.584 . . . . 0.0 111.145 178.358 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -83.56 -36.74 23.75 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.03 -178.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 83.19 17.91 65.92 Favored Glycine 0 N--CA 1.449 -0.475 0 N-CA-C 110.99 -0.844 . . . . 0.0 110.99 -174.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 3.9 p -68.99 -29.75 68.02 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.23 -0.485 . . . . 0.0 111.332 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -145.44 168.86 19.54 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.075 -179.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 49.5 m-80 -96.98 -15.09 21.26 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.397 0.618 . . . . 0.0 109.649 178.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 20.4 m -131.97 126.6 34.4 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.781 177.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -115.12 132.88 56.46 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 177.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.48 ' HA ' HD23 ' A' ' 103' ' ' LEU . 4.3 m -90.49 83.66 5.89 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.124 0.488 . . . . 0.0 109.773 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.481 HD23 HD21 ' A' ' 10' ' ' LEU . 7.7 mp -81.41 117.2 21.66 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.515 0.674 . . . . 0.0 110.762 -176.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.562 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 32.7 m -113.85 110.61 20.39 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.545 -177.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 60.9 t -85.55 99.69 7.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 176.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -95.64 109.38 21.64 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 178.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.483 HG11 ' HB3' ' A' ' 5' ' ' LEU . 83.3 t -75.42 102.96 2.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.445 -179.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.0 t70 51.76 82.61 0.24 Allowed Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 114.431 -1.258 . . . . 0.0 111.427 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -64.41 -11.34 27.85 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.871 2.38 . . . . 0.0 111.923 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -87.64 -14.86 38.87 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.081 178.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 24.0 m120 56.12 43.47 26.83 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.886 -178.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.05 -34.57 77.87 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.384 0.611 . . . . 0.0 110.09 177.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 39.5 t -111.42 98.75 7.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 172.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.406 HD22 HD11 ' A' ' 2' ' ' ILE . 3.9 t30 -59.06 112.29 1.63 Allowed 'General case' 0 C--O 1.235 0.311 0 O-C-N 123.35 0.406 . . . . 0.0 110.619 -173.527 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.449 ' HA ' ' O ' ' A' ' 3' ' ' PRO . 3.8 mp0 -82.41 166.93 18.98 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.705 -174.007 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -58.05 -100.83 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.395 0 CA-C-N 114.919 -1.037 . . . . 0.0 113.33 176.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.418 ' HB3' ' CG ' ' A' ' 97' ' ' ASN . 53.0 t30 -76.21 141.77 41.69 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 122.626 -0.338 . . . . 0.0 110.836 -177.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -59.87 -43.1 94.9 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.979 -173.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 20.1 m -89.78 3.22 53.52 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.827 -174.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.584 ' O ' ' HD2' ' A' ' 7' ' ' PRO . 5.9 m-20 -85.97 -24.4 26.52 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 -175.286 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.507 ' HA ' ' O ' ' A' ' 5' ' ' LEU . 13.8 p-10 -82.04 -5.34 58.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.007 0.432 . . . . 0.0 111.341 -174.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 4.9 m -116.17 152.27 34.04 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.066 0.46 . . . . 0.0 110.727 -178.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.562 ' O ' ' HA ' ' A' ' 81' ' ' THR . 56.0 tp -140.66 103.63 4.56 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.84 179.18 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 15.7 m -98.83 104.5 16.54 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.123 177.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -132.48 135.72 46.21 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.895 0.378 . . . . 0.0 111.035 -178.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.48 HD23 ' HA ' ' A' ' 79' ' ' THR . 82.4 mt -80.21 127.09 31.94 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.752 177.204 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.442 HG22 HD13 ' A' ' 80' ' ' LEU . 32.7 m -109.13 134.72 50.23 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 172.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -105.16 170.92 18.23 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.04 -1.076 . . . . 0.0 111.038 -177.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 25.0 p -85.54 125.74 33.32 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 117.485 0.642 . . . . 0.0 109.821 175.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.458 HD13 ' HB ' ' A' ' 14' ' ' THR . 30.2 tp . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.608 -174.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.449 -0.494 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -83.79 156.84 13.75 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 122.023 1.815 . . . . 0.0 111.175 172.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -139.3 113.72 9.01 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 -178.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.674 HD22 HD23 ' A' ' 57' ' ' LEU . 31.5 mt -99.83 126.88 46.0 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -173.079 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.539 ' O ' ' HA ' ' A' ' 27' ' ' ILE . 8.4 t -124.91 140.22 35.3 Favored Pre-proline 0 C--N 1.318 -0.787 0 C-N-CA 120.341 -0.544 . . . . 0.0 110.263 -176.061 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.47 ' HB2' ' HB2' ' A' ' 100' ' ' LEU . 12.2 Cg_endo -96.52 98.18 0.09 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.57 0 C-N-CA 123.548 2.832 . . . . 0.0 109.733 167.05 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 26.2 m -80.37 -28.26 11.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.53 -167.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.3 t -165.71 158.9 15.76 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-O 120.816 0.341 . . . . 0.0 111.166 -177.083 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 29.9 tp -127.6 126.58 42.34 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.298 175.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.44 ' HA ' ' HA ' ' A' ' 12' ' ' PRO . 62.5 p -122.21 131.53 24.39 Favored Pre-proline 0 C--N 1.319 -0.718 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.587 179.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.672 ' HD2' ' SD ' ' A' ' 23' ' ' MET . 95.8 Cg_endo -92.02 175.01 17.81 Favored 'Cis proline' 0 N--CA 1.455 -0.753 0 C-N-CA 123.742 -1.357 . . . . 0.0 112.947 1.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 17.6 m -91.13 -10.42 9.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-O 121.347 0.594 . . . . 0.0 110.599 178.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.54 ' HA ' ' O ' ' A' ' 105' ' ' GLY . 0.8 OUTLIER -120.05 151.14 39.45 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.155 174.574 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 17.1 m -143.06 157.25 17.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.217 0.532 . . . . 0.0 111.788 -176.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.761 HG12 ' H ' ' A' ' 18' ' ' ASN . 21.8 t -99.27 132.05 24.05 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.454 -0.793 . . . . 0.0 110.287 179.092 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.441 ' HA ' ' HG ' ' A' ' 71' ' ' LEU . 95.9 Cg_endo -92.62 11.3 2.2 Favored 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 122.834 2.356 . . . . 0.0 112.65 177.085 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.761 ' H ' HG12 ' A' ' 16' ' ' VAL . 66.6 m-20 -100.6 -14.26 18.25 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.141 -175.15 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 9.1 t -158.75 173.7 16.15 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 -175.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 54.9 t -69.54 133.1 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 CA-C-O 121.64 0.733 . . . . 0.0 109.752 176.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -114.22 133.47 55.6 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 114.638 -1.165 . . . . 0.0 108.927 -176.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 18.1 m -107.8 118.76 37.57 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-O 122.444 1.116 . . . . 0.0 108.693 -170.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . 0.672 ' SD ' ' HD2' ' A' ' 12' ' ' PRO . 97.3 mmm -109.04 123.49 49.23 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 112.868 -1.969 . . . . 0.0 110.794 -162.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 23.2 m -111.91 124.57 52.67 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 121.865 0.841 . . . . 0.0 109.793 -176.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -119.39 132.52 55.85 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.075 -1.42 . . . . 0.0 108.445 -175.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 45.4 m -112.31 121.01 43.68 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 121.93 0.871 . . . . 0.0 110.064 -168.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.539 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 9.4 mm -116.53 120.02 63.7 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 CA-C-N 114.001 -1.454 . . . . 0.0 109.123 -172.151 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -118.79 128.69 54.71 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 -177.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 31.2 t30 -83.82 95.04 8.33 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 177.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -95.51 57.15 1.89 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.183 -174.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -144.1 168.07 26.66 Favored Glycine 0 N--CA 1.442 -0.928 0 CA-C-N 114.879 -1.055 . . . . 0.0 110.669 178.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 44.8 m-80 -75.71 -21.34 57.64 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 111.77 0.285 . . . . 0.0 111.77 -174.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 61.7 tttp -101.32 138.55 38.19 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.944 0.402 . . . . 0.0 111.029 -177.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -76.99 140.05 40.28 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.745 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 13.9 p -105.74 155.76 18.96 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.03 0.443 . . . . 0.0 111.65 -175.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 12.6 p -99.1 -161.56 0.88 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.258 -177.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 9.8 m -53.76 136.3 40.07 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 122.656 0.383 . . . . 0.0 111.638 178.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.506 ' CE1' ' HB2' ' A' ' 57' ' ' LEU . 18.2 p90 -149.44 147.04 27.77 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 177.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.579 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 42.4 t-20 -101.2 125.46 47.82 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.439 0.162 . . . . 0.0 110.673 -176.137 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.53 HG22 ' HA ' ' A' ' 84' ' ' VAL . 2.7 t -111.28 127.02 68.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 121.185 0.517 . . . . 0.0 110.013 -179.198 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 19.5 m -119.88 144.08 47.59 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.662 -177.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 58.3 tp -100.11 112.7 25.0 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.874 178.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.429 ' HG ' HG22 ' A' ' 48' ' ' VAL . 5.0 mp -101.57 121.74 42.54 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.834 -178.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 89.1 t -97.27 115.33 36.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 172.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 25.5 t70 67.98 -75.02 0.07 Allowed 'General case' 0 N--CA 1.469 0.509 0 O-C-N 123.736 0.648 . . . . 0.0 110.739 -174.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -158.89 17.22 0.26 Allowed Glycine 0 N--CA 1.448 -0.554 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.8 178.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 9.9 mt -123.64 149.83 27.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.429 HG22 ' HG ' ' A' ' 43' ' ' LEU . 40.0 t -93.33 122.43 44.82 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 -177.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 26.5 m -96.95 -28.99 3.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.351 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 37.2 t0 -149.53 151.21 33.51 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 120.768 0.318 . . . . 0.0 110.441 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 21.9 m -144.13 121.84 11.88 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.954 -174.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -135.45 125.11 25.27 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.779 0.323 . . . . 0.0 110.555 -179.229 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.579 ' HA ' ' HA ' ' A' ' 39' ' ' ASN . 23.8 m -85.5 122.78 30.12 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.252 177.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 20.1 t -86.59 136.38 23.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 -179.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 14.6 m -55.28 -51.81 65.47 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 123.494 0.496 . . . . 0.0 111.844 -176.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 8.4 t -176.87 130.86 0.18 Allowed 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.674 HD23 HD22 ' A' ' 5' ' ' LEU . 21.1 tp -96.1 112.64 24.31 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.322 0.582 . . . . 0.0 110.088 177.442 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.41 ' HB2' ' HB3' ' A' ' 61' ' ' ASN . 38.3 mt-10 -71.82 144.62 49.06 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.542 -0.753 . . . . 0.0 110.577 -178.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 8.5 p -61.52 132.77 54.47 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.883 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 72.66 1.13 3.88 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.223 177.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.41 ' HB3' ' HB2' ' A' ' 58' ' ' GLU . 53.9 t30 -108.17 149.6 28.32 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.151 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 2.6 p -111.44 123.19 49.71 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.063 0.458 . . . . 0.0 110.789 -178.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 27.9 m -104.05 135.86 44.76 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.725 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -94.77 128.48 41.51 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.562 179.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 40.2 t -96.16 115.79 36.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.418 -179.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -84.07 101.11 11.54 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.594 179.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.481 ' CZ ' HG12 ' A' ' 40' ' ' VAL . 8.0 m-85 -100.47 148.62 24.56 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.015 0.436 . . . . 0.0 111.143 178.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 33.1 m-70 -120.05 107.87 13.6 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 178.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 14.4 t90 -115.97 118.73 33.73 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.342 0.591 . . . . 0.0 111.205 -172.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 4.6 m -88.7 113.48 24.31 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 168.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.441 ' HG ' ' HA ' ' A' ' 17' ' ' PRO . 0.1 OUTLIER -44.64 -40.54 5.93 Favored 'General case' 0 N--CA 1.469 0.516 0 O-C-N 123.898 0.748 . . . . 0.0 112.167 -169.669 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 15.9 t70 77.52 -53.9 0.53 Allowed 'General case' 0 N--CA 1.468 0.45 0 O-C-N 123.792 0.682 . . . . 0.0 111.035 175.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -117.21 -155.92 10.34 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 121.017 -0.611 . . . . 0.0 111.61 176.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 33.0 m -153.26 91.88 1.55 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.158 0.504 . . . . 0.0 110.47 177.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.523 ' H ' ' HE2' ' A' ' 78' ' ' TYR . . . -126.25 147.6 49.65 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.354 177.263 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -63.94 -27.14 68.94 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.227 0.454 . . . . 0.0 112.227 -173.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 38.4 m -145.67 119.26 9.12 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.058 0.456 . . . . 0.0 111.185 -179.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.523 ' HE2' ' H ' ' A' ' 75' ' ' ALA . 26.5 m-85 -105.74 141.67 36.77 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.177 177.309 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 21.9 m -93.43 100.02 12.4 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.056 178.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.452 HD13 HG22 ' A' ' 104' ' ' VAL . 8.6 mp -100.43 125.07 46.67 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.274 0.559 . . . . 0.0 110.519 -178.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.527 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 32.4 m -121.24 115.69 23.48 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.938 -176.494 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 92.9 t -86.94 108.6 18.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.685 175.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -101.8 121.19 41.62 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 176.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.53 ' HA ' HG22 ' A' ' 40' ' ' VAL . 77.8 t -87.58 108.8 18.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.187 -176.605 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 46.2 t0 61.61 85.25 0.18 Allowed Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 114.555 -1.202 . . . . 0.0 111.701 178.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -72.45 -4.36 15.12 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.732 2.288 . . . . 0.0 112.088 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -99.52 -15.87 18.51 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 177.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 48.04 71.89 0.31 Allowed 'General case' 0 C--O 1.233 0.201 0 CA-C-N 114.647 -1.16 . . . . 0.0 110.911 -177.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.06 -32.12 16.85 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.251 177.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 22.0 t -89.28 134.02 29.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.658 176.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -78.04 99.19 6.01 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 177.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -89.95 156.1 18.66 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.899 -171.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -57.47 -100.88 0.01 OUTLIER Glycine 0 CA--C 1.518 0.231 0 CA-C-N 115.088 -0.96 . . . . 0.0 112.78 171.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.645 ' HB2' ' HB3' ' A' ' 97' ' ' ASN . 78.9 m-20 -83.76 123.41 29.84 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 120.847 -0.341 . . . . 0.0 110.733 -178.088 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -72.67 -15.92 61.7 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.651 0.739 . . . . 0.0 109.724 176.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -89.03 7.18 36.19 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.826 176.141 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.645 ' HB3' ' HB2' ' A' ' 94' ' ' ASN . 1.7 t30 -116.98 -28.86 6.15 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -173.291 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 20.2 p-10 -75.69 10.99 1.47 Allowed 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.065 0.46 . . . . 0.0 111.86 -173.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -126.38 143.64 51.1 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.799 0.333 . . . . 0.0 110.399 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.527 ' O ' ' HA ' ' A' ' 81' ' ' THR . 44.1 tp -128.73 104.65 7.76 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.472 179.552 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 53.0 m -92.05 106.39 18.42 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 174.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -121.72 153.54 38.09 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.537 -177.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 88.7 mt -104.38 124.02 48.47 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.001 0.429 . . . . 0.0 110.481 179.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.452 HG22 HD13 ' A' ' 80' ' ' LEU . 22.4 m -116.17 132.42 65.77 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.618 178.534 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.54 ' O ' ' HA ' ' A' ' 14' ' ' THR . . . -110.96 166.27 12.27 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.423 -0.894 . . . . 0.0 112.01 -175.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 18.4 p -68.22 135.49 52.09 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.745 0.273 . . . . 0.0 110.275 177.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 61.9 tp . . . . . 0 C--N 1.327 -0.388 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.589 -176.827 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.435 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 7.5 tp . . . . . 0 CA--C 1.537 0.458 0 CA-C-O 120.488 0.185 . . . . 0.0 110.845 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.539 ' HG3' ' HD3' ' A' ' 33' ' ' LYS . 6.5 Cg_endo -88.58 174.03 4.26 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 123.146 2.564 . . . . 0.0 112.128 173.092 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . 0.402 ' O ' ' HA ' ' A' ' 29' ' ' ASN . 17.8 t70 -151.42 105.91 3.23 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 179.315 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.537 ' O ' ' HA ' ' A' ' 98' ' ' ASN . 96.9 mt -99.57 103.3 15.01 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.192 0.52 . . . . 0.0 111.473 -168.611 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.536 HG22 ' HB3' ' A' ' 97' ' ' ASN . 11.5 t -114.57 116.58 43.5 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.653 -173.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.478 ' HB2' ' HB2' ' A' ' 100' ' ' LEU . 3.8 Cg_exo -79.33 104.07 1.7 Allowed 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 122.544 2.163 . . . . 0.0 109.76 169.006 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 31.8 m -92.14 -15.06 8.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -169.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 27.8 t -159.36 156.83 29.23 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.516 -0.474 . . . . 0.0 111.507 -177.054 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 60.1 tp -142.48 114.12 7.96 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.07 178.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 8.8 p -126.96 145.8 55.2 Favored Pre-proline 0 C--N 1.32 -0.708 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.99 -176.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -77.77 155.88 95.21 Favored 'Cis proline' 0 C--N 1.341 0.18 0 C-N-CA 123.265 -1.556 . . . . 0.0 112.497 -0.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 30.2 m -80.16 -21.44 11.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.195 0.522 . . . . 0.0 110.282 177.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.627 ' HA ' ' O ' ' A' ' 105' ' ' GLY . 3.2 p -117.88 126.99 53.41 Favored 'General case' 0 N--CA 1.438 -1.067 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.355 176.236 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.497 ' HB ' ' ND2' ' A' ' 21' ' ' ASN . 29.2 m -113.57 140.36 34.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.134 0.492 . . . . 0.0 111.678 -173.032 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.417 ' HA ' ' HD3' ' A' ' 17' ' ' PRO . 8.1 m -90.67 124.67 61.76 Favored Pre-proline 0 N--CA 1.445 -0.698 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.425 174.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.496 ' HA ' ' HB3' ' A' ' 71' ' ' LEU . 3.0 Cg_exo -80.3 49.56 3.25 Favored 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 122.803 2.335 . . . . 0.0 111.723 178.408 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -116.71 -13.24 10.8 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.468 -175.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 15.2 t -167.98 -167.9 0.9 Allowed 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.928 -0.309 . . . . 0.0 110.799 -171.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.494 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 53.6 t -86.76 113.61 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 174.146 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.497 ' ND2' ' HB ' ' A' ' 15' ' ' VAL . 4.4 m-20 -88.08 137.07 32.65 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.237 -172.146 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 33.4 m -88.85 105.57 17.83 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.219 178.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . 0.52 ' HB2' ' HB2' ' A' ' 67' ' ' PHE . 92.6 mmm -92.9 119.79 32.57 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.002 -178.32 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.526 ' HA ' ' O ' ' A' ' 65' ' ' VAL . 11.5 m -108.68 114.55 28.44 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.635 -176.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -105.71 133.03 51.1 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.387 -179.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 25.4 m -94.08 110.2 21.92 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.924 0.392 . . . . 0.0 110.827 -178.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 27.4 mm -102.64 116.32 46.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.789 -179.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -115.52 129.07 56.41 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.902 0.382 . . . . 0.0 110.177 178.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.402 ' HA ' ' O ' ' A' ' 4' ' ' ASP . 24.6 t30 -92.76 98.87 11.67 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.114 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -96.22 53.85 1.38 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.707 -174.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -144.02 161.5 27.84 Favored Glycine 0 N--CA 1.448 -0.558 0 N-CA-C 111.441 -0.663 . . . . 0.0 111.441 179.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -86.93 46.73 1.4 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.473 0.654 . . . . 0.0 110.793 -174.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.539 ' HD3' ' HG3' ' A' ' 3' ' ' PRO . 31.5 tttm -161.51 146.21 13.3 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 174.203 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -76.55 149.27 36.67 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.023 0.44 . . . . 0.0 110.189 176.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.424 ' OG ' ' HB3' ' A' ' 57' ' ' LEU . 13.5 p -104.72 129.3 52.96 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 172.331 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -84.3 -148.57 0.1 Allowed 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 -176.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.526 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 56.4 m -65.18 108.36 1.85 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.005 0.431 . . . . 0.0 111.398 -175.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.526 ' HB2' ' HB2' ' A' ' 85' ' ' ASP . 54.0 p90 -123.09 154.9 37.96 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.032 177.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.483 ' O ' ' HA ' ' A' ' 85' ' ' ASP . 32.8 m-80 -105.27 110.92 23.47 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.107 -175.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.606 HG22 ' HA ' ' A' ' 84' ' ' VAL . 1.3 t -98.18 121.28 48.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 121.351 0.596 . . . . 0.0 109.716 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 11.8 m -114.37 137.56 51.66 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.436 -175.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 55.0 tp -96.65 111.77 23.78 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.972 175.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.557 ' HG ' HG22 ' A' ' 48' ' ' VAL . 5.1 mp -94.46 132.29 39.26 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.336 178.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 85.5 t -105.96 97.42 5.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 173.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 70.81 -62.89 0.43 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.133 -0.94 . . . . 0.0 111.921 -179.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -147.34 -6.78 0.28 Allowed Glycine 0 CA--C 1.521 0.443 0 C-N-CA 120.886 -0.674 . . . . 0.0 113.496 179.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 6.5 mt -116.0 151.25 17.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 117.477 0.639 . . . . 0.0 110.45 -177.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.557 HG22 ' HG ' ' A' ' 43' ' ' LEU . 48.0 t -95.0 118.61 41.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 177.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 17.8 m -93.31 -33.08 5.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -176.299 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -152.98 143.07 22.33 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 110.278 -0.268 . . . . 0.0 110.278 -177.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 39.2 m -132.86 132.55 42.24 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.318 -179.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -123.57 125.86 45.62 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 178.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 15.0 m -87.31 110.3 20.13 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 177.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.526 ' O ' ' HA ' ' A' ' 37' ' ' SER . 43.7 t -81.6 124.13 38.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.329 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 10.3 m -52.76 -44.18 66.3 Favored 'General case' 0 C--N 1.329 -0.287 0 O-C-N 123.543 0.527 . . . . 0.0 111.464 -177.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 34.1 t -179.95 157.76 0.72 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.598 -179.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.424 ' HB3' ' OG ' ' A' ' 35' ' ' SER . 47.9 tp -136.02 123.94 22.72 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.012 -179.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 44.4 mm-40 -71.98 161.12 31.39 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.817 -177.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 15.5 m -70.14 128.82 37.61 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.278 178.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 68.3 20.09 8.81 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.984 178.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -112.9 147.02 37.92 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.625 177.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 11.2 p -114.67 125.91 54.28 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.123 0.487 . . . . 0.0 110.576 179.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 50.9 m -118.21 138.7 52.14 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.208 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -94.28 133.69 37.55 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.101 0.477 . . . . 0.0 111.363 -177.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.535 HG21 HG11 ' A' ' 40' ' ' VAL . 21.5 t -96.77 135.36 31.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.961 179.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -104.05 97.31 7.31 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.926 -174.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.52 ' HB2' ' HB2' ' A' ' 23' ' ' MET . 57.0 m-85 -97.13 153.34 18.03 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.406 177.322 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 68.8 m-70 -128.67 116.05 18.97 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 171.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 3.5 t90 -129.69 124.23 33.08 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.657 -173.007 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.494 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 4.3 m -80.09 113.87 18.58 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.056 -178.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.496 ' HB3' ' HA ' ' A' ' 17' ' ' PRO . 0.8 OUTLIER -69.68 120.23 15.13 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.964 0.412 . . . . 0.0 110.973 177.409 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -87.73 -36.21 17.48 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.589 178.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 92.9 16.04 49.75 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.641 -0.79 . . . . 0.0 111.735 -178.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.5 -38.62 87.99 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.265 0.555 . . . . 0.0 110.621 -179.178 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -138.02 158.17 44.88 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.874 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.482 ' N ' HD22 ' A' ' 76' ' ' ASN . 1.0 OUTLIER -83.09 -12.3 57.21 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.027 0.441 . . . . 0.0 110.544 179.019 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 10.7 p -143.3 121.56 12.26 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.452 178.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 53.0 m-85 -105.73 149.97 25.92 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.314 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.518 ' HA ' HD23 ' A' ' 103' ' ' LEU . 8.9 m -96.46 88.27 4.66 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.906 0.384 . . . . 0.0 110.38 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.412 HD13 HG22 ' A' ' 104' ' ' VAL . 7.4 mp -88.13 120.2 29.25 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.555 0.693 . . . . 0.0 111.118 -177.341 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.444 ' HB ' ' HB2' ' A' ' 43' ' ' LEU . 34.5 m -118.28 117.66 29.72 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.34 -178.318 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 47.9 t -90.75 103.79 14.74 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 176.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -101.52 112.61 25.21 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 178.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.606 ' HA ' HG22 ' A' ' 40' ' ' VAL . 75.6 t -78.64 103.81 5.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.838 -176.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.526 ' HB2' ' HB2' ' A' ' 38' ' ' PHE . 7.9 t70 58.94 88.3 0.13 Allowed Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 114.091 -1.413 . . . . 0.0 112.019 179.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -72.63 -4.46 15.37 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 123.171 2.581 . . . . 0.0 111.561 176.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -83.77 -21.95 32.03 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.173 -179.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 64.09 35.3 10.53 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.581 -178.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -75.93 -34.27 59.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.56 177.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 95.2 t -99.98 112.11 31.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.173 172.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 61.8 t30 -82.74 126.0 31.9 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.509 -177.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -84.05 165.83 18.22 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.239 0.542 . . . . 0.0 111.281 178.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -57.58 -100.69 0.01 OUTLIER Glycine 0 N--CA 1.444 -0.813 0 N-CA-C 110.268 -1.133 . . . . 0.0 110.268 159.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 15.4 m-20 -72.8 88.44 1.32 Allowed 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 172.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -58.4 96.23 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.409 0 O-C-N 123.325 0.391 . . . . 0.0 110.913 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 7.8 m 173.35 -26.36 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.417 0 O-C-N 124.238 0.961 . . . . 0.0 110.072 -172.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.536 ' HB3' HG22 ' A' ' 6' ' ' VAL . 83.7 m-20 -74.68 -19.85 60.1 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.488 -177.603 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.597 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 24.9 p-10 -72.29 19.31 0.08 Allowed 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.624 0.602 . . . . 0.0 112.624 -175.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 1.4 m -130.36 149.03 52.23 Favored 'General case' 0 C--N 1.322 -0.625 0 O-C-N 121.881 -0.512 . . . . 0.0 111.235 -178.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.478 ' HB2' ' HB2' ' A' ' 7' ' ' PRO . 30.0 tp -145.45 103.46 3.82 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.686 178.114 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 15.4 m -92.37 98.26 11.37 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 177.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -116.59 127.71 54.74 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.117 0.484 . . . . 0.0 110.695 -177.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.518 HD23 ' HA ' ' A' ' 79' ' ' THR . 65.1 mt -85.77 120.12 26.84 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.649 178.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.412 HG22 HD13 ' A' ' 80' ' ' LEU . 26.8 m -106.46 132.92 52.44 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.409 178.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.627 ' O ' ' HA ' ' A' ' 14' ' ' THR . . . -117.32 155.6 16.07 Favored Glycine 0 N--CA 1.44 -1.097 0 C-N-CA 120.205 -0.998 . . . . 0.0 111.244 -176.325 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.473 ' HA ' ' O ' ' A' ' 15' ' ' VAL . 35.2 p -61.75 145.82 51.26 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 176.226 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.442 ' HA ' ' HB ' ' A' ' 14' ' ' THR . 49.3 tp . . . . . 0 C--N 1.327 -0.401 0 CA-C-O 120.816 0.341 . . . . 0.0 111.199 -176.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.434 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 1.1 tt . . . . . 0 N--CA 1.448 -0.553 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.519 ' HD2' ' O ' ' A' ' 91' ' ' ASN . 12.6 Cg_exo -70.72 157.04 59.63 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.44 2.093 . . . . 0.0 111.012 174.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . 0.571 ' HA ' ' OE1' ' A' ' 92' ' ' GLU . 13.7 t70 -132.73 91.78 2.96 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 175.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.529 ' O ' ' HB3' ' A' ' 97' ' ' ASN . 70.2 mt -99.76 126.45 45.84 Favored 'General case' 0 CA--C 1.499 -0.993 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 -173.105 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.4 ' HA ' ' HD3' ' A' ' 7' ' ' PRO . 11.0 t -125.4 140.57 36.6 Favored Pre-proline 0 C--N 1.311 -1.069 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.58 -173.132 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.573 ' HB2' ' HB2' ' A' ' 100' ' ' LEU . 17.2 Cg_endo -91.25 103.8 0.25 Allowed 'Trans proline' 0 N--CA 1.439 -1.688 0 C-N-CA 122.757 2.305 . . . . 0.0 109.495 168.045 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.8 t -80.02 -49.75 18.66 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 CA-C-N 114.765 -1.107 . . . . 0.0 111.306 -165.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 10.5 p -158.15 164.03 36.99 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.67 -178.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.53 HD11 ' HB3' ' A' ' 23' ' ' MET . 36.5 tp -127.73 126.51 41.97 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 176.486 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 37.0 p -122.3 131.71 24.36 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.502 176.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.543 ' HD2' ' SD ' ' A' ' 23' ' ' MET . 97.5 Cg_endo -90.83 176.4 18.03 Favored 'Cis proline' 0 N--CA 1.457 -0.619 0 C-N-CA 123.808 -1.33 . . . . 0.0 112.884 2.536 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.0 m -98.29 -12.05 8.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 121.431 0.634 . . . . 0.0 110.21 176.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.561 ' HA ' ' O ' ' A' ' 105' ' ' GLY . 0.8 OUTLIER -120.03 150.98 39.68 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.579 172.574 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.435 HG11 ' CZ3' ' A' ' 69' ' ' TRP . 7.5 m -143.14 155.15 17.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.056 0.455 . . . . 0.0 111.59 -173.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.9 m -104.33 130.26 23.63 Favored Pre-proline 0 N--CA 1.444 -0.764 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.15 -179.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -77.19 171.9 17.0 Favored 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 122.594 2.196 . . . . 0.0 111.648 175.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 73.9 21.39 2.67 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.32 0.648 . . . . 0.0 111.391 178.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 15.1 t -167.07 -176.79 3.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.661 0.267 . . . . 0.0 110.706 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 57.8 t -102.33 132.91 47.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 178.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 32.4 m-80 -106.03 134.84 48.51 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.934 0.397 . . . . 0.0 110.362 -176.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 15.0 m -95.34 97.22 9.68 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.567 178.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . 0.543 ' SD ' ' HD2' ' A' ' 12' ' ' PRO . 91.5 mmm -89.53 115.59 27.05 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.533 -175.087 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 25.2 m -93.44 111.28 22.91 Favored 'General case' 0 C--N 1.323 -0.576 0 O-C-N 123.563 0.54 . . . . 0.0 111.002 -178.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.537 ' HB3' ' HB ' ' A' ' 65' ' ' VAL . . . -99.01 119.53 37.95 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.09 175.236 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 5.7 m -83.5 108.81 16.88 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.082 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 28.5 mm -108.29 119.33 57.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 -179.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -117.67 133.11 56.29 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.608 0.242 . . . . 0.0 110.639 -177.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.595 ' ND2' ' HA ' ' A' ' 59' ' ' SER . 36.2 t30 -95.33 100.3 12.1 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.995 0.426 . . . . 0.0 109.889 177.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 67.5 mt-30 -104.89 52.36 0.74 Allowed 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.487 -173.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -143.99 178.19 22.18 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.11 -1.043 . . . . 0.0 113.183 -175.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -90.36 28.84 1.36 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.108 0.48 . . . . 0.0 111.711 -172.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.446 ' HD3' ' HD3' ' A' ' 3' ' ' PRO . 88.5 tttt -154.16 143.58 21.46 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 121.876 -0.515 . . . . 0.0 111.058 178.229 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -79.75 143.25 34.66 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 175.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.438 ' OG ' ' HB3' ' A' ' 57' ' ' LEU . 33.7 p -104.69 140.95 37.31 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.005 0.431 . . . . 0.0 111.429 -177.286 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 7.3 p -85.08 -165.49 1.22 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.052 -179.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.414 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 13.4 m -60.34 119.41 7.9 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.935 0.398 . . . . 0.0 111.547 179.59 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.507 ' CE2' HG23 ' A' ' 40' ' ' VAL . 26.4 p90 -137.26 153.19 50.39 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 177.574 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.597 ' O ' ' HD3' ' A' ' 86' ' ' PRO . 65.1 m-80 -94.98 138.56 32.55 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.094 0.473 . . . . 0.0 110.744 178.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.507 HG23 ' CE2' ' A' ' 38' ' ' PHE . 2.4 t -119.57 112.97 39.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 173.314 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.523 ' HB3' HG23 ' A' ' 51' ' ' THR . 33.4 p -108.79 139.28 43.84 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.24 -173.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 54.9 tp -96.46 115.85 28.1 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.403 177.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.55 ' HG ' HG22 ' A' ' 48' ' ' VAL . 5.5 mp -96.96 129.21 44.45 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.196 177.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.424 ' CG1' ' HD2' ' A' ' 78' ' ' TYR . 84.1 t -106.37 96.89 4.99 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.69 176.512 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.471 ' HA ' ' HB ' ' A' ' 79' ' ' THR . 2.9 m-20 70.9 -51.06 0.68 Allowed 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 115.156 -0.929 . . . . 0.0 112.452 178.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -166.29 14.73 0.08 OUTLIER Glycine 0 C--N 1.319 -0.391 0 C-N-CA 120.768 -0.73 . . . . 0.0 113.15 178.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 9.3 mt -136.18 152.14 29.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 -179.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.55 HG22 ' HG ' ' A' ' 43' ' ' LEU . 50.7 t -97.91 108.73 22.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 177.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 17.0 m -77.67 -37.83 24.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.592 -177.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -159.37 140.04 12.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.828 0.346 . . . . 0.0 110.175 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.523 HG23 ' HB3' ' A' ' 41' ' ' SER . 27.6 m -116.48 122.19 44.02 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.949 178.461 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 43.9 tt0 -105.13 122.7 46.44 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.014 0.435 . . . . 0.0 110.281 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 6.0 m -79.82 129.51 34.55 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.232 177.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.414 ' O ' ' HA ' ' A' ' 37' ' ' SER . 53.7 t -98.75 120.0 47.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 172.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.7 m -61.41 -38.01 85.54 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.629 -174.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 23.0 t -178.1 136.87 0.17 Allowed 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 178.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.467 HD23 HD22 ' A' ' 5' ' ' LEU . 39.7 tp -119.79 113.06 20.04 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.223 0.535 . . . . 0.0 109.731 176.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -67.84 156.9 36.07 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.888 -177.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.595 ' HA ' ' ND2' ' A' ' 29' ' ' ASN . 11.6 p -65.51 130.34 42.95 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.56 178.471 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 68.81 23.52 6.88 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.507 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -117.93 153.74 33.08 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.393 -0.821 . . . . 0.0 108.83 175.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 23.3 t -128.52 142.63 51.01 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 177.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 15.0 t -125.41 149.17 48.42 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.892 179.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -97.78 120.18 37.7 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.213 -178.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.537 ' HB ' ' HB3' ' A' ' 25' ' ' ALA . 21.4 t -98.7 107.02 19.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.546 -176.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -98.84 111.47 23.85 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.925 0.393 . . . . 0.0 110.666 -178.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -91.28 163.03 14.37 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.235 0.541 . . . . 0.0 111.194 -176.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 57.4 m80 -105.3 93.88 4.92 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.549 -0.751 . . . . 0.0 109.723 177.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . 0.435 ' CZ3' HG11 ' A' ' 15' ' ' VAL . 12.5 t90 -107.12 100.01 9.52 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.798 -177.201 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 12.3 t -73.82 121.96 21.71 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 172.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 15.9 tp -121.94 96.11 4.93 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.468 0.651 . . . . 0.0 111.671 -173.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -63.49 -60.71 3.0 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.876 -1.056 . . . . 0.0 109.916 172.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 128.38 67.33 0.13 Allowed Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.721 178.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 30.9 m -75.46 -69.48 0.48 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.884 0.374 . . . . 0.0 110.575 178.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -108.47 -173.19 2.21 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.456 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 -96.49 -18.21 20.0 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.866 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 20.6 m -133.7 133.93 42.44 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.995 0.426 . . . . 0.0 110.81 -179.186 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.424 ' HD2' ' CG1' ' A' ' 44' ' ' VAL . 49.3 m-85 -119.12 145.2 46.16 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.805 179.198 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.484 ' HA ' HD23 ' A' ' 103' ' ' LEU . 6.6 m -97.11 91.65 5.66 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.323 -179.235 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.411 HD13 HG22 ' A' ' 104' ' ' VAL . 7.9 mp -91.1 113.16 25.35 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.452 0.644 . . . . 0.0 111.265 -176.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.561 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 11.2 m -116.12 120.71 39.91 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.489 -178.05 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 85.8 t -86.96 109.63 19.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.399 178.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.551 ' HA ' ' O ' ' A' ' 98' ' ' ASN . 6.1 t30 -92.5 111.57 23.2 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.817 0.342 . . . . 0.0 110.204 176.02 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 94.0 t -92.02 124.77 44.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.338 179.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.755 ' OD2' ' HA ' ' A' ' 88' ' ' ASN . 31.2 t70 64.91 85.87 0.15 Allowed Pre-proline 0 N--CA 1.464 0.249 0 O-C-N 123.922 0.764 . . . . 0.0 111.461 176.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.597 ' HD3' ' O ' ' A' ' 39' ' ' ASN . 1.6 Cg_endo -85.15 -40.9 0.08 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 123.364 2.709 . . . . 0.0 112.754 178.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.482 ' OE1' ' HD2' ' A' ' 86' ' ' PRO . 27.1 mp0 -80.33 -10.28 59.75 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.174 -176.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . 0.755 ' HA ' ' OD2' ' A' ' 85' ' ' ASP . 12.9 m120 63.02 64.77 0.84 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.73 0.776 . . . . 0.0 110.273 -174.307 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -100.45 -28.58 12.85 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.641 -1.163 . . . . 0.0 109.172 178.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 54.7 t -115.81 107.67 23.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.421 175.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.519 ' O ' ' HD2' ' A' ' 3' ' ' PRO . 16.6 t-20 -66.13 106.19 1.57 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.29 -177.487 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.571 ' OE1' ' HA ' ' A' ' 4' ' ' ASP . 0.3 OUTLIER -79.95 151.48 30.05 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.439 -174.718 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.401 ' HA2' HD13 ' A' ' 2' ' ' ILE . . . -57.93 -101.11 0.01 OUTLIER Glycine 0 CA--C 1.522 0.515 0 CA-C-N 115.018 -0.992 . . . . 0.0 113.436 171.378 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.446 HD22 ' ND2' ' A' ' 97' ' ' ASN . 0.0 OUTLIER -78.44 132.18 37.2 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.03 -0.585 . . . . 0.0 111.136 -173.671 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -73.78 76.77 1.58 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.172 0.511 . . . . 0.0 110.961 177.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 17.9 m -160.47 -40.27 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.564 -0.743 . . . . 0.0 109.885 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.529 ' HB3' ' O ' ' A' ' 5' ' ' LEU . 86.5 m-20 -67.47 -13.19 61.81 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.292 -0.867 . . . . 0.0 112.439 -173.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.551 ' O ' ' HA ' ' A' ' 83' ' ' ASN . 19.0 m120 -71.68 -5.01 30.67 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 111.675 0.25 . . . . 0.0 111.675 -175.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 2.5 p -142.41 122.54 13.77 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.573 ' HB2' ' HB2' ' A' ' 7' ' ' PRO . 42.2 tp -111.25 104.87 13.4 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 169.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.5 m -89.75 100.16 13.02 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.444 -178.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -120.57 128.05 52.7 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.081 0.467 . . . . 0.0 111.196 -177.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.484 HD23 ' HA ' ' A' ' 79' ' ' THR . 62.6 mt -85.51 125.82 33.36 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.57 177.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.411 HG22 HD13 ' A' ' 80' ' ' LEU . 33.3 m -116.82 142.85 28.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 177.368 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.561 ' O ' ' HA ' ' A' ' 14' ' ' THR . . . -122.65 155.91 17.11 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.235 -0.983 . . . . 0.0 112.291 -175.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 38.1 p -63.86 139.65 58.79 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 177.13 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 35.4 tp . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.044 -179.563 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 13.7 tt . . . . . 0 N--CA 1.451 -0.375 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -80.63 156.81 21.55 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 122.314 2.01 . . . . 0.0 111.297 174.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . 0.441 ' HB3' ' O ' ' A' ' 30' ' ' GLN . 13.5 t70 -146.65 104.63 3.76 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 176.234 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.593 HD22 HD23 ' A' ' 57' ' ' LEU . 14.6 mt -99.68 126.6 45.73 Favored 'General case' 0 CA--C 1.51 -0.573 0 C-N-CA 119.484 -0.886 . . . . 0.0 108.945 -172.272 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.3 t -125.55 140.69 37.04 Favored Pre-proline 0 C--N 1.318 -0.785 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.501 -176.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.675 ' HD3' ' O ' ' A' ' 97' ' ' ASN . 3.2 Cg_exo -81.89 109.39 1.96 Allowed 'Trans proline' 0 N--CA 1.446 -1.299 0 C-N-CA 122.598 2.199 . . . . 0.0 109.572 169.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 11.6 t -73.93 -53.59 17.19 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.037 -170.284 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 26.8 t -155.09 163.66 39.95 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.079 -179.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 19.9 tp -127.64 126.56 42.21 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.156 0.503 . . . . 0.0 110.025 179.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.412 ' HA ' ' HA ' ' A' ' 12' ' ' PRO . 41.4 p -122.17 131.47 24.4 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.558 177.299 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.513 ' HD2' ' SD ' ' A' ' 23' ' ' MET . 66.5 Cg_endo -90.68 177.19 17.19 Favored 'Cis proline' 0 N--CA 1.456 -0.72 0 C-N-CA 123.772 -1.345 . . . . 0.0 112.982 3.126 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.3 m -98.91 -13.36 8.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.376 177.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.412 ' HA ' ' O ' ' A' ' 105' ' ' GLY . 0.0 OUTLIER -120.24 151.1 39.64 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.892 173.586 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 17.0 m -143.16 157.36 17.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.574 0.226 . . . . 0.0 110.683 -177.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.505 ' HA ' ' HD3' ' A' ' 17' ' ' PRO . 2.2 t -99.25 131.84 24.44 Favored Pre-proline 0 C--N 1.325 -0.485 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 -178.173 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.585 ' HA ' ' HG ' ' A' ' 71' ' ' LEU . 3.2 Cg_exo -80.45 15.28 1.79 Allowed 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 123.3 2.667 . . . . 0.0 115.07 -171.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 29.4 p-10 -127.26 -2.47 6.31 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 -172.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 13.5 t -143.14 176.56 9.02 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.418 -172.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 62.0 t -81.01 134.46 27.13 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 CA-C-O 121.591 0.71 . . . . 0.0 109.405 174.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.547 ' ND2' HD23 ' A' ' 71' ' ' LEU . 32.7 m-80 -114.42 132.98 56.05 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 114.558 -1.201 . . . . 0.0 108.847 -173.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 23.7 m -108.2 118.88 37.93 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 108.166 -1.049 . . . . 0.0 108.166 -174.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . 0.513 ' SD ' ' HD2' ' A' ' 12' ' ' PRO . 86.1 mmm -109.09 122.92 48.3 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 113.533 -1.667 . . . . 0.0 109.23 -166.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.529 ' HA ' ' O ' ' A' ' 65' ' ' VAL . 25.0 m -111.93 124.8 53.16 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-O 121.732 0.777 . . . . 0.0 109.531 -174.328 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -119.26 132.01 55.86 Favored 'General case' 0 N--CA 1.434 -1.248 0 CA-C-N 114.353 -1.294 . . . . 0.0 108.15 -176.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 93.6 m -112.36 121.45 44.89 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 -173.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 11.9 mm -116.14 131.86 67.39 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 -171.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -125.32 148.56 48.67 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.257 -177.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 37.6 t30 -101.15 95.99 6.92 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.442 -175.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.441 ' O ' ' HB3' ' A' ' 4' ' ' ASP . 92.8 mt-30 -88.08 62.2 6.68 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 122.048 0.927 . . . . 0.0 109.826 -179.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -173.5 147.14 9.31 Favored Glycine 0 N--CA 1.443 -0.841 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 178.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 32.5 p-10 -85.39 8.29 19.42 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 113.661 0.986 . . . . 0.0 113.661 -162.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -109.19 141.17 41.82 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 120.376 -0.529 . . . . 0.0 110.648 174.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -75.24 135.56 40.99 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.864 174.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 65.5 p -93.1 -161.75 0.87 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.909 -173.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 7.0 p -131.31 -167.97 1.94 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.436 178.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 13.4 m -59.38 124.27 19.49 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.876 178.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.523 ' HB2' ' HB2' ' A' ' 85' ' ' ASP . 23.9 p90 -136.53 150.73 48.79 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.95 -179.05 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.435 ' O ' ' HA ' ' A' ' 85' ' ' ASP . 22.1 m-80 -99.44 109.84 22.38 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.364 -173.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.479 HG23 ' CE2' ' A' ' 38' ' ' PHE . 2.4 t -98.3 114.2 35.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-O 121.337 0.589 . . . . 0.0 109.797 177.509 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.447 ' HA ' ' HA ' ' A' ' 51' ' ' THR . 25.2 p -112.65 141.91 45.88 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.745 -175.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 55.9 tp -96.47 114.45 26.12 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.982 177.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.528 ' HG ' HG22 ' A' ' 48' ' ' VAL . 5.1 mp -98.26 132.57 43.64 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.225 179.196 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 98.7 t -113.78 101.72 12.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.868 177.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 58.82 19.01 6.54 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.822 179.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 128.55 -38.71 2.01 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.892 177.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 5.6 mt -87.48 150.23 3.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 -177.085 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.528 HG22 ' HG ' ' A' ' 43' ' ' LEU . 44.8 t -96.77 121.11 46.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 19.9 m -94.73 -33.32 4.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -177.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 34.1 t0 -156.1 138.35 14.73 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.576 0.227 . . . . 0.0 110.518 -178.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.447 ' HA ' ' HA ' ' A' ' 41' ' ' SER . 30.6 m -126.83 123.29 36.98 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.262 -179.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -114.7 112.65 23.18 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.802 0.334 . . . . 0.0 110.377 -179.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 23.7 m -77.12 113.07 14.46 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.972 0.415 . . . . 0.0 110.607 177.149 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 27.5 t -83.36 144.15 10.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.881 -179.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.3 m -62.67 -49.06 76.61 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.585 -0.279 . . . . 0.0 111.231 -178.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 22.6 t -177.75 164.45 1.97 Allowed 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -178.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.593 HD23 HD22 ' A' ' 5' ' ' LEU . 18.1 tp -139.85 110.03 6.53 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.247 0.546 . . . . 0.0 110.79 175.645 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 29.3 mp0 -74.75 174.2 9.47 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.973 -178.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 34.6 p -74.89 128.94 36.77 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.699 0.285 . . . . 0.0 110.901 -177.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 66.95 18.34 10.59 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.026 178.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.457 ' O ' HD11 ' A' ' 57' ' ' LEU . 58.5 t30 -110.64 148.65 31.79 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 175.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -117.62 153.9 32.5 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 120.964 0.411 . . . . 0.0 111.015 -175.511 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.472 ' OG1' HD13 ' A' ' 57' ' ' LEU . 92.6 m -130.07 135.24 48.02 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.715 177.254 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -96.34 123.04 39.85 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.41 176.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.529 ' O ' ' HA ' ' A' ' 24' ' ' THR . 17.6 t -105.15 120.68 56.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.732 178.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -109.42 111.27 22.72 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.114 0.483 . . . . 0.0 110.321 -179.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -91.6 157.72 16.83 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.391 -177.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 65.1 m-70 -108.94 100.03 9.29 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.327 175.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 13.5 t90 -116.67 108.23 15.66 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.077 0.465 . . . . 0.0 110.925 -175.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 10.1 m -81.78 114.03 20.14 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.636 174.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.585 ' HG ' ' HA ' ' A' ' 17' ' ' PRO . 0.1 OUTLIER -72.64 124.73 25.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.701 0.286 . . . . 0.0 110.46 -177.462 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -84.3 -36.62 22.48 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.765 177.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 85.8 58.58 2.0 Allowed Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 121.104 -0.569 . . . . 0.0 112.917 174.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.4 p -112.09 -32.14 6.66 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.734 0.302 . . . . 0.0 111.636 178.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -124.1 166.3 16.02 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.785 0.326 . . . . 0.0 111.083 -177.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.499 ' HA ' HG23 ' A' ' 106' ' ' THR . 51.8 m-80 -101.65 -5.09 25.47 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.046 0.45 . . . . 0.0 110.321 177.267 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 20.5 m -145.18 114.21 6.95 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.841 178.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -105.91 138.79 41.5 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.15 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.456 ' HA ' HD23 ' A' ' 103' ' ' LEU . 9.5 m -90.59 88.23 7.05 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.529 -178.005 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.475 HD13 HG22 ' A' ' 104' ' ' VAL . 8.3 mp -89.02 124.82 34.64 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.35 0.595 . . . . 0.0 111.148 -177.295 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.473 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 76.2 m -123.53 124.4 42.76 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.67 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 61.7 t -90.28 99.03 8.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 174.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.538 ' HA ' ' O ' ' A' ' 98' ' ' ASN . 4.6 t30 -93.5 114.76 27.22 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 178.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.438 HG11 ' HB2' ' A' ' 5' ' ' LEU . 60.8 t -80.11 108.6 13.73 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.648 -178.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.523 ' HB2' ' HB2' ' A' ' 38' ' ' PHE . 8.1 t70 48.57 92.09 0.06 OUTLIER Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 114.056 -1.429 . . . . 0.0 112.511 -179.242 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -64.73 -8.19 16.92 Favored 'Trans proline' 0 C--O 1.234 0.313 0 C-N-CA 123.313 2.675 . . . . 0.0 112.452 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -94.26 -24.95 17.25 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.372 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 18.9 m120 58.57 48.18 12.24 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.686 -173.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -64.21 -25.66 68.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.012 176.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 20.4 t -101.66 125.74 55.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.564 175.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -74.83 116.53 15.65 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.435 -0.579 . . . . 0.0 109.435 176.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -118.41 168.38 10.7 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -171.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -57.97 -100.96 0.01 OUTLIER Glycine 0 CA--C 1.522 0.52 0 CA-C-N 113.985 -1.461 . . . . 0.0 114.756 179.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -85.54 -163.9 0.93 Allowed 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -166.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 49.0 mm-40 -100.45 -37.84 8.66 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.282 -173.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 15.3 m -84.98 -4.4 59.13 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.824 0.345 . . . . 0.0 111.749 -171.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.675 ' O ' ' HD3' ' A' ' 7' ' ' PRO . 23.6 p-10 -70.44 -34.07 72.03 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.562 -176.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.538 ' O ' ' HA ' ' A' ' 83' ' ' ASN . 9.2 m120 -77.56 -1.46 30.77 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -175.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 1.1 p -135.83 130.94 34.72 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -177.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.473 ' O ' ' HA ' ' A' ' 81' ' ' THR . 28.3 tp -128.35 98.52 5.09 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.234 168.152 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 98.5 m -95.72 107.0 19.18 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.121 0.486 . . . . 0.0 110.501 179.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -121.57 134.83 55.03 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.948 -179.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.456 HD23 ' HA ' ' A' ' 79' ' ' THR . 78.9 mt -84.96 120.03 26.05 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.349 0.595 . . . . 0.0 110.629 179.42 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.475 HG22 HD13 ' A' ' 80' ' ' LEU . 33.2 m -106.22 132.35 53.59 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.491 177.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.412 ' O ' ' HA ' ' A' ' 14' ' ' THR . . . -108.76 173.57 17.7 Favored Glycine 0 N--CA 1.443 -0.876 0 C-N-CA 120.399 -0.905 . . . . 0.0 111.855 -175.285 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.499 HG23 ' HA ' ' A' ' 76' ' ' ASN . 22.0 p -76.43 132.54 39.72 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 120.881 0.372 . . . . 0.0 110.084 176.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 37.2 tp . . . . . 0 C--N 1.322 -0.598 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.938 -175.718 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 16.1 tt . . . . . 0 CA--C 1.538 0.518 0 N-CA-C 110.301 -0.259 . . . . 0.0 110.301 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -71.68 165.08 33.62 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.647 2.231 . . . . 0.0 112.501 175.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -149.85 91.21 1.77 Allowed 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 177.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.474 HD22 HD23 ' A' ' 57' ' ' LEU . 66.3 mt -84.76 117.68 23.98 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.178 -168.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.536 HG22 ' HB3' ' A' ' 97' ' ' ASN . 21.7 t -120.52 110.41 35.63 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.118 -176.248 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.561 ' HD2' ' O ' ' A' ' 97' ' ' ASN . 20.3 Cg_endo -63.74 111.68 1.59 Allowed 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 122.388 2.059 . . . . 0.0 110.55 169.361 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.3 t -85.93 -48.78 15.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.454 -169.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 18.2 t -149.32 157.66 43.52 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.924 0.392 . . . . 0.0 111.097 -174.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 53.7 tp -135.51 111.95 9.88 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.213 178.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.56 ' OG1' ' HA ' ' A' ' 12' ' ' PRO . 13.6 t -131.0 148.13 69.05 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.656 -176.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.56 ' HA ' ' OG1' ' A' ' 11' ' ' THR . 5.8 Cg_exo -78.77 148.76 83.79 Favored 'Cis proline' 0 N--CA 1.46 -0.446 0 C-N-CA 123.366 -1.514 . . . . 0.0 112.44 1.21 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.5 m -72.13 -5.91 6.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.271 0.557 . . . . 0.0 110.957 177.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.575 ' HB ' ' HA ' ' A' ' 107' ' ' LEU . 0.9 OUTLIER -128.27 133.01 48.7 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.834 175.43 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.496 ' O ' ' HA ' ' A' ' 106' ' ' THR . 15.3 m -124.2 156.18 31.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 120.761 0.315 . . . . 0.0 111.232 -174.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.0 m -101.83 134.0 20.41 Favored Pre-proline 0 N--CA 1.445 -0.703 0 CA-C-O 121.038 0.446 . . . . 0.0 110.823 177.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.425 ' CB ' ' HA3' ' A' ' 73' ' ' GLY . 98.6 Cg_endo -79.63 174.04 12.26 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 122.42 2.08 . . . . 0.0 112.166 178.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 25.1 m-80 63.14 28.77 16.09 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.32 177.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 15.2 t -169.42 170.52 8.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.761 0.315 . . . . 0.0 110.602 -177.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.467 HG22 ' HA ' ' A' ' 70' ' ' THR . 58.4 t -91.4 129.88 41.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.853 0.359 . . . . 0.0 110.387 178.371 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 40.4 m-80 -106.9 116.15 31.43 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.608 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.587 ' HA ' ' O ' ' A' ' 67' ' ' PHE . 10.3 m -85.36 93.39 8.71 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 175.025 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . 0.582 ' O ' ' HA ' ' A' ' 66' ' ' ASP . 83.0 mtp -94.73 148.34 22.39 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.132 -174.197 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.459 HG23 ' HB3' ' A' ' 64' ' ' ASN . 20.9 m -109.67 114.07 27.36 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.146 -175.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -104.23 112.29 25.25 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 172.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 38.8 m -83.38 104.78 13.8 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 120.923 0.392 . . . . 0.0 110.044 -177.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 31.9 mm -97.05 116.62 39.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.893 -179.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -113.2 122.43 47.46 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.006 0.431 . . . . 0.0 110.135 -178.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 31.0 t30 -79.05 98.44 6.49 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.513 177.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -101.02 56.62 0.86 Allowed 'General case' 0 C--N 1.319 -0.761 0 CA-C-O 121.601 0.715 . . . . 0.0 109.976 -174.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -144.08 177.78 22.53 Favored Glycine 0 N--CA 1.444 -0.775 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.886 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.434 ' N ' HD22 ' A' ' 32' ' ' ASN . 0.9 OUTLIER -73.14 -39.17 65.91 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 -173.758 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.402 ' HG2' ' O ' ' A' ' 34' ' ' ASP . 55.7 tttp -101.21 147.58 26.1 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.424 0.631 . . . . 0.0 112.476 -170.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.402 ' O ' ' HG2' ' A' ' 33' ' ' LYS . 1.7 t70 -65.81 138.82 58.17 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 114.523 -1.217 . . . . 0.0 110.809 173.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.423 ' OG ' HD21 ' A' ' 5' ' ' LEU . 13.8 p -105.62 137.43 43.47 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.288 176.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.1 m -90.14 -133.2 0.11 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.248 -179.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.509 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 26.8 m -75.62 109.47 9.22 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.085 0.469 . . . . 0.0 111.568 -175.347 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.552 ' CE2' HG23 ' A' ' 40' ' ' VAL . 19.9 p90 -122.6 148.81 44.79 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.13 178.103 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.543 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 4.2 t-20 -99.83 115.19 29.02 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 120.913 -0.315 . . . . 0.0 110.963 -173.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.552 HG23 ' CE2' ' A' ' 38' ' ' PHE . 2.7 t -98.48 111.96 29.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.597 0.713 . . . . 0.0 110.161 -178.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.577 ' HB3' HG23 ' A' ' 51' ' ' THR . 16.2 p -104.1 131.69 51.11 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.919 -176.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 62.9 tp -98.17 109.77 22.47 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 174.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 5.1 mp -97.78 142.05 30.03 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.669 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 81.7 t -108.56 99.23 8.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 172.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 37.3 t70 67.06 -73.95 0.07 Allowed 'General case' 0 C--N 1.329 -0.298 0 O-C-N 124.123 0.89 . . . . 0.0 111.139 -176.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -143.64 4.96 1.75 Allowed Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 121.278 -0.486 . . . . 0.0 112.314 179.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 8.4 mt -112.62 153.72 14.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -179.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 54.7 t -106.51 124.9 62.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 17.5 m -94.56 -33.05 4.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 C-N-CA 120.961 -0.295 . . . . 0.0 111.191 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -159.68 142.18 13.64 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.923 0.392 . . . . 0.0 110.673 178.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.577 HG23 ' HB3' ' A' ' 41' ' ' SER . 7.1 m -124.06 109.34 13.38 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.294 178.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 47.0 tt0 -109.08 113.01 25.5 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.104 0.478 . . . . 0.0 111.183 -172.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.543 ' HA ' ' HA ' ' A' ' 39' ' ' ASN . 10.4 m -76.32 120.0 20.97 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.358 177.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.509 ' O ' ' HA ' ' A' ' 37' ' ' SER . 25.0 t -92.58 127.18 44.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 177.091 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 27.0 m -58.05 -38.72 76.8 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.075 -0.511 . . . . 0.0 112.337 -173.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 11.2 p -169.97 163.55 9.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.671 0.272 . . . . 0.0 111.422 -177.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.483 HD11 ' O ' ' A' ' 61' ' ' ASN . 38.4 tp -156.52 114.24 3.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.869 176.195 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -77.32 169.41 18.38 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.605 -175.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 16.6 m -63.44 125.96 25.93 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.745 -0.662 . . . . 0.0 111.114 -179.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 66.27 15.8 10.21 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.96 176.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.483 ' O ' HD11 ' A' ' 57' ' ' LEU . 41.5 t-20 -97.63 143.51 28.23 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 175.277 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -114.44 115.76 27.8 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.351 -178.43 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.412 ' OG1' HD13 ' A' ' 57' ' ' LEU . 50.0 m -104.33 124.43 49.17 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.093 0.473 . . . . 0.0 110.738 -179.296 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.459 ' HB3' HG23 ' A' ' 24' ' ' THR . 94.8 m-20 -80.14 115.76 19.88 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.683 178.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 18.2 t -96.77 107.56 20.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.322 -178.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.582 ' HA ' ' O ' ' A' ' 23' ' ' MET . 28.5 m-20 -93.75 111.74 23.49 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.785 179.362 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.587 ' O ' ' HA ' ' A' ' 22' ' ' THR . 80.7 m-85 -91.38 167.46 12.26 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.978 179.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 2.5 p-80 -117.58 95.31 4.89 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.502 174.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . 0.618 ' CZ2' HD13 ' A' ' 71' ' ' LEU . 9.7 t90 -94.38 100.52 12.53 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.552 -176.324 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.467 ' HA ' HG22 ' A' ' 20' ' ' VAL . 17.8 m -73.74 91.52 1.92 Allowed 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 173.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.618 HD13 ' CZ2' ' A' ' 69' ' ' TRP . 22.2 tp -95.84 117.8 31.26 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.445 0.64 . . . . 0.0 112.102 -169.298 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -65.13 -56.86 10.51 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.807 -1.088 . . . . 0.0 109.666 171.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.425 ' HA3' ' CB ' ' A' ' 17' ' ' PRO . . . 101.22 50.31 1.24 Allowed Glycine 0 N--CA 1.446 -0.64 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.656 -179.434 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.9 m -81.65 -29.42 33.16 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.146 0.498 . . . . 0.0 110.553 -177.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -123.45 162.01 23.69 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.543 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 69.8 m-20 -97.47 -2.5 41.89 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.052 0.453 . . . . 0.0 110.668 179.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.416 ' HA ' ' HA2' ' A' ' 105' ' ' GLY . 53.6 m -149.3 112.49 4.93 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.479 176.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -105.79 149.36 26.55 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.289 178.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 89.8 m -98.7 98.06 9.24 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.876 175.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.438 HD13 ' CG2' ' A' ' 104' ' ' VAL . 6.6 mp -94.19 132.25 38.92 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.381 0.61 . . . . 0.0 110.419 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.446 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 17.3 m -129.69 113.97 15.42 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.283 -176.179 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 69.0 t -86.21 109.29 18.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 177.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -104.68 115.09 29.72 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 176.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.587 ' HB ' ' HB2' ' A' ' 98' ' ' ASN . 74.9 t -82.66 114.02 22.85 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-O 121.404 0.621 . . . . 0.0 111.304 -177.281 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 45.2 t0 63.27 90.37 0.09 OUTLIER Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 114.211 -1.359 . . . . 0.0 112.35 176.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.528 ' HD3' ' O ' ' A' ' 39' ' ' ASN . 1.9 Cg_endo -84.7 -6.93 9.7 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 123.195 2.597 . . . . 0.0 111.563 174.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -92.84 -16.67 25.02 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.738 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 57.51 54.96 6.02 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.464 -179.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -93.45 -30.17 15.19 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.008 -0.996 . . . . 0.0 109.703 179.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 47.9 t -110.03 101.51 12.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.486 173.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -64.78 129.69 40.7 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.098 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.403 ' OE1' ' HB2' ' A' ' 5' ' ' LEU . 36.0 mt-10 -108.62 164.14 12.62 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.626 -173.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -58.42 -101.06 0.01 OUTLIER Glycine 0 CA--C 1.519 0.309 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.516 168.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -84.29 101.66 12.09 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 176.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -74.35 22.96 0.09 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.158 -174.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 16.2 m -111.82 -5.14 14.43 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.201 0.524 . . . . 0.0 109.839 174.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.561 ' O ' ' HD2' ' A' ' 7' ' ' PRO . 81.3 m-20 -87.52 -15.31 37.89 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.191 178.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.587 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 27.8 p-10 -77.04 1.64 17.37 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.685 -173.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 1.2 m -114.24 147.01 39.65 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.083 0.468 . . . . 0.0 110.984 -177.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.446 ' O ' ' HA ' ' A' ' 81' ' ' THR . 40.2 tp -143.57 102.19 3.9 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.904 179.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 8.5 m -95.96 110.64 22.82 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.969 178.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -128.5 138.8 52.45 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.902 -178.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 64.5 mt -87.67 121.46 30.12 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.449 177.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.438 ' CG2' HD13 ' A' ' 80' ' ' LEU . 27.3 m -113.29 121.41 65.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.842 179.192 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.538 ' O ' ' HA ' ' A' ' 14' ' ' THR . . . -103.66 174.05 22.37 Favored Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 120.397 -0.906 . . . . 0.0 111.054 -177.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.496 ' HA ' ' O ' ' A' ' 15' ' ' VAL . 20.7 p -73.29 154.59 40.09 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 117.286 0.543 . . . . 0.0 109.808 175.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.575 ' HA ' ' HB ' ' A' ' 14' ' ' THR . 49.7 tp . . . . . 0 C--N 1.327 -0.403 0 CA-C-O 121.184 0.516 . . . . 0.0 112.153 -172.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 12.6 tt . . . . . 0 N--CA 1.451 -0.395 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.603 ' HD2' ' O ' ' A' ' 91' ' ' ASN . 16.9 Cg_exo -68.04 151.51 77.47 Favored 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 122.4 2.067 . . . . 0.0 111.697 175.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -141.46 90.41 2.29 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 179.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.523 HD22 HD23 ' A' ' 57' ' ' LEU . 58.4 mt -85.05 109.05 17.94 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.073 -171.401 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.538 HG22 ' HB3' ' A' ' 97' ' ' ASN . 17.7 t -117.46 123.1 30.19 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.207 -176.248 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.556 ' HG3' HG23 ' A' ' 84' ' ' VAL . 3.3 Cg_exo -79.32 101.59 1.43 Allowed 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 122.599 2.199 . . . . 0.0 110.014 170.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 29.3 m -83.66 -27.9 7.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -171.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 43.6 t -175.2 166.01 3.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.667 0.27 . . . . 0.0 110.573 -176.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.478 ' C ' HD12 ' A' ' 10' ' ' LEU . 3.2 pp -146.27 152.25 38.86 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 172.383 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 22.9 p -129.72 144.73 54.13 Favored Pre-proline 0 C--N 1.322 -0.588 0 CA-C-N 116.693 -0.231 . . . . 0.0 110.506 177.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -90.53 162.68 32.36 Favored 'Cis proline' 0 N--CA 1.457 -0.622 0 C-N-CA 123.283 -1.549 . . . . 0.0 112.365 -2.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 30.7 m -91.74 9.72 3.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.63 0.728 . . . . 0.0 110.398 177.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.545 HG22 ' HA ' ' A' ' 107' ' ' LEU . 0.2 OUTLIER -142.29 122.22 13.61 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.223 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.43 HG21 ' CZ3' ' A' ' 69' ' ' TRP . 21.1 m -121.19 160.32 22.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -168.084 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.457 ' HA ' ' HD3' ' A' ' 17' ' ' PRO . 45.4 t -91.99 118.85 68.42 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.057 178.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.577 ' HA ' ' CB ' ' A' ' 71' ' ' LEU . 5.7 Cg_exo -77.79 16.14 1.17 Allowed 'Trans proline' 0 CA--C 1.53 0.318 0 C-N-CA 122.931 2.421 . . . . 0.0 113.455 -176.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.452 ' H ' HG12 ' A' ' 16' ' ' VAL . 51.3 m-80 -122.61 16.16 10.33 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 121.009 -0.276 . . . . 0.0 111.628 -175.277 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 14.3 t -169.68 178.77 3.98 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 110.408 -0.219 . . . . 0.0 110.408 -179.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 45.2 t -85.07 125.3 40.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 176.013 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.492 ' ND2' HD23 ' A' ' 71' ' ' LEU . 28.0 m-80 -97.5 124.22 41.65 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.673 -175.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 23.8 m -80.95 105.43 12.17 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.564 -0.743 . . . . 0.0 109.52 175.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . 0.439 ' HB2' ' HB2' ' A' ' 67' ' ' PHE . 42.0 mtp -102.69 136.53 42.34 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.36 -176.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.444 ' HA ' ' O ' ' A' ' 65' ' ' VAL . 22.0 m -115.33 103.74 11.1 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.863 -177.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -89.36 141.09 28.85 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.411 177.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 19.2 m -104.39 109.13 20.86 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.079 0.466 . . . . 0.0 110.376 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 14.3 mm -101.9 118.32 48.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.284 179.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -110.35 131.43 55.06 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 120.754 0.311 . . . . 0.0 110.698 -177.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 35.9 t30 -89.32 98.83 11.99 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.211 -0.449 . . . . 0.0 109.871 177.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -94.14 40.37 1.08 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.982 -174.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -143.96 147.36 18.62 Favored Glycine 0 N--CA 1.444 -0.831 0 N-CA-C 110.631 -0.987 . . . . 0.0 110.631 179.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -84.34 60.5 6.02 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.349 0.595 . . . . 0.0 111.157 -172.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.563 ' HD3' ' HD3' ' A' ' 3' ' ' PRO . 64.4 tttp -161.45 137.51 8.05 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.027 170.373 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -76.44 132.9 39.91 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.242 -176.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 58.7 p -95.69 145.1 25.54 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.144 0.497 . . . . 0.0 111.032 -176.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 24.1 p -86.47 -162.22 0.74 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.729 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.449 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 32.6 t -56.96 125.53 23.03 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 120.901 0.382 . . . . 0.0 111.085 178.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.558 ' HB2' ' HB2' ' A' ' 85' ' ' ASP . 42.6 p90 -138.32 143.66 40.04 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 177.354 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.568 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 65.2 t30 -102.55 115.56 30.83 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 121.048 -0.261 . . . . 0.0 111.422 -172.318 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.568 HG22 ' HA ' ' A' ' 84' ' ' VAL . 2.0 t -102.49 125.9 56.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.098 0.475 . . . . 0.0 110.566 -176.385 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.533 ' HB3' HG23 ' A' ' 51' ' ' THR . 52.5 p -117.66 138.27 52.09 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.914 -177.255 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 59.5 tp -96.46 107.8 20.26 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 176.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.456 ' HG ' HG22 ' A' ' 48' ' ' VAL . 4.6 mp -96.94 118.64 33.79 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.264 -179.099 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.527 HG22 ' HG ' ' A' ' 80' ' ' LEU . 95.8 t -100.87 102.08 12.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.083 178.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 59.29 22.45 10.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.374 -0.83 . . . . 0.0 112.399 176.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 121.81 -26.75 6.42 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.464 -0.874 . . . . 0.0 113.002 176.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 11.9 mm -97.85 148.6 5.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 -178.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.456 HG22 ' HG ' ' A' ' 43' ' ' LEU . 39.5 t -98.4 110.7 26.44 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 -179.383 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 28.7 m -91.53 -31.52 4.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.766 -175.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -148.95 139.82 22.85 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.676 0.274 . . . . 0.0 110.298 -177.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.533 HG23 ' HB3' ' A' ' 41' ' ' SER . 2.1 m -133.87 121.6 21.98 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.112 -0.495 . . . . 0.0 109.682 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -128.28 114.96 17.58 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.085 0.469 . . . . 0.0 110.297 -178.108 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.568 ' HA ' ' HA ' ' A' ' 39' ' ' ASN . 21.8 m -76.97 131.4 38.47 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.365 178.537 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.449 ' O ' ' HA ' ' A' ' 37' ' ' SER . 38.6 t -101.95 121.41 52.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 177.017 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.6 m -59.7 -36.16 75.96 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -174.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 21.2 t -172.53 152.46 2.63 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.959 0.409 . . . . 0.0 111.262 179.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.633 HD13 ' OG1' ' A' ' 63' ' ' THR . 23.3 tp -140.07 114.34 9.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.82 175.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -70.27 173.06 7.18 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.468 0.652 . . . . 0.0 112.035 -175.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 10.0 m -63.89 129.66 40.97 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.686 178.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 61.99 19.42 10.75 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.903 -0.59 . . . . 0.0 112.229 176.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -101.24 158.54 15.96 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 178.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 7.1 m -121.52 125.38 46.67 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.136 179.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.633 ' OG1' HD13 ' A' ' 57' ' ' LEU . 86.1 m -103.96 135.94 44.53 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.892 0.377 . . . . 0.0 110.973 -179.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -92.85 119.8 32.55 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.762 174.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.444 ' O ' ' HA ' ' A' ' 24' ' ' THR . 40.7 t -96.24 135.06 31.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.441 -177.34 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -96.39 112.13 23.98 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.579 -176.25 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.439 ' HB2' ' HB2' ' A' ' 23' ' ' MET . 36.1 m-85 -112.37 140.01 47.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.785 0.326 . . . . 0.0 111.016 177.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 22.0 m170 -115.86 97.46 6.12 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 176.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . 0.43 ' CZ3' HG21 ' A' ' 15' ' ' VAL . 18.6 t90 -108.65 114.38 28.14 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.17 0.509 . . . . 0.0 111.622 -173.511 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 9.7 m -82.88 123.9 29.83 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.05 176.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.577 ' CB ' ' HA ' ' A' ' 17' ' ' PRO . 1.0 OUTLIER -83.89 123.17 29.66 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.163 0.506 . . . . 0.0 111.756 -178.573 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 19.3 p-10 -79.19 -43.42 23.92 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.755 175.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 89.39 40.0 6.18 Favored Glycine 0 N--CA 1.45 -0.37 0 CA-C-N 115.772 -0.649 . . . . 0.0 113.152 176.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 18.2 m -99.39 -13.95 19.36 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.207 0.527 . . . . 0.0 110.524 178.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -145.04 152.5 40.22 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.567 178.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -90.09 -10.11 45.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.158 0.504 . . . . 0.0 110.645 179.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 24.7 m -140.53 121.52 14.61 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.316 179.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -116.32 153.31 32.21 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.252 179.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.422 ' HA ' HD23 ' A' ' 103' ' ' LEU . 4.4 m -96.54 89.59 5.06 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.881 179.125 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.527 ' HG ' HG22 ' A' ' 44' ' ' VAL . 10.7 mp -87.55 113.02 22.86 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.477 0.656 . . . . 0.0 110.256 -178.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.495 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 5.4 m -115.97 113.51 23.36 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.6 -173.209 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 59.9 t -87.55 109.16 19.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 116.311 -0.404 . . . . 0.0 109.94 177.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -105.83 120.78 42.61 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.135 0.493 . . . . 0.0 109.849 176.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.568 ' HA ' HG22 ' A' ' 40' ' ' VAL . 83.5 t -85.37 111.95 21.52 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.621 -175.601 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.558 ' HB2' ' HB2' ' A' ' 38' ' ' PHE . 20.6 t70 57.8 86.85 0.15 Allowed Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 114.294 -1.321 . . . . 0.0 112.92 173.493 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_exo -72.92 -9.0 23.18 Favored 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 122.797 2.331 . . . . 0.0 111.26 174.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -82.52 -27.12 31.9 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.27 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 10.2 m120 56.99 52.57 9.05 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.505 -177.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -83.98 -25.64 29.86 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.981 -1.009 . . . . 0.0 109.936 179.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 40.3 t -100.4 136.9 29.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.802 177.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.603 ' O ' ' HD2' ' A' ' 3' ' ' PRO . 43.8 m-80 -75.05 112.04 10.88 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 173.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.442 ' CD ' HD21 ' A' ' 98' ' ' ASN . 33.9 mt-10 -114.6 152.64 31.5 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 120.896 0.379 . . . . 0.0 111.752 -173.382 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -57.7 -101.09 0.01 OUTLIER Glycine 0 CA--C 1.519 0.326 0 CA-C-N 115.071 -0.968 . . . . 0.0 113.956 179.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -88.83 124.29 34.04 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.543 0.211 . . . . 0.0 111.015 -173.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -61.11 -33.76 73.88 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -174.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 10.9 p -75.05 -1.94 25.14 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.934 0.397 . . . . 0.0 111.398 -177.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.538 ' HB3' HG22 ' A' ' 6' ' ' VAL . 7.6 m-20 -91.7 -13.55 31.52 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.52 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.442 HD21 ' CD ' ' A' ' 92' ' ' GLU . 10.8 m120 -69.8 -18.02 63.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.903 -0.589 . . . . 0.0 112.257 -177.464 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 1.2 m -123.04 147.91 46.16 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.326 0.584 . . . . 0.0 112.102 -170.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.495 ' O ' ' HA ' ' A' ' 81' ' ' THR . 29.4 tp -131.89 104.61 6.96 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.096 -0.957 . . . . 0.0 109.694 178.52 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 7.0 m -87.98 99.47 12.18 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.277 178.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -113.62 148.85 35.49 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.91 0.386 . . . . 0.0 111.11 -178.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.422 HD23 ' HA ' ' A' ' 79' ' ' THR . 51.8 mt -112.83 120.46 41.53 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.384 178.535 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.446 HG22 HD13 ' A' ' 80' ' ' LEU . 27.8 m -110.19 156.78 11.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.371 -178.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.53 ' O ' ' HA ' ' A' ' 14' ' ' THR . . . -122.89 169.98 15.32 Favored Glycine 0 N--CA 1.442 -0.955 0 C-N-CA 120.292 -0.956 . . . . 0.0 111.468 179.153 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 27.3 p -81.47 139.28 35.29 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 174.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.545 ' HA ' HG22 ' A' ' 14' ' ' THR . 32.9 tp . . . . . 0 C--N 1.327 -0.381 0 CA-C-O 121.033 0.444 . . . . 0.0 111.907 -172.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 10.7 tt . . . . . 0 N--CA 1.452 -0.356 0 CA-C-O 120.78 0.324 . . . . 0.0 110.479 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.444 ' HA ' ' HA3' ' A' ' 31' ' ' GLY . 88.2 Cg_endo -95.75 169.93 1.27 Allowed 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 123.09 2.527 . . . . 0.0 113.196 175.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . 0.402 ' O ' ' HA ' ' A' ' 29' ' ' ASN . 5.5 m-20 -136.42 104.33 5.56 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.089 171.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.475 HD22 HD23 ' A' ' 57' ' ' LEU . 85.4 mt -89.69 90.79 8.38 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.34 0.59 . . . . 0.0 109.949 -176.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.489 ' HA ' ' HD2' ' A' ' 7' ' ' PRO . 25.0 t -104.24 111.73 65.25 Favored Pre-proline 0 C--N 1.319 -0.756 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.116 -174.155 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.524 ' HB2' HD22 ' A' ' 100' ' ' LEU . 18.5 Cg_endo -62.18 119.01 5.91 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 122.244 1.963 . . . . 0.0 109.956 169.099 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.5 t -91.0 -47.67 14.31 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.848 -168.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.9 t -160.67 173.68 15.1 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.489 -178.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 55.7 tp -136.46 127.74 28.22 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.83 -178.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.536 ' OG1' ' HA ' ' A' ' 12' ' ' PRO . 14.0 t -140.48 149.2 56.54 Favored Pre-proline 0 C--N 1.322 -0.589 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.536 ' HA ' ' OG1' ' A' ' 11' ' ' THR . 72.3 Cg_endo -76.56 148.12 88.33 Favored 'Cis proline' 0 N--CA 1.464 -0.251 0 C-N-CA 123.393 -1.503 . . . . 0.0 112.745 0.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 34.7 m -72.9 -22.35 19.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.724 177.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.622 ' HA ' ' O ' ' A' ' 105' ' ' GLY . 17.0 p -114.24 129.33 56.63 Favored 'General case' 0 N--CA 1.439 -1.016 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.164 174.17 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.499 HG11 ' CZ3' ' A' ' 69' ' ' TRP . 18.0 m -113.52 149.41 15.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.165 0.507 . . . . 0.0 111.923 -173.254 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 27.2 t -90.2 113.35 57.01 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.034 -179.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -83.27 42.09 1.2 Allowed 'Trans proline' 0 CA--C 1.53 0.289 0 C-N-CA 122.974 2.449 . . . . 0.0 113.384 -175.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -156.72 27.92 0.33 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.999 0.428 . . . . 0.0 110.984 177.055 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 11.2 t -170.99 -177.06 2.12 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.001 179.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 59.0 t -90.02 118.86 36.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.035 0.445 . . . . 0.0 109.91 177.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 44.8 m-80 -89.8 126.57 35.73 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.482 -178.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 17.8 m -80.04 89.0 5.35 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.527 175.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . 0.558 ' HB2' ' HB2' ' A' ' 67' ' ' PHE . 91.3 mmm -79.38 113.21 17.34 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.925 -0.579 . . . . 0.0 109.607 -176.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.5 ' CG2' ' HB3' ' A' ' 64' ' ' ASN . 26.4 m -102.11 112.8 25.6 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.431 -175.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -101.21 124.05 46.3 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.38 179.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 25.0 m -86.12 110.6 19.66 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.285 179.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 19.8 mm -107.64 120.79 59.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 178.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -115.41 127.59 55.47 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.878 0.37 . . . . 0.0 110.889 -179.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.402 ' HA ' ' O ' ' A' ' 4' ' ' ASP . 25.2 t30 -89.86 103.8 16.42 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.844 177.293 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 -99.51 56.73 1.01 Allowed 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.621 -175.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.444 ' HA3' ' HA ' ' A' ' 3' ' ' PRO . . . -144.05 170.73 25.81 Favored Glycine 0 N--CA 1.448 -0.527 0 N-CA-C 111.521 -0.632 . . . . 0.0 111.521 -179.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 7.6 p-10 -86.84 0.97 53.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.04 0.448 . . . . 0.0 110.92 -174.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -120.91 132.33 54.9 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.51 -179.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -66.76 139.93 57.83 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.619 173.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.448 ' OG ' HD21 ' A' ' 5' ' ' LEU . 15.7 p -100.87 136.22 41.07 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.622 177.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.602 ' O ' ' HA ' ' A' ' 56' ' ' SER . 2.0 m -82.41 -128.02 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 120.91 -0.316 . . . . 0.0 110.246 -179.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.406 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 9.7 t -90.71 121.43 32.6 Favored 'General case' 0 C--N 1.323 -0.554 0 O-C-N 121.786 -0.571 . . . . 0.0 111.399 -172.222 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -128.92 142.04 51.08 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.624 -0.717 . . . . 0.0 109.361 176.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.676 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 64.1 t30 -90.31 120.13 31.19 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 120.832 0.349 . . . . 0.0 110.234 -176.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.483 HG11 HG11 ' A' ' 65' ' ' VAL . 0.3 OUTLIER -106.46 147.29 12.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -176.259 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 9.9 p -137.8 139.43 40.0 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 120.756 -0.378 . . . . 0.0 111.479 -175.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 62.2 tp -105.47 111.31 23.98 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.705 175.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.416 ' HG ' HG22 ' A' ' 48' ' ' VAL . 4.2 mp -98.55 141.49 31.33 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.936 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.412 HG22 ' HG ' ' A' ' 80' ' ' LEU . 87.4 t -123.83 106.09 16.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 176.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 57.53 23.49 9.25 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 115.791 -0.641 . . . . 0.0 112.083 178.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 120.99 -33.09 4.52 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.907 176.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 11.2 mm -90.89 149.25 4.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 -177.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.416 HG22 ' HG ' ' A' ' 43' ' ' LEU . 39.0 t -96.66 110.39 24.72 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 179.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 26.7 m -90.98 -25.69 5.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.686 -175.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -147.34 145.15 29.22 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 -178.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 22.1 m -141.74 113.52 7.86 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.076 0.465 . . . . 0.0 109.961 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.407 ' O ' HG12 ' A' ' 40' ' ' VAL . 0.1 OUTLIER -122.99 116.36 23.42 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.794 -174.922 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.676 ' HA ' ' HA ' ' A' ' 39' ' ' ASN . 8.6 m -80.69 112.64 18.25 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 176.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.406 ' O ' ' HA ' ' A' ' 37' ' ' SER . 49.2 t -77.6 133.27 30.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 -178.53 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 26.3 m -63.74 -43.74 95.59 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.614 -175.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.602 ' HA ' ' O ' ' A' ' 36' ' ' THR . 38.7 t -177.36 151.11 0.75 Allowed 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 -178.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.475 HD23 HD22 ' A' ' 5' ' ' LEU . 26.5 tp -131.04 121.76 25.58 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.836 177.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.414 ' HB2' ' HB3' ' A' ' 61' ' ' ASN . 24.5 mt-10 -71.16 163.07 28.34 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.52 -0.764 . . . . 0.0 112.124 -174.274 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 4.9 m -67.16 124.09 22.12 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.814 178.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 63.46 20.56 12.32 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.956 176.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.414 ' HB3' ' HB2' ' A' ' 58' ' ' GLU . 56.1 t30 -113.26 153.0 29.12 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 177.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.3 m -109.0 133.33 53.12 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.872 0.367 . . . . 0.0 110.286 -179.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.42 ' HB ' HD13 ' A' ' 57' ' ' LEU . 20.5 m -123.62 127.32 48.09 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.115 177.35 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.5 ' HB3' ' CG2' ' A' ' 24' ' ' THR . 56.7 m-80 -90.22 135.14 33.85 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.409 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.483 HG11 HG11 ' A' ' 40' ' ' VAL . 13.7 t -96.4 138.57 21.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.862 -176.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -94.55 97.2 9.97 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.921 -179.079 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.558 ' HB2' ' HB2' ' A' ' 23' ' ' MET . 67.5 m-85 -98.69 145.78 26.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.364 176.692 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 35.6 m-70 -114.99 100.95 8.57 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.221 0.534 . . . . 0.0 110.827 179.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . 0.499 ' CZ3' HG11 ' A' ' 15' ' ' VAL . 10.2 t90 -103.22 98.01 8.01 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.483 -177.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 18.8 m -74.03 100.33 3.55 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 175.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 28.5 tp -107.7 106.6 17.0 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.211 0.529 . . . . 0.0 111.391 -172.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -78.2 -19.85 53.02 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.172 175.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 89.8 87.27 1.3 Allowed Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.519 177.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 11.6 m -106.64 -33.74 7.55 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.024 0.44 . . . . 0.0 110.329 178.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -134.47 175.69 9.3 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.055 -0.521 . . . . 0.0 109.93 178.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.454 ' HA ' HG23 ' A' ' 106' ' ' THR . 31.7 p-10 -107.84 -8.88 15.87 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.03 0.443 . . . . 0.0 110.935 -179.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 3.2 p -137.2 116.81 12.94 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.345 -179.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -118.01 142.83 46.95 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.967 -178.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 25.5 m -99.21 94.32 6.42 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.051 179.172 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.497 HD13 HG22 ' A' ' 104' ' ' VAL . 10.2 mp -91.96 136.88 32.82 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.325 0.583 . . . . 0.0 110.777 -177.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.477 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 23.6 m -131.86 123.59 27.82 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.155 -178.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 46.8 t -95.4 108.84 21.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 177.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -100.06 119.51 38.4 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.47 HG21 ' HD3' ' A' ' 7' ' ' PRO . 88.6 t -92.52 106.36 17.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.735 -176.393 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 45.5 t0 62.38 92.67 0.06 OUTLIER Pre-proline 0 C--N 1.33 -0.272 0 O-C-N 124.276 0.985 . . . . 0.0 112.084 177.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -94.05 15.82 1.22 Allowed 'Trans proline' 0 N--CA 1.451 -0.996 0 C-N-CA 123.101 2.534 . . . . 0.0 111.839 174.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -125.5 -1.97 7.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.731 -174.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 65.5 t30 61.21 51.46 4.34 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.453 0.644 . . . . 0.0 110.714 177.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -89.33 -34.7 16.46 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.841 177.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 63.9 t -119.09 115.33 47.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.186 177.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 59.1 t30 -79.77 133.29 36.31 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 177.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -122.06 172.81 7.97 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.153 0.501 . . . . 0.0 112.27 -174.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -57.72 -100.82 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.526 0 CA-C-N 114.55 -1.205 . . . . 0.0 112.023 169.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -63.54 153.24 36.28 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.918 0.389 . . . . 0.0 110.684 178.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -98.62 -3.53 35.95 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.648 0.737 . . . . 0.0 109.817 176.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 8.3 p -87.3 -4.39 59.06 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.62 178.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.419 ' O ' ' HD2' ' A' ' 7' ' ' PRO . 55.3 m-20 -70.62 -35.54 73.01 Favored 'General case' 0 C--O 1.223 -0.303 0 CA-C-O 121.062 0.458 . . . . 0.0 110.244 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.467 ' HA ' ' HB ' ' A' ' 84' ' ' VAL . 13.1 m120 -72.34 18.87 0.08 Allowed 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 -165.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 1.8 m -150.38 149.81 30.56 Favored 'General case' 0 C--N 1.323 -0.552 0 O-C-N 121.883 -0.511 . . . . 0.0 111.345 -179.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.524 HD22 ' HB2' ' A' ' 7' ' ' PRO . 41.9 tp -152.46 100.95 2.62 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.61 176.016 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 61.8 m -92.94 113.38 25.64 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.365 178.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -130.14 134.13 47.11 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.777 -179.336 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 76.3 mt -85.6 126.17 33.69 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.638 178.321 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.497 HG22 HD13 ' A' ' 80' ' ' LEU . 19.1 m -116.86 147.05 20.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.581 177.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.622 ' O ' ' HA ' ' A' ' 14' ' ' THR . . . -123.72 164.08 17.05 Favored Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 120.495 -0.859 . . . . 0.0 111.389 -177.494 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.454 HG23 ' HA ' ' A' ' 76' ' ' ASN . 35.3 p -70.59 150.19 46.31 Favored 'General case' 0 C--N 1.317 -0.807 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.739 178.203 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.522 ' HA ' ' HB ' ' A' ' 14' ' ' THR . 39.1 tp . . . . . 0 C--N 1.326 -0.442 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.644 -177.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 15.9 tt . . . . . 0 N--CA 1.45 -0.439 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.57 ' HD2' ' O ' ' A' ' 91' ' ' ASN . 8.0 Cg_exo -73.22 161.69 42.38 Favored 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 122.553 2.169 . . . . 0.0 112.309 177.004 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -145.45 92.83 2.28 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 175.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.566 HD22 HD23 ' A' ' 57' ' ' LEU . 60.8 mt -90.72 101.24 13.99 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.47 0.652 . . . . 0.0 110.801 -169.142 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 22.5 t -104.49 112.18 65.33 Favored Pre-proline 0 C--N 1.318 -0.798 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.471 -174.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.518 ' HB2' ' HB2' ' A' ' 100' ' ' LEU . 33.1 Cg_endo -67.65 103.11 0.79 Allowed 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 121.941 1.76 . . . . 0.0 109.776 166.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 6.6 t -80.77 -49.18 18.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.315 -167.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 55.6 m -148.64 165.96 29.74 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.877 0.37 . . . . 0.0 111.312 -177.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.511 HD23 ' HB3' ' A' ' 102' ' ' ALA . 31.0 tp -139.8 104.33 4.86 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.654 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 21.5 p -123.71 145.26 46.87 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.28 -175.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -81.89 155.96 79.79 Favored 'Cis proline' 0 C--N 1.342 0.19 0 C-N-CA 123.723 -1.366 . . . . 0.0 112.015 -2.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 33.9 m -83.62 -11.47 11.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.892 0.377 . . . . 0.0 111.52 -177.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -116.72 126.88 53.8 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.82 0.343 . . . . 0.0 110.077 173.46 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.413 HG11 ' CZ3' ' A' ' 69' ' ' TRP . 34.7 m -113.52 165.39 8.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 120.896 0.379 . . . . 0.0 111.16 -176.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.432 ' HA ' ' HD3' ' A' ' 17' ' ' PRO . 4.9 t -110.15 117.61 51.27 Favored Pre-proline 0 C--N 1.324 -0.531 0 N-CA-C 109.524 -0.546 . . . . 0.0 109.524 177.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.471 ' HA ' ' HG ' ' A' ' 71' ' ' LEU . 7.1 Cg_exo -73.59 31.27 0.32 Allowed 'Trans proline' 0 CA--C 1.533 0.465 0 C-N-CA 123.295 2.664 . . . . 0.0 112.716 -178.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -105.82 -29.34 10.09 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.124 -176.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 8.9 t -151.21 178.62 9.05 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.159 -170.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 92.5 t -73.44 120.76 22.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 176.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 36.8 m-80 -92.49 123.91 36.14 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.345 -176.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.435 ' HA ' ' O ' ' A' ' 67' ' ' PHE . 24.9 m -89.88 96.29 10.62 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 177.567 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 86.5 mtp -97.23 135.87 38.55 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.459 -176.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.584 ' HA ' ' O ' ' A' ' 65' ' ' VAL . 31.3 m -108.46 115.78 30.74 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.873 -176.429 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -105.53 120.45 41.65 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.017 176.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 28.4 m -83.53 112.92 20.42 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 120.55 0.214 . . . . 0.0 110.458 -179.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.425 HD13 ' HA ' ' A' ' 7' ' ' PRO . 21.5 mm -103.3 120.01 52.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 177.249 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -116.22 126.47 53.67 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.772 0.32 . . . . 0.0 110.632 -177.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.438 ' HB2' ' HG ' ' A' ' 57' ' ' LEU . 33.1 t30 -90.03 101.77 14.48 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.134 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -103.39 54.3 0.75 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.515 -175.164 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -144.02 169.19 26.29 Favored Glycine 0 N--CA 1.447 -0.589 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.375 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -91.09 45.41 1.25 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.257 0.551 . . . . 0.0 110.885 -173.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 46.1 tptt -161.51 135.18 6.59 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.038 176.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -83.85 124.9 31.43 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 178.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 9.5 p -86.2 143.83 27.77 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.9 0.381 . . . . 0.0 111.402 -175.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 12.6 p -81.74 -164.13 0.75 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.967 -179.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.498 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 17.5 m -61.32 114.85 3.41 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 121.08 0.467 . . . . 0.0 111.562 -177.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.512 ' CE2' HG23 ' A' ' 40' ' ' VAL . 22.2 p90 -127.64 154.12 45.63 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.249 178.419 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.474 ' O ' ' HD3' ' A' ' 86' ' ' PRO . 55.1 m-80 -100.46 125.93 46.81 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.881 0.372 . . . . 0.0 110.984 -178.252 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.512 HG23 ' CE2' ' A' ' 38' ' ' PHE . 2.3 t -108.21 111.31 35.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-O 121.333 0.587 . . . . 0.0 109.453 177.399 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.517 ' HB3' HG23 ' A' ' 51' ' ' THR . 24.0 p -109.76 140.91 43.11 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.367 -174.11 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.403 HD11 ' HB3' ' A' ' 80' ' ' LEU . 52.7 tp -101.49 114.73 29.01 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.103 177.169 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.7 mp -101.18 126.45 47.9 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.243 179.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 86.2 t -104.87 104.07 16.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 116.148 -0.478 . . . . 0.0 109.873 178.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 57.18 28.89 15.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.411 178.039 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 107.46 -18.5 35.38 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.854 -0.688 . . . . 0.0 112.822 177.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 6.3 mm -95.44 148.16 5.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 -178.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 96.7 t -97.99 113.52 32.81 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-O 121.076 0.465 . . . . 0.0 110.126 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 27.9 m -96.77 -38.86 8.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.445 -177.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -153.16 143.2 22.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.855 0.359 . . . . 0.0 110.941 -175.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.517 HG23 ' HB3' ' A' ' 41' ' ' SER . 41.3 m -136.38 120.5 17.75 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.992 -179.281 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 45.8 tt0 -106.5 137.22 44.89 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.766 0.317 . . . . 0.0 110.377 -178.009 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 18.0 m -97.56 114.88 26.87 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.195 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.498 ' O ' ' HA ' ' A' ' 37' ' ' SER . 23.5 t -91.03 120.7 40.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.7 m -56.11 -43.15 77.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.58 -177.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 44.0 t -172.88 150.5 2.07 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.997 -0.372 . . . . 0.0 109.997 -179.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.566 HD23 HD22 ' A' ' 5' ' ' LEU . 28.3 tp -133.63 112.54 11.53 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 176.127 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -83.23 162.08 21.32 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.377 -174.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 5.8 p -65.5 138.36 58.03 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.073 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 68.66 5.72 5.06 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 123.183 0.593 . . . . 0.0 111.218 -179.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -103.48 147.56 27.0 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.874 0.369 . . . . 0.0 110.419 179.081 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 2.9 p -121.57 122.69 40.23 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.26 177.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 33.5 m -104.1 126.01 50.88 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.502 -179.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.436 ' HB3' ' CG2' ' A' ' 24' ' ' THR . 90.8 m-20 -83.15 117.87 23.2 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.894 177.353 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.584 ' O ' ' HA ' ' A' ' 24' ' ' THR . 44.8 t -96.02 115.8 36.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.964 -176.148 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 40.4 m-20 -96.67 108.21 20.79 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.748 0.309 . . . . 0.0 110.351 -179.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.435 ' O ' ' HA ' ' A' ' 22' ' ' THR . 65.3 m-85 -91.34 154.97 18.85 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 120.932 0.396 . . . . 0.0 110.097 179.463 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 50.7 m-70 -114.74 88.28 2.83 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 176.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . 0.413 ' CZ3' HG11 ' A' ' 15' ' ' VAL . 15.1 t90 -98.28 111.18 23.61 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.449 -172.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 7.3 m -86.06 118.65 25.66 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 170.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.561 HD11 ' CZ ' ' A' ' 78' ' ' TYR . 0.1 OUTLIER -55.2 -43.82 74.77 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.454 0.539 . . . . 0.0 112.454 -167.947 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.42 ' HB3' ' O ' ' A' ' 71' ' ' LEU . 31.5 t70 71.46 4.21 4.97 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.534 0.683 . . . . 0.0 110.997 176.002 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 179.18 -158.78 23.1 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 121.084 -0.579 . . . . 0.0 111.996 179.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 85.2 m -155.16 94.93 1.67 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.139 0.495 . . . . 0.0 110.344 177.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.412 ' HB3' ' CE1' ' A' ' 78' ' ' TYR . . . -112.51 172.31 7.0 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.111 175.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -79.15 -30.17 43.44 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.451 -0.5 . . . . 0.0 110.534 -178.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.499 ' HB2' HD21 ' A' ' 103' ' ' LEU . 70.7 p -150.91 157.94 43.53 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.283 -178.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.561 ' CZ ' HD11 ' A' ' 71' ' ' LEU . 27.9 m-85 -136.64 152.4 50.38 Favored 'General case' 0 C--N 1.328 -0.331 0 O-C-N 123.152 0.282 . . . . 0.0 110.487 -179.397 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 4.4 m -103.22 89.36 3.38 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.92 0.391 . . . . 0.0 110.219 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.523 HD13 HG22 ' A' ' 104' ' ' VAL . 9.4 mp -92.47 122.36 34.83 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.246 0.546 . . . . 0.0 111.189 -175.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.515 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 73.2 m -120.43 119.76 33.97 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.647 -179.628 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.417 ' HB ' ' HB3' ' A' ' 100' ' ' LEU . 98.9 t -85.63 107.85 16.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 174.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -95.31 113.9 25.62 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.172 177.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.569 ' HB ' ' HB2' ' A' ' 98' ' ' ASN . 96.2 t -85.48 111.25 20.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.614 179.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 56.5 t0 62.89 95.49 0.05 OUTLIER Pre-proline 0 N--CA 1.467 0.424 0 CA-C-N 114.825 -1.08 . . . . 0.0 112.236 178.143 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.474 ' HD3' ' O ' ' A' ' 39' ' ' ASN . 2.2 Cg_endo -85.41 1.55 8.21 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 123.167 2.578 . . . . 0.0 111.832 175.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -98.97 -20.29 16.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.095 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 15.3 m120 64.8 33.64 10.05 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.218 -178.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -73.23 -37.09 66.52 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.402 177.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 43.7 t -96.65 118.0 42.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.192 178.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.57 ' O ' ' HD2' ' A' ' 3' ' ' PRO . 53.6 t30 -85.7 135.7 33.65 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 175.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.4 ' OE2' ' HB3' ' A' ' 98' ' ' ASN . 40.6 mt-10 -115.71 159.4 21.44 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.246 0.546 . . . . 0.0 112.383 -171.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -57.96 -100.59 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 114.613 -1.176 . . . . 0.0 112.501 172.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 39.7 t30 -68.4 96.52 0.68 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.68 0.276 . . . . 0.0 110.325 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -73.97 78.76 1.67 Allowed 'General case' 0 C--O 1.233 0.226 0 CA-C-O 121.475 0.655 . . . . 0.0 110.39 -176.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 20.9 t -179.29 25.46 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.61 -1.177 . . . . 0.0 108.814 176.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 24.1 p-10 -118.68 -28.11 5.71 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.596 -170.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.569 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 22.4 p-10 -68.88 0.34 4.54 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -169.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -119.92 118.38 30.58 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.157 0.503 . . . . 0.0 111.521 178.613 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.518 ' HB2' ' HB2' ' A' ' 7' ' ' PRO . 26.3 tp -111.34 99.94 8.65 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.759 176.518 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 96.2 m -93.74 97.36 10.39 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.502 0.668 . . . . 0.0 110.104 178.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.511 ' HB3' HD23 ' A' ' 10' ' ' LEU . . . -107.99 115.73 30.67 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.166 -0.925 . . . . 0.0 109.589 178.628 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.499 HD21 ' HB2' ' A' ' 77' ' ' SER . 5.0 tt -78.65 101.39 7.46 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.523 HG22 HD13 ' A' ' 80' ' ' LEU . 29.9 m -90.57 158.78 2.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.219 -176.361 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -123.58 -170.88 13.47 Favored Glycine 0 N--CA 1.436 -1.317 0 C-N-CA 120.435 -0.888 . . . . 0.0 111.519 -178.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 18.6 p -107.95 140.05 41.67 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 177.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 47.6 tp . . . . . 0 C--N 1.33 -0.247 0 O-C-N 123.576 0.547 . . . . 0.0 110.653 -177.25 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.466 HG13 ' HD2' ' A' ' 3' ' ' PRO . 19.2 tt . . . . . 0 CA--C 1.534 0.346 0 N-CA-C 110.241 -0.281 . . . . 0.0 110.241 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.542 ' HD3' ' HD3' ' A' ' 33' ' ' LYS . 36.0 Cg_exo -60.9 136.53 66.5 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.411 2.074 . . . . 0.0 112.389 174.456 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -117.09 86.86 2.59 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 177.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.422 HD22 HD23 ' A' ' 57' ' ' LEU . 82.5 mt -82.1 107.96 15.2 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.332 -170.687 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.407 ' HA ' ' HD2' ' A' ' 7' ' ' PRO . 18.6 t -123.32 106.33 33.15 Favored Pre-proline 0 C--N 1.32 -0.702 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.984 -177.287 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.552 ' HD2' ' O ' ' A' ' 97' ' ' ASN . 11.2 Cg_endo -57.75 119.44 6.7 Favored 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 122.361 2.041 . . . . 0.0 110.465 167.596 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.9 t -93.16 -54.27 7.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.099 -169.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.8 p -150.79 154.36 37.17 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.051 0.453 . . . . 0.0 111.688 -177.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 49.8 tp -121.98 110.25 15.6 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.675 177.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 16.1 p -118.2 143.94 33.94 Favored Pre-proline 0 C--N 1.32 -0.71 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.949 -178.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -88.97 160.62 39.53 Favored 'Cis proline' 0 N--CA 1.458 -0.599 0 C-N-CA 123.372 -1.512 . . . . 0.0 112.414 -2.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 31.7 m -81.52 6.05 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.045 0.45 . . . . 0.0 111.343 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.406 ' HA ' ' O ' ' A' ' 105' ' ' GLY . 0.1 OUTLIER -141.96 129.77 21.71 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 176.776 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.488 HG21 HD21 ' A' ' 71' ' ' LEU . 17.3 m -121.9 153.1 25.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 -171.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.435 ' HA ' ' HD3' ' A' ' 17' ' ' PRO . 2.5 t -83.83 110.98 29.04 Favored Pre-proline 0 CA--C 1.533 0.296 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 -179.482 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 16' ' ' VAL . 6.3 Cg_exo -79.75 58.3 6.9 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 123.288 2.659 . . . . 0.0 113.803 -172.574 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.405 ' OD1' HG12 ' A' ' 16' ' ' VAL . 33.2 p-10 -163.0 13.43 0.07 Allowed 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 176.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 15.3 t -162.34 179.23 8.0 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.711 0.291 . . . . 0.0 110.371 -177.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.556 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 41.1 t -84.05 119.91 34.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 176.404 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.404 ' ND2' HD23 ' A' ' 71' ' ' LEU . 24.4 m-80 -100.33 114.29 27.68 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.27 -177.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.52 ' HA ' ' O ' ' A' ' 67' ' ' PHE . 33.5 m -79.52 90.15 5.09 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 176.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . 0.633 ' O ' ' HA ' ' A' ' 66' ' ' ASP . 82.1 mtp -87.32 153.43 21.47 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.901 -176.02 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.476 ' CG2' ' HB3' ' A' ' 64' ' ' ASN . 10.9 m -115.72 112.99 22.87 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.313 -174.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -101.7 116.03 31.84 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 173.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 28.7 m -83.85 109.08 17.27 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.167 -178.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.426 HD11 HG11 ' A' ' 82' ' ' VAL . 27.7 mm -103.22 117.96 49.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.54 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 31.0 tt0 -111.09 135.5 51.52 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.147 0.498 . . . . 0.0 111.301 -177.268 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 25.5 t30 -97.17 95.07 7.5 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.536 -0.757 . . . . 0.0 109.354 176.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 64.6 mt-30 -87.96 51.06 2.11 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.362 0.601 . . . . 0.0 110.555 -175.104 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -144.39 168.17 26.77 Favored Glycine 0 N--CA 1.445 -0.755 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.196 -178.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 31.4 p-10 -88.17 -1.98 58.33 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.806 0.336 . . . . 0.0 111.604 -173.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.542 ' HD3' ' HD3' ' A' ' 3' ' ' PRO . 85.1 tttt -111.27 128.74 56.03 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.773 0.32 . . . . 0.0 110.412 179.49 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -67.84 135.18 52.15 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.841 179.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.567 ' HB3' ' HB3' ' A' ' 57' ' ' LEU . 29.5 t -89.64 139.55 30.44 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.108 -178.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -88.22 -165.7 1.39 Allowed 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.717 179.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.428 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 31.9 m -61.01 119.38 8.18 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.961 0.41 . . . . 0.0 111.746 -177.479 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.497 ' CE2' HG23 ' A' ' 40' ' ' VAL . 24.4 p90 -135.06 155.72 50.26 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.887 179.523 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.5 ' HB2' ' HD2' ' A' ' 86' ' ' PRO . 15.1 m120 -99.21 117.31 33.4 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.747 -0.206 . . . . 0.0 110.855 -176.449 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.497 HG23 ' CE2' ' A' ' 38' ' ' PHE . 2.3 t -104.08 114.3 43.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 121.285 0.564 . . . . 0.0 109.779 175.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 19.4 p -110.57 138.32 47.12 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.573 -0.739 . . . . 0.0 111.135 -175.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 51.3 tp -98.06 117.92 33.5 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.015 177.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.9 mp -104.71 127.66 52.56 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.432 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 97.9 t -99.55 103.54 14.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.822 177.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 59.93 17.88 7.0 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.565 179.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 123.55 -26.91 5.88 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.744 -0.741 . . . . 0.0 113.036 177.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 6.2 mt -91.79 147.17 5.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.995 0.397 . . . . 0.0 110.173 -178.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 61.4 t -91.18 121.26 41.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-O 120.799 0.333 . . . . 0.0 110.437 -177.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 30.9 m -104.74 -28.01 3.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.541 -0.299 . . . . 0.0 111.639 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -151.15 138.84 19.72 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 121.127 -0.229 . . . . 0.0 110.537 -177.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 28.5 m -127.49 110.82 13.14 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 175.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.19 121.4 44.79 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.14 0.495 . . . . 0.0 110.304 -175.502 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 59.1 m -82.11 110.87 17.72 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.685 178.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.428 ' O ' ' HA ' ' A' ' 37' ' ' SER . 40.9 t -85.2 121.36 36.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 177.264 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -59.37 -39.87 84.68 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.863 -173.398 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 42.7 t -175.45 155.01 1.75 Allowed 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.567 ' HB3' ' HB3' ' A' ' 35' ' ' SER . 18.7 tp -130.74 110.74 11.57 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.185 0.517 . . . . 0.0 109.946 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.521 ' HB3' ' HB2' ' A' ' 61' ' ' ASN . 26.3 tt0 -61.65 149.61 38.91 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.55 -174.592 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.3 p -60.73 128.93 38.97 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.669 -179.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 60.98 25.41 15.44 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.012 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.521 ' HB2' ' HB3' ' A' ' 58' ' ' GLU . 17.9 m-80 -121.4 160.25 24.47 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.607 178.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.54 ' HA ' ' HA ' ' A' ' 28' ' ' GLU . 0.0 OUTLIER -116.07 144.13 44.54 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.399 178.58 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 19.6 m -121.52 134.05 55.04 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.385 177.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.476 ' HB3' ' CG2' ' A' ' 24' ' ' THR . 88.7 m-20 -88.86 115.62 26.54 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.494 -179.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 6.4 t -97.66 112.58 30.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.492 -178.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.633 ' HA ' ' O ' ' A' ' 23' ' ' MET . 16.7 m-20 -97.31 115.17 27.18 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.977 0.418 . . . . 0.0 110.772 -178.553 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.52 ' O ' ' HA ' ' A' ' 22' ' ' THR . 84.4 m-85 -91.97 165.19 13.34 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.246 -177.039 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 38.5 m-70 -114.78 87.73 2.71 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 175.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 16.4 t90 -110.33 113.01 25.33 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.284 0.564 . . . . 0.0 111.224 -176.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.556 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 5.7 m -81.69 114.05 20.1 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.015 176.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.488 HD21 HG21 ' A' ' 15' ' ' VAL . 0.5 OUTLIER -69.09 118.23 11.74 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.058 0.456 . . . . 0.0 111.329 -178.211 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -77.53 -34.76 53.82 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.845 177.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 83.47 15.63 70.8 Favored Glycine 0 C--N 1.329 0.194 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.661 176.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 22.9 m -75.81 -27.73 58.05 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.909 0.385 . . . . 0.0 111.013 -179.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -130.92 160.93 33.06 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.526 -178.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.437 ' HA ' HG23 ' A' ' 106' ' ' THR . 36.8 m-80 -101.9 -4.0 26.94 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.235 0.541 . . . . 0.0 110.452 177.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 37.3 m -144.71 118.38 9.2 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.022 177.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 81.1 m-85 -112.41 139.46 47.96 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.903 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.416 ' HA ' HD23 ' A' ' 103' ' ' LEU . 8.3 m -92.1 85.77 5.59 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.068 0.461 . . . . 0.0 109.949 179.184 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.437 HD13 HG22 ' A' ' 104' ' ' VAL . 7.6 mp -81.96 117.14 21.95 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.559 0.695 . . . . 0.0 110.979 -176.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.508 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 12.9 m -115.96 118.07 31.9 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.172 -177.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.426 HG11 HD11 ' A' ' 27' ' ' ILE . 66.5 t -87.81 110.25 20.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 177.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -98.91 112.65 24.69 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.885 0.374 . . . . 0.0 110.257 175.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.554 ' HB ' ' HB2' ' A' ' 98' ' ' ASN . 86.6 t -84.58 111.91 20.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.826 179.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 18.6 t0 65.38 96.04 0.05 OUTLIER Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 114.924 -1.034 . . . . 0.0 112.779 176.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.5 ' HD2' ' HB2' ' A' ' 39' ' ' ASN . 98.4 Cg_endo -95.16 6.05 2.21 Favored 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 123.186 2.59 . . . . 0.0 111.923 173.194 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -103.05 -11.39 18.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.615 -176.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 68.22 32.64 4.68 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.708 0.766 . . . . 0.0 109.555 -176.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -73.76 -38.57 64.67 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.987 177.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 65.7 t -128.92 115.06 35.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.17 -179.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -89.1 145.32 25.53 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 175.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -80.24 162.09 24.82 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.167 0.508 . . . . 0.0 111.962 -174.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -57.49 -100.56 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.558 0 N-CA-C 109.811 -1.315 . . . . 0.0 109.811 158.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -65.6 105.49 1.23 Allowed 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 170.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -77.81 68.75 3.93 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -169.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 48.3 m -165.91 18.64 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 111.821 0.304 . . . . 0.0 111.821 179.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.552 ' O ' ' HD2' ' A' ' 7' ' ' PRO . 44.9 m-80 -115.37 -18.83 10.93 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.484 -0.487 . . . . 0.0 111.965 -173.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.554 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 18.6 p-10 -61.16 -9.54 4.94 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 -172.465 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 1.4 m -114.26 145.26 41.98 Favored 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 120.222 -0.591 . . . . 0.0 111.129 179.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.508 ' O ' ' HA ' ' A' ' 81' ' ' THR . 40.8 tp -138.81 101.64 4.36 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.674 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 26.2 m -94.28 102.48 14.48 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.801 0.334 . . . . 0.0 110.348 -179.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -119.05 163.14 17.42 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.955 -178.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.416 HD23 ' HA ' ' A' ' 79' ' ' THR . 96.2 mt -112.12 129.64 56.16 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.458 178.329 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.437 HG22 HD13 ' A' ' 80' ' ' LEU . 34.2 m -119.35 141.76 37.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.788 177.17 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.406 ' O ' ' HA ' ' A' ' 14' ' ' THR . . . -111.57 177.47 18.93 Favored Glycine 0 N--CA 1.443 -0.837 0 C-N-CA 120.373 -0.918 . . . . 0.0 111.685 -177.327 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.437 HG23 ' HA ' ' A' ' 76' ' ' ASN . 40.2 p -87.59 131.98 34.22 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 120.866 0.365 . . . . 0.0 110.044 176.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 33.1 tp . . . . . 0 C--N 1.325 -0.481 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.663 -176.125 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.432 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 7.7 tt . . . . . 0 C--O 1.236 0.38 0 N-CA-C 110.257 -0.275 . . . . 0.0 110.257 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.486 ' HD3' ' HD3' ' A' ' 33' ' ' LYS . 3.6 Cg_exo -82.11 122.69 3.82 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 122.919 2.413 . . . . 0.0 111.068 172.63 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -111.57 95.01 5.25 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 -179.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.484 HD22 HD23 ' A' ' 57' ' ' LEU . 87.5 mt -79.83 108.73 13.62 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.56 -175.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.416 ' HA ' ' HD2' ' A' ' 7' ' ' PRO . 60.3 t -116.15 109.41 44.62 Favored Pre-proline 0 C--N 1.321 -0.647 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.097 -177.311 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.501 ' HD2' ' O ' ' A' ' 97' ' ' ASN . 28.4 Cg_endo -66.21 102.47 0.57 Allowed 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 122.219 1.946 . . . . 0.0 109.929 167.3 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 15.1 t -78.64 -55.78 9.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.674 -169.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 50.7 m -150.28 155.84 40.44 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.982 0.42 . . . . 0.0 111.172 -177.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 55.2 tp -119.27 107.35 13.3 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.21 177.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.7 p -117.76 146.17 38.22 Favored Pre-proline 0 C--N 1.32 -0.68 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.524 -175.297 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -79.55 164.16 82.64 Favored 'Cis proline' 0 CA--C 1.53 0.289 0 C-N-CA 123.153 -1.603 . . . . 0.0 112.639 -0.009 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 34.8 m -80.16 -22.03 11.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.043 0.449 . . . . 0.0 110.887 -179.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.574 ' HB ' ' HA ' ' A' ' 107' ' ' LEU . 23.2 p -114.5 130.43 56.74 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.741 174.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.9 m -113.48 157.48 14.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.257 0.551 . . . . 0.0 112.153 -171.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.712 HG22 HD22 ' A' ' 107' ' ' LEU . 21.3 t -92.64 107.22 22.51 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.148 -177.714 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.572 ' HA ' ' HB3' ' A' ' 71' ' ' LEU . 7.1 Cg_exo -74.21 9.9 1.63 Allowed 'Trans proline' 0 CA--C 1.531 0.373 0 C-N-CA 123.492 2.795 . . . . 0.0 114.497 -171.391 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -127.51 27.88 5.75 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.711 0.291 . . . . 0.0 111.574 -177.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 15.0 t -167.94 167.77 12.56 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.244 179.323 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.531 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 58.2 t -79.94 124.46 38.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 174.684 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.473 HD22 ' N ' ' A' ' 21' ' ' ASN . 0.9 OUTLIER -100.14 117.79 35.12 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.908 0.385 . . . . 0.0 110.244 -175.249 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.494 HG22 ' HB3' ' A' ' 66' ' ' ASP . 6.9 m -83.21 83.85 7.71 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 173.566 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . 0.521 ' O ' ' HA ' ' A' ' 66' ' ' ASP . 71.8 mtp -82.31 142.36 32.12 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.899 -174.024 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.483 HG23 ' HB2' ' A' ' 64' ' ' ASN . 26.5 m -106.93 110.52 22.7 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.094 -175.695 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.605 ' HB3' ' HB ' ' A' ' 65' ' ' VAL . . . -91.76 122.21 34.1 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 172.389 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 24.4 m -91.24 104.67 17.19 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.236 -177.233 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 15.5 mm -102.04 117.1 46.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 179.444 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.569 ' HG2' ' HB3' ' A' ' 62' ' ' SER . 53.0 mt-10 -109.6 139.7 44.3 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.945 0.403 . . . . 0.0 110.862 179.652 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.539 ' HB2' ' HG ' ' A' ' 57' ' ' LEU . 32.5 t30 -92.31 93.88 8.87 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.766 175.264 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 83.0 mm-40 -90.06 52.1 2.2 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.683 0.754 . . . . 0.0 110.236 -178.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -144.07 157.48 27.13 Favored Glycine 0 N--CA 1.441 -0.977 0 N-CA-C 110.353 -1.099 . . . . 0.0 110.353 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 33.8 p-10 -85.63 5.18 32.97 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.896 0.379 . . . . 0.0 111.76 -173.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.486 ' HD3' ' HD3' ' A' ' 3' ' ' PRO . 63.6 tttp -116.43 135.07 54.16 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 173.645 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -71.53 139.89 49.69 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.833 0.349 . . . . 0.0 110.161 -179.052 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.423 ' CB ' HD21 ' A' ' 5' ' ' LEU . 35.7 t -94.94 139.38 31.41 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.722 -177.026 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 24.3 p -83.45 -165.27 1.06 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.472 177.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 26.1 t -57.29 131.6 50.51 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.923 0.392 . . . . 0.0 110.943 178.08 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.421 ' CE2' HG23 ' A' ' 40' ' ' VAL . 31.3 p90 -142.46 148.62 38.03 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.395 177.211 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.465 ' O ' ' HA ' ' A' ' 85' ' ' ASP . 65.8 t30 -104.34 112.9 26.12 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.307 -172.013 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.587 HG22 ' HA ' ' A' ' 84' ' ' VAL . 2.2 t -102.77 123.47 56.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.035 0.445 . . . . 0.0 110.503 -175.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 11.2 t -114.17 144.32 43.38 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.553 -175.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.421 HD11 ' HB3' ' A' ' 80' ' ' LEU . 51.2 tp -105.9 112.58 25.69 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.232 178.414 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.8 mp -101.21 127.25 47.88 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.635 179.11 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.545 HG22 ' HG ' ' A' ' 80' ' ' LEU . 92.3 t -110.7 104.2 16.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 -177.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 64.49 19.2 11.72 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.049 0.452 . . . . 0.0 110.555 -176.15 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 117.74 -27.08 7.7 Favored Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.995 178.074 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.528 HG23 ' O ' ' A' ' 44' ' ' VAL . 0.1 OUTLIER -91.94 136.58 24.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.425 0.631 . . . . 0.0 112.385 -174.832 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 88.8 t -78.59 105.84 8.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.325 179.054 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 22.8 m -86.81 -40.64 14.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.588 179.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -155.29 154.95 32.89 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.714 0.292 . . . . 0.0 110.47 -178.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 13.6 m -143.4 130.29 20.5 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.028 -174.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -119.87 124.56 46.35 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.239 -179.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.427 ' HA ' ' HA ' ' A' ' 39' ' ' ASN . 15.5 m -90.92 116.02 28.41 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.912 0.387 . . . . 0.0 110.181 177.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.431 HG13 HG21 ' A' ' 63' ' ' THR . 43.0 t -82.34 140.32 16.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.987 -178.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 28.6 m -71.59 -43.35 66.42 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.82 0.343 . . . . 0.0 111.194 -177.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 32.6 t -173.14 146.94 1.52 Allowed 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 -177.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.539 ' HG ' ' HB2' ' A' ' 29' ' ' ASN . 31.5 tp -128.51 107.13 9.47 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.314 0.578 . . . . 0.0 109.963 178.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -75.34 163.04 27.87 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.986 -173.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 13.4 m -64.71 132.12 48.75 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.439 178.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 42.7 mm-40 67.12 9.41 6.91 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.522 -179.557 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -101.14 148.52 24.99 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.449 -0.342 . . . . 0.0 110.188 179.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.569 ' HB3' ' HG2' ' A' ' 28' ' ' GLU . 33.5 p -113.9 131.01 56.44 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.9 176.203 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.431 HG21 HG13 ' A' ' 54' ' ' VAL . 54.0 m -107.51 125.66 51.55 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 120.955 0.407 . . . . 0.0 110.084 175.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.483 ' HB2' HG23 ' A' ' 24' ' ' THR . 5.0 p-10 -80.34 114.76 19.47 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.093 177.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.605 ' HB ' ' HB3' ' A' ' 25' ' ' ALA . 21.9 t -96.7 105.89 17.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.773 178.227 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.521 ' HA ' ' O ' ' A' ' 23' ' ' MET . 41.8 m-20 -99.81 111.34 23.66 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.468 -175.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.474 ' O ' ' HA ' ' A' ' 22' ' ' THR . 72.1 m-85 -91.79 158.57 16.27 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.914 -176.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 30.8 m-70 -110.13 88.22 2.7 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.428 178.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 13.2 t90 -117.33 113.8 22.66 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.102 -175.332 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.531 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 5.7 t -80.12 120.49 24.33 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 171.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.572 ' HB3' ' HA ' ' A' ' 17' ' ' PRO . 0.2 OUTLIER -65.9 -45.03 83.48 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.598 -170.047 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.439 ' HB3' ' O ' ' A' ' 71' ' ' LEU . 20.9 t70 73.0 -54.27 0.7 Allowed 'General case' 0 N--CA 1.469 0.498 0 O-C-N 123.968 0.792 . . . . 0.0 110.503 -174.268 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 90.93 51.98 2.51 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 121.059 -0.591 . . . . 0.0 111.997 179.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -84.75 -38.67 19.37 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.139 0.495 . . . . 0.0 110.509 -179.23 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -134.93 171.13 14.84 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.919 -177.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.412 ' O ' HG23 ' A' ' 106' ' ' THR . 28.2 p-10 -79.15 -15.17 58.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.379 -178.309 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.489 ' HB3' ' CD2' ' A' ' 103' ' ' LEU . 44.2 m -154.87 147.74 24.51 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.717 0.294 . . . . 0.0 110.765 -177.733 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -126.99 142.66 51.49 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.215 178.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 5.7 m -90.58 90.95 8.21 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.769 0.319 . . . . 0.0 110.428 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.554 HD13 HG22 ' A' ' 104' ' ' VAL . 10.9 mp -91.64 116.22 28.7 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.354 0.597 . . . . 0.0 111.172 -176.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.46 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 52.9 m -113.75 118.86 35.48 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.473 -179.5 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.486 ' HB ' ' HB3' ' A' ' 100' ' ' LEU . 60.3 t -88.1 106.91 16.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.617 176.359 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -100.29 110.92 23.17 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 177.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.587 ' HA ' HG22 ' A' ' 40' ' ' VAL . 69.7 t -76.04 110.38 11.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.902 -179.102 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.465 ' HA ' ' O ' ' A' ' 39' ' ' ASN . 1.8 t70 56.52 94.97 0.05 OUTLIER Pre-proline 0 N--CA 1.465 0.29 0 CA-C-N 114.32 -1.309 . . . . 0.0 112.035 178.622 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -60.15 -24.74 77.94 Favored 'Trans proline' 0 N--CA 1.473 0.289 0 C-N-CA 123.369 2.713 . . . . 0.0 112.806 -178.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -92.12 -18.0 24.16 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.207 -179.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 25.6 m120 53.08 54.97 9.54 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.818 -171.034 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.85 -40.07 94.05 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.999 -178.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 41.0 t -83.71 139.36 17.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.79 178.334 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 60.9 t30 -75.09 95.04 2.99 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 175.234 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.411 ' CD ' HD21 ' A' ' 98' ' ' ASN . 20.5 mt-10 -93.88 177.18 6.08 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.28 -173.529 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -58.14 -100.78 0.01 OUTLIER Glycine 0 CA--C 1.521 0.432 0 CA-C-N 115.341 -0.845 . . . . 0.0 113.063 175.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 55.6 t30 -117.32 145.12 44.22 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.746 0.308 . . . . 0.0 110.242 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.638 ' HA ' ' OD1' ' A' ' 98' ' ' ASN . 42.3 mt-10 -75.43 -12.91 60.34 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.013 0.435 . . . . 0.0 111.567 -174.352 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 16.4 m -69.62 -9.57 54.67 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.793 -178.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.501 ' O ' ' HD2' ' A' ' 7' ' ' PRO . 2.6 p-10 -117.78 10.64 13.34 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.906 -0.318 . . . . 0.0 111.458 177.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.638 ' OD1' ' HA ' ' A' ' 95' ' ' GLU . 7.5 m120 -76.42 -27.69 56.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.859 0.361 . . . . 0.0 110.764 177.361 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -103.75 122.66 45.55 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.718 -179.484 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.486 ' HB3' ' HB ' ' A' ' 82' ' ' VAL . 38.5 tp -109.32 100.17 9.33 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.89 173.353 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 41.5 m -87.58 97.39 10.83 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.218 0.533 . . . . 0.0 110.371 179.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -113.28 107.39 15.82 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.964 179.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.489 ' CD2' ' HB3' ' A' ' 77' ' ' SER . 5.0 tt -83.81 105.67 14.89 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 108.806 -0.812 . . . . 0.0 108.806 -178.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.554 HG22 HD13 ' A' ' 80' ' ' LEU . 21.2 m -89.64 144.13 9.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.614 -174.562 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -107.38 -179.03 22.47 Favored Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 120.793 -0.718 . . . . 0.0 111.31 -179.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.412 HG23 ' O ' ' A' ' 76' ' ' ASN . 23.0 p -83.43 153.36 24.53 Favored 'General case' 0 C--N 1.315 -0.904 0 C-N-CA 120.904 -0.318 . . . . 0.0 110.481 178.738 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.712 HD22 HG22 ' A' ' 16' ' ' VAL . 19.2 tp . . . . . 0 C--N 1.331 -0.211 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.954 -178.235 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.415 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 6.6 tt . . . . . 0 N--CA 1.452 -0.334 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.451 ' HD2' ' O ' ' A' ' 91' ' ' ASN . 3.3 Cg_exo -84.26 156.94 12.86 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.804 2.336 . . . . 0.0 111.34 171.447 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -138.75 108.67 6.32 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 174.305 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.533 HD22 HD23 ' A' ' 57' ' ' LEU . 69.4 mt -99.81 126.96 45.98 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -173.422 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.441 HG22 ' ND2' ' A' ' 97' ' ' ASN . 2.4 t -125.36 140.39 36.12 Favored Pre-proline 0 C--N 1.317 -0.844 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.332 -176.234 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.443 ' HB2' ' HB2' ' A' ' 100' ' ' LEU . 9.3 Cg_endo -92.8 93.31 0.16 Allowed 'Trans proline' 0 N--CA 1.445 -1.367 0 C-N-CA 122.952 2.435 . . . . 0.0 109.758 166.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 28.3 m -83.84 -12.88 11.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-N 115.869 -0.605 . . . . 0.0 112.313 -169.233 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 31.4 t -163.43 143.42 8.71 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.124 0.487 . . . . 0.0 111.723 -176.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 62.7 tp -127.8 126.93 42.63 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.065 175.09 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.0 p -137.7 145.28 48.04 Favored Pre-proline 0 C--N 1.32 -0.709 0 CA-C-N 116.572 -0.286 . . . . 0.0 110.813 -177.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.493 ' HD2' ' SD ' ' A' ' 23' ' ' MET . 98.3 Cg_endo -80.23 163.02 82.89 Favored 'Cis proline' 0 N--CA 1.465 -0.199 0 C-N-CA 123.369 -1.513 . . . . 0.0 112.719 -1.555 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 24.5 m -85.51 -15.26 10.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.152 0.501 . . . . 0.0 110.565 177.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.567 ' HA ' ' O ' ' A' ' 105' ' ' GLY . 0.1 OUTLIER -131.61 124.94 30.98 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.647 174.718 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.411 HG12 ' HG2' ' A' ' 12' ' ' PRO . 20.5 m -114.57 150.47 16.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.625 -0.261 . . . . 0.0 111.141 -174.064 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.411 ' HA ' ' HD3' ' A' ' 17' ' ' PRO . 6.2 m -88.53 121.55 70.05 Favored Pre-proline 0 N--CA 1.445 -0.685 0 CA-C-O 120.957 0.408 . . . . 0.0 110.194 176.289 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.467 ' HA ' ' CB ' ' A' ' 71' ' ' LEU . 17.6 Cg_exo -68.04 172.51 10.77 Favored 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 122.497 2.132 . . . . 0.0 112.59 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 43.8 m-80 71.93 25.06 3.16 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.274 175.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 12.9 t -175.69 175.62 2.03 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.654 -0.248 . . . . 0.0 110.386 177.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.814 HG22 ' HB ' ' A' ' 70' ' ' THR . 44.4 t -91.24 135.37 27.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.343 178.51 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 21.7 m-80 -108.71 149.88 28.37 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.467 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.9 m -83.05 91.02 7.11 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.258 179.444 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . 0.526 ' HB2' ' HB2' ' A' ' 67' ' ' PHE . 89.8 mmm -81.6 109.75 16.33 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.372 0.606 . . . . 0.0 110.246 -178.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 25.5 m -103.26 110.15 22.02 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.474 -177.491 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -101.33 120.13 39.79 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.072 178.062 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 28.5 m -85.88 104.43 15.53 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.62 -178.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.423 HG12 HG23 ' A' ' 65' ' ' VAL . 23.3 mm -98.5 119.35 46.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 178.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -120.55 139.18 53.31 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.425 -175.174 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.474 ' O ' ' HA ' ' A' ' 60' ' ' GLU . 54.8 t-20 -91.87 99.72 12.53 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 178.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -102.14 52.25 0.81 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.651 0.738 . . . . 0.0 110.418 -176.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -143.94 175.81 23.61 Favored Glycine 0 N--CA 1.446 -0.634 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.093 179.042 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -99.8 45.49 0.99 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.287 0.565 . . . . 0.0 111.402 -173.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.486 ' HG2' ' N ' ' A' ' 34' ' ' ASP . 50.3 tttm -161.49 157.06 24.38 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.254 169.167 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.486 ' N ' ' HG2' ' A' ' 33' ' ' LYS . 8.7 p-10 -68.42 165.13 19.48 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.06 173.553 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.474 ' OG ' ' HB3' ' A' ' 57' ' ' LEU . 10.0 p -129.99 134.4 47.41 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.925 0.393 . . . . 0.0 110.703 178.164 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 11.3 p -80.66 -167.59 1.43 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.322 -177.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 18.8 t -62.61 120.78 11.82 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.058 0.456 . . . . 0.0 111.109 -177.06 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -131.46 160.19 35.87 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.685 178.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -106.08 125.63 51.23 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 121.277 -0.169 . . . . 0.0 110.617 -176.219 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.573 HG11 HG21 ' A' ' 65' ' ' VAL . 1.4 t -111.49 123.85 67.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.156 0.503 . . . . 0.0 110.546 178.216 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 18.2 m -117.83 145.5 44.51 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.912 -176.184 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 49.7 tp -104.04 108.87 20.42 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.853 176.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.7 mp -98.45 112.73 24.66 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.201 -179.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 87.8 t -97.12 107.08 19.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.113 179.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 59.08 22.21 10.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.656 178.026 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 116.36 -25.19 9.37 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.598 -0.81 . . . . 0.0 112.953 176.358 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 8.8 mt -96.39 151.31 4.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 -178.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 47.5 t -97.2 109.69 23.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 110.094 -0.335 . . . . 0.0 110.094 -178.503 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 28.1 m -87.18 -29.72 5.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 C-N-CA 120.904 -0.318 . . . . 0.0 111.502 -177.26 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -158.0 159.56 36.55 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.836 0.35 . . . . 0.0 110.537 -179.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 95.9 m -149.81 126.87 11.23 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.986 -178.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -125.04 122.85 38.42 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.93 0.395 . . . . 0.0 109.988 179.182 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 19.5 m -80.09 130.88 35.58 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.056 177.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 42.6 t -98.16 131.72 44.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.2 m -61.55 -47.0 87.55 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.717 -177.093 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 29.8 t -179.98 152.8 0.48 Allowed 'General case' 0 C--O 1.235 0.293 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 -178.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.533 HD23 HD22 ' A' ' 5' ' ' LEU . 40.3 tp -129.75 125.68 36.4 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.057 0.456 . . . . 0.0 110.323 178.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -76.56 160.2 29.65 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.042 -176.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 10.5 m -60.31 120.18 9.35 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.259 -177.26 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.474 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 44.2 mt-10 60.81 25.53 15.41 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.325 177.585 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -101.24 160.96 13.96 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 171.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -122.31 119.03 29.91 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 -176.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 54.1 m -111.5 127.17 55.62 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.072 0.463 . . . . 0.0 110.719 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -86.76 134.89 33.54 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.54 179.5 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.573 HG21 HG11 ' A' ' 40' ' ' VAL . 28.2 t -96.16 133.55 36.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.154 179.544 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -97.75 97.0 8.63 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.297 -177.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.526 ' HB2' ' HB2' ' A' ' 23' ' ' MET . 21.3 m-85 -97.66 152.38 19.15 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.669 178.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 17.1 m80 -120.77 93.7 4.12 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 178.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 24.0 t90 -114.83 118.58 33.95 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.319 -174.084 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.814 ' HB ' HG22 ' A' ' 20' ' ' VAL . 15.1 t -89.73 144.85 25.64 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.433 179.46 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.467 ' CB ' ' HA ' ' A' ' 17' ' ' PRO . 3.1 mm? -110.47 127.46 55.15 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.94 0.4 . . . . 0.0 111.763 179.554 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 -90.39 -28.3 18.76 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.682 172.133 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 87.44 33.91 11.07 Favored Glycine 0 N--CA 1.448 -0.517 0 N-CA-C 111.226 -0.75 . . . . 0.0 111.226 -175.268 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.63 -33.03 74.15 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.229 0.538 . . . . 0.0 110.711 -178.607 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -141.27 155.54 45.98 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.237 -178.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -67.89 -30.97 70.45 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.426 178.003 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 19.5 m -136.85 135.96 38.35 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.073 0.464 . . . . 0.0 110.898 -179.025 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -112.48 146.46 38.42 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.12 178.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.488 ' HA ' HD23 ' A' ' 103' ' ' LEU . 6.6 m -95.43 87.61 4.83 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.885 0.374 . . . . 0.0 110.499 -178.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.513 HD13 HG22 ' A' ' 104' ' ' VAL . 9.4 mp -87.7 120.16 28.74 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.184 0.516 . . . . 0.0 111.272 -176.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.58 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 73.5 m -119.64 115.7 24.49 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.606 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 46.5 t -88.16 107.8 17.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.648 175.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -97.97 117.15 31.68 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.847 0.356 . . . . 0.0 110.075 176.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.542 ' HB ' ' HB2' ' A' ' 98' ' ' ASN . 94.7 t -85.71 109.01 17.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.957 -179.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 39.2 t0 65.68 91.91 0.07 OUTLIER Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 114.583 -1.189 . . . . 0.0 112.002 178.221 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -89.52 6.23 4.47 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 123.021 2.481 . . . . 0.0 111.714 174.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -110.76 -8.98 14.51 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.38 -178.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 5.3 m120 56.64 53.9 7.93 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.266 178.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -88.91 -35.3 16.58 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.55 176.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 61.6 t -108.76 119.73 58.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.439 -0.801 . . . . 0.0 109.882 176.016 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.451 ' O ' ' HD2' ' A' ' 3' ' ' PRO . 53.4 m-80 -74.12 124.19 25.85 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.443 179.212 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.492 ' HB2' ' HA ' ' A' ' 95' ' ' GLU . 0.4 OUTLIER -95.93 150.51 20.36 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.587 -175.543 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -57.78 -100.87 0.01 OUTLIER Glycine 0 CA--C 1.52 0.359 0 CA-C-N 115.068 -0.969 . . . . 0.0 112.734 172.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.467 ' HB3' ' OD1' ' A' ' 97' ' ' ASN . 11.1 t30 -65.33 -24.15 67.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.644 0.259 . . . . 0.0 110.491 -177.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.492 ' HA ' ' HB2' ' A' ' 92' ' ' GLU . 29.5 tt0 76.02 -63.0 0.41 Allowed 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 168.329 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 37.0 m -64.83 -4.93 4.92 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -171.034 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.467 ' OD1' ' HB3' ' A' ' 94' ' ' ASN . 4.0 p-10 -96.01 11.06 35.4 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.808 178.4 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.542 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 24.4 p-10 -85.0 3.02 40.51 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.92 0.39 . . . . 0.0 110.487 179.031 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -119.31 118.32 30.92 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 121.215 0.531 . . . . 0.0 111.575 -178.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.58 ' O ' ' HA ' ' A' ' 81' ' ' THR . 25.2 tp -108.46 99.39 8.78 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.241 178.568 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 93.1 m -92.15 97.75 11.11 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 121.155 0.503 . . . . 0.0 109.717 175.304 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -114.88 126.37 54.72 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.344 -177.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.488 HD23 ' HA ' ' A' ' 79' ' ' THR . 51.2 mt -78.93 115.88 18.9 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.214 0.531 . . . . 0.0 110.573 177.641 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.513 HG22 HD13 ' A' ' 80' ' ' LEU . 23.0 m -106.36 144.56 15.39 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.01 178.279 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.567 ' O ' ' HA ' ' A' ' 14' ' ' THR . . . -118.96 169.9 13.69 Favored Glycine 0 N--CA 1.437 -1.255 0 C-N-CA 120.004 -1.094 . . . . 0.0 111.271 -177.366 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 41.6 p -77.06 129.88 36.66 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 173.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 42.7 tp . . . . . 0 C--N 1.324 -0.505 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.19 -176.927 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.459 HG13 ' HD2' ' A' ' 3' ' ' PRO . 18.3 tt . . . . . 0 N--CA 1.451 -0.392 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.53 ' HD3' ' HD3' ' A' ' 33' ' ' LYS . 58.2 Cg_endo -76.0 157.1 38.68 Favored 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 122.453 2.102 . . . . 0.0 112.325 176.2 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -146.05 100.12 3.35 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 179.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.539 HD22 HD23 ' A' ' 57' ' ' LEU . 41.0 mt -99.88 126.76 46.06 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-O 121.545 0.688 . . . . 0.0 109.265 -170.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 6.0 t -125.46 140.37 36.17 Favored Pre-proline 0 N--CA 1.441 -0.92 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.638 -175.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.458 ' HB2' ' HB2' ' A' ' 100' ' ' LEU . 1.1 Cg_endo -87.34 107.09 0.65 Allowed 'Trans proline' 0 N--CA 1.446 -1.29 0 C-N-CA 122.815 2.343 . . . . 0.0 109.63 166.489 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.9 t -76.91 -60.23 2.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.566 -170.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 9.5 t -154.65 154.97 33.82 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 177.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.411 ' HA ' ' O ' ' A' ' 24' ' ' THR . 1.8 pp -127.95 127.49 43.38 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.399 0.618 . . . . 0.0 110.117 177.064 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.6 p -121.63 131.66 24.39 Favored Pre-proline 0 C--N 1.311 -1.075 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.792 -175.526 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.413 ' HD2' ' SD ' ' A' ' 23' ' ' MET . 84.4 Cg_endo -90.55 175.1 20.41 Favored 'Cis proline' 0 N--CA 1.461 -0.392 0 C-N-CA 123.539 -1.442 . . . . 0.0 113.5 8.723 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.5 m -99.25 -11.98 8.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.087 0.47 . . . . 0.0 111.274 178.2 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -120.09 151.0 39.69 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 174.26 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 20.9 m -143.29 157.36 17.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.029 0.442 . . . . 0.0 111.475 -177.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.4 ' HA ' ' HD3' ' A' ' 17' ' ' PRO . 2.8 m -99.11 144.13 27.66 Favored Pre-proline 0 N--CA 1.448 -0.564 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.114 178.606 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.531 ' HA ' ' CB ' ' A' ' 71' ' ' LEU . 2.9 Cg_endo -82.64 165.5 15.87 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.868 2.378 . . . . 0.0 112.589 178.79 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 34.9 m-80 71.87 24.2 3.4 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.639 175.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.5 t -163.52 162.91 24.79 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.983 -0.287 . . . . 0.0 110.592 -178.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 1.005 HG22 ' HB ' ' A' ' 70' ' ' THR . 21.2 t -94.56 130.81 42.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 175.464 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -119.65 152.63 36.79 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.273 179.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 90.9 m -96.83 109.22 21.96 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.332 -178.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . 0.55 ' HB2' ' HB2' ' A' ' 67' ' ' PHE . 83.4 mmm -92.42 123.74 35.95 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.669 178.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.486 ' HA ' ' O ' ' A' ' 65' ' ' VAL . 19.3 m -106.87 103.06 12.4 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.637 0.256 . . . . 0.0 111.259 -177.577 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -97.75 123.12 41.55 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.494 176.28 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 18.8 m -87.81 121.29 30.05 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 120.813 0.34 . . . . 0.0 110.589 178.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 24.6 mm -106.88 116.37 50.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 179.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -110.27 128.91 55.77 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.918 0.389 . . . . 0.0 110.659 -178.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.431 ' ND2' ' HA ' ' A' ' 59' ' ' SER . 26.1 t30 -88.62 96.08 10.5 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.467 177.437 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 -92.74 43.98 1.14 Allowed 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.634 -174.522 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -144.08 150.13 22.17 Favored Glycine 0 N--CA 1.447 -0.582 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 179.157 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 16.1 t30 -84.47 62.77 7.46 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.497 0.665 . . . . 0.0 111.567 -172.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.53 ' HD3' ' HD3' ' A' ' 3' ' ' PRO . 62.3 tttp -161.46 136.84 7.63 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.321 166.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -72.16 114.39 10.23 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 177.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 16.1 p -83.56 144.77 29.26 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.054 0.454 . . . . 0.0 110.856 -178.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 3.1 p -83.4 -169.63 2.64 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.557 -178.154 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 33.0 t -54.76 132.63 46.37 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.577 -178.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 55.1 p90 -143.98 159.22 42.97 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.947 178.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 21.0 m-80 -109.04 110.5 21.79 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.483 0.182 . . . . 0.0 111.273 -175.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.487 HG22 ' HA ' ' A' ' 84' ' ' VAL . 1.5 t -98.43 124.85 51.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.271 0.558 . . . . 0.0 109.926 -179.594 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 18.7 m -120.56 148.18 44.2 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.047 -174.453 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 50.4 tp -102.21 117.36 34.59 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.787 177.106 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.574 ' HG ' HG22 ' A' ' 48' ' ' VAL . 5.0 mp -100.34 126.69 46.72 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.81 179.486 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 99.5 t -106.08 103.12 14.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 120.815 0.34 . . . . 0.0 110.201 179.366 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.489 ' HA ' ' HB ' ' A' ' 79' ' ' THR . 8.7 m-20 62.62 13.09 6.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.352 -0.84 . . . . 0.0 112.095 176.665 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 138.38 -38.63 1.67 Allowed Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.604 -0.808 . . . . 0.0 113.306 176.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 8.3 mt -98.19 150.8 4.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 120.77 0.319 . . . . 0.0 110.537 -174.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.574 HG22 ' HG ' ' A' ' 43' ' ' LEU . 55.9 t -87.43 127.17 40.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 -179.724 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 18.4 m -99.84 -39.34 7.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 111.852 0.316 . . . . 0.0 111.852 179.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -149.44 149.49 30.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.736 0.303 . . . . 0.0 110.936 -176.117 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 95.9 m -133.96 128.27 34.11 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.52 -178.157 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -118.97 119.28 33.85 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 177.637 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 25.6 m -80.9 126.42 31.34 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.362 178.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 47.7 t -96.6 128.92 47.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 178.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.8 p -56.4 -43.6 79.47 Favored 'General case' 0 C--N 1.329 -0.324 0 O-C-N 123.355 0.409 . . . . 0.0 111.957 -177.069 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 17.2 p -178.08 155.22 0.93 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.393 179.149 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.672 HD13 HG23 ' A' ' 63' ' ' THR . 17.4 tp -130.42 109.26 10.59 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.07 0.462 . . . . 0.0 109.783 177.44 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -63.98 160.86 16.92 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.41 -176.241 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.431 ' HA ' ' ND2' ' A' ' 29' ' ' ASN . 4.4 p -61.9 125.73 24.88 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.122 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 61.23 35.93 18.11 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.436 -179.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 13.5 m-80 -121.32 162.09 20.9 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.04 176.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 3.5 p -132.55 127.82 35.92 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.025 0.44 . . . . 0.0 111.54 -178.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.672 HG23 HD13 ' A' ' 57' ' ' LEU . 17.6 p -104.22 153.29 21.15 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.455 177.628 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -104.29 125.12 50.28 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 176.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.486 ' O ' ' HA ' ' A' ' 24' ' ' THR . 59.3 t -96.14 128.66 47.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-O 121.169 0.509 . . . . 0.0 110.963 -175.071 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -95.61 97.21 9.57 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.368 -177.097 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.55 ' HB2' ' HB2' ' A' ' 23' ' ' MET . 26.3 m-85 -92.26 147.18 23.13 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.212 0.529 . . . . 0.0 111.443 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 7.2 m80 -114.93 98.25 6.71 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.041 179.189 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 20.4 t90 -122.78 122.21 38.16 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.064 0.459 . . . . 0.0 111.444 -174.163 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 1.005 ' HB ' HG22 ' A' ' 20' ' ' VAL . 8.4 t -105.61 141.29 37.32 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.261 177.657 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.531 ' CB ' ' HA ' ' A' ' 17' ' ' PRO . 1.7 mm? -100.89 119.23 38.39 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.112 0.482 . . . . 0.0 111.038 176.348 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -84.37 -25.14 29.34 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.054 176.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -153.19 -155.21 7.04 Favored Glycine 0 N--CA 1.445 -0.731 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.856 -177.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 2.8 t -145.74 90.91 2.04 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-O 121.934 0.874 . . . . 0.0 111.267 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -80.87 2.45 26.47 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.882 172.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.487 ' O ' ' HA2' ' A' ' 105' ' ' GLY . 95.5 m-20 70.83 -59.11 0.55 Allowed 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.803 179.447 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 41.0 t -104.3 114.21 28.29 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 120.888 0.375 . . . . 0.0 110.415 -178.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.423 ' HB2' HG23 ' A' ' 104' ' ' VAL . 65.1 m-85 -116.92 134.0 55.31 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.323 179.105 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.489 ' HB ' ' HA ' ' A' ' 45' ' ' ASP . 7.3 m -96.69 88.05 4.52 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.911 0.386 . . . . 0.0 110.478 -177.014 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.41 HD22 HG11 ' A' ' 104' ' ' VAL . 8.1 mp -87.58 113.59 23.41 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.611 0.719 . . . . 0.0 110.56 -178.169 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.532 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 25.8 m -115.33 123.28 48.32 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.418 -177.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 49.5 t -90.17 112.03 24.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 176.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -108.19 117.76 34.98 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 175.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.614 ' HB ' ' HB2' ' A' ' 98' ' ' ASN . 84.8 t -83.57 103.37 10.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.995 -177.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.9 t70 59.81 89.54 0.1 Allowed Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 114.266 -1.334 . . . . 0.0 112.347 177.103 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -70.78 -12.46 30.99 Favored 'Trans proline' 0 C--O 1.232 0.215 0 C-N-CA 123.33 2.687 . . . . 0.0 112.217 179.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -89.73 -6.5 55.99 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.464 -178.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . 0.404 HD22 ' HA ' ' A' ' 88' ' ' ASN . 2.8 t-20 58.41 42.1 21.82 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.61 177.402 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -69.26 -26.79 64.94 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.334 178.05 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 61.4 t -110.6 122.63 65.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.681 176.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 54.0 t30 -80.86 130.4 35.03 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 176.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -125.65 159.92 30.99 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.948 0.404 . . . . 0.0 112.008 -173.076 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -58.3 -100.81 0.01 OUTLIER Glycine 0 CA--C 1.522 0.489 0 CA-C-N 114.948 -1.024 . . . . 0.0 113.818 174.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -58.24 160.51 5.02 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 122.972 0.509 . . . . 0.0 111.452 -177.117 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.2 2.68 24.91 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 121.144 0.497 . . . . 0.0 111.413 -175.722 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 18.3 m -125.8 24.33 7.11 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.0 0.428 . . . . 0.0 110.465 -179.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 26.4 p-10 -98.09 -39.94 8.66 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.705 -174.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.614 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 23.9 p-10 -83.77 10.68 8.9 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.316 0.488 . . . . 0.0 112.316 -168.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 2.6 m -119.32 150.12 40.67 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.981 0.419 . . . . 0.0 110.643 -179.237 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.532 ' O ' ' HA ' ' A' ' 81' ' ' THR . 54.2 tp -148.52 106.59 3.72 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.649 178.565 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 31.0 m -93.51 98.65 11.32 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 120.9 0.381 . . . . 0.0 110.222 177.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -109.46 118.98 38.06 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.374 -179.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.44 HD22 ' HA ' ' A' ' 103' ' ' LEU . 1.8 tm? -81.47 111.24 17.63 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.161 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.423 HG23 ' HB2' ' A' ' 78' ' ' TYR . 21.5 m -103.38 162.85 3.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -179.302 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.487 ' HA2' ' O ' ' A' ' 76' ' ' ASN . . . -131.87 167.08 22.91 Favored Glycine 0 N--CA 1.439 -1.102 0 C-N-CA 119.858 -1.163 . . . . 0.0 111.955 -178.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 22.4 p -84.26 131.52 34.73 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 173.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 36.5 tp . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.634 -174.366 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 13.3 tt . . . . . 0 N--CA 1.454 -0.227 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -68.69 155.95 67.1 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 121.947 1.764 . . . . 0.0 111.484 176.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -147.51 76.78 1.41 Allowed 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 176.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.741 ' HG ' ' OE1' ' A' ' 92' ' ' GLU . 27.1 mt -72.8 103.66 3.74 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 114.948 -1.024 . . . . 0.0 110.856 -176.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.584 HG22 ' HB3' ' A' ' 97' ' ' ASN . 25.7 t -114.68 121.0 36.53 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.923 -177.228 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.509 ' HB2' ' HB2' ' A' ' 100' ' ' LEU . 1.9 Cg_endo -79.03 108.01 2.32 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 122.333 2.022 . . . . 0.0 109.919 171.185 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 27.3 m -93.95 -27.27 4.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 -171.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 60.7 m -146.49 145.04 30.05 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.983 0.421 . . . . 0.0 111.872 -175.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.477 HD23 ' HB3' ' A' ' 102' ' ' ALA . 50.1 tp -130.54 110.53 11.49 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.407 174.046 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.573 ' OG1' ' HA ' ' A' ' 12' ' ' PRO . 5.6 t -128.69 149.56 72.36 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.017 -177.143 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.573 ' HA ' ' OG1' ' A' ' 11' ' ' THR . 82.8 Cg_endo -77.76 154.2 94.41 Favored 'Cis proline' 0 N--CA 1.463 -0.296 0 C-N-CA 123.42 -1.492 . . . . 0.0 112.675 1.722 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.5 m -79.62 -6.64 9.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.13 178.193 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.427 ' HA ' ' O ' ' A' ' 105' ' ' GLY . 1.5 p -130.35 125.51 34.81 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.319 178.323 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.4 m -121.1 158.02 24.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.125 0.488 . . . . 0.0 112.115 -172.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.488 HG22 HD22 ' A' ' 107' ' ' LEU . 41.8 t -80.22 120.56 79.96 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.732 177.748 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.658 ' HA ' ' HG ' ' A' ' 71' ' ' LEU . 2.8 Cg_exo -75.5 59.28 5.47 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 123.193 2.596 . . . . 0.0 113.946 -173.286 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -176.98 -56.88 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.718 0.294 . . . . 0.0 111.506 174.27 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 14.6 t -80.4 178.29 8.4 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.293 -172.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 45.2 t -80.74 124.29 38.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.106 178.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.571 ' ND2' HD23 ' A' ' 71' ' ' LEU . 38.7 m-80 -102.44 135.03 44.8 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.169 -179.308 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 21.2 m -82.9 97.68 8.8 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.033 -0.53 . . . . 0.0 109.95 177.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . 0.553 ' HB2' ' HB2' ' A' ' 67' ' ' PHE . 91.5 mmm -91.56 132.26 36.42 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.269 -176.366 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.508 ' HA ' ' O ' ' A' ' 65' ' ' VAL . 10.4 m -116.27 117.07 29.0 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.638 -178.088 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.414 ' HB3' ' HB ' ' A' ' 65' ' ' VAL . . . -105.58 119.48 39.22 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.265 178.358 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 17.6 m -85.9 110.28 19.31 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.51 -178.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 24.4 mm -102.13 115.67 44.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.21 -179.065 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -103.15 132.74 49.18 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.091 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.458 ' HB2' ' HG ' ' A' ' 57' ' ' LEU . 51.9 t-20 -90.49 101.53 14.27 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 173.304 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 79.2 mm-40 -93.31 33.23 1.24 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.179 -176.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -144.09 166.87 27.0 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.024 -178.269 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -97.5 54.22 1.18 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.448 0.642 . . . . 0.0 111.063 -173.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 73.8 tttt -161.47 144.72 12.51 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.121 172.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.495 ' HB3' ' HA ' ' A' ' 58' ' ' GLU . 1.2 m-20 -89.19 129.71 35.73 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 -177.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 36.9 p -85.07 153.92 22.41 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 110.311 -0.255 . . . . 0.0 110.311 -179.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.407 HG22 ' H ' ' A' ' 37' ' ' SER . 0.2 OUTLIER -85.19 -167.82 1.98 Allowed 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 177.382 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.51 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 39.9 m -60.42 113.47 2.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.955 0.407 . . . . 0.0 110.701 178.692 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.4 ' CE2' HG23 ' A' ' 40' ' ' VAL . 41.4 p90 -124.25 154.21 40.52 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.313 -178.422 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.412 ' O ' ' HD3' ' A' ' 86' ' ' PRO . 79.7 m-20 -100.52 111.37 23.62 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.424 -176.072 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.53 HG11 HG21 ' A' ' 65' ' ' VAL . 1.4 t -98.34 119.11 45.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 176.356 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.447 ' HB3' HG13 ' A' ' 48' ' ' VAL . 41.2 m -113.49 138.15 50.53 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.327 -174.117 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 62.5 tp -97.89 111.82 23.97 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.58 174.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.427 ' HA ' ' O ' ' A' ' 47' ' ' ILE . 5.2 mp -96.9 140.8 30.91 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.024 -179.721 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 91.0 t -122.57 111.56 30.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 173.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 20.0 t70 67.71 -72.78 0.09 Allowed 'General case' 0 N--CA 1.47 0.542 0 O-C-N 124.036 0.835 . . . . 0.0 110.761 -176.06 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -153.08 9.15 0.52 Allowed Glycine 0 N--CA 1.448 -0.564 0 CA-C-N 115.969 -0.559 . . . . 0.0 112.14 177.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.427 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 3.4 mt -110.89 151.2 13.1 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.315 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 -178.603 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.447 HG13 ' HB3' ' A' ' 41' ' ' SER . 45.4 t -99.21 107.19 20.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 173.792 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 29.8 m -77.8 -33.51 18.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.304 -175.258 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -160.01 135.49 8.25 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.273 -179.101 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 95.4 m -120.88 126.41 49.97 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.832 177.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -109.83 123.27 49.27 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.068 178.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 30.3 m -81.25 104.18 11.54 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.249 -0.432 . . . . 0.0 109.905 176.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.51 ' O ' ' HA ' ' A' ' 37' ' ' SER . 21.9 t -81.4 123.26 37.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 178.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 20.9 m -56.14 -42.85 77.58 Favored 'General case' 0 C--N 1.329 -0.3 0 O-C-N 123.458 0.474 . . . . 0.0 111.594 -173.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 50.7 p 179.2 136.89 0.1 Allowed 'General case' 0 C--N 1.33 -0.261 0 O-C-N 123.246 0.341 . . . . 0.0 110.526 174.355 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.576 HD23 HD22 ' A' ' 5' ' ' LEU . 26.7 tp -105.94 110.23 22.43 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.123 0.487 . . . . 0.0 109.762 175.469 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.495 ' HA ' ' HB3' ' A' ' 34' ' ' ASP . 42.7 mt-10 -66.95 160.49 26.24 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.201 -177.044 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 2.7 p -60.73 124.87 21.68 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.372 -178.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 65.03 16.97 10.87 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.527 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -96.17 148.45 22.7 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 178.203 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 17.9 m -111.48 134.52 53.0 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.002 179.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 91.7 m -139.88 129.63 24.55 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.131 0.491 . . . . 0.0 111.123 -179.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -90.31 132.57 35.48 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.627 -179.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.53 HG21 HG11 ' A' ' 40' ' ' VAL . 40.2 t -96.53 133.07 39.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.448 -179.129 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -102.56 105.31 15.8 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.468 -177.251 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.553 ' HB2' ' HB2' ' A' ' 23' ' ' MET . 49.9 m-85 -102.03 147.83 26.1 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.912 179.046 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 35.5 m-70 -115.13 92.41 3.92 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 175.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 14.7 t90 -100.22 105.44 17.01 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.238 -173.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 6.8 m -73.96 108.7 6.94 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.014 171.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.658 ' HG ' ' HA ' ' A' ' 17' ' ' PRO . 0.1 OUTLIER -59.42 -69.13 0.22 Allowed 'General case' 0 C--O 1.234 0.284 0 O-C-N 123.131 0.27 . . . . 0.0 111.517 -172.645 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.446 ' HB3' ' O ' ' A' ' 71' ' ' LEU . 20.0 t70 72.87 -47.37 0.67 Allowed 'General case' 0 N--CA 1.47 0.57 0 O-C-N 123.918 0.761 . . . . 0.0 111.981 -178.126 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.558 ' HA3' ' OH ' ' A' ' 78' ' ' TYR . . . -74.34 -174.52 31.83 Favored Glycine 0 CA--C 1.518 0.244 0 C-N-CA 121.249 -0.501 . . . . 0.0 113.478 -177.511 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 9.5 t -142.43 12.82 1.95 Allowed 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.087 0.47 . . . . 0.0 111.347 -175.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.45 ' HB3' ' CE1' ' A' ' 78' ' ' TYR . . . -71.81 141.49 49.66 Favored 'General case' 0 C--N 1.33 -0.272 0 O-C-N 122.081 -0.387 . . . . 0.0 110.286 -179.446 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.551 ' HA ' HG23 ' A' ' 106' ' ' THR . 25.0 p-10 -77.73 -5.66 51.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.78 0.324 . . . . 0.0 111.514 -175.311 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 43.7 m -150.83 116.01 5.34 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.862 0.363 . . . . 0.0 110.722 -178.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.558 ' OH ' ' HA3' ' A' ' 73' ' ' GLY . 43.0 m-85 -111.47 138.26 48.21 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.89 176.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.405 ' HA ' HD23 ' A' ' 103' ' ' LEU . 37.2 m -92.65 97.97 11.14 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.88 179.133 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.517 HD13 HG22 ' A' ' 104' ' ' VAL . 10.2 mp -97.31 135.79 38.72 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.453 -179.479 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.491 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 27.4 m -130.36 116.96 19.04 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.64 -176.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.425 ' HB ' ' HB3' ' A' ' 100' ' ' LEU . 59.5 t -89.11 104.17 14.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 175.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -99.26 117.6 34.08 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 178.2 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.504 HG23 ' HG3' ' A' ' 7' ' ' PRO . 84.5 t -85.1 106.4 14.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.355 -176.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 51.3 t0 61.6 85.77 0.17 Allowed Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 114.563 -1.199 . . . . 0.0 111.487 178.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.412 ' HD3' ' O ' ' A' ' 39' ' ' ASN . 4.6 Cg_exo -74.91 -7.14 18.96 Favored 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 123.023 2.482 . . . . 0.0 111.715 178.174 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -94.57 -22.62 18.08 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 178.224 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 59.99 69.15 0.72 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.182 -179.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -93.05 -28.76 16.17 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.793 178.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.7 t -106.33 135.15 45.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.31 176.211 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -82.48 112.0 19.01 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.873 0.368 . . . . 0.0 110.008 178.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.766 ' HG3' HD21 ' A' ' 98' ' ' ASN . 66.6 mm-40 -100.43 173.63 6.49 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.478 -176.349 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -57.77 -101.11 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.387 0 CA-C-N 115.255 -0.884 . . . . 0.0 112.485 174.015 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.45 ' O ' ' HB2' ' A' ' 97' ' ' ASN . 60.5 m-20 -96.77 135.31 38.9 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -60.86 -29.24 69.41 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.138 0.494 . . . . 0.0 110.656 177.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 5.3 m -65.85 -19.72 65.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.252 0.548 . . . . 0.0 110.539 178.497 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.584 ' HB3' HG22 ' A' ' 6' ' ' VAL . 7.2 m-20 -81.24 -21.78 39.23 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.788 -178.296 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.766 HD21 ' HG3' ' A' ' 92' ' ' GLU . 16.7 m120 -78.11 -4.74 48.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.403 -177.617 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 3.2 m -110.32 154.74 23.06 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.079 0.466 . . . . 0.0 111.33 -175.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.509 ' HB2' ' HB2' ' A' ' 7' ' ' PRO . 48.8 tp -146.96 103.42 3.61 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.478 175.095 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 7.7 m -90.26 96.2 10.55 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 178.229 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.477 ' HB3' HD23 ' A' ' 10' ' ' LEU . . . -114.95 121.08 42.07 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.162 0.506 . . . . 0.0 110.82 -176.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.405 HD23 ' HA ' ' A' ' 79' ' ' THR . 87.1 mt -86.26 121.21 28.52 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.215 177.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.517 HG22 HD13 ' A' ' 80' ' ' LEU . 18.5 m -111.48 137.26 44.79 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.72 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.427 ' O ' ' HA ' ' A' ' 14' ' ' THR . . . -107.61 -177.78 22.42 Favored Glycine 0 N--CA 1.439 -1.128 0 C-N-CA 120.532 -0.842 . . . . 0.0 111.22 -177.204 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.551 HG23 ' HA ' ' A' ' 76' ' ' ASN . 24.7 p -82.54 153.95 25.28 Favored 'General case' 0 C--N 1.312 -1.056 0 C-N-CA 120.856 -0.338 . . . . 0.0 110.338 178.112 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.488 HD22 HG22 ' A' ' 16' ' ' VAL . 27.1 tp . . . . . 0 C--N 1.326 -0.448 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.395 179.483 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 13.4 tt . . . . . 0 C--O 1.237 0.396 0 N-CA-C 110.424 -0.213 . . . . 0.0 110.424 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.634 ' O ' ' HA ' ' A' ' 92' ' ' GLU . 18.4 Cg_exo -68.54 148.7 73.24 Favored 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.64 2.226 . . . . 0.0 111.203 170.094 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -130.0 93.09 3.42 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 175.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.549 ' HB3' HG11 ' A' ' 84' ' ' VAL . 70.5 mt -76.08 102.18 5.6 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.108 -173.483 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.488 HG22 HD21 ' A' ' 97' ' ' ASN . 60.9 t -107.68 110.41 62.64 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.124 -179.197 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.556 ' HB2' ' HB2' ' A' ' 100' ' ' LEU . 56.8 Cg_endo -73.12 103.51 1.62 Allowed 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 121.898 1.732 . . . . 0.0 109.825 168.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.2 t -79.31 -51.25 16.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.573 -168.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 21.6 t -157.25 176.36 12.82 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.019 0.437 . . . . 0.0 111.028 -178.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 35.6 tp -145.44 104.32 3.9 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.071 -178.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.3 p -112.98 145.52 33.25 Favored Pre-proline 0 C--N 1.321 -0.659 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.431 -175.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -86.0 157.22 56.85 Favored 'Cis proline' 0 N--CA 1.46 -0.474 0 C-N-CA 123.132 -1.612 . . . . 0.0 112.319 -2.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.462 ' HA ' HG12 ' A' ' 104' ' ' VAL . 35.9 m -83.94 13.0 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.25 0.547 . . . . 0.0 110.952 -179.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.704 HG22 ' HA ' ' A' ' 107' ' ' LEU . 0.3 OUTLIER -148.54 119.56 7.68 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 178.311 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.537 HG21 ' CZ3' ' A' ' 69' ' ' TRP . 24.9 m -128.41 153.53 37.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -167.21 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.471 HG22 HD23 ' A' ' 107' ' ' LEU . 7.4 t -76.01 129.77 79.97 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.052 179.086 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.59 ' HA ' ' CB ' ' A' ' 71' ' ' LEU . 6.1 Cg_exo -74.1 -173.88 1.57 Allowed 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 122.643 2.229 . . . . 0.0 111.577 174.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 8.1 p30 51.36 17.26 0.5 Allowed 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.349 1.059 . . . . 0.0 113.844 175.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 15.0 t -150.82 168.7 23.65 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 121.721 -0.612 . . . . 0.0 110.93 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 25.9 t -99.0 112.39 30.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 175.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.449 ' ND2' ' HB ' ' A' ' 15' ' ' VAL . 26.5 p30 -101.62 162.84 12.61 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.049 -175.348 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.465 ' HA ' ' O ' ' A' ' 67' ' ' PHE . 7.9 m -113.48 95.77 5.53 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.006 -179.534 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . 0.485 ' O ' ' HA ' ' A' ' 66' ' ' ASP . 80.0 mtp -92.74 150.56 20.58 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.755 -176.814 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.405 ' HA ' ' O ' ' A' ' 65' ' ' VAL . 3.1 m -118.02 115.91 25.82 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.424 -175.07 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -96.97 134.08 40.8 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.022 0.439 . . . . 0.0 110.457 176.035 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 4.1 m -91.33 100.2 13.04 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.087 179.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 21.9 mm -98.3 111.51 28.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 176.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.526 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 27.7 tt0 -119.19 132.27 55.94 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.149 0.5 . . . . 0.0 111.1 -176.557 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.578 ' HB2' ' HG ' ' A' ' 57' ' ' LEU . 54.2 t-20 -86.81 113.8 22.93 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.858 -179.471 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 83.0 mm-40 -101.13 54.92 0.84 Allowed 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.193 0.521 . . . . 0.0 110.745 179.077 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -143.99 -172.57 14.81 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.777 -0.725 . . . . 0.0 111.755 -177.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 29.9 p-10 -113.4 6.85 17.4 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.846 0.355 . . . . 0.0 111.729 -174.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.404 ' HD3' ' HD3' ' A' ' 3' ' ' PRO . 87.6 tttt -122.33 133.11 54.67 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 171.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -73.87 132.28 42.36 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.504 -179.179 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.491 ' OG ' ' HB3' ' A' ' 57' ' ' LEU . 4.5 p -93.11 138.81 31.21 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.084 0.469 . . . . 0.0 111.151 -178.199 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.0 p -83.1 -165.47 1.09 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.238 -179.23 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.586 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 22.4 m -56.91 121.5 10.04 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.99 0.424 . . . . 0.0 111.624 -179.073 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.46 ' CE2' HG23 ' A' ' 40' ' ' VAL . 31.3 p90 -133.87 153.73 51.54 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.295 -179.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.424 ' O ' ' HD3' ' A' ' 86' ' ' PRO . 89.3 m-20 -94.26 113.84 25.82 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.818 0.342 . . . . 0.0 111.245 -176.115 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.46 HG23 ' CE2' ' A' ' 38' ' ' PHE . 1.5 t -103.56 125.51 58.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.138 0.494 . . . . 0.0 109.815 176.453 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 9.7 m -113.3 139.39 48.88 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.676 -177.046 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 61.1 tp -103.01 116.97 33.55 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 174.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.494 ' HG ' HG22 ' A' ' 48' ' ' VAL . 5.1 mp -105.72 137.89 42.83 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.554 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 78.9 t -100.94 100.29 10.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 171.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 8.7 t70 69.2 -76.12 0.06 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.38 -176.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -136.95 -7.68 1.52 Allowed Glycine 0 CA--C 1.519 0.34 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.885 178.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 6.9 mt -100.03 148.75 6.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 110.029 -0.359 . . . . 0.0 110.029 -178.485 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.494 HG22 ' HG ' ' A' ' 43' ' ' LEU . 48.5 t -97.84 121.08 47.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.413 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 28.3 m -104.05 -28.51 2.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 C-N-CA 120.831 -0.347 . . . . 0.0 111.688 -177.213 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -144.27 150.07 37.3 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 -177.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 24.2 m -149.43 110.55 4.38 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 177.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -114.85 138.15 51.12 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.896 0.379 . . . . 0.0 110.546 -177.274 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 28.9 m -87.18 107.32 18.42 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 173.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.586 ' O ' ' HA ' ' A' ' 37' ' ' SER . 39.0 t -77.64 127.16 38.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 9.6 m -63.07 -39.39 94.56 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.896 -170.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 79.5 p -170.99 161.79 7.02 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.713 0.292 . . . . 0.0 110.52 178.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.578 ' HG ' ' HB2' ' A' ' 29' ' ' ASN . 37.9 tp -142.87 114.09 7.79 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.066 -0.515 . . . . 0.0 109.705 175.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -79.54 157.26 27.44 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.57 -0.741 . . . . 0.0 112.132 -172.126 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 16.5 m -59.63 119.9 8.45 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.362 -179.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.407 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 45.2 mt-10 60.5 28.65 18.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.66 179.072 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -124.9 159.64 30.68 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 172.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.526 ' HA ' ' HA ' ' A' ' 28' ' ' GLU . 33.2 p -112.76 163.86 14.07 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.059 0.457 . . . . 0.0 111.241 -176.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 79.9 m -133.97 124.46 26.36 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.918 173.207 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 31.4 m-80 -80.5 106.08 12.24 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.416 177.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.405 ' O ' ' HA ' ' A' ' 24' ' ' THR . 3.8 t -96.57 115.6 36.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.769 -175.702 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.485 ' HA ' ' O ' ' A' ' 23' ' ' MET . 19.2 m-20 -96.25 118.85 33.64 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.82 0.343 . . . . 0.0 111.223 -179.344 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.465 ' O ' ' HA ' ' A' ' 22' ' ' THR . 84.7 m-85 -102.1 174.27 6.01 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.952 178.401 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 86.3 m-70 -128.45 109.64 11.59 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 176.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . 0.537 ' CZ3' HG21 ' A' ' 15' ' ' VAL . 15.2 t90 -120.05 122.04 40.22 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.251 0.548 . . . . 0.0 111.281 -172.574 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 10.3 m -86.49 113.94 22.83 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.648 178.222 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.59 ' CB ' ' HA ' ' A' ' 17' ' ' PRO . 1.1 mm? -77.7 122.81 25.85 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.115 0.483 . . . . 0.0 111.678 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 16.4 p-10 -87.35 -33.72 19.07 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.154 173.063 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 82.64 19.55 63.55 Favored Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 115.589 -0.732 . . . . 0.0 113.55 172.054 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 30.0 m -70.45 -41.2 73.15 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.095 0.474 . . . . 0.0 110.401 179.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -110.25 157.24 19.67 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.041 176.382 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -97.05 -9.01 28.94 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.195 0.521 . . . . 0.0 109.734 178.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 71.9 p -137.62 110.1 7.47 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.935 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 46.5 m-85 -106.23 138.59 42.14 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.316 0.579 . . . . 0.0 111.095 -179.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.442 ' HA ' HD23 ' A' ' 103' ' ' LEU . 7.7 m -91.31 83.85 5.54 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.208 -0.906 . . . . 0.0 109.6 -179.59 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.435 HD13 HG22 ' A' ' 104' ' ' VAL . 7.9 mp -80.53 120.36 24.4 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.656 0.741 . . . . 0.0 110.267 -178.289 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.582 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 17.1 m -117.99 116.38 26.79 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.24 -173.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.437 ' HB ' ' HB3' ' A' ' 100' ' ' LEU . 92.8 t -87.43 110.98 21.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 177.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -96.57 117.14 30.33 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 175.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.549 HG11 ' HB3' ' A' ' 5' ' ' LEU . 47.5 t -93.47 108.14 20.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.975 -178.828 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 56.8 t0 66.38 95.91 0.05 OUTLIER Pre-proline 0 N--CA 1.466 0.374 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.447 178.005 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.424 ' HD3' ' O ' ' A' ' 39' ' ' ASN . 3.7 Cg_endo -85.1 0.56 8.81 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 123.319 2.679 . . . . 0.0 111.822 178.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -109.3 -14.82 14.39 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.043 -179.038 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . 0.4 HD22 ' HA ' ' A' ' 88' ' ' ASN . 2.1 t-20 57.85 42.7 22.82 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.703 -178.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -80.58 -29.68 36.95 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.911 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 60.5 t -100.22 129.29 51.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.771 -0.649 . . . . 0.0 109.553 175.302 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -73.28 133.13 43.82 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.324 179.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.634 ' HA ' ' O ' ' A' ' 3' ' ' PRO . 0.0 OUTLIER -128.6 164.45 22.83 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.847 -179.544 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -57.72 -101.14 0.01 OUTLIER Glycine 0 CA--C 1.517 0.184 0 CA-C-N 115.251 -0.886 . . . . 0.0 112.999 173.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.495 ' O ' ' HB3' ' A' ' 97' ' ' ASN . 27.8 t-20 -89.38 126.11 35.41 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.868 0.366 . . . . 0.0 110.42 -179.446 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -76.32 -12.58 60.09 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.934 -173.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 22.3 m -92.31 -6.06 51.05 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.563 0.697 . . . . 0.0 109.774 174.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.495 ' HB3' ' O ' ' A' ' 94' ' ' ASN . 1.9 t30 -86.81 -21.66 26.32 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.082 -178.589 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.443 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 16.9 p-10 -74.24 -3.75 31.9 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.976 0.417 . . . . 0.0 111.189 -176.573 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 1.3 m -101.66 149.05 24.53 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.215 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.582 ' O ' ' HA ' ' A' ' 81' ' ' THR . 48.9 tp -136.48 111.6 9.0 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.394 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 6.2 m -90.43 89.86 7.77 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.941 178.07 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -102.69 112.02 24.6 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.04 0.448 . . . . 0.0 110.794 -177.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.442 HD23 ' HA ' ' A' ' 79' ' ' THR . 61.7 mt -83.79 116.24 22.62 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.44 178.606 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.462 HG12 ' HA ' ' A' ' 13' ' ' VAL . 17.9 m -118.25 136.26 56.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.176 -177.31 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.514 ' O ' ' HA ' ' A' ' 14' ' ' THR . . . -111.6 173.74 15.99 Favored Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 120.378 -0.915 . . . . 0.0 111.858 -177.515 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 21.0 p -77.97 138.12 38.67 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.329 176.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.704 ' HA ' HG22 ' A' ' 14' ' ' THR . 32.3 tp . . . . . 0 C--N 1.326 -0.419 0 CA-C-N 115.677 -0.692 . . . . 0.0 112.098 -172.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.469 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 17.5 tt . . . . . 0 N--CA 1.452 -0.329 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.529 ' HD3' ' HD3' ' A' ' 33' ' ' LYS . 15.9 Cg_exo -70.25 159.76 51.93 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 122.611 2.207 . . . . 0.0 112.178 176.245 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -143.62 90.36 2.15 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 176.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.496 HD22 HD23 ' A' ' 57' ' ' LEU . 78.3 mt -85.59 109.82 18.82 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.417 0.627 . . . . 0.0 110.753 -170.013 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.407 ' HA ' ' HD2' ' A' ' 7' ' ' PRO . 45.9 t -114.79 111.29 45.81 Favored Pre-proline 0 C--N 1.32 -0.68 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.602 -175.055 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.505 ' HD2' ' O ' ' A' ' 97' ' ' ASN . 34.2 Cg_endo -68.08 101.66 0.72 Allowed 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 122.2 1.933 . . . . 0.0 109.81 167.113 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.7 t -79.34 -55.37 9.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.441 -169.55 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.3 t -146.21 163.42 35.48 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.54 -174.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 58.8 tp -134.59 104.61 6.14 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.712 -178.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 15.6 p -107.45 143.03 26.38 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.45 -177.153 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -86.25 157.73 55.23 Favored 'Cis proline' 0 N--CA 1.457 -0.624 0 C-N-CA 122.964 -1.682 . . . . 0.0 112.021 -3.556 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 34.9 m -82.69 5.84 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.355 0.597 . . . . 0.0 110.257 178.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.522 ' HA ' ' O ' ' A' ' 105' ' ' GLY . 2.6 m -147.35 116.94 7.06 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 176.065 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.442 HG21 HD21 ' A' ' 71' ' ' LEU . 22.0 m -113.47 152.2 15.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.139 0.495 . . . . 0.0 111.77 -170.61 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.608 HG22 HD22 ' A' ' 107' ' ' LEU . 1.8 t -97.77 115.59 65.75 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.65 178.71 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.523 ' HA ' ' CB ' ' A' ' 71' ' ' LEU . 23.9 Cg_exo -64.93 -175.3 0.36 Allowed 'Trans proline' 0 C--O 1.234 0.277 0 C-N-CA 122.495 2.13 . . . . 0.0 112.564 179.754 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 19.5 m-80 74.25 17.77 3.19 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.474 176.476 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 12.1 t -164.28 166.58 20.8 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 110.532 -0.173 . . . . 0.0 110.532 -177.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.508 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 52.6 t -85.84 109.7 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 172.365 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.669 ' OD1' HD23 ' A' ' 71' ' ' LEU . 9.8 m120 -85.52 125.64 33.22 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.068 -174.054 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 53.3 m -79.19 106.09 10.98 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.572 172.311 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . 0.435 ' SD ' ' HE3' ' A' ' 69' ' ' TRP . 62.1 mtp -104.88 144.13 32.2 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.956 0.407 . . . . 0.0 110.339 -179.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.498 HG23 ' HB3' ' A' ' 64' ' ' ASN . 31.2 m -115.02 111.4 21.05 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.055 -174.666 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.4 ' HB3' ' HB ' ' A' ' 65' ' ' VAL . . . -97.92 118.37 34.33 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 173.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 38.7 m -87.59 107.81 18.77 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 120.878 0.37 . . . . 0.0 110.174 -179.257 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 20.2 mm -103.11 115.13 44.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.863 -179.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.555 ' HG2' ' HB3' ' A' ' 62' ' ' SER . 46.2 mt-10 -104.14 134.07 48.0 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.751 0.31 . . . . 0.0 110.836 177.527 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.493 ' HB2' ' HG ' ' A' ' 57' ' ' LEU . 29.9 t30 -90.44 92.06 8.72 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 173.496 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 80.4 mt-30 -87.86 53.18 2.68 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.615 0.721 . . . . 0.0 110.168 -176.087 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -143.89 160.5 27.76 Favored Glycine 0 N--CA 1.444 -0.829 0 CA-C-N 114.953 -1.022 . . . . 0.0 110.638 179.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 26.6 p-10 -84.9 -0.88 55.66 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 117.011 0.405 . . . . 0.0 111.91 -171.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.529 ' HD3' ' HD3' ' A' ' 3' ' ' PRO . 48.2 tttm -112.59 144.8 41.46 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 176.346 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 -75.15 148.77 39.34 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 176.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 35.7 p -109.12 141.99 40.52 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.95 0.405 . . . . 0.0 110.763 -178.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.9 p -76.61 -164.81 0.45 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.382 -179.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.443 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 16.8 m -65.13 129.66 40.51 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.736 0.303 . . . . 0.0 110.965 -179.16 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.569 ' HB2' ' HB2' ' A' ' 85' ' ' ASP . 49.4 p90 -141.12 152.54 44.82 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.216 179.707 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.457 ' O ' ' HA ' ' A' ' 85' ' ' ASP . 30.1 m-80 -103.35 113.32 26.72 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.561 -175.065 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.503 HG11 HG21 ' A' ' 65' ' ' VAL . 1.4 t -98.36 122.39 49.97 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-O 121.269 0.557 . . . . 0.0 109.659 178.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 10.4 m -115.35 142.79 46.22 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.057 -174.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.49 HD11 ' HB3' ' A' ' 80' ' ' LEU . 45.0 tp -102.49 110.92 23.01 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.816 176.401 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.457 ' HG ' HG22 ' A' ' 48' ' ' VAL . 4.7 mp -98.9 114.58 27.26 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.24 -179.812 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.451 HG22 ' HG ' ' A' ' 80' ' ' LEU . 96.5 t -97.51 105.53 17.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.085 178.65 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 58.74 21.49 8.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.708 177.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 122.42 -33.66 4.08 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.908 176.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 8.5 mt -91.62 150.56 3.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 O-C-N 122.737 -0.272 . . . . 0.0 110.348 -176.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.457 HG22 ' HG ' ' A' ' 43' ' ' LEU . 44.5 t -96.74 118.15 42.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -179.251 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 27.2 m -97.11 -23.23 4.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.608 -177.39 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -153.36 142.34 21.24 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.254 -179.028 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.2 m -133.46 108.26 8.55 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.759 178.121 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -109.19 138.72 45.11 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.235 -175.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 17.3 m -105.61 110.14 22.35 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.912 0.387 . . . . 0.0 111.078 -178.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.443 ' O ' ' HA ' ' A' ' 37' ' ' SER . 45.4 t -77.78 128.74 38.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 176.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 12.3 m -60.22 -42.72 95.78 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.607 -177.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 30.2 t 178.21 129.93 0.06 Allowed 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 -178.058 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.529 HD13 ' OG1' ' A' ' 63' ' ' THR . 24.1 tp -108.51 117.37 33.98 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.159 0.504 . . . . 0.0 110.038 178.676 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -73.0 162.24 29.72 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.494 -175.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 2.9 p -61.5 124.35 20.4 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.329 -0.85 . . . . 0.0 111.352 179.23 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 61.01 28.62 18.4 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.854 179.014 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -108.95 156.78 19.31 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 174.541 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.555 ' HB3' ' HG2' ' A' ' 28' ' ' GLU . 32.5 p -114.09 125.83 54.42 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.535 179.211 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.529 ' OG1' HD13 ' A' ' 57' ' ' LEU . 53.2 m -112.78 129.44 56.43 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.975 0.417 . . . . 0.0 110.149 176.326 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.498 ' HB3' HG23 ' A' ' 24' ' ' THR . 94.1 m-20 -90.19 128.88 36.48 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.704 177.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.503 HG21 HG11 ' A' ' 40' ' ' VAL . 43.9 t -96.09 123.46 48.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.676 -177.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -86.19 97.64 10.47 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.446 -178.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -93.4 141.99 27.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.179 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 7.0 m80 -118.15 96.51 5.36 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . 0.435 ' HE3' ' SD ' ' A' ' 23' ' ' MET . 12.1 t90 -114.43 113.64 24.77 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.271 0.558 . . . . 0.0 110.621 -175.618 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.508 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 6.8 m -78.75 102.32 8.04 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.465 -0.788 . . . . 0.0 110.074 176.573 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.669 HD23 ' OD1' ' A' ' 21' ' ' ASN . 0.5 OUTLIER -61.05 113.9 2.81 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.095 0.474 . . . . 0.0 110.393 178.84 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -79.19 -32.98 44.3 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.569 -0.742 . . . . 0.0 111.075 -175.211 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -160.79 -146.29 4.57 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.05 -178.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 25.9 m -136.09 83.97 2.05 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.152 0.501 . . . . 0.0 110.497 179.253 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.422 ' O ' ' HB2' ' A' ' 76' ' ' ASN . . . -86.86 1.4 52.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.367 178.515 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.545 ' O ' ' HA2' ' A' ' 105' ' ' GLY . 17.0 m120 73.69 -50.4 0.69 Allowed 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.307 0.643 . . . . 0.0 112.229 -179.302 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 16.2 p -132.15 124.53 29.28 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 120.963 0.411 . . . . 0.0 111.708 -179.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -117.24 144.44 44.8 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.083 177.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.557 ' HA ' HD23 ' A' ' 103' ' ' LEU . 28.6 m -94.74 90.17 5.98 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.926 0.394 . . . . 0.0 110.094 -179.378 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.55 HD13 HG22 ' A' ' 104' ' ' VAL . 10.4 mp -94.18 117.23 29.8 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.308 0.575 . . . . 0.0 110.506 -178.093 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.525 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 18.8 m -114.2 119.03 35.65 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.459 -0.792 . . . . 0.0 110.394 -177.077 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 50.6 t -90.56 101.46 12.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 176.192 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -97.79 116.95 31.02 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 177.353 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.595 ' HB ' ' HB2' ' A' ' 98' ' ' ASN . 93.9 t -82.86 105.92 13.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 121.327 0.584 . . . . 0.0 111.264 -177.148 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.569 ' HB2' ' HB2' ' A' ' 38' ' ' PHE . 8.7 t70 54.42 90.86 0.08 OUTLIER Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 114.293 -1.321 . . . . 0.0 111.824 179.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_exo -58.17 -30.49 90.72 Favored 'Trans proline' 0 C--O 1.233 0.254 0 C-N-CA 123.052 2.501 . . . . 0.0 112.032 179.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -71.0 -25.56 62.74 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.093 177.427 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 56.48 44.98 23.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.974 -177.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -65.18 -32.16 73.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.153 -0.931 . . . . 0.0 110.439 -179.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 49.5 t -86.9 123.96 40.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.394 175.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.493 ' O ' ' HD2' ' A' ' 3' ' ' PRO . 3.9 m-20 -77.89 130.95 37.24 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.892 -0.411 . . . . 0.0 109.892 178.678 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -124.09 161.42 25.65 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.75 -173.123 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -58.21 -100.77 0.01 OUTLIER Glycine 0 CA--C 1.521 0.448 0 CA-C-N 115.033 -0.985 . . . . 0.0 112.528 172.171 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -57.94 156.37 9.24 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 176.459 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 -102.46 -24.93 13.78 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.15 0.5 . . . . 0.0 110.965 179.371 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 5.9 p -98.89 21.44 11.55 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.313 0.578 . . . . 0.0 110.972 -177.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.505 ' O ' ' HD2' ' A' ' 7' ' ' PRO . 26.4 p-10 -96.27 -33.82 11.84 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.106 -177.493 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.595 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 19.5 p-10 -83.7 9.77 10.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.968 -169.433 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 1.6 m -117.65 147.42 42.9 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.747 0.308 . . . . 0.0 110.22 177.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.525 ' O ' ' HA ' ' A' ' 81' ' ' THR . 50.2 tp -144.74 98.82 3.25 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.233 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 6.9 m -92.54 104.58 16.87 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.685 177.404 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -126.62 138.2 53.41 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.135 0.493 . . . . 0.0 111.359 -176.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.557 HD23 ' HA ' ' A' ' 79' ' ' THR . 74.0 mt -89.83 124.6 34.81 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.992 175.623 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.55 HG22 HD13 ' A' ' 80' ' ' LEU . 28.3 m -108.97 141.51 24.05 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 176.219 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.545 ' HA2' ' O ' ' A' ' 76' ' ' ASN . . . -102.47 166.72 17.3 Favored Glycine 0 N--CA 1.439 -1.101 0 C-N-CA 120.273 -0.965 . . . . 0.0 111.789 -176.064 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.529 ' OG1' ' HA ' ' A' ' 76' ' ' ASN . 24.5 p -91.85 140.86 29.26 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 173.169 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.608 HD22 HG22 ' A' ' 16' ' ' VAL . 7.7 tp . . . . . 0 C--N 1.326 -0.431 0 O-C-N 123.378 0.424 . . . . 0.0 111.126 -173.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.529 HG13 ' HD2' ' A' ' 3' ' ' PRO . 4.0 tp . . . . . 0 N--CA 1.451 -0.403 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.529 ' HD2' HG13 ' A' ' 2' ' ' ILE . 11.9 Cg_exo -70.96 177.24 6.63 Favored 'Trans proline' 0 C--O 1.236 0.398 0 C-N-CA 122.498 2.132 . . . . 0.0 112.226 178.108 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . 0.487 ' HB3' ' C ' ' A' ' 30' ' ' GLN . 24.8 t70 -149.14 77.91 1.37 Allowed 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 175.536 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.539 HD22 HD23 ' A' ' 57' ' ' LEU . 83.4 mt -75.36 109.63 9.05 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.932 -176.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 25.8 t -118.79 120.65 31.34 Favored Pre-proline 0 C--N 1.319 -0.744 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.247 -178.476 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.522 ' HB2' ' HB2' ' A' ' 100' ' ' LEU . 5.7 Cg_exo -73.68 111.22 3.24 Favored 'Trans proline' 0 N--CA 1.45 -1.06 0 C-N-CA 121.947 1.765 . . . . 0.0 109.726 172.43 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.0 t -80.55 -57.71 4.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.457 -169.023 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 32.8 t -144.94 167.32 22.92 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.631 -175.267 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 58.5 tp -138.62 114.61 10.1 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.149 -177.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.5 p -125.41 157.93 66.09 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.656 -179.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.63 159.51 96.43 Favored 'Cis proline' 0 N--CA 1.465 -0.185 0 C-N-CA 123.357 -1.518 . . . . 0.0 111.871 -3.356 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 29.7 m -78.31 -19.89 13.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.221 0.534 . . . . 0.0 110.249 -178.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.511 ' HA ' ' O ' ' A' ' 105' ' ' GLY . 17.3 p -124.5 130.61 52.78 Favored 'General case' 0 N--CA 1.437 -1.124 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.993 174.768 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.425 HG11 ' CZ3' ' A' ' 69' ' ' TRP . 31.3 m -113.06 146.56 17.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 120.766 0.317 . . . . 0.0 111.112 -177.02 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.603 HG22 HD22 ' A' ' 107' ' ' LEU . 18.1 t -92.13 113.0 57.76 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 116.633 -0.258 . . . . 0.0 110.963 -175.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.532 ' HA ' ' HB3' ' A' ' 71' ' ' LEU . 4.7 Cg_exo -72.44 97.86 0.9 Allowed 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 122.429 2.086 . . . . 0.0 109.934 173.727 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 -177.49 -46.07 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.417 -169.178 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 14.8 t -148.76 -169.63 3.41 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.954 -175.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.516 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 43.2 t -78.84 128.34 38.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 176.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.417 ' ND2' HD23 ' A' ' 71' ' ' LEU . 23.6 m-80 -102.82 125.19 49.47 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.64 -179.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.5 m -80.16 103.89 10.34 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 178.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . 0.553 ' HB2' ' HB2' ' A' ' 67' ' ' PHE . 95.8 mmm -87.63 133.05 33.88 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.734 -174.694 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.534 ' HA ' ' O ' ' A' ' 65' ' ' VAL . 42.4 m -105.86 109.33 21.24 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.825 -177.719 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.429 ' HB3' ' HB ' ' A' ' 65' ' ' VAL . . . -102.58 112.15 24.78 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.594 174.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 21.8 m -83.48 105.69 14.63 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.077 -178.017 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 21.5 mm -100.51 121.12 50.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 -179.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -113.1 134.78 54.38 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 -179.236 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.499 ' HB2' ' HG ' ' A' ' 57' ' ' LEU . 41.3 t30 -94.48 107.16 19.14 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.05 0.452 . . . . 0.0 109.819 177.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.487 ' C ' ' HB3' ' A' ' 4' ' ' ASP . 73.0 mt-30 -113.89 56.65 0.7 Allowed 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.243 -175.579 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -143.88 -165.65 10.97 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.36 -0.924 . . . . 0.0 112.493 -174.661 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.429 ' N ' HD22 ' A' ' 32' ' ' ASN . 0.9 OUTLIER -93.2 4.0 54.74 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 -169.448 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -155.41 150.19 26.43 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.785 -177.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -73.72 146.45 44.4 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 175.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.491 ' OG ' ' HB3' ' A' ' 57' ' ' LEU . 35.3 p -93.49 149.1 21.5 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.031 0.444 . . . . 0.0 110.807 -179.277 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.435 ' OG1' HG22 ' A' ' 90' ' ' VAL . 38.8 p -86.13 -158.9 0.43 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.885 177.057 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.461 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 37.8 t -69.71 107.95 3.69 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.752 0.31 . . . . 0.0 110.256 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.433 ' HB3' ' CG2' ' A' ' 90' ' ' VAL . 55.7 p90 -118.11 140.37 49.87 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.103 0.477 . . . . 0.0 109.878 179.723 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.514 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 65.3 t30 -90.35 128.37 36.44 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.897 -176.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.539 HG23 ' HA ' ' A' ' 84' ' ' VAL . 0.3 OUTLIER -116.62 136.91 52.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 -175.403 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.406 ' HB3' ' CG1' ' A' ' 48' ' ' VAL . 27.9 m -124.42 135.34 53.19 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.288 -173.467 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 57.8 tp -98.95 112.79 24.8 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.069 0.461 . . . . 0.0 110.168 175.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.552 ' HG ' HG22 ' A' ' 48' ' ' VAL . 5.0 mp -96.59 120.17 36.42 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.579 179.46 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 72.2 t -103.47 109.12 26.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 174.184 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 16.1 t70 74.39 -66.21 0.31 Allowed 'General case' 0 N--CA 1.464 0.273 0 O-C-N 124.188 0.93 . . . . 0.0 110.74 -179.516 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -162.62 14.04 0.12 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 121.144 -0.55 . . . . 0.0 112.682 179.064 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 10.8 mt -131.09 150.81 34.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 -179.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.552 HG22 ' HG ' ' A' ' 43' ' ' LEU . 29.6 t -93.12 94.9 4.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.504 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 32.8 m -70.82 -27.23 29.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.924 -173.355 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -157.93 152.85 25.32 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 178.263 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 25.2 m -139.09 128.71 24.57 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.287 -174.15 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.412 ' O ' HG12 ' A' ' 40' ' ' VAL . 2.5 tt0 -127.38 132.47 50.15 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 179.06 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.514 ' HA ' ' HA ' ' A' ' 39' ' ' ASN . 20.5 m -92.28 122.78 35.07 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 177.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.461 ' O ' ' HA ' ' A' ' 37' ' ' SER . 64.5 t -86.2 127.98 39.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 178.674 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 14.4 m -62.47 -45.35 93.42 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.139 -0.482 . . . . 0.0 112.087 -173.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 36.9 t -178.41 125.77 0.11 Allowed 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -177.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.539 HD23 HD22 ' A' ' 5' ' ' LEU . 25.2 tp -104.55 112.15 25.11 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.546 0.689 . . . . 0.0 110.558 178.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.41 ' HB3' ' HB2' ' A' ' 61' ' ' ASN . 34.5 tt0 -66.13 145.92 55.25 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.679 -179.082 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 5.9 t -64.25 137.96 58.2 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 178.719 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 68.87 9.67 7.5 Favored 'General case' 0 N--CA 1.464 0.231 0 O-C-N 123.741 0.651 . . . . 0.0 111.542 -178.423 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.41 ' HB2' ' HB3' ' A' ' 58' ' ' GLU . 4.7 m-20 -114.38 161.3 18.11 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.885 0.374 . . . . 0.0 110.598 177.768 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.3 m -123.9 124.52 42.82 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.503 179.245 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 54.5 m -104.21 124.02 48.37 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 176.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.469 ' HB3' HG23 ' A' ' 24' ' ' THR . 45.3 m-80 -87.0 126.0 34.45 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 179.599 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.534 ' O ' ' HA ' ' A' ' 24' ' ' THR . 22.1 t -96.07 136.34 27.3 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.828 -178.42 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -111.02 102.86 11.3 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.002 0.43 . . . . 0.0 110.209 -178.108 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.553 ' HB2' ' HB2' ' A' ' 23' ' ' MET . 66.5 m-85 -91.76 144.73 25.2 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.212 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 33.9 m-70 -99.59 87.88 3.69 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.029 179.605 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . 0.425 ' CZ3' HG11 ' A' ' 15' ' ' VAL . 18.2 t90 -108.02 110.45 22.16 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.276 0.56 . . . . 0.0 111.099 -173.827 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.516 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 5.5 m -80.87 122.78 27.64 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.858 177.383 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.532 ' HB3' ' HA ' ' A' ' 17' ' ' PRO . 0.9 OUTLIER -88.04 119.76 28.72 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.217 0.532 . . . . 0.0 112.09 -177.248 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -83.99 -38.69 20.62 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.827 173.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 88.4 24.87 32.43 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 121.017 -0.611 . . . . 0.0 113.501 174.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 85.5 m -64.0 -51.1 65.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.197 0.522 . . . . 0.0 110.985 177.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -110.6 146.91 35.31 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.408 179.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 17.3 p-10 -81.89 -6.91 59.49 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.033 0.444 . . . . 0.0 110.94 -177.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 8.8 t -149.23 124.97 10.48 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 176.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -112.84 156.2 23.32 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.163 0.506 . . . . 0.0 111.542 -177.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.445 ' HA ' HD23 ' A' ' 103' ' ' LEU . 6.0 m -96.78 97.51 9.38 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.279 177.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.519 HD13 HG22 ' A' ' 104' ' ' VAL . 9.4 mp -96.64 117.82 31.81 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.346 0.593 . . . . 0.0 110.592 -177.532 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.574 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 24.7 m -117.08 119.58 35.69 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.372 -177.243 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 39.8 t -94.99 109.6 22.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 177.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -99.03 125.61 44.56 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 120.419 -0.513 . . . . 0.0 110.019 178.129 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.577 ' HB ' ' HB2' ' A' ' 98' ' ' ASN . 96.6 t -98.2 111.35 27.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.917 -176.06 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 24.1 t70 66.89 92.34 0.07 OUTLIER Pre-proline 0 N--CA 1.466 0.341 0 CA-C-N 115.136 -0.938 . . . . 0.0 112.641 177.04 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -101.03 19.83 0.25 Allowed 'Trans proline' 0 N--CA 1.451 -1.008 0 C-N-CA 123.525 2.816 . . . . 0.0 111.718 171.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 58.8 mt-10 -128.17 -7.71 5.37 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.945 -174.282 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 8.1 t30 60.31 47.07 9.42 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.822 0.82 . . . . 0.0 109.882 -175.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -83.91 -37.3 22.54 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 174.075 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.435 HG22 ' OG1' ' A' ' 36' ' ' THR . 21.7 t -120.87 105.79 17.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 114.584 -1.189 . . . . 0.0 108.3 170.036 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -77.49 104.38 7.98 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.003 0.43 . . . . 0.0 110.116 -177.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 50.9 mm-40 -77.91 176.07 9.45 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.814 -177.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -57.91 -100.93 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.725 172.316 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 28.5 p-10 -87.77 174.89 8.11 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 173.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -115.21 24.71 11.43 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.117 0.484 . . . . 0.0 111.122 178.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 41.3 m -110.39 18.63 19.63 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.398 0.618 . . . . 0.0 110.003 175.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 28.3 p-10 -124.29 -24.82 4.22 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.894 -177.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.577 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 26.5 p-10 -86.6 23.57 1.62 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.744 -173.044 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.56 144.64 46.33 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.893 0.378 . . . . 0.0 110.788 -179.611 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.574 ' O ' ' HA ' ' A' ' 81' ' ' THR . 30.0 tp -136.97 115.66 12.08 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.085 178.775 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 15.0 m -104.9 102.45 11.97 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 178.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -121.65 135.35 54.98 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.974 0.416 . . . . 0.0 111.248 -176.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.445 HD23 ' HA ' ' A' ' 79' ' ' THR . 60.9 mt -87.43 125.17 34.12 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.559 175.677 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.519 HG22 HD13 ' A' ' 80' ' ' LEU . 25.6 m -112.64 155.43 13.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 175.666 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.511 ' O ' ' HA ' ' A' ' 14' ' ' THR . . . -120.49 171.34 14.63 Favored Glycine 0 N--CA 1.444 -0.787 0 C-N-CA 120.156 -1.021 . . . . 0.0 111.461 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 32.1 p -76.32 169.05 18.95 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.689 -0.485 . . . . 0.0 109.689 174.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.603 HD22 HG22 ' A' ' 16' ' ' VAL . 29.1 tp . . . . . 0 C--N 1.323 -0.587 0 CA-C-O 121.206 0.527 . . . . 0.0 110.745 -178.455 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.485 HG12 ' HD2' ' A' ' 3' ' ' PRO . 6.2 tt . . . . . 0 CA--C 1.535 0.386 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.485 ' HD2' HG12 ' A' ' 2' ' ' ILE . 2.7 Cg_exo -76.04 -174.25 1.99 Allowed 'Trans proline' 0 C--O 1.237 0.45 0 C-N-CA 122.598 2.199 . . . . 0.0 112.128 178.072 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -162.23 75.51 0.45 Allowed 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 179.296 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.421 HD22 HD23 ' A' ' 57' ' ' LEU . 73.3 mt -70.09 103.24 2.24 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.813 -177.592 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.462 ' HA ' ' HD2' ' A' ' 7' ' ' PRO . 42.7 t -110.72 110.47 57.35 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.002 -179.015 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.524 ' HD3' HG21 ' A' ' 84' ' ' VAL . 20.7 Cg_endo -63.85 114.27 2.52 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 122.271 1.981 . . . . 0.0 109.978 168.686 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 6.3 t -89.25 -58.9 3.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.25 -168.613 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.7 p -136.66 154.09 50.73 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.565 -174.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 62.1 tp -130.11 100.1 5.3 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.239 176.056 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.527 HG23 ' HA ' ' A' ' 12' ' ' PRO . 56.6 m -115.61 141.11 26.88 Favored Pre-proline 0 C--N 1.317 -0.84 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.198 -175.13 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.533 ' HG2' HG12 ' A' ' 15' ' ' VAL . 72.1 Cg_endo -83.46 133.79 21.79 Favored 'Cis proline' 0 N--CA 1.461 -0.397 0 C-N-CA 123.383 -1.507 . . . . 0.0 113.244 1.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 35.0 m -65.75 -11.44 12.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.818 175.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.517 ' HA ' ' O ' ' A' ' 105' ' ' GLY . 0.6 OUTLIER -135.39 118.94 16.95 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 175.969 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.533 HG12 ' HG2' ' A' ' 12' ' ' PRO . 27.4 m -113.54 166.0 7.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.828 -170.106 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 1.7 t -108.09 119.72 49.07 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.166 179.107 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.514 ' HA ' ' HB3' ' A' ' 71' ' ' LEU . 36.5 Cg_exo -60.94 88.53 0.09 OUTLIER 'Trans proline' 0 C--O 1.236 0.402 0 C-N-CA 122.339 2.026 . . . . 0.0 109.719 167.013 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -158.25 -50.69 0.06 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.954 -167.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 8.9 t -153.76 -169.82 3.39 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.006 -172.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.508 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 39.0 t -77.76 114.24 18.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 174.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.529 ' OD1' HD23 ' A' ' 71' ' ' LEU . 9.6 m120 -86.84 132.81 33.72 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.479 -175.28 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 20.6 m -79.23 93.69 5.29 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.249 177.554 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . 0.549 ' HB2' ' HB2' ' A' ' 67' ' ' PHE . 93.1 mmm -85.67 107.57 17.61 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.795 -178.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 17.7 m -97.96 113.15 24.92 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.819 -176.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -104.29 110.04 22.11 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.98 -0.554 . . . . 0.0 109.959 177.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 24.7 m -87.47 113.91 23.6 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 120.965 0.412 . . . . 0.0 110.324 -178.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 15.9 mm -100.8 122.86 53.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.708 -179.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -115.08 120.57 40.26 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 -179.21 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 32.4 t30 -82.7 98.39 9.04 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 178.276 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -94.18 44.24 1.11 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.353 0.596 . . . . 0.0 110.679 -175.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -143.96 147.97 19.51 Favored Glycine 0 N--CA 1.444 -0.789 0 N-CA-C 111.206 -0.758 . . . . 0.0 111.206 -177.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 14.5 t30 -84.89 61.68 6.98 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.489 0.662 . . . . 0.0 111.399 -172.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.448 ' HD3' ' HD3' ' A' ' 3' ' ' PRO . 54.4 tttm -161.69 156.85 23.57 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 170.311 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -80.7 154.57 27.22 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 120.867 0.365 . . . . 0.0 110.044 175.65 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 22.2 p -124.26 136.46 54.16 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.999 177.032 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 3.7 p -77.08 -166.53 0.72 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.889 179.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.425 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 7.5 t -60.93 113.04 2.31 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.989 0.423 . . . . 0.0 110.494 179.267 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.475 ' HB2' ' HB2' ' A' ' 85' ' ' ASP . 33.9 p90 -118.28 147.52 43.37 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.521 178.676 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.495 ' HB3' ' HD2' ' A' ' 86' ' ' PRO . 51.6 t-20 -90.29 128.59 36.46 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.368 -175.353 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.557 HG11 HG21 ' A' ' 65' ' ' VAL . 2.2 t -118.66 111.87 35.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-O 121.588 0.709 . . . . 0.0 109.821 176.144 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 8.9 m -111.77 143.15 43.17 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.807 -175.05 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 63.6 tp -102.75 113.76 27.44 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 176.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.553 ' HG ' HG22 ' A' ' 48' ' ' VAL . 4.8 mp -102.12 139.77 37.29 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.547 179.445 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 93.4 t -110.47 110.67 33.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 172.113 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 20.1 t70 67.73 -74.0 0.08 Allowed 'General case' 0 N--CA 1.464 0.273 0 O-C-N 124.042 0.839 . . . . 0.0 110.587 -174.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -150.3 6.95 0.71 Allowed Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.903 179.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 6.0 mt -116.85 147.44 20.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 117.104 0.452 . . . . 0.0 109.874 -179.319 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.553 HG22 ' HG ' ' A' ' 43' ' ' LEU . 25.5 t -94.08 114.8 31.44 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.294 -177.658 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 28.5 m -91.03 -30.0 4.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.594 -0.276 . . . . 0.0 111.47 -177.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -148.69 145.48 27.71 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 -178.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 58.3 m -137.51 114.39 10.61 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.909 -176.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -126.18 105.55 8.92 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.06 0.457 . . . . 0.0 110.24 -177.591 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.492 ' HA ' ' HA ' ' A' ' 39' ' ' ASN . 15.2 m -74.18 131.06 40.9 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.934 178.391 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.425 ' O ' ' HA ' ' A' ' 37' ' ' SER . 44.6 t -92.57 139.23 18.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 116.263 -0.426 . . . . 0.0 109.892 -179.146 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 18.6 m -59.55 -53.67 55.42 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.11 -0.495 . . . . 0.0 112.132 -177.038 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 35.3 t -176.81 149.95 0.77 Allowed 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -177.451 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.554 HD13 ' OG1' ' A' ' 63' ' ' THR . 25.2 tp -133.84 133.34 41.46 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.135 0.493 . . . . 0.0 110.424 178.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -89.79 174.62 7.61 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.775 -176.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 3.7 p -69.57 129.18 38.96 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.151 -179.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 50.5 mm-40 66.33 15.63 10.16 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.166 177.09 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -104.21 154.21 20.04 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 -179.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 7.3 m -113.1 143.73 43.84 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.829 0.347 . . . . 0.0 110.774 -178.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.554 ' OG1' HD13 ' A' ' 57' ' ' LEU . 95.6 m -128.86 127.91 42.8 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.078 174.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 40.1 m-80 -90.89 124.96 35.59 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.179 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.557 HG21 HG11 ' A' ' 40' ' ' VAL . 39.2 t -96.19 132.1 41.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.069 -178.335 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -101.81 97.3 7.7 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.525 -174.142 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.549 ' HB2' ' HB2' ' A' ' 23' ' ' MET . 32.2 m-85 -96.01 144.73 26.04 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.179 0.514 . . . . 0.0 111.302 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 15.9 m-70 -116.32 103.0 10.04 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.937 179.127 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . 0.41 ' CE2' HD22 ' A' ' 71' ' ' LEU . 11.3 t90 -116.51 111.2 19.61 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.516 -176.462 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.508 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 6.7 m -80.46 108.17 13.87 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.319 178.459 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.529 HD23 ' OD1' ' A' ' 21' ' ' ASN . 0.2 OUTLIER -69.25 116.02 9.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.953 0.406 . . . . 0.0 111.065 -178.302 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -84.54 -35.65 22.7 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.575 176.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 90.3 35.17 7.63 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.673 177.456 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 25.5 m -79.59 -38.63 33.53 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.023 0.44 . . . . 0.0 110.768 177.276 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -126.28 161.15 28.43 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.46 -174.417 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 -91.07 -12.02 36.94 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.461 178.146 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.562 ' HB2' HD21 ' A' ' 103' ' ' LEU . 28.4 p -147.34 137.83 23.37 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.363 177.685 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 40.3 m-85 -125.73 134.03 51.9 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.144 -178.212 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 21.4 m -89.53 92.92 9.3 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 120.927 0.394 . . . . 0.0 110.059 178.24 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.491 HD13 HG22 ' A' ' 104' ' ' VAL . 9.0 mp -88.37 137.92 31.9 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.194 0.521 . . . . 0.0 110.607 -179.445 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.416 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 19.1 m -131.44 114.56 15.08 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.428 -179.412 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.546 ' HB ' ' HB3' ' A' ' 100' ' ' LEU . 61.8 t -88.39 105.24 15.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 175.101 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -94.61 110.45 22.27 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.006 0.432 . . . . 0.0 110.104 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.524 HG21 ' HD3' ' A' ' 7' ' ' PRO . 85.6 t -83.19 114.47 24.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.341 -177.697 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.475 ' HB2' ' HB2' ' A' ' 38' ' ' PHE . 39.8 t0 58.74 73.66 0.69 Allowed Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 114.232 -1.349 . . . . 0.0 112.089 177.759 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.495 ' HD2' ' HB3' ' A' ' 39' ' ' ASN . 6.6 Cg_exo -74.19 -18.08 21.22 Favored 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 122.758 2.305 . . . . 0.0 111.141 176.301 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -87.77 -13.1 43.23 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.384 -177.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 62.79 45.62 5.62 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.194 177.616 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -77.12 -22.7 52.27 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.316 178.37 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 13.5 t -119.16 143.35 30.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.961 178.153 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 43.0 t-20 -89.54 105.38 17.76 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 178.596 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -98.82 147.21 25.14 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -174.474 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -57.76 -101.1 0.01 OUTLIER Glycine 0 CA--C 1.518 0.243 0 CA-C-N 114.965 -1.016 . . . . 0.0 113.195 174.124 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -73.92 106.54 5.68 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.929 0.395 . . . . 0.0 111.363 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.585 ' HA ' ' OD1' ' A' ' 98' ' ' ASN . 40.8 mt-10 -68.37 -11.71 60.0 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.089 179.418 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 8.1 m -70.82 -7.79 47.83 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.93 177.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.483 ' O ' ' HD2' ' A' ' 7' ' ' PRO . 88.6 m-20 -97.27 -21.73 17.09 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.139 -178.652 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.585 ' OD1' ' HA ' ' A' ' 95' ' ' GLU . 14.3 m120 -59.3 -34.89 72.85 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -172.234 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.49 125.0 49.8 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.258 0.551 . . . . 0.0 112.019 -178.073 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.546 ' HB3' ' HB ' ' A' ' 82' ' ' VAL . 28.5 tp -107.33 98.12 7.79 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.371 175.334 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 20.0 m -90.96 94.66 9.74 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.234 0.54 . . . . 0.0 110.105 -179.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -112.62 112.29 23.71 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.212 -178.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.562 HD21 ' HB2' ' A' ' 77' ' ' SER . 5.9 tt -80.86 104.29 11.27 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 179.681 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.491 HG22 HD13 ' A' ' 80' ' ' LEU . 18.3 m -93.83 149.86 4.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.655 -177.818 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.517 ' O ' ' HA ' ' A' ' 14' ' ' THR . . . -119.72 170.95 14.25 Favored Glycine 0 N--CA 1.443 -0.876 0 C-N-CA 119.941 -1.123 . . . . 0.0 111.876 -176.726 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 42.5 p -89.5 130.22 35.87 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 173.286 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.485 ' N ' HG22 ' A' ' 14' ' ' THR . 17.9 tp . . . . . 0 C--N 1.328 -0.332 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 -175.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.459 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 0.8 OUTLIER . . . . . 0 N--CA 1.453 -0.314 0 CA-C-O 120.676 0.274 . . . . 0.0 110.455 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.462 ' HD2' ' O ' ' A' ' 91' ' ' ASN . 12.9 Cg_endo -91.05 156.89 3.9 Favored 'Trans proline' 0 N--CA 1.445 -1.36 0 C-N-CA 122.883 2.388 . . . . 0.0 111.024 172.196 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -137.39 105.23 5.61 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 -179.126 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.531 HD22 HD23 ' A' ' 57' ' ' LEU . 27.4 mt -99.78 126.69 45.89 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 -171.145 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.532 HG22 ' HB3' ' A' ' 97' ' ' ASN . 4.6 t -125.42 140.29 35.94 Favored Pre-proline 0 C--N 1.317 -0.845 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.444 -176.52 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.473 ' HD3' ' O ' ' A' ' 97' ' ' ASN . 6.8 Cg_endo -92.79 100.72 0.17 Allowed 'Trans proline' 0 N--CA 1.445 -1.375 0 C-N-CA 123.13 2.553 . . . . 0.0 110.054 167.514 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 27.4 m -79.53 -28.86 13.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.811 -171.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 35.4 t -156.67 147.54 21.86 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.772 0.32 . . . . 0.0 110.888 -176.452 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.541 HD11 ' HB3' ' A' ' 23' ' ' MET . 19.4 tp -127.68 126.14 41.38 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 171.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.519 ' OG1' ' HA ' ' A' ' 12' ' ' PRO . 6.5 t -122.26 152.05 60.01 Favored Pre-proline 0 C--N 1.317 -0.835 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.912 178.278 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.64 ' HD2' ' SD ' ' A' ' 23' ' ' MET . 98.5 Cg_endo -80.92 149.92 77.75 Favored 'Cis proline' 0 N--CA 1.46 -0.467 0 C-N-CA 123.483 -1.465 . . . . 0.0 112.492 -3.54 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 35.3 m -69.09 -21.57 25.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.059 177.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.558 ' HA ' ' O ' ' A' ' 105' ' ' GLY . 0.7 OUTLIER -124.71 131.19 53.48 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.152 174.288 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.0 m -114.56 149.2 16.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 121.04 0.448 . . . . 0.0 111.789 -174.381 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.9 m -98.34 117.69 64.44 Favored Pre-proline 0 N--CA 1.447 -0.577 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.346 178.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.553 ' HA ' ' HB3' ' A' ' 71' ' ' LEU . 10.0 Cg_exo -71.06 91.31 0.64 Allowed 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 122.597 2.198 . . . . 0.0 110.443 173.139 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -163.23 -41.6 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.216 -171.489 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 13.5 t -145.73 -170.23 3.42 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.001 -172.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.439 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 62.1 t -84.34 116.51 28.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 172.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.587 ' OD1' HD23 ' A' ' 71' ' ' LEU . 9.2 m120 -91.47 118.44 30.56 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.636 -174.177 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.628 ' HA ' ' O ' ' A' ' 67' ' ' PHE . 58.7 m -80.6 96.26 6.79 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-O 121.319 0.581 . . . . 0.0 109.873 177.34 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . 0.64 ' SD ' ' HD2' ' A' ' 12' ' ' PRO . 93.3 mmm -79.14 126.56 30.89 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.478 -176.154 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.49 ' HA ' ' O ' ' A' ' 65' ' ' VAL . 17.5 m -105.07 112.34 25.44 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.975 0.416 . . . . 0.0 111.36 -176.208 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -104.15 130.41 51.89 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.012 176.275 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 23.7 m -95.8 108.34 20.67 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 120.695 0.283 . . . . 0.0 110.431 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.429 ' O ' ' HA ' ' A' ' 62' ' ' SER . 19.7 mm -100.06 119.95 48.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.863 -179.668 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -115.18 136.22 53.34 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.249 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 32.9 t30 -91.89 99.96 12.72 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.305 178.392 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -99.35 45.97 0.98 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.835 -175.281 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -144.01 160.08 27.73 Favored Glycine 0 N--CA 1.449 -0.463 0 N-CA-C 111.533 -0.627 . . . . 0.0 111.533 179.32 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -87.33 56.3 3.91 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.232 0.539 . . . . 0.0 110.924 -174.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.9 tptp -161.64 139.94 9.34 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 174.233 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -76.3 149.73 37.03 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 174.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.3 p -120.49 140.63 51.15 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.929 0.395 . . . . 0.0 110.498 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 3.9 p -91.84 -163.29 1.02 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.017 -178.278 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.557 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 48.5 m -49.03 115.6 1.35 Allowed 'General case' 0 C--O 1.234 0.276 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -179.482 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.463 ' CE2' HG23 ' A' ' 40' ' ' VAL . 30.4 p90 -130.57 149.52 52.2 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.12 177.632 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 11.8 m-80 -98.46 108.6 21.33 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.296 -172.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.463 HG23 ' CE2' ' A' ' 38' ' ' PHE . 2.3 t -98.32 117.88 43.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.401 0.62 . . . . 0.0 110.492 178.333 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 16.9 m -108.28 146.59 32.66 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.957 -176.372 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.42 HD11 ' HB3' ' A' ' 80' ' ' LEU . 47.6 tp -106.82 113.89 27.65 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 174.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.545 ' HG ' HG22 ' A' ' 48' ' ' VAL . 4.8 mp -101.07 121.01 41.03 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.277 -179.552 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 98.0 t -100.54 102.2 13.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 178.166 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 60.75 17.25 7.45 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.708 178.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 128.38 -34.45 2.92 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.943 176.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 11.5 mm -89.99 150.33 3.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.945 0.372 . . . . 0.0 110.209 -176.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.545 HG22 ' HG ' ' A' ' 43' ' ' LEU . 52.4 t -96.98 112.21 28.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 -179.375 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 24.3 m -86.01 -32.85 7.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.382 -177.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 38.4 t0 -159.68 162.32 35.06 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 120.889 0.376 . . . . 0.0 110.645 -178.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 85.0 m -149.81 129.86 13.52 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.785 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -117.69 118.82 33.14 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 110.175 -0.306 . . . . 0.0 110.175 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 27.6 m -74.86 108.35 7.54 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.034 175.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.557 ' O ' ' HA ' ' A' ' 37' ' ' SER . 40.3 t -77.53 128.37 38.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 178.196 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 7.3 m -57.44 -50.14 73.99 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 123.333 0.395 . . . . 0.0 111.763 -173.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 45.7 m -170.8 151.19 3.38 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 -177.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.531 HD23 HD22 ' A' ' 5' ' ' LEU . 23.8 tp -136.97 112.35 9.23 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.145 0.498 . . . . 0.0 110.364 177.73 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 23.9 mm-40 -76.28 174.38 10.24 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.889 -177.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 24.2 m -67.4 129.15 39.0 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.969 -179.069 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.457 ' HG2' ' O ' ' A' ' 60' ' ' GLU . 37.0 tt0 69.61 10.21 7.53 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.136 178.322 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 58.5 t30 -93.34 146.24 23.87 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.542 -0.463 . . . . 0.0 109.839 178.523 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.429 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 9.3 m -119.07 131.43 55.94 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.738 177.631 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.552 HG21 HG11 ' A' ' 54' ' ' VAL . 9.3 t -114.56 139.84 49.26 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.957 0.408 . . . . 0.0 110.42 179.014 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -92.2 114.06 26.5 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.146 178.218 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.49 ' O ' ' HA ' ' A' ' 24' ' ' THR . 10.0 t -96.4 122.88 48.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.582 -179.581 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.581 ' HB3' ' CG2' ' A' ' 22' ' ' THR . 17.3 m-20 -111.78 109.44 19.27 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.012 0.434 . . . . 0.0 110.862 -176.217 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.628 ' O ' ' HA ' ' A' ' 22' ' ' THR . 61.7 m-85 -91.5 163.93 13.98 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.372 -175.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 17.4 m80 -111.92 93.43 4.45 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.34 177.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 15.4 t90 -113.53 110.56 20.46 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.068 0.461 . . . . 0.0 110.679 -176.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.439 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 22.0 m -81.41 112.44 18.68 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.913 176.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.587 HD23 ' OD1' ' A' ' 21' ' ' ASN . 0.3 OUTLIER -71.6 119.52 15.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.121 0.486 . . . . 0.0 111.503 -177.317 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 24.5 p-10 -83.32 -33.58 25.87 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.612 175.209 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 77.38 29.62 55.63 Favored Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.87 174.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 25.6 m -80.05 -51.33 9.16 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.011 0.434 . . . . 0.0 110.501 179.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -105.85 148.29 27.73 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.302 179.372 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 -86.43 -9.19 56.78 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.877 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 24.4 t -137.54 119.51 15.37 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.067 179.37 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -116.58 150.37 38.13 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.956 178.264 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.41 ' HA ' HD23 ' A' ' 103' ' ' LEU . 26.0 m -101.36 89.73 3.86 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.012 179.295 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.484 HD13 HG22 ' A' ' 104' ' ' VAL . 9.2 mp -87.72 114.05 23.96 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.472 0.653 . . . . 0.0 110.493 -178.399 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.564 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 27.1 m -111.69 120.8 43.27 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.381 -177.84 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.467 ' HB ' ' HB3' ' A' ' 100' ' ' LEU . 61.8 t -89.64 103.21 13.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 176.374 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -95.83 114.04 25.74 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 178.234 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.417 ' HA ' HG22 ' A' ' 40' ' ' VAL . 95.7 t -81.02 104.21 9.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.129 -178.48 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.7 t70 53.49 90.85 0.08 OUTLIER Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 114.278 -1.328 . . . . 0.0 112.899 177.407 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -79.22 16.31 1.39 Allowed 'Trans proline' 0 N--CA 1.463 -0.323 0 C-N-CA 123.316 2.677 . . . . 0.0 111.935 177.446 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -116.18 -17.17 10.89 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.264 -177.622 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 12.2 m120 62.94 48.99 3.68 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.587 -178.009 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -66.5 -33.0 74.72 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.404 0.621 . . . . 0.0 109.752 174.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 4.1 t -107.53 169.26 2.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 174.389 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.462 ' O ' ' HD2' ' A' ' 3' ' ' PRO . 65.1 t30 -106.13 93.29 4.54 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 175.778 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 14.9 mp0 -76.51 149.7 36.7 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.772 -173.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -57.41 -100.85 0.01 OUTLIER Glycine 0 CA--C 1.522 0.5 0 CA-C-N 114.655 -1.157 . . . . 0.0 113.472 170.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 16.7 m-80 -84.71 130.72 34.66 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 122.758 -0.26 . . . . 0.0 111.351 -173.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -64.14 -32.12 73.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.076 0.465 . . . . 0.0 110.515 177.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 49.3 m -59.54 -29.41 67.88 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.82 176.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.532 ' HB3' HG22 ' A' ' 6' ' ' VAL . 7.0 m-20 -84.58 -13.25 52.26 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.913 -175.391 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -73.65 -10.67 59.93 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.011 178.203 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 3.7 p -130.8 125.13 32.93 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -173.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.564 ' O ' ' HA ' ' A' ' 81' ' ' THR . 46.1 tp -108.63 102.41 11.47 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.879 169.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 21.8 m -85.11 95.32 9.09 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 175.246 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -111.33 119.72 39.82 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.618 -177.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.41 HD23 ' HA ' ' A' ' 79' ' ' THR . 41.9 mt -82.43 114.99 21.25 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.389 0.614 . . . . 0.0 110.324 176.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.484 HG22 HD13 ' A' ' 80' ' ' LEU . 27.4 m -108.13 140.05 28.03 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.319 178.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.558 ' O ' ' HA ' ' A' ' 14' ' ' THR . . . -116.75 165.35 12.33 Favored Glycine 0 N--CA 1.438 -1.199 0 C-N-CA 120.182 -1.009 . . . . 0.0 111.149 -178.346 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 27.0 p -72.35 137.25 46.48 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 175.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 49.8 tp . . . . . 0 C--N 1.326 -0.415 0 CA-C-O 120.917 0.389 . . . . 0.0 110.584 -177.73 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 7.6 tp . . . . . 0 CA--C 1.538 0.496 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.538 ' HD3' ' HD3' ' A' ' 33' ' ' LYS . 5.4 Cg_exo -75.44 157.08 41.1 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.346 2.031 . . . . 0.0 111.143 174.379 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -140.13 102.76 4.45 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 178.067 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.552 HD22 HD23 ' A' ' 57' ' ' LEU . 25.4 mt -99.74 126.72 45.85 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -172.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.48 ' O ' ' HA ' ' A' ' 27' ' ' ILE . 8.3 t -125.22 140.23 35.61 Favored Pre-proline 0 C--N 1.313 -1.002 0 C-N-CA 119.865 -0.734 . . . . 0.0 110.635 -175.182 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.518 ' HG2' ' HB2' ' A' ' 100' ' ' LEU . 11.8 Cg_endo -96.99 110.05 0.1 Allowed 'Trans proline' 0 N--CA 1.447 -1.212 0 C-N-CA 123.672 2.915 . . . . 0.0 110.478 169.398 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 19.3 m -86.5 -39.14 13.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -169.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 51.0 m -156.37 161.17 40.16 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.723 0.297 . . . . 0.0 111.099 -178.327 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.436 HD11 ' HB3' ' A' ' 23' ' ' MET . 26.9 tp -127.61 126.49 42.16 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 172.403 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.511 HG22 ' HB ' ' A' ' 24' ' ' THR . 0.7 OUTLIER -122.6 131.73 24.35 Favored Pre-proline 0 C--N 1.318 -0.773 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.978 177.101 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.541 ' HD2' ' SD ' ' A' ' 23' ' ' MET . 90.4 Cg_endo -95.2 145.76 7.99 Favored 'Cis proline' 0 N--CA 1.449 -1.125 0 C-N-CA 123.789 -1.338 . . . . 0.0 113.345 5.114 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.432 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 35.4 m -67.37 -18.04 23.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.435 175.713 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.27 151.19 39.53 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 175.645 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 16.4 m -142.93 157.17 17.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.308 0.575 . . . . 0.0 111.346 -174.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.46 ' HA ' ' HD3' ' A' ' 17' ' ' PRO . 14.4 t -99.32 131.95 24.18 Favored Pre-proline 0 C--N 1.321 -0.663 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.647 -175.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 16' ' ' VAL . 1.6 Cg_endo -84.13 18.23 1.57 Allowed 'Trans proline' 0 CA--C 1.529 0.264 0 C-N-CA 122.786 2.324 . . . . 0.0 112.856 179.244 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 56.0 m-20 -106.67 -22.91 12.6 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.669 0.271 . . . . 0.0 111.583 -174.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 8.9 t -145.54 178.23 8.28 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.136 -173.029 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.626 HG22 HG23 ' A' ' 70' ' ' THR . 51.5 t -73.29 141.89 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 172.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.66 ' ND2' HD23 ' A' ' 71' ' ' LEU . 39.7 m-80 -114.41 132.76 56.12 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.361 -173.433 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.7 m -108.19 118.88 37.9 Favored 'General case' 0 N--CA 1.437 -1.089 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 -175.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . 0.541 ' SD ' ' HD2' ' A' ' 12' ' ' PRO . 87.2 mmm -108.93 122.99 48.39 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 113.938 -1.483 . . . . 0.0 109.855 -165.402 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.632 ' HA ' ' O ' ' A' ' 65' ' ' VAL . 17.0 m -111.99 124.44 52.4 Favored 'General case' 0 C--N 1.309 -1.152 0 CA-C-O 121.854 0.835 . . . . 0.0 109.765 -173.749 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -119.16 132.1 55.94 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 114.221 -1.354 . . . . 0.0 108.522 -175.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 19.5 m -112.35 121.01 43.65 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 121.714 0.769 . . . . 0.0 109.61 -171.063 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.48 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 8.7 mm -116.9 131.92 68.16 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 CA-C-N 114.314 -1.312 . . . . 0.0 109.236 -172.325 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -121.0 138.64 54.06 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 178.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.499 ' HB2' ' HG ' ' A' ' 57' ' ' LEU . 39.1 t30 -93.84 98.12 10.86 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 175.168 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 69.5 mt-30 -102.25 47.1 0.9 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.329 -173.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -144.18 154.65 25.83 Favored Glycine 0 N--CA 1.445 -0.743 0 N-CA-C 110.488 -1.045 . . . . 0.0 110.488 177.658 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -82.84 53.79 2.51 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.392 0.615 . . . . 0.0 111.466 -174.016 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.538 ' HD3' ' HD3' ' A' ' 3' ' ' PRO . 87.9 tttt -161.47 136.47 7.4 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 171.5 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -80.34 135.37 36.18 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 120.978 0.418 . . . . 0.0 110.756 -175.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 35.8 t -95.85 142.62 27.89 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.56 178.195 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.405 ' O ' ' HA ' ' A' ' 56' ' ' SER . 2.2 m -99.29 -129.57 0.2 Allowed 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.348 -179.631 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.605 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 48.5 m -82.85 108.8 16.45 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.027 0.441 . . . . 0.0 111.624 -173.641 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.547 ' HB2' ' HB2' ' A' ' 85' ' ' ASP . 52.9 p90 -122.38 146.01 47.73 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.014 177.196 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.485 ' O ' ' HA ' ' A' ' 85' ' ' ASP . 22.0 m-80 -92.56 110.58 22.01 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.794 -174.333 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -98.35 127.11 51.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 -178.46 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 37.0 m -118.72 141.65 48.41 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.297 -174.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 56.4 tp -100.24 111.51 23.79 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.575 173.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.472 ' HG ' HG22 ' A' ' 48' ' ' VAL . 4.9 mp -102.06 124.86 48.4 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.592 -178.031 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.511 HG13 ' HB3' ' A' ' 78' ' ' TYR . 86.2 t -93.68 95.96 5.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 175.485 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 64.03 5.66 2.5 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.96 -179.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 140.56 -34.99 1.92 Allowed Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.406 179.057 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.42 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 9.5 mt -82.36 147.93 5.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 -179.14 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.472 HG22 ' HG ' ' A' ' 43' ' ' LEU . 36.1 t -99.79 119.68 48.17 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.442 -176.724 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 20.3 m -97.6 -27.22 3.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 111.887 0.329 . . . . 0.0 111.887 -177.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 42.2 t0 -162.29 136.49 6.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.655 0.264 . . . . 0.0 110.332 -178.507 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 86.2 m -124.81 122.38 37.27 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.185 179.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -115.11 117.99 32.11 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 -178.445 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.454 ' HA ' ' HA ' ' A' ' 39' ' ' ASN . 22.7 m -82.86 111.18 18.51 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.327 -179.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.605 ' O ' ' HA ' ' A' ' 37' ' ' SER . 59.1 t -77.68 123.12 33.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 179.206 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.4 m -58.43 -39.97 81.24 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.727 -0.669 . . . . 0.0 112.128 -173.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.405 ' HA ' ' O ' ' A' ' 36' ' ' THR . 46.7 t -173.31 143.75 1.12 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.834 0.35 . . . . 0.0 110.486 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.552 HD23 HD22 ' A' ' 5' ' ' LEU . 23.5 tp -126.86 104.31 7.97 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.339 0.59 . . . . 0.0 109.532 175.246 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -70.75 160.68 32.24 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.525 -175.212 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 11.8 m -61.36 120.31 10.19 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.63 179.153 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 70.27 17.34 7.11 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 123.805 0.69 . . . . 0.0 110.889 -179.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -102.1 157.73 16.67 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 173.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 26.3 t -127.61 143.36 51.17 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.119 0.485 . . . . 0.0 110.71 -178.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 91.1 m -124.84 130.52 52.54 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.63 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 37.1 m-80 -101.19 117.7 35.52 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.943 177.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.632 ' O ' ' HA ' ' A' ' 24' ' ' THR . 3.7 t -102.82 125.16 57.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.911 -175.32 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -102.4 112.62 25.42 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.792 0.33 . . . . 0.0 110.914 178.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.402 ' HB2' ' HB2' ' A' ' 23' ' ' MET . 96.0 m-85 -91.62 159.01 16.1 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.953 179.467 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 15.8 m80 -108.64 109.74 21.02 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.727 -179.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 16.2 t90 -131.35 108.16 9.45 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.319 0.581 . . . . 0.0 111.404 -175.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.626 HG23 HG22 ' A' ' 20' ' ' VAL . 5.6 m -85.4 122.14 29.13 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.886 175.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.66 HD23 ' ND2' ' A' ' 21' ' ' ASN . 0.2 OUTLIER -72.3 122.33 20.94 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.19 0.519 . . . . 0.0 111.021 -177.633 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 24.2 p-10 -90.3 -41.62 11.44 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.436 179.058 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 99.07 23.62 11.27 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.81 -0.71 . . . . 0.0 113.204 175.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 92.6 m -74.96 -41.19 60.08 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.023 0.439 . . . . 0.0 110.583 177.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -128.33 162.31 27.37 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.372 178.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -100.71 -6.77 24.57 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.224 0.535 . . . . 0.0 110.183 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 22.7 t -146.95 112.26 5.53 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.508 177.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.511 ' HB3' HG13 ' A' ' 44' ' ' VAL . 83.2 m-85 -105.76 150.21 25.73 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.315 177.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.1 m -93.95 86.97 5.2 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 178.081 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.487 HD22 HG21 ' A' ' 104' ' ' VAL . 6.4 mp -81.43 114.32 20.1 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.714 0.769 . . . . 0.0 110.349 -177.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.513 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 7.3 m -116.94 117.8 30.69 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.475 -175.003 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 46.3 t -85.56 108.04 16.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 176.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.551 ' HA ' ' O ' ' A' ' 98' ' ' ASN . 6.3 t30 -101.64 116.69 33.3 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 178.696 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 58.2 t -82.64 104.42 11.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 115.615 -0.721 . . . . 0.0 111.214 -177.236 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.547 ' HB2' ' HB2' ' A' ' 38' ' ' PHE . 7.3 t70 54.5 89.66 0.1 Allowed Pre-proline 0 N--CA 1.468 0.47 0 CA-C-N 114.234 -1.348 . . . . 0.0 112.308 179.105 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -62.59 -24.43 75.1 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 123.29 2.66 . . . . 0.0 112.215 179.276 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 50.8 mm-40 -75.93 -28.81 58.13 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.812 177.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 56.2 53.84 8.47 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.812 -1.085 . . . . 0.0 109.807 -175.31 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -74.13 -25.04 59.54 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.865 -1.061 . . . . 0.0 109.706 178.24 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 17.3 t -108.31 97.49 5.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.213 -0.903 . . . . 0.0 108.897 174.392 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -61.15 134.31 56.89 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 -178.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.43 ' HA ' ' O ' ' A' ' 3' ' ' PRO . 3.0 mt-10 -111.22 166.22 11.27 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.966 -177.279 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -57.93 -101.04 0.01 OUTLIER Glycine 0 N--CA 1.453 -0.188 0 CA-C-N 115.588 -0.733 . . . . 0.0 112.851 174.044 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 28.4 t30 -70.17 100.74 1.72 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.683 -0.258 . . . . 0.0 110.538 179.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -75.9 53.94 0.79 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.211 0.529 . . . . 0.0 111.997 -177.207 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 13.9 t -137.64 16.1 2.91 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 174.102 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 18.1 p-10 -98.8 -27.27 14.02 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 113.58 -1.645 . . . . 0.0 111.746 -172.448 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.551 ' O ' ' HA ' ' A' ' 83' ' ' ASN . 17.9 m120 -55.13 -34.07 63.43 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 -168.731 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 1.5 p -107.23 123.38 48.21 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 -174.718 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.518 ' HB2' ' HG2' ' A' ' 7' ' ' PRO . 39.2 tp -107.26 106.63 17.17 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 170.17 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 28.3 m -89.96 102.4 15.11 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.669 -177.603 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -119.88 116.93 26.84 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.547 179.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 52.3 mt -74.86 119.03 18.49 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.126 175.535 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.487 HG21 HD22 ' A' ' 80' ' ' LEU . 27.6 m -113.1 133.39 59.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.693 178.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -120.9 166.55 13.95 Favored Glycine 0 N--CA 1.442 -0.956 0 C-N-CA 120.432 -0.89 . . . . 0.0 111.671 -176.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 59.3 p -69.09 146.02 52.92 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 177.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 62.4 tp . . . . . 0 C--N 1.328 -0.365 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -172.37 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 83.9 mmm . . . . . 0 N--CA 1.48 1.026 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.437 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 16.6 tt -143.72 139.24 16.01 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.301 -176.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.521 ' HB3' ' HB2' ' A' ' 35' ' ' SER . 12.4 Cg_exo -69.84 116.99 4.82 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.17 1.913 . . . . 0.0 111.24 175.344 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -103.16 79.94 1.79 Allowed 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 178.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.517 HD22 HD23 ' A' ' 57' ' ' LEU . 61.9 mt -73.27 103.42 3.96 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.775 -173.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.548 HG22 ' HB3' ' A' ' 97' ' ' ASN . 47.1 t -114.27 111.4 47.21 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.511 -176.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.584 ' HD2' ' O ' ' A' ' 97' ' ' ASN . 18.2 Cg_endo -64.03 107.44 0.78 Allowed 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 122.057 1.838 . . . . 0.0 110.046 167.37 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.0 t -82.51 -55.74 7.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.126 -170.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 58.6 p -141.44 158.3 44.04 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.182 -177.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.481 HD21 HD23 ' A' ' 80' ' ' LEU . 54.0 tp -130.24 104.42 7.28 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.021 177.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 22.0 p -115.02 146.18 35.64 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.216 -175.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.403 ' HD2' ' HG2' ' A' ' 23' ' ' MET . 88.1 Cg_endo -78.99 152.64 89.12 Favored 'Cis proline' 0 C--N 1.341 0.183 0 C-N-CA 123.186 -1.589 . . . . 0.0 112.562 -0.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.2 m -73.57 -19.77 18.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.045 0.45 . . . . 0.0 111.206 -178.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.458 ' HB ' HD13 ' A' ' 107' ' ' LEU . 0.2 OUTLIER -126.37 128.35 46.91 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 177.178 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.468 ' HB ' ' ND2' ' A' ' 21' ' ' ASN . 18.7 m -114.13 140.14 36.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -167.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.439 ' HA ' ' HD3' ' A' ' 17' ' ' PRO . 5.8 m -84.17 121.4 75.49 Favored Pre-proline 0 N--CA 1.449 -0.512 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.098 176.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 16' ' ' VAL . 4.6 Cg_exo -77.97 55.75 5.42 Favored 'Trans proline' 0 N--CA 1.463 -0.269 0 C-N-CA 123.006 2.471 . . . . 0.0 111.667 176.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -122.97 -18.26 6.48 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.161 -0.472 . . . . 0.0 112.042 -176.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 14.7 t -157.25 -173.96 4.67 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.736 -0.386 . . . . 0.0 110.938 -171.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.402 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 46.7 t -82.32 110.11 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 169.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.468 ' ND2' ' HB ' ' A' ' 15' ' ' VAL . 5.1 m-20 -84.38 108.23 17.09 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.309 0.576 . . . . 0.0 110.702 -169.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.622 ' HA ' ' O ' ' A' ' 67' ' ' PHE . 11.3 m -79.41 83.44 5.43 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.256 -0.883 . . . . 0.0 109.355 176.341 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.449 ' O ' ' HA ' ' A' ' 66' ' ' ASP . 82.8 mtp -79.5 152.21 30.34 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.41 -0.813 . . . . 0.0 110.403 -176.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 30.8 m -114.11 109.58 18.65 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.065 -175.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.441 ' HB3' ' HB ' ' A' ' 65' ' ' VAL . . . -92.14 120.09 32.41 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.548 173.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 61.2 m -92.76 101.29 13.68 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-O 121.12 0.486 . . . . 0.0 109.769 -179.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 15.3 mm -95.17 118.98 42.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.246 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -113.74 125.15 53.79 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.51 ' HB2' ' HG ' ' A' ' 57' ' ' LEU . 29.6 t30 -81.78 90.03 6.35 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.607 178.604 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -87.11 43.99 1.14 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.559 0.695 . . . . 0.0 110.788 -173.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -143.98 145.07 14.37 Favored Glycine 0 N--CA 1.442 -0.956 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 176.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -81.17 63.65 5.6 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.526 0.679 . . . . 0.0 111.039 -173.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.413 ' HA ' ' HD2' ' A' ' 33' ' ' LYS . 50.6 tptt -161.5 121.31 2.57 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.056 171.481 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -69.06 124.09 22.83 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.985 0.421 . . . . 0.0 110.567 -175.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.521 ' HB2' ' HB3' ' A' ' 3' ' ' PRO . 46.4 t -87.7 147.01 25.42 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.19 -174.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 21.7 p -86.54 -163.0 0.83 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.444 178.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.463 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 15.0 m -61.68 134.09 56.37 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 120.929 0.395 . . . . 0.0 111.338 -179.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.52 ' CE1' ' HB ' ' A' ' 54' ' ' VAL . 31.1 p90 -144.9 144.35 31.05 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.294 -177.339 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.515 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 25.7 m-80 -92.62 108.67 20.16 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.219 -174.272 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.452 HG22 ' HA ' ' A' ' 84' ' ' VAL . 2.1 t -98.29 116.75 41.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 121.392 0.615 . . . . 0.0 110.289 178.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 46.3 m -109.95 144.14 38.9 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.689 -177.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 46.9 tp -98.68 108.66 21.41 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.697 175.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.498 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 5.2 mp -98.93 108.45 21.13 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.427 -179.047 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 82.4 t -88.96 101.48 12.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 60.06 18.43 7.67 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.422 -179.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 124.49 -36.04 3.02 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.785 178.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.474 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 9.8 mm -79.81 145.55 9.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.905 0.383 . . . . 0.0 110.096 -176.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.42 HG22 ' HG ' ' A' ' 43' ' ' LEU . 40.8 t -96.96 101.75 12.65 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.824 -178.036 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 28.4 m -83.59 -30.78 8.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.615 -175.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 33.7 t0 -159.56 141.37 13.19 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.915 -0.314 . . . . 0.0 111.002 -177.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 88.6 m -129.07 123.36 32.05 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.308 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -127.3 105.69 8.71 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 -178.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.515 ' HA ' ' HA ' ' A' ' 39' ' ' ASN . 7.1 t -74.52 131.02 40.64 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.068 0.461 . . . . 0.0 110.38 178.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.52 ' HB ' ' CE1' ' A' ' 38' ' ' PHE . 39.1 t -95.28 138.57 20.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.774 -179.288 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.0 m -55.07 -43.28 73.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.246 -0.434 . . . . 0.0 112.039 -177.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 47.7 t -174.76 153.51 1.77 Allowed 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 -175.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.517 HD23 HD22 ' A' ' 5' ' ' LEU . 27.6 tp -134.15 109.5 8.95 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.16 0.505 . . . . 0.0 110.066 177.092 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.473 ' HB2' ' HB3' ' A' ' 61' ' ' ASN . 35.9 mt-10 -70.98 158.78 35.92 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.542 -0.754 . . . . 0.0 112.154 -174.278 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 12.3 p -64.12 122.98 17.88 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.095 179.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 65.09 20.2 11.98 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.453 179.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.473 ' HB3' ' HB2' ' A' ' 58' ' ' GLU . 61.1 t30 -116.62 155.2 29.17 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 176.036 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 2.4 m -115.28 145.66 42.25 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.657 0.265 . . . . 0.0 110.752 -175.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 13.3 t -119.2 143.85 47.04 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 175.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -96.05 112.03 23.88 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.873 0.368 . . . . 0.0 110.261 178.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.441 ' HB ' ' HB3' ' A' ' 25' ' ' ALA . 13.2 t -96.86 118.13 42.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.911 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.452 ' HB2' ' CG2' ' A' ' 22' ' ' THR . 5.3 p-10 -95.13 119.67 34.04 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.512 0.672 . . . . 0.0 110.559 -179.227 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.622 ' O ' ' HA ' ' A' ' 22' ' ' THR . 33.2 m-85 -95.67 146.8 24.22 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.726 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 15.2 m80 -110.73 90.27 3.28 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.663 -0.698 . . . . 0.0 109.485 -178.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 12.5 t90 -123.62 113.67 18.99 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.389 0.614 . . . . 0.0 111.416 -172.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.402 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 49.7 m -78.22 114.67 17.33 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.351 -0.841 . . . . 0.0 110.282 174.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.428 ' CB ' ' HA ' ' A' ' 17' ' ' PRO . 1.0 OUTLIER -63.54 118.78 8.66 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.326 0.584 . . . . 0.0 111.145 178.358 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -83.56 -36.74 23.75 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.03 -178.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 83.19 17.91 65.92 Favored Glycine 0 N--CA 1.449 -0.475 0 N-CA-C 110.99 -0.844 . . . . 0.0 110.99 -174.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 3.9 p -68.99 -29.75 68.02 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.23 -0.485 . . . . 0.0 111.332 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -145.44 168.86 19.54 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.075 -179.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 49.5 m-80 -96.98 -15.09 21.26 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.397 0.618 . . . . 0.0 109.649 178.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 20.4 m -131.97 126.6 34.4 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.781 177.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -115.12 132.88 56.46 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 177.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.48 ' HA ' HD23 ' A' ' 103' ' ' LEU . 4.3 m -90.49 83.66 5.89 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.124 0.488 . . . . 0.0 109.773 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.481 HD23 HD21 ' A' ' 10' ' ' LEU . 7.7 mp -81.41 117.2 21.66 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.515 0.674 . . . . 0.0 110.762 -176.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.562 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 32.7 m -113.85 110.61 20.39 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.545 -177.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 60.9 t -85.55 99.69 7.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 176.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -95.64 109.38 21.64 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 178.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.483 HG11 ' HB3' ' A' ' 5' ' ' LEU . 83.3 t -75.42 102.96 2.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.445 -179.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.0 t70 51.76 82.61 0.24 Allowed Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 114.431 -1.258 . . . . 0.0 111.427 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -64.41 -11.34 27.85 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.871 2.38 . . . . 0.0 111.923 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -87.64 -14.86 38.87 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.081 178.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 24.0 m120 56.12 43.47 26.83 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.886 -178.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.05 -34.57 77.87 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.384 0.611 . . . . 0.0 110.09 177.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 39.5 t -111.42 98.75 7.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 172.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.406 HD22 HD11 ' A' ' 2' ' ' ILE . 3.9 t30 -59.06 112.29 1.63 Allowed 'General case' 0 C--O 1.235 0.311 0 O-C-N 123.35 0.406 . . . . 0.0 110.619 -173.527 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.449 ' HA ' ' O ' ' A' ' 3' ' ' PRO . 3.8 mp0 -82.41 166.93 18.98 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.705 -174.007 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -58.05 -100.83 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.395 0 CA-C-N 114.919 -1.037 . . . . 0.0 113.33 176.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.418 ' HB3' ' CG ' ' A' ' 97' ' ' ASN . 53.0 t30 -76.21 141.77 41.69 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 122.626 -0.338 . . . . 0.0 110.836 -177.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -59.87 -43.1 94.9 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.979 -173.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 20.1 m -89.78 3.22 53.52 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.827 -174.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.584 ' O ' ' HD2' ' A' ' 7' ' ' PRO . 5.9 m-20 -85.97 -24.4 26.52 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 -175.286 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.507 ' HA ' ' O ' ' A' ' 5' ' ' LEU . 13.8 p-10 -82.04 -5.34 58.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.007 0.432 . . . . 0.0 111.341 -174.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 4.9 m -116.17 152.27 34.04 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.066 0.46 . . . . 0.0 110.727 -178.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.562 ' O ' ' HA ' ' A' ' 81' ' ' THR . 56.0 tp -140.66 103.63 4.56 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.84 179.18 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 15.7 m -98.83 104.5 16.54 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.123 177.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -132.48 135.72 46.21 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.895 0.378 . . . . 0.0 111.035 -178.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.48 HD23 ' HA ' ' A' ' 79' ' ' THR . 82.4 mt -80.21 127.09 31.94 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.752 177.204 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.442 HG22 HD13 ' A' ' 80' ' ' LEU . 32.7 m -109.13 134.72 50.23 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 172.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -105.16 170.92 18.23 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.04 -1.076 . . . . 0.0 111.038 -177.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 25.0 p -85.54 125.74 33.32 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 117.485 0.642 . . . . 0.0 109.821 175.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.458 HD13 ' HB ' ' A' ' 14' ' ' THR . 30.2 tp -64.16 133.78 53.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.608 -174.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -62.17 -45.6 92.69 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.589 -179.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -84.51 120.59 26.51 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.162 179.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 27.1 m170 -105.83 138.93 41.19 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.284 -178.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 50.2 t-80 -68.74 -25.84 64.95 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.225 0.536 . . . . 0.0 109.662 178.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 12.1 t-80 -139.72 142.56 36.84 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 176.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 6.2 t60 -55.37 -57.57 11.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.057 0.456 . . . . 0.0 110.048 -179.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 64.2 t60 . . . . . 0 C--O 1.243 0.745 0 CA-C-O 118.171 -0.919 . . . . 0.0 109.207 173.96 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.8 mtt . . . . . 0 N--CA 1.48 1.037 0 CA-C-O 121.107 0.48 . . . . 0.0 110.809 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -114.27 142.42 28.02 Favored Pre-proline 0 C--N 1.32 -0.69 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.913 175.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -83.79 156.84 13.75 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 122.023 1.815 . . . . 0.0 111.175 172.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -139.3 113.72 9.01 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 -178.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.674 HD22 HD23 ' A' ' 57' ' ' LEU . 31.5 mt -99.83 126.88 46.0 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -173.079 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.539 ' O ' ' HA ' ' A' ' 27' ' ' ILE . 8.4 t -124.91 140.22 35.3 Favored Pre-proline 0 C--N 1.318 -0.787 0 C-N-CA 120.341 -0.544 . . . . 0.0 110.263 -176.061 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.47 ' HB2' ' HB2' ' A' ' 100' ' ' LEU . 12.2 Cg_endo -96.52 98.18 0.09 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.57 0 C-N-CA 123.548 2.832 . . . . 0.0 109.733 167.05 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 26.2 m -80.37 -28.26 11.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.53 -167.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.3 t -165.71 158.9 15.76 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-O 120.816 0.341 . . . . 0.0 111.166 -177.083 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 29.9 tp -127.6 126.58 42.34 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.298 175.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.44 ' HA ' ' HA ' ' A' ' 12' ' ' PRO . 62.5 p -122.21 131.53 24.39 Favored Pre-proline 0 C--N 1.319 -0.718 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.587 179.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.672 ' HD2' ' SD ' ' A' ' 23' ' ' MET . 95.8 Cg_endo -92.02 175.01 17.81 Favored 'Cis proline' 0 N--CA 1.455 -0.753 0 C-N-CA 123.742 -1.357 . . . . 0.0 112.947 1.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 17.6 m -91.13 -10.42 9.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-O 121.347 0.594 . . . . 0.0 110.599 178.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.54 ' HA ' ' O ' ' A' ' 105' ' ' GLY . 0.8 OUTLIER -120.05 151.14 39.45 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.155 174.574 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 17.1 m -143.06 157.25 17.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.217 0.532 . . . . 0.0 111.788 -176.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.761 HG12 ' H ' ' A' ' 18' ' ' ASN . 21.8 t -99.27 132.05 24.05 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.454 -0.793 . . . . 0.0 110.287 179.092 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.441 ' HA ' ' HG ' ' A' ' 71' ' ' LEU . 95.9 Cg_endo -92.62 11.3 2.2 Favored 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 122.834 2.356 . . . . 0.0 112.65 177.085 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.761 ' H ' HG12 ' A' ' 16' ' ' VAL . 66.6 m-20 -100.6 -14.26 18.25 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.141 -175.15 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 9.1 t -158.75 173.7 16.15 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 -175.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 54.9 t -69.54 133.1 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 CA-C-O 121.64 0.733 . . . . 0.0 109.752 176.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -114.22 133.47 55.6 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 114.638 -1.165 . . . . 0.0 108.927 -176.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 18.1 m -107.8 118.76 37.57 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-O 122.444 1.116 . . . . 0.0 108.693 -170.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.672 ' SD ' ' HD2' ' A' ' 12' ' ' PRO . 97.3 mmm -109.04 123.49 49.23 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 112.868 -1.969 . . . . 0.0 110.794 -162.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 23.2 m -111.91 124.57 52.67 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 121.865 0.841 . . . . 0.0 109.793 -176.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -119.39 132.52 55.85 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.075 -1.42 . . . . 0.0 108.445 -175.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 45.4 m -112.31 121.01 43.68 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 121.93 0.871 . . . . 0.0 110.064 -168.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.539 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 9.4 mm -116.53 120.02 63.7 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 CA-C-N 114.001 -1.454 . . . . 0.0 109.123 -172.151 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -118.79 128.69 54.71 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 -177.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 31.2 t30 -83.82 95.04 8.33 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 177.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -95.51 57.15 1.89 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.183 -174.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -144.1 168.07 26.66 Favored Glycine 0 N--CA 1.442 -0.928 0 CA-C-N 114.879 -1.055 . . . . 0.0 110.669 178.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 44.8 m-80 -75.71 -21.34 57.64 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 111.77 0.285 . . . . 0.0 111.77 -174.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 61.7 tttp -101.32 138.55 38.19 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.944 0.402 . . . . 0.0 111.029 -177.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -76.99 140.05 40.28 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.745 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 13.9 p -105.74 155.76 18.96 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.03 0.443 . . . . 0.0 111.65 -175.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 12.6 p -99.1 -161.56 0.88 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.258 -177.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 9.8 m -53.76 136.3 40.07 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 122.656 0.383 . . . . 0.0 111.638 178.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.506 ' CE1' ' HB2' ' A' ' 57' ' ' LEU . 18.2 p90 -149.44 147.04 27.77 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 177.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.579 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 42.4 t-20 -101.2 125.46 47.82 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.439 0.162 . . . . 0.0 110.673 -176.137 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.53 HG22 ' HA ' ' A' ' 84' ' ' VAL . 2.7 t -111.28 127.02 68.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 121.185 0.517 . . . . 0.0 110.013 -179.198 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 19.5 m -119.88 144.08 47.59 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.662 -177.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 58.3 tp -100.11 112.7 25.0 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.874 178.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.429 ' HG ' HG22 ' A' ' 48' ' ' VAL . 5.0 mp -101.57 121.74 42.54 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.834 -178.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 89.1 t -97.27 115.33 36.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 172.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 25.5 t70 67.98 -75.02 0.07 Allowed 'General case' 0 N--CA 1.469 0.509 0 O-C-N 123.736 0.648 . . . . 0.0 110.739 -174.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -158.89 17.22 0.26 Allowed Glycine 0 N--CA 1.448 -0.554 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.8 178.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 9.9 mt -123.64 149.83 27.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.429 HG22 ' HG ' ' A' ' 43' ' ' LEU . 40.0 t -93.33 122.43 44.82 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 -177.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 26.5 m -96.95 -28.99 3.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.351 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 37.2 t0 -149.53 151.21 33.51 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 120.768 0.318 . . . . 0.0 110.441 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 21.9 m -144.13 121.84 11.88 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.954 -174.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -135.45 125.11 25.27 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.779 0.323 . . . . 0.0 110.555 -179.229 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.579 ' HA ' ' HA ' ' A' ' 39' ' ' ASN . 23.8 m -85.5 122.78 30.12 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.252 177.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 20.1 t -86.59 136.38 23.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 -179.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 14.6 m -55.28 -51.81 65.47 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 123.494 0.496 . . . . 0.0 111.844 -176.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 8.4 t -176.87 130.86 0.18 Allowed 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.674 HD23 HD22 ' A' ' 5' ' ' LEU . 21.1 tp -96.1 112.64 24.31 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.322 0.582 . . . . 0.0 110.088 177.442 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.41 ' HB2' ' HB3' ' A' ' 61' ' ' ASN . 38.3 mt-10 -71.82 144.62 49.06 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.542 -0.753 . . . . 0.0 110.577 -178.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 8.5 p -61.52 132.77 54.47 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.883 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 72.66 1.13 3.88 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.223 177.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.41 ' HB3' ' HB2' ' A' ' 58' ' ' GLU . 53.9 t30 -108.17 149.6 28.32 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.151 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 2.6 p -111.44 123.19 49.71 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.063 0.458 . . . . 0.0 110.789 -178.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 27.9 m -104.05 135.86 44.76 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.725 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -94.77 128.48 41.51 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.562 179.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 40.2 t -96.16 115.79 36.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.418 -179.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -84.07 101.11 11.54 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.594 179.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.481 ' CZ ' HG12 ' A' ' 40' ' ' VAL . 8.0 m-85 -100.47 148.62 24.56 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.015 0.436 . . . . 0.0 111.143 178.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 33.1 m-70 -120.05 107.87 13.6 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 178.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 14.4 t90 -115.97 118.73 33.73 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.342 0.591 . . . . 0.0 111.205 -172.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 4.6 m -88.7 113.48 24.31 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 168.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.441 ' HG ' ' HA ' ' A' ' 17' ' ' PRO . 0.1 OUTLIER -44.64 -40.54 5.93 Favored 'General case' 0 N--CA 1.469 0.516 0 O-C-N 123.898 0.748 . . . . 0.0 112.167 -169.669 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 15.9 t70 77.52 -53.9 0.53 Allowed 'General case' 0 N--CA 1.468 0.45 0 O-C-N 123.792 0.682 . . . . 0.0 111.035 175.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -117.21 -155.92 10.34 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 121.017 -0.611 . . . . 0.0 111.61 176.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 33.0 m -153.26 91.88 1.55 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.158 0.504 . . . . 0.0 110.47 177.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.523 ' H ' ' HE2' ' A' ' 78' ' ' TYR . . . -126.25 147.6 49.65 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.354 177.263 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -63.94 -27.14 68.94 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.227 0.454 . . . . 0.0 112.227 -173.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 38.4 m -145.67 119.26 9.12 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.058 0.456 . . . . 0.0 111.185 -179.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.523 ' HE2' ' H ' ' A' ' 75' ' ' ALA . 26.5 m-85 -105.74 141.67 36.77 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.177 177.309 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 21.9 m -93.43 100.02 12.4 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.056 178.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.452 HD13 HG22 ' A' ' 104' ' ' VAL . 8.6 mp -100.43 125.07 46.67 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.274 0.559 . . . . 0.0 110.519 -178.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.527 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 32.4 m -121.24 115.69 23.48 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.938 -176.494 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 92.9 t -86.94 108.6 18.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.685 175.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -101.8 121.19 41.62 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 176.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.53 ' HA ' HG22 ' A' ' 40' ' ' VAL . 77.8 t -87.58 108.8 18.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.187 -176.605 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 46.2 t0 61.61 85.25 0.18 Allowed Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 114.555 -1.202 . . . . 0.0 111.701 178.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -72.45 -4.36 15.12 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.732 2.288 . . . . 0.0 112.088 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -99.52 -15.87 18.51 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 177.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 48.04 71.89 0.31 Allowed 'General case' 0 C--O 1.233 0.201 0 CA-C-N 114.647 -1.16 . . . . 0.0 110.911 -177.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.06 -32.12 16.85 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.251 177.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 22.0 t -89.28 134.02 29.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.658 176.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -78.04 99.19 6.01 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 177.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -89.95 156.1 18.66 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.899 -171.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -57.47 -100.88 0.01 OUTLIER Glycine 0 CA--C 1.518 0.231 0 CA-C-N 115.088 -0.96 . . . . 0.0 112.78 171.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.645 ' HB2' ' HB3' ' A' ' 97' ' ' ASN . 78.9 m-20 -83.76 123.41 29.84 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 120.847 -0.341 . . . . 0.0 110.733 -178.088 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -72.67 -15.92 61.7 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.651 0.739 . . . . 0.0 109.724 176.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -89.03 7.18 36.19 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.826 176.141 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.645 ' HB3' ' HB2' ' A' ' 94' ' ' ASN . 1.7 t30 -116.98 -28.86 6.15 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -173.291 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 20.2 p-10 -75.69 10.99 1.47 Allowed 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.065 0.46 . . . . 0.0 111.86 -173.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -126.38 143.64 51.1 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.799 0.333 . . . . 0.0 110.399 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.527 ' O ' ' HA ' ' A' ' 81' ' ' THR . 44.1 tp -128.73 104.65 7.76 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.472 179.552 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 53.0 m -92.05 106.39 18.42 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 174.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -121.72 153.54 38.09 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.537 -177.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 88.7 mt -104.38 124.02 48.47 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.001 0.429 . . . . 0.0 110.481 179.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.452 HG22 HD13 ' A' ' 80' ' ' LEU . 22.4 m -116.17 132.42 65.77 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.618 178.534 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.54 ' O ' ' HA ' ' A' ' 14' ' ' THR . . . -110.96 166.27 12.27 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.423 -0.894 . . . . 0.0 112.01 -175.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 18.4 p -68.22 135.49 52.09 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.745 0.273 . . . . 0.0 110.275 177.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 61.9 tp -55.24 110.63 0.71 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.589 -176.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 -71.54 113.06 8.18 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.34 173.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 27.9 t60 -75.07 98.17 3.59 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 176.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . 0.432 ' HB3' ' O ' ' A' ' 112' ' ' HIS . 20.7 m170 -88.15 144.3 26.56 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.424 -178.201 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 76.6 m80 -69.87 -45.4 67.77 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 176.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . 0.432 ' O ' ' HB3' ' A' ' 110' ' ' HIS . 70.5 m-70 -98.98 132.99 43.89 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 171.461 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 30.0 m170 -76.47 71.45 3.12 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.634 0.73 . . . . 0.0 110.689 -176.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.245 0.842 0 CA-C-N 114.731 -1.122 . . . . 0.0 109.325 178.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.539 ' O ' ' HD2' ' A' ' 33' ' ' LYS . 66.7 mtm . . . . . 0 N--CA 1.479 1.008 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.435 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 7.5 tp -114.28 141.42 26.43 Favored Pre-proline 0 CA--C 1.537 0.458 0 CA-C-N 116.72 -0.218 . . . . 0.0 110.845 -177.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.539 ' HG3' ' HD3' ' A' ' 33' ' ' LYS . 6.5 Cg_endo -88.58 174.03 4.26 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 123.146 2.564 . . . . 0.0 112.128 173.092 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.402 ' O ' ' HA ' ' A' ' 29' ' ' ASN . 17.8 t70 -151.42 105.91 3.23 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 179.315 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.537 ' O ' ' HA ' ' A' ' 98' ' ' ASN . 96.9 mt -99.57 103.3 15.01 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.192 0.52 . . . . 0.0 111.473 -168.611 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.536 HG22 ' HB3' ' A' ' 97' ' ' ASN . 11.5 t -114.57 116.58 43.5 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.653 -173.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.478 ' HB2' ' HB2' ' A' ' 100' ' ' LEU . 3.8 Cg_exo -79.33 104.07 1.7 Allowed 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 122.544 2.163 . . . . 0.0 109.76 169.006 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 31.8 m -92.14 -15.06 8.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -169.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 27.8 t -159.36 156.83 29.23 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.516 -0.474 . . . . 0.0 111.507 -177.054 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 60.1 tp -142.48 114.12 7.96 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.07 178.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 8.8 p -126.96 145.8 55.2 Favored Pre-proline 0 C--N 1.32 -0.708 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.99 -176.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -77.77 155.88 95.21 Favored 'Cis proline' 0 C--N 1.341 0.18 0 C-N-CA 123.265 -1.556 . . . . 0.0 112.497 -0.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 30.2 m -80.16 -21.44 11.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.195 0.522 . . . . 0.0 110.282 177.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.627 ' HA ' ' O ' ' A' ' 105' ' ' GLY . 3.2 p -117.88 126.99 53.41 Favored 'General case' 0 N--CA 1.438 -1.067 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.355 176.236 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.497 ' HB ' ' ND2' ' A' ' 21' ' ' ASN . 29.2 m -113.57 140.36 34.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.134 0.492 . . . . 0.0 111.678 -173.032 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.417 ' HA ' ' HD3' ' A' ' 17' ' ' PRO . 8.1 m -90.67 124.67 61.76 Favored Pre-proline 0 N--CA 1.445 -0.698 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.425 174.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.496 ' HA ' ' HB3' ' A' ' 71' ' ' LEU . 3.0 Cg_exo -80.3 49.56 3.25 Favored 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 122.803 2.335 . . . . 0.0 111.723 178.408 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -116.71 -13.24 10.8 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.468 -175.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 15.2 t -167.98 -167.9 0.9 Allowed 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.928 -0.309 . . . . 0.0 110.799 -171.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.494 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 53.6 t -86.76 113.61 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 174.146 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.497 ' ND2' ' HB ' ' A' ' 15' ' ' VAL . 4.4 m-20 -88.08 137.07 32.65 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.237 -172.146 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 33.4 m -88.85 105.57 17.83 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.219 178.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.52 ' HB2' ' HB2' ' A' ' 67' ' ' PHE . 92.6 mmm -92.9 119.79 32.57 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.002 -178.32 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.526 ' HA ' ' O ' ' A' ' 65' ' ' VAL . 11.5 m -108.68 114.55 28.44 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.635 -176.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -105.71 133.03 51.1 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.387 -179.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 25.4 m -94.08 110.2 21.92 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.924 0.392 . . . . 0.0 110.827 -178.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 27.4 mm -102.64 116.32 46.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.789 -179.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -115.52 129.07 56.41 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.902 0.382 . . . . 0.0 110.177 178.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.402 ' HA ' ' O ' ' A' ' 4' ' ' ASP . 24.6 t30 -92.76 98.87 11.67 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.114 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -96.22 53.85 1.38 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.707 -174.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -144.02 161.5 27.84 Favored Glycine 0 N--CA 1.448 -0.558 0 N-CA-C 111.441 -0.663 . . . . 0.0 111.441 179.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.466 ' O ' ' HB3' ' A' ' 1' ' ' MET . 5.7 t30 -86.93 46.73 1.4 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.473 0.654 . . . . 0.0 110.793 -174.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.539 ' HD3' ' HG3' ' A' ' 3' ' ' PRO . 31.5 tttm -161.51 146.21 13.3 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 174.203 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -76.55 149.27 36.67 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.023 0.44 . . . . 0.0 110.189 176.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.424 ' OG ' ' HB3' ' A' ' 57' ' ' LEU . 13.5 p -104.72 129.3 52.96 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 172.331 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -84.3 -148.57 0.1 Allowed 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 -176.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.526 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 56.4 m -65.18 108.36 1.85 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.005 0.431 . . . . 0.0 111.398 -175.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.526 ' HB2' ' HB2' ' A' ' 85' ' ' ASP . 54.0 p90 -123.09 154.9 37.96 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.032 177.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.483 ' O ' ' HA ' ' A' ' 85' ' ' ASP . 32.8 m-80 -105.27 110.92 23.47 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.107 -175.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.606 HG22 ' HA ' ' A' ' 84' ' ' VAL . 1.3 t -98.18 121.28 48.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 121.351 0.596 . . . . 0.0 109.716 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 11.8 m -114.37 137.56 51.66 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.436 -175.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 55.0 tp -96.65 111.77 23.78 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.972 175.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.557 ' HG ' HG22 ' A' ' 48' ' ' VAL . 5.1 mp -94.46 132.29 39.26 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.336 178.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 85.5 t -105.96 97.42 5.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 173.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 70.81 -62.89 0.43 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.133 -0.94 . . . . 0.0 111.921 -179.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -147.34 -6.78 0.28 Allowed Glycine 0 CA--C 1.521 0.443 0 C-N-CA 120.886 -0.674 . . . . 0.0 113.496 179.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 6.5 mt -116.0 151.25 17.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 117.477 0.639 . . . . 0.0 110.45 -177.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.557 HG22 ' HG ' ' A' ' 43' ' ' LEU . 48.0 t -95.0 118.61 41.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 177.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 17.8 m -93.31 -33.08 5.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -176.299 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -152.98 143.07 22.33 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 110.278 -0.268 . . . . 0.0 110.278 -177.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 39.2 m -132.86 132.55 42.24 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.318 -179.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -123.57 125.86 45.62 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 178.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 15.0 m -87.31 110.3 20.13 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 177.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.526 ' O ' ' HA ' ' A' ' 37' ' ' SER . 43.7 t -81.6 124.13 38.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.329 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 10.3 m -52.76 -44.18 66.3 Favored 'General case' 0 C--N 1.329 -0.287 0 O-C-N 123.543 0.527 . . . . 0.0 111.464 -177.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 34.1 t -179.95 157.76 0.72 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.598 -179.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.424 ' HB3' ' OG ' ' A' ' 35' ' ' SER . 47.9 tp -136.02 123.94 22.72 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.012 -179.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 44.4 mm-40 -71.98 161.12 31.39 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.817 -177.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 15.5 m -70.14 128.82 37.61 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.278 178.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 68.3 20.09 8.81 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.984 178.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -112.9 147.02 37.92 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.625 177.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 11.2 p -114.67 125.91 54.28 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.123 0.487 . . . . 0.0 110.576 179.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 50.9 m -118.21 138.7 52.14 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.208 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -94.28 133.69 37.55 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.101 0.477 . . . . 0.0 111.363 -177.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.535 HG21 HG11 ' A' ' 40' ' ' VAL . 21.5 t -96.77 135.36 31.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.961 179.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -104.05 97.31 7.31 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.926 -174.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.52 ' HB2' ' HB2' ' A' ' 23' ' ' MET . 57.0 m-85 -97.13 153.34 18.03 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.406 177.322 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 68.8 m-70 -128.67 116.05 18.97 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 171.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 3.5 t90 -129.69 124.23 33.08 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.657 -173.007 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.494 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 4.3 m -80.09 113.87 18.58 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.056 -178.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.496 ' HB3' ' HA ' ' A' ' 17' ' ' PRO . 0.8 OUTLIER -69.68 120.23 15.13 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.964 0.412 . . . . 0.0 110.973 177.409 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -87.73 -36.21 17.48 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.589 178.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 92.9 16.04 49.75 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.641 -0.79 . . . . 0.0 111.735 -178.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.5 -38.62 87.99 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.265 0.555 . . . . 0.0 110.621 -179.178 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -138.02 158.17 44.88 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.874 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.482 ' N ' HD22 ' A' ' 76' ' ' ASN . 1.0 OUTLIER -83.09 -12.3 57.21 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.027 0.441 . . . . 0.0 110.544 179.019 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 10.7 p -143.3 121.56 12.26 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.452 178.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 53.0 m-85 -105.73 149.97 25.92 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.314 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.518 ' HA ' HD23 ' A' ' 103' ' ' LEU . 8.9 m -96.46 88.27 4.66 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.906 0.384 . . . . 0.0 110.38 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.412 HD13 HG22 ' A' ' 104' ' ' VAL . 7.4 mp -88.13 120.2 29.25 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.555 0.693 . . . . 0.0 111.118 -177.341 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.444 ' HB ' ' HB2' ' A' ' 43' ' ' LEU . 34.5 m -118.28 117.66 29.72 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.34 -178.318 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 47.9 t -90.75 103.79 14.74 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 176.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -101.52 112.61 25.21 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 178.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.606 ' HA ' HG22 ' A' ' 40' ' ' VAL . 75.6 t -78.64 103.81 5.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.838 -176.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.526 ' HB2' ' HB2' ' A' ' 38' ' ' PHE . 7.9 t70 58.94 88.3 0.13 Allowed Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 114.091 -1.413 . . . . 0.0 112.019 179.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -72.63 -4.46 15.37 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 123.171 2.581 . . . . 0.0 111.561 176.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -83.77 -21.95 32.03 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.173 -179.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 64.09 35.3 10.53 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.581 -178.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -75.93 -34.27 59.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.56 177.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 95.2 t -99.98 112.11 31.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.173 172.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 61.8 t30 -82.74 126.0 31.9 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.509 -177.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -84.05 165.83 18.22 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.239 0.542 . . . . 0.0 111.281 178.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -57.58 -100.69 0.01 OUTLIER Glycine 0 N--CA 1.444 -0.813 0 N-CA-C 110.268 -1.133 . . . . 0.0 110.268 159.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 15.4 m-20 -72.8 88.44 1.32 Allowed 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 172.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -58.4 96.23 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.409 0 O-C-N 123.325 0.391 . . . . 0.0 110.913 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 7.8 m 173.35 -26.36 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.417 0 O-C-N 124.238 0.961 . . . . 0.0 110.072 -172.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.536 ' HB3' HG22 ' A' ' 6' ' ' VAL . 83.7 m-20 -74.68 -19.85 60.1 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.488 -177.603 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.597 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 24.9 p-10 -72.29 19.31 0.08 Allowed 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.624 0.602 . . . . 0.0 112.624 -175.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 1.4 m -130.36 149.03 52.23 Favored 'General case' 0 C--N 1.322 -0.625 0 O-C-N 121.881 -0.512 . . . . 0.0 111.235 -178.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.478 ' HB2' ' HB2' ' A' ' 7' ' ' PRO . 30.0 tp -145.45 103.46 3.82 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.686 178.114 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 15.4 m -92.37 98.26 11.37 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 177.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -116.59 127.71 54.74 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.117 0.484 . . . . 0.0 110.695 -177.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.518 HD23 ' HA ' ' A' ' 79' ' ' THR . 65.1 mt -85.77 120.12 26.84 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.649 178.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.412 HG22 HD13 ' A' ' 80' ' ' LEU . 26.8 m -106.46 132.92 52.44 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.409 178.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.627 ' O ' ' HA ' ' A' ' 14' ' ' THR . . . -117.32 155.6 16.07 Favored Glycine 0 N--CA 1.44 -1.097 0 C-N-CA 120.205 -0.998 . . . . 0.0 111.244 -176.325 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.473 ' HA ' ' O ' ' A' ' 15' ' ' VAL . 35.2 p -61.75 145.82 51.26 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 176.226 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.494 ' HG ' ' H ' ' A' ' 109' ' ' HIS . 49.3 tp -52.77 126.8 21.19 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.816 0.341 . . . . 0.0 111.199 -176.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.634 ' HA ' ' HD2' ' A' ' 111' ' ' HIS . 35.5 mt-10 -54.77 -31.07 58.28 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.185 -178.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.494 ' H ' ' HG ' ' A' ' 107' ' ' LEU . 51.5 t60 -60.98 -24.36 66.06 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.989 -176.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 5.4 t-80 -100.66 17.94 20.56 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.06 0.457 . . . . 0.0 110.688 179.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . 0.634 ' HD2' ' HA ' ' A' ' 108' ' ' GLU . 89.2 m-70 -103.91 -37.27 7.47 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 168.197 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 13.7 t60 -77.87 -26.23 49.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.254 -0.884 . . . . 0.0 109.079 176.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 23.9 m170 -110.32 169.57 8.65 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.305 -0.862 . . . . 0.0 109.383 172.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 21.9 m-70 . . . . . 0 C--O 1.248 0.983 0 CA-C-O 118.251 -0.88 . . . . 0.0 109.844 177.178 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.468 ' O ' ' HD2' ' A' ' 33' ' ' LYS . 63.7 mtt . . . . . 0 N--CA 1.478 0.934 0 CA-C-O 120.877 0.37 . . . . 0.0 110.338 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.434 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 1.1 tt -114.27 142.46 28.08 Favored Pre-proline 0 C--N 1.319 -0.736 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 174.517 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.519 ' HD2' ' O ' ' A' ' 91' ' ' ASN . 12.6 Cg_exo -70.72 157.04 59.63 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.44 2.093 . . . . 0.0 111.012 174.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.571 ' HA ' ' OE1' ' A' ' 92' ' ' GLU . 13.7 t70 -132.73 91.78 2.96 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 175.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.529 ' O ' ' HB3' ' A' ' 97' ' ' ASN . 70.2 mt -99.76 126.45 45.84 Favored 'General case' 0 CA--C 1.499 -0.993 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 -173.105 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.4 ' HA ' ' HD3' ' A' ' 7' ' ' PRO . 11.0 t -125.4 140.57 36.6 Favored Pre-proline 0 C--N 1.311 -1.069 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.58 -173.132 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.573 ' HB2' ' HB2' ' A' ' 100' ' ' LEU . 17.2 Cg_endo -91.25 103.8 0.25 Allowed 'Trans proline' 0 N--CA 1.439 -1.688 0 C-N-CA 122.757 2.305 . . . . 0.0 109.495 168.045 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.8 t -80.02 -49.75 18.66 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 CA-C-N 114.765 -1.107 . . . . 0.0 111.306 -165.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 10.5 p -158.15 164.03 36.99 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.67 -178.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.53 HD11 ' HB3' ' A' ' 23' ' ' MET . 36.5 tp -127.73 126.51 41.97 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 176.486 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 37.0 p -122.3 131.71 24.36 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.502 176.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.543 ' HD2' ' SD ' ' A' ' 23' ' ' MET . 97.5 Cg_endo -90.83 176.4 18.03 Favored 'Cis proline' 0 N--CA 1.457 -0.619 0 C-N-CA 123.808 -1.33 . . . . 0.0 112.884 2.536 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.0 m -98.29 -12.05 8.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 121.431 0.634 . . . . 0.0 110.21 176.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.561 ' HA ' ' O ' ' A' ' 105' ' ' GLY . 0.8 OUTLIER -120.03 150.98 39.68 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.579 172.574 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.435 HG11 ' CZ3' ' A' ' 69' ' ' TRP . 7.5 m -143.14 155.15 17.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.056 0.455 . . . . 0.0 111.59 -173.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.9 m -104.33 130.26 23.63 Favored Pre-proline 0 N--CA 1.444 -0.764 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.15 -179.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -77.19 171.9 17.0 Favored 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 122.594 2.196 . . . . 0.0 111.648 175.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 73.9 21.39 2.67 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.32 0.648 . . . . 0.0 111.391 178.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 15.1 t -167.07 -176.79 3.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.661 0.267 . . . . 0.0 110.706 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 57.8 t -102.33 132.91 47.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 178.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 32.4 m-80 -106.03 134.84 48.51 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.934 0.397 . . . . 0.0 110.362 -176.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 15.0 m -95.34 97.22 9.68 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.567 178.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.543 ' SD ' ' HD2' ' A' ' 12' ' ' PRO . 91.5 mmm -89.53 115.59 27.05 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.533 -175.087 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 25.2 m -93.44 111.28 22.91 Favored 'General case' 0 C--N 1.323 -0.576 0 O-C-N 123.563 0.54 . . . . 0.0 111.002 -178.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.537 ' HB3' ' HB ' ' A' ' 65' ' ' VAL . . . -99.01 119.53 37.95 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.09 175.236 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 5.7 m -83.5 108.81 16.88 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.082 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 28.5 mm -108.29 119.33 57.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 -179.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -117.67 133.11 56.29 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.608 0.242 . . . . 0.0 110.639 -177.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.595 ' ND2' ' HA ' ' A' ' 59' ' ' SER . 36.2 t30 -95.33 100.3 12.1 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.995 0.426 . . . . 0.0 109.889 177.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 67.5 mt-30 -104.89 52.36 0.74 Allowed 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.487 -173.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -143.99 178.19 22.18 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.11 -1.043 . . . . 0.0 113.183 -175.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -90.36 28.84 1.36 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.108 0.48 . . . . 0.0 111.711 -172.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.468 ' HD2' ' O ' ' A' ' 1' ' ' MET . 88.5 tttt -154.16 143.58 21.46 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 121.876 -0.515 . . . . 0.0 111.058 178.229 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -79.75 143.25 34.66 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 175.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.438 ' OG ' ' HB3' ' A' ' 57' ' ' LEU . 33.7 p -104.69 140.95 37.31 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.005 0.431 . . . . 0.0 111.429 -177.286 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 7.3 p -85.08 -165.49 1.22 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.052 -179.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.414 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 13.4 m -60.34 119.41 7.9 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.935 0.398 . . . . 0.0 111.547 179.59 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.507 ' CE2' HG23 ' A' ' 40' ' ' VAL . 26.4 p90 -137.26 153.19 50.39 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 177.574 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.597 ' O ' ' HD3' ' A' ' 86' ' ' PRO . 65.1 m-80 -94.98 138.56 32.55 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.094 0.473 . . . . 0.0 110.744 178.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.507 HG23 ' CE2' ' A' ' 38' ' ' PHE . 2.4 t -119.57 112.97 39.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 173.314 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.523 ' HB3' HG23 ' A' ' 51' ' ' THR . 33.4 p -108.79 139.28 43.84 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.24 -173.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 54.9 tp -96.46 115.85 28.1 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.403 177.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.55 ' HG ' HG22 ' A' ' 48' ' ' VAL . 5.5 mp -96.96 129.21 44.45 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.196 177.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.424 ' CG1' ' HD2' ' A' ' 78' ' ' TYR . 84.1 t -106.37 96.89 4.99 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.69 176.512 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.471 ' HA ' ' HB ' ' A' ' 79' ' ' THR . 2.9 m-20 70.9 -51.06 0.68 Allowed 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 115.156 -0.929 . . . . 0.0 112.452 178.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -166.29 14.73 0.08 OUTLIER Glycine 0 C--N 1.319 -0.391 0 C-N-CA 120.768 -0.73 . . . . 0.0 113.15 178.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 9.3 mt -136.18 152.14 29.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 -179.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.55 HG22 ' HG ' ' A' ' 43' ' ' LEU . 50.7 t -97.91 108.73 22.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 177.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 17.0 m -77.67 -37.83 24.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.592 -177.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -159.37 140.04 12.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.828 0.346 . . . . 0.0 110.175 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.523 HG23 ' HB3' ' A' ' 41' ' ' SER . 27.6 m -116.48 122.19 44.02 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.949 178.461 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 43.9 tt0 -105.13 122.7 46.44 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.014 0.435 . . . . 0.0 110.281 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 6.0 m -79.82 129.51 34.55 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.232 177.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.414 ' O ' ' HA ' ' A' ' 37' ' ' SER . 53.7 t -98.75 120.0 47.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 172.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.7 m -61.41 -38.01 85.54 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.629 -174.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 23.0 t -178.1 136.87 0.17 Allowed 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 178.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.467 HD23 HD22 ' A' ' 5' ' ' LEU . 39.7 tp -119.79 113.06 20.04 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.223 0.535 . . . . 0.0 109.731 176.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -67.84 156.9 36.07 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.888 -177.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.595 ' HA ' ' ND2' ' A' ' 29' ' ' ASN . 11.6 p -65.51 130.34 42.95 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.56 178.471 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 68.81 23.52 6.88 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.507 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -117.93 153.74 33.08 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.393 -0.821 . . . . 0.0 108.83 175.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 23.3 t -128.52 142.63 51.01 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 177.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 15.0 t -125.41 149.17 48.42 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.892 179.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -97.78 120.18 37.7 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.213 -178.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.537 ' HB ' ' HB3' ' A' ' 25' ' ' ALA . 21.4 t -98.7 107.02 19.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.546 -176.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -98.84 111.47 23.85 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.925 0.393 . . . . 0.0 110.666 -178.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -91.28 163.03 14.37 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.235 0.541 . . . . 0.0 111.194 -176.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 57.4 m80 -105.3 93.88 4.92 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.549 -0.751 . . . . 0.0 109.723 177.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . 0.435 ' CZ3' HG11 ' A' ' 15' ' ' VAL . 12.5 t90 -107.12 100.01 9.52 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.798 -177.201 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 12.3 t -73.82 121.96 21.71 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 172.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 15.9 tp -121.94 96.11 4.93 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.468 0.651 . . . . 0.0 111.671 -173.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -63.49 -60.71 3.0 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.876 -1.056 . . . . 0.0 109.916 172.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 128.38 67.33 0.13 Allowed Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.721 178.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 30.9 m -75.46 -69.48 0.48 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.884 0.374 . . . . 0.0 110.575 178.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -108.47 -173.19 2.21 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.456 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 -96.49 -18.21 20.0 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.866 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 20.6 m -133.7 133.93 42.44 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.995 0.426 . . . . 0.0 110.81 -179.186 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.424 ' HD2' ' CG1' ' A' ' 44' ' ' VAL . 49.3 m-85 -119.12 145.2 46.16 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.805 179.198 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.484 ' HA ' HD23 ' A' ' 103' ' ' LEU . 6.6 m -97.11 91.65 5.66 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.323 -179.235 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.411 HD13 HG22 ' A' ' 104' ' ' VAL . 7.9 mp -91.1 113.16 25.35 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.452 0.644 . . . . 0.0 111.265 -176.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.561 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 11.2 m -116.12 120.71 39.91 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.489 -178.05 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 85.8 t -86.96 109.63 19.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.399 178.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.551 ' HA ' ' O ' ' A' ' 98' ' ' ASN . 6.1 t30 -92.5 111.57 23.2 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.817 0.342 . . . . 0.0 110.204 176.02 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 94.0 t -92.02 124.77 44.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.338 179.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.755 ' OD2' ' HA ' ' A' ' 88' ' ' ASN . 31.2 t70 64.91 85.87 0.15 Allowed Pre-proline 0 N--CA 1.464 0.249 0 O-C-N 123.922 0.764 . . . . 0.0 111.461 176.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.597 ' HD3' ' O ' ' A' ' 39' ' ' ASN . 1.6 Cg_endo -85.15 -40.9 0.08 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 123.364 2.709 . . . . 0.0 112.754 178.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.482 ' OE1' ' HD2' ' A' ' 86' ' ' PRO . 27.1 mp0 -80.33 -10.28 59.75 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.174 -176.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . 0.755 ' HA ' ' OD2' ' A' ' 85' ' ' ASP . 12.9 m120 63.02 64.77 0.84 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.73 0.776 . . . . 0.0 110.273 -174.307 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -100.45 -28.58 12.85 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.641 -1.163 . . . . 0.0 109.172 178.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 54.7 t -115.81 107.67 23.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.421 175.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.519 ' O ' ' HD2' ' A' ' 3' ' ' PRO . 16.6 t-20 -66.13 106.19 1.57 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.29 -177.487 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.571 ' OE1' ' HA ' ' A' ' 4' ' ' ASP . 0.3 OUTLIER -79.95 151.48 30.05 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.439 -174.718 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.401 ' HA2' HD13 ' A' ' 2' ' ' ILE . . . -57.93 -101.11 0.01 OUTLIER Glycine 0 CA--C 1.522 0.515 0 CA-C-N 115.018 -0.992 . . . . 0.0 113.436 171.378 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.446 HD22 ' ND2' ' A' ' 97' ' ' ASN . 0.0 OUTLIER -78.44 132.18 37.2 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.03 -0.585 . . . . 0.0 111.136 -173.671 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -73.78 76.77 1.58 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.172 0.511 . . . . 0.0 110.961 177.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 17.9 m -160.47 -40.27 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.564 -0.743 . . . . 0.0 109.885 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.529 ' HB3' ' O ' ' A' ' 5' ' ' LEU . 86.5 m-20 -67.47 -13.19 61.81 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.292 -0.867 . . . . 0.0 112.439 -173.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.551 ' O ' ' HA ' ' A' ' 83' ' ' ASN . 19.0 m120 -71.68 -5.01 30.67 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 111.675 0.25 . . . . 0.0 111.675 -175.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 2.5 p -142.41 122.54 13.77 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.573 ' HB2' ' HB2' ' A' ' 7' ' ' PRO . 42.2 tp -111.25 104.87 13.4 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 169.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.5 m -89.75 100.16 13.02 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.444 -178.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -120.57 128.05 52.7 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.081 0.467 . . . . 0.0 111.196 -177.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.484 HD23 ' HA ' ' A' ' 79' ' ' THR . 62.6 mt -85.51 125.82 33.36 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.57 177.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.411 HG22 HD13 ' A' ' 80' ' ' LEU . 33.3 m -116.82 142.85 28.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 177.368 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.561 ' O ' ' HA ' ' A' ' 14' ' ' THR . . . -122.65 155.91 17.11 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.235 -0.983 . . . . 0.0 112.291 -175.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 38.1 p -63.86 139.65 58.79 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 177.13 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 35.4 tp -52.48 121.29 6.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.044 -179.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -68.04 -20.83 65.01 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.918 -171.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 56.4 m170 -86.11 -5.42 59.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.278 0.561 . . . . 0.0 110.414 176.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -117.66 78.99 1.29 Allowed 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 173.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 51.5 m80 -57.47 118.45 5.19 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.367 -0.833 . . . . 0.0 112.678 -168.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 33.1 t-80 -90.87 124.44 35.18 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.175 176.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 -131.11 136.87 48.76 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.828 175.062 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 4.8 t60 . . . . . 0 C--O 1.247 0.946 0 CA-C-O 118.105 -0.95 . . . . 0.0 109.684 -175.782 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.482 ' HA ' ' OD1' ' A' ' 32' ' ' ASN . 83.4 mtp . . . . . 0 N--CA 1.478 0.937 0 CA-C-O 120.722 0.296 . . . . 0.0 110.354 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 13.7 tt -114.23 142.5 28.12 Favored Pre-proline 0 C--N 1.323 -0.582 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 176.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -80.63 156.81 21.55 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 122.314 2.01 . . . . 0.0 111.297 174.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.441 ' HB3' ' O ' ' A' ' 30' ' ' GLN . 13.5 t70 -146.65 104.63 3.76 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 176.234 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.593 HD22 HD23 ' A' ' 57' ' ' LEU . 14.6 mt -99.68 126.6 45.73 Favored 'General case' 0 CA--C 1.51 -0.573 0 C-N-CA 119.484 -0.886 . . . . 0.0 108.945 -172.272 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.3 t -125.55 140.69 37.04 Favored Pre-proline 0 C--N 1.318 -0.785 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.501 -176.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.675 ' HD3' ' O ' ' A' ' 97' ' ' ASN . 3.2 Cg_exo -81.89 109.39 1.96 Allowed 'Trans proline' 0 N--CA 1.446 -1.299 0 C-N-CA 122.598 2.199 . . . . 0.0 109.572 169.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 11.6 t -73.93 -53.59 17.19 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.037 -170.284 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 26.8 t -155.09 163.66 39.95 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.079 -179.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 19.9 tp -127.64 126.56 42.21 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.156 0.503 . . . . 0.0 110.025 179.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.412 ' HA ' ' HA ' ' A' ' 12' ' ' PRO . 41.4 p -122.17 131.47 24.4 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.558 177.299 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.513 ' HD2' ' SD ' ' A' ' 23' ' ' MET . 66.5 Cg_endo -90.68 177.19 17.19 Favored 'Cis proline' 0 N--CA 1.456 -0.72 0 C-N-CA 123.772 -1.345 . . . . 0.0 112.982 3.126 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.3 m -98.91 -13.36 8.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.376 177.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.412 ' HA ' ' O ' ' A' ' 105' ' ' GLY . 0.0 OUTLIER -120.24 151.1 39.64 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.892 173.586 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 17.0 m -143.16 157.36 17.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.574 0.226 . . . . 0.0 110.683 -177.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.505 ' HA ' ' HD3' ' A' ' 17' ' ' PRO . 2.2 t -99.25 131.84 24.44 Favored Pre-proline 0 C--N 1.325 -0.485 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 -178.173 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.585 ' HA ' ' HG ' ' A' ' 71' ' ' LEU . 3.2 Cg_exo -80.45 15.28 1.79 Allowed 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 123.3 2.667 . . . . 0.0 115.07 -171.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 29.4 p-10 -127.26 -2.47 6.31 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 -172.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 13.5 t -143.14 176.56 9.02 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.418 -172.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 62.0 t -81.01 134.46 27.13 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 CA-C-O 121.591 0.71 . . . . 0.0 109.405 174.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.547 ' ND2' HD23 ' A' ' 71' ' ' LEU . 32.7 m-80 -114.42 132.98 56.05 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 114.558 -1.201 . . . . 0.0 108.847 -173.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 23.7 m -108.2 118.88 37.93 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 108.166 -1.049 . . . . 0.0 108.166 -174.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.513 ' SD ' ' HD2' ' A' ' 12' ' ' PRO . 86.1 mmm -109.09 122.92 48.3 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 113.533 -1.667 . . . . 0.0 109.23 -166.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.529 ' HA ' ' O ' ' A' ' 65' ' ' VAL . 25.0 m -111.93 124.8 53.16 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-O 121.732 0.777 . . . . 0.0 109.531 -174.328 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -119.26 132.01 55.86 Favored 'General case' 0 N--CA 1.434 -1.248 0 CA-C-N 114.353 -1.294 . . . . 0.0 108.15 -176.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 93.6 m -112.36 121.45 44.89 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 -173.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 11.9 mm -116.14 131.86 67.39 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 -171.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -125.32 148.56 48.67 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.257 -177.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 37.6 t30 -101.15 95.99 6.92 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.442 -175.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.441 ' O ' ' HB3' ' A' ' 4' ' ' ASP . 92.8 mt-30 -88.08 62.2 6.68 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 122.048 0.927 . . . . 0.0 109.826 -179.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -173.5 147.14 9.31 Favored Glycine 0 N--CA 1.443 -0.841 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 178.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.482 ' OD1' ' HA ' ' A' ' 1' ' ' MET . 32.5 p-10 -85.39 8.29 19.42 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 113.661 0.986 . . . . 0.0 113.661 -162.23 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -109.19 141.17 41.82 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 120.376 -0.529 . . . . 0.0 110.648 174.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -75.24 135.56 40.99 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.864 174.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 65.5 p -93.1 -161.75 0.87 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.909 -173.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 7.0 p -131.31 -167.97 1.94 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.436 178.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 13.4 m -59.38 124.27 19.49 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.876 178.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.523 ' HB2' ' HB2' ' A' ' 85' ' ' ASP . 23.9 p90 -136.53 150.73 48.79 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.95 -179.05 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.435 ' O ' ' HA ' ' A' ' 85' ' ' ASP . 22.1 m-80 -99.44 109.84 22.38 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.364 -173.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.479 HG23 ' CE2' ' A' ' 38' ' ' PHE . 2.4 t -98.3 114.2 35.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-O 121.337 0.589 . . . . 0.0 109.797 177.509 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.447 ' HA ' ' HA ' ' A' ' 51' ' ' THR . 25.2 p -112.65 141.91 45.88 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.745 -175.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 55.9 tp -96.47 114.45 26.12 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.982 177.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.528 ' HG ' HG22 ' A' ' 48' ' ' VAL . 5.1 mp -98.26 132.57 43.64 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.225 179.196 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 98.7 t -113.78 101.72 12.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.868 177.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 58.82 19.01 6.54 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.822 179.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 128.55 -38.71 2.01 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.892 177.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 5.6 mt -87.48 150.23 3.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 -177.085 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.528 HG22 ' HG ' ' A' ' 43' ' ' LEU . 44.8 t -96.77 121.11 46.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 19.9 m -94.73 -33.32 4.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -177.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 34.1 t0 -156.1 138.35 14.73 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.576 0.227 . . . . 0.0 110.518 -178.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.447 ' HA ' ' HA ' ' A' ' 41' ' ' SER . 30.6 m -126.83 123.29 36.98 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.262 -179.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -114.7 112.65 23.18 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.802 0.334 . . . . 0.0 110.377 -179.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 23.7 m -77.12 113.07 14.46 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.972 0.415 . . . . 0.0 110.607 177.149 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 27.5 t -83.36 144.15 10.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.881 -179.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.3 m -62.67 -49.06 76.61 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.585 -0.279 . . . . 0.0 111.231 -178.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 22.6 t -177.75 164.45 1.97 Allowed 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -178.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.593 HD23 HD22 ' A' ' 5' ' ' LEU . 18.1 tp -139.85 110.03 6.53 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.247 0.546 . . . . 0.0 110.79 175.645 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 29.3 mp0 -74.75 174.2 9.47 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.973 -178.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 34.6 p -74.89 128.94 36.77 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.699 0.285 . . . . 0.0 110.901 -177.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 66.95 18.34 10.59 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.026 178.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.457 ' O ' HD11 ' A' ' 57' ' ' LEU . 58.5 t30 -110.64 148.65 31.79 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 175.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -117.62 153.9 32.5 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 120.964 0.411 . . . . 0.0 111.015 -175.511 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.472 ' OG1' HD13 ' A' ' 57' ' ' LEU . 92.6 m -130.07 135.24 48.02 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.715 177.254 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -96.34 123.04 39.85 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.41 176.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.529 ' O ' ' HA ' ' A' ' 24' ' ' THR . 17.6 t -105.15 120.68 56.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.732 178.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -109.42 111.27 22.72 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.114 0.483 . . . . 0.0 110.321 -179.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -91.6 157.72 16.83 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.391 -177.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 65.1 m-70 -108.94 100.03 9.29 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.327 175.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 13.5 t90 -116.67 108.23 15.66 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.077 0.465 . . . . 0.0 110.925 -175.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 10.1 m -81.78 114.03 20.14 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.636 174.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.585 ' HG ' ' HA ' ' A' ' 17' ' ' PRO . 0.1 OUTLIER -72.64 124.73 25.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.701 0.286 . . . . 0.0 110.46 -177.462 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -84.3 -36.62 22.48 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.765 177.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 85.8 58.58 2.0 Allowed Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 121.104 -0.569 . . . . 0.0 112.917 174.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.4 p -112.09 -32.14 6.66 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.734 0.302 . . . . 0.0 111.636 178.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -124.1 166.3 16.02 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.785 0.326 . . . . 0.0 111.083 -177.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.499 ' HA ' HG23 ' A' ' 106' ' ' THR . 51.8 m-80 -101.65 -5.09 25.47 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.046 0.45 . . . . 0.0 110.321 177.267 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 20.5 m -145.18 114.21 6.95 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.841 178.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -105.91 138.79 41.5 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.15 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.456 ' HA ' HD23 ' A' ' 103' ' ' LEU . 9.5 m -90.59 88.23 7.05 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.529 -178.005 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.475 HD13 HG22 ' A' ' 104' ' ' VAL . 8.3 mp -89.02 124.82 34.64 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.35 0.595 . . . . 0.0 111.148 -177.295 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.473 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 76.2 m -123.53 124.4 42.76 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.67 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 61.7 t -90.28 99.03 8.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 174.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.538 ' HA ' ' O ' ' A' ' 98' ' ' ASN . 4.6 t30 -93.5 114.76 27.22 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 178.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.438 HG11 ' HB2' ' A' ' 5' ' ' LEU . 60.8 t -80.11 108.6 13.73 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.648 -178.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.523 ' HB2' ' HB2' ' A' ' 38' ' ' PHE . 8.1 t70 48.57 92.09 0.06 OUTLIER Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 114.056 -1.429 . . . . 0.0 112.511 -179.242 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -64.73 -8.19 16.92 Favored 'Trans proline' 0 C--O 1.234 0.313 0 C-N-CA 123.313 2.675 . . . . 0.0 112.452 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -94.26 -24.95 17.25 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.372 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 18.9 m120 58.57 48.18 12.24 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.686 -173.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -64.21 -25.66 68.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.012 176.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 20.4 t -101.66 125.74 55.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.564 175.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -74.83 116.53 15.65 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.435 -0.579 . . . . 0.0 109.435 176.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -118.41 168.38 10.7 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -171.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -57.97 -100.96 0.01 OUTLIER Glycine 0 CA--C 1.522 0.52 0 CA-C-N 113.985 -1.461 . . . . 0.0 114.756 179.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -85.54 -163.9 0.93 Allowed 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -166.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 49.0 mm-40 -100.45 -37.84 8.66 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.282 -173.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 15.3 m -84.98 -4.4 59.13 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.824 0.345 . . . . 0.0 111.749 -171.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.675 ' O ' ' HD3' ' A' ' 7' ' ' PRO . 23.6 p-10 -70.44 -34.07 72.03 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.562 -176.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.538 ' O ' ' HA ' ' A' ' 83' ' ' ASN . 9.2 m120 -77.56 -1.46 30.77 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -175.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 1.1 p -135.83 130.94 34.72 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -177.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.473 ' O ' ' HA ' ' A' ' 81' ' ' THR . 28.3 tp -128.35 98.52 5.09 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.234 168.152 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 98.5 m -95.72 107.0 19.18 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.121 0.486 . . . . 0.0 110.501 179.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -121.57 134.83 55.03 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.948 -179.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.456 HD23 ' HA ' ' A' ' 79' ' ' THR . 78.9 mt -84.96 120.03 26.05 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.349 0.595 . . . . 0.0 110.629 179.42 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.475 HG22 HD13 ' A' ' 80' ' ' LEU . 33.2 m -106.22 132.35 53.59 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.491 177.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.412 ' O ' ' HA ' ' A' ' 14' ' ' THR . . . -108.76 173.57 17.7 Favored Glycine 0 N--CA 1.443 -0.876 0 C-N-CA 120.399 -0.905 . . . . 0.0 111.855 -175.285 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.499 HG23 ' HA ' ' A' ' 76' ' ' ASN . 22.0 p -76.43 132.54 39.72 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 120.881 0.372 . . . . 0.0 110.084 176.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 37.2 tp -63.19 123.41 18.56 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.938 -175.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -56.82 -47.11 81.04 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.872 177.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 58.6 m-70 -75.96 102.1 5.47 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.596 178.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 7.9 t60 -60.21 -26.63 66.53 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.307 -170.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 44.3 m80 -142.95 149.3 38.2 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 171.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 16.8 t-80 -79.34 74.83 5.93 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.777 0.799 . . . . 0.0 109.045 177.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -160.93 -26.65 0.06 Allowed 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.323 -1.308 . . . . 0.0 108.087 -174.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 16.5 t-80 . . . . . 0 C--O 1.245 0.855 0 CA-C-N 114.735 -1.121 . . . . 0.0 109.013 171.734 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.552 ' HG2' ' HB2' ' A' ' 33' ' ' LYS . 24.7 ttt . . . . . 0 N--CA 1.481 1.095 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 16.1 tt -130.64 148.48 70.24 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.301 -171.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -71.68 165.08 33.62 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.647 2.231 . . . . 0.0 112.501 175.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -149.85 91.21 1.77 Allowed 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 177.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.474 HD22 HD23 ' A' ' 57' ' ' LEU . 66.3 mt -84.76 117.68 23.98 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.178 -168.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.536 HG22 ' HB3' ' A' ' 97' ' ' ASN . 21.7 t -120.52 110.41 35.63 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.118 -176.248 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.561 ' HD2' ' O ' ' A' ' 97' ' ' ASN . 20.3 Cg_endo -63.74 111.68 1.59 Allowed 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 122.388 2.059 . . . . 0.0 110.55 169.361 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.3 t -85.93 -48.78 15.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.454 -169.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 18.2 t -149.32 157.66 43.52 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.924 0.392 . . . . 0.0 111.097 -174.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 53.7 tp -135.51 111.95 9.88 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.213 178.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.56 ' OG1' ' HA ' ' A' ' 12' ' ' PRO . 13.6 t -131.0 148.13 69.05 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.656 -176.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.56 ' HA ' ' OG1' ' A' ' 11' ' ' THR . 5.8 Cg_exo -78.77 148.76 83.79 Favored 'Cis proline' 0 N--CA 1.46 -0.446 0 C-N-CA 123.366 -1.514 . . . . 0.0 112.44 1.21 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.5 m -72.13 -5.91 6.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.271 0.557 . . . . 0.0 110.957 177.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.575 ' HB ' ' HA ' ' A' ' 107' ' ' LEU . 0.9 OUTLIER -128.27 133.01 48.7 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.834 175.43 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.496 ' O ' ' HA ' ' A' ' 106' ' ' THR . 15.3 m -124.2 156.18 31.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 120.761 0.315 . . . . 0.0 111.232 -174.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.0 m -101.83 134.0 20.41 Favored Pre-proline 0 N--CA 1.445 -0.703 0 CA-C-O 121.038 0.446 . . . . 0.0 110.823 177.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.425 ' CB ' ' HA3' ' A' ' 73' ' ' GLY . 98.6 Cg_endo -79.63 174.04 12.26 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 122.42 2.08 . . . . 0.0 112.166 178.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 25.1 m-80 63.14 28.77 16.09 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.32 177.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 15.2 t -169.42 170.52 8.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.761 0.315 . . . . 0.0 110.602 -177.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.467 HG22 ' HA ' ' A' ' 70' ' ' THR . 58.4 t -91.4 129.88 41.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.853 0.359 . . . . 0.0 110.387 178.371 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 40.4 m-80 -106.9 116.15 31.43 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.608 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.587 ' HA ' ' O ' ' A' ' 67' ' ' PHE . 10.3 m -85.36 93.39 8.71 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 175.025 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.582 ' O ' ' HA ' ' A' ' 66' ' ' ASP . 83.0 mtp -94.73 148.34 22.39 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.132 -174.197 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.459 HG23 ' HB3' ' A' ' 64' ' ' ASN . 20.9 m -109.67 114.07 27.36 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.146 -175.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -104.23 112.29 25.25 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 172.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 38.8 m -83.38 104.78 13.8 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 120.923 0.392 . . . . 0.0 110.044 -177.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 31.9 mm -97.05 116.62 39.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.893 -179.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -113.2 122.43 47.46 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.006 0.431 . . . . 0.0 110.135 -178.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 31.0 t30 -79.05 98.44 6.49 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.513 177.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -101.02 56.62 0.86 Allowed 'General case' 0 C--N 1.319 -0.761 0 CA-C-O 121.601 0.715 . . . . 0.0 109.976 -174.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -144.08 177.78 22.53 Favored Glycine 0 N--CA 1.444 -0.775 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.886 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.457 ' HB3' ' HG3' ' A' ' 1' ' ' MET . 0.9 OUTLIER -73.14 -39.17 65.91 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 -173.758 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.552 ' HB2' ' HG2' ' A' ' 1' ' ' MET . 55.7 tttp -101.21 147.58 26.1 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.424 0.631 . . . . 0.0 112.476 -170.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.402 ' O ' ' HG2' ' A' ' 33' ' ' LYS . 1.7 t70 -65.81 138.82 58.17 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 114.523 -1.217 . . . . 0.0 110.809 173.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.423 ' OG ' HD21 ' A' ' 5' ' ' LEU . 13.8 p -105.62 137.43 43.47 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.288 176.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.1 m -90.14 -133.2 0.11 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.248 -179.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.509 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 26.8 m -75.62 109.47 9.22 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.085 0.469 . . . . 0.0 111.568 -175.347 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.552 ' CE2' HG23 ' A' ' 40' ' ' VAL . 19.9 p90 -122.6 148.81 44.79 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.13 178.103 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.543 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 4.2 t-20 -99.83 115.19 29.02 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 120.913 -0.315 . . . . 0.0 110.963 -173.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.552 HG23 ' CE2' ' A' ' 38' ' ' PHE . 2.7 t -98.48 111.96 29.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.597 0.713 . . . . 0.0 110.161 -178.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.577 ' HB3' HG23 ' A' ' 51' ' ' THR . 16.2 p -104.1 131.69 51.11 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.919 -176.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 62.9 tp -98.17 109.77 22.47 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 174.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 5.1 mp -97.78 142.05 30.03 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.669 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 81.7 t -108.56 99.23 8.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 172.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 37.3 t70 67.06 -73.95 0.07 Allowed 'General case' 0 C--N 1.329 -0.298 0 O-C-N 124.123 0.89 . . . . 0.0 111.139 -176.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -143.64 4.96 1.75 Allowed Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 121.278 -0.486 . . . . 0.0 112.314 179.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 8.4 mt -112.62 153.72 14.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -179.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 54.7 t -106.51 124.9 62.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 17.5 m -94.56 -33.05 4.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 C-N-CA 120.961 -0.295 . . . . 0.0 111.191 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -159.68 142.18 13.64 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.923 0.392 . . . . 0.0 110.673 178.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.577 HG23 ' HB3' ' A' ' 41' ' ' SER . 7.1 m -124.06 109.34 13.38 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.294 178.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 47.0 tt0 -109.08 113.01 25.5 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.104 0.478 . . . . 0.0 111.183 -172.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.543 ' HA ' ' HA ' ' A' ' 39' ' ' ASN . 10.4 m -76.32 120.0 20.97 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.358 177.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.509 ' O ' ' HA ' ' A' ' 37' ' ' SER . 25.0 t -92.58 127.18 44.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 177.091 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 27.0 m -58.05 -38.72 76.8 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.075 -0.511 . . . . 0.0 112.337 -173.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 11.2 p -169.97 163.55 9.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.671 0.272 . . . . 0.0 111.422 -177.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.483 HD11 ' O ' ' A' ' 61' ' ' ASN . 38.4 tp -156.52 114.24 3.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.869 176.195 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -77.32 169.41 18.38 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.605 -175.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 16.6 m -63.44 125.96 25.93 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.745 -0.662 . . . . 0.0 111.114 -179.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 66.27 15.8 10.21 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.96 176.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.483 ' O ' HD11 ' A' ' 57' ' ' LEU . 41.5 t-20 -97.63 143.51 28.23 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 175.277 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -114.44 115.76 27.8 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.351 -178.43 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.412 ' OG1' HD13 ' A' ' 57' ' ' LEU . 50.0 m -104.33 124.43 49.17 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.093 0.473 . . . . 0.0 110.738 -179.296 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.459 ' HB3' HG23 ' A' ' 24' ' ' THR . 94.8 m-20 -80.14 115.76 19.88 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.683 178.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 18.2 t -96.77 107.56 20.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.322 -178.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.582 ' HA ' ' O ' ' A' ' 23' ' ' MET . 28.5 m-20 -93.75 111.74 23.49 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.785 179.362 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.587 ' O ' ' HA ' ' A' ' 22' ' ' THR . 80.7 m-85 -91.38 167.46 12.26 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.978 179.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 2.5 p-80 -117.58 95.31 4.89 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.502 174.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . 0.618 ' CZ2' HD13 ' A' ' 71' ' ' LEU . 9.7 t90 -94.38 100.52 12.53 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.552 -176.324 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.467 ' HA ' HG22 ' A' ' 20' ' ' VAL . 17.8 m -73.74 91.52 1.92 Allowed 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 173.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.618 HD13 ' CZ2' ' A' ' 69' ' ' TRP . 22.2 tp -95.84 117.8 31.26 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.445 0.64 . . . . 0.0 112.102 -169.298 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -65.13 -56.86 10.51 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.807 -1.088 . . . . 0.0 109.666 171.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.425 ' HA3' ' CB ' ' A' ' 17' ' ' PRO . . . 101.22 50.31 1.24 Allowed Glycine 0 N--CA 1.446 -0.64 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.656 -179.434 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.9 m -81.65 -29.42 33.16 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.146 0.498 . . . . 0.0 110.553 -177.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -123.45 162.01 23.69 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.543 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 69.8 m-20 -97.47 -2.5 41.89 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.052 0.453 . . . . 0.0 110.668 179.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.416 ' HA ' ' HA2' ' A' ' 105' ' ' GLY . 53.6 m -149.3 112.49 4.93 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.479 176.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -105.79 149.36 26.55 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.289 178.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 89.8 m -98.7 98.06 9.24 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.876 175.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.438 HD13 ' CG2' ' A' ' 104' ' ' VAL . 6.6 mp -94.19 132.25 38.92 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.381 0.61 . . . . 0.0 110.419 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.446 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 17.3 m -129.69 113.97 15.42 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.283 -176.179 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 69.0 t -86.21 109.29 18.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 177.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -104.68 115.09 29.72 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 176.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.587 ' HB ' ' HB2' ' A' ' 98' ' ' ASN . 74.9 t -82.66 114.02 22.85 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-O 121.404 0.621 . . . . 0.0 111.304 -177.281 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 45.2 t0 63.27 90.37 0.09 OUTLIER Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 114.211 -1.359 . . . . 0.0 112.35 176.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.528 ' HD3' ' O ' ' A' ' 39' ' ' ASN . 1.9 Cg_endo -84.7 -6.93 9.7 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 123.195 2.597 . . . . 0.0 111.563 174.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -92.84 -16.67 25.02 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.738 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 57.51 54.96 6.02 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.464 -179.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -93.45 -30.17 15.19 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.008 -0.996 . . . . 0.0 109.703 179.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 47.9 t -110.03 101.51 12.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.486 173.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -64.78 129.69 40.7 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.098 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.403 ' OE1' ' HB2' ' A' ' 5' ' ' LEU . 36.0 mt-10 -108.62 164.14 12.62 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.626 -173.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -58.42 -101.06 0.01 OUTLIER Glycine 0 CA--C 1.519 0.309 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.516 168.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -84.29 101.66 12.09 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 176.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -74.35 22.96 0.09 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.158 -174.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 16.2 m -111.82 -5.14 14.43 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.201 0.524 . . . . 0.0 109.839 174.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.561 ' O ' ' HD2' ' A' ' 7' ' ' PRO . 81.3 m-20 -87.52 -15.31 37.89 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.191 178.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.587 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 27.8 p-10 -77.04 1.64 17.37 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.685 -173.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 1.2 m -114.24 147.01 39.65 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.083 0.468 . . . . 0.0 110.984 -177.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.446 ' O ' ' HA ' ' A' ' 81' ' ' THR . 40.2 tp -143.57 102.19 3.9 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.904 179.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 8.5 m -95.96 110.64 22.82 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.969 178.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -128.5 138.8 52.45 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.902 -178.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 64.5 mt -87.67 121.46 30.12 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.449 177.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.438 ' CG2' HD13 ' A' ' 80' ' ' LEU . 27.3 m -113.29 121.41 65.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.842 179.192 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.538 ' O ' ' HA ' ' A' ' 14' ' ' THR . . . -103.66 174.05 22.37 Favored Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 120.397 -0.906 . . . . 0.0 111.054 -177.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.496 ' HA ' ' O ' ' A' ' 15' ' ' VAL . 20.7 p -73.29 154.59 40.09 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 117.286 0.543 . . . . 0.0 109.808 175.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.575 ' HA ' ' HB ' ' A' ' 14' ' ' THR . 49.7 tp -60.58 108.01 0.77 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.184 0.516 . . . . 0.0 112.153 -172.336 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -100.69 112.08 24.42 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.438 -0.801 . . . . 0.0 108.851 172.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 18.2 t-80 -94.02 143.06 26.69 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 -174.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 13.7 t60 -72.31 140.32 48.48 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 176.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 92.1 m-70 -133.24 170.04 16.01 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 178.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 63.4 t60 -82.92 -27.26 30.73 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 174.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 77.8 m-70 67.83 -83.03 0.03 OUTLIER 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.068 -176.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 42.4 t60 . . . . . 0 C--O 1.245 0.826 0 CA-C-O 118.406 -0.807 . . . . 0.0 109.3 176.375 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 86.5 mtp . . . . . 0 N--CA 1.481 1.119 0 CA-C-O 120.865 0.364 . . . . 0.0 110.692 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 12.6 tt -140.49 138.89 19.32 Favored Pre-proline 0 C--N 1.321 -0.634 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 177.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.603 ' HD2' ' O ' ' A' ' 91' ' ' ASN . 16.9 Cg_exo -68.04 151.51 77.47 Favored 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 122.4 2.067 . . . . 0.0 111.697 175.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -141.46 90.41 2.29 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 179.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.523 HD22 HD23 ' A' ' 57' ' ' LEU . 58.4 mt -85.05 109.05 17.94 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.073 -171.401 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.538 HG22 ' HB3' ' A' ' 97' ' ' ASN . 17.7 t -117.46 123.1 30.19 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.207 -176.248 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.556 ' HG3' HG23 ' A' ' 84' ' ' VAL . 3.3 Cg_exo -79.32 101.59 1.43 Allowed 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 122.599 2.199 . . . . 0.0 110.014 170.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 29.3 m -83.66 -27.9 7.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -171.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 43.6 t -175.2 166.01 3.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.667 0.27 . . . . 0.0 110.573 -176.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.478 ' C ' HD12 ' A' ' 10' ' ' LEU . 3.2 pp -146.27 152.25 38.86 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 172.383 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 22.9 p -129.72 144.73 54.13 Favored Pre-proline 0 C--N 1.322 -0.588 0 CA-C-N 116.693 -0.231 . . . . 0.0 110.506 177.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -90.53 162.68 32.36 Favored 'Cis proline' 0 N--CA 1.457 -0.622 0 C-N-CA 123.283 -1.549 . . . . 0.0 112.365 -2.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 30.7 m -91.74 9.72 3.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.63 0.728 . . . . 0.0 110.398 177.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.545 HG22 ' HA ' ' A' ' 107' ' ' LEU . 0.2 OUTLIER -142.29 122.22 13.61 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.223 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.43 HG21 ' CZ3' ' A' ' 69' ' ' TRP . 21.1 m -121.19 160.32 22.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -168.084 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.457 ' HA ' ' HD3' ' A' ' 17' ' ' PRO . 45.4 t -91.99 118.85 68.42 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.057 178.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.577 ' HA ' ' CB ' ' A' ' 71' ' ' LEU . 5.7 Cg_exo -77.79 16.14 1.17 Allowed 'Trans proline' 0 CA--C 1.53 0.318 0 C-N-CA 122.931 2.421 . . . . 0.0 113.455 -176.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.452 ' H ' HG12 ' A' ' 16' ' ' VAL . 51.3 m-80 -122.61 16.16 10.33 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 121.009 -0.276 . . . . 0.0 111.628 -175.277 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 14.3 t -169.68 178.77 3.98 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 110.408 -0.219 . . . . 0.0 110.408 -179.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 45.2 t -85.07 125.3 40.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 176.013 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.492 ' ND2' HD23 ' A' ' 71' ' ' LEU . 28.0 m-80 -97.5 124.22 41.65 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.673 -175.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 23.8 m -80.95 105.43 12.17 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.564 -0.743 . . . . 0.0 109.52 175.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.439 ' HB2' ' HB2' ' A' ' 67' ' ' PHE . 42.0 mtp -102.69 136.53 42.34 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.36 -176.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.444 ' HA ' ' O ' ' A' ' 65' ' ' VAL . 22.0 m -115.33 103.74 11.1 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.863 -177.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -89.36 141.09 28.85 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.411 177.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 19.2 m -104.39 109.13 20.86 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.079 0.466 . . . . 0.0 110.376 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 14.3 mm -101.9 118.32 48.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.284 179.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -110.35 131.43 55.06 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 120.754 0.311 . . . . 0.0 110.698 -177.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 35.9 t30 -89.32 98.83 11.99 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.211 -0.449 . . . . 0.0 109.871 177.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -94.14 40.37 1.08 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.982 -174.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -143.96 147.36 18.62 Favored Glycine 0 N--CA 1.444 -0.831 0 N-CA-C 110.631 -0.987 . . . . 0.0 110.631 179.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -84.34 60.5 6.02 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.349 0.595 . . . . 0.0 111.157 -172.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.563 ' HD3' ' HD3' ' A' ' 3' ' ' PRO . 64.4 tttp -161.45 137.51 8.05 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.027 170.373 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -76.44 132.9 39.91 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.242 -176.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 58.7 p -95.69 145.1 25.54 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.144 0.497 . . . . 0.0 111.032 -176.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 24.1 p -86.47 -162.22 0.74 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.729 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.449 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 32.6 t -56.96 125.53 23.03 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 120.901 0.382 . . . . 0.0 111.085 178.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.558 ' HB2' ' HB2' ' A' ' 85' ' ' ASP . 42.6 p90 -138.32 143.66 40.04 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 177.354 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.568 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 65.2 t30 -102.55 115.56 30.83 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 121.048 -0.261 . . . . 0.0 111.422 -172.318 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.568 HG22 ' HA ' ' A' ' 84' ' ' VAL . 2.0 t -102.49 125.9 56.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.098 0.475 . . . . 0.0 110.566 -176.385 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.533 ' HB3' HG23 ' A' ' 51' ' ' THR . 52.5 p -117.66 138.27 52.09 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.914 -177.255 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 59.5 tp -96.46 107.8 20.26 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 176.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.456 ' HG ' HG22 ' A' ' 48' ' ' VAL . 4.6 mp -96.94 118.64 33.79 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.264 -179.099 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.527 HG22 ' HG ' ' A' ' 80' ' ' LEU . 95.8 t -100.87 102.08 12.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.083 178.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 59.29 22.45 10.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.374 -0.83 . . . . 0.0 112.399 176.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 121.81 -26.75 6.42 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.464 -0.874 . . . . 0.0 113.002 176.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 11.9 mm -97.85 148.6 5.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 -178.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.456 HG22 ' HG ' ' A' ' 43' ' ' LEU . 39.5 t -98.4 110.7 26.44 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 -179.383 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 28.7 m -91.53 -31.52 4.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.766 -175.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -148.95 139.82 22.85 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.676 0.274 . . . . 0.0 110.298 -177.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.533 HG23 ' HB3' ' A' ' 41' ' ' SER . 2.1 m -133.87 121.6 21.98 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.112 -0.495 . . . . 0.0 109.682 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -128.28 114.96 17.58 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.085 0.469 . . . . 0.0 110.297 -178.108 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.568 ' HA ' ' HA ' ' A' ' 39' ' ' ASN . 21.8 m -76.97 131.4 38.47 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.365 178.537 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.449 ' O ' ' HA ' ' A' ' 37' ' ' SER . 38.6 t -101.95 121.41 52.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 177.017 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.6 m -59.7 -36.16 75.96 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -174.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 21.2 t -172.53 152.46 2.63 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.959 0.409 . . . . 0.0 111.262 179.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.633 HD13 ' OG1' ' A' ' 63' ' ' THR . 23.3 tp -140.07 114.34 9.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.82 175.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -70.27 173.06 7.18 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.468 0.652 . . . . 0.0 112.035 -175.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 10.0 m -63.89 129.66 40.97 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.686 178.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 61.99 19.42 10.75 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.903 -0.59 . . . . 0.0 112.229 176.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -101.24 158.54 15.96 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 178.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 7.1 m -121.52 125.38 46.67 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.136 179.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.633 ' OG1' HD13 ' A' ' 57' ' ' LEU . 86.1 m -103.96 135.94 44.53 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.892 0.377 . . . . 0.0 110.973 -179.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -92.85 119.8 32.55 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.762 174.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.444 ' O ' ' HA ' ' A' ' 24' ' ' THR . 40.7 t -96.24 135.06 31.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.441 -177.34 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -96.39 112.13 23.98 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.579 -176.25 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.439 ' HB2' ' HB2' ' A' ' 23' ' ' MET . 36.1 m-85 -112.37 140.01 47.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.785 0.326 . . . . 0.0 111.016 177.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 22.0 m170 -115.86 97.46 6.12 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 176.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . 0.43 ' CZ3' HG21 ' A' ' 15' ' ' VAL . 18.6 t90 -108.65 114.38 28.14 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.17 0.509 . . . . 0.0 111.622 -173.511 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 9.7 m -82.88 123.9 29.83 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.05 176.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.577 ' CB ' ' HA ' ' A' ' 17' ' ' PRO . 1.0 OUTLIER -83.89 123.17 29.66 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.163 0.506 . . . . 0.0 111.756 -178.573 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 19.3 p-10 -79.19 -43.42 23.92 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.755 175.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 89.39 40.0 6.18 Favored Glycine 0 N--CA 1.45 -0.37 0 CA-C-N 115.772 -0.649 . . . . 0.0 113.152 176.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 18.2 m -99.39 -13.95 19.36 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.207 0.527 . . . . 0.0 110.524 178.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -145.04 152.5 40.22 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.567 178.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -90.09 -10.11 45.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.158 0.504 . . . . 0.0 110.645 179.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 24.7 m -140.53 121.52 14.61 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.316 179.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -116.32 153.31 32.21 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.252 179.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.422 ' HA ' HD23 ' A' ' 103' ' ' LEU . 4.4 m -96.54 89.59 5.06 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.881 179.125 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.527 ' HG ' HG22 ' A' ' 44' ' ' VAL . 10.7 mp -87.55 113.02 22.86 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.477 0.656 . . . . 0.0 110.256 -178.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.495 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 5.4 m -115.97 113.51 23.36 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.6 -173.209 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 59.9 t -87.55 109.16 19.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 116.311 -0.404 . . . . 0.0 109.94 177.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -105.83 120.78 42.61 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.135 0.493 . . . . 0.0 109.849 176.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.568 ' HA ' HG22 ' A' ' 40' ' ' VAL . 83.5 t -85.37 111.95 21.52 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.621 -175.601 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.558 ' HB2' ' HB2' ' A' ' 38' ' ' PHE . 20.6 t70 57.8 86.85 0.15 Allowed Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 114.294 -1.321 . . . . 0.0 112.92 173.493 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_exo -72.92 -9.0 23.18 Favored 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 122.797 2.331 . . . . 0.0 111.26 174.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -82.52 -27.12 31.9 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.27 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 10.2 m120 56.99 52.57 9.05 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.505 -177.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -83.98 -25.64 29.86 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.981 -1.009 . . . . 0.0 109.936 179.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 40.3 t -100.4 136.9 29.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.802 177.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.603 ' O ' ' HD2' ' A' ' 3' ' ' PRO . 43.8 m-80 -75.05 112.04 10.88 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 173.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.442 ' CD ' HD21 ' A' ' 98' ' ' ASN . 33.9 mt-10 -114.6 152.64 31.5 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 120.896 0.379 . . . . 0.0 111.752 -173.382 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -57.7 -101.09 0.01 OUTLIER Glycine 0 CA--C 1.519 0.326 0 CA-C-N 115.071 -0.968 . . . . 0.0 113.956 179.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -88.83 124.29 34.04 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.543 0.211 . . . . 0.0 111.015 -173.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -61.11 -33.76 73.88 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -174.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 10.9 p -75.05 -1.94 25.14 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.934 0.397 . . . . 0.0 111.398 -177.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.538 ' HB3' HG22 ' A' ' 6' ' ' VAL . 7.6 m-20 -91.7 -13.55 31.52 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.52 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.442 HD21 ' CD ' ' A' ' 92' ' ' GLU . 10.8 m120 -69.8 -18.02 63.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.903 -0.589 . . . . 0.0 112.257 -177.464 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 1.2 m -123.04 147.91 46.16 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.326 0.584 . . . . 0.0 112.102 -170.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.495 ' O ' ' HA ' ' A' ' 81' ' ' THR . 29.4 tp -131.89 104.61 6.96 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.096 -0.957 . . . . 0.0 109.694 178.52 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 7.0 m -87.98 99.47 12.18 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.277 178.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -113.62 148.85 35.49 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.91 0.386 . . . . 0.0 111.11 -178.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.422 HD23 ' HA ' ' A' ' 79' ' ' THR . 51.8 mt -112.83 120.46 41.53 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.384 178.535 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.446 HG22 HD13 ' A' ' 80' ' ' LEU . 27.8 m -110.19 156.78 11.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.371 -178.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.53 ' O ' ' HA ' ' A' ' 14' ' ' THR . . . -122.89 169.98 15.32 Favored Glycine 0 N--CA 1.442 -0.955 0 C-N-CA 120.292 -0.956 . . . . 0.0 111.468 179.153 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 27.3 p -81.47 139.28 35.29 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 174.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.545 ' HA ' HG22 ' A' ' 14' ' ' THR . 32.9 tp -54.67 120.34 6.6 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.033 0.444 . . . . 0.0 111.907 -172.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -59.69 -30.83 69.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.152 176.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.541 ' H ' ' HG ' ' A' ' 107' ' ' LEU . 35.9 p-80 46.61 80.48 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.231 0 O-C-N 124.484 1.115 . . . . 0.0 110.795 -172.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 64.0 m170 -66.48 -18.75 65.54 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 114.909 -1.042 . . . . 0.0 110.63 -177.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 30.9 m170 -80.11 100.46 8.23 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 171.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 19.4 m80 -91.48 99.55 12.47 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.257 0.551 . . . . 0.0 111.44 -176.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 15.2 p-80 -76.33 -18.78 58.76 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 169.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 77.2 t60 . . . . . 0 C--O 1.245 0.826 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.099 175.747 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 71.8 mtm . . . . . 0 N--CA 1.48 1.03 0 CA-C-O 120.85 0.357 . . . . 0.0 110.907 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 10.7 tt -143.68 137.36 14.33 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-O 120.78 0.324 . . . . 0.0 110.479 -178.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.444 ' HA ' ' HA3' ' A' ' 31' ' ' GLY . 88.2 Cg_endo -95.75 169.93 1.27 Allowed 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 123.09 2.527 . . . . 0.0 113.196 175.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.402 ' O ' ' HA ' ' A' ' 29' ' ' ASN . 5.5 m-20 -136.42 104.33 5.56 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.089 171.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.475 HD22 HD23 ' A' ' 57' ' ' LEU . 85.4 mt -89.69 90.79 8.38 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.34 0.59 . . . . 0.0 109.949 -176.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.489 ' HA ' ' HD2' ' A' ' 7' ' ' PRO . 25.0 t -104.24 111.73 65.25 Favored Pre-proline 0 C--N 1.319 -0.756 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.116 -174.155 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.524 ' HB2' HD22 ' A' ' 100' ' ' LEU . 18.5 Cg_endo -62.18 119.01 5.91 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 122.244 1.963 . . . . 0.0 109.956 169.099 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.5 t -91.0 -47.67 14.31 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.848 -168.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.9 t -160.67 173.68 15.1 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.489 -178.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 55.7 tp -136.46 127.74 28.22 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.83 -178.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.536 ' OG1' ' HA ' ' A' ' 12' ' ' PRO . 14.0 t -140.48 149.2 56.54 Favored Pre-proline 0 C--N 1.322 -0.589 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.536 ' HA ' ' OG1' ' A' ' 11' ' ' THR . 72.3 Cg_endo -76.56 148.12 88.33 Favored 'Cis proline' 0 N--CA 1.464 -0.251 0 C-N-CA 123.393 -1.503 . . . . 0.0 112.745 0.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 34.7 m -72.9 -22.35 19.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.724 177.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.622 ' HA ' ' O ' ' A' ' 105' ' ' GLY . 17.0 p -114.24 129.33 56.63 Favored 'General case' 0 N--CA 1.439 -1.016 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.164 174.17 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.499 HG11 ' CZ3' ' A' ' 69' ' ' TRP . 18.0 m -113.52 149.41 15.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.165 0.507 . . . . 0.0 111.923 -173.254 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 27.2 t -90.2 113.35 57.01 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.034 -179.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -83.27 42.09 1.2 Allowed 'Trans proline' 0 CA--C 1.53 0.289 0 C-N-CA 122.974 2.449 . . . . 0.0 113.384 -175.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -156.72 27.92 0.33 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.999 0.428 . . . . 0.0 110.984 177.055 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 11.2 t -170.99 -177.06 2.12 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.001 179.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 59.0 t -90.02 118.86 36.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.035 0.445 . . . . 0.0 109.91 177.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 44.8 m-80 -89.8 126.57 35.73 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.482 -178.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 17.8 m -80.04 89.0 5.35 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.527 175.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.558 ' HB2' ' HB2' ' A' ' 67' ' ' PHE . 91.3 mmm -79.38 113.21 17.34 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.925 -0.579 . . . . 0.0 109.607 -176.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.5 ' CG2' ' HB3' ' A' ' 64' ' ' ASN . 26.4 m -102.11 112.8 25.6 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.431 -175.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -101.21 124.05 46.3 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.38 179.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 25.0 m -86.12 110.6 19.66 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.285 179.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 19.8 mm -107.64 120.79 59.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 178.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -115.41 127.59 55.47 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.878 0.37 . . . . 0.0 110.889 -179.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.402 ' HA ' ' O ' ' A' ' 4' ' ' ASP . 25.2 t30 -89.86 103.8 16.42 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.844 177.293 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 -99.51 56.73 1.01 Allowed 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.621 -175.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.444 ' HA3' ' HA ' ' A' ' 3' ' ' PRO . . . -144.05 170.73 25.81 Favored Glycine 0 N--CA 1.448 -0.527 0 N-CA-C 111.521 -0.632 . . . . 0.0 111.521 -179.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 7.6 p-10 -86.84 0.97 53.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.04 0.448 . . . . 0.0 110.92 -174.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -120.91 132.33 54.9 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.51 -179.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -66.76 139.93 57.83 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.619 173.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.448 ' OG ' HD21 ' A' ' 5' ' ' LEU . 15.7 p -100.87 136.22 41.07 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.622 177.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.602 ' O ' ' HA ' ' A' ' 56' ' ' SER . 2.0 m -82.41 -128.02 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 120.91 -0.316 . . . . 0.0 110.246 -179.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.406 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 9.7 t -90.71 121.43 32.6 Favored 'General case' 0 C--N 1.323 -0.554 0 O-C-N 121.786 -0.571 . . . . 0.0 111.399 -172.222 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -128.92 142.04 51.08 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.624 -0.717 . . . . 0.0 109.361 176.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.676 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 64.1 t30 -90.31 120.13 31.19 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 120.832 0.349 . . . . 0.0 110.234 -176.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.483 HG11 HG11 ' A' ' 65' ' ' VAL . 0.3 OUTLIER -106.46 147.29 12.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -176.259 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 9.9 p -137.8 139.43 40.0 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 120.756 -0.378 . . . . 0.0 111.479 -175.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 62.2 tp -105.47 111.31 23.98 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.705 175.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.416 ' HG ' HG22 ' A' ' 48' ' ' VAL . 4.2 mp -98.55 141.49 31.33 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.936 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.412 HG22 ' HG ' ' A' ' 80' ' ' LEU . 87.4 t -123.83 106.09 16.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 176.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 57.53 23.49 9.25 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 115.791 -0.641 . . . . 0.0 112.083 178.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 120.99 -33.09 4.52 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.907 176.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 11.2 mm -90.89 149.25 4.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 -177.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.416 HG22 ' HG ' ' A' ' 43' ' ' LEU . 39.0 t -96.66 110.39 24.72 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 179.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 26.7 m -90.98 -25.69 5.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.686 -175.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -147.34 145.15 29.22 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 -178.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 22.1 m -141.74 113.52 7.86 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.076 0.465 . . . . 0.0 109.961 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.407 ' O ' HG12 ' A' ' 40' ' ' VAL . 0.1 OUTLIER -122.99 116.36 23.42 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.794 -174.922 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.676 ' HA ' ' HA ' ' A' ' 39' ' ' ASN . 8.6 m -80.69 112.64 18.25 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 176.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.406 ' O ' ' HA ' ' A' ' 37' ' ' SER . 49.2 t -77.6 133.27 30.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 -178.53 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 26.3 m -63.74 -43.74 95.59 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.614 -175.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.602 ' HA ' ' O ' ' A' ' 36' ' ' THR . 38.7 t -177.36 151.11 0.75 Allowed 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 -178.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.475 HD23 HD22 ' A' ' 5' ' ' LEU . 26.5 tp -131.04 121.76 25.58 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.836 177.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.414 ' HB2' ' HB3' ' A' ' 61' ' ' ASN . 24.5 mt-10 -71.16 163.07 28.34 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.52 -0.764 . . . . 0.0 112.124 -174.274 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 4.9 m -67.16 124.09 22.12 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.814 178.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 63.46 20.56 12.32 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.956 176.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.414 ' HB3' ' HB2' ' A' ' 58' ' ' GLU . 56.1 t30 -113.26 153.0 29.12 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 177.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.3 m -109.0 133.33 53.12 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.872 0.367 . . . . 0.0 110.286 -179.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.42 ' HB ' HD13 ' A' ' 57' ' ' LEU . 20.5 m -123.62 127.32 48.09 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.115 177.35 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.5 ' HB3' ' CG2' ' A' ' 24' ' ' THR . 56.7 m-80 -90.22 135.14 33.85 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.409 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.483 HG11 HG11 ' A' ' 40' ' ' VAL . 13.7 t -96.4 138.57 21.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.862 -176.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -94.55 97.2 9.97 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.921 -179.079 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.558 ' HB2' ' HB2' ' A' ' 23' ' ' MET . 67.5 m-85 -98.69 145.78 26.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.364 176.692 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 35.6 m-70 -114.99 100.95 8.57 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.221 0.534 . . . . 0.0 110.827 179.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . 0.499 ' CZ3' HG11 ' A' ' 15' ' ' VAL . 10.2 t90 -103.22 98.01 8.01 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.483 -177.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 18.8 m -74.03 100.33 3.55 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 175.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 28.5 tp -107.7 106.6 17.0 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.211 0.529 . . . . 0.0 111.391 -172.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -78.2 -19.85 53.02 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.172 175.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 89.8 87.27 1.3 Allowed Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.519 177.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 11.6 m -106.64 -33.74 7.55 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.024 0.44 . . . . 0.0 110.329 178.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -134.47 175.69 9.3 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.055 -0.521 . . . . 0.0 109.93 178.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.454 ' HA ' HG23 ' A' ' 106' ' ' THR . 31.7 p-10 -107.84 -8.88 15.87 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.03 0.443 . . . . 0.0 110.935 -179.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 3.2 p -137.2 116.81 12.94 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.345 -179.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -118.01 142.83 46.95 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.967 -178.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 25.5 m -99.21 94.32 6.42 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.051 179.172 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.497 HD13 HG22 ' A' ' 104' ' ' VAL . 10.2 mp -91.96 136.88 32.82 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.325 0.583 . . . . 0.0 110.777 -177.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.477 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 23.6 m -131.86 123.59 27.82 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.155 -178.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 46.8 t -95.4 108.84 21.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 177.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -100.06 119.51 38.4 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.47 HG21 ' HD3' ' A' ' 7' ' ' PRO . 88.6 t -92.52 106.36 17.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.735 -176.393 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 45.5 t0 62.38 92.67 0.06 OUTLIER Pre-proline 0 C--N 1.33 -0.272 0 O-C-N 124.276 0.985 . . . . 0.0 112.084 177.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -94.05 15.82 1.22 Allowed 'Trans proline' 0 N--CA 1.451 -0.996 0 C-N-CA 123.101 2.534 . . . . 0.0 111.839 174.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -125.5 -1.97 7.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.731 -174.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 65.5 t30 61.21 51.46 4.34 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.453 0.644 . . . . 0.0 110.714 177.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -89.33 -34.7 16.46 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.841 177.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 63.9 t -119.09 115.33 47.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.186 177.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 59.1 t30 -79.77 133.29 36.31 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 177.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -122.06 172.81 7.97 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.153 0.501 . . . . 0.0 112.27 -174.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -57.72 -100.82 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.526 0 CA-C-N 114.55 -1.205 . . . . 0.0 112.023 169.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -63.54 153.24 36.28 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.918 0.389 . . . . 0.0 110.684 178.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -98.62 -3.53 35.95 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.648 0.737 . . . . 0.0 109.817 176.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 8.3 p -87.3 -4.39 59.06 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.62 178.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.419 ' O ' ' HD2' ' A' ' 7' ' ' PRO . 55.3 m-20 -70.62 -35.54 73.01 Favored 'General case' 0 C--O 1.223 -0.303 0 CA-C-O 121.062 0.458 . . . . 0.0 110.244 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.467 ' HA ' ' HB ' ' A' ' 84' ' ' VAL . 13.1 m120 -72.34 18.87 0.08 Allowed 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 -165.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 1.8 m -150.38 149.81 30.56 Favored 'General case' 0 C--N 1.323 -0.552 0 O-C-N 121.883 -0.511 . . . . 0.0 111.345 -179.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.524 HD22 ' HB2' ' A' ' 7' ' ' PRO . 41.9 tp -152.46 100.95 2.62 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.61 176.016 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 61.8 m -92.94 113.38 25.64 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.365 178.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -130.14 134.13 47.11 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.777 -179.336 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 76.3 mt -85.6 126.17 33.69 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.638 178.321 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.497 HG22 HD13 ' A' ' 80' ' ' LEU . 19.1 m -116.86 147.05 20.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.581 177.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.622 ' O ' ' HA ' ' A' ' 14' ' ' THR . . . -123.72 164.08 17.05 Favored Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 120.495 -0.859 . . . . 0.0 111.389 -177.494 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.454 HG23 ' HA ' ' A' ' 76' ' ' ASN . 35.3 p -70.59 150.19 46.31 Favored 'General case' 0 C--N 1.317 -0.807 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.739 178.203 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.522 ' HA ' ' HB ' ' A' ' 14' ' ' THR . 39.1 tp -51.66 121.82 7.11 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.644 -177.316 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -62.23 -64.87 0.8 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.771 -177.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 12.3 m170 -79.39 101.36 8.09 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 173.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 54.3 m80 -65.19 131.45 46.56 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.877 -172.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 33.9 m170 -121.22 136.98 54.88 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.623 178.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 69.1 m80 -113.63 143.93 43.76 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.706 -178.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 14.8 m-70 -96.17 99.51 11.23 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.736 177.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 24.7 t60 . . . . . 0 C--O 1.245 0.82 0 CA-C-O 118.496 -0.764 . . . . 0.0 109.662 -178.94 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.5 mtt . . . . . 0 N--CA 1.479 0.98 0 CA-C-O 121.168 0.508 . . . . 0.0 111.031 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 15.9 tt -144.08 135.75 12.87 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.514 177.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.57 ' HD2' ' O ' ' A' ' 91' ' ' ASN . 8.0 Cg_exo -73.22 161.69 42.38 Favored 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 122.553 2.169 . . . . 0.0 112.309 177.004 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -145.45 92.83 2.28 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 175.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.566 HD22 HD23 ' A' ' 57' ' ' LEU . 60.8 mt -90.72 101.24 13.99 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.47 0.652 . . . . 0.0 110.801 -169.142 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 22.5 t -104.49 112.18 65.33 Favored Pre-proline 0 C--N 1.318 -0.798 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.471 -174.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.518 ' HB2' ' HB2' ' A' ' 100' ' ' LEU . 33.1 Cg_endo -67.65 103.11 0.79 Allowed 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 121.941 1.76 . . . . 0.0 109.776 166.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 6.6 t -80.77 -49.18 18.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.315 -167.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 55.6 m -148.64 165.96 29.74 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.877 0.37 . . . . 0.0 111.312 -177.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.511 HD23 ' HB3' ' A' ' 102' ' ' ALA . 31.0 tp -139.8 104.33 4.86 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.654 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 21.5 p -123.71 145.26 46.87 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.28 -175.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -81.89 155.96 79.79 Favored 'Cis proline' 0 C--N 1.342 0.19 0 C-N-CA 123.723 -1.366 . . . . 0.0 112.015 -2.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 33.9 m -83.62 -11.47 11.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.892 0.377 . . . . 0.0 111.52 -177.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -116.72 126.88 53.8 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.82 0.343 . . . . 0.0 110.077 173.46 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.413 HG11 ' CZ3' ' A' ' 69' ' ' TRP . 34.7 m -113.52 165.39 8.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 120.896 0.379 . . . . 0.0 111.16 -176.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.432 ' HA ' ' HD3' ' A' ' 17' ' ' PRO . 4.9 t -110.15 117.61 51.27 Favored Pre-proline 0 C--N 1.324 -0.531 0 N-CA-C 109.524 -0.546 . . . . 0.0 109.524 177.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.471 ' HA ' ' HG ' ' A' ' 71' ' ' LEU . 7.1 Cg_exo -73.59 31.27 0.32 Allowed 'Trans proline' 0 CA--C 1.533 0.465 0 C-N-CA 123.295 2.664 . . . . 0.0 112.716 -178.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -105.82 -29.34 10.09 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.124 -176.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 8.9 t -151.21 178.62 9.05 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.159 -170.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 92.5 t -73.44 120.76 22.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 176.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 36.8 m-80 -92.49 123.91 36.14 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.345 -176.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.435 ' HA ' ' O ' ' A' ' 67' ' ' PHE . 24.9 m -89.88 96.29 10.62 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 177.567 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 86.5 mtp -97.23 135.87 38.55 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.459 -176.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.584 ' HA ' ' O ' ' A' ' 65' ' ' VAL . 31.3 m -108.46 115.78 30.74 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.873 -176.429 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -105.53 120.45 41.65 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.017 176.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 28.4 m -83.53 112.92 20.42 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 120.55 0.214 . . . . 0.0 110.458 -179.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.425 HD13 ' HA ' ' A' ' 7' ' ' PRO . 21.5 mm -103.3 120.01 52.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 177.249 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -116.22 126.47 53.67 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.772 0.32 . . . . 0.0 110.632 -177.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.438 ' HB2' ' HG ' ' A' ' 57' ' ' LEU . 33.1 t30 -90.03 101.77 14.48 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.134 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -103.39 54.3 0.75 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.515 -175.164 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -144.02 169.19 26.29 Favored Glycine 0 N--CA 1.447 -0.589 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.375 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -91.09 45.41 1.25 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.257 0.551 . . . . 0.0 110.885 -173.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 46.1 tptt -161.51 135.18 6.59 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.038 176.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -83.85 124.9 31.43 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 178.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 9.5 p -86.2 143.83 27.77 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.9 0.381 . . . . 0.0 111.402 -175.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 12.6 p -81.74 -164.13 0.75 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.967 -179.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.498 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 17.5 m -61.32 114.85 3.41 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 121.08 0.467 . . . . 0.0 111.562 -177.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.512 ' CE2' HG23 ' A' ' 40' ' ' VAL . 22.2 p90 -127.64 154.12 45.63 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.249 178.419 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.474 ' O ' ' HD3' ' A' ' 86' ' ' PRO . 55.1 m-80 -100.46 125.93 46.81 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.881 0.372 . . . . 0.0 110.984 -178.252 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.512 HG23 ' CE2' ' A' ' 38' ' ' PHE . 2.3 t -108.21 111.31 35.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-O 121.333 0.587 . . . . 0.0 109.453 177.399 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.517 ' HB3' HG23 ' A' ' 51' ' ' THR . 24.0 p -109.76 140.91 43.11 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.367 -174.11 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.403 HD11 ' HB3' ' A' ' 80' ' ' LEU . 52.7 tp -101.49 114.73 29.01 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.103 177.169 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.7 mp -101.18 126.45 47.9 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.243 179.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 86.2 t -104.87 104.07 16.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 116.148 -0.478 . . . . 0.0 109.873 178.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 57.18 28.89 15.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.411 178.039 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 107.46 -18.5 35.38 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.854 -0.688 . . . . 0.0 112.822 177.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 6.3 mm -95.44 148.16 5.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 -178.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 96.7 t -97.99 113.52 32.81 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-O 121.076 0.465 . . . . 0.0 110.126 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 27.9 m -96.77 -38.86 8.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.445 -177.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -153.16 143.2 22.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.855 0.359 . . . . 0.0 110.941 -175.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.517 HG23 ' HB3' ' A' ' 41' ' ' SER . 41.3 m -136.38 120.5 17.75 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.992 -179.281 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 45.8 tt0 -106.5 137.22 44.89 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.766 0.317 . . . . 0.0 110.377 -178.009 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 18.0 m -97.56 114.88 26.87 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.195 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.498 ' O ' ' HA ' ' A' ' 37' ' ' SER . 23.5 t -91.03 120.7 40.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.7 m -56.11 -43.15 77.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.58 -177.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 44.0 t -172.88 150.5 2.07 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.997 -0.372 . . . . 0.0 109.997 -179.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.566 HD23 HD22 ' A' ' 5' ' ' LEU . 28.3 tp -133.63 112.54 11.53 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 176.127 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -83.23 162.08 21.32 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.377 -174.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 5.8 p -65.5 138.36 58.03 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.073 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 68.66 5.72 5.06 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 123.183 0.593 . . . . 0.0 111.218 -179.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -103.48 147.56 27.0 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.874 0.369 . . . . 0.0 110.419 179.081 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 2.9 p -121.57 122.69 40.23 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.26 177.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 33.5 m -104.1 126.01 50.88 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.502 -179.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.436 ' HB3' ' CG2' ' A' ' 24' ' ' THR . 90.8 m-20 -83.15 117.87 23.2 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.894 177.353 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.584 ' O ' ' HA ' ' A' ' 24' ' ' THR . 44.8 t -96.02 115.8 36.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.964 -176.148 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 40.4 m-20 -96.67 108.21 20.79 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.748 0.309 . . . . 0.0 110.351 -179.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.435 ' O ' ' HA ' ' A' ' 22' ' ' THR . 65.3 m-85 -91.34 154.97 18.85 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 120.932 0.396 . . . . 0.0 110.097 179.463 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 50.7 m-70 -114.74 88.28 2.83 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 176.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . 0.413 ' CZ3' HG11 ' A' ' 15' ' ' VAL . 15.1 t90 -98.28 111.18 23.61 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.449 -172.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 7.3 m -86.06 118.65 25.66 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 170.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.561 HD11 ' CZ ' ' A' ' 78' ' ' TYR . 0.1 OUTLIER -55.2 -43.82 74.77 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.454 0.539 . . . . 0.0 112.454 -167.947 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.42 ' HB3' ' O ' ' A' ' 71' ' ' LEU . 31.5 t70 71.46 4.21 4.97 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.534 0.683 . . . . 0.0 110.997 176.002 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 179.18 -158.78 23.1 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 121.084 -0.579 . . . . 0.0 111.996 179.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 85.2 m -155.16 94.93 1.67 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.139 0.495 . . . . 0.0 110.344 177.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.412 ' HB3' ' CE1' ' A' ' 78' ' ' TYR . . . -112.51 172.31 7.0 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.111 175.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -79.15 -30.17 43.44 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.451 -0.5 . . . . 0.0 110.534 -178.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.499 ' HB2' HD21 ' A' ' 103' ' ' LEU . 70.7 p -150.91 157.94 43.53 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.283 -178.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.561 ' CZ ' HD11 ' A' ' 71' ' ' LEU . 27.9 m-85 -136.64 152.4 50.38 Favored 'General case' 0 C--N 1.328 -0.331 0 O-C-N 123.152 0.282 . . . . 0.0 110.487 -179.397 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 4.4 m -103.22 89.36 3.38 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.92 0.391 . . . . 0.0 110.219 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.523 HD13 HG22 ' A' ' 104' ' ' VAL . 9.4 mp -92.47 122.36 34.83 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.246 0.546 . . . . 0.0 111.189 -175.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.515 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 73.2 m -120.43 119.76 33.97 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.647 -179.628 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.417 ' HB ' ' HB3' ' A' ' 100' ' ' LEU . 98.9 t -85.63 107.85 16.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 174.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -95.31 113.9 25.62 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.172 177.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.569 ' HB ' ' HB2' ' A' ' 98' ' ' ASN . 96.2 t -85.48 111.25 20.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.614 179.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 56.5 t0 62.89 95.49 0.05 OUTLIER Pre-proline 0 N--CA 1.467 0.424 0 CA-C-N 114.825 -1.08 . . . . 0.0 112.236 178.143 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.474 ' HD3' ' O ' ' A' ' 39' ' ' ASN . 2.2 Cg_endo -85.41 1.55 8.21 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 123.167 2.578 . . . . 0.0 111.832 175.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -98.97 -20.29 16.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.095 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 15.3 m120 64.8 33.64 10.05 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.218 -178.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -73.23 -37.09 66.52 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.402 177.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 43.7 t -96.65 118.0 42.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.192 178.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.57 ' O ' ' HD2' ' A' ' 3' ' ' PRO . 53.6 t30 -85.7 135.7 33.65 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 175.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.4 ' OE2' ' HB3' ' A' ' 98' ' ' ASN . 40.6 mt-10 -115.71 159.4 21.44 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.246 0.546 . . . . 0.0 112.383 -171.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -57.96 -100.59 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 114.613 -1.176 . . . . 0.0 112.501 172.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 39.7 t30 -68.4 96.52 0.68 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.68 0.276 . . . . 0.0 110.325 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -73.97 78.76 1.67 Allowed 'General case' 0 C--O 1.233 0.226 0 CA-C-O 121.475 0.655 . . . . 0.0 110.39 -176.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 20.9 t -179.29 25.46 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.61 -1.177 . . . . 0.0 108.814 176.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 24.1 p-10 -118.68 -28.11 5.71 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.596 -170.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.569 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 22.4 p-10 -68.88 0.34 4.54 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -169.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -119.92 118.38 30.58 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.157 0.503 . . . . 0.0 111.521 178.613 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.518 ' HB2' ' HB2' ' A' ' 7' ' ' PRO . 26.3 tp -111.34 99.94 8.65 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.759 176.518 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 96.2 m -93.74 97.36 10.39 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.502 0.668 . . . . 0.0 110.104 178.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.511 ' HB3' HD23 ' A' ' 10' ' ' LEU . . . -107.99 115.73 30.67 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.166 -0.925 . . . . 0.0 109.589 178.628 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.499 HD21 ' HB2' ' A' ' 77' ' ' SER . 5.0 tt -78.65 101.39 7.46 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.523 HG22 HD13 ' A' ' 80' ' ' LEU . 29.9 m -90.57 158.78 2.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.219 -176.361 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -123.58 -170.88 13.47 Favored Glycine 0 N--CA 1.436 -1.317 0 C-N-CA 120.435 -0.888 . . . . 0.0 111.519 -178.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 18.6 p -107.95 140.05 41.67 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 177.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 47.6 tp -50.38 111.53 0.55 Allowed 'General case' 0 C--N 1.33 -0.247 0 O-C-N 123.576 0.547 . . . . 0.0 110.653 -177.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -61.35 -36.73 81.02 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.169 -176.106 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 63.4 t60 -90.06 79.72 6.46 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.146 0.498 . . . . 0.0 109.876 177.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 46.7 t-80 -80.59 142.19 34.29 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.172 178.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 36.4 m80 -73.29 176.79 5.63 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 10.2 m-70 -108.37 13.43 25.58 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.436 0.636 . . . . 0.0 110.312 178.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -136.91 -62.39 0.64 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.427 173.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 38.9 m-70 . . . . . 0 C--O 1.246 0.9 0 CA-C-O 118.485 -0.769 . . . . 0.0 109.607 173.994 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.532 ' SD ' ' HB2' ' A' ' 33' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.479 0.98 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.466 HG13 ' HD2' ' A' ' 3' ' ' PRO . 19.2 tt -144.37 146.17 31.91 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 115.762 -0.653 . . . . 0.0 110.241 -175.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.542 ' HD3' ' HD3' ' A' ' 33' ' ' LYS . 36.0 Cg_exo -60.9 136.53 66.5 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.411 2.074 . . . . 0.0 112.389 174.456 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -117.09 86.86 2.59 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 177.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.422 HD22 HD23 ' A' ' 57' ' ' LEU . 82.5 mt -82.1 107.96 15.2 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.332 -170.687 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.407 ' HA ' ' HD2' ' A' ' 7' ' ' PRO . 18.6 t -123.32 106.33 33.15 Favored Pre-proline 0 C--N 1.32 -0.702 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.984 -177.287 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.552 ' HD2' ' O ' ' A' ' 97' ' ' ASN . 11.2 Cg_endo -57.75 119.44 6.7 Favored 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 122.361 2.041 . . . . 0.0 110.465 167.596 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.9 t -93.16 -54.27 7.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.099 -169.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.8 p -150.79 154.36 37.17 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.051 0.453 . . . . 0.0 111.688 -177.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 49.8 tp -121.98 110.25 15.6 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.675 177.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 16.1 p -118.2 143.94 33.94 Favored Pre-proline 0 C--N 1.32 -0.71 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.949 -178.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -88.97 160.62 39.53 Favored 'Cis proline' 0 N--CA 1.458 -0.599 0 C-N-CA 123.372 -1.512 . . . . 0.0 112.414 -2.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 31.7 m -81.52 6.05 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.045 0.45 . . . . 0.0 111.343 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.406 ' HA ' ' O ' ' A' ' 105' ' ' GLY . 0.1 OUTLIER -141.96 129.77 21.71 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 176.776 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.488 HG21 HD21 ' A' ' 71' ' ' LEU . 17.3 m -121.9 153.1 25.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 -171.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.435 ' HA ' ' HD3' ' A' ' 17' ' ' PRO . 2.5 t -83.83 110.98 29.04 Favored Pre-proline 0 CA--C 1.533 0.296 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 -179.482 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 16' ' ' VAL . 6.3 Cg_exo -79.75 58.3 6.9 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 123.288 2.659 . . . . 0.0 113.803 -172.574 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.405 ' OD1' HG12 ' A' ' 16' ' ' VAL . 33.2 p-10 -163.0 13.43 0.07 Allowed 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 176.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 15.3 t -162.34 179.23 8.0 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.711 0.291 . . . . 0.0 110.371 -177.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.556 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 41.1 t -84.05 119.91 34.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 176.404 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.404 ' ND2' HD23 ' A' ' 71' ' ' LEU . 24.4 m-80 -100.33 114.29 27.68 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.27 -177.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.52 ' HA ' ' O ' ' A' ' 67' ' ' PHE . 33.5 m -79.52 90.15 5.09 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 176.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.633 ' O ' ' HA ' ' A' ' 66' ' ' ASP . 82.1 mtp -87.32 153.43 21.47 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.901 -176.02 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.476 ' CG2' ' HB3' ' A' ' 64' ' ' ASN . 10.9 m -115.72 112.99 22.87 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.313 -174.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -101.7 116.03 31.84 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 173.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 28.7 m -83.85 109.08 17.27 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.167 -178.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.426 HD11 HG11 ' A' ' 82' ' ' VAL . 27.7 mm -103.22 117.96 49.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.54 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 31.0 tt0 -111.09 135.5 51.52 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.147 0.498 . . . . 0.0 111.301 -177.268 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 25.5 t30 -97.17 95.07 7.5 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.536 -0.757 . . . . 0.0 109.354 176.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 64.6 mt-30 -87.96 51.06 2.11 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.362 0.601 . . . . 0.0 110.555 -175.104 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -144.39 168.17 26.77 Favored Glycine 0 N--CA 1.445 -0.755 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.196 -178.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.412 ' OD1' ' HA ' ' A' ' 1' ' ' MET . 31.4 p-10 -88.17 -1.98 58.33 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.806 0.336 . . . . 0.0 111.604 -173.105 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.542 ' HD3' ' HD3' ' A' ' 3' ' ' PRO . 85.1 tttt -111.27 128.74 56.03 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.773 0.32 . . . . 0.0 110.412 179.49 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -67.84 135.18 52.15 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.841 179.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.567 ' HB3' ' HB3' ' A' ' 57' ' ' LEU . 29.5 t -89.64 139.55 30.44 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.108 -178.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -88.22 -165.7 1.39 Allowed 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.717 179.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.428 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 31.9 m -61.01 119.38 8.18 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.961 0.41 . . . . 0.0 111.746 -177.479 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.497 ' CE2' HG23 ' A' ' 40' ' ' VAL . 24.4 p90 -135.06 155.72 50.26 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.887 179.523 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.5 ' HB2' ' HD2' ' A' ' 86' ' ' PRO . 15.1 m120 -99.21 117.31 33.4 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.747 -0.206 . . . . 0.0 110.855 -176.449 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.497 HG23 ' CE2' ' A' ' 38' ' ' PHE . 2.3 t -104.08 114.3 43.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 121.285 0.564 . . . . 0.0 109.779 175.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 19.4 p -110.57 138.32 47.12 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.573 -0.739 . . . . 0.0 111.135 -175.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 51.3 tp -98.06 117.92 33.5 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.015 177.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.9 mp -104.71 127.66 52.56 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.432 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 97.9 t -99.55 103.54 14.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.822 177.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 59.93 17.88 7.0 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.565 179.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 123.55 -26.91 5.88 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.744 -0.741 . . . . 0.0 113.036 177.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 6.2 mt -91.79 147.17 5.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.995 0.397 . . . . 0.0 110.173 -178.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 61.4 t -91.18 121.26 41.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-O 120.799 0.333 . . . . 0.0 110.437 -177.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 30.9 m -104.74 -28.01 3.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.541 -0.299 . . . . 0.0 111.639 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -151.15 138.84 19.72 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 121.127 -0.229 . . . . 0.0 110.537 -177.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 28.5 m -127.49 110.82 13.14 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 175.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.19 121.4 44.79 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.14 0.495 . . . . 0.0 110.304 -175.502 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 59.1 m -82.11 110.87 17.72 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.685 178.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.428 ' O ' ' HA ' ' A' ' 37' ' ' SER . 40.9 t -85.2 121.36 36.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 177.264 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -59.37 -39.87 84.68 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.863 -173.398 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 42.7 t -175.45 155.01 1.75 Allowed 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.567 ' HB3' ' HB3' ' A' ' 35' ' ' SER . 18.7 tp -130.74 110.74 11.57 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.185 0.517 . . . . 0.0 109.946 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.521 ' HB3' ' HB2' ' A' ' 61' ' ' ASN . 26.3 tt0 -61.65 149.61 38.91 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.55 -174.592 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.3 p -60.73 128.93 38.97 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.669 -179.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 60.98 25.41 15.44 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.012 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.521 ' HB2' ' HB3' ' A' ' 58' ' ' GLU . 17.9 m-80 -121.4 160.25 24.47 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.607 178.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.54 ' HA ' ' HA ' ' A' ' 28' ' ' GLU . 0.0 OUTLIER -116.07 144.13 44.54 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.399 178.58 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 19.6 m -121.52 134.05 55.04 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.385 177.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.476 ' HB3' ' CG2' ' A' ' 24' ' ' THR . 88.7 m-20 -88.86 115.62 26.54 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.494 -179.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 6.4 t -97.66 112.58 30.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.492 -178.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.633 ' HA ' ' O ' ' A' ' 23' ' ' MET . 16.7 m-20 -97.31 115.17 27.18 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.977 0.418 . . . . 0.0 110.772 -178.553 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.52 ' O ' ' HA ' ' A' ' 22' ' ' THR . 84.4 m-85 -91.97 165.19 13.34 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.246 -177.039 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 38.5 m-70 -114.78 87.73 2.71 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 175.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 16.4 t90 -110.33 113.01 25.33 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.284 0.564 . . . . 0.0 111.224 -176.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.556 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 5.7 m -81.69 114.05 20.1 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.015 176.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.488 HD21 HG21 ' A' ' 15' ' ' VAL . 0.5 OUTLIER -69.09 118.23 11.74 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.058 0.456 . . . . 0.0 111.329 -178.211 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -77.53 -34.76 53.82 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.845 177.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 83.47 15.63 70.8 Favored Glycine 0 C--N 1.329 0.194 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.661 176.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 22.9 m -75.81 -27.73 58.05 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.909 0.385 . . . . 0.0 111.013 -179.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -130.92 160.93 33.06 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.526 -178.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.437 ' HA ' HG23 ' A' ' 106' ' ' THR . 36.8 m-80 -101.9 -4.0 26.94 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.235 0.541 . . . . 0.0 110.452 177.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 37.3 m -144.71 118.38 9.2 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.022 177.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 81.1 m-85 -112.41 139.46 47.96 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.903 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.416 ' HA ' HD23 ' A' ' 103' ' ' LEU . 8.3 m -92.1 85.77 5.59 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.068 0.461 . . . . 0.0 109.949 179.184 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.437 HD13 HG22 ' A' ' 104' ' ' VAL . 7.6 mp -81.96 117.14 21.95 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.559 0.695 . . . . 0.0 110.979 -176.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.508 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 12.9 m -115.96 118.07 31.9 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.172 -177.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.426 HG11 HD11 ' A' ' 27' ' ' ILE . 66.5 t -87.81 110.25 20.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 177.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -98.91 112.65 24.69 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.885 0.374 . . . . 0.0 110.257 175.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.554 ' HB ' ' HB2' ' A' ' 98' ' ' ASN . 86.6 t -84.58 111.91 20.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.826 179.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 18.6 t0 65.38 96.04 0.05 OUTLIER Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 114.924 -1.034 . . . . 0.0 112.779 176.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.5 ' HD2' ' HB2' ' A' ' 39' ' ' ASN . 98.4 Cg_endo -95.16 6.05 2.21 Favored 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 123.186 2.59 . . . . 0.0 111.923 173.194 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -103.05 -11.39 18.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.615 -176.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 68.22 32.64 4.68 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.708 0.766 . . . . 0.0 109.555 -176.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -73.76 -38.57 64.67 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.987 177.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 65.7 t -128.92 115.06 35.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.17 -179.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -89.1 145.32 25.53 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 175.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -80.24 162.09 24.82 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.167 0.508 . . . . 0.0 111.962 -174.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -57.49 -100.56 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.558 0 N-CA-C 109.811 -1.315 . . . . 0.0 109.811 158.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -65.6 105.49 1.23 Allowed 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 170.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -77.81 68.75 3.93 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -169.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 48.3 m -165.91 18.64 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 111.821 0.304 . . . . 0.0 111.821 179.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.552 ' O ' ' HD2' ' A' ' 7' ' ' PRO . 44.9 m-80 -115.37 -18.83 10.93 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.484 -0.487 . . . . 0.0 111.965 -173.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.554 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 18.6 p-10 -61.16 -9.54 4.94 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 -172.465 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 1.4 m -114.26 145.26 41.98 Favored 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 120.222 -0.591 . . . . 0.0 111.129 179.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.508 ' O ' ' HA ' ' A' ' 81' ' ' THR . 40.8 tp -138.81 101.64 4.36 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.674 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 26.2 m -94.28 102.48 14.48 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.801 0.334 . . . . 0.0 110.348 -179.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -119.05 163.14 17.42 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.955 -178.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.416 HD23 ' HA ' ' A' ' 79' ' ' THR . 96.2 mt -112.12 129.64 56.16 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.458 178.329 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.437 HG22 HD13 ' A' ' 80' ' ' LEU . 34.2 m -119.35 141.76 37.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.788 177.17 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.406 ' O ' ' HA ' ' A' ' 14' ' ' THR . . . -111.57 177.47 18.93 Favored Glycine 0 N--CA 1.443 -0.837 0 C-N-CA 120.373 -0.918 . . . . 0.0 111.685 -177.327 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.437 HG23 ' HA ' ' A' ' 76' ' ' ASN . 40.2 p -87.59 131.98 34.22 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 120.866 0.365 . . . . 0.0 110.044 176.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.51 ' HG ' ' H ' ' A' ' 109' ' ' HIS . 33.1 tp -60.44 133.94 56.58 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.663 -176.125 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -60.36 -34.19 73.5 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.326 178.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.51 ' H ' ' HG ' ' A' ' 107' ' ' LEU . 96.3 m-70 -85.03 108.93 17.86 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.538 178.224 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -98.45 40.89 1.16 Allowed 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 179.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . 0.485 ' O ' ' HB2' ' A' ' 112' ' ' HIS . 30.4 m170 67.88 -169.79 0.19 Allowed 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.192 -176.159 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . 0.485 ' HB2' ' O ' ' A' ' 111' ' ' HIS . 45.2 m-70 77.31 -4.45 2.31 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.516 0.726 . . . . 0.0 110.644 -176.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 78.4 m-70 -150.42 136.55 18.59 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.442 176.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 31.0 t-80 . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.836 -0.602 . . . . 0.0 109.508 177.903 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.479 ' HA ' ' OD1' ' A' ' 32' ' ' ASN . 87.1 mtp . . . . . 0 N--CA 1.48 1.049 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.432 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 7.7 tt -144.14 141.67 18.68 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.257 -179.008 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.486 ' HD3' ' HD3' ' A' ' 33' ' ' LYS . 3.6 Cg_exo -82.11 122.69 3.82 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 122.919 2.413 . . . . 0.0 111.068 172.63 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -111.57 95.01 5.25 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 -179.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.484 HD22 HD23 ' A' ' 57' ' ' LEU . 87.5 mt -79.83 108.73 13.62 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.56 -175.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.416 ' HA ' ' HD2' ' A' ' 7' ' ' PRO . 60.3 t -116.15 109.41 44.62 Favored Pre-proline 0 C--N 1.321 -0.647 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.097 -177.311 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.501 ' HD2' ' O ' ' A' ' 97' ' ' ASN . 28.4 Cg_endo -66.21 102.47 0.57 Allowed 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 122.219 1.946 . . . . 0.0 109.929 167.3 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 15.1 t -78.64 -55.78 9.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.674 -169.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 50.7 m -150.28 155.84 40.44 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.982 0.42 . . . . 0.0 111.172 -177.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 55.2 tp -119.27 107.35 13.3 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.21 177.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.7 p -117.76 146.17 38.22 Favored Pre-proline 0 C--N 1.32 -0.68 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.524 -175.297 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -79.55 164.16 82.64 Favored 'Cis proline' 0 CA--C 1.53 0.289 0 C-N-CA 123.153 -1.603 . . . . 0.0 112.639 -0.009 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 34.8 m -80.16 -22.03 11.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.043 0.449 . . . . 0.0 110.887 -179.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.574 ' HB ' ' HA ' ' A' ' 107' ' ' LEU . 23.2 p -114.5 130.43 56.74 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.741 174.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.9 m -113.48 157.48 14.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.257 0.551 . . . . 0.0 112.153 -171.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.712 HG22 HD22 ' A' ' 107' ' ' LEU . 21.3 t -92.64 107.22 22.51 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.148 -177.714 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.572 ' HA ' ' HB3' ' A' ' 71' ' ' LEU . 7.1 Cg_exo -74.21 9.9 1.63 Allowed 'Trans proline' 0 CA--C 1.531 0.373 0 C-N-CA 123.492 2.795 . . . . 0.0 114.497 -171.391 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -127.51 27.88 5.75 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.711 0.291 . . . . 0.0 111.574 -177.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 15.0 t -167.94 167.77 12.56 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.244 179.323 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.531 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 58.2 t -79.94 124.46 38.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 174.684 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.473 HD22 ' N ' ' A' ' 21' ' ' ASN . 0.9 OUTLIER -100.14 117.79 35.12 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.908 0.385 . . . . 0.0 110.244 -175.249 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.494 HG22 ' HB3' ' A' ' 66' ' ' ASP . 6.9 m -83.21 83.85 7.71 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 173.566 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.521 ' O ' ' HA ' ' A' ' 66' ' ' ASP . 71.8 mtp -82.31 142.36 32.12 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.899 -174.024 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.483 HG23 ' HB2' ' A' ' 64' ' ' ASN . 26.5 m -106.93 110.52 22.7 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.094 -175.695 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.605 ' HB3' ' HB ' ' A' ' 65' ' ' VAL . . . -91.76 122.21 34.1 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 172.389 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 24.4 m -91.24 104.67 17.19 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.236 -177.233 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 15.5 mm -102.04 117.1 46.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 179.444 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.569 ' HG2' ' HB3' ' A' ' 62' ' ' SER . 53.0 mt-10 -109.6 139.7 44.3 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.945 0.403 . . . . 0.0 110.862 179.652 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.539 ' HB2' ' HG ' ' A' ' 57' ' ' LEU . 32.5 t30 -92.31 93.88 8.87 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.766 175.264 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 83.0 mm-40 -90.06 52.1 2.2 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.683 0.754 . . . . 0.0 110.236 -178.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -144.07 157.48 27.13 Favored Glycine 0 N--CA 1.441 -0.977 0 N-CA-C 110.353 -1.099 . . . . 0.0 110.353 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.479 ' OD1' ' HA ' ' A' ' 1' ' ' MET . 33.8 p-10 -85.63 5.18 32.97 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.896 0.379 . . . . 0.0 111.76 -173.4 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.486 ' HD3' ' HD3' ' A' ' 3' ' ' PRO . 63.6 tttp -116.43 135.07 54.16 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 173.645 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -71.53 139.89 49.69 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.833 0.349 . . . . 0.0 110.161 -179.052 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.423 ' CB ' HD21 ' A' ' 5' ' ' LEU . 35.7 t -94.94 139.38 31.41 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.722 -177.026 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 24.3 p -83.45 -165.27 1.06 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.472 177.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 26.1 t -57.29 131.6 50.51 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.923 0.392 . . . . 0.0 110.943 178.08 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.421 ' CE2' HG23 ' A' ' 40' ' ' VAL . 31.3 p90 -142.46 148.62 38.03 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.395 177.211 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.465 ' O ' ' HA ' ' A' ' 85' ' ' ASP . 65.8 t30 -104.34 112.9 26.12 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.307 -172.013 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.587 HG22 ' HA ' ' A' ' 84' ' ' VAL . 2.2 t -102.77 123.47 56.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.035 0.445 . . . . 0.0 110.503 -175.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 11.2 t -114.17 144.32 43.38 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.553 -175.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.421 HD11 ' HB3' ' A' ' 80' ' ' LEU . 51.2 tp -105.9 112.58 25.69 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.232 178.414 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.8 mp -101.21 127.25 47.88 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.635 179.11 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.545 HG22 ' HG ' ' A' ' 80' ' ' LEU . 92.3 t -110.7 104.2 16.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 -177.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 64.49 19.2 11.72 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.049 0.452 . . . . 0.0 110.555 -176.15 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 117.74 -27.08 7.7 Favored Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.995 178.074 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.528 HG23 ' O ' ' A' ' 44' ' ' VAL . 0.1 OUTLIER -91.94 136.58 24.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.425 0.631 . . . . 0.0 112.385 -174.832 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 88.8 t -78.59 105.84 8.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.325 179.054 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 22.8 m -86.81 -40.64 14.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.588 179.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -155.29 154.95 32.89 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.714 0.292 . . . . 0.0 110.47 -178.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 13.6 m -143.4 130.29 20.5 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.028 -174.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -119.87 124.56 46.35 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.239 -179.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.427 ' HA ' ' HA ' ' A' ' 39' ' ' ASN . 15.5 m -90.92 116.02 28.41 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.912 0.387 . . . . 0.0 110.181 177.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.431 HG13 HG21 ' A' ' 63' ' ' THR . 43.0 t -82.34 140.32 16.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.987 -178.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 28.6 m -71.59 -43.35 66.42 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.82 0.343 . . . . 0.0 111.194 -177.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 32.6 t -173.14 146.94 1.52 Allowed 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 -177.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.539 ' HG ' ' HB2' ' A' ' 29' ' ' ASN . 31.5 tp -128.51 107.13 9.47 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.314 0.578 . . . . 0.0 109.963 178.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -75.34 163.04 27.87 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.986 -173.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 13.4 m -64.71 132.12 48.75 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.439 178.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 42.7 mm-40 67.12 9.41 6.91 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.522 -179.557 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -101.14 148.52 24.99 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.449 -0.342 . . . . 0.0 110.188 179.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.569 ' HB3' ' HG2' ' A' ' 28' ' ' GLU . 33.5 p -113.9 131.01 56.44 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.9 176.203 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.431 HG21 HG13 ' A' ' 54' ' ' VAL . 54.0 m -107.51 125.66 51.55 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 120.955 0.407 . . . . 0.0 110.084 175.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.483 ' HB2' HG23 ' A' ' 24' ' ' THR . 5.0 p-10 -80.34 114.76 19.47 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.093 177.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.605 ' HB ' ' HB3' ' A' ' 25' ' ' ALA . 21.9 t -96.7 105.89 17.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.773 178.227 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.521 ' HA ' ' O ' ' A' ' 23' ' ' MET . 41.8 m-20 -99.81 111.34 23.66 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.468 -175.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.474 ' O ' ' HA ' ' A' ' 22' ' ' THR . 72.1 m-85 -91.79 158.57 16.27 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.914 -176.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 30.8 m-70 -110.13 88.22 2.7 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.428 178.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 13.2 t90 -117.33 113.8 22.66 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.102 -175.332 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.531 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 5.7 t -80.12 120.49 24.33 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 171.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.572 ' HB3' ' HA ' ' A' ' 17' ' ' PRO . 0.2 OUTLIER -65.9 -45.03 83.48 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.598 -170.047 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.439 ' HB3' ' O ' ' A' ' 71' ' ' LEU . 20.9 t70 73.0 -54.27 0.7 Allowed 'General case' 0 N--CA 1.469 0.498 0 O-C-N 123.968 0.792 . . . . 0.0 110.503 -174.268 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 90.93 51.98 2.51 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 121.059 -0.591 . . . . 0.0 111.997 179.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -84.75 -38.67 19.37 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.139 0.495 . . . . 0.0 110.509 -179.23 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -134.93 171.13 14.84 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.919 -177.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.412 ' O ' HG23 ' A' ' 106' ' ' THR . 28.2 p-10 -79.15 -15.17 58.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.379 -178.309 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.489 ' HB3' ' CD2' ' A' ' 103' ' ' LEU . 44.2 m -154.87 147.74 24.51 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.717 0.294 . . . . 0.0 110.765 -177.733 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -126.99 142.66 51.49 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.215 178.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 5.7 m -90.58 90.95 8.21 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.769 0.319 . . . . 0.0 110.428 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.554 HD13 HG22 ' A' ' 104' ' ' VAL . 10.9 mp -91.64 116.22 28.7 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.354 0.597 . . . . 0.0 111.172 -176.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.46 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 52.9 m -113.75 118.86 35.48 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.473 -179.5 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.486 ' HB ' ' HB3' ' A' ' 100' ' ' LEU . 60.3 t -88.1 106.91 16.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.617 176.359 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -100.29 110.92 23.17 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 177.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.587 ' HA ' HG22 ' A' ' 40' ' ' VAL . 69.7 t -76.04 110.38 11.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.902 -179.102 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.465 ' HA ' ' O ' ' A' ' 39' ' ' ASN . 1.8 t70 56.52 94.97 0.05 OUTLIER Pre-proline 0 N--CA 1.465 0.29 0 CA-C-N 114.32 -1.309 . . . . 0.0 112.035 178.622 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -60.15 -24.74 77.94 Favored 'Trans proline' 0 N--CA 1.473 0.289 0 C-N-CA 123.369 2.713 . . . . 0.0 112.806 -178.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -92.12 -18.0 24.16 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.207 -179.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 25.6 m120 53.08 54.97 9.54 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.818 -171.034 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.85 -40.07 94.05 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.999 -178.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 41.0 t -83.71 139.36 17.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.79 178.334 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 60.9 t30 -75.09 95.04 2.99 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 175.234 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.411 ' CD ' HD21 ' A' ' 98' ' ' ASN . 20.5 mt-10 -93.88 177.18 6.08 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.28 -173.529 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -58.14 -100.78 0.01 OUTLIER Glycine 0 CA--C 1.521 0.432 0 CA-C-N 115.341 -0.845 . . . . 0.0 113.063 175.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 55.6 t30 -117.32 145.12 44.22 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.746 0.308 . . . . 0.0 110.242 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.638 ' HA ' ' OD1' ' A' ' 98' ' ' ASN . 42.3 mt-10 -75.43 -12.91 60.34 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.013 0.435 . . . . 0.0 111.567 -174.352 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 16.4 m -69.62 -9.57 54.67 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.793 -178.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.501 ' O ' ' HD2' ' A' ' 7' ' ' PRO . 2.6 p-10 -117.78 10.64 13.34 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.906 -0.318 . . . . 0.0 111.458 177.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.638 ' OD1' ' HA ' ' A' ' 95' ' ' GLU . 7.5 m120 -76.42 -27.69 56.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.859 0.361 . . . . 0.0 110.764 177.361 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -103.75 122.66 45.55 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.718 -179.484 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.486 ' HB3' ' HB ' ' A' ' 82' ' ' VAL . 38.5 tp -109.32 100.17 9.33 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.89 173.353 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 41.5 m -87.58 97.39 10.83 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.218 0.533 . . . . 0.0 110.371 179.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -113.28 107.39 15.82 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.964 179.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.489 ' CD2' ' HB3' ' A' ' 77' ' ' SER . 5.0 tt -83.81 105.67 14.89 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 108.806 -0.812 . . . . 0.0 108.806 -178.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.554 HG22 HD13 ' A' ' 80' ' ' LEU . 21.2 m -89.64 144.13 9.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.614 -174.562 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -107.38 -179.03 22.47 Favored Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 120.793 -0.718 . . . . 0.0 111.31 -179.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.412 HG23 ' O ' ' A' ' 76' ' ' ASN . 23.0 p -83.43 153.36 24.53 Favored 'General case' 0 C--N 1.315 -0.904 0 C-N-CA 120.904 -0.318 . . . . 0.0 110.481 178.738 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.712 HD22 HG22 ' A' ' 16' ' ' VAL . 19.2 tp -50.18 123.62 8.74 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.954 -178.235 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.425 ' HG3' ' H ' ' A' ' 108' ' ' GLU . 0.0 OUTLIER -65.39 -35.07 79.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.418 -175.425 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 77.6 m80 -126.28 108.58 11.4 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 172.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 22.4 t-80 -53.21 -32.34 47.63 Favored 'General case' 0 N--CA 1.464 0.269 0 O-C-N 123.798 0.686 . . . . 0.0 111.104 -173.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 2.8 m170 -138.2 118.74 13.89 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.964 171.028 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 10.0 m-70 -76.27 116.15 16.68 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.841 -179.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 69.2 m80 -80.19 -12.0 59.68 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.018 -178.213 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 64.9 t60 . . . . . 0 C--O 1.246 0.918 0 CA-C-N 115.332 -0.849 . . . . 0.0 108.936 172.187 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.503 ' O ' ' HD2' ' A' ' 33' ' ' LYS . 71.4 mtm . . . . . 0 N--CA 1.481 1.117 0 CA-C-O 120.885 0.374 . . . . 0.0 110.923 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.415 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 6.6 tt -114.25 142.54 28.19 Favored Pre-proline 0 C--N 1.319 -0.729 0 C-N-CA 120.596 -0.441 . . . . 0.0 110.158 179.612 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.451 ' HD2' ' O ' ' A' ' 91' ' ' ASN . 3.3 Cg_exo -84.26 156.94 12.86 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.804 2.336 . . . . 0.0 111.34 171.447 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -138.75 108.67 6.32 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 174.305 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.533 HD22 HD23 ' A' ' 57' ' ' LEU . 69.4 mt -99.81 126.96 45.98 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -173.422 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.441 HG22 ' ND2' ' A' ' 97' ' ' ASN . 2.4 t -125.36 140.39 36.12 Favored Pre-proline 0 C--N 1.317 -0.844 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.332 -176.234 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.443 ' HB2' ' HB2' ' A' ' 100' ' ' LEU . 9.3 Cg_endo -92.8 93.31 0.16 Allowed 'Trans proline' 0 N--CA 1.445 -1.367 0 C-N-CA 122.952 2.435 . . . . 0.0 109.758 166.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 28.3 m -83.84 -12.88 11.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-N 115.869 -0.605 . . . . 0.0 112.313 -169.233 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 31.4 t -163.43 143.42 8.71 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.124 0.487 . . . . 0.0 111.723 -176.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 62.7 tp -127.8 126.93 42.63 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.065 175.09 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.0 p -137.7 145.28 48.04 Favored Pre-proline 0 C--N 1.32 -0.709 0 CA-C-N 116.572 -0.286 . . . . 0.0 110.813 -177.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.493 ' HD2' ' SD ' ' A' ' 23' ' ' MET . 98.3 Cg_endo -80.23 163.02 82.89 Favored 'Cis proline' 0 N--CA 1.465 -0.199 0 C-N-CA 123.369 -1.513 . . . . 0.0 112.719 -1.555 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 24.5 m -85.51 -15.26 10.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.152 0.501 . . . . 0.0 110.565 177.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.567 ' HA ' ' O ' ' A' ' 105' ' ' GLY . 0.1 OUTLIER -131.61 124.94 30.98 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.647 174.718 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.411 HG12 ' HG2' ' A' ' 12' ' ' PRO . 20.5 m -114.57 150.47 16.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.625 -0.261 . . . . 0.0 111.141 -174.064 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.411 ' HA ' ' HD3' ' A' ' 17' ' ' PRO . 6.2 m -88.53 121.55 70.05 Favored Pre-proline 0 N--CA 1.445 -0.685 0 CA-C-O 120.957 0.408 . . . . 0.0 110.194 176.289 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.467 ' HA ' ' CB ' ' A' ' 71' ' ' LEU . 17.6 Cg_exo -68.04 172.51 10.77 Favored 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 122.497 2.132 . . . . 0.0 112.59 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 43.8 m-80 71.93 25.06 3.16 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.274 175.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 12.9 t -175.69 175.62 2.03 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.654 -0.248 . . . . 0.0 110.386 177.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.814 HG22 ' HB ' ' A' ' 70' ' ' THR . 44.4 t -91.24 135.37 27.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.343 178.51 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 21.7 m-80 -108.71 149.88 28.37 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.467 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.9 m -83.05 91.02 7.11 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.258 179.444 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.526 ' HB2' ' HB2' ' A' ' 67' ' ' PHE . 89.8 mmm -81.6 109.75 16.33 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.372 0.606 . . . . 0.0 110.246 -178.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 25.5 m -103.26 110.15 22.02 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.474 -177.491 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -101.33 120.13 39.79 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.072 178.062 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 28.5 m -85.88 104.43 15.53 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.62 -178.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.423 HG12 HG23 ' A' ' 65' ' ' VAL . 23.3 mm -98.5 119.35 46.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 178.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -120.55 139.18 53.31 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.425 -175.174 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.474 ' O ' ' HA ' ' A' ' 60' ' ' GLU . 54.8 t-20 -91.87 99.72 12.53 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 178.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -102.14 52.25 0.81 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.651 0.738 . . . . 0.0 110.418 -176.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -143.94 175.81 23.61 Favored Glycine 0 N--CA 1.446 -0.634 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.093 179.042 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -99.8 45.49 0.99 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.287 0.565 . . . . 0.0 111.402 -173.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.503 ' HD2' ' O ' ' A' ' 1' ' ' MET . 50.3 tttm -161.49 157.06 24.38 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.254 169.167 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.486 ' N ' ' HG2' ' A' ' 33' ' ' LYS . 8.7 p-10 -68.42 165.13 19.48 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.06 173.553 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.474 ' OG ' ' HB3' ' A' ' 57' ' ' LEU . 10.0 p -129.99 134.4 47.41 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.925 0.393 . . . . 0.0 110.703 178.164 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 11.3 p -80.66 -167.59 1.43 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.322 -177.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 18.8 t -62.61 120.78 11.82 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.058 0.456 . . . . 0.0 111.109 -177.06 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -131.46 160.19 35.87 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.685 178.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -106.08 125.63 51.23 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 121.277 -0.169 . . . . 0.0 110.617 -176.219 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.573 HG11 HG21 ' A' ' 65' ' ' VAL . 1.4 t -111.49 123.85 67.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.156 0.503 . . . . 0.0 110.546 178.216 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 18.2 m -117.83 145.5 44.51 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.912 -176.184 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 49.7 tp -104.04 108.87 20.42 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.853 176.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.7 mp -98.45 112.73 24.66 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.201 -179.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 87.8 t -97.12 107.08 19.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.113 179.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 59.08 22.21 10.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.656 178.026 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 116.36 -25.19 9.37 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.598 -0.81 . . . . 0.0 112.953 176.358 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 8.8 mt -96.39 151.31 4.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 -178.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 47.5 t -97.2 109.69 23.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 110.094 -0.335 . . . . 0.0 110.094 -178.503 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 28.1 m -87.18 -29.72 5.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 C-N-CA 120.904 -0.318 . . . . 0.0 111.502 -177.26 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -158.0 159.56 36.55 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.836 0.35 . . . . 0.0 110.537 -179.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 95.9 m -149.81 126.87 11.23 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.986 -178.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -125.04 122.85 38.42 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.93 0.395 . . . . 0.0 109.988 179.182 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 19.5 m -80.09 130.88 35.58 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.056 177.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 42.6 t -98.16 131.72 44.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.2 m -61.55 -47.0 87.55 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.717 -177.093 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 29.8 t -179.98 152.8 0.48 Allowed 'General case' 0 C--O 1.235 0.293 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 -178.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.533 HD23 HD22 ' A' ' 5' ' ' LEU . 40.3 tp -129.75 125.68 36.4 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.057 0.456 . . . . 0.0 110.323 178.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -76.56 160.2 29.65 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.042 -176.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 10.5 m -60.31 120.18 9.35 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.259 -177.26 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.474 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 44.2 mt-10 60.81 25.53 15.41 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.325 177.585 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -101.24 160.96 13.96 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 171.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -122.31 119.03 29.91 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 -176.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 54.1 m -111.5 127.17 55.62 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.072 0.463 . . . . 0.0 110.719 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -86.76 134.89 33.54 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.54 179.5 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.573 HG21 HG11 ' A' ' 40' ' ' VAL . 28.2 t -96.16 133.55 36.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.154 179.544 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -97.75 97.0 8.63 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.297 -177.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.526 ' HB2' ' HB2' ' A' ' 23' ' ' MET . 21.3 m-85 -97.66 152.38 19.15 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.669 178.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 17.1 m80 -120.77 93.7 4.12 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 178.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 24.0 t90 -114.83 118.58 33.95 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.319 -174.084 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.814 ' HB ' HG22 ' A' ' 20' ' ' VAL . 15.1 t -89.73 144.85 25.64 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.433 179.46 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.467 ' CB ' ' HA ' ' A' ' 17' ' ' PRO . 3.1 mm? -110.47 127.46 55.15 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.94 0.4 . . . . 0.0 111.763 179.554 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 -90.39 -28.3 18.76 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.682 172.133 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 87.44 33.91 11.07 Favored Glycine 0 N--CA 1.448 -0.517 0 N-CA-C 111.226 -0.75 . . . . 0.0 111.226 -175.268 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.63 -33.03 74.15 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.229 0.538 . . . . 0.0 110.711 -178.607 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -141.27 155.54 45.98 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.237 -178.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -67.89 -30.97 70.45 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.426 178.003 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 19.5 m -136.85 135.96 38.35 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.073 0.464 . . . . 0.0 110.898 -179.025 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -112.48 146.46 38.42 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.12 178.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.488 ' HA ' HD23 ' A' ' 103' ' ' LEU . 6.6 m -95.43 87.61 4.83 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.885 0.374 . . . . 0.0 110.499 -178.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.513 HD13 HG22 ' A' ' 104' ' ' VAL . 9.4 mp -87.7 120.16 28.74 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.184 0.516 . . . . 0.0 111.272 -176.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.58 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 73.5 m -119.64 115.7 24.49 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.606 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 46.5 t -88.16 107.8 17.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.648 175.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -97.97 117.15 31.68 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.847 0.356 . . . . 0.0 110.075 176.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.542 ' HB ' ' HB2' ' A' ' 98' ' ' ASN . 94.7 t -85.71 109.01 17.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.957 -179.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 39.2 t0 65.68 91.91 0.07 OUTLIER Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 114.583 -1.189 . . . . 0.0 112.002 178.221 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -89.52 6.23 4.47 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 123.021 2.481 . . . . 0.0 111.714 174.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -110.76 -8.98 14.51 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.38 -178.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 5.3 m120 56.64 53.9 7.93 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.266 178.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -88.91 -35.3 16.58 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.55 176.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 61.6 t -108.76 119.73 58.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.439 -0.801 . . . . 0.0 109.882 176.016 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.451 ' O ' ' HD2' ' A' ' 3' ' ' PRO . 53.4 m-80 -74.12 124.19 25.85 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.443 179.212 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.492 ' HB2' ' HA ' ' A' ' 95' ' ' GLU . 0.4 OUTLIER -95.93 150.51 20.36 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.587 -175.543 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -57.78 -100.87 0.01 OUTLIER Glycine 0 CA--C 1.52 0.359 0 CA-C-N 115.068 -0.969 . . . . 0.0 112.734 172.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.467 ' HB3' ' OD1' ' A' ' 97' ' ' ASN . 11.1 t30 -65.33 -24.15 67.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.644 0.259 . . . . 0.0 110.491 -177.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.492 ' HA ' ' HB2' ' A' ' 92' ' ' GLU . 29.5 tt0 76.02 -63.0 0.41 Allowed 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 168.329 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 37.0 m -64.83 -4.93 4.92 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -171.034 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.467 ' OD1' ' HB3' ' A' ' 94' ' ' ASN . 4.0 p-10 -96.01 11.06 35.4 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.808 178.4 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.542 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 24.4 p-10 -85.0 3.02 40.51 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.92 0.39 . . . . 0.0 110.487 179.031 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -119.31 118.32 30.92 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 121.215 0.531 . . . . 0.0 111.575 -178.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.58 ' O ' ' HA ' ' A' ' 81' ' ' THR . 25.2 tp -108.46 99.39 8.78 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.241 178.568 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 93.1 m -92.15 97.75 11.11 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 121.155 0.503 . . . . 0.0 109.717 175.304 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -114.88 126.37 54.72 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.344 -177.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.488 HD23 ' HA ' ' A' ' 79' ' ' THR . 51.2 mt -78.93 115.88 18.9 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.214 0.531 . . . . 0.0 110.573 177.641 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.513 HG22 HD13 ' A' ' 80' ' ' LEU . 23.0 m -106.36 144.56 15.39 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.01 178.279 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.567 ' O ' ' HA ' ' A' ' 14' ' ' THR . . . -118.96 169.9 13.69 Favored Glycine 0 N--CA 1.437 -1.255 0 C-N-CA 120.004 -1.094 . . . . 0.0 111.271 -177.366 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 41.6 p -77.06 129.88 36.66 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 173.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.629 ' HG ' ' H ' ' A' ' 109' ' ' HIS . 42.7 tp -57.06 129.15 40.47 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.19 -176.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.52 8.98 6.61 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.497 0.665 . . . . 0.0 110.86 -176.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.629 ' H ' ' HG ' ' A' ' 107' ' ' LEU . 73.3 m80 -136.21 173.85 11.26 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.989 -1.005 . . . . 0.0 108.49 172.465 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 41.1 m80 -123.55 19.3 9.6 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.04 0.448 . . . . 0.0 111.43 -177.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -125.4 93.88 3.99 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.958 174.024 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 47.7 t-80 -91.14 86.16 6.12 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 179.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 18.7 t60 -98.24 126.21 43.63 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.449 -176.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 85.1 t60 . . . . . 0 C--O 1.246 0.884 0 CA-C-O 118.532 -0.747 . . . . 0.0 109.474 178.158 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.416 ' O ' ' HD2' ' A' ' 33' ' ' LYS . 84.7 mtp . . . . . 0 N--CA 1.477 0.916 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.459 HG13 ' HD2' ' A' ' 3' ' ' PRO . 18.3 tt -114.39 142.58 28.34 Favored Pre-proline 0 C--N 1.321 -0.664 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 178.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.53 ' HD3' ' HD3' ' A' ' 33' ' ' LYS . 58.2 Cg_endo -76.0 157.1 38.68 Favored 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 122.453 2.102 . . . . 0.0 112.325 176.2 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -146.05 100.12 3.35 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 179.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.539 HD22 HD23 ' A' ' 57' ' ' LEU . 41.0 mt -99.88 126.76 46.06 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-O 121.545 0.688 . . . . 0.0 109.265 -170.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 6.0 t -125.46 140.37 36.17 Favored Pre-proline 0 N--CA 1.441 -0.92 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.638 -175.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.458 ' HB2' ' HB2' ' A' ' 100' ' ' LEU . 1.1 Cg_endo -87.34 107.09 0.65 Allowed 'Trans proline' 0 N--CA 1.446 -1.29 0 C-N-CA 122.815 2.343 . . . . 0.0 109.63 166.489 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.9 t -76.91 -60.23 2.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.566 -170.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 9.5 t -154.65 154.97 33.82 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 177.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.411 ' HA ' ' O ' ' A' ' 24' ' ' THR . 1.8 pp -127.95 127.49 43.38 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.399 0.618 . . . . 0.0 110.117 177.064 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.6 p -121.63 131.66 24.39 Favored Pre-proline 0 C--N 1.311 -1.075 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.792 -175.526 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.413 ' HD2' ' SD ' ' A' ' 23' ' ' MET . 84.4 Cg_endo -90.55 175.1 20.41 Favored 'Cis proline' 0 N--CA 1.461 -0.392 0 C-N-CA 123.539 -1.442 . . . . 0.0 113.5 8.723 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.5 m -99.25 -11.98 8.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.087 0.47 . . . . 0.0 111.274 178.2 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -120.09 151.0 39.69 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 174.26 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 20.9 m -143.29 157.36 17.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.029 0.442 . . . . 0.0 111.475 -177.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.4 ' HA ' ' HD3' ' A' ' 17' ' ' PRO . 2.8 m -99.11 144.13 27.66 Favored Pre-proline 0 N--CA 1.448 -0.564 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.114 178.606 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.531 ' HA ' ' CB ' ' A' ' 71' ' ' LEU . 2.9 Cg_endo -82.64 165.5 15.87 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.868 2.378 . . . . 0.0 112.589 178.79 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 34.9 m-80 71.87 24.2 3.4 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.639 175.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.5 t -163.52 162.91 24.79 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.983 -0.287 . . . . 0.0 110.592 -178.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 1.005 HG22 ' HB ' ' A' ' 70' ' ' THR . 21.2 t -94.56 130.81 42.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 175.464 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -119.65 152.63 36.79 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.273 179.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 90.9 m -96.83 109.22 21.96 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.332 -178.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.55 ' HB2' ' HB2' ' A' ' 67' ' ' PHE . 83.4 mmm -92.42 123.74 35.95 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.669 178.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.486 ' HA ' ' O ' ' A' ' 65' ' ' VAL . 19.3 m -106.87 103.06 12.4 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.637 0.256 . . . . 0.0 111.259 -177.577 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -97.75 123.12 41.55 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.494 176.28 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 18.8 m -87.81 121.29 30.05 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 120.813 0.34 . . . . 0.0 110.589 178.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 24.6 mm -106.88 116.37 50.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 179.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -110.27 128.91 55.77 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.918 0.389 . . . . 0.0 110.659 -178.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.431 ' ND2' ' HA ' ' A' ' 59' ' ' SER . 26.1 t30 -88.62 96.08 10.5 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.467 177.437 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 -92.74 43.98 1.14 Allowed 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.634 -174.522 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -144.08 150.13 22.17 Favored Glycine 0 N--CA 1.447 -0.582 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 179.157 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 16.1 t30 -84.47 62.77 7.46 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.497 0.665 . . . . 0.0 111.567 -172.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.53 ' HD3' ' HD3' ' A' ' 3' ' ' PRO . 62.3 tttp -161.46 136.84 7.63 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.321 166.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -72.16 114.39 10.23 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 177.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 16.1 p -83.56 144.77 29.26 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.054 0.454 . . . . 0.0 110.856 -178.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 3.1 p -83.4 -169.63 2.64 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.557 -178.154 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 33.0 t -54.76 132.63 46.37 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.577 -178.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 55.1 p90 -143.98 159.22 42.97 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.947 178.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 21.0 m-80 -109.04 110.5 21.79 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.483 0.182 . . . . 0.0 111.273 -175.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.487 HG22 ' HA ' ' A' ' 84' ' ' VAL . 1.5 t -98.43 124.85 51.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.271 0.558 . . . . 0.0 109.926 -179.594 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 18.7 m -120.56 148.18 44.2 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.047 -174.453 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 50.4 tp -102.21 117.36 34.59 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.787 177.106 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.574 ' HG ' HG22 ' A' ' 48' ' ' VAL . 5.0 mp -100.34 126.69 46.72 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.81 179.486 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 99.5 t -106.08 103.12 14.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 120.815 0.34 . . . . 0.0 110.201 179.366 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.489 ' HA ' ' HB ' ' A' ' 79' ' ' THR . 8.7 m-20 62.62 13.09 6.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.352 -0.84 . . . . 0.0 112.095 176.665 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 138.38 -38.63 1.67 Allowed Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.604 -0.808 . . . . 0.0 113.306 176.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 8.3 mt -98.19 150.8 4.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 120.77 0.319 . . . . 0.0 110.537 -174.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.574 HG22 ' HG ' ' A' ' 43' ' ' LEU . 55.9 t -87.43 127.17 40.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 -179.724 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 18.4 m -99.84 -39.34 7.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 111.852 0.316 . . . . 0.0 111.852 179.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -149.44 149.49 30.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.736 0.303 . . . . 0.0 110.936 -176.117 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 95.9 m -133.96 128.27 34.11 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.52 -178.157 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -118.97 119.28 33.85 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 177.637 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 25.6 m -80.9 126.42 31.34 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.362 178.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 47.7 t -96.6 128.92 47.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 178.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.8 p -56.4 -43.6 79.47 Favored 'General case' 0 C--N 1.329 -0.324 0 O-C-N 123.355 0.409 . . . . 0.0 111.957 -177.069 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 17.2 p -178.08 155.22 0.93 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.393 179.149 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.672 HD13 HG23 ' A' ' 63' ' ' THR . 17.4 tp -130.42 109.26 10.59 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.07 0.462 . . . . 0.0 109.783 177.44 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -63.98 160.86 16.92 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.41 -176.241 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.431 ' HA ' ' ND2' ' A' ' 29' ' ' ASN . 4.4 p -61.9 125.73 24.88 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.122 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 61.23 35.93 18.11 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.436 -179.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 13.5 m-80 -121.32 162.09 20.9 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.04 176.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 3.5 p -132.55 127.82 35.92 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.025 0.44 . . . . 0.0 111.54 -178.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.672 HG23 HD13 ' A' ' 57' ' ' LEU . 17.6 p -104.22 153.29 21.15 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.455 177.628 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -104.29 125.12 50.28 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 176.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.486 ' O ' ' HA ' ' A' ' 24' ' ' THR . 59.3 t -96.14 128.66 47.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-O 121.169 0.509 . . . . 0.0 110.963 -175.071 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -95.61 97.21 9.57 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.368 -177.097 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.55 ' HB2' ' HB2' ' A' ' 23' ' ' MET . 26.3 m-85 -92.26 147.18 23.13 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.212 0.529 . . . . 0.0 111.443 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 7.2 m80 -114.93 98.25 6.71 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.041 179.189 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 20.4 t90 -122.78 122.21 38.16 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.064 0.459 . . . . 0.0 111.444 -174.163 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 1.005 ' HB ' HG22 ' A' ' 20' ' ' VAL . 8.4 t -105.61 141.29 37.32 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.261 177.657 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.531 ' CB ' ' HA ' ' A' ' 17' ' ' PRO . 1.7 mm? -100.89 119.23 38.39 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.112 0.482 . . . . 0.0 111.038 176.348 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -84.37 -25.14 29.34 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.054 176.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -153.19 -155.21 7.04 Favored Glycine 0 N--CA 1.445 -0.731 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.856 -177.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 2.8 t -145.74 90.91 2.04 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-O 121.934 0.874 . . . . 0.0 111.267 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -80.87 2.45 26.47 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.882 172.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.487 ' O ' ' HA2' ' A' ' 105' ' ' GLY . 95.5 m-20 70.83 -59.11 0.55 Allowed 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.803 179.447 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 41.0 t -104.3 114.21 28.29 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 120.888 0.375 . . . . 0.0 110.415 -178.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.423 ' HB2' HG23 ' A' ' 104' ' ' VAL . 65.1 m-85 -116.92 134.0 55.31 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.323 179.105 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.489 ' HB ' ' HA ' ' A' ' 45' ' ' ASP . 7.3 m -96.69 88.05 4.52 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.911 0.386 . . . . 0.0 110.478 -177.014 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.41 HD22 HG11 ' A' ' 104' ' ' VAL . 8.1 mp -87.58 113.59 23.41 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.611 0.719 . . . . 0.0 110.56 -178.169 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.532 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 25.8 m -115.33 123.28 48.32 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.418 -177.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 49.5 t -90.17 112.03 24.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 176.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -108.19 117.76 34.98 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 175.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.614 ' HB ' ' HB2' ' A' ' 98' ' ' ASN . 84.8 t -83.57 103.37 10.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.995 -177.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.9 t70 59.81 89.54 0.1 Allowed Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 114.266 -1.334 . . . . 0.0 112.347 177.103 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -70.78 -12.46 30.99 Favored 'Trans proline' 0 C--O 1.232 0.215 0 C-N-CA 123.33 2.687 . . . . 0.0 112.217 179.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -89.73 -6.5 55.99 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.464 -178.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . 0.404 HD22 ' HA ' ' A' ' 88' ' ' ASN . 2.8 t-20 58.41 42.1 21.82 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.61 177.402 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -69.26 -26.79 64.94 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.334 178.05 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 61.4 t -110.6 122.63 65.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.681 176.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 54.0 t30 -80.86 130.4 35.03 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 176.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -125.65 159.92 30.99 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.948 0.404 . . . . 0.0 112.008 -173.076 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -58.3 -100.81 0.01 OUTLIER Glycine 0 CA--C 1.522 0.489 0 CA-C-N 114.948 -1.024 . . . . 0.0 113.818 174.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -58.24 160.51 5.02 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 122.972 0.509 . . . . 0.0 111.452 -177.117 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.2 2.68 24.91 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 121.144 0.497 . . . . 0.0 111.413 -175.722 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 18.3 m -125.8 24.33 7.11 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.0 0.428 . . . . 0.0 110.465 -179.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 26.4 p-10 -98.09 -39.94 8.66 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.705 -174.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.614 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 23.9 p-10 -83.77 10.68 8.9 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.316 0.488 . . . . 0.0 112.316 -168.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 2.6 m -119.32 150.12 40.67 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.981 0.419 . . . . 0.0 110.643 -179.237 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.532 ' O ' ' HA ' ' A' ' 81' ' ' THR . 54.2 tp -148.52 106.59 3.72 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.649 178.565 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 31.0 m -93.51 98.65 11.32 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 120.9 0.381 . . . . 0.0 110.222 177.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -109.46 118.98 38.06 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.374 -179.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.44 HD22 ' HA ' ' A' ' 103' ' ' LEU . 1.8 tm? -81.47 111.24 17.63 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.161 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.423 HG23 ' HB2' ' A' ' 78' ' ' TYR . 21.5 m -103.38 162.85 3.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -179.302 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.487 ' HA2' ' O ' ' A' ' 76' ' ' ASN . . . -131.87 167.08 22.91 Favored Glycine 0 N--CA 1.439 -1.102 0 C-N-CA 119.858 -1.163 . . . . 0.0 111.955 -178.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 22.4 p -84.26 131.52 34.73 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 173.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 36.5 tp -55.02 117.88 3.84 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.634 -174.366 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.24 -25.01 62.3 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.957 -176.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 57.4 m80 -68.87 115.44 8.2 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 170.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 29.3 m-70 -108.73 91.42 3.63 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.069 0.461 . . . . 0.0 110.264 -177.224 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 -125.14 109.82 13.35 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.269 179.153 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 89.6 m-70 -91.16 -78.85 0.38 Allowed 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 172.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 89.6 m-70 -139.35 21.01 2.58 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.705 0.764 . . . . 0.0 109.285 173.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.245 0.839 0 CA-C-N 114.704 -1.134 . . . . 0.0 109.403 178.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 90.7 mtp . . . . . 0 N--CA 1.481 1.076 0 CA-C-O 120.914 0.388 . . . . 0.0 110.214 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 13.3 tt -137.31 143.38 41.25 Favored Pre-proline 0 C--N 1.32 -0.691 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -68.69 155.95 67.1 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 121.947 1.764 . . . . 0.0 111.484 176.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -147.51 76.78 1.41 Allowed 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 176.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.741 ' HG ' ' OE1' ' A' ' 92' ' ' GLU . 27.1 mt -72.8 103.66 3.74 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 114.948 -1.024 . . . . 0.0 110.856 -176.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.584 HG22 ' HB3' ' A' ' 97' ' ' ASN . 25.7 t -114.68 121.0 36.53 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.923 -177.228 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.509 ' HB2' ' HB2' ' A' ' 100' ' ' LEU . 1.9 Cg_endo -79.03 108.01 2.32 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 122.333 2.022 . . . . 0.0 109.919 171.185 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 27.3 m -93.95 -27.27 4.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 -171.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 60.7 m -146.49 145.04 30.05 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.983 0.421 . . . . 0.0 111.872 -175.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.477 HD23 ' HB3' ' A' ' 102' ' ' ALA . 50.1 tp -130.54 110.53 11.49 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.407 174.046 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.573 ' OG1' ' HA ' ' A' ' 12' ' ' PRO . 5.6 t -128.69 149.56 72.36 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.017 -177.143 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.573 ' HA ' ' OG1' ' A' ' 11' ' ' THR . 82.8 Cg_endo -77.76 154.2 94.41 Favored 'Cis proline' 0 N--CA 1.463 -0.296 0 C-N-CA 123.42 -1.492 . . . . 0.0 112.675 1.722 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.5 m -79.62 -6.64 9.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.13 178.193 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.427 ' HA ' ' O ' ' A' ' 105' ' ' GLY . 1.5 p -130.35 125.51 34.81 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.319 178.323 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.4 m -121.1 158.02 24.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.125 0.488 . . . . 0.0 112.115 -172.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.488 HG22 HD22 ' A' ' 107' ' ' LEU . 41.8 t -80.22 120.56 79.96 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.732 177.748 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.658 ' HA ' ' HG ' ' A' ' 71' ' ' LEU . 2.8 Cg_exo -75.5 59.28 5.47 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 123.193 2.596 . . . . 0.0 113.946 -173.286 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -176.98 -56.88 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.718 0.294 . . . . 0.0 111.506 174.27 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 14.6 t -80.4 178.29 8.4 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.293 -172.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 45.2 t -80.74 124.29 38.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.106 178.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.571 ' ND2' HD23 ' A' ' 71' ' ' LEU . 38.7 m-80 -102.44 135.03 44.8 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.169 -179.308 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 21.2 m -82.9 97.68 8.8 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.033 -0.53 . . . . 0.0 109.95 177.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.553 ' HB2' ' HB2' ' A' ' 67' ' ' PHE . 91.5 mmm -91.56 132.26 36.42 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.269 -176.366 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.508 ' HA ' ' O ' ' A' ' 65' ' ' VAL . 10.4 m -116.27 117.07 29.0 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.638 -178.088 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.414 ' HB3' ' HB ' ' A' ' 65' ' ' VAL . . . -105.58 119.48 39.22 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.265 178.358 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 17.6 m -85.9 110.28 19.31 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.51 -178.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 24.4 mm -102.13 115.67 44.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.21 -179.065 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -103.15 132.74 49.18 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.091 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.458 ' HB2' ' HG ' ' A' ' 57' ' ' LEU . 51.9 t-20 -90.49 101.53 14.27 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 173.304 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 79.2 mm-40 -93.31 33.23 1.24 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.179 -176.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -144.09 166.87 27.0 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.024 -178.269 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -97.5 54.22 1.18 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.448 0.642 . . . . 0.0 111.063 -173.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 73.8 tttt -161.47 144.72 12.51 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.121 172.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.495 ' HB3' ' HA ' ' A' ' 58' ' ' GLU . 1.2 m-20 -89.19 129.71 35.73 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 -177.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 36.9 p -85.07 153.92 22.41 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 110.311 -0.255 . . . . 0.0 110.311 -179.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.407 HG22 ' H ' ' A' ' 37' ' ' SER . 0.2 OUTLIER -85.19 -167.82 1.98 Allowed 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 177.382 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.51 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 39.9 m -60.42 113.47 2.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.955 0.407 . . . . 0.0 110.701 178.692 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.4 ' CE2' HG23 ' A' ' 40' ' ' VAL . 41.4 p90 -124.25 154.21 40.52 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.313 -178.422 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.412 ' O ' ' HD3' ' A' ' 86' ' ' PRO . 79.7 m-20 -100.52 111.37 23.62 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.424 -176.072 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.53 HG11 HG21 ' A' ' 65' ' ' VAL . 1.4 t -98.34 119.11 45.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 176.356 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.447 ' HB3' HG13 ' A' ' 48' ' ' VAL . 41.2 m -113.49 138.15 50.53 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.327 -174.117 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 62.5 tp -97.89 111.82 23.97 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.58 174.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.427 ' HA ' ' O ' ' A' ' 47' ' ' ILE . 5.2 mp -96.9 140.8 30.91 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.024 -179.721 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 91.0 t -122.57 111.56 30.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 173.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 20.0 t70 67.71 -72.78 0.09 Allowed 'General case' 0 N--CA 1.47 0.542 0 O-C-N 124.036 0.835 . . . . 0.0 110.761 -176.06 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -153.08 9.15 0.52 Allowed Glycine 0 N--CA 1.448 -0.564 0 CA-C-N 115.969 -0.559 . . . . 0.0 112.14 177.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.427 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 3.4 mt -110.89 151.2 13.1 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.315 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 -178.603 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.447 HG13 ' HB3' ' A' ' 41' ' ' SER . 45.4 t -99.21 107.19 20.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 173.792 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 29.8 m -77.8 -33.51 18.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.304 -175.258 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -160.01 135.49 8.25 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.273 -179.101 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 95.4 m -120.88 126.41 49.97 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.832 177.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -109.83 123.27 49.27 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.068 178.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 30.3 m -81.25 104.18 11.54 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.249 -0.432 . . . . 0.0 109.905 176.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.51 ' O ' ' HA ' ' A' ' 37' ' ' SER . 21.9 t -81.4 123.26 37.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 178.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 20.9 m -56.14 -42.85 77.58 Favored 'General case' 0 C--N 1.329 -0.3 0 O-C-N 123.458 0.474 . . . . 0.0 111.594 -173.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 50.7 p 179.2 136.89 0.1 Allowed 'General case' 0 C--N 1.33 -0.261 0 O-C-N 123.246 0.341 . . . . 0.0 110.526 174.355 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.576 HD23 HD22 ' A' ' 5' ' ' LEU . 26.7 tp -105.94 110.23 22.43 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.123 0.487 . . . . 0.0 109.762 175.469 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.495 ' HA ' ' HB3' ' A' ' 34' ' ' ASP . 42.7 mt-10 -66.95 160.49 26.24 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.201 -177.044 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 2.7 p -60.73 124.87 21.68 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.372 -178.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 65.03 16.97 10.87 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.527 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -96.17 148.45 22.7 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 178.203 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 17.9 m -111.48 134.52 53.0 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.002 179.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 91.7 m -139.88 129.63 24.55 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.131 0.491 . . . . 0.0 111.123 -179.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -90.31 132.57 35.48 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.627 -179.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.53 HG21 HG11 ' A' ' 40' ' ' VAL . 40.2 t -96.53 133.07 39.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.448 -179.129 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -102.56 105.31 15.8 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.468 -177.251 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.553 ' HB2' ' HB2' ' A' ' 23' ' ' MET . 49.9 m-85 -102.03 147.83 26.1 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.912 179.046 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 35.5 m-70 -115.13 92.41 3.92 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 175.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 14.7 t90 -100.22 105.44 17.01 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.238 -173.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 6.8 m -73.96 108.7 6.94 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.014 171.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.658 ' HG ' ' HA ' ' A' ' 17' ' ' PRO . 0.1 OUTLIER -59.42 -69.13 0.22 Allowed 'General case' 0 C--O 1.234 0.284 0 O-C-N 123.131 0.27 . . . . 0.0 111.517 -172.645 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.446 ' HB3' ' O ' ' A' ' 71' ' ' LEU . 20.0 t70 72.87 -47.37 0.67 Allowed 'General case' 0 N--CA 1.47 0.57 0 O-C-N 123.918 0.761 . . . . 0.0 111.981 -178.126 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.558 ' HA3' ' OH ' ' A' ' 78' ' ' TYR . . . -74.34 -174.52 31.83 Favored Glycine 0 CA--C 1.518 0.244 0 C-N-CA 121.249 -0.501 . . . . 0.0 113.478 -177.511 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 9.5 t -142.43 12.82 1.95 Allowed 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.087 0.47 . . . . 0.0 111.347 -175.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.45 ' HB3' ' CE1' ' A' ' 78' ' ' TYR . . . -71.81 141.49 49.66 Favored 'General case' 0 C--N 1.33 -0.272 0 O-C-N 122.081 -0.387 . . . . 0.0 110.286 -179.446 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.551 ' HA ' HG23 ' A' ' 106' ' ' THR . 25.0 p-10 -77.73 -5.66 51.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.78 0.324 . . . . 0.0 111.514 -175.311 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 43.7 m -150.83 116.01 5.34 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.862 0.363 . . . . 0.0 110.722 -178.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.558 ' OH ' ' HA3' ' A' ' 73' ' ' GLY . 43.0 m-85 -111.47 138.26 48.21 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.89 176.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.405 ' HA ' HD23 ' A' ' 103' ' ' LEU . 37.2 m -92.65 97.97 11.14 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.88 179.133 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.517 HD13 HG22 ' A' ' 104' ' ' VAL . 10.2 mp -97.31 135.79 38.72 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.453 -179.479 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.491 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 27.4 m -130.36 116.96 19.04 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.64 -176.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.425 ' HB ' ' HB3' ' A' ' 100' ' ' LEU . 59.5 t -89.11 104.17 14.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 175.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -99.26 117.6 34.08 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 178.2 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.504 HG23 ' HG3' ' A' ' 7' ' ' PRO . 84.5 t -85.1 106.4 14.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.355 -176.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 51.3 t0 61.6 85.77 0.17 Allowed Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 114.563 -1.199 . . . . 0.0 111.487 178.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.412 ' HD3' ' O ' ' A' ' 39' ' ' ASN . 4.6 Cg_exo -74.91 -7.14 18.96 Favored 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 123.023 2.482 . . . . 0.0 111.715 178.174 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -94.57 -22.62 18.08 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 178.224 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 59.99 69.15 0.72 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.182 -179.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -93.05 -28.76 16.17 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.793 178.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.7 t -106.33 135.15 45.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.31 176.211 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -82.48 112.0 19.01 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.873 0.368 . . . . 0.0 110.008 178.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.766 ' HG3' HD21 ' A' ' 98' ' ' ASN . 66.6 mm-40 -100.43 173.63 6.49 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.478 -176.349 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -57.77 -101.11 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.387 0 CA-C-N 115.255 -0.884 . . . . 0.0 112.485 174.015 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.45 ' O ' ' HB2' ' A' ' 97' ' ' ASN . 60.5 m-20 -96.77 135.31 38.9 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -60.86 -29.24 69.41 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.138 0.494 . . . . 0.0 110.656 177.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 5.3 m -65.85 -19.72 65.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.252 0.548 . . . . 0.0 110.539 178.497 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.584 ' HB3' HG22 ' A' ' 6' ' ' VAL . 7.2 m-20 -81.24 -21.78 39.23 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.788 -178.296 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.766 HD21 ' HG3' ' A' ' 92' ' ' GLU . 16.7 m120 -78.11 -4.74 48.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.403 -177.617 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 3.2 m -110.32 154.74 23.06 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.079 0.466 . . . . 0.0 111.33 -175.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.509 ' HB2' ' HB2' ' A' ' 7' ' ' PRO . 48.8 tp -146.96 103.42 3.61 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.478 175.095 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 7.7 m -90.26 96.2 10.55 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 178.229 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.477 ' HB3' HD23 ' A' ' 10' ' ' LEU . . . -114.95 121.08 42.07 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.162 0.506 . . . . 0.0 110.82 -176.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.405 HD23 ' HA ' ' A' ' 79' ' ' THR . 87.1 mt -86.26 121.21 28.52 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.215 177.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.517 HG22 HD13 ' A' ' 80' ' ' LEU . 18.5 m -111.48 137.26 44.79 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.72 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.427 ' O ' ' HA ' ' A' ' 14' ' ' THR . . . -107.61 -177.78 22.42 Favored Glycine 0 N--CA 1.439 -1.128 0 C-N-CA 120.532 -0.842 . . . . 0.0 111.22 -177.204 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.551 HG23 ' HA ' ' A' ' 76' ' ' ASN . 24.7 p -82.54 153.95 25.28 Favored 'General case' 0 C--N 1.312 -1.056 0 C-N-CA 120.856 -0.338 . . . . 0.0 110.338 178.112 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.488 HD22 HG22 ' A' ' 16' ' ' VAL . 27.1 tp -52.22 119.36 4.31 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.395 179.483 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -58.54 -51.79 68.4 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.861 -176.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 75.2 m80 -87.92 111.04 21.02 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.052 -179.427 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . 0.635 ' HB3' ' HA ' ' A' ' 113' ' ' HIS . 43.5 m80 -74.44 112.63 10.81 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.647 -175.385 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 43.5 t-80 -67.25 -56.27 10.53 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 168.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 7.9 t-80 -96.4 110.85 23.13 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 107.456 -1.312 . . . . 0.0 107.456 167.32 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . 0.635 ' HA ' ' HB3' ' A' ' 110' ' ' HIS . 96.0 m-70 -62.32 -40.72 97.26 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.862 -170.007 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 21.4 p80 . . . . . 0 C--O 1.245 0.855 0 CA-C-O 118.732 -0.652 . . . . 0.0 109.673 178.426 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 84.7 mmm . . . . . 0 N--CA 1.479 1.02 0 CA-C-O 120.66 0.267 . . . . 0.0 110.494 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 13.4 tt -144.14 140.56 17.07 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 116.604 -0.271 . . . . 0.0 110.424 178.61 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.634 ' O ' ' HA ' ' A' ' 92' ' ' GLU . 18.4 Cg_exo -68.54 148.7 73.24 Favored 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.64 2.226 . . . . 0.0 111.203 170.094 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -130.0 93.09 3.42 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 175.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.549 ' HB3' HG11 ' A' ' 84' ' ' VAL . 70.5 mt -76.08 102.18 5.6 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.108 -173.483 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.488 HG22 HD21 ' A' ' 97' ' ' ASN . 60.9 t -107.68 110.41 62.64 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.124 -179.197 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.556 ' HB2' ' HB2' ' A' ' 100' ' ' LEU . 56.8 Cg_endo -73.12 103.51 1.62 Allowed 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 121.898 1.732 . . . . 0.0 109.825 168.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.2 t -79.31 -51.25 16.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.573 -168.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 21.6 t -157.25 176.36 12.82 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.019 0.437 . . . . 0.0 111.028 -178.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 35.6 tp -145.44 104.32 3.9 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.071 -178.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.3 p -112.98 145.52 33.25 Favored Pre-proline 0 C--N 1.321 -0.659 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.431 -175.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -86.0 157.22 56.85 Favored 'Cis proline' 0 N--CA 1.46 -0.474 0 C-N-CA 123.132 -1.612 . . . . 0.0 112.319 -2.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.462 ' HA ' HG12 ' A' ' 104' ' ' VAL . 35.9 m -83.94 13.0 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.25 0.547 . . . . 0.0 110.952 -179.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.704 HG22 ' HA ' ' A' ' 107' ' ' LEU . 0.3 OUTLIER -148.54 119.56 7.68 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 178.311 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.537 HG21 ' CZ3' ' A' ' 69' ' ' TRP . 24.9 m -128.41 153.53 37.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -167.21 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.471 HG22 HD23 ' A' ' 107' ' ' LEU . 7.4 t -76.01 129.77 79.97 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.052 179.086 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.59 ' HA ' ' CB ' ' A' ' 71' ' ' LEU . 6.1 Cg_exo -74.1 -173.88 1.57 Allowed 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 122.643 2.229 . . . . 0.0 111.577 174.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 8.1 p30 51.36 17.26 0.5 Allowed 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.349 1.059 . . . . 0.0 113.844 175.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 15.0 t -150.82 168.7 23.65 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 121.721 -0.612 . . . . 0.0 110.93 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 25.9 t -99.0 112.39 30.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 175.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.449 ' ND2' ' HB ' ' A' ' 15' ' ' VAL . 26.5 p30 -101.62 162.84 12.61 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.049 -175.348 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.465 ' HA ' ' O ' ' A' ' 67' ' ' PHE . 7.9 m -113.48 95.77 5.53 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.006 -179.534 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.485 ' O ' ' HA ' ' A' ' 66' ' ' ASP . 80.0 mtp -92.74 150.56 20.58 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.755 -176.814 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.405 ' HA ' ' O ' ' A' ' 65' ' ' VAL . 3.1 m -118.02 115.91 25.82 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.424 -175.07 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -96.97 134.08 40.8 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.022 0.439 . . . . 0.0 110.457 176.035 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 4.1 m -91.33 100.2 13.04 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.087 179.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 21.9 mm -98.3 111.51 28.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 176.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.526 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 27.7 tt0 -119.19 132.27 55.94 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.149 0.5 . . . . 0.0 111.1 -176.557 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.578 ' HB2' ' HG ' ' A' ' 57' ' ' LEU . 54.2 t-20 -86.81 113.8 22.93 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.858 -179.471 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 83.0 mm-40 -101.13 54.92 0.84 Allowed 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.193 0.521 . . . . 0.0 110.745 179.077 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -143.99 -172.57 14.81 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.777 -0.725 . . . . 0.0 111.755 -177.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 29.9 p-10 -113.4 6.85 17.4 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.846 0.355 . . . . 0.0 111.729 -174.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.404 ' HD3' ' HD3' ' A' ' 3' ' ' PRO . 87.6 tttt -122.33 133.11 54.67 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 171.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -73.87 132.28 42.36 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.504 -179.179 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.491 ' OG ' ' HB3' ' A' ' 57' ' ' LEU . 4.5 p -93.11 138.81 31.21 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.084 0.469 . . . . 0.0 111.151 -178.199 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.0 p -83.1 -165.47 1.09 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.238 -179.23 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.586 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 22.4 m -56.91 121.5 10.04 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.99 0.424 . . . . 0.0 111.624 -179.073 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.46 ' CE2' HG23 ' A' ' 40' ' ' VAL . 31.3 p90 -133.87 153.73 51.54 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.295 -179.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.424 ' O ' ' HD3' ' A' ' 86' ' ' PRO . 89.3 m-20 -94.26 113.84 25.82 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.818 0.342 . . . . 0.0 111.245 -176.115 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.46 HG23 ' CE2' ' A' ' 38' ' ' PHE . 1.5 t -103.56 125.51 58.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.138 0.494 . . . . 0.0 109.815 176.453 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 9.7 m -113.3 139.39 48.88 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.676 -177.046 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 61.1 tp -103.01 116.97 33.55 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 174.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.494 ' HG ' HG22 ' A' ' 48' ' ' VAL . 5.1 mp -105.72 137.89 42.83 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.554 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 78.9 t -100.94 100.29 10.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 171.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 8.7 t70 69.2 -76.12 0.06 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.38 -176.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -136.95 -7.68 1.52 Allowed Glycine 0 CA--C 1.519 0.34 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.885 178.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 6.9 mt -100.03 148.75 6.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 110.029 -0.359 . . . . 0.0 110.029 -178.485 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.494 HG22 ' HG ' ' A' ' 43' ' ' LEU . 48.5 t -97.84 121.08 47.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.413 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 28.3 m -104.05 -28.51 2.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 C-N-CA 120.831 -0.347 . . . . 0.0 111.688 -177.213 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -144.27 150.07 37.3 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 -177.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 24.2 m -149.43 110.55 4.38 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 177.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -114.85 138.15 51.12 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.896 0.379 . . . . 0.0 110.546 -177.274 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 28.9 m -87.18 107.32 18.42 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 173.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.586 ' O ' ' HA ' ' A' ' 37' ' ' SER . 39.0 t -77.64 127.16 38.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 9.6 m -63.07 -39.39 94.56 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.896 -170.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 79.5 p -170.99 161.79 7.02 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.713 0.292 . . . . 0.0 110.52 178.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.578 ' HG ' ' HB2' ' A' ' 29' ' ' ASN . 37.9 tp -142.87 114.09 7.79 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.066 -0.515 . . . . 0.0 109.705 175.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -79.54 157.26 27.44 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.57 -0.741 . . . . 0.0 112.132 -172.126 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 16.5 m -59.63 119.9 8.45 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.362 -179.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.407 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 45.2 mt-10 60.5 28.65 18.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.66 179.072 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -124.9 159.64 30.68 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 172.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.526 ' HA ' ' HA ' ' A' ' 28' ' ' GLU . 33.2 p -112.76 163.86 14.07 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.059 0.457 . . . . 0.0 111.241 -176.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 79.9 m -133.97 124.46 26.36 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.918 173.207 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 31.4 m-80 -80.5 106.08 12.24 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.416 177.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.405 ' O ' ' HA ' ' A' ' 24' ' ' THR . 3.8 t -96.57 115.6 36.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.769 -175.702 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.485 ' HA ' ' O ' ' A' ' 23' ' ' MET . 19.2 m-20 -96.25 118.85 33.64 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.82 0.343 . . . . 0.0 111.223 -179.344 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.465 ' O ' ' HA ' ' A' ' 22' ' ' THR . 84.7 m-85 -102.1 174.27 6.01 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.952 178.401 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 86.3 m-70 -128.45 109.64 11.59 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 176.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . 0.537 ' CZ3' HG21 ' A' ' 15' ' ' VAL . 15.2 t90 -120.05 122.04 40.22 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.251 0.548 . . . . 0.0 111.281 -172.574 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 10.3 m -86.49 113.94 22.83 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.648 178.222 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.59 ' CB ' ' HA ' ' A' ' 17' ' ' PRO . 1.1 mm? -77.7 122.81 25.85 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.115 0.483 . . . . 0.0 111.678 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 16.4 p-10 -87.35 -33.72 19.07 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.154 173.063 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 82.64 19.55 63.55 Favored Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 115.589 -0.732 . . . . 0.0 113.55 172.054 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 30.0 m -70.45 -41.2 73.15 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.095 0.474 . . . . 0.0 110.401 179.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -110.25 157.24 19.67 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.041 176.382 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -97.05 -9.01 28.94 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.195 0.521 . . . . 0.0 109.734 178.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 71.9 p -137.62 110.1 7.47 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.935 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 46.5 m-85 -106.23 138.59 42.14 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.316 0.579 . . . . 0.0 111.095 -179.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.442 ' HA ' HD23 ' A' ' 103' ' ' LEU . 7.7 m -91.31 83.85 5.54 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.208 -0.906 . . . . 0.0 109.6 -179.59 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.435 HD13 HG22 ' A' ' 104' ' ' VAL . 7.9 mp -80.53 120.36 24.4 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.656 0.741 . . . . 0.0 110.267 -178.289 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.582 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 17.1 m -117.99 116.38 26.79 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.24 -173.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.437 ' HB ' ' HB3' ' A' ' 100' ' ' LEU . 92.8 t -87.43 110.98 21.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 177.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -96.57 117.14 30.33 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 175.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.549 HG11 ' HB3' ' A' ' 5' ' ' LEU . 47.5 t -93.47 108.14 20.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.975 -178.828 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 56.8 t0 66.38 95.91 0.05 OUTLIER Pre-proline 0 N--CA 1.466 0.374 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.447 178.005 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.424 ' HD3' ' O ' ' A' ' 39' ' ' ASN . 3.7 Cg_endo -85.1 0.56 8.81 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 123.319 2.679 . . . . 0.0 111.822 178.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -109.3 -14.82 14.39 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.043 -179.038 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . 0.4 HD22 ' HA ' ' A' ' 88' ' ' ASN . 2.1 t-20 57.85 42.7 22.82 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.703 -178.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -80.58 -29.68 36.95 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.911 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 60.5 t -100.22 129.29 51.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.771 -0.649 . . . . 0.0 109.553 175.302 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -73.28 133.13 43.82 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.324 179.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.634 ' HA ' ' O ' ' A' ' 3' ' ' PRO . 0.0 OUTLIER -128.6 164.45 22.83 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.847 -179.544 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -57.72 -101.14 0.01 OUTLIER Glycine 0 CA--C 1.517 0.184 0 CA-C-N 115.251 -0.886 . . . . 0.0 112.999 173.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.495 ' O ' ' HB3' ' A' ' 97' ' ' ASN . 27.8 t-20 -89.38 126.11 35.41 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.868 0.366 . . . . 0.0 110.42 -179.446 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -76.32 -12.58 60.09 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.934 -173.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 22.3 m -92.31 -6.06 51.05 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.563 0.697 . . . . 0.0 109.774 174.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.495 ' HB3' ' O ' ' A' ' 94' ' ' ASN . 1.9 t30 -86.81 -21.66 26.32 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.082 -178.589 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.443 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 16.9 p-10 -74.24 -3.75 31.9 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.976 0.417 . . . . 0.0 111.189 -176.573 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 1.3 m -101.66 149.05 24.53 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.215 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.582 ' O ' ' HA ' ' A' ' 81' ' ' THR . 48.9 tp -136.48 111.6 9.0 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.394 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 6.2 m -90.43 89.86 7.77 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.941 178.07 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -102.69 112.02 24.6 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.04 0.448 . . . . 0.0 110.794 -177.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.442 HD23 ' HA ' ' A' ' 79' ' ' THR . 61.7 mt -83.79 116.24 22.62 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.44 178.606 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.462 HG12 ' HA ' ' A' ' 13' ' ' VAL . 17.9 m -118.25 136.26 56.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.176 -177.31 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.514 ' O ' ' HA ' ' A' ' 14' ' ' THR . . . -111.6 173.74 15.99 Favored Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 120.378 -0.915 . . . . 0.0 111.858 -177.515 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 21.0 p -77.97 138.12 38.67 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.329 176.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.704 ' HA ' HG22 ' A' ' 14' ' ' THR . 32.3 tp -63.1 107.31 1.0 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.677 -0.692 . . . . 0.0 112.098 -172.637 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -121.17 90.64 3.36 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.025 174.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 61.6 m-70 -66.25 106.71 1.75 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.778 179.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 2.4 t-80 -74.24 105.01 5.23 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 177.199 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 45.0 m80 -81.31 140.04 35.04 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.761 -170.03 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 7.9 t-80 -97.57 116.63 30.16 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.362 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 37.4 m80 -60.52 -48.1 83.27 Favored 'General case' 0 C--N 1.327 -0.374 0 O-C-N 123.169 0.293 . . . . 0.0 111.238 -173.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 10.6 p80 . . . . . 0 C--O 1.248 0.978 0 CA-C-O 118.054 -0.974 . . . . 0.0 109.745 173.287 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.506 ' HA ' ' OD1' ' A' ' 32' ' ' ASN . 82.8 mtp . . . . . 0 N--CA 1.48 1.032 0 CA-C-O 120.749 0.309 . . . . 0.0 110.22 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.469 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 17.5 tt -144.24 139.54 15.91 Favored Pre-proline 0 C--N 1.322 -0.615 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 -179.697 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.529 ' HD3' ' HD3' ' A' ' 33' ' ' LYS . 15.9 Cg_exo -70.25 159.76 51.93 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 122.611 2.207 . . . . 0.0 112.178 176.245 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -143.62 90.36 2.15 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 176.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.496 HD22 HD23 ' A' ' 57' ' ' LEU . 78.3 mt -85.59 109.82 18.82 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.417 0.627 . . . . 0.0 110.753 -170.013 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.407 ' HA ' ' HD2' ' A' ' 7' ' ' PRO . 45.9 t -114.79 111.29 45.81 Favored Pre-proline 0 C--N 1.32 -0.68 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.602 -175.055 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.505 ' HD2' ' O ' ' A' ' 97' ' ' ASN . 34.2 Cg_endo -68.08 101.66 0.72 Allowed 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 122.2 1.933 . . . . 0.0 109.81 167.113 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.7 t -79.34 -55.37 9.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.441 -169.55 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.3 t -146.21 163.42 35.48 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.54 -174.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 58.8 tp -134.59 104.61 6.14 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.712 -178.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 15.6 p -107.45 143.03 26.38 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.45 -177.153 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -86.25 157.73 55.23 Favored 'Cis proline' 0 N--CA 1.457 -0.624 0 C-N-CA 122.964 -1.682 . . . . 0.0 112.021 -3.556 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 34.9 m -82.69 5.84 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.355 0.597 . . . . 0.0 110.257 178.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.522 ' HA ' ' O ' ' A' ' 105' ' ' GLY . 2.6 m -147.35 116.94 7.06 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 176.065 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.442 HG21 HD21 ' A' ' 71' ' ' LEU . 22.0 m -113.47 152.2 15.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.139 0.495 . . . . 0.0 111.77 -170.61 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.608 HG22 HD22 ' A' ' 107' ' ' LEU . 1.8 t -97.77 115.59 65.75 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.65 178.71 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.523 ' HA ' ' CB ' ' A' ' 71' ' ' LEU . 23.9 Cg_exo -64.93 -175.3 0.36 Allowed 'Trans proline' 0 C--O 1.234 0.277 0 C-N-CA 122.495 2.13 . . . . 0.0 112.564 179.754 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 19.5 m-80 74.25 17.77 3.19 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.474 176.476 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 12.1 t -164.28 166.58 20.8 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 110.532 -0.173 . . . . 0.0 110.532 -177.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.508 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 52.6 t -85.84 109.7 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 172.365 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.669 ' OD1' HD23 ' A' ' 71' ' ' LEU . 9.8 m120 -85.52 125.64 33.22 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.068 -174.054 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 53.3 m -79.19 106.09 10.98 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.572 172.311 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.435 ' SD ' ' HE3' ' A' ' 69' ' ' TRP . 62.1 mtp -104.88 144.13 32.2 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.956 0.407 . . . . 0.0 110.339 -179.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.498 HG23 ' HB3' ' A' ' 64' ' ' ASN . 31.2 m -115.02 111.4 21.05 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.055 -174.666 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.4 ' HB3' ' HB ' ' A' ' 65' ' ' VAL . . . -97.92 118.37 34.33 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 173.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 38.7 m -87.59 107.81 18.77 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 120.878 0.37 . . . . 0.0 110.174 -179.257 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 20.2 mm -103.11 115.13 44.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.863 -179.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.555 ' HG2' ' HB3' ' A' ' 62' ' ' SER . 46.2 mt-10 -104.14 134.07 48.0 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.751 0.31 . . . . 0.0 110.836 177.527 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.493 ' HB2' ' HG ' ' A' ' 57' ' ' LEU . 29.9 t30 -90.44 92.06 8.72 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 173.496 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 80.4 mt-30 -87.86 53.18 2.68 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.615 0.721 . . . . 0.0 110.168 -176.087 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -143.89 160.5 27.76 Favored Glycine 0 N--CA 1.444 -0.829 0 CA-C-N 114.953 -1.022 . . . . 0.0 110.638 179.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.506 ' OD1' ' HA ' ' A' ' 1' ' ' MET . 26.6 p-10 -84.9 -0.88 55.66 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 117.011 0.405 . . . . 0.0 111.91 -171.718 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.529 ' HD3' ' HD3' ' A' ' 3' ' ' PRO . 48.2 tttm -112.59 144.8 41.46 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 176.346 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 -75.15 148.77 39.34 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 176.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 35.7 p -109.12 141.99 40.52 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.95 0.405 . . . . 0.0 110.763 -178.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.9 p -76.61 -164.81 0.45 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.382 -179.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.443 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 16.8 m -65.13 129.66 40.51 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.736 0.303 . . . . 0.0 110.965 -179.16 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.569 ' HB2' ' HB2' ' A' ' 85' ' ' ASP . 49.4 p90 -141.12 152.54 44.82 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.216 179.707 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.457 ' O ' ' HA ' ' A' ' 85' ' ' ASP . 30.1 m-80 -103.35 113.32 26.72 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.561 -175.065 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.503 HG11 HG21 ' A' ' 65' ' ' VAL . 1.4 t -98.36 122.39 49.97 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-O 121.269 0.557 . . . . 0.0 109.659 178.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 10.4 m -115.35 142.79 46.22 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.057 -174.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.49 HD11 ' HB3' ' A' ' 80' ' ' LEU . 45.0 tp -102.49 110.92 23.01 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.816 176.401 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.457 ' HG ' HG22 ' A' ' 48' ' ' VAL . 4.7 mp -98.9 114.58 27.26 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.24 -179.812 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.451 HG22 ' HG ' ' A' ' 80' ' ' LEU . 96.5 t -97.51 105.53 17.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.085 178.65 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 58.74 21.49 8.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.708 177.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 122.42 -33.66 4.08 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.908 176.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 8.5 mt -91.62 150.56 3.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 O-C-N 122.737 -0.272 . . . . 0.0 110.348 -176.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.457 HG22 ' HG ' ' A' ' 43' ' ' LEU . 44.5 t -96.74 118.15 42.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -179.251 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 27.2 m -97.11 -23.23 4.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.608 -177.39 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -153.36 142.34 21.24 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.254 -179.028 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.2 m -133.46 108.26 8.55 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.759 178.121 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -109.19 138.72 45.11 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.235 -175.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 17.3 m -105.61 110.14 22.35 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.912 0.387 . . . . 0.0 111.078 -178.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.443 ' O ' ' HA ' ' A' ' 37' ' ' SER . 45.4 t -77.78 128.74 38.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 176.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 12.3 m -60.22 -42.72 95.78 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.607 -177.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 30.2 t 178.21 129.93 0.06 Allowed 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 -178.058 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.529 HD13 ' OG1' ' A' ' 63' ' ' THR . 24.1 tp -108.51 117.37 33.98 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.159 0.504 . . . . 0.0 110.038 178.676 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -73.0 162.24 29.72 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.494 -175.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 2.9 p -61.5 124.35 20.4 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.329 -0.85 . . . . 0.0 111.352 179.23 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 61.01 28.62 18.4 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.854 179.014 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -108.95 156.78 19.31 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 174.541 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.555 ' HB3' ' HG2' ' A' ' 28' ' ' GLU . 32.5 p -114.09 125.83 54.42 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.535 179.211 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.529 ' OG1' HD13 ' A' ' 57' ' ' LEU . 53.2 m -112.78 129.44 56.43 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.975 0.417 . . . . 0.0 110.149 176.326 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.498 ' HB3' HG23 ' A' ' 24' ' ' THR . 94.1 m-20 -90.19 128.88 36.48 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.704 177.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.503 HG21 HG11 ' A' ' 40' ' ' VAL . 43.9 t -96.09 123.46 48.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.676 -177.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -86.19 97.64 10.47 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.446 -178.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -93.4 141.99 27.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.179 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 7.0 m80 -118.15 96.51 5.36 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . 0.435 ' HE3' ' SD ' ' A' ' 23' ' ' MET . 12.1 t90 -114.43 113.64 24.77 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.271 0.558 . . . . 0.0 110.621 -175.618 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.508 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 6.8 m -78.75 102.32 8.04 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.465 -0.788 . . . . 0.0 110.074 176.573 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.669 HD23 ' OD1' ' A' ' 21' ' ' ASN . 0.5 OUTLIER -61.05 113.9 2.81 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.095 0.474 . . . . 0.0 110.393 178.84 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -79.19 -32.98 44.3 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.569 -0.742 . . . . 0.0 111.075 -175.211 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -160.79 -146.29 4.57 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.05 -178.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 25.9 m -136.09 83.97 2.05 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.152 0.501 . . . . 0.0 110.497 179.253 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.422 ' O ' ' HB2' ' A' ' 76' ' ' ASN . . . -86.86 1.4 52.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.367 178.515 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.545 ' O ' ' HA2' ' A' ' 105' ' ' GLY . 17.0 m120 73.69 -50.4 0.69 Allowed 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.307 0.643 . . . . 0.0 112.229 -179.302 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 16.2 p -132.15 124.53 29.28 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 120.963 0.411 . . . . 0.0 111.708 -179.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -117.24 144.44 44.8 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.083 177.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.557 ' HA ' HD23 ' A' ' 103' ' ' LEU . 28.6 m -94.74 90.17 5.98 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.926 0.394 . . . . 0.0 110.094 -179.378 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.55 HD13 HG22 ' A' ' 104' ' ' VAL . 10.4 mp -94.18 117.23 29.8 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.308 0.575 . . . . 0.0 110.506 -178.093 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.525 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 18.8 m -114.2 119.03 35.65 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.459 -0.792 . . . . 0.0 110.394 -177.077 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 50.6 t -90.56 101.46 12.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 176.192 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -97.79 116.95 31.02 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 177.353 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.595 ' HB ' ' HB2' ' A' ' 98' ' ' ASN . 93.9 t -82.86 105.92 13.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 121.327 0.584 . . . . 0.0 111.264 -177.148 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.569 ' HB2' ' HB2' ' A' ' 38' ' ' PHE . 8.7 t70 54.42 90.86 0.08 OUTLIER Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 114.293 -1.321 . . . . 0.0 111.824 179.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_exo -58.17 -30.49 90.72 Favored 'Trans proline' 0 C--O 1.233 0.254 0 C-N-CA 123.052 2.501 . . . . 0.0 112.032 179.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -71.0 -25.56 62.74 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.093 177.427 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 56.48 44.98 23.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.974 -177.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -65.18 -32.16 73.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.153 -0.931 . . . . 0.0 110.439 -179.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 49.5 t -86.9 123.96 40.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.394 175.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.493 ' O ' ' HD2' ' A' ' 3' ' ' PRO . 3.9 m-20 -77.89 130.95 37.24 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.892 -0.411 . . . . 0.0 109.892 178.678 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -124.09 161.42 25.65 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.75 -173.123 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -58.21 -100.77 0.01 OUTLIER Glycine 0 CA--C 1.521 0.448 0 CA-C-N 115.033 -0.985 . . . . 0.0 112.528 172.171 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -57.94 156.37 9.24 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 176.459 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 -102.46 -24.93 13.78 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.15 0.5 . . . . 0.0 110.965 179.371 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 5.9 p -98.89 21.44 11.55 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.313 0.578 . . . . 0.0 110.972 -177.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.505 ' O ' ' HD2' ' A' ' 7' ' ' PRO . 26.4 p-10 -96.27 -33.82 11.84 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.106 -177.493 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.595 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 19.5 p-10 -83.7 9.77 10.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.968 -169.433 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 1.6 m -117.65 147.42 42.9 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.747 0.308 . . . . 0.0 110.22 177.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.525 ' O ' ' HA ' ' A' ' 81' ' ' THR . 50.2 tp -144.74 98.82 3.25 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.233 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 6.9 m -92.54 104.58 16.87 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.685 177.404 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -126.62 138.2 53.41 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.135 0.493 . . . . 0.0 111.359 -176.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.557 HD23 ' HA ' ' A' ' 79' ' ' THR . 74.0 mt -89.83 124.6 34.81 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.992 175.623 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.55 HG22 HD13 ' A' ' 80' ' ' LEU . 28.3 m -108.97 141.51 24.05 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 176.219 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.545 ' HA2' ' O ' ' A' ' 76' ' ' ASN . . . -102.47 166.72 17.3 Favored Glycine 0 N--CA 1.439 -1.101 0 C-N-CA 120.273 -0.965 . . . . 0.0 111.789 -176.064 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.529 ' OG1' ' HA ' ' A' ' 76' ' ' ASN . 24.5 p -91.85 140.86 29.26 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 173.169 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.608 HD22 HG22 ' A' ' 16' ' ' VAL . 7.7 tp -57.84 133.02 55.06 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 123.378 0.424 . . . . 0.0 111.126 -173.736 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 29.6 mm-40 -51.46 -38.04 51.84 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.061 -0.972 . . . . 0.0 112.058 -179.196 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 60.3 m80 -104.71 94.4 5.27 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -174.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 20.1 t60 -58.12 135.98 57.13 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 163.328 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -44.31 -50.24 9.1 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 123.589 0.556 . . . . 0.0 111.564 -167.054 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 12.1 m170 -114.67 106.83 14.69 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 167.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 58.4 t-80 -107.56 138.0 44.57 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.57 -177.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 54.3 t-80 . . . . . 0 C--O 1.245 0.82 0 CA-C-O 118.435 -0.793 . . . . 0.0 109.879 176.118 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.8 mtt . . . . . 0 N--CA 1.481 1.078 0 CA-C-O 121.152 0.501 . . . . 0.0 110.724 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.529 HG13 ' HD2' ' A' ' 3' ' ' PRO . 4.0 tp -123.25 145.74 47.24 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.09 -179.067 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.529 ' HD2' HG13 ' A' ' 2' ' ' ILE . 11.9 Cg_exo -70.96 177.24 6.63 Favored 'Trans proline' 0 C--O 1.236 0.398 0 C-N-CA 122.498 2.132 . . . . 0.0 112.226 178.108 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.487 ' HB3' ' C ' ' A' ' 30' ' ' GLN . 24.8 t70 -149.14 77.91 1.37 Allowed 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 175.536 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.539 HD22 HD23 ' A' ' 57' ' ' LEU . 83.4 mt -75.36 109.63 9.05 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.932 -176.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 25.8 t -118.79 120.65 31.34 Favored Pre-proline 0 C--N 1.319 -0.744 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.247 -178.476 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.522 ' HB2' ' HB2' ' A' ' 100' ' ' LEU . 5.7 Cg_exo -73.68 111.22 3.24 Favored 'Trans proline' 0 N--CA 1.45 -1.06 0 C-N-CA 121.947 1.765 . . . . 0.0 109.726 172.43 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.0 t -80.55 -57.71 4.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.457 -169.023 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 32.8 t -144.94 167.32 22.92 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.631 -175.267 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 58.5 tp -138.62 114.61 10.1 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.149 -177.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.5 p -125.41 157.93 66.09 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.656 -179.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.63 159.51 96.43 Favored 'Cis proline' 0 N--CA 1.465 -0.185 0 C-N-CA 123.357 -1.518 . . . . 0.0 111.871 -3.356 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 29.7 m -78.31 -19.89 13.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.221 0.534 . . . . 0.0 110.249 -178.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.511 ' HA ' ' O ' ' A' ' 105' ' ' GLY . 17.3 p -124.5 130.61 52.78 Favored 'General case' 0 N--CA 1.437 -1.124 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.993 174.768 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.425 HG11 ' CZ3' ' A' ' 69' ' ' TRP . 31.3 m -113.06 146.56 17.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 120.766 0.317 . . . . 0.0 111.112 -177.02 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.603 HG22 HD22 ' A' ' 107' ' ' LEU . 18.1 t -92.13 113.0 57.76 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 116.633 -0.258 . . . . 0.0 110.963 -175.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.532 ' HA ' ' HB3' ' A' ' 71' ' ' LEU . 4.7 Cg_exo -72.44 97.86 0.9 Allowed 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 122.429 2.086 . . . . 0.0 109.934 173.727 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 -177.49 -46.07 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.417 -169.178 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 14.8 t -148.76 -169.63 3.41 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.954 -175.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.516 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 43.2 t -78.84 128.34 38.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 176.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.417 ' ND2' HD23 ' A' ' 71' ' ' LEU . 23.6 m-80 -102.82 125.19 49.47 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.64 -179.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.5 m -80.16 103.89 10.34 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 178.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.553 ' HB2' ' HB2' ' A' ' 67' ' ' PHE . 95.8 mmm -87.63 133.05 33.88 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.734 -174.694 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.534 ' HA ' ' O ' ' A' ' 65' ' ' VAL . 42.4 m -105.86 109.33 21.24 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.825 -177.719 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.429 ' HB3' ' HB ' ' A' ' 65' ' ' VAL . . . -102.58 112.15 24.78 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.594 174.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 21.8 m -83.48 105.69 14.63 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.077 -178.017 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 21.5 mm -100.51 121.12 50.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 -179.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -113.1 134.78 54.38 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 -179.236 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.499 ' HB2' ' HG ' ' A' ' 57' ' ' LEU . 41.3 t30 -94.48 107.16 19.14 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.05 0.452 . . . . 0.0 109.819 177.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.487 ' C ' ' HB3' ' A' ' 4' ' ' ASP . 73.0 mt-30 -113.89 56.65 0.7 Allowed 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.243 -175.579 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -143.88 -165.65 10.97 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.36 -0.924 . . . . 0.0 112.493 -174.661 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.429 ' N ' HD22 ' A' ' 32' ' ' ASN . 0.9 OUTLIER -93.2 4.0 54.74 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 -169.448 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -155.41 150.19 26.43 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.785 -177.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -73.72 146.45 44.4 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 175.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.491 ' OG ' ' HB3' ' A' ' 57' ' ' LEU . 35.3 p -93.49 149.1 21.5 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.031 0.444 . . . . 0.0 110.807 -179.277 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.435 ' OG1' HG22 ' A' ' 90' ' ' VAL . 38.8 p -86.13 -158.9 0.43 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.885 177.057 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.461 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 37.8 t -69.71 107.95 3.69 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.752 0.31 . . . . 0.0 110.256 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.433 ' HB3' ' CG2' ' A' ' 90' ' ' VAL . 55.7 p90 -118.11 140.37 49.87 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.103 0.477 . . . . 0.0 109.878 179.723 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.514 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 65.3 t30 -90.35 128.37 36.44 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.897 -176.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.539 HG23 ' HA ' ' A' ' 84' ' ' VAL . 0.3 OUTLIER -116.62 136.91 52.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 -175.403 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.406 ' HB3' ' CG1' ' A' ' 48' ' ' VAL . 27.9 m -124.42 135.34 53.19 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.288 -173.467 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 57.8 tp -98.95 112.79 24.8 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.069 0.461 . . . . 0.0 110.168 175.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.552 ' HG ' HG22 ' A' ' 48' ' ' VAL . 5.0 mp -96.59 120.17 36.42 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.579 179.46 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 72.2 t -103.47 109.12 26.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 174.184 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 16.1 t70 74.39 -66.21 0.31 Allowed 'General case' 0 N--CA 1.464 0.273 0 O-C-N 124.188 0.93 . . . . 0.0 110.74 -179.516 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -162.62 14.04 0.12 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 121.144 -0.55 . . . . 0.0 112.682 179.064 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 10.8 mt -131.09 150.81 34.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 -179.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.552 HG22 ' HG ' ' A' ' 43' ' ' LEU . 29.6 t -93.12 94.9 4.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.504 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 32.8 m -70.82 -27.23 29.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.924 -173.355 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -157.93 152.85 25.32 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 178.263 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 25.2 m -139.09 128.71 24.57 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.287 -174.15 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.412 ' O ' HG12 ' A' ' 40' ' ' VAL . 2.5 tt0 -127.38 132.47 50.15 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 179.06 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.514 ' HA ' ' HA ' ' A' ' 39' ' ' ASN . 20.5 m -92.28 122.78 35.07 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 177.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.461 ' O ' ' HA ' ' A' ' 37' ' ' SER . 64.5 t -86.2 127.98 39.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 178.674 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 14.4 m -62.47 -45.35 93.42 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.139 -0.482 . . . . 0.0 112.087 -173.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 36.9 t -178.41 125.77 0.11 Allowed 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -177.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.539 HD23 HD22 ' A' ' 5' ' ' LEU . 25.2 tp -104.55 112.15 25.11 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.546 0.689 . . . . 0.0 110.558 178.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.41 ' HB3' ' HB2' ' A' ' 61' ' ' ASN . 34.5 tt0 -66.13 145.92 55.25 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.679 -179.082 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 5.9 t -64.25 137.96 58.2 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 178.719 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 68.87 9.67 7.5 Favored 'General case' 0 N--CA 1.464 0.231 0 O-C-N 123.741 0.651 . . . . 0.0 111.542 -178.423 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.41 ' HB2' ' HB3' ' A' ' 58' ' ' GLU . 4.7 m-20 -114.38 161.3 18.11 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.885 0.374 . . . . 0.0 110.598 177.768 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.3 m -123.9 124.52 42.82 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.503 179.245 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 54.5 m -104.21 124.02 48.37 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 176.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.469 ' HB3' HG23 ' A' ' 24' ' ' THR . 45.3 m-80 -87.0 126.0 34.45 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 179.599 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.534 ' O ' ' HA ' ' A' ' 24' ' ' THR . 22.1 t -96.07 136.34 27.3 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.828 -178.42 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -111.02 102.86 11.3 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.002 0.43 . . . . 0.0 110.209 -178.108 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.553 ' HB2' ' HB2' ' A' ' 23' ' ' MET . 66.5 m-85 -91.76 144.73 25.2 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.212 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 33.9 m-70 -99.59 87.88 3.69 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.029 179.605 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . 0.425 ' CZ3' HG11 ' A' ' 15' ' ' VAL . 18.2 t90 -108.02 110.45 22.16 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.276 0.56 . . . . 0.0 111.099 -173.827 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.516 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 5.5 m -80.87 122.78 27.64 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.858 177.383 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.532 ' HB3' ' HA ' ' A' ' 17' ' ' PRO . 0.9 OUTLIER -88.04 119.76 28.72 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.217 0.532 . . . . 0.0 112.09 -177.248 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -83.99 -38.69 20.62 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.827 173.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 88.4 24.87 32.43 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 121.017 -0.611 . . . . 0.0 113.501 174.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 85.5 m -64.0 -51.1 65.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.197 0.522 . . . . 0.0 110.985 177.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -110.6 146.91 35.31 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.408 179.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 17.3 p-10 -81.89 -6.91 59.49 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.033 0.444 . . . . 0.0 110.94 -177.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 8.8 t -149.23 124.97 10.48 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 176.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -112.84 156.2 23.32 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.163 0.506 . . . . 0.0 111.542 -177.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.445 ' HA ' HD23 ' A' ' 103' ' ' LEU . 6.0 m -96.78 97.51 9.38 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.279 177.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.519 HD13 HG22 ' A' ' 104' ' ' VAL . 9.4 mp -96.64 117.82 31.81 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.346 0.593 . . . . 0.0 110.592 -177.532 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.574 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 24.7 m -117.08 119.58 35.69 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.372 -177.243 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 39.8 t -94.99 109.6 22.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 177.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -99.03 125.61 44.56 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 120.419 -0.513 . . . . 0.0 110.019 178.129 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.577 ' HB ' ' HB2' ' A' ' 98' ' ' ASN . 96.6 t -98.2 111.35 27.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.917 -176.06 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 24.1 t70 66.89 92.34 0.07 OUTLIER Pre-proline 0 N--CA 1.466 0.341 0 CA-C-N 115.136 -0.938 . . . . 0.0 112.641 177.04 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -101.03 19.83 0.25 Allowed 'Trans proline' 0 N--CA 1.451 -1.008 0 C-N-CA 123.525 2.816 . . . . 0.0 111.718 171.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 58.8 mt-10 -128.17 -7.71 5.37 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.945 -174.282 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 8.1 t30 60.31 47.07 9.42 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.822 0.82 . . . . 0.0 109.882 -175.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -83.91 -37.3 22.54 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 174.075 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.435 HG22 ' OG1' ' A' ' 36' ' ' THR . 21.7 t -120.87 105.79 17.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 114.584 -1.189 . . . . 0.0 108.3 170.036 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -77.49 104.38 7.98 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.003 0.43 . . . . 0.0 110.116 -177.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 50.9 mm-40 -77.91 176.07 9.45 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.814 -177.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -57.91 -100.93 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.725 172.316 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 28.5 p-10 -87.77 174.89 8.11 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 173.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -115.21 24.71 11.43 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.117 0.484 . . . . 0.0 111.122 178.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 41.3 m -110.39 18.63 19.63 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.398 0.618 . . . . 0.0 110.003 175.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 28.3 p-10 -124.29 -24.82 4.22 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.894 -177.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.577 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 26.5 p-10 -86.6 23.57 1.62 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.744 -173.044 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.56 144.64 46.33 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.893 0.378 . . . . 0.0 110.788 -179.611 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.574 ' O ' ' HA ' ' A' ' 81' ' ' THR . 30.0 tp -136.97 115.66 12.08 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.085 178.775 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 15.0 m -104.9 102.45 11.97 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 178.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -121.65 135.35 54.98 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.974 0.416 . . . . 0.0 111.248 -176.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.445 HD23 ' HA ' ' A' ' 79' ' ' THR . 60.9 mt -87.43 125.17 34.12 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.559 175.677 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.519 HG22 HD13 ' A' ' 80' ' ' LEU . 25.6 m -112.64 155.43 13.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 175.666 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.511 ' O ' ' HA ' ' A' ' 14' ' ' THR . . . -120.49 171.34 14.63 Favored Glycine 0 N--CA 1.444 -0.787 0 C-N-CA 120.156 -1.021 . . . . 0.0 111.461 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 32.1 p -76.32 169.05 18.95 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.689 -0.485 . . . . 0.0 109.689 174.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.603 HD22 HG22 ' A' ' 16' ' ' VAL . 29.1 tp -69.02 94.44 0.64 Allowed 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.206 0.527 . . . . 0.0 110.745 -178.455 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -82.66 15.17 2.72 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.672 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 6.0 t-80 -79.43 -4.57 51.74 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 176.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 41.0 m170 -94.55 -6.58 43.34 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.42 173.441 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 4.7 t-160 -90.75 28.75 1.46 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.265 -178.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 32.1 t-80 -74.87 113.86 12.65 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.195 -176.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 28.5 t-80 -86.18 -74.38 0.42 Allowed 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 177.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 92.1 m-70 . . . . . 0 C--O 1.247 0.926 0 CA-C-O 118.384 -0.817 . . . . 0.0 109.021 175.692 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.43 ' O ' ' HD2' ' A' ' 33' ' ' LYS . 26.3 ttt . . . . . 0 N--CA 1.477 0.884 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.485 HG12 ' HD2' ' A' ' 3' ' ' PRO . 6.2 tt -140.09 147.64 51.4 Favored Pre-proline 0 CA--C 1.535 0.386 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 -175.228 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.485 ' HD2' HG12 ' A' ' 2' ' ' ILE . 2.7 Cg_exo -76.04 -174.25 1.99 Allowed 'Trans proline' 0 C--O 1.237 0.45 0 C-N-CA 122.598 2.199 . . . . 0.0 112.128 178.072 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -162.23 75.51 0.45 Allowed 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 179.296 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.421 HD22 HD23 ' A' ' 57' ' ' LEU . 73.3 mt -70.09 103.24 2.24 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.813 -177.592 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.462 ' HA ' ' HD2' ' A' ' 7' ' ' PRO . 42.7 t -110.72 110.47 57.35 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.002 -179.015 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.524 ' HD3' HG21 ' A' ' 84' ' ' VAL . 20.7 Cg_endo -63.85 114.27 2.52 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 122.271 1.981 . . . . 0.0 109.978 168.686 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 6.3 t -89.25 -58.9 3.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.25 -168.613 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.7 p -136.66 154.09 50.73 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.565 -174.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 62.1 tp -130.11 100.1 5.3 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.239 176.056 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.527 HG23 ' HA ' ' A' ' 12' ' ' PRO . 56.6 m -115.61 141.11 26.88 Favored Pre-proline 0 C--N 1.317 -0.84 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.198 -175.13 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.533 ' HG2' HG12 ' A' ' 15' ' ' VAL . 72.1 Cg_endo -83.46 133.79 21.79 Favored 'Cis proline' 0 N--CA 1.461 -0.397 0 C-N-CA 123.383 -1.507 . . . . 0.0 113.244 1.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 35.0 m -65.75 -11.44 12.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.818 175.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.517 ' HA ' ' O ' ' A' ' 105' ' ' GLY . 0.6 OUTLIER -135.39 118.94 16.95 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 175.969 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.533 HG12 ' HG2' ' A' ' 12' ' ' PRO . 27.4 m -113.54 166.0 7.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.828 -170.106 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 1.7 t -108.09 119.72 49.07 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.166 179.107 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.607 ' HD2' ' O ' ' A' ' 111' ' ' HIS . 36.5 Cg_exo -60.94 88.53 0.09 OUTLIER 'Trans proline' 0 C--O 1.236 0.402 0 C-N-CA 122.339 2.026 . . . . 0.0 109.719 167.013 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -158.25 -50.69 0.06 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.954 -167.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 8.9 t -153.76 -169.82 3.39 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.006 -172.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.508 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 39.0 t -77.76 114.24 18.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 174.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.529 ' OD1' HD23 ' A' ' 71' ' ' LEU . 9.6 m120 -86.84 132.81 33.72 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.479 -175.28 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 20.6 m -79.23 93.69 5.29 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.249 177.554 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.549 ' HB2' ' HB2' ' A' ' 67' ' ' PHE . 93.1 mmm -85.67 107.57 17.61 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.795 -178.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 17.7 m -97.96 113.15 24.92 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.819 -176.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -104.29 110.04 22.11 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.98 -0.554 . . . . 0.0 109.959 177.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 24.7 m -87.47 113.91 23.6 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 120.965 0.412 . . . . 0.0 110.324 -178.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 15.9 mm -100.8 122.86 53.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.708 -179.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -115.08 120.57 40.26 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 -179.21 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 32.4 t30 -82.7 98.39 9.04 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 178.276 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -94.18 44.24 1.11 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.353 0.596 . . . . 0.0 110.679 -175.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -143.96 147.97 19.51 Favored Glycine 0 N--CA 1.444 -0.789 0 N-CA-C 111.206 -0.758 . . . . 0.0 111.206 -177.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 14.5 t30 -84.89 61.68 6.98 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.489 0.662 . . . . 0.0 111.399 -172.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.448 ' HD3' ' HD3' ' A' ' 3' ' ' PRO . 54.4 tttm -161.69 156.85 23.57 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 170.311 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -80.7 154.57 27.22 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 120.867 0.365 . . . . 0.0 110.044 175.65 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 22.2 p -124.26 136.46 54.16 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.999 177.032 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 3.7 p -77.08 -166.53 0.72 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.889 179.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.425 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 7.5 t -60.93 113.04 2.31 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.989 0.423 . . . . 0.0 110.494 179.267 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.475 ' HB2' ' HB2' ' A' ' 85' ' ' ASP . 33.9 p90 -118.28 147.52 43.37 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.521 178.676 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.495 ' HB3' ' HD2' ' A' ' 86' ' ' PRO . 51.6 t-20 -90.29 128.59 36.46 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.368 -175.353 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.557 HG11 HG21 ' A' ' 65' ' ' VAL . 2.2 t -118.66 111.87 35.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-O 121.588 0.709 . . . . 0.0 109.821 176.144 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 8.9 m -111.77 143.15 43.17 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.807 -175.05 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 63.6 tp -102.75 113.76 27.44 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 176.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.553 ' HG ' HG22 ' A' ' 48' ' ' VAL . 4.8 mp -102.12 139.77 37.29 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.547 179.445 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 93.4 t -110.47 110.67 33.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 172.113 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 20.1 t70 67.73 -74.0 0.08 Allowed 'General case' 0 N--CA 1.464 0.273 0 O-C-N 124.042 0.839 . . . . 0.0 110.587 -174.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -150.3 6.95 0.71 Allowed Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.903 179.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 6.0 mt -116.85 147.44 20.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 117.104 0.452 . . . . 0.0 109.874 -179.319 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.553 HG22 ' HG ' ' A' ' 43' ' ' LEU . 25.5 t -94.08 114.8 31.44 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.294 -177.658 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 28.5 m -91.03 -30.0 4.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.594 -0.276 . . . . 0.0 111.47 -177.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -148.69 145.48 27.71 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 -178.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 58.3 m -137.51 114.39 10.61 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.909 -176.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -126.18 105.55 8.92 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.06 0.457 . . . . 0.0 110.24 -177.591 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.492 ' HA ' ' HA ' ' A' ' 39' ' ' ASN . 15.2 m -74.18 131.06 40.9 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.934 178.391 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.425 ' O ' ' HA ' ' A' ' 37' ' ' SER . 44.6 t -92.57 139.23 18.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 116.263 -0.426 . . . . 0.0 109.892 -179.146 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 18.6 m -59.55 -53.67 55.42 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.11 -0.495 . . . . 0.0 112.132 -177.038 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 35.3 t -176.81 149.95 0.77 Allowed 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -177.451 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.554 HD13 ' OG1' ' A' ' 63' ' ' THR . 25.2 tp -133.84 133.34 41.46 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.135 0.493 . . . . 0.0 110.424 178.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -89.79 174.62 7.61 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.775 -176.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 3.7 p -69.57 129.18 38.96 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.151 -179.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 50.5 mm-40 66.33 15.63 10.16 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.166 177.09 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -104.21 154.21 20.04 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 -179.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 7.3 m -113.1 143.73 43.84 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.829 0.347 . . . . 0.0 110.774 -178.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.554 ' OG1' HD13 ' A' ' 57' ' ' LEU . 95.6 m -128.86 127.91 42.8 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.078 174.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 40.1 m-80 -90.89 124.96 35.59 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.179 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.557 HG21 HG11 ' A' ' 40' ' ' VAL . 39.2 t -96.19 132.1 41.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.069 -178.335 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -101.81 97.3 7.7 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.525 -174.142 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.549 ' HB2' ' HB2' ' A' ' 23' ' ' MET . 32.2 m-85 -96.01 144.73 26.04 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.179 0.514 . . . . 0.0 111.302 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 15.9 m-70 -116.32 103.0 10.04 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.937 179.127 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . 0.41 ' CE2' HD22 ' A' ' 71' ' ' LEU . 11.3 t90 -116.51 111.2 19.61 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.516 -176.462 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.508 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 6.7 m -80.46 108.17 13.87 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.319 178.459 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.529 HD23 ' OD1' ' A' ' 21' ' ' ASN . 0.2 OUTLIER -69.25 116.02 9.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.953 0.406 . . . . 0.0 111.065 -178.302 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -84.54 -35.65 22.7 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.575 176.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 90.3 35.17 7.63 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.673 177.456 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 25.5 m -79.59 -38.63 33.53 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.023 0.44 . . . . 0.0 110.768 177.276 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -126.28 161.15 28.43 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.46 -174.417 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 -91.07 -12.02 36.94 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.461 178.146 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.562 ' HB2' HD21 ' A' ' 103' ' ' LEU . 28.4 p -147.34 137.83 23.37 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.363 177.685 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 40.3 m-85 -125.73 134.03 51.9 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.144 -178.212 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 21.4 m -89.53 92.92 9.3 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 120.927 0.394 . . . . 0.0 110.059 178.24 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.491 HD13 HG22 ' A' ' 104' ' ' VAL . 9.0 mp -88.37 137.92 31.9 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.194 0.521 . . . . 0.0 110.607 -179.445 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.416 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 19.1 m -131.44 114.56 15.08 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.428 -179.412 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.546 ' HB ' ' HB3' ' A' ' 100' ' ' LEU . 61.8 t -88.39 105.24 15.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 175.101 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -94.61 110.45 22.27 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.006 0.432 . . . . 0.0 110.104 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.524 HG21 ' HD3' ' A' ' 7' ' ' PRO . 85.6 t -83.19 114.47 24.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.341 -177.697 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.475 ' HB2' ' HB2' ' A' ' 38' ' ' PHE . 39.8 t0 58.74 73.66 0.69 Allowed Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 114.232 -1.349 . . . . 0.0 112.089 177.759 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.495 ' HD2' ' HB3' ' A' ' 39' ' ' ASN . 6.6 Cg_exo -74.19 -18.08 21.22 Favored 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 122.758 2.305 . . . . 0.0 111.141 176.301 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -87.77 -13.1 43.23 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.384 -177.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 62.79 45.62 5.62 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.194 177.616 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -77.12 -22.7 52.27 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.316 178.37 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 13.5 t -119.16 143.35 30.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.961 178.153 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 43.0 t-20 -89.54 105.38 17.76 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 178.596 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -98.82 147.21 25.14 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -174.474 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -57.76 -101.1 0.01 OUTLIER Glycine 0 CA--C 1.518 0.243 0 CA-C-N 114.965 -1.016 . . . . 0.0 113.195 174.124 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -73.92 106.54 5.68 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.929 0.395 . . . . 0.0 111.363 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.585 ' HA ' ' OD1' ' A' ' 98' ' ' ASN . 40.8 mt-10 -68.37 -11.71 60.0 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.089 179.418 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 8.1 m -70.82 -7.79 47.83 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.93 177.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.483 ' O ' ' HD2' ' A' ' 7' ' ' PRO . 88.6 m-20 -97.27 -21.73 17.09 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.139 -178.652 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.585 ' OD1' ' HA ' ' A' ' 95' ' ' GLU . 14.3 m120 -59.3 -34.89 72.85 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -172.234 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.49 125.0 49.8 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.258 0.551 . . . . 0.0 112.019 -178.073 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.546 ' HB3' ' HB ' ' A' ' 82' ' ' VAL . 28.5 tp -107.33 98.12 7.79 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.371 175.334 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 20.0 m -90.96 94.66 9.74 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.234 0.54 . . . . 0.0 110.105 -179.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -112.62 112.29 23.71 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.212 -178.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.562 HD21 ' HB2' ' A' ' 77' ' ' SER . 5.9 tt -80.86 104.29 11.27 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 179.681 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.491 HG22 HD13 ' A' ' 80' ' ' LEU . 18.3 m -93.83 149.86 4.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.655 -177.818 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.517 ' O ' ' HA ' ' A' ' 14' ' ' THR . . . -119.72 170.95 14.25 Favored Glycine 0 N--CA 1.443 -0.876 0 C-N-CA 119.941 -1.123 . . . . 0.0 111.876 -176.726 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 42.5 p -89.5 130.22 35.87 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 173.286 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.773 HD23 ' HB2' ' A' ' 110' ' ' HIS . 17.9 tp -56.64 130.22 44.35 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 -175.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -82.17 -55.04 4.79 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.666 -0.414 . . . . 0.0 111.666 -170.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 10.4 t-160 -69.26 -19.33 63.93 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 120.891 0.377 . . . . 0.0 111.137 -177.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . 0.773 ' HB2' HD23 ' A' ' 107' ' ' LEU . 5.3 m-70 -128.15 81.85 2.05 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 169.535 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . 0.607 ' O ' ' HD2' ' A' ' 17' ' ' PRO . 0.8 OUTLIER -92.8 -73.55 0.55 Allowed 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.759 -0.377 . . . . 0.0 111.612 -169.1 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 56.0 t60 -105.2 83.87 2.03 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 119.852 -0.739 . . . . 0.0 110.607 -179.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 43.5 t-80 -79.64 149.47 31.29 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.601 176.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 16.6 p-80 . . . . . 0 C--O 1.244 0.802 0 CA-C-O 118.593 -0.718 . . . . 0.0 109.627 174.235 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 83.0 mmm . . . . . 0 N--CA 1.478 0.928 0 CA-C-O 121.079 0.466 . . . . 0.0 110.106 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.459 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 0.8 OUTLIER -114.48 142.36 28.03 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.455 179.286 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.462 ' HD2' ' O ' ' A' ' 91' ' ' ASN . 12.9 Cg_endo -91.05 156.89 3.9 Favored 'Trans proline' 0 N--CA 1.445 -1.36 0 C-N-CA 122.883 2.388 . . . . 0.0 111.024 172.196 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -137.39 105.23 5.61 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 -179.126 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.531 HD22 HD23 ' A' ' 57' ' ' LEU . 27.4 mt -99.78 126.69 45.89 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 -171.145 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.532 HG22 ' HB3' ' A' ' 97' ' ' ASN . 4.6 t -125.42 140.29 35.94 Favored Pre-proline 0 C--N 1.317 -0.845 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.444 -176.52 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.473 ' HD3' ' O ' ' A' ' 97' ' ' ASN . 6.8 Cg_endo -92.79 100.72 0.17 Allowed 'Trans proline' 0 N--CA 1.445 -1.375 0 C-N-CA 123.13 2.553 . . . . 0.0 110.054 167.514 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 27.4 m -79.53 -28.86 13.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.811 -171.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 35.4 t -156.67 147.54 21.86 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.772 0.32 . . . . 0.0 110.888 -176.452 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.541 HD11 ' HB3' ' A' ' 23' ' ' MET . 19.4 tp -127.68 126.14 41.38 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 171.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.519 ' OG1' ' HA ' ' A' ' 12' ' ' PRO . 6.5 t -122.26 152.05 60.01 Favored Pre-proline 0 C--N 1.317 -0.835 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.912 178.278 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.64 ' HD2' ' SD ' ' A' ' 23' ' ' MET . 98.5 Cg_endo -80.92 149.92 77.75 Favored 'Cis proline' 0 N--CA 1.46 -0.467 0 C-N-CA 123.483 -1.465 . . . . 0.0 112.492 -3.54 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 35.3 m -69.09 -21.57 25.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.059 177.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.558 ' HA ' ' O ' ' A' ' 105' ' ' GLY . 0.7 OUTLIER -124.71 131.19 53.48 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.152 174.288 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.0 m -114.56 149.2 16.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 121.04 0.448 . . . . 0.0 111.789 -174.381 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.9 m -98.34 117.69 64.44 Favored Pre-proline 0 N--CA 1.447 -0.577 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.346 178.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.553 ' HA ' ' HB3' ' A' ' 71' ' ' LEU . 10.0 Cg_exo -71.06 91.31 0.64 Allowed 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 122.597 2.198 . . . . 0.0 110.443 173.139 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -163.23 -41.6 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.216 -171.489 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 13.5 t -145.73 -170.23 3.42 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.001 -172.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.439 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 62.1 t -84.34 116.51 28.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 172.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.587 ' OD1' HD23 ' A' ' 71' ' ' LEU . 9.2 m120 -91.47 118.44 30.56 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.636 -174.177 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.628 ' HA ' ' O ' ' A' ' 67' ' ' PHE . 58.7 m -80.6 96.26 6.79 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-O 121.319 0.581 . . . . 0.0 109.873 177.34 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.64 ' SD ' ' HD2' ' A' ' 12' ' ' PRO . 93.3 mmm -79.14 126.56 30.89 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.478 -176.154 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.49 ' HA ' ' O ' ' A' ' 65' ' ' VAL . 17.5 m -105.07 112.34 25.44 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.975 0.416 . . . . 0.0 111.36 -176.208 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -104.15 130.41 51.89 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.012 176.275 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 23.7 m -95.8 108.34 20.67 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 120.695 0.283 . . . . 0.0 110.431 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.429 ' O ' ' HA ' ' A' ' 62' ' ' SER . 19.7 mm -100.06 119.95 48.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.863 -179.668 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -115.18 136.22 53.34 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.249 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 32.9 t30 -91.89 99.96 12.72 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.305 178.392 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -99.35 45.97 0.98 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.835 -175.281 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -144.01 160.08 27.73 Favored Glycine 0 N--CA 1.449 -0.463 0 N-CA-C 111.533 -0.627 . . . . 0.0 111.533 179.32 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -87.33 56.3 3.91 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.232 0.539 . . . . 0.0 110.924 -174.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.9 tptp -161.64 139.94 9.34 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 174.233 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -76.3 149.73 37.03 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 174.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.3 p -120.49 140.63 51.15 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.929 0.395 . . . . 0.0 110.498 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 3.9 p -91.84 -163.29 1.02 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.017 -178.278 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.557 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 48.5 m -49.03 115.6 1.35 Allowed 'General case' 0 C--O 1.234 0.276 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -179.482 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.463 ' CE2' HG23 ' A' ' 40' ' ' VAL . 30.4 p90 -130.57 149.52 52.2 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.12 177.632 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 11.8 m-80 -98.46 108.6 21.33 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.296 -172.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.463 HG23 ' CE2' ' A' ' 38' ' ' PHE . 2.3 t -98.32 117.88 43.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.401 0.62 . . . . 0.0 110.492 178.333 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 16.9 m -108.28 146.59 32.66 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.957 -176.372 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.42 HD11 ' HB3' ' A' ' 80' ' ' LEU . 47.6 tp -106.82 113.89 27.65 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 174.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.545 ' HG ' HG22 ' A' ' 48' ' ' VAL . 4.8 mp -101.07 121.01 41.03 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.277 -179.552 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 98.0 t -100.54 102.2 13.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 178.166 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 60.75 17.25 7.45 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.708 178.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 128.38 -34.45 2.92 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.943 176.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 11.5 mm -89.99 150.33 3.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.945 0.372 . . . . 0.0 110.209 -176.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.545 HG22 ' HG ' ' A' ' 43' ' ' LEU . 52.4 t -96.98 112.21 28.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 -179.375 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 24.3 m -86.01 -32.85 7.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.382 -177.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 38.4 t0 -159.68 162.32 35.06 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 120.889 0.376 . . . . 0.0 110.645 -178.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 85.0 m -149.81 129.86 13.52 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.785 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -117.69 118.82 33.14 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 110.175 -0.306 . . . . 0.0 110.175 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 27.6 m -74.86 108.35 7.54 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.034 175.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.557 ' O ' ' HA ' ' A' ' 37' ' ' SER . 40.3 t -77.53 128.37 38.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 178.196 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 7.3 m -57.44 -50.14 73.99 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 123.333 0.395 . . . . 0.0 111.763 -173.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 45.7 m -170.8 151.19 3.38 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 -177.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.531 HD23 HD22 ' A' ' 5' ' ' LEU . 23.8 tp -136.97 112.35 9.23 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.145 0.498 . . . . 0.0 110.364 177.73 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 23.9 mm-40 -76.28 174.38 10.24 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.889 -177.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 24.2 m -67.4 129.15 39.0 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.969 -179.069 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.457 ' HG2' ' O ' ' A' ' 60' ' ' GLU . 37.0 tt0 69.61 10.21 7.53 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.136 178.322 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 58.5 t30 -93.34 146.24 23.87 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.542 -0.463 . . . . 0.0 109.839 178.523 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.429 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 9.3 m -119.07 131.43 55.94 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.738 177.631 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.552 HG21 HG11 ' A' ' 54' ' ' VAL . 9.3 t -114.56 139.84 49.26 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.957 0.408 . . . . 0.0 110.42 179.014 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -92.2 114.06 26.5 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.146 178.218 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.49 ' O ' ' HA ' ' A' ' 24' ' ' THR . 10.0 t -96.4 122.88 48.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.582 -179.581 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.581 ' HB3' ' CG2' ' A' ' 22' ' ' THR . 17.3 m-20 -111.78 109.44 19.27 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.012 0.434 . . . . 0.0 110.862 -176.217 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.628 ' O ' ' HA ' ' A' ' 22' ' ' THR . 61.7 m-85 -91.5 163.93 13.98 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.372 -175.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 17.4 m80 -111.92 93.43 4.45 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.34 177.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 15.4 t90 -113.53 110.56 20.46 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.068 0.461 . . . . 0.0 110.679 -176.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.439 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 22.0 m -81.41 112.44 18.68 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.913 176.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.587 HD23 ' OD1' ' A' ' 21' ' ' ASN . 0.3 OUTLIER -71.6 119.52 15.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.121 0.486 . . . . 0.0 111.503 -177.317 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 24.5 p-10 -83.32 -33.58 25.87 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.612 175.209 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 77.38 29.62 55.63 Favored Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.87 174.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 25.6 m -80.05 -51.33 9.16 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.011 0.434 . . . . 0.0 110.501 179.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -105.85 148.29 27.73 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.302 179.372 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 -86.43 -9.19 56.78 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.877 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 24.4 t -137.54 119.51 15.37 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.067 179.37 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -116.58 150.37 38.13 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.956 178.264 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.41 ' HA ' HD23 ' A' ' 103' ' ' LEU . 26.0 m -101.36 89.73 3.86 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.012 179.295 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.484 HD13 HG22 ' A' ' 104' ' ' VAL . 9.2 mp -87.72 114.05 23.96 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.472 0.653 . . . . 0.0 110.493 -178.399 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.564 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 27.1 m -111.69 120.8 43.27 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.381 -177.84 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.467 ' HB ' ' HB3' ' A' ' 100' ' ' LEU . 61.8 t -89.64 103.21 13.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 176.374 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -95.83 114.04 25.74 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 178.234 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.417 ' HA ' HG22 ' A' ' 40' ' ' VAL . 95.7 t -81.02 104.21 9.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.129 -178.48 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.7 t70 53.49 90.85 0.08 OUTLIER Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 114.278 -1.328 . . . . 0.0 112.899 177.407 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -79.22 16.31 1.39 Allowed 'Trans proline' 0 N--CA 1.463 -0.323 0 C-N-CA 123.316 2.677 . . . . 0.0 111.935 177.446 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -116.18 -17.17 10.89 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.264 -177.622 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 12.2 m120 62.94 48.99 3.68 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.587 -178.009 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -66.5 -33.0 74.72 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.404 0.621 . . . . 0.0 109.752 174.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 4.1 t -107.53 169.26 2.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 174.389 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.462 ' O ' ' HD2' ' A' ' 3' ' ' PRO . 65.1 t30 -106.13 93.29 4.54 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 175.778 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 14.9 mp0 -76.51 149.7 36.7 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.772 -173.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -57.41 -100.85 0.01 OUTLIER Glycine 0 CA--C 1.522 0.5 0 CA-C-N 114.655 -1.157 . . . . 0.0 113.472 170.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 16.7 m-80 -84.71 130.72 34.66 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 122.758 -0.26 . . . . 0.0 111.351 -173.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -64.14 -32.12 73.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.076 0.465 . . . . 0.0 110.515 177.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 49.3 m -59.54 -29.41 67.88 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.82 176.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.532 ' HB3' HG22 ' A' ' 6' ' ' VAL . 7.0 m-20 -84.58 -13.25 52.26 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.913 -175.391 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -73.65 -10.67 59.93 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.011 178.203 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 3.7 p -130.8 125.13 32.93 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -173.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.564 ' O ' ' HA ' ' A' ' 81' ' ' THR . 46.1 tp -108.63 102.41 11.47 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.879 169.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 21.8 m -85.11 95.32 9.09 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 175.246 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -111.33 119.72 39.82 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.618 -177.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.41 HD23 ' HA ' ' A' ' 79' ' ' THR . 41.9 mt -82.43 114.99 21.25 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.389 0.614 . . . . 0.0 110.324 176.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.484 HG22 HD13 ' A' ' 80' ' ' LEU . 27.4 m -108.13 140.05 28.03 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.319 178.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.558 ' O ' ' HA ' ' A' ' 14' ' ' THR . . . -116.75 165.35 12.33 Favored Glycine 0 N--CA 1.438 -1.199 0 C-N-CA 120.182 -1.009 . . . . 0.0 111.149 -178.346 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 27.0 p -72.35 137.25 46.48 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 175.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.57 ' HG ' ' H ' ' A' ' 109' ' ' HIS . 49.8 tp -59.31 147.24 36.66 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.917 0.389 . . . . 0.0 110.584 -177.73 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.438 ' O ' ' HB3' ' A' ' 109' ' ' HIS . 34.2 mt-10 -58.48 -34.15 70.57 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.079 -178.431 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.57 ' H ' ' HG ' ' A' ' 107' ' ' LEU . 86.0 t60 69.31 13.77 8.52 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 122.132 0.968 . . . . 0.0 109.197 -179.499 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 21.2 m170 -105.98 140.19 39.36 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.03 -0.986 . . . . 0.0 109.149 179.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 8.8 m-70 -80.13 -10.2 59.75 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.194 0.521 . . . . 0.0 110.467 179.292 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 20.8 m170 -105.13 90.12 3.34 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 167.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 65.7 t-80 -80.53 150.01 29.77 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.628 -173.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 70.6 m80 . . . . . 0 C--O 1.245 0.864 0 CA-C-O 118.91 -0.567 . . . . 0.0 109.585 174.59 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.467 ' O ' ' HD2' ' A' ' 33' ' ' LYS . 58.7 mtm . . . . . 0 N--CA 1.479 1.002 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 7.6 tp -114.46 142.58 28.37 Favored Pre-proline 0 C--N 1.321 -0.662 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 -179.21 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.538 ' HD3' ' HD3' ' A' ' 33' ' ' LYS . 5.4 Cg_exo -75.44 157.08 41.1 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.346 2.031 . . . . 0.0 111.143 174.379 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -140.13 102.76 4.45 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 178.067 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.552 HD22 HD23 ' A' ' 57' ' ' LEU . 25.4 mt -99.74 126.72 45.85 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -172.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.48 ' O ' ' HA ' ' A' ' 27' ' ' ILE . 8.3 t -125.22 140.23 35.61 Favored Pre-proline 0 C--N 1.313 -1.002 0 C-N-CA 119.865 -0.734 . . . . 0.0 110.635 -175.182 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.518 ' HG2' ' HB2' ' A' ' 100' ' ' LEU . 11.8 Cg_endo -96.99 110.05 0.1 Allowed 'Trans proline' 0 N--CA 1.447 -1.212 0 C-N-CA 123.672 2.915 . . . . 0.0 110.478 169.398 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 19.3 m -86.5 -39.14 13.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -169.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 51.0 m -156.37 161.17 40.16 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.723 0.297 . . . . 0.0 111.099 -178.327 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.436 HD11 ' HB3' ' A' ' 23' ' ' MET . 26.9 tp -127.61 126.49 42.16 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 172.403 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.511 HG22 ' HB ' ' A' ' 24' ' ' THR . 0.7 OUTLIER -122.6 131.73 24.35 Favored Pre-proline 0 C--N 1.318 -0.773 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.978 177.101 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.541 ' HD2' ' SD ' ' A' ' 23' ' ' MET . 90.4 Cg_endo -95.2 145.76 7.99 Favored 'Cis proline' 0 N--CA 1.449 -1.125 0 C-N-CA 123.789 -1.338 . . . . 0.0 113.345 5.114 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.432 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 35.4 m -67.37 -18.04 23.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.435 175.713 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.27 151.19 39.53 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 175.645 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 16.4 m -142.93 157.17 17.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.308 0.575 . . . . 0.0 111.346 -174.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.46 ' HA ' ' HD3' ' A' ' 17' ' ' PRO . 14.4 t -99.32 131.95 24.18 Favored Pre-proline 0 C--N 1.321 -0.663 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.647 -175.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 16' ' ' VAL . 1.6 Cg_endo -84.13 18.23 1.57 Allowed 'Trans proline' 0 CA--C 1.529 0.264 0 C-N-CA 122.786 2.324 . . . . 0.0 112.856 179.244 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 56.0 m-20 -106.67 -22.91 12.6 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.669 0.271 . . . . 0.0 111.583 -174.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 8.9 t -145.54 178.23 8.28 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.136 -173.029 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.626 HG22 HG23 ' A' ' 70' ' ' THR . 51.5 t -73.29 141.89 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 172.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.66 ' ND2' HD23 ' A' ' 71' ' ' LEU . 39.7 m-80 -114.41 132.76 56.12 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.361 -173.433 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.7 m -108.19 118.88 37.9 Favored 'General case' 0 N--CA 1.437 -1.089 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 -175.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.541 ' SD ' ' HD2' ' A' ' 12' ' ' PRO . 87.2 mmm -108.93 122.99 48.39 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 113.938 -1.483 . . . . 0.0 109.855 -165.402 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.632 ' HA ' ' O ' ' A' ' 65' ' ' VAL . 17.0 m -111.99 124.44 52.4 Favored 'General case' 0 C--N 1.309 -1.152 0 CA-C-O 121.854 0.835 . . . . 0.0 109.765 -173.749 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -119.16 132.1 55.94 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 114.221 -1.354 . . . . 0.0 108.522 -175.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 19.5 m -112.35 121.01 43.65 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 121.714 0.769 . . . . 0.0 109.61 -171.063 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.48 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 8.7 mm -116.9 131.92 68.16 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 CA-C-N 114.314 -1.312 . . . . 0.0 109.236 -172.325 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -121.0 138.64 54.06 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 178.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.499 ' HB2' ' HG ' ' A' ' 57' ' ' LEU . 39.1 t30 -93.84 98.12 10.86 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 175.168 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 69.5 mt-30 -102.25 47.1 0.9 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.329 -173.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -144.18 154.65 25.83 Favored Glycine 0 N--CA 1.445 -0.743 0 N-CA-C 110.488 -1.045 . . . . 0.0 110.488 177.658 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -82.84 53.79 2.51 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.392 0.615 . . . . 0.0 111.466 -174.016 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.538 ' HD3' ' HD3' ' A' ' 3' ' ' PRO . 87.9 tttt -161.47 136.47 7.4 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 171.5 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -80.34 135.37 36.18 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 120.978 0.418 . . . . 0.0 110.756 -175.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 35.8 t -95.85 142.62 27.89 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.56 178.195 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.405 ' O ' ' HA ' ' A' ' 56' ' ' SER . 2.2 m -99.29 -129.57 0.2 Allowed 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.348 -179.631 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.605 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 48.5 m -82.85 108.8 16.45 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.027 0.441 . . . . 0.0 111.624 -173.641 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.547 ' HB2' ' HB2' ' A' ' 85' ' ' ASP . 52.9 p90 -122.38 146.01 47.73 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.014 177.196 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.485 ' O ' ' HA ' ' A' ' 85' ' ' ASP . 22.0 m-80 -92.56 110.58 22.01 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.794 -174.333 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -98.35 127.11 51.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 -178.46 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 37.0 m -118.72 141.65 48.41 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.297 -174.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 56.4 tp -100.24 111.51 23.79 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.575 173.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.472 ' HG ' HG22 ' A' ' 48' ' ' VAL . 4.9 mp -102.06 124.86 48.4 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.592 -178.031 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.511 HG13 ' HB3' ' A' ' 78' ' ' TYR . 86.2 t -93.68 95.96 5.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 175.485 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 64.03 5.66 2.5 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.96 -179.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 140.56 -34.99 1.92 Allowed Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.406 179.057 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.42 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 9.5 mt -82.36 147.93 5.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 -179.14 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.472 HG22 ' HG ' ' A' ' 43' ' ' LEU . 36.1 t -99.79 119.68 48.17 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.442 -176.724 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 20.3 m -97.6 -27.22 3.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 111.887 0.329 . . . . 0.0 111.887 -177.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 42.2 t0 -162.29 136.49 6.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.655 0.264 . . . . 0.0 110.332 -178.507 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 86.2 m -124.81 122.38 37.27 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.185 179.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -115.11 117.99 32.11 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 -178.445 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.454 ' HA ' ' HA ' ' A' ' 39' ' ' ASN . 22.7 m -82.86 111.18 18.51 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.327 -179.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.605 ' O ' ' HA ' ' A' ' 37' ' ' SER . 59.1 t -77.68 123.12 33.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 179.206 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.4 m -58.43 -39.97 81.24 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.727 -0.669 . . . . 0.0 112.128 -173.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.405 ' HA ' ' O ' ' A' ' 36' ' ' THR . 46.7 t -173.31 143.75 1.12 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.834 0.35 . . . . 0.0 110.486 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.552 HD23 HD22 ' A' ' 5' ' ' LEU . 23.5 tp -126.86 104.31 7.97 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.339 0.59 . . . . 0.0 109.532 175.246 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -70.75 160.68 32.24 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.525 -175.212 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 11.8 m -61.36 120.31 10.19 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.63 179.153 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 70.27 17.34 7.11 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 123.805 0.69 . . . . 0.0 110.889 -179.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -102.1 157.73 16.67 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 173.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 26.3 t -127.61 143.36 51.17 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.119 0.485 . . . . 0.0 110.71 -178.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 91.1 m -124.84 130.52 52.54 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.63 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 37.1 m-80 -101.19 117.7 35.52 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.943 177.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.632 ' O ' ' HA ' ' A' ' 24' ' ' THR . 3.7 t -102.82 125.16 57.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.911 -175.32 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -102.4 112.62 25.42 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.792 0.33 . . . . 0.0 110.914 178.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.402 ' HB2' ' HB2' ' A' ' 23' ' ' MET . 96.0 m-85 -91.62 159.01 16.1 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.953 179.467 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 15.8 m80 -108.64 109.74 21.02 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.727 -179.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 16.2 t90 -131.35 108.16 9.45 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.319 0.581 . . . . 0.0 111.404 -175.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.626 HG23 HG22 ' A' ' 20' ' ' VAL . 5.6 m -85.4 122.14 29.13 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.886 175.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.66 HD23 ' ND2' ' A' ' 21' ' ' ASN . 0.2 OUTLIER -72.3 122.33 20.94 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.19 0.519 . . . . 0.0 111.021 -177.633 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 24.2 p-10 -90.3 -41.62 11.44 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.436 179.058 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 99.07 23.62 11.27 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.81 -0.71 . . . . 0.0 113.204 175.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 92.6 m -74.96 -41.19 60.08 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.023 0.439 . . . . 0.0 110.583 177.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -128.33 162.31 27.37 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.372 178.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -100.71 -6.77 24.57 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.224 0.535 . . . . 0.0 110.183 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 22.7 t -146.95 112.26 5.53 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.508 177.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.511 ' HB3' HG13 ' A' ' 44' ' ' VAL . 83.2 m-85 -105.76 150.21 25.73 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.315 177.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.1 m -93.95 86.97 5.2 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 178.081 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.487 HD22 HG21 ' A' ' 104' ' ' VAL . 6.4 mp -81.43 114.32 20.1 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.714 0.769 . . . . 0.0 110.349 -177.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.513 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 7.3 m -116.94 117.8 30.69 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.475 -175.003 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 46.3 t -85.56 108.04 16.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 176.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.551 ' HA ' ' O ' ' A' ' 98' ' ' ASN . 6.3 t30 -101.64 116.69 33.3 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 178.696 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 58.2 t -82.64 104.42 11.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 115.615 -0.721 . . . . 0.0 111.214 -177.236 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.547 ' HB2' ' HB2' ' A' ' 38' ' ' PHE . 7.3 t70 54.5 89.66 0.1 Allowed Pre-proline 0 N--CA 1.468 0.47 0 CA-C-N 114.234 -1.348 . . . . 0.0 112.308 179.105 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -62.59 -24.43 75.1 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 123.29 2.66 . . . . 0.0 112.215 179.276 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 50.8 mm-40 -75.93 -28.81 58.13 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.812 177.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 56.2 53.84 8.47 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.812 -1.085 . . . . 0.0 109.807 -175.31 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -74.13 -25.04 59.54 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.865 -1.061 . . . . 0.0 109.706 178.24 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 17.3 t -108.31 97.49 5.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.213 -0.903 . . . . 0.0 108.897 174.392 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -61.15 134.31 56.89 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 -178.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.43 ' HA ' ' O ' ' A' ' 3' ' ' PRO . 3.0 mt-10 -111.22 166.22 11.27 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.966 -177.279 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -57.93 -101.04 0.01 OUTLIER Glycine 0 N--CA 1.453 -0.188 0 CA-C-N 115.588 -0.733 . . . . 0.0 112.851 174.044 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 28.4 t30 -70.17 100.74 1.72 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.683 -0.258 . . . . 0.0 110.538 179.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -75.9 53.94 0.79 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.211 0.529 . . . . 0.0 111.997 -177.207 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 13.9 t -137.64 16.1 2.91 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 174.102 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 18.1 p-10 -98.8 -27.27 14.02 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 113.58 -1.645 . . . . 0.0 111.746 -172.448 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.551 ' O ' ' HA ' ' A' ' 83' ' ' ASN . 17.9 m120 -55.13 -34.07 63.43 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 -168.731 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 1.5 p -107.23 123.38 48.21 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 -174.718 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.518 ' HB2' ' HG2' ' A' ' 7' ' ' PRO . 39.2 tp -107.26 106.63 17.17 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 170.17 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 28.3 m -89.96 102.4 15.11 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.669 -177.603 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -119.88 116.93 26.84 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.547 179.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 52.3 mt -74.86 119.03 18.49 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.126 175.535 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.487 HG21 HD22 ' A' ' 80' ' ' LEU . 27.6 m -113.1 133.39 59.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.693 178.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -120.9 166.55 13.95 Favored Glycine 0 N--CA 1.442 -0.956 0 C-N-CA 120.432 -0.89 . . . . 0.0 111.671 -176.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 59.3 p -69.09 146.02 52.92 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 177.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 62.4 tp -53.68 104.51 0.1 Allowed 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -172.37 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -82.71 126.5 32.43 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 107.734 -1.209 . . . . 0.0 107.734 171.073 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -71.55 -23.68 61.8 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -167.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 74.7 m80 -85.82 -72.65 0.48 Allowed 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.943 -0.303 . . . . 0.0 111.466 -176.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 18.4 m170 -87.05 122.8 31.37 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.307 0.575 . . . . 0.0 111.286 -174.008 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 5.4 m-70 -116.27 165.27 13.37 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.321 175.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 15.7 t60 -103.16 73.58 1.24 Allowed 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 172.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 66.0 t60 . . . . . 0 C--O 1.249 1.065 0 CA-C-N 115.173 -0.922 . . . . 0.0 109.19 -175.625 . . . . . . . . 0 0 . 1 stop_ save_